Clustering O 0 3.3206084481207654e-05
of O 0 6.648514272455941e-08
missense O 0 4.581870962283574e-05
mutations O 0 1.3689576917386148e-05
in O 0 3.7490785587124265e-08
the O 0 2.4422402589152625e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 4.912267468171194e-05
in O 0 1.061102761212851e-08
a O 0 1.0104662884202753e-08
sporadic B-Disease 0 0.00022415291459765285
T I-Disease 1 0.9999654293060303
- I-Disease 1 0.9972074627876282
cell I-Disease 0 0.02198866382241249
leukaemia I-Disease 0 0.49347123503685
. O 0 1.654648713156348e-06

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.6256375908851624
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.0148822610366324e-09
is O 0 1.379970582249257e-10
a O 0 5.626567545213845e-10
recessive B-Disease 0 5.97207726968918e-05
multi I-Disease 1 0.9997543692588806
- I-Disease 1 0.9999994039535522
system I-Disease 1 0.52815181016922
disorder I-Disease 1 0.9247451424598694
caused O 0 1.632315260735595e-08
by O 0 6.963844501051142e-10
mutations O 0 2.1862470589439909e-07
in O 0 1.1714925696182377e-09
the O 0 3.737401221837189e-10
ATM O 0 2.1316188281161885e-07
gene O 0 8.957157859867948e-08
at O 0 1.6789252654803022e-08
11q22 O 0 2.5163242298731348e-06
- O 0 2.3374448119284352e-06
q23 O 0 1.4744174450243008e-06
( O 0 3.0877789214400764e-09
ref O 0 4.0641759824211476e-07
. O 0 2.0820953849920443e-09
3 O 0 3.4084202127360186e-09
) O 0 5.3750999207125005e-09
. O 0 5.136977065944848e-08

The O 0 1.0645128867281528e-07
risk O 0 5.4258707677945495e-06
of O 0 9.278694479419869e-10
cancer B-Disease 0 1.0755926496130996e-06
, O 0 9.911503839887814e-10
especially O 0 6.203989766362383e-09
lymphoid B-Disease 0 8.613569093540718e-07
neoplasias I-Disease 0 2.428138213872444e-05
, O 0 2.880087057732794e-09
is O 0 1.3667769138692165e-09
substantially O 0 3.349466126678635e-08
elevated O 0 2.1109538295149832e-07
in O 0 2.0058880068063445e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.00043832079973071814
and O 0 1.4156201766368781e-09
has O 0 1.9154033914503543e-09
long O 0 8.96116958415405e-09
been O 0 1.1087709417267888e-08
associated O 0 2.5059179620257055e-08
with O 0 2.0144207724115404e-07
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.0036599633167498e-05

By O 0 1.9430241593454411e-07
analysing O 0 1.7533466234453954e-05
tumour B-Disease 1 0.9999988079071045
DNA O 0 2.023917431870359e-06
from O 0 1.0260715832544065e-08
patients O 0 4.693741573191801e-08
with O 0 1.1146162881559007e-09
sporadic B-Disease 0 2.846978895831853e-05
T I-Disease 1 0.9999057054519653
- I-Disease 0 0.20909635722637177
cell I-Disease 0 0.0003027473285328597
prolymphocytic I-Disease 0 0.0026569257024675608
leukaemia I-Disease 0 0.009727171622216702
( O 0 1.6696898086365763e-08
T B-Disease 0 3.011983608303126e-05
- I-Disease 0 9.774480531632435e-07
PLL I-Disease 0 1.4987620033934945e-06
) O 0 7.560493897607046e-10
, O 0 4.5143853932838596e-11
a O 0 1.9342213941619946e-10
rare O 0 4.190821467631167e-09
clonal B-Disease 0 5.614871270154254e-07
malignancy I-Disease 0 2.3910781237646006e-05
with O 0 3.484710853207673e-10
similarities O 0 4.327839775442044e-08
to O 0 1.816122474629367e-09
a O 0 2.8393642992341483e-09
mature B-Disease 0 1.9485055702261889e-07
T I-Disease 0 4.1238305129809305e-05
- I-Disease 0 2.9785426249873126e-06
cell I-Disease 0 1.2250357031007297e-06
leukaemia I-Disease 0 2.1967984139337204e-05
seen O 0 3.618746973188536e-07
in O 0 1.905115176725758e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
T I-Disease 1 1.0
, O 0 3.089841049686015e-09
we O 0 5.10231634720526e-10
demonstrate O 0 5.938737834831898e-10
a O 0 1.3680750976519107e-10
high O 0 2.327961157178038e-09
frequency O 0 1.1404247324264816e-08
of O 0 6.556929443846116e-10
ATM O 0 1.928633082570741e-06
mutations O 0 1.5192457567536621e-06
in O 0 3.7672641894914705e-08
T B-Disease 0 0.0008106220629997551
- I-Disease 0 2.9368648029048927e-05
PLL I-Disease 0 0.00012062455789418891
. O 0 6.90839215167216e-07

In O 0 4.108551010517658e-08
marked O 0 1.3895967043708879e-08
contrast O 0 1.1248961762078125e-08
to O 0 4.695384636654865e-10
the O 0 3.328148312498058e-10
ATM O 0 6.32797195976309e-07
mutation O 0 1.746399647117869e-07
pattern O 0 2.367438867167948e-07
in O 0 9.823672826314578e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 1.4673028347900186e-09
the O 0 6.126035789755235e-11
most O 0 1.3984226276964051e-10
frequent O 0 3.047303076542107e-09
nucleotide O 0 4.711231582632536e-08
changes O 0 4.512564988345957e-09
in O 0 5.198486641155853e-10
this O 0 4.019426125267955e-09
leukaemia B-Disease 0 1.7764707081369124e-05
were O 0 5.735260799610842e-08
missense O 0 3.155410377075896e-05
mutations O 0 1.818340751924552e-05
. O 0 6.929216169737629e-07

These O 0 3.232388223750604e-08
clustered O 0 2.0273741085929942e-07
in O 0 4.676269593772986e-09
the O 0 1.2843183183619544e-09
region O 0 7.796729484255138e-09
corresponding O 0 4.664626462869137e-09
to O 0 5.706274341932271e-10
the O 0 3.746843946217382e-10
kinase O 0 1.2751607769700968e-08
domain O 0 5.373275158149227e-09
, O 0 7.619790909352275e-10
which O 0 6.69479027770592e-10
is O 0 2.082237299250167e-10
highly O 0 3.197982156866175e-10
conserved O 0 2.151263389649216e-09
in O 0 6.264809782052794e-10
ATM O 0 9.87217163128662e-07
- O 0 1.8007263236086146e-07
related O 0 5.599954278068253e-09
proteins O 0 1.0942529105051335e-09
in O 0 5.58250445870101e-10
mouse O 0 3.9506424798219086e-08
, O 0 2.017916722607538e-09
yeast O 0 2.010771993354865e-07
and O 0 7.768037768585145e-09
Drosophila O 0 3.358115350238222e-07
. O 0 2.1281292106323235e-07

The O 0 1.3929407316481957e-07
resulting O 0 1.0619616830354062e-07
amino O 0 4.389378887026396e-07
- O 0 8.609068800069508e-07
acid O 0 2.369950280467492e-08
substitutions O 0 3.376932289356205e-09
are O 0 3.842148821320279e-10
predicted O 0 1.1046989101259896e-08
to O 0 3.191316100270569e-10
interfere O 0 2.443744584468277e-08
with O 0 2.3260879888908903e-09
ATP O 0 2.391857663042174e-07
binding O 0 1.4373630108366342e-07
or O 0 2.852115699170099e-08
substrate O 0 2.426093487883918e-06
recognition O 0 9.551187076795031e-07
. O 0 1.7726782743920921e-06

Two O 0 3.744604626376713e-08
of O 0 4.355114047172037e-09
seventeen O 0 1.453812643603669e-07
mutated O 0 1.9217407043470303e-06
T B-Disease 0 2.5028068193932995e-05
- I-Disease 0 2.956052469471615e-07
PLL I-Disease 0 8.769261512497906e-07
samples O 0 1.645516256587598e-08
had O 0 2.3484492128744705e-09
a O 0 3.845447849037953e-10
previously O 0 1.6289509119360446e-07
reported O 0 2.0238041543052532e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
allele O 0 0.00012027574848616496
. O 0 1.1988944379481836e-06

In O 0 4.347986504171786e-08
contrast O 0 7.254931944089549e-08
, O 0 4.299058886658713e-09
no O 0 4.355662053256992e-09
mutations O 0 6.375012873149899e-08
were O 0 3.0064060130285952e-09
detected O 0 1.0380877313309611e-07
in O 0 8.105132121016823e-10
the O 0 4.600178293845403e-10
p53 O 0 1.2602998644695163e-08
gene O 0 8.426015440932133e-09
, O 0 1.807533844822018e-10
suggesting O 0 4.280216181484775e-09
that O 0 2.777183483182455e-10
this O 0 3.0007001328158367e-09
tumour B-Disease 1 1.0
suppressor O 0 1.1018159966624808e-06
is O 0 8.520851579874034e-09
not O 0 1.8081451891305278e-09
frequently O 0 7.662467993441169e-09
altered O 0 6.218363068910548e-08
in O 0 7.480571717621842e-09
this O 0 4.517216822819137e-08
leukaemia B-Disease 0 0.0002037462982116267
. O 0 4.220600260396168e-07

Occasional O 0 7.786168134771287e-05
missense O 0 0.00022249078028835356
mutations O 0 1.3064113772998098e-05
in O 0 1.2929954884555173e-08
ATM O 0 8.974007528195216e-07
were O 0 6.48217390875061e-09
also O 0 1.6274867009613558e-09
found O 0 3.4115421598812645e-09
in O 0 7.96611132614089e-09
tumour B-Disease 1 1.0
DNA O 0 1.067120592779247e-06
from O 0 1.1414295064682278e-09
patients O 0 1.5282591192544714e-08
with O 0 1.1719931691800411e-09
B B-Disease 0 3.208193675163784e-06
- I-Disease 0 2.2558062937605428e-06
cell I-Disease 0 0.0007340263109654188
non I-Disease 1 0.7715567946434021
- I-Disease 1 0.9960086345672607
Hodgkins I-Disease 1 0.999817430973053
lymphomas I-Disease 0 0.0016414555720984936
( O 0 6.104707850340674e-09
B B-Disease 0 3.0180078169905755e-07
- I-Disease 0 1.1262277155310585e-07
NHL I-Disease 0 9.644052667567848e-09
) O 0 2.4532598175142084e-10
and O 0 1.9505667914199165e-10
a O 0 1.7099757165794927e-09
B B-Disease 0 1.162748844762973e-06
- I-Disease 0 5.137986249792448e-07
NHL I-Disease 0 1.6390735879667773e-07
cell O 0 4.273374543117825e-07
line O 0 5.884969027647458e-07
. O 0 2.3109967628442973e-07

The O 0 1.2340908739361112e-08
evidence O 0 6.635109350838775e-09
of O 0 8.163712761355413e-11
a O 0 3.5310773749408497e-10
significant O 0 5.286732829290486e-09
proportion O 0 1.7675316144050157e-07
of O 0 3.581215046732922e-10
loss O 0 3.022267947017099e-07
- O 0 6.601218274226994e-07
of O 0 1.1794337728687765e-09
- O 0 1.8672891428650473e-06
function O 0 9.372079112779375e-09
mutations O 0 7.055082562601456e-08
and O 0 7.704025195565123e-10
a O 0 1.7303196375717533e-10
complete O 0 1.4878531739981327e-09
absence O 0 2.002369825504502e-09
of O 0 1.6853620929402346e-11
the O 0 5.754109341782332e-11
normal O 0 5.522488577547335e-10
copy O 0 3.6158367411331938e-09
of O 0 2.3476226171381676e-11
ATM O 0 1.845828201396671e-08
in O 0 1.915614333825033e-10
the O 0 4.720896451537726e-10
majority O 0 3.8957338688305754e-08
of O 0 6.265434393526448e-09
mutated O 0 0.0018560480093583465
tumours B-Disease 1 1.0
establishes O 0 1.1456197626102949e-06
somatic O 0 8.25806409920915e-07
inactivation O 0 5.5786895245546475e-06
of O 0 1.692591761193185e-10
this O 0 2.0162575775639624e-10
gene O 0 9.1768805887682e-09
in O 0 8.30158275455517e-10
the O 0 1.1276065636778299e-09
pathogenesis O 0 6.106165528763086e-08
of O 0 9.512766130370665e-10
sporadic B-Disease 0 6.070567906135693e-05
T I-Disease 1 0.9994480013847351
- I-Disease 0 0.00017536159430164844
PLL I-Disease 0 5.979553407087224e-06
and O 0 1.9248007632199915e-09
suggests O 0 3.3825666712061775e-09
that O 0 1.1748843564696188e-10
ATM O 0 2.9124876732566918e-08
acts O 0 8.765548287215097e-09
as O 0 5.349367171447739e-09
a O 0 1.0366394320726613e-07
tumour B-Disease 1 0.9999998807907104
suppressor O 0 0.00019878678722307086
. O 0 5.565198080148548e-06

As O 0 3.547106075529882e-08
constitutional O 0 1.0315660325943554e-08
DNA O 0 5.425305005246628e-08
was O 0 1.8162193970994167e-09
not O 0 1.6858676954445428e-10
available O 0 3.785649294041349e-10
, O 0 7.023078646417602e-11
a O 0 7.76492259380035e-10
putative O 0 2.2512158466270193e-06
hereditary O 0 0.0011699782917276025
predisposition O 0 2.6299590899725445e-05
to O 0 2.103135017250679e-07
T B-Disease 0 0.16507507860660553
- I-Disease 0 8.752728717809077e-06
PLL I-Disease 0 5.623479410132859e-06
will O 0 2.7680044922817615e-09
require O 0 3.208394661058378e-09
further O 0 7.199468798901876e-10
investigation O 0 1.0459538124507617e-08
. O 0 6.75916478343197e-09
. O 0 5.697090443845809e-08

Myotonic B-Disease 1 0.9999938011169434
dystrophy I-Disease 1 0.9999096393585205
protein O 0 8.871649697539397e-06
kinase O 0 6.408296940207947e-06
is O 0 4.769783235047953e-09
involved O 0 4.304909317909278e-09
in O 0 2.9276003843392573e-10
the O 0 7.972288801338934e-11
modulation O 0 1.4692583150122118e-08
of O 0 3.723405750388764e-10
the O 0 1.7617047376461414e-08
Ca2 O 0 1.3888308785681147e-05
+ O 0 4.390406047605211e-06
homeostasis O 0 1.2547119695227593e-05
in O 0 6.80902374483594e-08
skeletal O 0 6.647043483098969e-05
muscle O 0 5.257455268292688e-05
cells O 0 8.54567679198226e-06
. O 0 8.568196676606021e-07

Myotonic B-Disease 1 0.999998927116394
dystrophy I-Disease 1 0.9999996423721313
( O 0 1.528347456769552e-05
DM B-Disease 1 1.0
) O 0 2.4558653777262407e-08
, O 0 2.020361100640855e-10
the O 0 4.963645813815809e-11
most O 0 1.5860787128119114e-09
prevalent O 0 1.952011189132463e-06
muscular B-Disease 0 1.0087496775668114e-05
disorder I-Disease 0 0.007711973041296005
in O 0 6.432072652273746e-09
adults O 0 9.355344445793889e-07
, O 0 2.8245372707402794e-09
is O 0 5.164610072938558e-09
caused O 0 7.802591461825159e-09
by O 0 5.296894034501065e-10
( O 0 1.1890515239088018e-09
CTG O 0 3.8252548506534367e-07
) O 0 1.7360360926588214e-09
n O 0 2.2973901536715857e-07
- O 0 8.106961786324973e-07
repeat O 0 2.636918736698135e-07
expansion O 0 5.491191057416245e-09
in O 0 2.4799398645747317e-10
a O 0 1.1374257785634612e-10
gene O 0 3.890400890327328e-09
encoding O 0 6.628683824061454e-09
a O 0 3.1069911088366098e-09
protein O 0 9.034420145326294e-08
kinase O 0 3.151237478959956e-06
( O 0 3.731386044592e-08
DM B-Disease 1 0.9999996423721313
protein O 0 4.5563729145214893e-07
kinase O 0 4.829315685128677e-07
; O 0 4.885969406842605e-09
DMPK O 0 5.194780214878847e-07
) O 0 9.70035163305738e-10
and O 0 3.196847786490764e-10
involves O 0 2.7328148632932425e-09
changes O 0 9.744379525500335e-09
in O 0 1.90325821769477e-09
cytoarchitecture O 0 1.7407373889000155e-06
and O 0 5.171828831862513e-08
ion O 0 3.998632564616855e-06
homeostasis O 0 5.057878661318682e-05
. O 0 1.296444793297269e-06

To O 0 2.020440170724669e-08
obtain O 0 2.7873010566281664e-08
clues O 0 4.636236283772632e-08
to O 0 1.0346907775016234e-09
the O 0 1.9463636258265637e-10
normal O 0 6.368058969030699e-09
biological O 0 3.635811296476277e-08
role O 0 2.1231338465099725e-08
of O 0 5.640041211840696e-10
DMPK O 0 6.758160679964931e-07
in O 0 2.149516120653061e-09
cellular O 0 1.0359535451698321e-07
ion O 0 8.041681809345391e-08
homeostasis O 0 3.8397794810407504e-07
, O 0 1.7294395915357086e-09
we O 0 2.9088775832519786e-09
have O 0 1.0972791564256568e-09
compared O 0 3.237557333335417e-09
the O 0 9.978119441811373e-10
resting O 0 2.140492512126002e-07
[ O 0 5.3362143148660834e-08
Ca2 O 0 2.4550487864871684e-07
+ O 0 8.817197283406131e-08
] O 0 2.2885943806727482e-08
i O 0 1.1919904174817475e-08
, O 0 2.410070407132814e-11
the O 0 1.9694409297832394e-11
amplitude O 0 1.5708867540098481e-09
and O 0 1.092684387415943e-09
shape O 0 7.368421250930624e-08
of O 0 9.881151452617587e-10
depolarization O 0 5.122154789205524e-07
- O 0 2.2887461454956792e-05
induced O 0 3.72663225789438e-06
Ca2 O 0 1.946386191775673e-06
+ O 0 1.0645900516692564e-07
transients O 0 3.801557681981649e-07
, O 0 6.30051955052835e-10
and O 0 1.6809294234310102e-10
the O 0 6.353881309983933e-11
content O 0 1.1683194411915565e-09
of O 0 8.198416945326414e-11
ATP O 0 1.4030599970737967e-07
- O 0 2.744695848377887e-07
driven O 0 9.772302433930236e-08
ion O 0 1.2594749421168672e-07
pumps O 0 3.095275360465166e-07
in O 0 2.3006903049349603e-09
cultured O 0 4.029703859487199e-07
skeletal O 0 1.0378932984167477e-06
muscle O 0 1.647376137725587e-07
cells O 0 9.767192388210333e-09
of O 0 5.097508526397121e-11
wild O 0 4.146462728726874e-09
- O 0 2.759583730949089e-05
type O 0 1.8657723330761655e-06
and O 0 5.274897407758772e-09
DMPK O 0 4.960700721312605e-07
[ O 0 1.7398424034809068e-08
- O 0 4.001071545189916e-07
/ O 0 5.880525577595108e-07
- O 0 1.6214598872466013e-06
] O 0 3.8423362980211095e-07
knockout O 0 6.968833076825831e-06
mice O 0 3.927430498151807e-06
. O 0 2.878546183637809e-07

In O 0 4.3555320416999166e-07
vitro O 0 7.402398478006944e-05
- O 0 3.914573244401254e-05
differentiated O 0 5.556384621741017e-06
DMPK O 0 6.1835885389882606e-06
[ O 0 4.2831175051105674e-07
- O 0 2.0052236777701182e-06
/ O 0 1.1093271723439102e-06
- O 0 5.50119978015573e-07
] O 0 2.3052157516190164e-08
myotubes O 0 4.663107588953608e-08
exhibit O 0 4.692109811799128e-09
a O 0 3.278208149382067e-09
higher O 0 2.6328599744829262e-08
resting O 0 1.2171550167749956e-07
[ O 0 6.658133600012661e-08
Ca2 O 0 6.961207077438303e-07
+ O 0 1.1363052720980704e-07
] O 0 1.7850398492669228e-08
i O 0 4.7370534161927935e-09
than O 0 9.544220275214954e-11
do O 0 9.172378412358739e-10
wild O 0 1.1357527140987145e-09
- O 0 8.772610016194449e-08
type O 0 2.0867000571911376e-08
myotubes O 0 1.1862934456985386e-07
because O 0 4.110022544523417e-09
of O 0 1.0221925736408899e-11
an O 0 4.1998356181682794e-11
altered O 0 4.9843638549873504e-08
open O 0 3.096066336638614e-08
probability O 0 3.0108362469860595e-09
of O 0 2.652429109684107e-10
voltage O 0 3.563670588846435e-06
- O 0 9.120391769101843e-05
dependent O 0 1.0872012353502214e-05
l O 0 6.711131572956219e-05
- O 0 1.8499080169931403e-06
type O 0 1.0420428679935867e-06
Ca2 O 0 2.435874193906784e-06
+ O 0 7.592877864226466e-07
and O 0 5.5365109830063375e-08
Na O 0 4.7677849579486065e-06
+ O 0 5.968210530227225e-07
channels O 0 2.167349066439783e-06
. O 0 8.281992904812796e-07

The O 0 1.5368273409421818e-07
mutant O 0 2.982596015499439e-06
myotubes O 0 2.7939495339524e-06
exhibit O 0 9.592944394398728e-08
smaller O 0 1.280975112649685e-07
and O 0 1.2765770662781506e-08
slower O 0 1.9257350913903792e-07
Ca2 O 0 1.8358762190473499e-06
+ O 0 1.6969387672816083e-07
responses O 0 1.3844273283325492e-08
upon O 0 1.5191790048163512e-09
triggering O 0 1.990581210975506e-08
by O 0 7.855358585828753e-10
acetylcholine O 0 1.002485305434675e-06
or O 0 0.00012948839867021888
high O 0 1.1294881915091537e-05
external O 0 0.0006388427573256195
K O 0 7.1683280111756176e-06
+ O 0 1.909304046421312e-06
. O 0 2.652432726790721e-07

In O 0 3.7403644626010646e-08
addition O 0 1.521441816976221e-08
, O 0 2.3502326751412284e-09
we O 0 1.1504410757368078e-09
observed O 0 2.0026904579140137e-09
that O 0 1.21342366710131e-10
these O 0 2.5329420783037904e-09
Ca2 O 0 4.477095671973075e-07
+ O 0 2.636302838254778e-07
transients O 0 1.3276676327222958e-06
partially O 0 2.6297693693777546e-06
result O 0 4.123244856657493e-09
from O 0 1.2108319902282005e-10
an O 0 1.18246273883571e-10
influx O 0 2.57949448467798e-08
of O 0 4.490650906685545e-10
extracellular O 0 5.653262391547287e-08
Ca2 O 0 4.251273821864743e-07
+ O 0 3.2061450383480405e-08
through O 0 1.0765300872961348e-09
the O 0 2.361844497755783e-09
l O 0 2.3300292468775297e-06
- O 0 1.1284848824288929e-06
type O 0 1.2673719993472332e-06
Ca2 O 0 5.0023922995023895e-06
+ O 0 1.0517092050577048e-06
channel O 0 3.8007058265066007e-06
. O 0 6.24231404344755e-07

Neither O 0 2.376709971940727e-06
the O 0 4.997326552569348e-09
content O 0 1.657132209231804e-08
nor O 0 2.002431820358197e-08
the O 0 5.372739475539845e-10
activity O 0 1.6668513680428987e-08
of O 0 2.000216881015149e-09
Na O 0 3.6818460102949757e-06
+ O 0 1.3301681747179828e-06
/ O 0 1.2665842632486601e-06
K O 0 2.307077693330939e-06
+ O 0 1.6449316717626061e-06
ATPase O 0 2.8888451197417453e-05
and O 0 6.156452769801035e-08
sarcoplasmic O 0 1.0514911991776899e-05
reticulum O 0 3.0001927370904014e-05
Ca2 O 0 4.500715294852853e-05
+ O 0 4.635780715034343e-05
- O 0 4.645968147087842e-05
ATPase O 0 5.661313480231911e-05
are O 0 6.419277553959546e-09
affected O 0 9.421313507118612e-09
by O 0 4.137614695309821e-09
DMPK O 0 1.6353014871128835e-05
absence O 0 4.772133479491458e-07
. O 0 3.736321900760231e-07

In O 0 7.263516010880267e-08
conclusion O 0 2.2592063331217105e-08
, O 0 1.5677140696723768e-09
our O 0 7.540964519492377e-10
data O 0 1.901404145243646e-09
suggest O 0 2.6132167540993123e-09
that O 0 2.091443684903993e-10
DMPK O 0 7.086560316338364e-08
is O 0 1.5862292035428993e-10
involved O 0 2.3084253952809775e-10
in O 0 1.0161223251703433e-10
modulating O 0 1.1187125004141762e-08
the O 0 1.678789052217411e-10
initial O 0 2.4892341521365324e-09
events O 0 1.99568184200416e-09
of O 0 2.908299157056149e-10
excitation O 0 9.618738658900838e-07
- O 0 0.0014967303723096848
contraction O 0 4.470888143259799e-06
coupling O 0 5.598835173259431e-07
in O 0 9.517688859261852e-09
skeletal O 0 5.397866516432259e-06
muscle O 0 4.655003976949956e-06
. O 0 5.8798644175794834e-08
. O 0 2.3147023853198334e-07

Constitutional O 0 4.4019820052199066e-05
RB1 O 0 0.0025562706869095564
- O 0 0.00014225188351701945
gene O 0 4.700622866948834e-06
mutations O 0 3.8946491258684546e-06
in O 0 7.10901737477343e-09
patients O 0 1.1920432285705829e-07
with O 0 4.984922252759816e-09
isolated O 0 3.2221939818555256e-06
unilateral B-Disease 0 0.0032198510598391294
retinoblastoma I-Disease 0 0.0007205254514701664
. O 0 5.014811449655099e-06

In O 0 1.1280442890893028e-07
most O 0 1.8198926809986915e-08
patients O 0 8.518109240185368e-08
with O 0 1.0111579351601563e-09
isolated O 0 4.129693707000115e-07
unilateral B-Disease 0 1.0184410712099634e-05
retinoblastoma I-Disease 0 2.126293293258641e-05
, O 0 2.9344237262307615e-08
tumor B-Disease 0 7.154465606618032e-07
development O 0 1.6173675732034098e-09
is O 0 6.06004024739093e-10
initiated O 0 3.328016529025035e-09
by O 0 4.130389918977073e-10
somatic O 0 8.78984423025031e-08
inactivation O 0 1.2474415598262567e-06
of O 0 2.9670293999473074e-10
both O 0 4.427495703396289e-09
alleles O 0 7.141800040244561e-08
of O 0 1.1146694678387803e-09
the O 0 2.9395661016451413e-08
RB1 O 0 4.07695843023248e-05
gene O 0 3.6102987905906048e-06
. O 0 6.824234901614545e-07

However O 0 1.1373199271247358e-07
, O 0 4.5061804287982454e-10
some O 0 4.56937716830641e-11
of O 0 2.4083793986884316e-11
these O 0 8.114537375369935e-10
patients O 0 1.1046293657557271e-08
can O 0 2.506600482732324e-09
transmit O 0 1.7044742151028913e-07
retinoblastoma B-Disease 0 3.3840735795820365e-06
predisposition O 0 3.7049524053145433e-06
to O 0 1.3466815218521333e-08
their O 0 4.644121887054098e-08
offspring O 0 1.990871624002466e-06
. O 0 5.623472247862082e-07

To O 0 2.0943799583506006e-08
determine O 0 1.912184721675203e-08
the O 0 2.948637722877123e-10
frequency O 0 3.9476368840496434e-08
and O 0 1.8465914353171797e-09
nature O 0 3.838649398346661e-09
of O 0 3.477427512610376e-10
constitutional O 0 8.444214927294524e-08
RB1 O 0 9.36134165385738e-05
- O 0 1.4416891644941643e-06
gene O 0 3.3585766345822776e-07
mutations O 0 2.8959976816622657e-07
in O 0 1.3411056709600189e-09
patients O 0 2.7028589144606485e-08
with O 0 8.640680948523993e-10
isolated O 0 3.944096533814445e-07
unilateral B-Disease 0 6.5605772761045955e-06
retinoblastoma I-Disease 0 5.948294074187288e-06
, O 0 5.529130930881365e-09
we O 0 2.9526239231358886e-09
analyzed O 0 8.935807649379512e-09
DNA O 0 4.0979855953082733e-08
from O 0 6.731833979145563e-10
peripheral O 0 1.6662926327626337e-07
blood O 0 5.808790319861146e-07
and O 0 1.2178627883940862e-08
from O 0 1.988585296430756e-08
tumor B-Disease 0 1.7886301066027954e-05
tissue O 0 6.658489292021841e-05
. O 0 2.7311648409522604e-06

The O 0 2.9622713171306714e-08
analysis O 0 1.26071626027624e-07
of O 0 4.048572144199625e-09
tumors B-Disease 1 1.0
from O 0 1.9243859838979915e-09
54 O 0 1.5329826297261206e-08
( O 0 4.054783453444344e-10
71 O 0 7.388627487614485e-09
% O 0 4.597353608915e-10
) O 0 2.964506418123847e-10
of O 0 4.7317389589851544e-11
76 O 0 1.4892905575436544e-08
informative O 0 8.461466194376044e-08
patients O 0 4.448295669590152e-07
showed O 0 1.6558500703922618e-07
loss O 0 5.0244818083911014e-08
of O 0 6.328099155794575e-10
constitutional O 0 3.2841560937413306e-07
heterozygosity O 0 0.00042836315697059035
( O 0 7.847085470302773e-08
LOH O 1 0.9999983310699463
) O 0 5.6158736327915904e-08
at O 0 4.3103177915782e-08
intragenic O 0 5.3618296078639105e-06
loci O 0 3.0540948046109406e-06
. O 0 4.376555011731398e-07

Three O 0 6.995681900434647e-08
of O 0 1.9499728498573177e-09
13 O 0 1.68018754465038e-08
uninformative O 0 5.496440735441865e-06
patients O 0 1.3071489775029477e-06
had O 0 3.1335478212213275e-08
constitutional O 0 4.019053392312344e-07
deletions O 0 1.4958154679334257e-05
. O 0 1.2493642316258047e-06

For O 0 1.711561594675004e-07
39 O 0 2.321221330703338e-07
randomly O 0 1.8684740155094914e-07
selected O 0 4.550068126718543e-07
tumors B-Disease 1 1.0
, O 0 3.960888506071569e-08
SSCP O 0 2.035999932559207e-05
, O 0 2.4885327576384952e-08
hetero O 0 0.00020304540521465242
- O 0 1.8480388916941592e-06
duplex O 0 1.1534538089108537e-06
analysis O 0 1.0657049465123691e-08
, O 0 9.306481280058065e-11
sequencing O 0 1.0770785374702996e-09
, O 0 3.339460374895964e-10
and O 0 4.454030200218284e-10
Southern O 0 2.1743726819067888e-09
blot O 0 3.9825283693062374e-07
analysis O 0 4.248138729678885e-09
were O 0 1.7414210351507364e-10
used O 0 1.7908774463393229e-09
to O 0 2.282381394991262e-09
identify O 0 1.1047116004192503e-06
mutations O 0 8.990919013740495e-06
. O 0 4.0054928263089096e-07

Mutations O 0 2.9246313715702854e-05
were O 0 1.5071620396156504e-08
detected O 0 4.470622982921668e-08
in O 0 9.416493140790294e-10
21 O 0 1.8614969565788897e-09
( O 0 1.4220764843475564e-10
91 O 0 1.8916372912514134e-09
% O 0 5.043988560160528e-10
) O 0 1.1586085424397652e-09
of O 0 1.8817412072991146e-09
23 O 0 0.006270933896303177
tumors B-Disease 1 1.0
with O 0 8.491620974382386e-06
LOH O 1 1.0
. O 0 2.5932583866961068e-06

In O 0 8.492348513300385e-08
6 O 0 2.3525165815385662e-08
( O 0 7.020135583957199e-10
38 O 0 3.330753672869946e-09
% O 0 4.81769124593967e-10
) O 0 4.4939924004339105e-10
of O 0 8.995140743373042e-10
16 O 0 0.00040978071046993136
tumors B-Disease 1 1.0
without O 0 5.817864075652324e-05
LOH O 1 0.9999998807907104
, O 0 1.725353970805088e-09
one O 0 8.494624448296406e-10
mutation O 0 1.9918269700269775e-08
was O 0 2.5940527503820476e-09
detected O 0 1.653252290623186e-08
, O 0 1.6107723488367753e-10
and O 0 3.2069857880401287e-10
in O 0 3.9325950829116607e-10
9 O 0 1.2124687920334054e-09
( O 0 1.2571631236024672e-10
56 O 0 1.1801899457708487e-09
% O 0 1.6528155233341835e-10
) O 0 1.3621463679225343e-10
of O 0 1.1415726003383142e-10
the O 0 7.5628681770467665e-06
tumors B-Disease 1 1.0
without O 0 0.00024975705309771
LOH O 1 0.9999998807907104
, O 0 3.813902083038556e-09
both O 0 2.6271700370728013e-09
mutations O 0 1.732455388037124e-07
were O 0 4.794410202180188e-09
found O 0 4.9504354393548056e-08
. O 0 2.0688592883288948e-07

Thus O 0 1.260446964579387e-07
, O 0 1.7016206221853736e-09
a O 0 5.680591552703618e-10
total O 0 5.840068428852874e-10
of O 0 1.409180966360779e-10
45 O 0 1.957074502456635e-09
mutations O 0 6.201437230402007e-08
were O 0 2.475234239796009e-09
identified O 0 1.288237569951889e-07
in O 0 3.946222193462745e-07
tumors B-Disease 1 1.0
of O 0 1.9108211901652794e-08
36 O 0 3.2559765372752736e-07
patients O 0 9.427137115380901e-07
. O 0 2.293388519092332e-07

Thirty O 0 3.816250682575628e-06
- O 0 4.1156119550578296e-05
nine O 0 1.2645425151447398e-08
of O 0 8.231069992259421e-11
the O 0 2.7085689247030587e-10
mutations O 0 4.8839037702919086e-08
- O 0 5.501666677787398e-08
including O 0 7.159496884234784e-10
34 O 0 3.4206641963407947e-09
small O 0 7.250114730794621e-09
mutations O 0 3.9871378021416604e-07
, O 0 1.2347635136578106e-09
2 O 0 2.5040725049052526e-09
large O 0 1.2685307915205613e-08
structural O 0 3.704180562635884e-05
alterations O 0 4.454052202618186e-07
, O 0 8.413292285069929e-10
and O 0 5.549868897780641e-10
hypermethylation O 0 1.6120993961976637e-07
in O 0 7.188687423109741e-09
3 O 0 5.842681503054337e-07
tumors O 1 1.0
- O 0 0.23774388432502747
were O 0 7.218282416232569e-09
not O 0 1.187943077241016e-09
detected O 0 1.0502518854593745e-08
in O 0 1.3870372905788741e-10
the O 0 4.684381771369317e-10
corresponding O 0 5.380744383387537e-08
peripheral O 0 2.5695171643747017e-06
blood O 0 8.539058740097971e-07
DNA O 0 4.8845836317923386e-06
. O 0 5.292970968184818e-07

In O 0 1.2675023697283905e-07
6 O 0 2.0026458713573447e-08
( O 0 6.921958561889596e-10
17 O 0 9.036549286633999e-10
% O 0 1.0410566159135826e-10
) O 0 6.17660367296935e-11
of O 0 1.4102611439748003e-11
the O 0 8.490283476270122e-10
36 O 0 1.3760923955885573e-08
patients O 0 1.5858315549621693e-08
, O 0 1.2278911221130784e-10
a O 0 5.827872628927366e-10
mutation O 0 1.4308611184787878e-07
was O 0 1.601980592624841e-08
detected O 0 7.063525231387757e-08
in O 0 3.803591608342316e-10
constitutional O 0 1.053268361417281e-09
DNA O 0 2.049566205641895e-08
, O 0 2.901650031361669e-10
and O 0 1.9749002433400165e-10
1 O 0 4.1256026372948895e-10
of O 0 1.3609354095056592e-11
these O 0 3.5135827580745627e-10
mutations O 0 3.221586197810211e-08
is O 0 1.1124429849518336e-10
known O 0 1.1893894757974977e-09
to O 0 4.967682931678041e-10
be O 0 2.0417967316888053e-09
associated O 0 5.638947531139138e-09
with O 0 2.4143378407615046e-09
reduced O 0 5.299567646943615e-07
expressivity O 0 9.04267726582475e-05
. O 0 7.091650218171708e-07

The O 0 2.579464997154446e-08
presence O 0 1.6464770880020296e-08
of O 0 7.3180725368438e-11
a O 0 3.1506428022076705e-10
constitutional O 0 7.272329405338951e-09
mutation O 0 1.9044472310270066e-07
was O 0 2.4231644246697215e-08
not O 0 1.2241968549986382e-09
associated O 0 4.4196299398002736e-10
with O 0 2.937555407256376e-11
an O 0 7.225438303226639e-11
early O 0 4.838231504322721e-08
age O 0 2.4934360354222918e-08
at O 0 1.2498387214066042e-08
treatment O 0 2.825218530233542e-07
. O 0 1.5508746287196118e-07

In O 0 2.779036378797173e-07
1 O 0 9.588993066245166e-08
patient O 0 1.7834139498518198e-07
, O 0 2.0590396054842586e-09
somatic O 0 4.817861736228224e-07
mosaicism O 0 6.881745503051206e-05
was O 0 9.332321582178338e-08
demonstrated O 0 1.1552550915894244e-08
by O 0 2.586951486360789e-10
molecular O 0 2.4185611735560997e-08
analysis O 0 1.691596374087112e-08
of O 0 2.7828783721872696e-10
DNA O 0 2.0425657965006394e-07
and O 0 5.091693289216437e-09
RNA O 0 7.618780983875695e-08
from O 0 5.086887799876649e-09
peripheral O 0 2.078870011246181e-06
blood O 0 6.197468337632017e-06
. O 0 8.021779649425298e-07

In O 0 1.294445723942772e-07
2 O 0 4.6808850129309576e-08
patients O 0 8.055129541162387e-08
without O 0 2.659152675832388e-09
a O 0 3.327229602945181e-09
detectable O 0 1.1151930266350973e-05
mutation O 0 8.747928745833633e-07
in O 0 5.769566602253917e-09
peripheral O 0 1.3586055729319924e-06
blood O 0 8.495181305079313e-07
, O 0 1.2626764078760289e-09
mosaicism O 0 1.41178600188141e-06
was O 0 6.583047884589632e-09
suggested O 0 1.1943777522560595e-08
because O 0 2.426752354622863e-09
1 O 0 2.53768950297939e-10
of O 0 1.6907196129234414e-11
the O 0 7.790557088327432e-10
patients O 0 8.145868690689895e-08
showed O 0 2.0506030296019162e-07
multifocal O 1 0.9980615973472595
tumors B-Disease 1 1.0
and O 0 2.6070904368680203e-07
the O 0 2.512874630600237e-10
other O 0 6.905171989757264e-10
later O 0 2.0642666243020358e-08
developed O 0 7.530393020260817e-08
bilateral B-Disease 0 5.716432269764482e-07
retinoblastoma I-Disease 0 3.418239066377282e-05
. O 0 1.3306529353940277e-06

In O 0 8.618304292440371e-08
conclusion O 0 1.7644925520698962e-08
, O 0 1.6065849761659479e-09
our O 0 1.6929285751032808e-09
results O 0 1.6731925844837292e-09
emphasize O 0 4.664893360484257e-09
that O 0 2.614980454396232e-10
the O 0 1.9139781426424918e-10
manifestation O 0 7.587829919941669e-09
and O 0 7.622684150554448e-10
transmissibility O 0 7.474656626982323e-08
of O 0 1.2644303659659073e-10
retinoblastoma B-Disease 0 2.3512651381452088e-08
depend O 0 9.09690811567998e-09
on O 0 8.697859654738238e-10
the O 0 7.9691572785201e-11
nature O 0 4.726996571946529e-10
of O 0 8.356142167098568e-12
the O 0 5.226121618795432e-11
first O 0 1.1264629229401635e-09
mutation O 0 5.926136026346285e-09
, O 0 5.999280239255e-11
its O 0 7.961105386034006e-11
time O 0 3.053342245706858e-09
in O 0 2.0525217636624404e-10
development O 0 2.0709964299037154e-10
, O 0 1.68129482558399e-10
and O 0 1.779985880911994e-10
the O 0 2.2536854327182e-11
number O 0 3.2951325001917553e-10
and O 0 9.043101267813825e-10
types O 0 2.7634572408175018e-09
of O 0 4.11824220558632e-11
cells O 0 6.442361755176762e-09
that O 0 4.6409825982252073e-10
are O 0 1.103868552121412e-09
affected O 0 1.4588146690641679e-08
. O 0 1.4676841963989773e-08
. O 0 1.0572527031627033e-07

Hereditary B-Disease 1 0.9999922513961792
deficiency I-Disease 1 0.9999817609786987
of I-Disease 0 3.3312557157216816e-09
the I-Disease 0 1.6935388646999172e-09
fifth I-Disease 0 1.700479401733901e-08
component I-Disease 0 3.992685293496834e-08
of I-Disease 0 1.819887157639144e-10
complement I-Disease 0 1.4504357714884009e-08
in O 0 4.485584792490727e-09
man O 0 6.925886282260763e-07
. O 0 2.2785422970628133e-07

I O 0 0.0004972692113369703
. O 0 5.001209501642734e-06

Clinical O 0 5.1514969527488574e-05
, O 0 3.061502340528932e-08
immunochemical O 0 3.1021752420201665e-06
, O 0 1.0990517829156943e-08
and O 0 1.2107593150290086e-08
family O 0 1.376161264943221e-07
studies O 0 1.3076776212983532e-06
. O 0 4.2120558418901055e-07

The O 0 2.887012762187169e-08
first O 0 5.248002477031832e-09
recognized O 0 2.2592063331217105e-08
human O 0 6.032837784886169e-09
kindred O 0 9.384905297338264e-07
with O 0 3.124988978697729e-08
hereditary B-Disease 1 0.9999598264694214
deficiency I-Disease 1 0.9999542236328125
of I-Disease 0 3.773660550709934e-10
the I-Disease 0 1.5634528116592605e-09
fifth I-Disease 0 2.369624851894514e-08
component I-Disease 0 1.3695965606075333e-07
of I-Disease 0 5.568105976294646e-10
complement I-Disease 0 8.234788140271121e-08
( O 0 3.501382295212352e-09
C5 O 0 2.8978931254641793e-07
) O 0 2.161224310626153e-09
is O 0 1.7218003689478678e-09
described O 0 9.91249464732391e-08
. O 0 5.054221219324972e-07

The O 0 4.3598703314273735e-08
proband O 0 9.515275678495527e-07
, O 0 1.5586383295129735e-09
a O 0 3.1741667627649406e-10
20 O 0 1.0619951584800447e-09
- O 0 5.6986774410461294e-08
year O 0 1.9992794975109973e-08
- O 0 8.593746088081389e-07
old O 0 4.5540446080849506e-07
black O 0 1.2747319999562023e-07
female O 0 1.800753750558215e-07
with O 0 1.0301644692845002e-07
systemic B-Disease 1 1.0
lupus I-Disease 1 0.9995177984237671
erythematosus I-Disease 1 1.0
since O 0 1.5277719285222702e-05
age O 0 1.7032068910793896e-07
11 O 0 6.030249188881953e-09
, O 0 1.055049936304897e-09
lacked O 0 4.918023819300288e-07
serum O 0 1.2158016033936292e-06
hemolytic O 0 3.6991516481066355e-06
complement O 0 2.8588583944610946e-08
activity O 0 4.591294455735806e-08
, O 0 1.2106963209745913e-09
even O 0 1.140337690941351e-08
during O 0 7.974841054192439e-08
remission O 0 4.664789685193682e-06
. O 0 2.225670669986357e-07

C5 O 0 0.0006104046478867531
was O 0 7.224675186989771e-07
undetectable O 0 1.8892603748099646e-06
in O 0 2.0161354807868292e-09
her O 0 7.842847260519648e-09
serum O 0 3.404692350272853e-08
by O 0 3.8661948642548793e-10
both O 0 9.493303032570566e-09
immunodiffusion O 0 6.264710918912897e-06
and O 0 1.3845915702859202e-07
hemolytic O 0 0.00011516507947817445
assays O 0 0.00016220795805566013
. O 0 2.0119471173529746e-06

Other O 0 1.1281062306522927e-08
complement O 0 7.853819816716623e-09
components O 0 2.62003574391656e-08
were O 0 8.969305853590015e-10
normal O 0 2.3570201346245767e-09
during O 0 3.0512115056779976e-09
remission O 0 6.592272683292322e-08
of O 0 2.5652241442131185e-10
lupus O 0 8.00087673269445e-06
, O 0 1.2472947119590572e-09
but O 0 1.7676455854598316e-08
C1 O 0 4.1120702007901855e-06
, O 0 1.379802827550236e-09
C4 O 0 1.520260184406652e-07
, O 0 2.150594591299182e-09
C2 O 0 2.845585242994275e-07
, O 0 7.514101563188547e-10
and O 0 8.655959504721977e-09
C3 O 0 3.372935225343099e-06
levels O 0 1.5606656234012917e-07
fell O 0 1.1869616400872474e-06
during O 0 1.720065512245128e-07
exacerbations O 0 0.00024454740923829377
. O 0 8.275053460238269e-07

A O 0 3.0009195484126394e-07
younger O 0 2.1160410312859312e-07
half O 0 2.6177479739430964e-08
- O 0 1.606672270781928e-07
sister O 0 2.1190112775570924e-08
, O 0 2.6000998576414247e-10
who O 0 3.727870456771143e-09
had O 0 4.289003641133604e-08
no O 0 1.3457853498266559e-08
underlying O 0 3.2579129765508696e-05
disease O 0 4.909649078399525e-07
, O 0 1.0741590950047453e-09
was O 0 7.49718722659054e-08
also O 0 2.327819048630886e-09
found O 0 3.5032792222722264e-09
to O 0 8.95559981728411e-09
lack O 0 3.889746267304872e-07
immunochemically O 0 9.866133768809959e-05
detectable O 0 0.0005822476232424378
C5 O 0 4.0588151023257524e-05
. O 0 9.955854238796746e-07

By O 0 7.140300795072108e-07
hemolytic O 0 0.00032631377689540386
assay O 0 4.6827804908389226e-05
, O 0 2.811879973307896e-08
she O 0 4.7926022261890466e-08
exhibited O 0 5.435245142848544e-09
1 O 0 3.761912559241409e-09
- O 0 7.999200590802502e-08
2 O 0 3.7019791676584646e-09
% O 0 2.805678467332484e-10
of O 0 2.1275694747635576e-11
the O 0 1.4249715851732958e-09
normal O 0 1.0267728356438965e-07
serum O 0 4.7039500827850134e-07
C5 O 0 2.1124984073139785e-07
level O 0 1.180307585002538e-08
and O 0 7.87469534024865e-10
normal O 0 2.727659431656093e-09
concentrations O 0 3.884618493543712e-08
of O 0 5.6370921819315356e-11
other O 0 8.617835889346281e-10
complement O 0 3.5378292295717984e-08
components O 0 4.628372778370249e-07
. O 0 2.8378994443301053e-07

C5 O 0 0.00011294105934211984
levels O 0 1.4019808531884337e-06
of O 0 2.5977797690757143e-10
other O 0 3.284527927416292e-10
family O 0 7.260600454195298e-10
members O 0 1.6396028978959976e-10
were O 0 3.9984351940525187e-10
either O 0 5.42974054607015e-10
normal O 0 2.150434719183636e-09
or O 0 4.102047868048686e-10
approximately O 0 3.0818408935928687e-10
half O 0 5.374856471007661e-08
- O 0 7.453597208950669e-05
normal O 0 5.004750391890411e-08
, O 0 5.004124892238337e-10
consistent O 0 5.981438899738123e-09
with O 0 1.1061215277052838e-09
autosomal O 0 2.2070039449317846e-06
codominant O 0 6.478981049440335e-07
inheritance O 0 9.683519408554275e-08
of O 0 4.865851610524885e-10
the O 0 5.512777345728637e-09
gene O 0 1.524939125374658e-05
determining O 0 0.3645469546318054
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.441043989165337e-06

Normal O 0 0.00015924166655167937
hemolytic O 0 0.009187493473291397
titers O 0 0.0010289199417456985
were O 0 1.1704650404453787e-07
restored O 0 6.933989027402276e-08
to O 0 1.761431778213307e-09
both O 0 2.206711968710806e-08
homozygous O 1 0.9263254404067993
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 6.953948883392513e-08
C5D B-Disease 1 1.0
) O 0 4.8979873490395676e-09
sera O 0 1.0767668534583663e-08
by O 0 7.218219771898404e-11
addition O 0 1.0762858382307172e-09
of O 0 2.7551719239404804e-10
highly O 0 3.1151280666108505e-08
purified O 0 4.0419200786345755e-07
human O 0 7.26928206518096e-08
C5 O 0 4.947442903358024e-06
. O 0 1.1201905891766728e-07

In O 0 3.2208436095970683e-07
specific O 0 1.9468878065254103e-07
C5 O 0 2.170621428376762e-06
titrations O 0 1.394706850987859e-05
, O 0 3.332030873437475e-09
however O 0 1.4613426024823184e-09
, O 0 2.0193402505697122e-10
it O 0 9.588784211089774e-10
was O 0 1.6536014779688912e-09
noted O 0 2.142867133736459e-10
that O 0 3.3027820062203617e-11
when O 0 5.922381474121607e-10
limited O 0 3.2182728704199803e-10
amounts O 0 9.550471524732984e-10
of O 0 7.880161106976757e-11
C5 O 0 1.7335288760023104e-08
were O 0 2.643968655124951e-10
assayed O 0 1.883706346461622e-08
in O 0 1.5998292968166794e-10
the O 0 1.83782739027194e-10
presence O 0 3.2755582690668916e-09
of O 0 1.8595690265410525e-10
low O 0 3.095859923973876e-08
dilutions O 0 1.7676238712738268e-06
of O 0 8.03383970460203e-10
either O 0 2.445582367727184e-07
C5D B-Disease 1 1.0
serum O 0 3.361037386184762e-07
, O 0 2.998387371722089e-10
curving O 0 6.646737382709489e-09
rather O 0 1.3142484878159166e-09
than O 0 2.536673371356102e-10
linear O 0 8.000035300881336e-09
dose O 0 9.537278629068169e-07
- O 0 1.1853808246087283e-07
response O 0 3.1832021463173987e-09
plots O 0 3.382503876991905e-08
were O 0 2.553723676967934e-09
consistently O 0 7.125143586250715e-09
obtained O 0 1.847895170214997e-09
, O 0 2.330279025297699e-10
suggesting O 0 6.270311825318231e-09
some O 0 6.324237800114929e-10
inhibitory O 0 4.2991064219677355e-07
effect O 0 9.328332453151233e-07
. O 0 2.9623683417412394e-07

Further O 0 1.7317286449269886e-07
studies O 0 5.890045073897454e-08
suggested O 0 1.9558962449650608e-08
that O 0 1.0588581123016638e-09
low O 0 6.501107918666094e-08
dilutions O 0 7.487385573767824e-06
of O 0 5.623201904114694e-09
C5D B-Disease 1 0.9999998807907104
serum O 0 3.137794806207239e-07
contain O 0 4.923069951701109e-09
a O 0 1.2378195135553938e-09
factor O 0 8.945800544779559e-09
( O 0 8.889508573695082e-11
or O 0 1.1121082943432725e-09
factors O 0 3.0816365015340352e-09
) O 0 1.566404089770046e-10
interfering O 0 2.504521479096411e-09
at O 0 2.950100719267823e-10
some O 0 2.8981641739256325e-11
step O 0 3.4751943545074937e-09
in O 0 1.482177047762434e-09
the O 0 5.899981836421375e-09
hemolytic O 0 9.155770385405049e-06
assay O 0 2.4092435069178464e-06
of O 0 6.873975832988322e-10
C5 O 0 9.15644591259479e-08
, O 0 1.2188887399400272e-10
rather O 0 3.053748365289266e-10
than O 0 2.552013600443104e-10
a O 0 2.953671529581925e-09
true O 0 1.0485909029966933e-07
C5 O 0 1.4026295502844732e-06
inhibitor O 0 3.54246168399186e-07
or O 0 3.072775456303134e-08
inactivator O 0 4.693961727753049e-06
. O 0 4.6045192902965937e-07

Of O 0 1.4361896560899368e-08
clinical O 0 6.616420478167129e-07
interest O 0 1.0604169098371585e-08
are O 0 5.575098716015248e-10
( O 0 8.435108167503813e-11
a O 0 1.643789410143981e-10
) O 0 2.938795318208065e-10
the O 0 8.395142220285479e-11
documentation O 0 3.2070808231310366e-08
of O 0 3.2102740465944635e-09
membranous O 1 0.9992577433586121
glomerulonephritis B-Disease 1 1.0
, O 0 6.16733668721281e-05
vasculitis B-Disease 1 1.0
, O 0 3.2538281402594293e-08
and O 0 1.2811166016035713e-05
arthritis B-Disease 1 1.0
in O 0 6.938193575223295e-09
an O 0 9.541057943707187e-10
individual O 0 5.088811860787246e-08
lacking O 0 2.7139351459481986e-06
C5 O 0 6.994387149461545e-07
( O 0 5.105704192764904e-10
and O 0 1.5488962890053415e-10
its O 0 1.5339755854437698e-10
biologic O 0 1.3805247611742288e-08
functions O 0 8.218069003085304e-10
) O 0 3.9896513870374406e-10
, O 0 1.4131698589103792e-10
and O 0 5.275156422790417e-10
( O 0 3.137210768944243e-10
b O 0 1.0492987811971943e-08
) O 0 7.561527792798728e-11
a O 0 4.6313945734066664e-11
remarkable O 0 2.7883044761978226e-09
propensity O 0 2.1425510965400463e-07
to O 0 5.229889410429678e-08
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 3.072861742836608e-09
the O 0 1.758275608443327e-10
proband O 0 9.435324699325065e-08
, O 0 1.1590280124540442e-10
even O 0 2.592122627653737e-10
during O 0 2.523441455792863e-10
periods O 0 3.6144163217954883e-09
of O 0 9.830315728098782e-11
low O 0 6.808634367416744e-08
- O 0 6.841477784291783e-08
dose O 0 9.677850698608381e-08
or O 0 9.052385507857252e-10
alternate O 0 1.3160151191016212e-08
- O 0 6.23323558102129e-07
day O 0 5.6375302648348224e-08
corticosteroid O 0 5.501002760865958e-06
therapy O 0 1.6635250403851387e-06
. O 0 1.277893062479052e-07

Other O 0 2.4025057498988645e-08
observations O 0 2.877249904997825e-08
indicate O 0 1.9589204924841397e-08
that O 0 2.7224811294246365e-10
the O 0 1.0475544875987453e-09
C5D B-Disease 1 1.0
state O 0 4.008791965048886e-09
is O 0 3.401495196619919e-10
compatible O 0 3.468896503378005e-09
with O 0 4.3844666786085895e-10
normal O 0 9.136170930901244e-09
coagulation O 0 2.040162705441162e-08
function O 0 5.452148510443067e-09
and O 0 1.5552825693987415e-09
the O 0 3.560428341042865e-10
capacity O 0 2.7348381337333194e-09
to O 0 6.414916375874213e-10
mount O 0 1.6719403106435493e-07
a O 0 1.0588711774062176e-07
neutrophilic O 0 0.001013854518532753
leukocytosis O 0 0.00022787225316278636
during O 0 1.5555940535705304e-06
pyogenic B-Disease 0 0.030863847583532333
infection I-Disease 0 0.003349385457113385
. O 0 7.372174337660908e-08
. O 0 3.4313669061702967e-07

Susceptibility O 0 0.0006736831273883581
to O 0 4.8023666749941185e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 4.714786996373732e-07
twins O 0 3.07528551957148e-07
: O 0 7.490590925307572e-10
the O 0 6.991843215509164e-11
role O 0 4.012762122584945e-09
of O 0 4.894956662226946e-11
genes O 0 5.754224652321227e-09
, O 0 6.935782503880716e-10
HLA O 0 4.669845310445453e-08
, O 0 5.81236447860789e-10
and O 0 1.9446539933909435e-09
the O 0 4.969069156146588e-09
environment O 0 3.0637372105957184e-07
. O 0 1.5005683451363439e-07

OBJECTIVE O 0 1.6307023997796932e-06
To O 0 4.4156296397090955e-09
determine O 0 4.62318228144909e-09
the O 0 1.1399647198429008e-10
relative O 0 4.3442791586301155e-09
effects O 0 2.4544744903209903e-08
of O 0 2.905702761735185e-11
genetic O 0 8.430262710135139e-08
and O 0 1.7351191594627835e-09
environmental O 0 9.148341639786395e-09
factors O 0 2.533657283976254e-09
in O 0 9.324663263754474e-10
susceptibility O 0 1.0974702036037343e-06
to O 0 3.4928132208733587e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 2.2849014840176096e-06
AS B-Disease 1 0.999998927116394
) O 0 4.477304926808756e-08
. O 0 1.9273740292646835e-07

METHODS O 0 3.3827279821707634e-06
Twins O 0 3.855440695588186e-07
with O 0 1.7876421454232627e-09
AS B-Disease 1 0.9999454021453857
were O 0 1.010664330003408e-09
identified O 0 4.3812251604435914e-09
from O 0 2.046369046437846e-10
the O 0 1.1146609191214907e-09
Royal O 0 2.8842478627666424e-07
National O 0 1.0496350455468928e-08
Hospital O 0 2.3286422390356165e-07
for O 0 3.279410876189104e-08
Rheumatic B-Disease 0 0.018580162897706032
Diseases I-Disease 0 4.7834306315053254e-05
database O 0 3.107688598902314e-06
. O 0 1.316930024586327e-06

Clinical O 0 7.519297651015222e-05
and O 0 8.75410677281252e-08
radiographic O 0 4.95349449920468e-05
examinations O 0 2.2784561224398203e-06
were O 0 1.6887006237809032e-09
performed O 0 8.018470332160632e-10
to O 0 1.4818964111373845e-10
establish O 0 5.504456446203676e-09
diagnoses O 0 6.719269549648743e-06
, O 0 1.6811612102429763e-09
and O 0 4.1180125975870396e-08
disease O 0 3.619310007252352e-07
severity O 0 3.4254654224241676e-07
was O 0 3.3458633641458846e-09
assessed O 0 2.934937404219795e-09
using O 0 1.5036983880278854e-09
a O 0 5.261651114807364e-10
combination O 0 1.4110866253247423e-08
of O 0 2.756228301148411e-10
validated O 0 7.68919079519037e-08
scoring O 0 3.353180133558453e-08
systems O 0 4.372437274469121e-07
. O 0 1.822425303998898e-07

HLA O 0 0.00029355890001170337
typing O 0 2.0525985746644437e-05
for O 0 4.4698218459870986e-08
HLA O 0 6.786503035982605e-06
- O 0 3.6353028463054216e-06
B27 O 0 1.5605153294018237e-06
, O 0 3.279158944380356e-09
HLA O 0 2.6114673801203026e-07
- O 0 1.4143503790364775e-07
B60 O 0 1.291159890115523e-07
, O 0 6.282327991158354e-10
and O 0 2.065687398911109e-09
HLA O 0 1.1042754977097502e-06
- O 0 2.369671710766852e-05
DR1 O 0 0.0006569657707586884
was O 0 8.916465787933703e-09
performed O 0 1.987696895966451e-09
by O 0 1.2931593296183763e-10
polymerase O 0 1.5067769254528685e-08
chain O 0 2.591204122381896e-07
reaction O 0 6.124336149326837e-09
with O 0 6.481450098849706e-11
sequence O 0 6.88990109409815e-09
- O 0 6.488918558034129e-08
specific O 0 1.7994511436469907e-09
primers O 0 2.2439657243467082e-07
, O 0 6.524891182912995e-10
and O 0 4.959257449144161e-10
zygosity O 0 1.260660980051398e-07
was O 0 2.7886715159297637e-09
assessed O 0 1.621519807315508e-08
using O 0 1.666574789283004e-08
microsatellite O 0 1.9632838302641176e-05
markers O 0 6.2186391005525365e-06
. O 0 8.654508860672649e-07

Genetic O 0 2.7584523195400834e-05
and O 0 3.179756902227382e-08
environmental O 0 2.0688585067318854e-08
variance O 0 9.851310878161712e-09
components O 0 5.1917542265300654e-08
were O 0 1.5161309985245452e-09
assessed O 0 6.97244662006824e-09
with O 0 1.7153224673993606e-10
the O 0 5.617131759727556e-10
program O 0 3.5780898244297532e-09
Mx O 0 1.4914055768144863e-08
, O 0 1.1261267092443905e-11
using O 0 3.8692320181166195e-11
data O 0 5.486822662881252e-10
from O 0 1.9376283563743435e-11
this O 0 2.509214364065926e-11
and O 0 4.5868958631345436e-10
previous O 0 1.3362957851370538e-08
studies O 0 4.813175191742403e-09
of O 0 4.999295075136523e-11
twins O 0 3.4614430433066445e-08
with O 0 1.5483446746955565e-09
AS B-Disease 1 0.9999992847442627
. O 0 5.011169150748174e-07

RESULTS O 0 6.063970431569032e-06
Six O 0 2.9894362540972e-08
of O 0 1.2790818404440074e-09
8 O 0 3.0429834652068166e-08
monozygotic O 0 3.019112682522973e-06
( O 0 2.303457513619378e-08
MZ O 0 0.0628194510936737
) O 0 1.6906414046502505e-08
twin O 0 6.690411282761488e-07
pairs O 0 7.781312660881667e-08
were O 0 7.153333569931419e-08
disease O 0 9.104721954145134e-08
concordant O 0 1.3782127439299074e-07
, O 0 3.500038314729892e-10
compared O 0 1.551578865388592e-09
with O 0 1.197083682180633e-10
4 O 0 1.4282423022038415e-09
of O 0 1.837553859074248e-10
15 O 0 5.43895772864289e-09
B27 O 0 4.344335593486903e-07
- O 0 7.246280802064575e-07
positive O 0 4.589692181866667e-08
dizygotic O 0 6.30350598385121e-07
( O 0 2.5410715753793056e-09
DZ O 0 2.3328352654061746e-06
) O 0 3.201523712803578e-09
twin O 0 1.3323031566869759e-07
pairs O 0 1.9540541629226027e-08
( O 0 1.4037787599008311e-09
27 O 0 3.1580387194196646e-09
% O 0 2.335698856548163e-10
) O 0 1.186513526318933e-10
and O 0 4.417666232825468e-10
4 O 0 9.4484631230074e-10
of O 0 1.8060039574940845e-10
32 O 0 3.6365047861863786e-08
DZ O 0 0.0025081734638661146
twin O 0 4.353390977485105e-06
pairs O 0 6.384674833270765e-08
overall O 0 5.042242534614161e-08
( O 0 3.631565881345722e-10
12 O 0 5.525786495041984e-10
. O 0 9.332972172870768e-10
5 O 0 2.5990400942532688e-09
% O 0 1.841891972276244e-09
) O 0 4.156376132158357e-09
. O 0 5.35690496406005e-08

Nonsignificant O 0 4.5429136662278324e-05
increases O 0 4.960256205777114e-07
in O 0 6.362592119835142e-10
similarity O 0 2.286402844831059e-09
with O 0 3.0311791271442345e-11
regard O 0 4.878442649847159e-10
to O 0 2.9946836677119393e-10
age O 0 5.896134247507234e-09
at O 0 5.42426725758105e-09
disease O 0 2.4259390940528647e-08
onset O 0 2.186142289417603e-08
and O 0 2.570572366078494e-10
all O 0 3.202418191738943e-11
of O 0 1.45901832282469e-11
the O 0 1.6148706816210279e-09
disease O 0 2.6491639459891303e-07
severity O 0 1.59560030965622e-07
scores O 0 2.2387453668670787e-08
assessed O 0 7.623807363188462e-09
were O 0 1.0109535431013228e-09
noted O 0 3.930078040781382e-09
in O 0 9.283725788122865e-09
disease O 0 1.4318633475340903e-05
- O 0 0.0010728361085057259
concordant O 0 0.00024825919535942376
MZ O 0 0.10966935753822327
twins O 0 1.3441482451526099e-06
compared O 0 4.483175430891606e-08
with O 0 1.2016876382858754e-08
concordant O 0 6.645143730565906e-05
DZ O 0 0.0031154484022408724
twins O 0 3.0161831091390923e-05
. O 0 1.1879637895617634e-06

HLA O 0 0.003141324734315276
- O 0 0.0018908862257376313
B27 O 0 4.736333266919246e-06
and O 0 1.1718909398439337e-08
B60 O 0 1.0682430939823462e-07
were O 0 1.4083808563825073e-09
associated O 0 7.891475806154347e-10
with O 0 2.7812227521017974e-10
the O 0 1.0377068093703201e-09
disease O 0 2.256829034763541e-08
in O 0 8.132475248778803e-11
probands O 0 7.750635688807961e-08
, O 0 1.4124908187529428e-10
and O 0 1.0786075504976012e-10
the O 0 7.937422247250581e-11
rate O 0 5.0061061074302415e-08
of O 0 5.261048818816505e-10
disease O 0 8.938982176687205e-08
concordance O 0 3.794913894239471e-08
was O 0 1.6144959147368354e-08
significantly O 0 4.345640647329674e-08
increased O 0 1.765650736729185e-08
among O 0 7.015133363097448e-09
DZ O 0 9.18583737075096e-06
twin O 0 3.87522106848337e-07
pairs O 0 7.105140031882229e-09
in O 0 9.997855876520134e-10
which O 0 7.991781125760156e-10
the O 0 1.0970804265042489e-09
co O 0 0.0008939487743191421
- O 0 0.00014828842540737242
twin O 0 0.00042793096508830786
was O 0 5.1328608030587475e-09
positive O 0 1.005657113140046e-09
for O 0 1.3428198830656157e-10
both O 0 3.2753457723799784e-09
B27 O 0 1.8187945443060016e-06
and O 0 1.1135462330003065e-07
DR1 O 0 0.00023004040122032166
. O 0 9.822285846894374e-07

Additive O 0 2.146683755199774e-06
genetic O 0 1.2872836805399857e-06
effects O 0 3.6460374985836097e-07
were O 0 1.3372308815817746e-09
estimated O 0 8.589888800258905e-10
to O 0 6.670000107789065e-10
contribute O 0 2.682790878338892e-09
97 O 0 3.6503664535558755e-09
% O 0 4.4490972017641184e-10
of O 0 4.646320828083361e-11
the O 0 1.2429036688743622e-09
population O 0 1.542382399577491e-08
variance O 0 1.6393488522226107e-07
. O 0 3.3079385275414097e-07

CONCLUSION O 0 5.87595081924519e-07
Susceptibility O 0 1.2772744639732991e-06
to O 0 2.162957457585435e-08
AS B-Disease 1 0.9999990463256836
is O 0 7.515362776544521e-10
largely O 0 1.5981527212716173e-09
genetically O 0 1.9491472880162064e-09
determined O 0 6.328150892187523e-09
, O 0 9.444494492028e-11
and O 0 1.48731901794541e-10
the O 0 1.298777890790248e-10
environmental O 0 3.712755880513896e-09
trigger O 0 4.9774950383607575e-08
for O 0 8.173221544005571e-10
the O 0 6.49150333487114e-09
disease O 0 2.980373210448306e-07
is O 0 5.783427514671757e-09
probably O 0 6.711135114301214e-08
ubiquitous O 0 1.7912561816046946e-06
. O 0 7.363826171058463e-07

HLA O 0 0.0003471414092928171
- O 0 2.2000896933604963e-05
B27 O 0 3.7048354784019466e-07
accounts O 0 3.40400241327643e-09
for O 0 1.1164008606456832e-10
a O 0 1.3428864964470932e-10
minority O 0 4.4638664320473254e-08
of O 0 6.616449749197173e-11
the O 0 1.044223152391055e-09
overall O 0 3.061730069475743e-08
genetic O 0 2.197568562678498e-07
susceptibility O 0 7.954079705996264e-07
to O 0 6.145283037994886e-08
AS B-Disease 1 0.9999967813491821
. O 0 7.098342393874191e-07

Cell O 0 0.0003650881117209792
cycle O 0 0.00018963729962706566
- O 0 0.00021704882965423167
dependent O 0 4.167820861766813e-06
colocalization O 0 2.6851425900531467e-06
of O 0 1.6793983981244764e-09
BARD1 O 0 2.503542191334418e-06
and O 0 7.506341326291022e-09
BRCA1 O 0 3.6247604384698207e-07
proteins O 0 4.015487942155005e-09
in O 0 9.447561621911404e-10
discrete O 0 3.03739398077596e-07
nuclear O 0 1.0548407772148494e-05
domains O 0 2.684420451259939e-06
. O 0 5.783253413937928e-07

Germ O 0 0.0034400334116071463
- O 0 0.030594976618885994
line O 0 1.8745187162494403e-06
mutations O 0 5.117223622619349e-07
of O 0 7.063275520025059e-10
the O 0 1.5967998034938091e-09
BRCA1 O 0 5.833516638631409e-07
gene O 0 8.065860157557836e-08
predispose O 0 2.0522757893104426e-07
women O 0 2.9797573297685176e-09
to O 0 3.084810740183741e-10
early O 0 4.422484778388025e-08
- O 0 0.00616509048268199
onset O 0 0.07153793424367905
breast B-Disease 1 1.0
and I-Disease 1 0.9999986886978149
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.0307709130685794e-09
compromising O 0 6.007716706335486e-07
the O 0 1.5334147285273048e-09
genes O 0 1.230692276976697e-07
presumptive O 0 1.7994454992731335e-06
function O 0 3.040338114601582e-08
as O 0 6.3797540583721e-09
a O 0 3.500716161397577e-08
tumor B-Disease 0 1.4832285160082392e-05
suppressor O 0 8.403897663811222e-05
. O 0 4.354702923592413e-06

Although O 0 4.853417294725659e-07
the O 0 5.07098141255824e-09
biochemical O 0 1.6551301484923897e-07
properties O 0 5.983506667917027e-08
of O 0 7.842858584794499e-10
BRCA1 O 0 5.219176841819717e-07
polypeptides O 0 1.9257204542100226e-07
are O 0 1.9142565310659165e-09
not O 0 3.115328439662335e-09
understood O 0 7.678533364696705e-09
, O 0 3.194324527111547e-10
their O 0 3.5097114103876947e-10
expression O 0 8.249089411549448e-09
pattern O 0 2.3291620721010986e-07
and O 0 1.5314045143099975e-08
subcellular O 0 5.166647838450444e-07
localization O 0 1.0663458738235931e-07
suggest O 0 3.657142499946531e-08
a O 0 5.752992526808498e-10
role O 0 5.55334489504844e-09
in O 0 1.3322232206292028e-09
cell O 0 7.522090527345426e-06
- O 0 0.02442745305597782
cycle O 0 5.299832992022857e-06
regulation O 0 4.210557733586029e-07
. O 0 2.6038105715997517e-07

When O 0 1.1014546998922015e-06
resting O 0 5.09022925143654e-07
cells O 0 9.384103094589591e-08
are O 0 1.5976712175458374e-09
induced O 0 2.435359647279256e-08
to O 0 1.8884063757163005e-10
proliferate O 0 4.493731253774058e-08
, O 0 9.822238161705243e-11
the O 0 1.2818850148033079e-10
steady O 0 3.3082280026519584e-08
- O 0 1.9688812358253927e-07
state O 0 7.599735951657749e-09
levels O 0 4.406333076190094e-09
of O 0 4.4891583506068145e-11
BRCA1 O 0 4.0431256564943396e-08
increase O 0 8.065945134028141e-10
in O 0 7.112156003019621e-11
late O 0 3.1984597193002173e-09
G1 O 0 1.403683711487247e-07
and O 0 6.899549820360562e-10
reach O 0 7.035202420624387e-10
a O 0 3.5049482760562967e-10
maximum O 0 3.188348696170351e-09
during O 0 2.65871769045134e-08
S O 0 3.831903541140491e-06
phase O 0 4.2809412548194814e-07
. O 0 2.4827068045851775e-07

Moreover O 0 5.798595339001622e-06
, O 0 2.5450406226923405e-08
in O 0 1.8067430218593472e-08
S O 0 7.879472832428291e-06
phase O 0 4.5036503593109956e-07
cells O 0 2.0661107669184275e-07
, O 0 2.0390296118222295e-09
BRCA1 O 0 3.7871669178457523e-07
polypeptides O 0 1.6407000202889321e-07
are O 0 1.8873160811949674e-09
hyperphosphorylated O 0 1.5867034619532205e-07
and O 0 2.3991022501945736e-09
accumulate O 0 3.164479878137172e-08
into O 0 1.5932646313387977e-09
discrete O 0 5.955861297479714e-07
subnuclear O 0 3.386438766028732e-05
foci O 0 1.5687035556766205e-05
termed O 0 3.5832456433126936e-06
" O 0 2.418635176582029e-07
BRCA1 O 0 1.3155229680705816e-05
nuclear O 0 1.9069020709139295e-06
dots O 0 1.0750946785265114e-05
. O 0 9.162025094155979e-07

" O 0 2.4636733542138245e-06
BRCA1 O 0 2.8984703021706082e-05
associates O 0 2.704801090658293e-06
in O 0 2.9548434810067192e-09
vivo O 0 3.6865612855763175e-06
with O 0 2.791374686950121e-09
a O 0 2.7407295988268743e-08
structurally O 0 5.127460553921992e-06
related O 0 4.930430463900848e-07
protein O 0 1.6739742250138079e-06
termed O 0 5.557306849368615e-06
BARD1 O 0 0.00013734889216721058
. O 0 1.659294525779842e-06

Here O 0 1.4451950391958235e-07
we O 0 1.1830889157238289e-08
show O 0 2.5376811763067053e-09
that O 0 5.1220097607718174e-11
the O 0 4.933988287381119e-11
steady O 0 4.061769232066581e-08
- O 0 2.987168272738927e-07
state O 0 4.720187796181108e-09
levels O 0 4.133481557033747e-09
of O 0 1.613058991933869e-11
BARD1 O 0 3.456910491195231e-08
, O 0 1.978209089592564e-11
unlike O 0 2.589523317997333e-10
those O 0 1.9286808261576027e-10
of O 0 5.212165074541808e-11
BRCA1 O 0 3.809480517702468e-07
, O 0 1.1824408119309737e-09
remain O 0 3.5140805820788046e-09
relatively O 0 2.6437885214392054e-09
constant O 0 2.1907172964574784e-08
during O 0 8.978418719607362e-08
cell O 0 7.681885108468123e-06
cycle O 0 7.469249794667121e-06
progression O 0 3.921763891412411e-06
. O 0 6.445559961321123e-07

However O 0 3.619613551109069e-07
, O 0 1.002769245417312e-08
immunostaining O 0 1.2715802313323366e-06
revealed O 0 1.0777370818004783e-07
that O 0 5.7976525802416745e-09
BARD1 O 0 1.5348542774518137e-06
resides O 0 1.1410104860942738e-07
within O 0 6.949875341888401e-09
BRCA1 O 0 1.4195436506270198e-06
nuclear O 0 1.5419303167618637e-07
dots O 0 1.415085648659442e-07
during O 0 1.6782848888396984e-08
S O 0 7.547863560830592e-07
phase O 0 7.987152272903586e-09
of O 0 2.5582501395060575e-11
the O 0 1.3461794179381315e-10
cell O 0 5.334717911864573e-08
cycle O 0 1.8107206400941322e-08
, O 0 1.2133496984922942e-10
but O 0 3.696755956905662e-10
not O 0 3.0429109232343876e-10
during O 0 6.923780437873006e-10
the O 0 2.5656070601343117e-09
G1 O 0 2.295511876582168e-06
phase O 0 4.1486333657303476e-07
. O 0 2.0976507641989883e-07

Nevertheless O 0 8.678984158905223e-06
, O 0 6.005276276255245e-08
BARD1 O 0 1.1831248230009805e-06
polypeptides O 0 1.7932167395429133e-07
are O 0 9.234942810465441e-10
found O 0 7.500598475651543e-10
exclusively O 0 8.285478969582982e-10
in O 0 3.1474656214669494e-10
the O 0 1.542686950406491e-10
nuclear O 0 1.0149166840278667e-08
fractions O 0 1.1278518119439696e-09
of O 0 1.588650738737485e-11
both O 0 3.3919908548618594e-10
G1 O 0 4.2888197526735894e-07
- O 0 1.928067092649144e-07
and O 0 1.0183701881771867e-08
S O 0 5.4556903705815785e-06
- O 0 4.714607371170132e-07
phase O 0 2.0601412131782126e-07
cells O 0 3.2982237030410033e-07
. O 0 8.122813710542687e-08

Therefore O 0 3.4631014500519086e-07
, O 0 6.520192386005874e-09
progression O 0 3.9445886557132326e-08
to O 0 9.300492820329964e-09
S O 0 3.107923112111166e-05
phase O 0 2.0163986391708022e-07
is O 0 9.405490830616259e-10
accompanied O 0 7.90325527244562e-10
by O 0 1.0933907251819974e-10
the O 0 1.591362736030888e-10
aggregation O 0 9.317290050603333e-09
of O 0 8.04638411455727e-10
nuclear O 0 5.091525849820755e-07
BARD1 O 0 8.378723350688233e-07
polypeptides O 0 4.3985684783365286e-07
into O 0 6.404970775975016e-08
BRCA1 O 0 1.4290244507719763e-05
nuclear O 0 1.994524154724786e-06
dots O 0 1.0362305147282314e-05
. O 0 1.1027148048015079e-06

This O 0 5.652453793913992e-08
cell O 0 3.2515627026441507e-06
cycle O 0 3.987962827523006e-06
- O 0 5.950812919763848e-06
dependent O 0 3.8936579471737787e-07
colocalization O 0 4.4276248445385136e-07
of O 0 4.6519540997103093e-10
BARD1 O 0 1.4013819509273162e-06
and O 0 3.95217814030957e-09
BRCA1 O 0 2.269407985977523e-07
indicates O 0 5.591628937651194e-09
a O 0 1.757564926929689e-10
role O 0 5.518584700325846e-09
for O 0 6.77041256391675e-10
BARD1 O 0 7.51326240333583e-07
in O 0 7.730966089525282e-09
BRCA1 O 0 5.699937537428923e-05
- O 0 3.0922725272830576e-05
mediated O 0 1.685567076492589e-05
tumor B-Disease 0 1.4816577277088072e-05
suppression O 0 1.504157353338087e-06
. O 0 5.435236971607083e-07

Ethnic O 0 7.313414971577004e-05
differences O 0 1.8298793293070048e-05
in O 0 9.0916728368029e-08
the O 0 6.414482101035901e-08
HFE O 0 0.00025600497610867023
codon O 0 2.2448686650022864e-05
282 O 0 1.918029511216446e-06
( O 0 1.2192369069907727e-07
Cys O 0 0.010677022859454155
/ O 0 1.834593786043115e-05
Tyr O 0 2.5912664568750188e-05
) O 0 1.4081579990943283e-07
polymorphism O 0 1.0541046322032344e-05
. O 0 1.071730480362021e-06

Recent O 0 5.880873459318536e-07
studies O 0 1.4213762256076734e-07
have O 0 6.025478338500534e-09
shown O 0 5.7424415444984334e-08
that O 0 1.0012976190409972e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 9.14011081931676e-07
HH B-Disease 0 0.23267488181591034
) O 0 3.2181026732303053e-09
is O 0 2.8567295751180666e-10
likely O 0 2.992367020837605e-09
to O 0 7.085675379769896e-10
be O 0 2.9450870631109183e-09
caused O 0 5.538660086124025e-10
by O 0 4.619625168511554e-11
homozygosity O 0 3.448599272815045e-08
for O 0 9.326187738745162e-11
a O 0 8.080018876199802e-10
Cys282Tyr O 0 7.113237074918288e-07
mutation O 0 3.219906830054242e-07
in O 0 2.3553259342889987e-09
the O 0 5.040317052618093e-09
HFE O 0 1.4885010386933573e-05
gene O 0 5.113662382427719e-07
located O 0 1.2796333237474755e-07
4 O 0 1.9993181865629595e-07
. O 0 4.5785617430738057e-07

5 O 0 7.525843557232292e-06
Mb O 0 2.4230403141700663e-05
telomeric O 0 0.0001840521872509271
to O 0 4.0486983721166325e-07
HLA O 0 5.224334745435044e-05
- O 0 0.00012387913011480123
A O 0 5.55337862806482e-07
. O 0 7.953495924084564e-07

Population O 0 5.585129656537902e-07
studies O 0 1.0023259733316081e-07
of O 0 1.445341901717967e-10
this O 0 1.7755438785904687e-10
polymorphism O 0 5.786056433976228e-08
are O 0 1.8084374275861848e-10
facilitated O 0 5.566003213886006e-10
by O 0 6.499784738212e-11
the O 0 5.635823405181206e-11
fact O 0 8.704698073458417e-10
that O 0 2.6380450601770633e-10
the O 0 9.648205567813761e-10
Cys282Tyr O 0 8.90630417416105e-07
mutation O 0 3.075350036851887e-07
creates O 0 3.209975574236523e-08
a O 0 7.17550907580744e-09
Rsal O 0 1.1956722119066399e-06
restriction O 0 1.0894328283939103e-07
site O 0 3.149571057292633e-07
. O 0 2.3509429070145416e-07

We O 0 5.405792080637184e-07
have O 0 5.676933589882083e-09
studied O 0 3.060433684254349e-08
the O 0 3.3942515464957523e-09
codon O 0 1.097860717891308e-06
282 O 0 1.8553521385911154e-07
( O 0 1.8505202703522627e-08
Cys O 0 0.0003677081549540162
/ O 0 1.5846393353058374e-06
Tyr O 0 1.6383593219870818e-06
) O 0 1.93204674481251e-09
polymorphism O 0 6.182033018831135e-08
in O 0 5.598904673220773e-10
different O 0 1.977045638312802e-09
ethnic O 0 9.076027396304198e-08
groups O 0 3.447508163390012e-07
. O 0 4.099795773981896e-07

In O 0 1.0187221732849139e-07
agreement O 0 3.855741326219686e-08
with O 0 6.518224293650121e-10
previous O 0 4.62460203465298e-09
observations O 0 1.4320892027797072e-08
the O 0 8.263273953978967e-10
Tyr O 0 2.18200227664056e-07
allele O 0 4.3374257074901834e-08
appeared O 0 1.8262061862728274e-09
to O 0 1.1233192154236349e-10
be O 0 1.1215486872551139e-10
rare O 0 6.110215111654327e-10
or O 0 3.0085227642473455e-09
absent O 0 3.9925023287423755e-08
in O 0 3.2256368687200165e-09
Asiatic O 0 3.58453320359331e-08
( O 0 3.2921987358491833e-10
Indian O 0 2.56986298907691e-09
, O 0 2.398488074817351e-10
Chinese O 0 3.9169420484874706e-10
) O 0 2.023439638065838e-09
populations O 0 7.512661426289924e-08
. O 0 1.067654409325769e-07

The O 0 1.3775873242138914e-07
highest O 0 3.2855095355444064e-07
allele O 0 6.600224082831119e-07
frequency O 0 5.648287242365768e-07
( O 0 2.0106554199372795e-09
7 O 0 1.6732978336264637e-09
. O 0 3.517793834006966e-10
5 O 0 5.500402355806955e-10
% O 0 2.8751512282099156e-10
) O 0 3.086782218719719e-10
was O 0 1.806638727508414e-09
found O 0 4.574491896391919e-09
in O 0 9.711018655877979e-09
Swedes O 0 7.552777969976887e-05
. O 0 2.9694422210013727e-07

Saamis O 0 8.079139661276713e-05
( O 0 5.616109177708495e-08
2 O 0 1.992115805649064e-08
% O 0 3.164248862930208e-09
) O 0 4.776918860471824e-10
and O 0 7.135394497481684e-10
Mordvinians O 0 8.035027576624998e-08
( O 0 1.6626997001445432e-10
1 O 0 3.4882885469045277e-10
. O 0 2.4259552700023335e-10
8 O 0 5.932964119992334e-10
% O 0 1.1049043624478116e-10
) O 0 2.6203078595798956e-10
had O 0 4.610792192494273e-09
significantly O 0 1.7869101753831274e-08
lower O 0 9.67707158849862e-09
frequencies O 0 4.2853322668179317e-08
of O 0 7.388257783347285e-10
the O 0 9.30826615785918e-09
Tyr O 0 8.648421498946846e-06
allele O 0 3.1277431844500825e-06
. O 0 3.9157217202046013e-07

Comparisons O 0 4.4034285906491277e-07
with O 0 4.349585580598614e-09
allele O 0 9.449499316360743e-08
frequencies O 0 6.876761915464158e-08
based O 0 1.2522583858753933e-08
on O 0 5.8814544345864306e-09
prevalence O 0 9.011494057631353e-07
estimates O 0 4.832116928810137e-08
of O 0 7.912939192777912e-10
HH B-Disease 1 0.7812405824661255
showed O 0 3.167426854133737e-08
some O 0 1.7735740653890275e-10
disagreements O 0 5.4830621820656233e-08
with O 0 9.601534151082447e-11
the O 0 1.618702949457429e-10
RFLP O 0 5.4715076913680605e-08
data O 0 2.559516820710428e-09
, O 0 1.1279716743972656e-10
particularly O 0 9.555627400459343e-10
in O 0 4.8257131624040994e-09
Finns O 0 3.3734081625880208e-06
. O 0 1.4577027229734085e-07

The O 0 2.5542081516505277e-07
newly O 0 4.898261067864951e-07
described O 0 6.15893043232063e-08
HFE O 0 4.3931954678555485e-06
marker O 0 3.245492052883492e-07
provides O 0 3.914494506318533e-09
a O 0 5.717342710376272e-10
new O 0 7.668810031447038e-10
approach O 0 2.6630555538531553e-09
to O 0 1.057450862984588e-10
the O 0 1.110202485499201e-10
screening O 0 1.3248425467793368e-08
of O 0 1.236657998227031e-10
HH B-Disease 0 7.464080226782244e-06
as O 0 7.131666368564993e-10
well O 0 5.717648576819556e-10
as O 0 3.432937267788816e-10
studies O 0 1.7865684487361477e-09
of O 0 1.1135229890935072e-11
the O 0 2.2470467153645757e-10
relationship O 0 2.4498957529317522e-08
between O 0 2.329346937557375e-09
the O 0 6.729989010523241e-09
HFE O 0 2.4385342840105295e-05
Tyr O 0 1.229943109137821e-06
allele O 0 3.754467172711884e-07
and O 0 6.094574622750315e-09
different O 0 2.5193079622454206e-08
disorders O 0 3.3404852729290724e-05
including O 0 2.295769547799864e-07
cancer B-Disease 0 0.0007741130539216101

Autosomal B-Disease 1 0.9994229078292847
dominant I-Disease 1 0.9987838864326477
neurohypophyseal I-Disease 1 0.999870777130127
diabetes I-Disease 1 0.999998927116394
insipidus I-Disease 1 0.997323215007782
associated O 0 3.6266317238187185e-06
with O 0 2.645131580436555e-08
a O 0 8.48257073471359e-08
missense O 0 3.673536775750108e-05
mutation O 0 3.2225318591372343e-06
encoding O 0 1.5555881418549689e-06
Gly23 O 0 9.017748379847035e-05
- O 0 0.002146268030628562
- O 0 7.967376586748287e-05
> O 0 2.7790201784227975e-06
Val O 0 0.0001349265075987205
in O 0 8.276357021941294e-08
neurophysin O 0 3.44527761626523e-05
II O 0 9.867166227195412e-06
. O 0 9.004672847368056e-07

Autosomal B-Disease 1 0.9989751577377319
dominant I-Disease 1 0.9980695843696594
neurohypophyseal I-Disease 1 0.9998629093170166
diabetes I-Disease 1 0.9999973773956299
insipidus I-Disease 1 0.9899780750274658
( O 0 6.742145330917992e-08
ADNDI B-Disease 0 5.822239472763613e-06
) O 0 3.6721476970313915e-09
is O 0 3.2061862054177936e-09
an O 0 7.377295219157531e-08
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 5.846331987413578e-06
by O 0 7.029894444343654e-09
progressive O 0 1.8268327721671085e-06
degeneration O 0 7.83601626608288e-06
of O 0 1.215926470621298e-09
the O 0 2.4637791806725318e-09
magnocellular O 0 1.9424476249696454e-06
neurons O 0 1.8119304456831742e-07
of O 0 1.3613567217962697e-10
the O 0 2.1719594178737367e-10
hypothalamus O 0 2.2327069970629054e-08
leading O 0 9.635704678601087e-09
to O 0 1.494873447249745e-09
decreased O 0 1.8534590751073665e-08
ability O 0 5.679662962165821e-09
to O 0 6.696271870332282e-10
produce O 0 4.124637076330373e-09
the O 0 5.264836122620409e-09
hormone O 0 6.816781024099328e-07
arginine O 0 3.567162139006541e-07
vasopressin O 0 9.851677305050544e-07
( O 0 8.54852544307505e-09
AVP O 0 1.4145704199108877e-06
) O 0 2.3489969080969786e-08
. O 0 8.96731151556196e-08

Affected O 0 1.0196411039942177e-06
individuals O 0 5.394933388913614e-09
are O 0 8.039113263969e-10
not O 0 1.2352039391316794e-09
symptomatic O 0 1.510460023723681e-08
at O 0 1.1168316271792378e-09
birth O 0 5.733759689263707e-09
, O 0 8.246882621243401e-10
but O 0 1.5248350138108435e-08
usually O 0 2.1583875309261202e-07
develop O 0 2.1211478724580957e-06
diabetes B-Disease 0 7.009467663010582e-05
insipidus I-Disease 0 1.543876715004444e-05
at O 0 2.4827675915162217e-08
1 O 0 6.397010565706296e-08
- O 0 0.00010928002302534878
6 O 0 1.8238389998259663e-07
yr O 0 7.811267096258234e-06
of O 0 2.345145633242396e-09
age O 0 7.538282176255962e-08
. O 0 7.378603328334066e-08

The O 0 1.3899074247092358e-07
genetic O 0 1.4781286381548853e-06
locus O 0 1.299960899814323e-06
of O 0 2.418684141858307e-09
the O 0 6.641440730703607e-09
disease O 0 3.549874918462592e-07
is O 0 4.5490133881997963e-10
the O 0 2.4117787766897436e-09
AVP O 0 0.0005167862982489169
- O 0 7.888924301369116e-05
neurophysin O 0 3.227474735467695e-05
II O 0 2.831546339621127e-07
( O 0 5.862120788791003e-10
NPII O 0 5.521409107700492e-08
) O 0 5.6577194318396806e-11
gene O 0 1.5214989268486079e-09
, O 0 2.6468346958630207e-10
and O 0 8.015442753972479e-10
mutations O 0 5.08423276812664e-08
that O 0 3.6212047249684076e-10
cause O 0 1.6956397397294154e-09
ADNDI B-Disease 0 8.135719440360845e-07
have O 0 2.7617816922287375e-09
been O 0 2.568422363680156e-09
found O 0 8.393368777781518e-10
in O 0 2.367752105492116e-10
both O 0 5.525692126084891e-10
the O 0 2.9376576171635804e-10
signal O 0 6.295525878385888e-09
peptide O 0 1.5076616621811922e-09
of O 0 2.426203855876441e-11
the O 0 4.614378878997627e-10
prepro O 0 2.3532065824838355e-06
- O 0 1.5651684179829317e-06
AVP O 0 1.5321926184697077e-05
- O 0 3.8977933058959024e-07
NPII O 0 7.563153303635772e-07
precursor O 0 4.0442365900617006e-08
and O 0 1.2282337369384777e-09
within O 0 2.8862019441078246e-09
NPII O 0 1.7899276372190798e-06
itself O 0 1.918095762221128e-07
. O 0 1.5473364101126208e-07

An O 0 1.823937445522006e-08
affected O 0 7.394439194285951e-08
girl O 0 4.971120119989791e-07
who O 0 1.8694565895316373e-09
presented O 0 4.2801404087633443e-10
at O 0 3.717076368925376e-10
9 O 0 2.2623303230773217e-10
months O 0 1.6747698783348142e-09
of O 0 1.4499522242583662e-11
age O 0 3.3992662018533792e-09
and O 0 1.7691894615978754e-09
her O 0 1.0208672129863317e-08
similarly O 0 5.0909477522509405e-08
affected O 0 7.121855549740985e-09
younger O 0 1.4398560121975379e-09
brother O 0 1.3093894857263422e-09
and O 0 3.081846722263748e-10
father O 0 1.1790154408330977e-09
were O 0 5.467297725658682e-10
all O 0 1.824923025195435e-11
found O 0 9.950138629699623e-11
to O 0 1.1500127239383318e-10
have O 0 1.1272324185185312e-09
a O 0 5.362685850940352e-10
novel O 0 1.0480210477226137e-07
missense O 0 3.0740234251425136e-06
mutation O 0 4.7566757643835444e-07
( O 0 3.0406612783195897e-09
G1758 O 0 6.360244242387125e-07
- O 0 9.466522897128016e-06
- O 0 4.424755843501771e-06
> O 0 1.0493231883401677e-07
T O 0 4.737959500289435e-07
) O 0 4.58831361793699e-10
encoding O 0 3.485364219457665e-09
the O 0 5.52485890370491e-10
amino O 0 1.487763245933138e-08
acid O 0 6.540096020302144e-09
substitution O 0 6.3330776178815995e-09
Gly23 O 0 1.0092230695590843e-06
- O 0 2.7207065613765735e-06
- O 0 3.8267471609287895e-06
> O 0 7.089460041243001e-07
Val O 0 1.2846866411564406e-05
within O 0 8.358023961818617e-08
NPII O 0 2.4796858269837685e-05
. O 0 3.3442321978327527e-07

The O 0 1.8767282483622694e-07
mutation O 0 3.353581632836722e-06
was O 0 5.629589949762703e-08
confirmed O 0 9.39072375416572e-09
by O 0 6.298668808746299e-10
restriction O 0 4.628611094403823e-08
endonuclease O 0 2.9039231321803527e-06
analysis O 0 9.291876494899043e-07
. O 0 5.010051040699182e-07

A O 0 5.602258852377417e-07
T1 O 0 3.639257556642406e-05
- O 0 1.0425239906908246e-06
weighted O 0 5.297465222042774e-08
magnetic O 0 1.8427222414629796e-08
resonance O 0 2.2692738355090114e-07
imaging O 0 1.2849219274357893e-05
of O 0 1.4919340207697473e-09
the O 0 7.900350595946293e-09
fathers O 0 9.528806117486965e-07
pituitary O 0 4.551953225018224e-06
gland O 0 1.6107053397718119e-06
demonstrates O 0 4.281549337292745e-08
an O 0 6.542765884631763e-09
attenuated O 0 8.91876425157534e-06
posterior O 0 0.0002715258451644331
pituitary O 0 0.0012231370201334357
bright O 0 1.6886175217223354e-05
spot O 0 1.2810067346435972e-05
. O 0 2.0793358999071643e-06

This O 0 4.131355169079143e-08
mutation O 0 2.745198628417711e-07
may O 0 5.902266675406054e-09
be O 0 2.236633447894043e-11
valuable O 0 1.8611906460463956e-10
for O 0 1.021859749594789e-10
developing O 0 1.871118815444106e-09
models O 0 2.763574613595665e-08
of O 0 6.485311176973596e-10
dominantly B-Disease 0 5.1977138355141506e-05
inherited I-Disease 1 0.9783174991607666
neurodegeneration I-Disease 1 1.0
, O 0 2.9474416241015433e-09
as O 0 1.2397755044801784e-10
the O 0 4.5159868899968814e-11
early O 0 1.0962339480613537e-08
age O 0 3.954364835578872e-09
of O 0 1.6741590058710898e-10
onset O 0 6.199479685164988e-07
of O 0 2.070492000072477e-09
symptoms O 0 3.6229980082680413e-07
suggests O 0 3.274746029902076e-09
that O 0 1.0888101531492111e-10
this O 0 1.6166326610722592e-10
mutation O 0 4.944169873510873e-08
may O 0 7.0691696940627935e-09
be O 0 2.9020930103484943e-10
particularly O 0 3.0789633065353428e-09
deleterious O 0 1.7644934757754527e-07
to O 0 3.090890210444286e-09
the O 0 8.297882381214094e-09
magnocellular O 0 5.835609044879675e-06
neuron O 0 7.325274964387063e-07
. O 0 5.059313679112165e-08
. O 0 2.0208918272146548e-07

Frequent O 0 0.00013704327284358442
inactivation O 0 0.00016113626770675182
of O 0 4.916850926406369e-08
PTEN O 0 0.00016346049960702658
/ O 0 1.7404403479304165e-05
MMAC1 O 0 3.1785148166818544e-05
in O 0 4.2675671352299105e-07
primary O 1 0.9995288848876953
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.474107643341995e-06

Sporadic B-Disease 1 0.9846389889717102
prostate I-Disease 1 0.9999955892562866
carcinoma I-Disease 1 1.0
is O 0 7.555311754003924e-08
the O 0 4.401727593528193e-10
most O 0 5.649580803179788e-10
common O 0 9.614501195187586e-09
male B-Disease 0 1.0014545637204719e-07
cancer I-Disease 0 1.1732858951063463e-07
in O 0 2.6882240877768027e-10
the O 0 2.2930050913583244e-10
Western O 0 9.630560349194184e-09
world O 0 8.562167863601644e-09
, O 0 5.855681217692421e-11
yet O 0 2.812236277183189e-10
many O 0 2.5343121698440108e-11
of O 0 3.162977041740178e-12
the O 0 2.2420579282034225e-11
major O 0 4.073061055098748e-10
genetic O 0 2.973619794843785e-09
events O 0 3.111556012846961e-10
involved O 0 7.604893936807855e-10
in O 0 1.3377481067333719e-10
the O 0 4.677772405536906e-11
progression O 0 8.705959841925903e-10
of O 0 1.9374179344167075e-11
this O 0 5.373846367895396e-10
often O 0 2.836183512044954e-06
fatal O 0 0.10795958340167999
cancer B-Disease 0 0.00024102727184072137
remain O 0 2.9978185267509616e-08
to O 0 2.68395261571186e-09
be O 0 1.061538057456346e-08
elucidated O 0 5.175024398340611e-06
. O 0 4.384107512578339e-07

Numerous O 0 3.626340685514151e-07
cytogenetic O 0 6.029972792020999e-05
and O 0 4.486049576257756e-08
allelotype O 0 9.000286240734567e-07
studies O 0 5.6104560997027875e-08
have O 0 3.0104572168454524e-09
reported O 0 1.7955194664409646e-08
frequent O 0 1.3774125307008944e-07
loss O 0 2.280981732383225e-07
of O 0 6.194869617281995e-10
heterozygosity O 0 2.0938796296832152e-05
on O 0 5.0917826399654587e-08
chromosomal O 0 0.32661208510398865
arm O 0 0.0003440506407059729
10q O 0 1.3665237929672003e-05
in O 0 1.9718989108241658e-07
sporadic B-Disease 1 0.9976121187210083
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.3295981463888893e-06

Deletion O 0 3.621296855271794e-05
mapping O 0 4.632966465578647e-06
studies O 0 5.556621545110829e-07
have O 0 7.565012616339573e-09
unambiguously O 0 1.068190158548532e-07
identified O 0 2.7667020674471132e-08
a O 0 2.1543511419253036e-09
region O 0 2.1677442063605667e-08
of O 0 1.5830917132753086e-10
chromosome O 0 7.986881200849894e-08
10q23 O 0 5.000294223123092e-08
to O 0 3.8445019390209723e-10
be O 0 2.7403507241174907e-10
the O 0 8.130304068876271e-11
minimal O 0 1.0405494244025704e-08
area O 0 2.0383151166925018e-08
of O 0 3.567608874988082e-09
loss O 0 2.943819026768324e-06
. O 0 2.7552175652090227e-07

A O 0 7.659460834474885e-07
new O 0 3.3652966635600023e-07
tumor B-Disease 0 4.484365490498021e-06
suppressor O 0 3.0830310606688727e-06
gene O 0 3.4171819152106764e-06
, O 0 2.71473705737435e-08
PTEN O 0 2.1736232156399637e-05
/ O 0 2.8266945264476817e-06
MMAC1 O 0 1.2929486729262862e-05
, O 0 3.1828377711207168e-09
was O 0 2.536234333661014e-09
isolated O 0 1.7244534689098145e-08
recently O 0 2.11005931305408e-06
at O 0 4.076700310662318e-09
this O 0 4.585216373254042e-10
region O 0 7.608758068045063e-09
of O 0 1.261787480055787e-10
chromosome O 0 8.959806052644126e-08
10q23 O 0 9.795124356060114e-08
and O 0 3.9199840595749436e-10
found O 0 3.197158648937659e-10
to O 0 4.8978612832151214e-11
be O 0 2.9940552814800014e-10
inactivated O 0 8.742805590600256e-09
by O 0 1.3886466976309464e-10
mutation O 0 2.3826638440027637e-08
in O 0 6.545786135347953e-09
three O 0 2.4365632270928472e-05
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 2.19481298699975e-05
lines O 0 6.0426886193454266e-05
. O 0 9.842727877185098e-07

We O 0 2.225692924184841e-06
screened O 0 1.2217632502142806e-05
80 O 0 1.6313556443492416e-06
prostate B-Disease 1 0.9088094830513
tumors I-Disease 1 1.0
by O 0 7.317158878805685e-09
microsatellite O 0 4.05749051424209e-06
analysis O 0 1.0842958886314591e-07
and O 0 3.248394442323388e-09
found O 0 2.7244149158889286e-09
chromosome O 0 8.621707792144662e-08
10q23 O 0 1.293922338163611e-07
to O 0 4.249643970055672e-10
be O 0 3.091601974425373e-10
deleted O 0 2.1851668918770883e-08
in O 0 1.6351844323025944e-09
23 O 0 5.912542455632774e-09
cases O 0 3.2576096486991446e-08
. O 0 2.8683356845249364e-07

We O 0 8.777284961070109e-07
then O 0 1.6570185223940825e-08
proceeded O 0 7.220912312533301e-09
with O 0 6.048743450559613e-11
sequence O 0 1.133443672252099e-09
analysis O 0 3.74191833074633e-09
of O 0 7.106867871975453e-11
the O 0 1.1200955718493333e-09
entire O 0 9.441680504096439e-08
PTEN O 0 4.666611857828684e-05
/ O 0 8.576200229981623e-07
MMAC1 O 0 3.906440724676941e-06
coding O 0 4.49360368293128e-06
region O 0 8.0331737706274e-08
and O 0 2.8398519091865637e-09
tested O 0 4.965260647082914e-09
for O 0 7.077135405486601e-11
homozygous O 0 2.0378331910819725e-08
deletion O 0 2.167438317712822e-08
with O 0 2.104416640946738e-10
new O 0 1.3255115893784364e-09
intragenic O 0 3.276472071434e-08
markers O 0 2.8199201196343893e-08
in O 0 2.5990834484623804e-10
these O 0 1.92623958450433e-10
23 O 0 4.57792831420889e-10
cases O 0 5.248560475124009e-10
with O 0 9.564690151009358e-10
10q23 O 0 1.219617615788593e-06
loss O 0 1.0926896010232667e-07
of O 0 3.5012084342866956e-09
heterozygosity O 0 6.570662662852556e-05
. O 0 9.120536219597852e-07

The O 0 3.792575142824717e-09
identification O 0 7.975399896054114e-09
of O 0 1.0110128706442012e-10
the O 0 2.2847276848203535e-10
second O 0 3.1397322519666204e-09
mutational O 0 6.275890314100252e-07
event O 0 2.0125865418663125e-08
in O 0 9.887410890030424e-10
10 O 0 7.334398088865157e-10
( O 0 3.4081909516814335e-10
43 O 0 1.1134120292410898e-08
% O 0 7.808740321024743e-09
) O 0 2.508694763037056e-07
tumors B-Disease 1 1.0
establishes O 0 3.862922312691808e-06
PTEN O 0 4.202700438327156e-05
/ O 0 1.4819044054092956e-06
MMAC1 O 0 2.2943650037632324e-06
as O 0 3.330353548491871e-09
a O 0 1.447903130724626e-09
main O 0 2.2747203232142965e-08
inactivation O 0 1.6191204394999659e-06
target O 0 3.385731162097727e-08
of O 0 1.0953424278703494e-10
10q O 0 2.788593747027335e-07
loss O 0 9.976491810448351e-08
in O 0 2.0591663485447498e-08
sporadic B-Disease 1 0.9994575381278992
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1612545591788148e-07
. O 0 3.0487123581224296e-07

Risk O 0 0.00016017760208342224
reversals O 0 2.1239980014797766e-06
in O 0 5.926813706480516e-09
predictive O 0 1.2165137377451174e-06
testing O 0 5.739144626204506e-07
for O 0 9.277251677985987e-08
Huntington B-Disease 1 0.9999994039535522
disease I-Disease 1 0.9999996423721313
. O 0 1.5625226978954743e-06

The O 0 1.0964304131277913e-08
first O 0 3.125893321964668e-09
predictive O 0 2.0753765284098336e-07
testing O 0 1.1535480126667608e-07
for O 0 1.658536241677666e-08
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999997615814209
( O 0 3.3939471233424e-09
HD B-Disease 0 3.6526300391415134e-05
) O 0 3.462108155716237e-09
was O 0 6.3134386607544e-10
based O 0 5.537983405190516e-10
on O 0 3.7758421389533225e-10
analysis O 0 6.317899536867344e-09
of O 0 2.1258991789174786e-10
linked O 0 1.5893508020781155e-07
polymorphic O 0 4.3924060832978284e-08
DNA O 0 2.9520792921289285e-08
markers O 0 1.812714423010675e-08
to O 0 4.029111211334424e-10
estimate O 0 5.297219995981095e-09
the O 0 2.5567295502959553e-10
likelihood O 0 8.417083918743629e-09
of O 0 7.44654130024891e-11
inheriting O 0 2.1428203211826258e-08
the O 0 4.960459265568318e-10
mutation O 0 1.6966539817531157e-07
for O 0 8.613633362131168e-09
HD B-Disease 0 3.3803888072725385e-05
. O 0 4.037778467136377e-07

Limits O 0 3.253847467021842e-07
to O 0 3.5521279251327087e-09
accuracy O 0 3.667697257014879e-08
included O 0 1.9353736391281018e-09
recombination O 0 1.690254514130629e-08
between O 0 9.185754934470935e-10
the O 0 1.9211174318023438e-10
DNA O 0 1.824908402170422e-08
markers O 0 5.992860963033309e-08
and O 0 1.811179095589921e-09
the O 0 8.537537898867242e-10
mutation O 0 2.343823837236414e-07
, O 0 9.18561449125832e-10
pedigree O 0 1.2328230525326944e-07
structure O 0 6.245725359121934e-08
, O 0 9.691918378962328e-10
and O 0 2.2815488387450955e-10
whether O 0 6.454780598907917e-10
DNA O 0 9.903912356890032e-09
samples O 0 2.0534116629278287e-09
were O 0 3.5646685603296646e-10
available O 0 1.188319220801759e-09
from O 0 6.02701555330043e-10
family O 0 1.2916791192196797e-08
members O 0 8.738037848843305e-09
. O 0 2.3535629622983834e-07

With O 0 1.596779419799077e-08
direct O 0 4.078988879996359e-08
tests O 0 6.286541065492202e-08
for O 0 1.6545059766670533e-10
the O 0 2.0108269216390084e-10
HD B-Disease 0 4.1797434846557735e-07
mutation O 0 1.7373752214666638e-08
, O 0 1.764265400439058e-10
we O 0 1.9038490228773242e-10
have O 0 4.882462142918875e-11
assessed O 0 3.7955832921099386e-10
the O 0 2.914039148871339e-11
accuracy O 0 1.295735785333818e-08
of O 0 2.720507152886853e-11
results O 0 1.3267207332745556e-09
obtained O 0 6.1662003281171e-10
by O 0 7.153514586244469e-11
linkage O 0 1.125125770329305e-08
approaches O 0 6.490982862317196e-09
when O 0 1.033274688033714e-09
requested O 0 2.8105417992918547e-10
to O 0 1.56886184599081e-10
do O 0 1.2950308603265626e-09
so O 0 7.318687322843687e-11
by O 0 4.941598172325534e-11
the O 0 1.3551347821660897e-09
test O 0 6.498888183159579e-08
individuals O 0 6.2628053854041354e-09
. O 0 6.755275450132103e-08

For O 0 5.2081059465081125e-09
six O 0 3.665134584718288e-10
such O 0 3.0018074831383856e-11
individuals O 0 1.0037708858545713e-10
, O 0 1.3010763300069783e-10
there O 0 2.9325519790290855e-10
was O 0 5.511453071704864e-09
significant O 0 3.446309460031216e-09
disparity O 0 4.083122107090276e-08
between O 0 1.4894177002844344e-09
the O 0 4.088528626766674e-09
tests O 0 3.1274757361643424e-07
. O 0 5.776837497251108e-08

Three O 0 3.78956137581099e-08
went O 0 1.8573093285567666e-08
from O 0 4.562577260447398e-10
a O 0 6.619659265183486e-10
decreased O 0 1.703335215097468e-07
risk O 0 2.862962844574213e-07
to O 0 1.7312340450104102e-10
an O 0 6.556788445521988e-11
increased O 0 1.377426350757105e-08
risk O 0 3.257585774463223e-07
, O 0 8.155216085770078e-11
while O 0 2.216851285874455e-10
in O 0 3.080563928947733e-11
another O 0 1.0951334977749028e-10
three O 0 5.580524375936591e-10
the O 0 5.683434167735868e-09
risk O 0 0.00012886783224530518
was O 0 1.0406213135638609e-07
decreased O 0 1.056159703693993e-06
. O 0 3.6278592574490176e-07

Knowledge O 0 1.7555839804117568e-07
of O 0 4.1116118842943195e-10
the O 0 2.740418725277749e-10
potential O 0 3.5673910492306504e-09
reasons O 0 1.0948415507527898e-09
for O 0 1.5792247717860697e-11
these O 0 5.2374778125585664e-11
changes O 0 3.9188474687534836e-10
in O 0 4.083079430117209e-10
results O 0 5.175746409236126e-08
and O 0 2.0149475421504803e-09
impact O 0 5.833658445197898e-09
of O 0 2.446063143701771e-11
these O 0 1.0133164307646325e-09
risk O 0 2.7159385851405204e-08
reversals O 0 1.6138061553760963e-08
on O 0 6.467547608579594e-10
both O 0 9.693230662577434e-10
patients O 0 2.8906039784004633e-09
and O 0 8.23747806077968e-11
the O 0 9.332558337238339e-11
counseling O 0 6.1479541457742926e-09
team O 0 1.318953835038883e-10
can O 0 4.287344784748015e-11
assist O 0 2.2303754329544567e-11
in O 0 8.554307262542693e-11
the O 0 7.611362234927199e-11
development O 0 5.2888051577104633e-11
of O 0 5.037752767028669e-12
strategies O 0 6.202401370281052e-10
for O 0 2.1626405527497283e-11
the O 0 4.940260006636166e-11
prevention O 0 8.386408234528631e-10
and O 0 3.5651989693796793e-10
, O 0 2.945567054157827e-11
where O 0 1.081248077183794e-10
necessary O 0 4.895202021515388e-10
, O 0 1.29489932665372e-10
management O 0 3.096695122550841e-10
of O 0 7.146283131226339e-12
a O 0 1.1904311980615034e-09
risk O 0 1.0221047830327734e-07
reversal O 0 2.3496019352364783e-08
in O 0 1.476699179603358e-10
any O 0 1.6447435635669194e-09
predictive O 0 2.2378920050414308e-07
testing O 0 4.072645509722861e-08
program O 0 7.84049891677796e-09
. O 0 2.486377548294172e-09
. O 0 2.7922389733703312e-08

A O 0 1.4976974682667787e-07
novel O 0 3.171634546106361e-07
common O 0 2.1954863882456266e-07
missense O 0 2.0565679733408615e-05
mutation O 0 3.555747071004589e-06
G301C O 0 1.1883263368872576e-06
in O 0 3.1093385643998772e-09
the O 0 1.3032949164326624e-09
N O 0 2.344307404200663e-06
- O 0 2.767602836684091e-06
acetylgalactosamine O 0 2.9170492780394852e-05
- O 0 9.425093594472855e-06
6 O 0 1.4761859290501889e-07
- O 0 1.3472231330524664e-06
sulfate O 0 2.326467665625387e-06
sulfatase O 0 8.324227565026376e-06
gene O 0 3.299510638044012e-07
in O 0 1.7384691020083665e-08
mucopolysaccharidosis B-Disease 0 1.28227529785363e-05
IVA I-Disease 0 8.433248876826838e-05
. O 0 6.859849008833407e-07

Mucopolysaccharidosis B-Disease 0 0.003037425223737955
IVA I-Disease 0 0.017420679330825806
( O 0 1.6118285657285014e-06
MPS B-Disease 1 0.9999997615814209
IVA I-Disease 1 1.0
) O 0 1.0822437168656052e-08
is O 0 1.6312221573500096e-09
an O 0 1.4152212735041303e-08
autosomal B-Disease 1 0.9998456239700317
recessive I-Disease 1 0.9998800754547119
lysosomal I-Disease 1 0.9998561143875122
storage I-Disease 1 0.9999445676803589
disorder I-Disease 1 0.9999998807907104
caused O 0 3.232480139558902e-06
by O 0 8.231454629026302e-09
a O 0 1.312322638113983e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 3.45915296406929e-08
N O 0 0.00028937432216480374
- O 0 1.5512887330260128e-05
acetylgalactosamine O 0 0.0005923592252656817
- O 0 2.0167317416053265e-05
6 O 0 2.4498777406734007e-07
- O 0 3.656783974292921e-06
sulfate O 0 6.660167855443433e-06
sulfatase O 0 1.1961778000113554e-05
( O 0 3.021870975672414e-09
GALNS O 0 7.749983979010722e-07
) O 0 1.779909553079051e-08
. O 0 8.210901114580338e-08

In O 0 3.6560891203407664e-08
previous O 0 2.1893930224337055e-08
studies O 0 9.154923041876373e-09
, O 0 2.2018495360320856e-10
we O 0 7.587941941444853e-10
have O 0 1.504179558686758e-10
found O 0 2.338252924616313e-10
two O 0 1.592577320019828e-10
common O 0 5.890907317507299e-09
mutations O 0 7.505042276534368e-08
in O 0 8.451329081005099e-10
Caucasians O 0 3.567097621726134e-07
and O 0 7.22683735077112e-09
Japanese O 0 4.275836573697234e-08
, O 0 1.7085672876504532e-09
respectively O 0 8.408760265865567e-08
. O 0 1.55478872443382e-07

To O 0 2.9846621174556276e-08
characterize O 0 3.407070607863716e-07
the O 0 2.972905255305136e-09
mutational O 0 9.52931486608577e-07
spectrum O 0 2.1876148892374658e-08
in O 0 4.704582279302372e-10
various O 0 2.833060730456083e-10
ethnic O 0 1.5316265589149225e-08
groups O 0 1.8929736000927733e-08
, O 0 2.371432161751841e-09
mutations O 0 6.411717379251058e-08
in O 0 4.696208422139136e-10
the O 0 4.720005497560464e-10
GALNS O 0 2.886396828216675e-07
gene O 0 5.2920118065458155e-08
in O 0 5.46697753733838e-09
Colombian O 0 3.6977971831220202e-06
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
patients O 0 1.2080463420716114e-06
were O 0 4.801271602516977e-10
investigated O 0 1.0782835957456882e-08
, O 0 2.1537173433561208e-10
and O 0 3.703425066614585e-10
genetic O 0 2.7669502244975774e-08
backgrounds O 0 1.708206553985292e-08
were O 0 2.961669243184417e-10
extensively O 0 2.735704107692527e-09
analyzed O 0 9.179559334882015e-09
to O 0 3.2902086610775427e-10
identify O 0 1.1615211015225668e-08
racial O 0 2.1338555811212245e-08
origin O 0 6.205161717787178e-09
, O 0 2.0289418756203048e-10
based O 0 1.2222464151889767e-09
on O 0 1.4641772239087913e-09
mitochondrial O 0 9.3821341806688e-08
DNA O 0 8.289389370474964e-07
( O 0 9.75985514628519e-09
mtDNA O 0 5.663406454914366e-07
) O 0 3.900663259059911e-08
lineages O 0 8.789355661065201e-07
. O 0 8.64325784277753e-07

Three O 0 4.6742385961806576e-07
novel O 0 9.412081567461428e-07
missense O 0 2.648150075401645e-05
mutations O 0 6.008403033774812e-06
never O 0 7.02639795235882e-07
identified O 0 2.971886381430977e-08
previously O 0 3.6909382217231723e-09
in O 0 1.9279670915306468e-10
other O 0 1.6698505078682757e-10
populations O 0 4.33502478358605e-09
and O 0 1.687676554062989e-09
found O 0 1.8819819036508534e-09
in O 0 3.5863417791048846e-10
16 O 0 6.363684579291373e-10
out O 0 1.853428938103363e-10
of O 0 2.47286913168665e-10
19 O 0 4.155046795517592e-08
Colombian O 0 6.535573902510805e-06
MPS B-Disease 1 0.999998927116394
IVA I-Disease 1 0.9999963045120239
unrelated O 0 7.401825996566913e-07
alleles O 0 3.8406730595852423e-07
account O 0 7.016340930476872e-08
for O 0 9.552224788933472e-09
84 O 0 3.7263441754475934e-07
. O 0 3.308364284748677e-07

2 O 0 3.248892141982651e-07
% O 0 9.417324697835738e-09
of O 0 1.048045608631476e-10
the O 0 5.079633380589144e-10
alleles O 0 3.435534878803992e-08
in O 0 1.2582384023573923e-09
this O 0 3.172316187516344e-09
study O 0 9.417687607538028e-08
. O 0 1.4764717093385116e-07

The O 0 5.846192507874548e-08
G301C O 0 1.7071338334062602e-06
and O 0 7.865827988950969e-09
S162F O 0 4.5506669721362414e-07
mutations O 0 2.2320602965919534e-07
account O 0 3.3032282686917824e-08
for O 0 4.190110480806197e-09
68 O 0 2.404287613444467e-07
. O 0 2.3094963808034663e-07

4 O 0 2.901088919315953e-06
% O 0 1.0181995691027623e-07
and O 0 3.317213170817013e-08
10 O 0 3.864097664063593e-08
. O 0 9.812121248842232e-08

5 O 0 6.737208764207026e-07
% O 0 1.8359932241196475e-08
of O 0 2.1023985330437256e-10
mutations O 0 5.321841811678496e-08
, O 0 8.374388404952526e-10
respectively O 0 1.7456594392228908e-08
, O 0 8.040048626867247e-10
whereas O 0 7.565517101681962e-09
the O 0 6.173402344877843e-10
remaining O 0 2.3111944358333858e-08
F69V O 0 3.5845650927512906e-06
is O 0 1.7584668443593188e-10
limited O 0 6.170177146991307e-10
to O 0 3.7211692061056567e-10
a O 0 4.244291584853954e-09
single O 0 2.1945400874301413e-07
allele O 0 9.630170097807422e-06
. O 0 1.0557287168921903e-06

The O 0 6.99497419986983e-08
skewed O 0 1.1229645906496444e-06
prevalence O 0 2.0739928459079238e-06
of O 0 4.323635616199084e-10
G301C O 0 3.947501170387113e-08
in O 0 2.0307346082493183e-10
only O 0 2.702577883706425e-10
Colombian O 0 6.695958632008114e-08
patients O 0 3.520079516761143e-08
and O 0 5.609572806264396e-10
haplotype O 0 1.1005059263879957e-07
analysis O 0 8.527273998026885e-09
by O 0 6.581424849549933e-10
restriction O 0 1.6356469956235742e-08
fragment O 0 3.753170574327669e-08
length O 0 2.6524926255433456e-08
polymorphisms O 0 1.3269234386825701e-06
in O 0 4.1856051957722684e-09
the O 0 1.2471709220918115e-09
GALNS O 0 2.936529881480965e-07
gene O 0 2.674678611924719e-08
suggest O 0 1.301467289493985e-08
that O 0 5.6654647639931e-10
G301C O 0 2.8448409850057033e-08
originated O 0 4.703866629540698e-09
from O 0 3.9790953865193046e-10
a O 0 1.040169839150451e-09
common O 0 1.9271345408355955e-08
ancestor O 0 4.372537318886316e-07
. O 0 1.0024193670687964e-06

Investigation O 0 4.188266586879763e-07
of O 0 1.0376988157645428e-09
the O 0 5.644669176518846e-10
genetic O 0 2.3679756822048148e-08
background O 0 1.7351432290979574e-08
by O 0 4.920307494771237e-10
means O 0 9.24929732804003e-09
of O 0 1.3973242007914166e-10
mtDNA O 0 7.373623134299123e-08
lineages O 0 1.2211820887841895e-08
indicate O 0 1.773562274820506e-08
that O 0 6.856651912912071e-10
all O 0 3.254513603057063e-10
our O 0 1.5108512219086379e-09
patients O 0 1.3262095865940182e-09
are O 0 3.376433160839909e-11
probably O 0 9.055252103706835e-10
of O 0 9.440244419511856e-11
native O 0 1.1081789708100587e-08
American O 0 1.1654810805339366e-06
descent O 0 0.0001507697015767917

Low O 0 3.2556054065935314e-05
frequency O 0 3.986342562711798e-06
of O 0 5.433330585447038e-08
BRCA1 O 0 2.0482222680584528e-05
germline O 0 1.4630113582825288e-05
mutations O 0 2.085790811179322e-06
in O 0 9.141295720382914e-09
45 O 0 1.1146087786073622e-07
German O 1 0.9944751858711243
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.697686457191594e-06
. O 0 7.612679269186629e-07

In O 0 2.7701608118491095e-08
this O 0 4.693119226573117e-10
study O 0 1.269631622058398e-09
we O 0 7.7858036684475e-10
investigated O 0 1.736394672491315e-08
45 O 0 1.053232878689414e-08
German O 0 0.03938588500022888
breast B-Disease 1 0.9999994039535522
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.453732399018918e-08
for O 0 4.8863704193991e-09
germline O 0 8.957515092333779e-06
mutations O 0 2.8496035611169646e-06
in O 0 9.623545516035392e-09
the O 0 1.7384625294880607e-08
BRCA1 O 0 2.329901690245606e-05
gene O 0 1.2245580364833586e-05
. O 0 1.5355453797383234e-06

We O 0 9.066646384781052e-07
identified O 0 1.315625439701762e-07
four O 0 5.289728655100134e-09
germline O 0 1.2351903251328622e-06
mutations O 0 3.578897462830355e-07
in O 0 2.366804974229808e-09
three O 0 2.4588931779589984e-08
breast B-Disease 1 0.9906814694404602
cancer I-Disease 0 0.0002676289586815983
families O 0 1.3339701565584505e-09
and O 0 6.156340992546916e-10
in O 0 2.0085970664496244e-09
one O 0 0.0013342490419745445
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.5513784035192657e-08
. O 0 3.8278996639107277e-10
among O 0 1.3427123302101052e-10
these O 0 1.541960309436874e-10
were O 0 1.5399096442436644e-09
one O 0 2.3967239304312216e-09
frameshift O 0 1.058592624758603e-05
mutation O 0 4.2292793978049303e-07
, O 0 1.1560568058399667e-09
one O 0 4.285084287403151e-09
nonsense O 0 1.118880959438684e-06
mutation O 0 3.8927669265831355e-07
, O 0 1.2319147923989249e-09
one O 0 1.454041442805476e-09
novel O 0 2.4490265815302337e-08
splice O 0 2.465252691763453e-06
site O 0 2.2433216884110152e-07
mutation O 0 7.817005212018557e-07
, O 0 3.0345543855503365e-09
and O 0 4.100805917062189e-09
one O 0 4.5342481769239384e-08
missense O 0 6.891306111356243e-05
mutation O 0 6.2592800532002e-05
. O 0 2.0233344457665225e-06

The O 0 3.402401489438489e-07
missense O 0 4.016927778138779e-05
mutation O 0 1.5495470506721176e-05
was O 0 3.509066743845324e-07
also O 0 6.983174039021378e-09
found O 0 5.861967355969e-09
in O 0 3.788540592353229e-09
2 O 0 7.064078033636179e-08
. O 0 2.4845971324793936e-07

8 O 0 4.4888656702823937e-07
% O 0 8.469116075104921e-09
of O 0 4.331053571338117e-11
the O 0 6.166009369756864e-11
general O 0 2.145701255562571e-10
population O 0 5.335343278289884e-10
, O 0 7.490130043974474e-11
suggesting O 0 2.7335080865498185e-09
that O 0 7.169044524690804e-11
it O 0 1.1794742960091753e-09
is O 0 2.1278394601864647e-09
not O 0 8.514633265122029e-08
disease O 0 2.217099392964883e-07
associated O 0 1.3795882125577918e-07
. O 0 2.6925584961645654e-07

The O 0 5.5513144303631634e-08
average O 0 2.155179004148522e-07
age O 0 2.1971615637994546e-08
of O 0 1.029819785003383e-09
disease O 0 3.3094815421463863e-07
onset O 0 7.713721288382658e-07
in O 0 2.2778714470206296e-09
those O 0 6.263378704574052e-09
families O 0 1.9278660445820606e-08
harbouring O 0 7.6002620517101604e-06
causative O 0 7.511443254770711e-05
mutations O 0 1.8477272533345968e-05
was O 0 7.973137172712086e-08
between O 0 1.0296160368739038e-08
32 O 0 1.7148178699244454e-07
. O 0 3.3602171356506005e-07

3 O 0 2.1601329081022413e-06
and O 0 1.0273252115666764e-07
37 O 0 8.585668638261268e-07
. O 0 6.91077730152756e-07

4 O 0 5.78486947233614e-07
years O 0 4.137947939852893e-08
, O 0 9.397636002717036e-10
whereas O 0 1.7954604469849755e-09
the O 0 1.863723619877078e-10
family O 0 5.901883870507163e-09
harbouring O 0 4.26638706585436e-07
the O 0 4.800684849648462e-10
missense O 0 4.821708898816723e-07
mutation O 0 1.2133698135130544e-07
had O 0 4.563545985547535e-09
an O 0 1.3281378774543384e-10
average O 0 1.4011154014781368e-08
age O 0 9.639748554945982e-09
of O 0 5.682878612134346e-10
onset O 0 7.949355449454742e-07
of O 0 6.49180043055253e-09
51 O 0 8.660800290272164e-07
. O 0 5.611969413621409e-07

2 O 0 3.5525811199477175e-06
years O 0 1.0239892844765563e-06
. O 0 8.47933335990092e-07

These O 0 6.10800654499144e-08
findings O 0 4.314743051736514e-08
show O 0 2.4093203876418556e-08
that O 0 1.0097626068628074e-09
BRCA1 O 0 2.661671487658168e-07
is O 0 1.2208017929893344e-09
implicated O 0 1.011930184091625e-08
in O 0 1.2673083416014919e-10
a O 0 1.2935097437605236e-10
small O 0 1.7114831774023287e-09
fraction O 0 9.653459898117944e-08
of O 0 5.1185995886271485e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.1614945449878178e-08
suggesting O 0 2.105113061645625e-08
the O 0 4.012101761929898e-10
involvement O 0 2.252919628631389e-08
of O 0 2.7287092030370275e-10
another O 0 7.247819233668906e-09
susceptibility O 0 8.656655268168834e-07
gene O 0 2.695481953196577e-06
( O 0 1.1273689182189628e-07
s O 0 9.15509881451726e-05
) O 0 1.6741084891691571e-06

Paternal O 0 0.00022728031035512686
transmission O 0 0.0004420471377670765
of O 0 2.4926762307586614e-06
congenital B-Disease 1 0.99998939037323
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
. O 0 5.763532317359932e-05

We O 0 1.5646894553356105e-06
report O 0 2.7333063812307046e-08
a O 0 9.548940527182026e-10
rare O 0 2.9189037853427635e-09
case O 0 8.043412158542651e-09
of O 0 4.60558879922246e-09
paternally O 0 0.0008621410233899951
transmitted O 0 0.09009889513254166
congenital B-Disease 1 0.9999978542327881
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.332840631424915e-05
DM B-Disease 1 1.0
) O 0 2.0635088731069118e-06
. O 0 1.052955553859647e-06

The O 0 2.090907358365257e-08
proband O 0 9.680035191195202e-07
is O 0 1.2999135101665615e-09
a O 0 4.670009934315544e-10
23 O 0 8.694840958334282e-10
year O 0 5.958639692771328e-10
old O 0 1.7617290382077044e-07
, O 0 7.54197504448939e-09
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 0.9999977350234985
male O 0 5.779212642664788e-06
who O 0 1.0744936389528448e-06
suffers O 0 0.3571411371231079
severe O 0 0.10410308837890625
muscular B-Disease 0 0.14353503286838531
weakness I-Disease 1 0.7844036817550659
. O 0 4.278669621271547e-06

He O 0 1.507648619281099e-07
presented O 0 1.5496750549459648e-08
with O 0 1.1619952999808447e-08
respiratory O 0 4.312367309466936e-06
and O 0 2.1116358439599026e-08
feeding O 0 5.175800765755412e-07
difficulties O 0 5.832309398101643e-06
at O 0 2.3427418227583985e-08
birth O 0 6.024136496307619e-07
. O 0 2.4998081471494515e-07

His O 0 4.0776012610876933e-07
two O 0 3.2071852729131933e-07
sibs O 0 0.0353512316942215
suffer O 0 0.00022074711159802973
from O 0 1.6770985666880733e-07
childhood O 0 9.150560072157532e-05
onset O 1 0.9419638514518738
DM B-Disease 1 1.0
. O 0 1.2892424820165616e-05

Their O 0 6.904783589334329e-08
late O 0 5.1289980262936297e-08
father O 0 4.3532146776215086e-08
had O 0 6.343716218992768e-09
the O 0 2.0122389865484536e-10
adult O 0 1.6215629727867054e-08
type O 0 1.0309763354143797e-07
of O 0 3.843250162560707e-09
DM B-Disease 1 1.0
, O 0 3.4207816579368e-09
with O 0 9.464985462059872e-10
onset O 0 2.849501186119596e-07
around O 0 7.747366304045045e-09
30 O 0 1.4966145656103436e-08
years O 0 5.353207654934522e-08
. O 0 1.4888169630467019e-07

Only O 0 2.1925732340832838e-08
six O 0 1.3171620460994404e-09
other O 0 4.8035679600655357e-11
cases O 0 4.3220116374698136e-10
of O 0 5.6528549202683465e-11
paternal O 0 3.04810157558677e-07
transmission O 0 0.0037320125848054886
of O 0 3.475580712120063e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.00027204721118323505
been O 0 5.045158104621805e-07
reported O 0 4.0863173467187153e-07
recently O 0 9.649535286371247e-07
. O 0 5.085896646050969e-07

We O 0 2.5435343786739395e-07
review O 0 1.5126742525239933e-08
the O 0 2.5019608607124155e-10
sex O 0 9.102913089975573e-09
related O 0 6.606998059766056e-09
effects O 0 7.339638585790453e-08
on O 0 3.837456130639794e-09
transmission O 0 3.6878975606668973e-06
of O 0 1.2629257639673597e-07
congenital B-Disease 1 0.9999958276748657
DM I-Disease 1 1.0
. O 0 8.248924132203683e-06

Decreased O 0 3.150834163534455e-05
fertility O 0 6.6386769503878895e-06
of O 0 2.8762496828704798e-09
males O 0 1.1104771857617379e-07
with O 0 6.097109039870929e-09
adult O 0 1.6487670109199826e-06
onset O 0 0.01013287901878357
DM B-Disease 1 1.0
and O 0 1.0157361884921556e-07
contraction O 0 1.2330795584603038e-07
of O 0 8.289363639946146e-11
the O 0 3.0142707774238886e-10
repeat O 0 3.574939810846445e-08
upon O 0 5.608556397085351e-10
male O 0 4.584571833277096e-09
transmission O 0 1.183915099289834e-08
contribute O 0 2.3226287559907632e-10
to O 0 5.27754923096424e-11
the O 0 8.36554020500202e-11
almost O 0 6.671221908227665e-10
absent O 0 1.60926312275933e-08
occurrence O 0 6.623516668469165e-08
of O 0 4.186353486090866e-10
paternal O 0 1.2611507145265932e-06
transmission O 0 0.0002360271173529327
of O 0 1.6517401491000783e-07
congenital B-Disease 1 0.9999990463256836
DM I-Disease 1 1.0
. O 0 8.940378393162973e-06

Also O 0 4.876308423718001e-08
the O 0 6.041540046020089e-10
fathers O 0 1.1225856688668046e-08
of O 0 5.247796988627762e-11
the O 0 9.90230231145972e-10
reported O 0 1.6972528271708143e-07
congenitally O 0 9.174711976811523e-07
affected O 0 1.6290712778754823e-08
children O 0 2.6160893451532274e-09
showed O 0 8.067781109843963e-09
, O 0 7.812903796144965e-11
on O 0 6.077298664308728e-10
average O 0 4.917457996356234e-09
, O 0 5.050785345517284e-10
shorter O 0 6.801456464700095e-08
CTG O 0 5.566836875914305e-07
repeat O 0 8.316519028994662e-08
lengths O 0 1.880232360917944e-07
and O 0 1.3657058817173606e-09
hence O 0 5.714631434727835e-09
less O 0 3.8881897701514845e-09
severe O 0 3.6503170122159645e-06
clinical O 0 1.203705232910579e-05
symptoms O 0 8.395856525567069e-07
than O 0 9.52169676438075e-10
the O 0 1.2494781875815875e-09
mothers O 0 6.599116630923163e-08
of O 0 2.883784877560913e-10
children O 0 1.8510355914713728e-08
with O 0 1.0192002264375333e-07
congenital B-Disease 1 0.9999978542327881
DM I-Disease 1 1.0
. O 0 1.4182352970237844e-05

We O 0 4.191687139609712e-07
conclude O 0 9.768406528110063e-08
that O 0 7.07797598309412e-10
paternal O 0 1.6092853627469594e-07
transmission O 0 1.8197072222392308e-06
of O 0 1.7595388257518607e-08
congenital B-Disease 1 0.9999996423721313
DM I-Disease 1 1.0
is O 0 1.316045228350049e-08
rare O 0 9.073202633658184e-09
and O 0 9.844280945969786e-10
preferentially O 0 2.0298420722042465e-08
occurs O 0 1.7283117159649919e-09
with O 0 1.2382274372502167e-10
onset O 0 1.0621621981954377e-07
of O 0 1.6391502599688579e-09
DM B-Disease 1 1.0
past O 0 1.3500819306955236e-07
30 O 0 4.50085702041747e-09
years O 0 1.1322617288200831e-09
in O 0 2.76529077414267e-10
the O 0 5.235862299279859e-10
father O 0 1.7353682935095094e-08
. O 0 4.428847510951073e-09
. O 0 1.2267480542504927e-07

The O 0 6.291410841186007e-07
RB1 O 0 7.267004548339173e-05
gene O 0 1.275778231502045e-06
mutation O 0 8.953961128099763e-07
in O 0 3.625124644912603e-09
a O 0 7.83111353541699e-09
child O 0 2.0182699245197e-06
with O 0 8.741390047362074e-07
ectopic B-Disease 1 0.9999967813491821
intracranial I-Disease 1 0.9999898672103882
retinoblastoma I-Disease 1 0.8554896116256714
. O 0 1.5974601410562173e-05

The O 0 1.2618509117601207e-06
RB1 O 0 0.0001325253542745486
gene O 0 2.6477521259948844e-06
mutation O 0 2.627242565722554e-06
was O 0 1.5701147049185238e-08
investigated O 0 3.8617617548197813e-08
in O 0 9.963057046036283e-10
a O 0 4.722186641714643e-09
child O 0 2.2211891064216616e-06
with O 0 4.732739000701258e-07
ectopic B-Disease 1 0.9999926090240479
intracranial I-Disease 1 0.9322439432144165
retinoblastoma I-Disease 0 5.429701104731066e-06
using O 0 3.459205899503104e-08
DNA O 0 6.450331824225941e-08
obtained O 0 5.9142570840720055e-09
from O 0 1.1431283697405092e-10
both O 0 2.1159880791987717e-10
the O 0 5.919129075770968e-10
pineal B-Disease 0 1.3606893389805919e-06
and I-Disease 0 2.619701433559385e-07
retinal I-Disease 0 0.32696184515953064
tumours I-Disease 1 1.0
of O 0 6.589177647953193e-09
the O 0 3.5237338380511574e-08
patient O 0 3.2978507533698576e-06
. O 0 3.0760011782149377e-07

A O 0 1.6721459132895689e-06
nonsense O 0 9.816566489462275e-06
mutation O 0 3.0483681712212274e-06
in O 0 1.911098301832226e-08
exon O 0 1.5736382010800298e-06
17 O 0 8.087349812058164e-08
( O 0 2.483140582043575e-09
codon O 0 2.2677420474792598e-07
556 O 0 1.9911546189632645e-08
) O 0 1.0738538946952758e-09
of O 0 5.142959322301799e-11
the O 0 7.235688159745735e-10
RB1 O 0 5.797959374831407e-07
gene O 0 2.4737770942806492e-08
was O 0 1.37649602827139e-09
found O 0 1.3709014479168502e-10
to O 0 6.633230076324992e-11
be O 0 1.5173597101014735e-10
present O 0 1.552329931264751e-10
homozygously O 0 2.930441489468194e-08
in O 0 7.015447944791475e-11
both O 0 1.5907132555614822e-10
the O 0 5.763954313842135e-10
retinal B-Disease 0 5.139260679243307e-07
and I-Disease 0 5.933773294941602e-08
the I-Disease 0 8.802074802360949e-08
pineal I-Disease 0 0.0053469594568014145
tumours I-Disease 1 1.0
. O 0 2.6101777166331885e-06

The O 0 2.4445510504733647e-08
same O 0 1.1434697633205815e-08
mutation O 0 8.77284449529725e-08
was O 0 3.030910411538912e-09
present O 0 9.31726695796442e-10
heterozygously O 0 1.1124021170871856e-07
in O 0 5.407984060568083e-10
the O 0 1.0801721322950542e-10
DNA O 0 1.1513218822756244e-08
from O 0 1.0726373955716184e-10
the O 0 1.7326942658435485e-10
constitutional O 0 3.1649671772271404e-09
cells O 0 4.8392809759434385e-09
of O 0 2.34056749676137e-11
the O 0 1.6632294153051674e-10
patient O 0 7.264593815392573e-09
, O 0 1.1720216464006228e-10
proving O 0 4.818851540022706e-09
it O 0 2.2641737096318337e-10
to O 0 3.0701710618252775e-10
be O 0 5.580194084586765e-10
of O 0 7.137735402729106e-10
germline O 0 1.31847571083199e-06
origin O 0 3.378384292318515e-07
. O 0 5.076132651993248e-07

The O 0 2.624226524972073e-08
initial O 0 4.5718422825302696e-08
mutation O 0 1.1585300541128163e-07
was O 0 1.504444346878131e-09
shown O 0 7.369412302615785e-10
to O 0 2.661962594796563e-10
have O 0 1.2298746465688737e-09
occurred O 0 5.49656675730148e-09
in O 0 8.857677369356054e-10
the O 0 7.025162229723492e-09
paternally O 0 9.169994882540777e-06
derived O 0 1.3698543170903577e-06
RB1 O 0 9.74387803580612e-05
allele O 0 9.773346391739324e-06
. O 0 9.092840400626301e-07

The O 0 4.569192313397252e-08
mutation O 0 1.950301538045096e-07
is O 0 9.268294465236693e-10
in O 0 2.3242685553981346e-10
an O 0 8.957811575838193e-11
area O 0 1.114232084375999e-08
of O 0 1.695438373028324e-10
the O 0 1.0597006605550519e-09
gene O 0 1.976959751459617e-08
that O 0 5.753947873721188e-10
encodes O 0 1.6090904164656195e-09
the O 0 1.3314732649760685e-10
protein O 0 1.578155384152069e-08
- O 0 8.363571168956696e-07
binding O 0 3.6729620234154936e-08
region O 0 5.350254905778229e-09
known O 0 1.2973573326746646e-09
as O 0 1.4808453074888206e-10
the O 0 1.5398912700526068e-10
pocket O 0 0.001151230768300593
region O 0 1.8044188720978127e-07
and O 0 8.04188147185414e-08
has O 0 1.0458840016269733e-08
been O 0 1.5233603267716944e-09
detected O 0 5.284404025474032e-09
in O 0 5.5972153994998664e-11
other O 0 9.331757588881828e-11
cases O 0 1.9965387121345657e-09
of O 0 2.7438967764581434e-10
retinoblastoma B-Disease 0 3.267199133460963e-07
. O 0 2.3764867407294332e-08
. O 0 2.483796208707645e-07

Low O 0 0.0995437502861023
levels O 0 8.559474622416019e-07
of O 0 2.408095667316701e-10
beta O 0 1.6543435066296297e-08
hexosaminidase O 0 1.4106862522567098e-07
A O 0 1.1072488481644882e-09
in O 0 3.245320956413167e-10
healthy O 0 2.253103037475057e-09
individuals O 0 6.145817188496494e-10
with O 0 1.4117534918867136e-09
apparent O 0 0.0006832795334048569
deficiency O 0 0.05978325754404068
of O 0 3.525155445327499e-10
this O 0 8.823250574607755e-09
enzyme O 0 1.8400270391794038e-06
. O 0 3.1110374720810796e-07

Appreciable O 0 0.00021123744954820722
beta O 0 1.401995905325748e-05
hexosaminidase O 0 2.5137956981780007e-05
A O 0 4.63499816305557e-08
( O 0 3.270021142753876e-09
hex O 0 2.553428828377946e-07
A O 0 1.4512181456538542e-09
) O 0 3.3289038192663156e-10
activity O 0 1.5382304319189188e-09
has O 0 1.0445437848005668e-09
been O 0 2.005159815965385e-09
detected O 0 1.5138864384312e-08
in O 0 6.789266926432447e-10
cultured O 0 3.222834550342668e-07
skin O 0 3.870304681186099e-06
fibroblasts O 0 3.278079248048016e-07
and O 0 7.318320882632179e-08
melanoma B-Disease 0 0.00017496306099928916
tissue O 0 2.2774973729156045e-07
from O 0 6.932105445223158e-10
healthy O 0 2.7991802209470507e-09
individuals O 0 1.6098510025042145e-10
previously O 0 1.0989386289850245e-08
reported O 0 4.415707977045713e-08
as O 0 5.459328988877132e-09
having O 0 0.0006714899209327996
deficiency B-Disease 0 0.0046220687218010426
of I-Disease 0 8.059913153557474e-11
hex I-Disease 0 6.51383061267552e-07
A I-Disease 0 5.569996686105583e-10
activity O 0 9.262532407738888e-10
indistinguishable O 0 2.2328165982798964e-09
from O 0 4.170953166182656e-11
that O 0 1.8580293553727145e-11
of O 0 2.742697041702158e-11
patients O 0 1.5993427027183316e-08
with O 0 9.155901352642104e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 0 0.419495165348053
( O 0 2.8703981413968904e-08
TSD B-Disease 0 3.7185498513281345e-05
) O 0 5.971615024691346e-08
. O 0 1.055769445201804e-07

Identification O 0 2.055577624560101e-06
and O 0 6.728566859237617e-08
quantitation O 0 1.0568172001512721e-05
of O 0 5.078375941991453e-09
hex O 0 1.8682972040551249e-06
A O 0 6.058668233777098e-09
, O 0 3.374574231163052e-10
amounting O 0 6.1333138567931655e-09
to O 0 7.0617174330323e-09
3 O 0 6.020954401719791e-08
. O 0 2.481393153175304e-07

5 O 0 3.059820528505952e-06
% O 0 3.595129385303153e-07
- O 0 7.458616892108694e-05
6 O 0 5.03000535445608e-07
. O 0 2.326041084188546e-07

9 O 0 7.082749107212294e-07
% O 0 1.7880147140658664e-08
of O 0 2.8551716546587613e-10
total O 0 8.5390688964182e-10
beta O 0 4.016761323555329e-08
hexosaminidase O 0 3.041956802007917e-07
activity O 0 1.96431582111245e-08
, O 0 1.0149606710641024e-09
has O 0 9.738726491903549e-10
been O 0 4.83781126270344e-10
obtained O 0 4.3431356289147516e-09
by O 0 4.634809869230594e-09
cellulose O 0 2.6182081001024926e-06
acetate O 0 1.0395158369647106e-06
gel O 0 4.369001544546336e-05
electrophoresis O 0 2.2695905954606133e-06
, O 0 6.811033959053248e-09
DEAE O 0 2.8268211735849036e-06
- O 0 5.436170340544777e-07
cellulose O 0 1.8743221517070197e-06
ion O 0 2.55694743600543e-07
- O 0 4.5143275428927154e-07
exchange O 0 5.4065246501977526e-08
chromatography O 0 4.397511474962812e-07
, O 0 1.1157287316265752e-09
radial O 0 1.7501777449524525e-07
immunodiffusion O 0 7.725117256995873e-07
, O 0 2.390505571270296e-09
and O 0 1.4306094975324868e-08
radioimmunoassay O 0 1.171246731246356e-05
. O 0 4.0964621916828037e-07

Previous O 0 1.1098881032012287e-06
family O 0 1.855655717974969e-08
studies O 0 1.0320816201669913e-08
suggested O 0 4.024274691261098e-09
that O 0 6.41200217921245e-11
these O 0 3.315190483244024e-11
individuals O 0 1.0411360662487823e-10
may O 0 1.1081742190555133e-09
be O 0 5.1230651665346016e-11
compound O 0 1.2978572661026533e-09
heterozygotes O 0 3.342764998137682e-08
for O 0 1.20505591616471e-10
the O 0 4.4818715405625653e-10
common O 0 1.6166127991823487e-08
mutant O 0 2.0021421676119644e-07
TSD B-Disease 0 1.1065726539527532e-06
gene O 0 6.013321751652256e-08
and O 0 2.237651397507534e-09
a O 0 9.720502180954327e-10
rare O 0 2.8917357397517662e-08
( O 0 8.703805676191223e-09
allelic O 0 9.027027658703446e-07
) O 0 2.2310807423764345e-08
mutant O 0 8.043919024203205e-07
gene O 0 4.495566827245057e-06
. O 0 1.318982526754553e-06

Thus O 0 5.532942282115982e-07
, O 0 7.00570712552917e-09
the O 0 7.110586008884923e-10
postulated O 0 8.381267235790801e-08
rate O 0 2.2785851427897796e-08
mutant O 0 2.0533537536948643e-08
gene O 0 1.098347723882398e-08
appears O 0 2.8496998094595938e-09
to O 0 4.953714868860537e-11
code O 0 1.4655762714532727e-10
for O 0 3.672507783991641e-11
the O 0 3.97561879250663e-11
expression O 0 3.561990979950025e-10
of O 0 4.721569663024283e-11
low O 0 1.4447617324719886e-08
amounts O 0 6.6976166834820106e-09
of O 0 7.625461373450548e-10
hex O 0 1.8470807390258415e-06
A O 0 2.4303018264504317e-08
. O 0 2.411076991393202e-07

Heterozygotes O 0 2.770046194200404e-05
for O 0 9.131484901558906e-09
the O 0 3.880142318557489e-10
rare O 0 1.9123369554563396e-09
mutant O 0 8.96761989110928e-08
may O 0 1.1906090335855879e-08
be O 0 1.7544096730937042e-10
indistinguishable O 0 4.33452074233287e-09
from O 0 1.5916178097707956e-10
heterozygotes O 0 4.56710118612591e-08
for O 0 3.672502857376969e-10
the O 0 2.266313359200467e-09
common O 0 2.155779128543145e-07
TSD B-Disease 0 5.975837120786309e-05
mutant O 0 6.475549071183195e-06
. O 0 4.3635102997541253e-07

However O 0 1.425647013775233e-07
, O 0 1.8132737533704812e-09
direct O 0 3.5734795122976948e-09
visualization O 0 1.6240461775396398e-07
and O 0 1.1539492028589393e-08
quantitation O 0 4.592101049638586e-06
of O 0 1.761771173391935e-09
hex O 0 5.241331109573366e-06
A O 0 1.0829576124748996e-09
by O 0 7.395500184470549e-11
the O 0 3.745684665212856e-11
methods O 0 1.3009610277947559e-08
described O 0 4.564016276020766e-09
may O 0 8.391820571773678e-09
prevent O 0 5.3130051469452155e-09
false O 0 2.560260448092322e-08
- O 0 1.1140221545247186e-07
positive O 0 1.4053172847638962e-08
prenatal O 0 6.510576326945738e-07
diagnosis O 0 1.4308255913419998e-07
of O 0 1.7202630986368206e-10
TSD B-Disease 0 8.754387863518787e-07
in O 0 1.8032270121537408e-09
fetuses O 0 5.282884671942156e-07
having O 0 1.0187432231134608e-08
the O 0 3.9135145124546966e-10
incomplete O 0 3.3753369876876604e-08
hex B-Disease 0 0.00022896815789863467
A I-Disease 0 9.193826144837658e-08
deficiency I-Disease 0 1.2383049579511862e-05
of O 0 5.179896442331078e-11
the O 0 2.945433896783811e-10
type O 0 1.644309151060952e-07
described O 0 1.1345711925514479e-08
in O 0 1.018076289938108e-09
the O 0 3.9675254193127785e-09
four O 0 4.709740153430175e-08
healthy O 0 4.7471681341448857e-07
individuals O 0 3.063237556943932e-07

The O 0 5.119957222632365e-07
tumor B-Disease 0 5.3296907935873605e-06
suppressor O 0 5.564194907492492e-06
gene O 0 4.022664143121801e-06
Smad4 O 0 1.4436027413466945e-05
/ O 0 4.670060206990456e-06
Dpc4 O 0 1.7459495893490384e-06
is O 0 1.512269642844899e-09
required O 0 5.375118128370104e-10
for O 0 7.992233957976325e-11
gastrulation O 0 1.852829889514851e-08
and O 0 1.1824701218188238e-09
later O 0 6.281276387909429e-09
for O 0 8.868732970235271e-10
anterior O 0 3.115281970167416e-06
development O 0 2.3082682432118418e-09
of O 0 2.3448673558412736e-10
the O 0 2.264779475069645e-09
mouse O 0 8.634599453216651e-07
embryo O 0 4.1305388549517374e-06
. O 0 4.7020571969369485e-07

Mutations O 0 7.47472295188345e-05
in O 0 4.728480007543112e-08
the O 0 2.6150530629820423e-08
SMAD4 O 0 7.708388875471428e-05
/ O 0 7.58597525418736e-06
DPC4 O 0 1.333535328740254e-05
tumor B-Disease 0 1.2138621059420984e-06
suppressor O 0 5.222562435847067e-07
gene O 0 2.5605785936022585e-07
, O 0 3.3024958323579767e-09
a O 0 6.401166818825743e-10
key O 0 5.537545888500972e-08
signal O 0 3.939911508155092e-08
transducer O 0 1.7567361965120654e-07
in O 0 8.896280934145295e-10
most O 0 1.394204751647976e-09
TGFbeta O 0 1.5815700180610293e-06
- O 0 2.5407271664334985e-07
related O 0 1.9855219690612103e-09
pathways O 0 1.930367199420857e-09
, O 0 2.3781062188921176e-11
are O 0 2.4265926074074073e-11
involved O 0 4.3603815003123714e-10
in O 0 3.116111257916998e-10
50 O 0 2.470508242424785e-09
% O 0 3.1120679366836157e-09
of O 0 1.3440333290759554e-08
pancreatic B-Disease 1 0.9989476799964905
cancers I-Disease 1 0.9999382495880127
. O 0 1.5970115327945678e-06

Homozygous O 0 0.0006798311369493604
Smad4 O 0 0.00012248114217072725
mutant O 0 2.4249866328318603e-05
mice O 0 4.960410296916962e-05
die O 0 0.00011235198326176032
before O 0 1.0457707588784615e-07
day O 0 7.507346566626438e-08
7 O 0 7.947538449570857e-08
. O 0 1.9632261683000252e-07

5 O 0 1.8643353314473643e-06
of O 0 3.043355079057619e-08
embryogenesis O 0 1.7077598386094905e-05
. O 0 2.666280124685727e-06

Mutant O 0 6.421008947654627e-06
embryos O 0 3.945698153984267e-06
have O 0 7.19512414093515e-08
reduced O 0 2.836383217186267e-08
size O 0 3.39333396937036e-08
, O 0 4.4675179111663965e-09
fail O 0 5.364169624044735e-07
to O 0 4.726870006521722e-10
gastrulate O 0 3.232253504847904e-07
or O 0 9.248608989764762e-09
express O 0 7.414151070861408e-09
a O 0 1.1896458262938836e-09
mesodermal O 0 4.3799161630886374e-07
marker O 0 3.6874928355246084e-07
, O 0 5.232890121220635e-09
and O 0 6.2925242794165115e-09
show O 0 8.249468805843208e-07
abnormal O 0 1.5165763898039586e-06
visceral O 0 2.7179498829354998e-06
endoderm O 0 0.00010122661478817463
development O 0 5.663428623847722e-07
. O 0 3.5431781952866004e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 0.9999995231628418
of O 0 1.714168584854292e-09
the O 0 3.396000147759537e-09
Smad4 O 0 1.9420254830038175e-05
- O 0 1.2375848200463224e-05
deficient O 0 1.167513460131886e-06
embryos O 0 8.686892982723293e-08
results O 0 1.4780729529206837e-08
from O 0 3.466784914696319e-10
reduced O 0 5.900240740430718e-09
cell O 0 5.7287341093115174e-08
proliferation O 0 5.757214083246254e-08
rather O 0 1.9332191403265142e-09
than O 0 1.112422376436939e-09
increased O 0 1.670511551310483e-08
apoptosis O 0 1.6818042070099182e-07
. O 0 2.2509573227580404e-07

Aggregation O 0 1.178172169602476e-05
of O 0 3.472956677796901e-08
mutant O 0 4.386685304780258e-06
Smad4 O 0 2.9640556022059172e-05
ES O 0 7.321775683521992e-07
cells O 0 2.5282469451326506e-08
with O 0 5.237510425359915e-10
wild O 0 4.938486952710264e-08
- O 0 0.00012082002649549395
type O 0 2.7954313281952636e-06
tetraploid O 0 1.7004256733343937e-05
morulae O 0 2.7121781386085786e-05
rescues O 0 5.184864676266443e-06
the O 0 7.838394111558955e-08
gastrulation B-Disease 0 3.705123526742682e-05
defect I-Disease 0 0.00010960083454847336
. O 0 9.245028991244908e-07

These O 0 1.7835023413681483e-07
results O 0 7.221521514111373e-08
indicate O 0 1.2585343434068363e-08
that O 0 3.11631331850748e-10
Smad4 O 0 5.81937023014234e-08
is O 0 1.0021868751541874e-10
initially O 0 6.570650690207458e-10
required O 0 1.4249111612851806e-10
for O 0 1.7797813570141763e-11
the O 0 2.8065336513116712e-11
differentiation O 0 7.464804330226116e-10
of O 0 4.607693046554395e-11
the O 0 1.959232220904994e-10
visceral O 0 1.1428592294748796e-08
endoderm O 0 9.762118224898586e-07
and O 0 1.116537640122317e-09
that O 0 8.257487055240986e-11
the O 0 1.1303622621250398e-10
gastrulation B-Disease 0 7.527263079509794e-08
defect I-Disease 0 1.8800780310357368e-07
in O 0 3.6061237329576556e-10
the O 0 3.366326106757356e-10
epiblast O 0 1.0346773251512786e-06
is O 0 2.5764101962977293e-09
secondary O 0 1.2896063772416255e-08
and O 0 3.4911791235714418e-09
non O 0 1.1694547765728203e-06
- O 0 9.688747923064511e-06
cell O 0 1.4307303217719891e-06
autonomous O 0 5.35113599653414e-07
. O 0 6.319745580185554e-07

Rescued O 0 2.2658279704046436e-05
embryos O 0 1.180052277049981e-05
show O 0 9.666146070230752e-06
severe O 0 9.308013250119984e-05
anterior O 0 0.00026644612080417573
truncations O 0 9.907985258905683e-06
, O 0 1.5986655554911522e-08
indicating O 0 1.6711235062416563e-08
a O 0 2.0734558514590162e-09
second O 0 2.8120017425692367e-09
important O 0 7.892740350179395e-10
role O 0 8.266903606113374e-09
for O 0 5.75722969298198e-10
Smad4 O 0 5.677201215803507e-07
in O 0 1.253603887363397e-08
anterior O 0 3.350139013491571e-05
patterning O 0 1.1476284271338955e-05
during O 0 4.4990699166191916e-07
embryogenesis O 0 2.3229129510582425e-05
. O 0 2.5663628093752777e-06

Prevalence O 0 0.002246730960905552
of O 0 4.059678104795239e-08
p16 O 0 4.327091119193938e-06
and O 0 8.361212877616708e-08
CDK4 O 0 1.965876617759932e-05
germline O 0 2.1568333977484144e-05
mutations O 0 2.9520788302761503e-06
in O 0 1.1647067310605053e-08
48 O 0 5.121876256453106e-07
melanoma B-Disease 1 0.9999499320983887
- O 1 0.9948909282684326
prone O 0 0.01380863692611456
families O 0 1.0988615173346261e-07
in O 0 3.536163006856441e-08
France O 0 3.9848255255492404e-05
. O 0 4.0591831407255086e-07

The O 0 1.9253143364039715e-06
French O 0 0.00021862194989807904
Familial B-Disease 0 0.13553404808044434
Melanoma I-Disease 1 0.9946675300598145
Study O 0 1.234102455782704e-06
Group O 0 1.3900958037993405e-06
. O 0 5.522288120118901e-07

Germline O 0 0.0014477610820904374
mutations O 0 5.623250763164833e-05
in O 0 4.678519616163612e-08
the O 0 5.150670556730574e-09
p16 O 0 3.4851336749852635e-07
and O 0 3.448702878827703e-09
CDK4 O 0 2.7312694328429643e-07
genes O 0 2.770615203928628e-08
have O 0 7.235181342934993e-09
been O 0 3.5025913280861687e-09
reported O 0 9.681465407140877e-09
in O 0 1.6060418273067256e-10
a O 0 4.083811344646193e-10
subset O 0 2.1494967583635116e-08
of O 0 6.944677055642501e-10
melanoma B-Disease 0 1.019507908495143e-05
pedigrees O 0 2.4894973194022896e-07
, O 0 4.189191216141808e-09
but O 0 2.2577674840817963e-08
their O 0 4.4838230905952514e-09
prevalence O 0 8.40124448586721e-06
is O 0 2.106421481684606e-09
not O 0 1.737586408090408e-09
well O 0 4.55023041467939e-09
known O 0 6.359334037142617e-08
. O 0 2.271413137577838e-07

We O 0 8.003381424259715e-08
searched O 0 7.847983596320773e-08
for O 0 4.500528838491391e-10
such O 0 1.5606194114781147e-09
germline O 0 2.081863840430742e-06
mutations O 0 3.4248023439431563e-07
in O 0 9.335201944793425e-09
48 O 0 3.451067414061981e-07
French O 0 6.715600466122851e-05
melanoma B-Disease 1 0.9999619722366333
- O 1 0.9204723834991455
prone O 0 8.855522537487559e-06
families O 0 1.1808428679316307e-09
selected O 0 1.5501405714601901e-10
according O 0 3.1138636807925835e-11
to O 0 2.9252544830882243e-11
two O 0 6.784292572170614e-11
major O 0 3.567813156024613e-09
criteria O 0 1.8233185627991588e-08
families O 0 6.434373173158647e-11
with O 0 1.9495988157203215e-11
at O 0 5.208947717605383e-10
least O 0 3.0452332322461473e-10
three O 0 1.7480642489076104e-09
affected O 0 3.7103349281863984e-09
members O 0 2.5926816249466356e-10
( O 0 1.212530631455877e-10
n O 0 2.9350282204632094e-08
= O 0 4.114762219842305e-08
20 O 0 2.714760360955637e-10
) O 0 4.952354498710676e-11
or O 0 2.6411159370631765e-10
families O 0 1.4288982497223657e-10
with O 0 2.0672697928492134e-11
two O 0 5.06608699435418e-10
affected O 0 1.2101676327702648e-09
members O 0 6.383057971071082e-11
, O 0 2.426240978958827e-11
one O 0 2.223439314608111e-11
of O 0 3.4023029619328904e-12
them O 0 7.953699504570366e-11
affected O 0 4.880537085583114e-10
before O 0 1.070475597053644e-09
the O 0 1.7693843612498483e-10
age O 0 9.77762537601734e-10
of O 0 2.0347229109929366e-11
50 O 0 2.5847221585273417e-10
( O 0 1.4688476823732088e-10
n O 0 7.149677827555934e-08
= O 0 1.0555238105780518e-07
28 O 0 1.9790413752218683e-09
) O 0 9.523326571780899e-11
, O 0 3.2919771075778925e-11
and O 0 1.1257320770008405e-10
one O 0 5.095119326448128e-10
additional O 0 5.126139512867667e-09
minor O 0 1.8697575399073685e-07
criterion O 0 6.354424044729967e-07
. O 0 1.7901616899962391e-07

Sixteen O 0 2.755190962488996e-06
different O 0 2.9776862220387557e-07
p16 O 0 1.0855746950255707e-05
germline O 0 1.6768417481216602e-05
mutations O 0 1.1841113973787287e-06
were O 0 8.256140660023448e-09
found O 0 3.4095515299981116e-09
in O 0 6.897102888814288e-10
21 O 0 1.292119522489088e-09
families O 0 2.504224050348114e-10
, O 0 9.911536175133406e-11
while O 0 8.765944636834888e-10
one O 0 2.3461299569760286e-09
germline O 0 9.858679277385818e-07
mutation O 0 2.4495412276337447e-07
, O 0 5.512396650253493e-10
Arg24His O 0 1.468866628329124e-07
, O 0 1.09799525027654e-09
was O 0 5.137160474788516e-09
detected O 0 2.5315138429959916e-08
in O 0 1.1248183495737862e-09
the O 0 4.374378193006123e-09
CDK4 O 0 7.2357056524197105e-06
gene O 0 1.5393076182590448e-06
. O 0 3.0339836598614056e-07

The O 0 3.17608375155487e-08
frequency O 0 1.7748592995303625e-07
of O 0 1.5531304020655057e-09
p16 O 0 4.032213780646998e-07
gene O 0 1.3063385040368303e-07
mutation O 0 1.254772854508701e-07
in O 0 7.417994551950358e-10
our O 0 6.520387563213603e-10
sample O 0 2.018374800627498e-09
( O 0 1.0220897045387645e-10
44 O 0 2.5494009681104046e-10
% O 0 1.4668206926859995e-10
) O 0 1.1869027982669422e-10
is O 0 1.3945125609815534e-10
among O 0 3.357611966237073e-10
the O 0 2.3345139710251317e-10
highest O 0 3.7284129916770326e-07
rates O 0 2.3468394374503987e-06
yet O 0 2.2040451241878145e-08
reported O 0 2.249930908249098e-08
and O 0 4.176463896943261e-10
the O 0 2.855781999766549e-10
CDK4 O 0 5.276626211525581e-07
mutation O 0 2.120887465650867e-08
is O 0 1.5879365877768947e-10
the O 0 1.4238786538722792e-10
second O 0 4.3335455224280395e-09
mutation O 0 4.617165672016199e-08
detected O 0 5.303176919824182e-08
in O 0 3.4324265651974883e-10
this O 0 6.119195150589007e-10
gene O 0 1.8709488358581439e-07
worldwide O 0 4.286762589345017e-07
. O 0 4.2533869759608933e-07

In O 0 4.436390810269586e-08
summary O 0 7.517104450016632e-08
, O 0 5.6094577871590445e-09
our O 0 5.6301345807696634e-09
results O 0 1.0590101240381955e-08
show O 0 9.993762262183736e-09
frequent O 0 2.156305001221881e-08
involvement O 0 3.070443455044369e-08
of O 0 1.8244854238513852e-10
the O 0 6.511489125671233e-10
p16 O 0 1.8254380051985208e-07
gene O 0 9.957253865877647e-08
in O 0 5.079732634527545e-09
familial B-Disease 0 0.00013595956261269748
melanoma I-Disease 1 0.9979390501976013
and O 0 2.7037200922563898e-08
confirm O 0 9.287148117209654e-08
the O 0 2.514341790327279e-10
role O 0 1.3270554433120196e-08
of O 0 8.85821346829907e-11
the O 0 4.948127463322294e-10
CDK4 O 0 2.420398175217997e-07
gene O 0 1.177052233458653e-08
as O 0 1.4024407191115529e-09
a O 0 8.875015389264718e-09
melanoma B-Disease 1 0.5774393677711487
- O 0 1.97893641598057e-05
predisposing O 0 1.193445405078819e-05
gene O 0 1.881702701211907e-06
. O 0 1.7920783079716784e-07
. O 0 5.366353548197367e-07

Progression O 0 1.4507460946333595e-05
of O 0 6.213098657781302e-08
somatic O 0 1.0091075637319591e-05
CTG O 0 3.560086770448834e-05
repeat O 0 3.0263192911661463e-06
length O 0 3.4446944852106753e-08
heterogeneity O 0 4.3699026264221175e-07
in O 0 5.178468764910349e-09
the O 0 3.7196385971327572e-09
blood O 0 1.473918302963284e-07
cells O 0 2.6880837822318426e-07
of O 0 4.455904090150398e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
patients O 0 0.001100017107091844
. O 0 1.0542115660427953e-06

The O 0 1.9284765784277624e-08
genetic O 0 3.860900790186861e-07
basis O 0 5.426753801884843e-08
of O 0 2.833290579928871e-08
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
( O 0 1.2789028005499858e-06
DM B-Disease 1 1.0
) O 0 2.8990918110594066e-08
is O 0 2.5596619268597465e-10
the O 0 4.2237748021367594e-11
expansion O 0 3.0082243362983263e-09
of O 0 1.4269509185371732e-10
an O 0 1.291195594887995e-09
unstable O 0 2.4666403533046832e-06
CTG O 0 1.5050842421260313e-06
repeat O 0 7.473714163097611e-07
in O 0 1.7701379251278127e-09
the O 0 1.1677112610186668e-09
34 O 0 8.061381784330024e-09
UTR O 0 2.700386119158793e-07
of O 0 6.700731081110689e-10
the O 0 2.2782113973107698e-08
DM B-Disease 1 0.9999983310699463
protein O 0 2.0553882507101662e-07
kinase O 0 3.1426702662429307e-07
gene O 0 1.717321822525264e-07
on O 0 2.257827702578652e-08
chromosome O 0 1.0693765034375247e-05
19 O 0 5.380989591685648e-07
. O 0 2.344253005048813e-07

One O 0 1.4696793471102865e-07
of O 0 5.670286462589047e-10
the O 0 3.381455393469679e-10
principal O 0 8.346359159361327e-09
features O 0 3.339500453947153e-09
of O 0 3.2268593352924313e-10
the O 0 2.2803154919870394e-08
DM B-Disease 1 1.0
mutation O 0 3.3596572848182404e-06
is O 0 1.5246713891414743e-09
an O 0 1.0704586522747306e-10
extraordinarily O 0 8.004145257700657e-08
high O 0 2.217107777369165e-07
level O 0 9.221042596152529e-09
of O 0 1.1909484509686763e-10
somatic O 0 3.8325133289163205e-08
mosaicism O 0 1.5623587614754797e-06
, O 0 2.282463995584294e-09
due O 0 1.3554811717497728e-09
to O 0 2.1510120074008654e-10
an O 0 1.0940269523640467e-10
extremely O 0 7.604927354520896e-09
high O 0 1.0649165105292013e-08
degree O 0 1.0039231668201865e-08
of O 0 1.1078988421120428e-10
somatic O 0 2.575707185314968e-07
instability O 0 6.617114536311419e-07
both O 0 2.5110842294395752e-09
within O 0 4.353426230618851e-10
and O 0 2.194538550881475e-09
between O 0 1.4899547151614456e-09
different O 0 1.0141948614261764e-08
tissues O 0 1.6511555713805137e-06
. O 0 5.411790766629565e-07

This O 0 2.51186207833598e-07
instability O 0 2.2535175503435312e-07
appears O 0 2.042526148215984e-08
to O 0 6.353739201436781e-10
be O 0 2.9675728541178614e-10
biased O 0 1.4518667157403797e-08
towards O 0 7.077867736349219e-10
further O 0 1.7088142012511298e-10
expansion O 0 8.40475911090266e-10
and O 0 1.657996795412231e-10
continuous O 0 3.6519315349536896e-10
throughout O 0 2.6710667011542455e-10
the O 0 9.292043523512206e-11
life O 0 3.1285998791652503e-10
of O 0 3.508998430365451e-12
an O 0 1.5568777170238413e-11
individual O 0 8.93995849571283e-11
, O 0 1.6018804338546744e-11
features O 0 5.267073444059633e-10
that O 0 7.538261681538927e-10
could O 0 2.1930334881403724e-08
be O 0 2.678821608981252e-10
associated O 0 4.169841694157128e-10
with O 0 1.1789698384223612e-10
the O 0 3.9408848406807806e-10
progressive O 0 1.5785767359943748e-08
nature O 0 1.5903751204859873e-08
of O 0 4.842455325615447e-10
the O 0 5.248115186873292e-08
disease O 0 5.185102054383606e-06
. O 0 2.477205782724923e-07

Although O 0 2.738133559887501e-07
increasing O 0 6.36904502471225e-08
measured O 0 2.6651463258531294e-07
allele O 0 6.862564418952388e-07
size O 0 9.069122341998082e-08
between O 0 1.886313150123442e-08
patients O 0 2.0612536388853187e-07
clearly O 0 3.4982048369158747e-09
correlates O 0 3.304909235168907e-09
with O 0 1.0179419113187649e-10
an O 0 1.1961297230467238e-10
increased O 0 5.355247800764573e-09
severity O 0 7.137938382584252e-07
of O 0 5.863864949162689e-10
symptoms O 0 6.347373187054473e-07
and O 0 4.448112989052788e-10
an O 0 8.330350992347135e-11
earlier O 0 3.125537162418368e-08
age O 0 6.134319718853476e-09
of O 0 6.48607487163666e-11
onset O 0 1.9929447603317385e-07
, O 0 3.169127738011923e-10
this O 0 4.590464466880384e-11
correlation O 0 9.768086783878971e-09
is O 0 2.0956565649488113e-10
not O 0 1.294645085581081e-10
precise O 0 7.545629898686457e-09
and O 0 1.134509930444949e-09
measured O 0 1.12815570219027e-08
allele O 0 2.3334834509114444e-08
length O 0 1.0180283283034441e-08
cannot O 0 6.108344052790926e-08
be O 0 1.3648093766249758e-10
used O 0 2.655785591443305e-10
as O 0 4.682717755222221e-11
an O 0 3.312080817940988e-11
accurate O 0 5.0465530421206495e-08
predictor O 0 2.185485300287837e-06
of O 0 6.165165600258149e-10
age O 0 3.837487128066641e-08
of O 0 7.46446637833742e-09
onset O 0 2.9248936698422767e-05
. O 0 1.0038830851044622e-06

In O 0 4.926378949221544e-08
order O 0 2.6553310661370233e-09
to O 0 3.851518548536603e-10
further O 0 5.401345481992337e-10
characterize O 0 2.8939538765371253e-08
the O 0 2.9094435749499326e-09
dynamics O 0 3.518274809266586e-07
of O 0 2.9581270766243506e-08
DM B-Disease 1 1.0
CTG O 0 2.973236951220315e-05
repeat O 0 3.711087629199028e-06
somatic O 0 9.418205308975303e-07
instability O 0 2.6207359837826516e-07
, O 0 5.342492004345445e-10
we O 0 2.48915693612517e-10
have O 0 1.2242849789512178e-10
studied O 0 1.3217802408149737e-09
repeat O 0 7.339047147780775e-09
length O 0 3.775345314149803e-10
changes O 0 7.096035425924185e-10
over O 0 1.590082232549861e-10
time O 0 9.598463135418456e-10
in O 0 1.1280023581861087e-09
111 O 0 3.485463082597562e-07
myotonic B-Disease 1 0.9999991655349731
dystrophy I-Disease 1 0.9999979734420776
patients O 0 1.3621265679830685e-06
with O 0 4.107888751381239e-10
varying O 0 1.4944694370910838e-08
clinical O 0 6.52060725769843e-06
severity O 0 2.746057134572766e-06
and O 0 9.544721457643845e-09
CTG O 0 6.415228881451185e-07
repeat O 0 2.6659037644094496e-07
size O 0 7.977742910725283e-09
over O 0 5.441435080300039e-10
time O 0 6.845544131550696e-10
intervals O 0 6.109262429276896e-09
of O 0 2.297856072086546e-10
1 O 0 1.7864772772213655e-08
- O 0 2.1847040443390142e-06
7 O 0 1.9963607655881788e-08
years O 0 3.094041645113066e-08
. O 0 8.967568732032305e-08

We O 0 6.414066433535481e-07
have O 0 2.153315969977143e-09
found O 0 3.3275324162751474e-10
a O 0 1.4437603890193884e-10
direct O 0 1.7438049892959384e-09
progression O 0 1.9264472683744316e-08
of O 0 1.7446391553654905e-10
the O 0 4.0164049863733453e-10
size O 0 7.553579095542773e-09
heterogeneity O 0 6.426299137274327e-08
over O 0 1.4883697607714907e-09
time O 0 1.4956036409330409e-09
related O 0 2.9658993039305415e-09
to O 0 9.415990209760139e-10
initial O 0 1.7978088351355836e-08
CTG O 0 4.7519876034129993e-07
repeat O 0 1.1742900341005225e-07
size O 0 5.542107661682394e-09
and O 0 5.714868023254382e-10
the O 0 7.832449966382882e-11
time O 0 1.3226577610936374e-09
interval O 0 7.362546128319991e-09
and O 0 9.041997151015835e-10
always O 0 8.534449591479643e-09
biased O 0 5.2124121907581866e-08
towards O 0 3.554120331372701e-09
further O 0 9.788284849321371e-09
expansion O 0 3.3957658729377727e-07
. O 0 3.6575056583387777e-07

Attempts O 0 1.1065684475397575e-06
to O 0 2.089376494041062e-08
mathematically O 0 2.2034697622075328e-07
model O 0 3.193852649019391e-08
the O 0 5.763800547953224e-10
dynamics O 0 5.580934825388795e-08
have O 0 5.520121693081137e-09
proved O 0 8.571220178055228e-09
only O 0 8.208403401432918e-10
partially O 0 5.907934763627054e-08
successful O 0 3.4923712810552843e-09
suggesting O 0 4.620669624699758e-09
that O 0 7.035681759415269e-11
individual O 0 7.597699552830406e-11
specific O 0 2.921932695798546e-10
genetic O 0 2.2002060617865027e-08
and O 0 2.2337878213818385e-09
/ O 0 2.9760554909330494e-08
or O 0 6.602261404253795e-09
environmental O 0 6.097248927972032e-09
factors O 0 7.773342858286014e-09
also O 0 5.672926017830093e-10
play O 0 1.593745024841553e-09
a O 0 4.464619784982915e-10
role O 0 3.028640804814131e-08
in O 0 4.884087356771261e-09
somatic O 0 1.00987494988658e-06
mosaicism O 0 1.9792933017015457e-05
. O 0 5.233351529909669e-08
. O 0 3.1962605362423346e-07

Aspartylglucosaminuria B-Disease 1 0.9999978542327881
among O 0 1.1526056368893478e-05
Palestinian O 0 0.00031587143894284964
Arabs O 0 0.0006260864902287722
. O 0 3.909101451426977e-06

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 3.3720152714522555e-06
AGU B-Disease 1 0.9999997615814209
) O 0 1.9758326530450177e-08
is O 0 8.585351318757262e-10
a O 0 1.489284140454572e-09
rare O 0 1.4562938588369434e-07
disorder B-Disease 0 0.020390475168824196
of I-Disease 0 7.554785130814423e-10
glycoprotein I-Disease 0 6.899898380652303e-06
metabolism I-Disease 0 0.00024734227918088436
caused O 0 1.6285967774365417e-07
by O 0 1.0297981356544028e-09
the O 0 2.1992621057620454e-08
deficiency B-Disease 0 0.0010508423438295722
of I-Disease 0 1.3440319690527502e-10
the I-Disease 0 3.949405247283266e-09
lysosomal I-Disease 0 2.4125354684656486e-05
enzyme I-Disease 0 3.567819248928572e-06
aspartylglucosaminidase I-Disease 0 4.627631824405398e-06
( O 0 1.0364018088182547e-08
AGA O 0 2.3635767831819976e-07
) O 0 2.939140131275053e-08
. O 0 1.1669063582075978e-07

AGU B-Disease 1 0.9999996423721313
is O 0 2.60128132367754e-07
inherited O 0 2.2801407340011792e-06
as O 0 6.560935794652778e-09
an O 0 5.367088995456015e-09
autosomal O 0 0.025074727833271027
recessive O 0 0.01646636240184307
trait O 0 0.008675944991409779
and O 0 2.558707912214686e-08
occurs O 0 1.7593508871982522e-08
with O 0 3.8303465954570015e-10
a O 0 1.2664027604358807e-09
high O 0 1.803141991274515e-08
frequency O 0 3.7764226590297767e-07
in O 0 1.4827149286134045e-08
Finland O 0 1.4805107639404014e-05
because O 0 2.6139062470065255e-08
of O 0 1.5387580099002207e-10
a O 0 1.8817412072991146e-09
founder O 0 9.413700041704942e-08
effect O 0 3.173855702698347e-07
. O 0 2.111056431886027e-07

While O 0 6.30461272521643e-07
very O 0 1.6056452167845237e-08
few O 0 2.4188379299516782e-08
patients O 0 5.017146520458482e-08
with O 0 1.2245073843786258e-09
AGU B-Disease 1 1.0
have O 0 6.0776494947845094e-09
been O 0 2.232458884421362e-09
reported O 0 2.431877144104533e-09
from O 0 1.2551695793838746e-10
non O 0 2.3504949240304995e-06
- O 0 1.1448530585767003e-06
Finnish O 0 1.2480164457429055e-08
origin O 0 7.360520526411563e-10
, O 0 2.887010075447449e-10
we O 0 1.0487306134621122e-08
diagnosed O 0 5.470453174893919e-07
the O 0 1.20315490903522e-09
disorder O 0 1.937925389938755e-06
in O 0 4.863838221069727e-10
8 O 0 1.7770152016538532e-09
patients O 0 2.408170551859712e-09
originating O 0 1.3553932420862225e-09
from O 0 1.9816806529071584e-10
3 O 0 3.0726432509453616e-10
unrelated O 0 2.1184363152570995e-09
families O 0 4.05172201345394e-10
, O 0 1.042535016648749e-10
all O 0 3.2940516980772827e-10
Palestinian O 0 3.636980636656517e-06
Arabs O 0 9.97449092210445e-07
from O 0 6.43522291010612e-10
the O 0 1.5508273554232233e-09
region O 0 3.294092465466747e-08
of O 0 1.3103763629729315e-09
Jerusalem O 0 0.0023003467358648777
. O 0 1.2371295952107175e-06

The O 0 1.866098386926751e-07
clinical O 0 5.8927585087076295e-06
diagnosis O 0 4.997168434783816e-05
of O 0 7.89105847331939e-09
AGU B-Disease 1 1.0
is O 0 1.0959265495102954e-08
often O 0 1.1676873690191769e-08
difficult O 0 3.0439997544817743e-07
, O 0 2.4588625580079793e-10
in O 0 3.048934021920857e-11
particular O 0 2.0363004338275204e-10
early O 0 3.6815872572759645e-09
in O 0 3.3616232020250436e-10
the O 0 2.7647317768497714e-10
course O 0 5.977973671633663e-08
of O 0 2.3831192227929954e-11
the O 0 8.139556251229862e-10
disease O 0 2.635472640122316e-08
, O 0 4.903254538501933e-11
and O 0 3.010764207389549e-11
most O 0 5.252593845983533e-11
of O 0 5.312186454609069e-12
the O 0 2.0105202225284557e-10
patients O 0 6.017392362167584e-09
are O 0 5.43308675826637e-10
diagnosed O 0 5.442259976007335e-07
after O 0 1.7130181717561754e-09
the O 0 2.7865326712728233e-10
age O 0 4.568048161956995e-09
of O 0 7.423992670618773e-11
5 O 0 3.7603276048514545e-09
years O 0 3.519005531416042e-08
. O 0 1.1816933209729541e-07

However O 0 1.780324652145282e-07
, O 0 5.223954158140032e-09
since O 0 6.79598155528538e-09
these O 0 5.76619751946339e-10
patients O 0 3.379013513438167e-09
excrete O 0 5.56844881316465e-09
early O 0 3.1816649315175027e-10
large O 0 3.021246863799121e-10
amounts O 0 1.5744864301225903e-09
of O 0 1.0732349037256839e-10
aspartylglucosamine O 0 1.4162993977606675e-07
in O 0 7.316904304666139e-10
urine O 0 1.2991905329329256e-08
, O 0 2.5716120899410555e-10
biochemical O 0 1.9416232177604797e-08
screening O 0 3.762079359148629e-08
is O 0 8.246993088434351e-10
easy O 0 8.403385542976594e-09
by O 0 1.6563603821850847e-09
urine O 0 1.101364759392709e-07
chromatography O 0 1.2085948810636182e-06
. O 0 1.349363110136892e-08
. O 0 2.0797513400339085e-07

Detection O 0 1.5885642596913385e-06
of O 0 2.092358508676284e-09
heterozygous O 0 3.5146126720064785e-07
carriers O 0 2.1340595424135245e-07
of O 0 8.594756573110374e-10
the O 0 2.2611899908042687e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.571394759343093e-07
ATM O 0 1.4314441614260431e-06
) O 0 7.51899431605807e-09
gene O 0 5.771441280444378e-08
by O 0 8.375190319043213e-09
G2 O 0 3.3221283501916332e-06
phase O 0 1.006335082820442e-06
chromosomal O 0 6.880216824356467e-05
radiosensitivity O 0 6.433979706343962e-06
of O 0 1.696015772267856e-08
peripheral O 0 2.7801130272564478e-05
blood O 0 4.68158395960927e-05
lymphocytes O 0 0.00025524725788272917
. O 0 3.843138983938843e-06

In O 0 3.949807432945818e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0069909957237541676
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5393575836242235e-07
patients O 0 1.026949050242365e-07
, O 0 3.6555275473304505e-10
mutations O 0 2.8469253621210555e-08
in O 0 1.9268421580509454e-10
a O 0 1.0443918646574346e-10
single O 0 8.342884716405763e-10
gene O 0 2.723448577768295e-09
, O 0 1.1310006403641992e-10
ATM O 0 2.6063290192723798e-08
, O 0 2.2777051078559651e-10
result O 0 3.0479425650042913e-09
in O 0 5.6767390788081684e-09
an O 0 0.001625773380510509
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 7.825006420603131e-09
embraces O 0 2.8397016293979505e-08
a O 0 8.575793408738264e-10
variety O 0 2.4085886618507857e-09
of O 0 1.5578112411152034e-10
clinical O 0 5.947461190203285e-08
features O 0 1.6237605038327274e-08
and O 0 8.563048936593987e-09
manifests O 0 3.880649401821756e-08
extreme O 0 4.8018435450103425e-08
radiosensitivity O 0 1.7785746422305238e-06
and O 0 2.1017581008919706e-09
a O 0 1.6180279338584569e-09
strong O 0 2.9011440361159657e-08
pre O 0 3.0348159270943142e-05
- O 0 7.527774414484156e-06
disposition O 0 4.381587359603145e-07
to O 0 8.097336490209273e-08
malignancy B-Disease 0 6.923219916643575e-05
. O 0 2.460188852637657e-07

Heterozygotes O 0 4.0312726923730224e-05
for O 0 2.0076253548495515e-08
the O 0 1.3600001125269046e-09
ATM O 0 1.3667755638380186e-07
gene O 0 7.562260861959658e-08
have O 0 1.0546822970525227e-08
no O 0 2.970071300012478e-09
clinical O 0 2.3688837558211162e-08
expression O 0 4.239857798182811e-09
of O 0 1.1839685898351604e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 9.000843874673592e-07
may O 0 4.46101502404872e-08
be O 0 7.3254540211564745e-09
cancer B-Disease 0 1.3507772678167385e-07
prone O 0 2.9726290762255303e-08
with O 0 1.336906418902828e-10
a O 0 1.7733720047985457e-09
moderate O 0 9.447901447856566e-07
increase O 0 5.1271591416934825e-08
in O 0 6.758339665680069e-09
in O 0 1.8401967949444042e-08
vitro O 0 2.1653409930877388e-05
radiosensitivity O 0 2.6885583793045953e-05
. O 0 4.886223905486986e-07

We O 0 1.9865246940753423e-06
performed O 0 1.7421976394871308e-07
a O 0 1.4560293415399883e-08
blind O 0 5.607529374174192e-07
chromosomal O 0 3.457485263425042e-06
analysis O 0 4.78196504616335e-08
on O 0 5.871366948184686e-09
G2 O 0 1.3793018069918617e-06
- O 0 8.368853059437242e-07
phase O 0 7.704576177047784e-08
lymphocytes O 0 7.987506478457362e-08
from O 0 3.0430791220226183e-10
7 O 0 1.7113722661221686e-09
unrelated O 0 8.357593372920746e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.902455200157419e-07
, O 0 3.782618107628366e-10
13 O 0 1.0427979590943437e-09
obligate O 0 7.319646755377107e-08
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999971389770508
T I-Disease 1 1.0
heterozygotes O 0 1.8765649656415917e-06
( O 0 2.959489597831322e-10
parents O 0 9.790016575195182e-10
of O 0 1.5057977434396186e-11
the O 0 1.504920077444183e-10
patients O 0 5.4323225917585205e-09
) O 0 9.39949507117177e-11
, O 0 2.3454443942583225e-10
and O 0 4.7612753739656455e-09
14 O 0 3.4099938428511223e-09
normal O 0 1.5611144377203345e-08
controls O 0 2.819167832512903e-07
following O 0 8.790561167870692e-09
X O 0 9.660226396590588e-07
- O 0 7.12948278192016e-08
irradiation O 0 4.2330238869681125e-08
with O 0 4.421695787293345e-10
1 O 0 3.065175890881733e-09
Gy O 0 4.506889865751873e-07
in O 0 1.4153764271718217e-10
order O 0 2.1215246226446993e-10
to O 0 8.12057157628665e-11
evaluate O 0 4.985625690068218e-09
this O 0 1.0173480113895295e-10
cytogenetic O 0 5.591952501049491e-08
method O 0 2.5949979942652135e-09
as O 0 2.181974462223124e-10
a O 0 6.746406905344671e-11
tool O 0 2.2900353613408697e-08
for O 0 2.7177804451383736e-10
detection O 0 1.5349078452686626e-08
of O 0 9.606558881714022e-10
ATM O 0 6.943922016944271e-06
carriers O 0 2.2645660919806687e-06
. O 0 2.8818419650633587e-07

Both O 0 4.277057996660005e-06
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999979734420776
T I-Disease 1 0.9999998807907104
homozygotes O 0 2.4524526452296413e-05
and O 0 5.259686908232197e-09
heterozygotes O 0 4.513436522302072e-07
showed O 0 3.07621164097327e-08
significantly O 0 2.7134479552159974e-08
increased O 0 4.712613410617905e-09
levels O 0 5.535135461087748e-09
of O 0 2.0320015114982937e-10
radiation O 0 1.0143505278392695e-05
- O 0 6.909401417942718e-05
induced O 0 3.6692899811896496e-06
chromatid O 0 0.0007069978746585548
damage O 0 3.8042448977648746e-06
relative O 0 1.271280059000901e-08
to O 0 3.7105027383965705e-10
that O 0 4.415273979763157e-10
of O 0 3.4006522597884725e-10
normal O 0 7.706780991156847e-08
controls O 0 1.4049726814846508e-05
. O 0 7.144360552047146e-07

These O 0 2.910766028207945e-08
results O 0 1.8638248278080027e-08
show O 0 5.111377543443041e-09
that O 0 2.7930616153248877e-10
the O 0 8.727006894915235e-10
G2 O 0 1.2702906815320603e-06
- O 0 9.969222674044431e-07
phase O 0 9.833986780449777e-08
chromosomal O 0 6.782858577025763e-07
radiosensitivity O 0 2.722014755818236e-07
assay O 0 6.433916155401675e-08
can O 0 3.0922328586591163e-10
be O 0 1.5148866536196515e-11
used O 0 6.550251313575117e-11
for O 0 7.76556596804312e-12
the O 0 3.0992285127151575e-11
detection O 0 2.7334522201272193e-08
of O 0 1.9503074710769397e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 0.00024513425887562335
. O 0 5.690161515303771e-07

In O 0 1.358418728614197e-07
combination O 0 2.3429566908816923e-07
with O 0 6.419127451806617e-10
molecular O 0 5.703766703391011e-08
genetic O 0 9.744383078214014e-08
analyses O 0 4.346635407159738e-08
, O 0 3.388538061255275e-10
this O 0 2.810380816953284e-10
test O 0 2.8123251283318496e-08
may O 0 1.099671909088329e-09
be O 0 2.6169949887688837e-11
of O 0 2.192451732316303e-12
value O 0 8.369374082661807e-10
in O 0 2.9346725050061195e-10
studies O 0 4.656519170254114e-09
of O 0 9.540780665506787e-11
familial B-Disease 0 2.322455657122191e-06
and I-Disease 0 9.695605740489555e-08
sporadic I-Disease 0 0.0030104194302111864
cancers I-Disease 1 0.99998939037323
aimed O 0 3.346989103647502e-07
at O 0 3.3310079139425852e-09
determination O 0 1.1881673422919903e-09
of O 0 1.3695494391341434e-11
the O 0 5.688590570818164e-11
potential O 0 3.693050754094429e-09
involvement O 0 5.3017887857720325e-09
of O 0 2.5819035798235745e-10
ATM O 0 1.0744566907305853e-06
mutations O 0 8.260923891612038e-07
in O 0 8.676622087477881e-09
tumor B-Disease 0 2.5499379262328148e-05
risk O 0 2.1081054001115263e-05
or O 0 2.5768784439605952e-08
development O 0 9.689594016037972e-09
. O 0 4.234106043554675e-08
. O 0 3.1943861245053995e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.3398157250321674e-07
identification O 0 4.173744727609119e-08
and O 0 2.3466222298651473e-09
detection O 0 2.0073343875992578e-08
of O 0 1.2673807836538487e-10
founder O 0 4.7665299263144334e-08
- O 0 0.000489643367473036
effect O 0 5.264030846774403e-07
mutations O 0 1.3132687115557928e-07
in O 0 3.7706457400865645e-10
the O 0 2.337552651443531e-10
ATM O 0 1.221063712364412e-07
gene O 0 6.057086920918664e-08
in O 0 1.1446306125151295e-08
ethnic O 0 5.537597758120683e-07
populations O 0 7.456481853296282e-06
. O 0 1.6367320085919346e-06

To O 0 1.7546826214243083e-08
facilitate O 0 4.799158404011905e-09
the O 0 5.310489825660625e-10
evaluation O 0 4.437302525417408e-09
of O 0 6.177922756700482e-11
ATM O 0 6.440570388122069e-08
heterozygotes O 0 6.7178845597482e-08
for O 0 1.0612940387622061e-10
susceptibility O 0 2.1526188831444415e-08
to O 0 9.049623272971985e-10
other O 0 3.086142230657174e-09
diseases O 0 2.6363153438069276e-07
, O 0 4.067950143404886e-11
such O 0 8.441352478127939e-11
as O 0 6.933007945519876e-09
breast B-Disease 0 0.00012474253890104592
cancer I-Disease 0 8.702862942300271e-06
, O 0 3.22380205863837e-10
we O 0 5.288696702798745e-10
have O 0 5.000906633245705e-11
attempted O 0 4.5036716023183487e-10
to O 0 5.498542940407525e-11
define O 0 2.010816624320455e-09
the O 0 5.353894064197284e-11
most O 0 3.160796901990892e-10
common O 0 3.2783333825392447e-09
mutations O 0 4.190224345279603e-08
and O 0 3.585575447662137e-10
their O 0 3.543248194848303e-10
frequencies O 0 1.7386291517595964e-07
in O 0 6.901227038724755e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 9.301544923800975e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 1.2351057954163025e-08
homozygotes O 0 4.909391577712086e-07
from O 0 1.3780879770664e-09
10 O 0 4.0407033274902915e-09
ethnic O 0 9.733125949651367e-08
populations O 0 1.7388824744557496e-06
. O 0 2.7663284640766506e-07

Both O 0 2.0075032125532744e-07
genomic O 0 4.849031029152684e-06
mutations O 0 5.455226983031025e-06
and O 0 2.568653734158488e-08
their O 0 3.867878461960572e-09
effects O 0 2.6568480393507343e-07
on O 0 3.5671869902387243e-09
cDNA O 0 1.548883687974012e-07
were O 0 3.397478565148049e-08
characterized O 0 2.41344423557166e-07
. O 0 4.6448437274193566e-07

Protein O 0 1.565362254041247e-05
- O 0 1.4643710528616793e-05
truncation O 0 3.131055791527615e-06
testing O 0 1.737303136906121e-07
of O 0 1.9412434160148706e-10
the O 0 3.089214717366673e-10
entire O 0 9.567286518574747e-09
ATM O 0 1.6123054535910342e-07
cDNA O 0 7.284840819465899e-08
detected O 0 1.1523682275083047e-07
92 O 0 1.1850989523054523e-08
( O 0 7.985670458232619e-10
66 O 0 1.2913785596424532e-08
% O 0 2.3811861371569876e-09
) O 0 1.399560023429558e-09
truncating O 0 4.2994466298296175e-07
mutations O 0 1.092253683054878e-06
in O 0 7.446747662953612e-09
140 O 0 3.576528939674972e-08
mutant O 0 2.9879824978706893e-06
alleles O 0 4.941558472637553e-06
screened O 0 1.0461678357387427e-05
. O 0 1.637550212763017e-06

The O 0 3.4119601366455754e-08
haplotyping O 0 1.1632236009972985e-06
of O 0 1.3532828191387125e-09
patients O 0 4.583245072353748e-08
with O 0 2.1740233224765149e-10
identical O 0 8.84522606270366e-08
mutations O 0 5.397075710789068e-07
indicates O 0 2.294871315200453e-08
that O 0 1.796720272562169e-10
almost O 0 2.6824517607160203e-10
all O 0 8.655324373885165e-11
of O 0 7.296215714935883e-12
these O 0 3.849577601133802e-11
represent O 0 3.3314254133109955e-10
common O 0 3.020816485843625e-09
ancestry O 0 1.2615352318334772e-07
and O 0 2.0390413801862906e-09
that O 0 3.102583745473453e-10
very O 0 1.0441174591591107e-09
few O 0 1.7769789195654084e-08
spontaneously O 0 2.258899058915631e-07
recurring O 0 6.817848316131858e-06
ATM O 0 3.5897908674087375e-05
mutations O 0 1.842916026362218e-05
exist O 0 1.1997316278211656e-06
. O 0 4.163504740972712e-07

Assays O 0 4.467506369110197e-05
requiring O 0 5.482695542013971e-07
minimal O 0 9.190581806706177e-08
amounts O 0 1.5733824909602845e-08
of O 0 1.5969270350524312e-10
genomic O 0 3.564604256212078e-08
DNA O 0 5.834540672822186e-08
were O 0 2.4751906080311414e-10
designed O 0 7.747214536557578e-10
to O 0 2.9657831746021657e-11
allow O 0 5.361254218350098e-10
rapid O 0 1.351283862582875e-09
screening O 0 1.1404551969462773e-08
for O 0 1.1246896747252322e-09
common O 0 4.465288228061581e-08
ethnic O 0 1.2949583378940588e-06
mutations O 0 9.051831148099154e-05
. O 0 1.0886097925322247e-06

These O 0 2.013381816823312e-07
rapid O 0 9.865168522082968e-07
assays O 0 5.544262876355788e-06
detected O 0 9.595704568710062e-07
mutations O 0 5.698437348655716e-07
in O 0 3.855731733892753e-09
76 O 0 4.716491375234e-08
% O 0 1.739652422116933e-09
of O 0 2.4075813565005433e-10
Costa O 0 9.206969764363748e-08
Rican O 0 1.3434879519991227e-07
patients O 0 3.068815956908111e-08
( O 0 9.673555706468662e-11
3 O 0 1.4181976426552723e-10
) O 0 5.237697428550625e-11
, O 0 5.290166915639105e-11
50 O 0 4.776554152208234e-10
% O 0 6.591059920069142e-10
of O 0 4.0495506947735294e-10
Norwegian O 1 0.9547190070152283
patients O 0 3.0344929768943985e-07
( O 0 1.2132524151997615e-10
1 O 0 1.7982698663487895e-10
) O 0 1.202254962251459e-10
, O 0 1.6032138117072492e-10
25 O 0 3.2737829114282135e-10
% O 0 1.5942122622014665e-10
of O 0 1.9447828070173756e-10
Polish O 0 0.00023002809030003846
patients O 0 5.3281695500118076e-08
( O 0 7.592976941639407e-11
4 O 0 1.1341805272735428e-10
) O 0 1.1415639267209343e-10
, O 0 7.360712733772701e-11
and O 0 5.779609568712374e-10
14 O 0 1.2918311975695929e-09
% O 0 4.1396966410367497e-10
of O 0 1.4528375724687237e-10
Italian O 0 7.762036693748087e-05
patients O 0 4.715403179034183e-08
( O 0 8.895564146405022e-11
1 O 0 2.868479620499187e-10
) O 0 1.818537542774834e-10
, O 0 2.2018735792994626e-11
as O 0 4.169425915634406e-11
well O 0 1.3674723853274173e-10
as O 0 1.5268822317615616e-10
in O 0 5.298045890889114e-10
patients O 0 8.130840001285833e-09
of O 0 2.8714572386512316e-10
Amish O 0 1.1680391480695107e-06
/ O 0 4.1693894559102773e-07
Mennonite O 0 7.176893745963753e-07
and O 0 1.709621955114926e-07
Irish O 0 8.344928232872917e-07
English O 0 1.9885175106537645e-07
backgrounds O 0 1.7568345356266946e-06
. O 0 2.9452942840180185e-07

Additional O 0 5.276299361867132e-07
mutations O 0 1.3941809129391913e-06
were O 0 5.44041034444831e-09
observed O 0 1.4753126720279397e-08
in O 0 6.690412113208311e-10
Japanese O 0 3.996385888882514e-09
, O 0 8.185916527958526e-11
Utah O 0 1.034118679577034e-09
Mormon O 0 4.0451606508895566e-09
, O 0 5.19854603808767e-10
and O 0 1.6345577114051935e-09
African O 0 9.54233758676537e-09
American O 0 1.631696733284116e-07
patients O 0 3.4506496149333543e-07
. O 0 1.019351927311618e-07

These O 0 1.6461818574953213e-08
assays O 0 2.848316569270537e-07
should O 0 1.994426179763309e-09
facilitate O 0 1.6646393152797145e-09
screening O 0 3.1427475732925814e-08
for O 0 5.845754991185004e-09
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999979734420776
T I-Disease 1 1.0
heterozygotes O 0 1.7625269492782536e-06
in O 0 1.2398326809659466e-09
the O 0 5.002349645621962e-10
populations O 0 1.500742285998058e-08
studied O 0 3.030755735267121e-08
. O 0 9.447639115478523e-09
. O 0 9.502147690909624e-08

The O 0 3.729295258381171e-06
von B-Disease 1 0.9981071949005127
Hippel I-Disease 1 0.9995908141136169
- I-Disease 1 0.9998801946640015
Lindau I-Disease 1 0.9984575510025024
tumor I-Disease 0 5.396135020419024e-05
suppressor O 0 2.9401883239188464e-06
gene O 0 4.3045423581133946e-07
is O 0 3.699240691545924e-09
required O 0 4.206012427232508e-09
for O 0 8.900150616497626e-10
cell O 0 4.963577566741151e-07
cycle O 0 6.65470565763826e-07
exit O 0 4.216400384393637e-07
upon O 0 3.794421843394957e-08
serum O 0 5.328130555426469e-06
withdrawal O 0 1.279334264836507e-05
. O 0 1.2023958788631717e-06

The O 0 7.241300892246727e-08
inactivation O 0 4.12047029385576e-06
of O 0 2.0397530331450753e-09
the O 0 3.9227927572937915e-08
von B-Disease 1 0.9984246492385864
Hippel I-Disease 1 0.9999505281448364
- I-Disease 1 0.9999871253967285
Lindau I-Disease 1 0.9999501705169678
( I-Disease 0 4.896995164926921e-07
VHL I-Disease 0 0.00015252569573931396
) I-Disease 0 3.5688152877355606e-08
tumor I-Disease 0 5.754062613050337e-07
suppressor O 0 8.729061278245354e-07
gene O 0 4.7358005872411013e-07
predisposes O 0 2.2208714653970674e-06
affected O 0 1.6064356955780568e-08
individuals O 0 5.70132441257698e-10
to O 0 6.542188457636655e-10
the O 0 3.2208598010896594e-09
human O 0 9.57205998020072e-07
VHL B-Disease 1 0.9999942779541016
cancer I-Disease 1 0.9999979734420776
syndrome I-Disease 1 0.9999858140945435
and O 0 2.01765892882122e-09
is O 0 7.329782336640278e-10
associated O 0 1.1847372860529504e-08
with O 0 3.18226263118504e-08
sporadic B-Disease 1 0.999971866607666
renal I-Disease 1 0.9999998807907104
cell I-Disease 1 0.9999996423721313
carcinomas I-Disease 1 1.0
( O 0 3.3796325169532793e-06
RCC B-Disease 1 0.602397084236145
) O 0 1.0243999781778257e-07
and O 0 7.930079704010495e-08
brain B-Disease 0 5.944099757471122e-05
hemangioblastomas I-Disease 0 0.00015453228843398392
. O 0 1.0829736538653378e-06

VHL O 0 0.020772302523255348
- O 0 0.2550046443939209
negative O 0 6.441026198444888e-05
786 O 0 3.6940986319677904e-05
- O 0 0.0002394579933024943
0 O 0 3.490362701086269e-07
RCC B-Disease 0 3.6271369481255533e-06
cells O 0 1.024329705501259e-07
are O 0 2.028223144989738e-09
tumorigenic O 0 3.231636753753264e-07
in O 0 2.7246436218320014e-09
nude O 0 7.2536417974333744e-06
mice O 0 4.238792712385475e-07
which O 0 1.0583715015499706e-09
is O 0 2.928125519829905e-10
suppressed O 0 2.2452439907283406e-09
by O 0 8.555726960235432e-11
the O 0 3.9164041454320397e-10
reintroduction O 0 8.638613024913866e-08
of O 0 1.1123167276139156e-08
VHL B-Disease 0 4.444568185135722e-05
. O 0 3.0067405987210805e-07

Remarkably O 0 2.0291972759878263e-06
, O 0 1.0902493130515722e-08
this O 0 2.806117282982967e-10
occurs O 0 1.4449180740783163e-09
without O 0 9.018297775220674e-10
affecting O 0 2.2697006496485983e-09
the O 0 5.390251023307258e-10
growth O 0 5.920670531622818e-08
rate O 0 3.4337265475414824e-08
and O 0 1.6666661384334702e-09
cell O 0 2.462024042415578e-07
cycle O 0 4.4472180604770983e-08
profile O 0 2.598883384052897e-07
of O 0 1.0699687663651147e-10
these O 0 6.975808264364503e-10
cells O 0 1.7776365268673544e-08
in O 0 2.967834644707068e-09
culture O 0 1.5000016162503016e-07
. O 0 1.1619802364748466e-07

The O 0 1.5946251608056627e-07
786 O 0 2.8856725293735508e-06
- O 0 6.597054834855953e-06
0 O 0 3.887368649202472e-08
cell O 0 9.071458606513261e-08
line O 0 4.5060303932586976e-08
, O 0 4.371373818479185e-10
like O 0 2.181459457517576e-09
many O 0 2.6118514018236283e-09
cancer B-Disease 0 1.2592623477303277e-07
cells O 0 1.608606403635804e-08
, O 0 1.334619081916344e-09
fails O 0 1.9633198178325983e-07
to O 0 1.5614858295265321e-09
exit O 0 8.648125060517486e-08
the O 0 3.1936377986596653e-09
cell O 0 4.765502694681345e-07
cycle O 0 1.0912172143662247e-07
upon O 0 9.90134285672184e-09
serum O 0 1.082087806025811e-06
withdrawal O 0 2.9470184017554857e-06
. O 0 5.611916549241869e-07

Here O 0 2.63196710648117e-07
, O 0 2.2736306171111664e-09
it O 0 3.061592646069755e-10
is O 0 4.2343257372623455e-11
shown O 0 2.1130519556322724e-10
that O 0 1.409400634394542e-11
reintroduction O 0 7.476403385275887e-10
of O 0 2.3707558485797087e-11
the O 0 2.0819911072944564e-10
wild O 0 2.111450569941553e-08
- O 0 0.00014248810475692153
type O 0 1.5993723536666948e-06
VHL B-Disease 0 7.127101980586303e-06
gene O 0 1.9166914455581718e-07
restores O 0 2.1826348017839337e-07
the O 0 9.610664486459086e-10
ability O 0 3.13472554580585e-08
of O 0 3.6354486088185922e-09
VHL O 0 0.00020016037160530686
- O 0 0.009407717734575272
negative O 0 1.5330755559261888e-05
RCC B-Disease 0 7.405116775771603e-05
cancer I-Disease 0 9.694567779661156e-07
cells O 0 1.6301839877996827e-08
to O 0 8.886444913258629e-10
exit O 0 3.151541605461716e-08
the O 0 4.80388173684787e-10
cell O 0 2.427286744932644e-07
cycle O 0 1.4116821489551512e-07
and O 0 3.996111441750827e-09
enter O 0 8.63325979594265e-08
G0 O 0 1.4280694813351147e-05
/ O 0 5.375363230086805e-07
quiescence O 0 3.3732183055690257e-06
in O 0 7.138599755762698e-08
low O 0 5.384087671700399e-06
serum O 0 7.956766239658464e-06
. O 0 2.5558895799804304e-07

Both O 0 2.017578935920028e-06
VHL O 0 0.00033664036891423166
- O 0 0.000658113625831902
positive O 0 3.071032779189409e-07
and O 0 5.2542450390546946e-08
VHL O 0 8.14043523860164e-05
- O 0 0.0001769181399140507
negative O 0 5.787838745163754e-06
RCC B-Disease 0 1.2922017049277201e-05
cells O 0 4.462427796170232e-07
exit O 0 3.222244515654893e-07
the O 0 3.5347718085887436e-09
cell O 0 4.336433505613968e-07
cycle O 0 9.57875627705107e-08
by O 0 1.0708962605576744e-09
contact O 0 3.361037386184762e-07
inhibition O 0 3.2941104564088164e-06
. O 0 6.372909524543502e-07

The O 0 1.0155439440495684e-06
cyclin O 0 0.008201055228710175
- O 0 0.000202214447199367
dependent O 0 3.4641027468751417e-06
kinase O 0 1.289608462684555e-06
inhibitor O 0 5.866980927748955e-07
, O 0 2.420017741755487e-09
p27 O 0 2.203810254286509e-07
, O 0 5.315881068668205e-10
accumulates O 0 5.324488849822728e-09
upon O 0 2.35688413230406e-10
serum O 0 2.0703664560528523e-08
withdrawal O 0 4.22065653538084e-08
, O 0 2.5874055675778607e-10
only O 0 8.373441523490399e-11
in O 0 1.629859025520375e-10
the O 0 2.21463694605184e-10
presence O 0 3.110074198175994e-09
of O 0 9.604282646957785e-11
VHL B-Disease 0 1.775868412323689e-07
, O 0 2.1715203246674974e-10
as O 0 1.2800671633783622e-10
a O 0 2.5560031868820943e-10
result O 0 3.5166687339938107e-09
of O 0 3.05566960623338e-11
the O 0 6.771601057664611e-10
stabilization O 0 6.949400699340913e-08
of O 0 2.883559224731158e-10
the O 0 3.259827074941768e-09
protein O 0 2.3115742919799231e-07
. O 0 1.1382868336795582e-07

We O 0 9.507277809461812e-08
propose O 0 4.375582207671869e-08
that O 0 2.2870777494077288e-10
the O 0 3.2236668889851217e-10
loss O 0 6.072156999437084e-09
of O 0 8.670922313491758e-11
wild O 0 2.031685575332176e-08
- O 0 0.0004073420132044703
type O 0 3.2624029699945822e-06
VHL B-Disease 0 5.013778263673885e-06
gene O 0 1.9596629385887354e-07
results O 0 2.3510228430723146e-08
in O 0 3.0721278299061794e-10
a O 0 4.0387287958409956e-10
specific O 0 5.340925923746909e-09
cellular O 0 4.913813427265268e-07
defect O 0 5.781587333331117e-07
in O 0 2.261447251683535e-09
serum O 0 1.0682691709007486e-06
- O 0 8.980044185591396e-06
dependent O 0 1.683928167039994e-05
growth O 0 3.848475387258077e-07
control O 0 6.982350697626316e-08
, O 0 8.963644271275939e-10
which O 0 3.8599190510524295e-09
may O 0 1.6839539540569604e-08
initiate O 0 1.2393444137615006e-07
tumor B-Disease 0 2.342465904803248e-06
formation O 0 7.530277912337624e-07
. O 0 4.5493564471144055e-07

This O 0 6.143419994941723e-08
is O 0 4.16853973561615e-09
corrected O 0 3.543819460105624e-08
by O 0 4.6294516831135724e-11
the O 0 8.897956677023089e-11
reintroduction O 0 3.4208076371555762e-09
of O 0 1.3235733342664702e-10
wild O 0 3.429125428056068e-08
- O 0 0.004654053598642349
type O 0 4.79154841741547e-05
VHL B-Disease 0 9.947528451448306e-05
, O 0 1.189832499193244e-08
implicating O 0 4.1971429709519725e-07
VHL B-Disease 0 3.771329602386686e-06
as O 0 1.6905116195786718e-09
the O 0 3.9926048578386997e-10
first O 0 2.464418225045506e-09
tumor B-Disease 0 4.4665320331205294e-08
suppressor O 0 6.19892972508751e-08
involved O 0 1.4671019954448639e-08
in O 0 8.403893692054965e-10
the O 0 2.9873814533232235e-10
regulation O 0 3.7976852773624614e-09
of O 0 8.621053870783157e-11
cell O 0 9.508293175031213e-08
cycle O 0 1.1716835501829337e-07
exit O 0 4.5891891886640224e-07
, O 0 1.298193996746022e-09
which O 0 6.43327524585402e-09
is O 0 1.6164731775347718e-09
consistent O 0 5.548644210762177e-09
with O 0 1.6641812927709054e-10
its O 0 1.548456918243346e-09
gatekeeper O 0 2.5868214947877277e-07
function O 0 1.1345365535930796e-08
in O 0 5.742383901718995e-09
the O 0 9.030488357097965e-09
kidney O 0 1.2829842717110296e-06
. O 0 1.530084858814007e-08
. O 0 1.62985529073012e-07

Piebaldism B-Disease 1 1.0
with O 0 0.0005263137863948941
deafness B-Disease 1 1.0
: O 0 2.562268264227896e-08
molecular O 0 3.83617013710591e-08
evidence O 0 6.865344293061071e-09
for O 0 1.6174878103569768e-09
an O 0 1.3343652405239936e-08
expanded O 0 0.0008796950569376349
syndrome O 1 0.999579131603241
. O 0 1.106930426431063e-06

In O 0 4.726235403040846e-08
a O 0 1.2416224492994843e-08
South O 0 1.5874597636411636e-08
African O 0 6.177458100609101e-09
girl O 0 5.0737217094365406e-08
of O 0 2.1172799624658012e-10
Xhosa O 0 4.634940751202521e-07
stock O 0 2.2516314857057296e-07
with O 0 1.206641231377148e-09
severe O 0 1.5927449794617132e-06
piebaldism B-Disease 0 1.6180203601834364e-05
and O 0 5.011886017314282e-08
profound O 0 3.07588879877585e-06
congenital O 1 0.9999781847000122
sensorineural B-Disease 1 0.999962329864502
deafness I-Disease 1 1.0
we O 0 0.00019926689856220037
identified O 0 1.6494905707986618e-07
a O 0 2.2864989901449917e-09
novel O 0 3.125137837400871e-08
missense O 0 9.597773669156595e-07
substitution O 0 1.95214333587046e-08
at O 0 1.4461402741972051e-08
a O 0 1.6567205385342731e-09
highly O 0 6.342772085332626e-09
conserved O 0 2.34776074137244e-08
residue O 0 2.7535759272723226e-07
in O 0 2.0655257504387237e-09
the O 0 3.123413971906075e-09
intracellular O 0 2.5394746216989006e-07
kinase O 0 1.5688895871335262e-07
domain O 0 1.375761815580745e-08
of O 0 3.684648142154856e-10
the O 0 3.490420175111808e-09
KIT O 0 2.2664501102553913e-06
proto O 0 2.3667222194490023e-05
- O 0 5.149031494511291e-06
oncogene O 0 6.38097662886139e-06
, O 0 1.8535368795369322e-08
R796G O 0 3.1683925953984726e-06
. O 0 2.222633384008077e-07

Though O 0 2.225709749836824e-06
auditory B-Disease 0 6.759490133845247e-06
anomalies I-Disease 0 5.123735718370881e-06
have O 0 2.509687035967545e-08
been O 0 4.721970814358656e-09
observed O 0 6.578754430108802e-09
in O 0 1.2783135661109668e-09
mice O 0 9.444669757385782e-08
with O 0 2.658589570714298e-09
dominant O 0 1.3099357602186501e-05
white O 0 1.7998162320509437e-06
spotting O 0 1.823841012082994e-05
( O 0 6.756689874265476e-09
W O 0 0.0016912048449739814
) O 0 1.942066729654357e-09
due O 0 2.9456039829511838e-09
to O 0 1.1408592959227803e-09
KIT O 0 9.399502232554369e-06
mutations O 0 7.4967242653656285e-06
, O 0 1.1913250119732766e-07
deafness B-Disease 1 1.0
is O 0 3.696477790526842e-08
not O 0 3.499592837741261e-09
typical O 0 2.6582309686773442e-08
in O 0 2.937188492424525e-09
human O 0 3.718214358627847e-08
piebaldism B-Disease 0 1.628904283279553e-05
. O 0 4.680947824908799e-07

Thus O 0 3.342245804560662e-07
, O 0 3.6030933792119413e-09
the O 0 8.14113998437449e-10
occurrence O 0 2.3640367885491287e-07
of O 0 5.837376360062763e-09
sensorineural B-Disease 1 0.99935382604599
deafness I-Disease 1 1.0
in O 0 9.46840685855932e-08
this O 0 3.3005560506893517e-09
patient O 0 5.011924031350645e-08
extends O 0 1.3450745406373699e-08
considerably O 0 1.4606104770109596e-08
the O 0 3.259626457641218e-10
phenotypic O 0 1.537906371140707e-07
range O 0 1.597940268993625e-08
of O 0 3.328402276014941e-10
piebaldism B-Disease 0 5.805406431136362e-07
due O 0 6.3661644844614784e-09
to O 0 1.0295860830566994e-09
KIT O 0 1.3198616954923637e-07
gene O 0 4.626554428455165e-08
mutation O 0 4.6345917326107156e-08
in O 0 1.593890019968569e-10
humans O 0 1.738435173592734e-09
and O 0 1.694062334856028e-09
tightens O 0 5.943434189248364e-06
the O 0 8.153400177235426e-10
clinical O 0 3.1542356282443507e-08
similarity O 0 4.653057050774123e-09
between O 0 5.862210161744486e-10
piebaldism B-Disease 0 3.290382153409155e-07
and O 0 5.689744231318627e-10
the O 0 1.164332519287825e-10
various O 0 5.958935012095878e-10
forms O 0 4.504414974348947e-08
of O 0 1.5881326476119284e-07
Waardenburg B-Disease 1 0.9999961853027344
syndrome I-Disease 1 0.9998780488967896
. O 0 5.9542145436353167e-08
. O 0 3.6756816257366154e-07

Cycloheximide O 0 3.374179141246714e-05
facilitates O 0 4.186872786249296e-07
the O 0 4.8253632201067376e-09
identification O 0 1.987015529891778e-08
of O 0 4.1504491510302444e-10
aberrant O 0 5.169038175267815e-08
transcripts O 0 1.5000588859948039e-07
resulting O 0 1.681392802765913e-08
from O 0 5.070291964059948e-10
a O 0 5.331843855316265e-10
novel O 0 3.0336476442016647e-08
splice O 0 1.655369851505384e-05
- O 0 7.3508426794433035e-06
site O 0 9.911984477639635e-08
mutation O 0 1.2996420650779328e-07
in O 0 1.0667171590483804e-09
COL17A1 O 0 3.440210605276661e-07
in O 0 6.391516205184189e-10
a O 0 2.0164507841258228e-09
patient O 0 8.69488232524418e-08
with O 0 9.083213825533676e-08
generalized O 0 9.01150779100135e-05
atrophic B-Disease 1 0.9985339641571045
benign I-Disease 1 0.9964750409126282
epidermolysis I-Disease 1 0.9933619499206543
bullosa I-Disease 1 0.9808593392372131
. O 0 3.1279221730073914e-05

Patients O 0 0.00015776716463733464
with O 0 1.1736802889572573e-06
generalized O 0 0.0002537581021897495
atrophic B-Disease 1 0.9992455244064331
benign I-Disease 1 0.9828054308891296
epidermolysis I-Disease 1 0.9526631832122803
bullosa I-Disease 0 0.496715784072876
often O 0 4.393312792672077e-06
show O 0 4.765448409216333e-07
decreased O 0 2.9596631634376536e-07
expression O 0 4.182303214861349e-08
of O 0 4.056881941494339e-09
type O 0 2.8448953344195616e-06
XVII O 0 5.257561042526504e-06
collagen O 0 1.5831756172701716e-06
, O 0 1.258416659766226e-08
a O 0 2.4933028086593367e-08
transmembrane O 0 4.483681095734937e-06
hemidesmosomal O 0 2.9067605282762088e-06
protein O 0 1.3360121897676436e-07
encoded O 0 1.0841448983001101e-07
by O 0 4.303261391669366e-08
COL17A1 O 0 3.61588281521108e-05
. O 0 1.0153900120712933e-06

This O 0 9.002734913110544e-08
report O 0 3.74804898228831e-08
documents O 0 1.775291735839346e-08
a O 0 1.3596681558425416e-09
novel O 0 5.0729575207242306e-08
splice O 0 1.3481661881087348e-05
- O 0 9.756573490449227e-06
site O 0 8.601980283629018e-08
mutation O 0 1.6083708942460362e-07
in O 0 1.0984518850065683e-09
COL17A1 O 0 4.24595384629356e-07
in O 0 7.814039970632791e-10
a O 0 1.631259460843637e-09
patient O 0 6.828206977615991e-08
with O 0 2.188695802374241e-08
generalized O 0 2.6299161618226208e-05
atrophic B-Disease 1 0.9951516389846802
benign I-Disease 0 0.19148413836956024
epidermolysis I-Disease 0 0.03677890822291374
bullosa I-Disease 0 0.33659565448760986
, O 0 6.334590096912507e-08
and O 0 1.8540239343778353e-09
applies O 0 8.43659719862444e-09
a O 0 6.057324641872697e-10
new O 0 1.3310347268813416e-09
methodology O 0 5.101773670190823e-09
to O 0 2.1184433374177303e-10
define O 0 1.720497877499838e-08
and O 0 1.6345609310519649e-09
characterize O 0 1.851262112495533e-07
the O 0 5.872150765640072e-09
resulting O 0 1.41917240625844e-07
mRNA O 0 4.495694554407237e-07
splice O 0 9.988418241846375e-06
variants O 0 3.7849347336305073e-06
. O 0 8.868400982464664e-07

Mutational O 0 0.0002679289609659463
analysis O 0 9.526607414045429e-07
of O 0 4.274774756396482e-09
COL17A1 O 0 3.09605707116134e-06
identified O 0 1.7794147311178676e-07
a O 0 1.0854604326482331e-08
maternally O 0 3.0236308248277055e-06
inherited O 0 4.557808551908238e-06
G O 0 5.045425950811477e-06
- O 0 4.2474016481719445e-06
to O 0 3.194876185830253e-08
- O 0 1.0596721949696075e-05
T O 0 1.42015289839037e-06
transversion O 0 1.1238115149581063e-07
at O 0 5.58118440352473e-10
the O 0 2.512270946830597e-10
- O 0 1.0050251830762136e-07
1 O 0 2.5616804233408175e-09
position O 0 1.3065710291471078e-08
of O 0 3.168825479793469e-10
exon O 0 4.4208744043316983e-07
32 O 0 1.5382349261017225e-07
. O 0 1.4998214226125128e-07

This O 0 1.8678966284824128e-07
acceptor O 0 1.0263875083182938e-06
splice O 0 1.0283744813932572e-05
- O 0 2.3575889827043284e-06
site O 0 3.663181402657756e-08
mutation O 0 5.716934481370117e-08
led O 0 1.6189817264589124e-09
to O 0 3.738064302538646e-10
the O 0 2.1702944996704332e-10
formation O 0 1.4384587965210471e-09
of O 0 8.184854877191228e-11
aberrant O 0 7.433748727692091e-09
transcripts O 0 1.5072481929223613e-08
present O 0 1.0539759065508747e-09
at O 0 1.2190852771709615e-08
extremely O 0 1.4788392377340642e-07
low O 0 1.1775251550716348e-05
levels O 0 2.0518464225460775e-06
. O 0 2.979634814437304e-07

Based O 0 7.823038572496444e-07
on O 0 1.544952965559787e-08
our O 0 7.394125312032429e-09
recent O 0 1.1787394171847154e-08
finding O 0 1.0848561160514691e-08
that O 0 2.823363098869436e-09
cycloheximide O 0 2.3002321540843695e-06
stabilized O 0 5.798346592200687e-06
mutant O 0 6.116762847341306e-07
COL17A1 O 0 6.769035962861381e-07
transcripts O 0 4.5003442750157774e-08
in O 0 7.917618782826708e-10
keratinocytes O 0 7.343699337525322e-08
homozygous O 0 2.088136028532972e-07
for O 0 7.147844538479831e-10
a O 0 2.751685990176611e-09
frameshift O 0 3.935273525712546e-06
mutation O 0 3.2921272463681817e-07
, O 0 1.6013564918537782e-09
the O 0 6.597751234238558e-10
effects O 0 3.963461495004594e-06
of O 0 2.0816576240534346e-10
the O 0 1.0247117598893851e-09
splice O 0 8.936270751291886e-05
- O 0 5.495895038620802e-06
site O 0 4.216729720951662e-08
mutation O 0 2.1233077518445498e-08
on O 0 3.1245209197727775e-10
splicing O 0 2.5137017800602734e-08
of O 0 1.5720010015929375e-10
COL17A1 O 0 9.087840879828946e-08
transcripts O 0 2.0342914908155763e-08
were O 0 5.78622649793914e-10
determined O 0 5.2349462542622405e-09
using O 0 8.461688238980969e-09
reverse O 0 6.528582048304088e-07
transcriptase O 0 2.200216158598778e-06
polymerase O 0 3.793459768530738e-07
chain O 0 5.057586918155721e-07
reaction O 0 4.191695168742626e-08
of O 0 5.409294123737141e-10
total O 0 1.4914047774539085e-09
RNA O 0 3.2637856861583714e-08
from O 0 9.51225875844841e-10
keratinocytes O 0 7.5588282300032e-08
incubated O 0 6.952993913955652e-08
for O 0 1.5914666251504173e-09
2 O 0 1.7446675215637697e-08
. O 0 6.681006681219515e-08

5 O 0 2.641028800098866e-07
h O 0 5.569152108364506e-07
in O 0 1.4681762472434912e-09
the O 0 5.153802939972252e-10
presence O 0 1.225309453900536e-08
or O 0 2.3703844220790415e-08
absence O 0 1.3376626917249723e-08
of O 0 3.2068880884139617e-10
10 O 0 3.781198909535988e-09
microg O 0 4.1618886825744994e-07
cycloheximide O 0 9.759836530065513e-07
per O 0 7.934088586125654e-08
ml O 0 4.0919435377873015e-06
. O 0 1.4228898237433896e-07

Using O 0 1.064319974375394e-07
this O 0 4.4079553340736766e-09
approach O 0 1.220798253598332e-07
, O 0 1.0695699437235362e-08
an O 0 2.4852537805486463e-09
abnormally O 0 4.047578840982169e-07
spliced O 0 6.229632163012866e-06
transcript O 0 1.6438416423625313e-05
was O 0 8.120583316895136e-08
identified O 0 1.0912811987395798e-08
that O 0 1.0633079833288761e-10
contains O 0 9.459025229752172e-11
an O 0 5.093892668783795e-11
extra O 0 1.797763271582653e-09
264 O 0 3.85156440074752e-09
bases O 0 1.9485599800361797e-09
upstream O 0 2.3781541180767363e-09
from O 0 4.35584318614346e-10
exon O 0 4.2951597833962296e-08
32 O 0 6.897843185527108e-09
, O 0 2.1028316588012075e-10
resulting O 0 3.696433603650462e-09
in O 0 2.951283883945166e-09
a O 0 1.5248202700490765e-08
premature O 0 4.774336730406503e-07
termination O 0 4.951417622578447e-07
codon O 0 1.3191737480156007e-06
27 O 0 4.202574288569849e-08
bp O 0 2.9050821126475057e-07
downstream O 0 1.6906511746128672e-08
from O 0 6.306446476145311e-10
the O 0 1.7617609593401085e-09
cryptic O 0 5.313869451128994e-07
splice O 0 1.2510545275290497e-05
site O 0 1.7164782093459507e-06
. O 0 3.1772717079547874e-07

Three O 0 3.48317286125166e-08
other O 0 2.022344069985138e-09
splice O 0 2.966207262034004e-07
variants O 0 4.2091603091876095e-08
, O 0 2.966129841741605e-10
including O 0 3.0382758808844557e-11
one O 0 3.40632383410977e-11
derived O 0 3.37605471356639e-10
from O 0 3.540314569283609e-11
the O 0 3.4468844445356694e-11
skipping O 0 6.54765974772431e-09
of O 0 5.804595692993075e-11
exon O 0 2.5495541677855726e-08
32 O 0 6.613516401188235e-09
, O 0 9.551964774701105e-10
were O 0 3.1346998330405995e-09
also O 0 1.309789787740101e-08
identified O 0 2.7254148449173954e-07
. O 0 1.8489049580239225e-07

These O 0 1.455013745044198e-07
results O 0 6.181254974535477e-08
indicate O 0 1.3340089921598519e-08
the O 0 2.46123676994614e-10
usefulness O 0 1.1668324972902155e-08
of O 0 8.710738380601768e-11
cycloheximide O 0 1.0228556135416511e-07
treatment O 0 2.047831237916853e-08
in O 0 1.8404161528096097e-10
evaluating O 0 2.2543938271724073e-08
the O 0 8.369390180895664e-10
abnormal O 0 3.644823820536658e-08
processing O 0 1.919529779570439e-08
of O 0 2.7066687779964127e-10
mRNA O 0 1.1092172513826881e-08
due O 0 4.043417156651685e-09
to O 0 7.315842931454597e-10
splice O 0 1.145058104157215e-05
- O 0 1.2917674894197262e-06
site O 0 4.846322099183453e-08
mutations O 0 2.407370800483477e-07
, O 0 7.092111342643648e-10
because O 0 2.1708670416842324e-09
( O 0 3.7773692507236944e-10
i O 0 6.474846436788084e-09
) O 0 2.328021941888636e-10
aberrant O 0 6.493905413407219e-09
splicing O 0 9.608124429405507e-08
often O 0 1.7582774347602026e-08
generates O 0 2.639406559978852e-08
a O 0 7.968436577243665e-09
premature O 0 2.496882416380686e-07
termination O 0 2.3315044472838053e-07
codon O 0 3.1333212291428936e-07
, O 0 1.0394856087003745e-09
( O 0 4.425078914405134e-10
ii O 0 7.084354436415197e-09
) O 0 3.1383179388555504e-10
transcripts O 0 8.639993609449448e-09
with O 0 1.3960195222040284e-09
premature O 0 8.229260828329643e-08
termination O 0 2.4031336920415924e-08
codons O 0 6.86615848621841e-08
can O 0 3.8745384678406936e-09
occur O 0 3.0899471870071693e-09
at O 0 3.8720120443258566e-09
low O 0 2.2759839168884355e-07
or O 0 2.46229888034577e-07
undetectable O 0 2.6468296709936112e-05
levels O 0 8.241355686777752e-08
due O 0 3.728438890959751e-09
to O 0 1.6174291905812765e-09
nonsense O 0 4.0333600281883264e-07
- O 0 2.625403965339501e-07
mediated O 0 7.914863431324193e-08
mRNA O 0 5.94507643114639e-09
decay O 0 6.366504212707014e-09
, O 0 1.1710005187737238e-10
and O 0 9.209574075574878e-11
( O 0 4.5612180699095006e-11
iii O 0 1.3593880465734287e-09
) O 0 2.493490691701794e-10
the O 0 2.2648129205382617e-10
levels O 0 3.563909167780821e-09
of O 0 2.0395672997719494e-12
these O 0 2.1995650092976327e-11
transcripts O 0 1.5991467039455642e-09
can O 0 8.138484886011099e-10
be O 0 1.7386862782853285e-10
increased O 0 5.042795625520569e-10
by O 0 1.1410682398960148e-09
cycloheximide O 0 4.513584372034529e-06
. O 0 2.0523364696600765e-07

A O 0 6.396638241312758e-07
deletion O 0 5.633356067846762e-06
mutation O 0 1.5546596614512964e-06
in O 0 6.183729528430604e-09
COL17A1 O 0 1.2651910310523817e-06
in O 0 3.74553144055767e-09
five O 0 6.40626351966489e-09
Austrian O 0 1.564428316669364e-06
families O 0 3.26027667085782e-08
with O 0 2.326000370089787e-08
generalized O 0 7.597021613037214e-05
atrophic B-Disease 1 0.9993940591812134
benign I-Disease 1 0.9893548488616943
epidermolysis I-Disease 1 0.9643620848655701
bullosa I-Disease 0 0.13846831023693085
represents O 0 4.5881517962698126e-07
propagation O 0 2.0973666892132314e-07
of O 0 3.6577054718378577e-09
an O 0 3.809140114441334e-09
ancestral O 0 2.1186108369875e-06
allele O 0 5.088473335490562e-05
. O 0 2.376281599936192e-06

Patients O 0 0.0001232192589668557
with O 0 3.44727823176072e-07
generalized O 0 0.0001321606250712648
atrophic B-Disease 1 0.999582827091217
benign I-Disease 1 0.9981281161308289
epidermolysis I-Disease 1 0.9877372980117798
bullosa I-Disease 1 0.9636989235877991
, O 0 1.714696793442272e-07
a O 0 9.438418047125197e-09
usually O 0 1.8670414547727887e-08
nonlethal O 0 1.1437159628258087e-06
form O 0 1.7517641026643105e-07
of O 0 9.463477113058616e-08
junctional B-Disease 0 0.025239767506718636
epidermolysis I-Disease 0 0.27658700942993164
bullosa I-Disease 0 0.018686536699533463
, O 0 1.9877433032888803e-08
have O 0 4.116345930782472e-09
generalized O 0 8.659316108605708e-08
blistering B-Disease 0 6.155701157695148e-07
, O 0 2.0223216878889616e-08
nail B-Disease 1 0.9562622904777527
dystrophy I-Disease 0 4.981737583875656e-05
, O 0 4.9356149389723214e-08
patchy B-Disease 0 0.00018041582370642573
alopecia I-Disease 1 0.9999399185180664
, O 0 2.2439529345774645e-07
and O 0 1.206015667776228e-06
dental B-Disease 1 0.99988853931427
abnormalities I-Disease 1 0.9999045133590698
. O 0 4.299866759538418e-06

Skin B-Disease 1 0.9930927753448486
fragility I-Disease 0 6.730749737471342e-05
in O 0 2.769261264745637e-09
most O 0 3.9717024113983257e-10
cases O 0 2.7547317760223677e-09
is O 0 1.9870523004783536e-09
due O 0 4.703382128212752e-09
to O 0 1.6184599216373385e-09
mutations O 0 3.968586526070794e-08
in O 0 4.1090170155300143e-10
the O 0 3.513375146368958e-10
gene O 0 7.742288232748251e-08
encoding O 0 3.339438876537315e-07
type O 0 1.2154689102317207e-05
XVII O 0 1.2218864867463708e-05
collagen O 0 3.4950867302541155e-06
( O 0 1.9517150562364805e-08
COL17A1 O 0 5.097927896713372e-06
) O 0 3.66864902900943e-08
. O 0 1.4319395802431245e-07

Recently O 0 1.3294034033606295e-06
, O 0 7.335772433947341e-09
we O 0 6.114881490049129e-09
reported O 0 1.2803885063306097e-08
five O 0 1.5282466403476747e-09
Austrian O 0 5.52207211512723e-07
families O 0 9.223118269119368e-09
with O 0 6.0929470357962145e-09
generalized O 0 1.6228557797148824e-05
atrophic B-Disease 1 0.992319643497467
benign I-Disease 0 0.10654028505086899
epidermolysis I-Disease 0 0.07661935687065125
bullosa I-Disease 0 0.46621623635292053
who O 0 1.512387825641781e-06
share O 0 1.3370994622619037e-07
the O 0 1.20256293811849e-09
same O 0 5.436181282902908e-08
COL17A1 O 0 3.1913350539980456e-05
mutation O 0 9.428248631593306e-06
. O 0 5.03758087688766e-07

Affected O 0 8.816051604298991e-07
individuals O 0 7.880153418682312e-09
in O 0 1.0120840832072986e-09
three O 0 5.640418132557556e-10
families O 0 3.3131442034317615e-10
are O 0 5.4837648311156784e-11
homozygous O 0 1.1505843389159054e-08
for O 0 9.041509901885902e-11
4003delTC O 0 1.8454938910394958e-08
, O 0 6.92571902605188e-11
whereas O 0 2.6184940327134143e-10
those O 0 6.12581374515031e-11
in O 0 1.5992678015219752e-10
two O 0 2.6082758175505205e-10
others O 0 2.4505673046348875e-09
are O 0 1.2067218335687357e-09
compound O 0 1.1439806257840246e-07
heterozygotes O 0 1.1574810741876718e-05
. O 0 5.473563646773982e-07

To O 0 3.462433539880294e-08
determine O 0 3.3930490417333203e-08
if O 0 3.5774618822870252e-09
the O 0 8.425379838250535e-11
occurrence O 0 1.3882059057834795e-08
of O 0 6.987510570155564e-11
4003delTC O 0 5.898353094835329e-08
in O 0 2.971356216630028e-10
these O 0 3.527348135801134e-10
unrelated O 0 1.1884399242489962e-08
families O 0 1.2913335956099559e-09
signifies O 0 1.0558953711381491e-09
propagation O 0 1.3808347798516252e-09
of O 0 4.8093341808996826e-11
an O 0 8.955761826578978e-11
ancestral O 0 3.25778977128266e-08
allele O 0 4.3059546328549914e-07
or O 0 4.090589911243114e-08
a O 0 3.5124456676527416e-09
mutational O 0 3.10526525026944e-06
hot O 0 8.17501984329283e-07
spot O 0 9.06251443666406e-07
, O 0 1.6489400955777e-09
haplotypes O 0 1.2849748998178256e-07
were O 0 3.911486690100219e-09
determined O 0 2.4434649859017554e-08
for O 0 4.6185438806745083e-10
polymorphisms O 0 2.8718392286464223e-07
both O 0 6.658398721270942e-09
within O 0 5.811802594735127e-09
and O 0 6.46270805759741e-08
flanking O 0 2.546936593716964e-05
COL17A1 O 0 0.0005632033571600914
. O 0 1.8829038026524358e-06

Five O 0 2.939295313808543e-07
intragenic O 0 1.6811030718599795e-06
polymorphisms O 0 2.69722272605577e-06
were O 0 8.024747977231073e-09
chosen O 0 4.33982361158769e-09
based O 0 4.573811107633219e-09
on O 0 4.586845570031528e-09
their O 0 1.529693705037971e-08
informativeness O 0 1.207554669235833e-05
. O 0 4.6681537924087024e-07

One O 0 2.557185752039004e-08
of O 0 5.0142882901393904e-11
these O 0 1.4484934085512435e-10
, O 0 2.187842129686146e-10
not O 0 5.880317899276122e-10
previously O 0 4.336888181910581e-08
reported O 0 4.4263156695478756e-08
, O 0 2.90045487627566e-10
was O 0 4.20014423241355e-09
2988 O 0 3.082114119479229e-08
A O 0 1.3688641331555118e-09
or O 0 1.4968600581255487e-08
C O 0 3.508135648644384e-08
that O 0 2.754876188282296e-11
introduces O 0 6.06236394418147e-10
a O 0 1.505945090851668e-10
new O 0 5.526071267247801e-10
restriction O 0 1.4620507027274243e-09
site O 0 2.8970010834683535e-09
for O 0 7.109908217728389e-10
Eco0109 O 0 6.05904062922491e-07
I O 0 4.339883901138819e-07
. O 0 1.1758196194477932e-07

All O 0 1.648371750206934e-08
the O 0 2.3518649250320323e-09
4003delTC O 0 1.6583628337230039e-07
alleles O 0 6.061109303345802e-08
showed O 0 6.716754707980499e-09
the O 0 7.13447911859788e-11
same O 0 5.285388793296875e-10
haplotype O 0 3.794588110395125e-08
for O 0 1.7564991128260488e-10
these O 0 9.090277419687709e-10
five O 0 3.4577198881891036e-09
polymorphic O 0 9.09767209122947e-07
markers O 0 5.8694158724392764e-06
. O 0 9.9976909950783e-07

Fourteen O 0 3.4591541862027952e-06
microsatellite O 0 3.321194526506588e-05
polymorphisms O 0 5.855996732861968e-06
were O 0 6.819457443185684e-09
selected O 0 1.2341466737453288e-09
based O 0 2.5875941389585932e-09
on O 0 1.2541222504935945e-09
their O 0 4.230632288937386e-09
high O 0 5.9176901601176723e-08
heterozygosity O 0 1.6800389630589052e-06
and O 0 2.8488955639005553e-09
their O 0 7.083701958343624e-10
location O 0 2.820640965239818e-08
within O 0 3.981937002350833e-09
10q23 O 0 3.500834509395645e-06
- O 0 1.2427817637217231e-05
q25 O 0 4.195257133687846e-06
near O 0 2.7121811285724107e-07
COL17A1 O 0 2.0823499653488398e-05
. O 0 5.668388780577516e-07

Three O 0 5.274920908959757e-07
families O 0 1.423287443458321e-07
shared O 0 5.584235651667768e-08
microsatellite O 0 4.127427928324323e-06
polymorphisms O 0 5.014122507418506e-06
covering O 0 2.2227095541893505e-07
at O 0 1.2889104894497905e-08
most O 0 1.2070624499926907e-09
19 O 0 1.1679117672969141e-09
cM O 0 5.775159905851979e-09
, O 0 4.248841556364624e-10
whereas O 0 2.8727735745803784e-09
the O 0 4.0263145595353933e-10
others O 0 2.518134589735155e-09
shared O 0 1.0446095100036246e-09
smaller O 0 1.9887103519522498e-08
regions O 0 1.1873568794840139e-08
consistent O 0 1.610694155829151e-08
with O 0 2.0730039906879938e-10
cross O 0 1.3428238965218497e-08
- O 0 1.3683718691481772e-07
over O 0 1.9251816807397404e-10
events O 0 2.1191465249259522e-10
during O 0 1.1505568719982762e-10
passage O 0 3.174039642228621e-10
of O 0 1.0665574326496063e-11
this O 0 1.4588132091208905e-10
mutation O 0 3.8591312367941555e-09
through O 0 2.623503359000523e-10
several O 0 3.30627725197985e-09
generations O 0 2.40300607856625e-07
. O 0 1.7535391805267864e-07

These O 0 9.788457333570477e-08
results O 0 4.8481158643198796e-08
indicate O 0 8.78973960283247e-09
that O 0 4.798634822833492e-10
4003delTC O 0 9.54701917521561e-08
occurs O 0 2.3945032623373663e-09
on O 0 4.899012862047414e-10
a O 0 6.985035327922162e-10
single O 0 1.0090199786816356e-08
ancestral O 0 1.6859843299243948e-07
allele O 0 1.963583599717822e-06
. O 0 6.895701432085843e-08
. O 0 2.6588401169647113e-07

The O 0 7.859380843910913e-07
haptoglobin O 0 0.00012445954780559987
- O 0 8.863793482305482e-06
gene O 0 1.3116920172251412e-06
deletion O 0 2.1475027551787207e-06
responsible O 0 2.724287071487197e-07
for O 0 1.614852962461555e-08
anhaptoglobinemia B-Disease 0 2.852038960554637e-05
. O 0 1.1076189139203052e-06

We O 0 6.644280574619188e-07
have O 0 4.959430199846793e-09
found O 0 1.759450696248166e-09
an O 0 2.435208701356828e-10
allelic O 0 1.6872789387889497e-07
deletion O 0 4.7675757741671987e-07
of O 0 1.2282383998751811e-09
the O 0 3.289457595201384e-09
haptoglobin O 0 2.057778374364716e-06
( O 0 1.2531227167045245e-09
Hp O 0 9.570608305864425e-09
) O 0 1.6276689718264237e-10
gene O 0 4.235234829508272e-09
from O 0 4.824219912435979e-10
an O 0 3.185435526464886e-10
individual O 0 6.2628053854041354e-09
with O 0 7.517948041879663e-09
anhaptoglobinemia B-Disease 0 2.946377389889676e-05
. O 0 5.008838002140692e-07

The O 0 1.477856557130508e-07
Hp O 0 7.071531626934302e-07
gene O 0 2.822837643634557e-07
cluster O 0 1.9783730920153175e-07
consists O 0 3.7102994010496104e-09
of O 0 7.116393585526737e-10
coding O 0 5.376920398703078e-06
regions O 0 2.3467046617042797e-07
of O 0 1.3761389805466706e-09
the O 0 2.3580275509971216e-09
alpha O 0 1.6388009171919293e-08
chain O 0 2.8270287657505833e-06
and O 0 4.322664892697503e-09
beta O 0 1.7343955605042538e-08
chain O 0 1.0558620999745472e-07
of O 0 2.7934718427324867e-10
the O 0 1.0678531392471768e-09
haptoglobin O 0 2.2724120185557695e-07
gene O 0 2.028889767302644e-08
( O 0 2.8101559967907974e-10
Hp O 0 3.841388540593016e-09
) O 0 2.649183372671615e-10
and O 0 6.536650665189825e-10
of O 0 1.0282373563708092e-10
the O 0 1.5321429680525966e-09
alpha O 0 7.551490099899638e-09
chain O 0 1.6181016917471425e-06
and O 0 2.571672430562444e-09
beta O 0 8.680660634752257e-09
chain O 0 4.1640756620608954e-08
of O 0 1.2244857905407969e-10
the O 0 9.965186453797514e-10
haptoglobin O 0 2.7833621061290614e-06
- O 0 2.669638661245699e-07
related O 0 1.5459137969742187e-08
gene O 0 5.396263702550641e-08
( O 0 4.498623418225378e-10
Hpr O 0 1.2349789813015377e-07
) O 0 7.529064594002932e-10
, O 0 2.562935419447854e-10
in O 0 2.9607091778238726e-10
tandem O 0 3.573712703541787e-08
from O 0 1.873307953204062e-09
the O 0 4.571648393181249e-09
5 O 0 4.574284417913077e-08
side O 0 1.0462349564477336e-06
. O 0 4.786587055605196e-07

Southern O 0 6.7454707277647685e-06
blot O 0 2.761571158771403e-05
and O 0 2.112941110965494e-08
PCR O 0 2.182655691740365e-07
analyses O 0 1.845022268298635e-08
have O 0 8.65470084487896e-10
indicated O 0 1.2298183582615252e-09
that O 0 5.589491022806037e-11
the O 0 5.230649247067731e-11
individual O 0 2.0037287107310675e-10
with O 0 9.729808625458247e-11
anhaptoglobinemia B-Disease 0 1.0256943028252863e-07
was O 0 8.798440309654154e-10
homozygous O 0 1.0005071438001778e-08
for O 0 4.2302571168217895e-11
the O 0 4.667362676902265e-11
gene O 0 4.608207149203736e-09
deletion O 0 8.664189721230287e-08
and O 0 1.3346980187733948e-09
that O 0 8.247775379333078e-11
the O 0 3.6329772523657766e-11
gene O 0 2.3785080571769868e-09
deletion O 0 3.4906349810626125e-08
was O 0 2.945676813581599e-09
included O 0 2.5011737125879563e-10
at O 0 5.152878679304251e-10
least O 0 1.1604281424659746e-10
from O 0 1.7922364980993422e-10
the O 0 4.97220487005734e-10
promoter O 0 1.567619847264723e-07
region O 0 8.654065908331177e-08
of O 0 4.791820829019855e-10
Hp O 0 3.4181027785962215e-08
to O 0 8.672348950078401e-10
Hpr O 0 3.864440998313512e-07
alpha O 0 7.3830350721948435e-09
but O 0 2.790512487749197e-09
not O 0 1.120257997477836e-09
to O 0 2.2046284797738736e-09
Hpr O 0 1.2590320466188132e-06
beta O 0 9.207724360749125e-08
( O 0 1.914592706597773e-09
Hpdel O 0 4.227734962114482e-07
) O 0 1.575051911117953e-08
. O 0 1.2468748877836333e-07

In O 0 2.0899147301634002e-08
addition O 0 4.958181865077904e-09
, O 0 5.224190524621974e-10
we O 0 5.963357585514473e-10
found O 0 7.394625883838657e-11
seven O 0 4.4414982108831325e-11
individuals O 0 2.4496021530651113e-11
with O 0 1.1931213829419196e-11
hypohaptoglobinemia B-Disease 0 2.6900375260652254e-08
in O 0 4.022323307761866e-10
three O 0 3.2230643154385064e-10
families O 0 3.4740860188620104e-10
, O 0 9.243361631661173e-11
and O 0 3.2723532217282525e-10
the O 0 1.6891893439563432e-10
genotypes O 0 2.1236845171301866e-08
of O 0 1.386407048192817e-11
six O 0 3.8407638180970594e-10
of O 0 1.2540801730409612e-11
the O 0 9.488026336823552e-11
seven O 0 2.8961211206990356e-10
individuals O 0 8.644088916875958e-11
were O 0 1.9623663805035108e-10
found O 0 3.91999877003002e-10
to O 0 5.741438990902736e-10
be O 0 7.988401939940104e-09
Hp2 O 0 4.286119292373769e-06
/ O 0 1.1332322173984721e-06
Hpdel O 0 1.2578255336848088e-05
. O 0 4.284081853711541e-07

The O 0 1.1224190643588372e-07
phenotypes O 0 3.1475640298594953e-06
and O 0 1.2822531481049282e-08
genotypes O 0 2.795855493786803e-07
in O 0 8.436335519057536e-10
one O 0 3.5511640850138804e-10
of O 0 1.3298456953692028e-11
these O 0 7.357400799712366e-11
three O 0 3.2477853739720786e-10
families O 0 8.758825331689479e-10
showed O 0 8.769326598212501e-09
the O 0 8.467798684463901e-11
father O 0 1.0108281989218426e-09
to O 0 2.7976310157384887e-10
be O 0 1.0529751515164776e-09
hypohaptoglobinemic B-Disease 0 7.33402671926342e-08
( O 0 2.918423558373462e-10
Hp2 O 0 3.320853281252312e-08
) O 0 4.5310363794293096e-10
and O 0 4.267912412370123e-10
Hp2 O 0 9.063347050641823e-08
/ O 0 3.0360382652361295e-08
Hpdel O 0 1.5435354328019457e-07
, O 0 3.9145145458441277e-10
the O 0 1.715976805094499e-10
mother O 0 7.2400823114548984e-09
to O 0 2.558295519872189e-10
be O 0 1.2703388341250843e-09
Hp2 O 0 2.426735932203883e-07
- O 0 1.3381301755543973e-07
1 O 0 2.53069187827748e-09
and O 0 7.055547257550643e-10
Hp1 O 0 7.618854169777478e-08
/ O 0 9.43174160994431e-09
Hp2 O 0 3.1567392255738014e-08
, O 0 1.2865389309446584e-10
one O 0 6.012373238162283e-11
of O 0 3.1479187746069615e-12
the O 0 1.9377133578246664e-11
two O 0 1.419523804058187e-10
children O 0 2.5829086092166165e-10
to O 0 1.0514413645301701e-10
be O 0 5.662980084863989e-10
hypohaptoglobinemic B-Disease 0 4.99362293737704e-08
( O 0 1.9882494262102313e-10
Hp2 O 0 2.3536925297662492e-08
) O 0 2.7427976556637645e-10
and O 0 4.043229917538582e-10
Hp2 O 0 9.994776206667666e-08
/ O 0 1.702101926071009e-08
Hpdel O 0 9.817999568895175e-08
, O 0 2.5634924738504594e-10
and O 0 4.235133077568065e-11
the O 0 6.875266415212744e-12
other O 0 4.9624530179537274e-11
child O 0 3.823849847872651e-10
to O 0 6.794081963690246e-11
be O 0 3.1451730109210985e-10
Hp1 O 0 3.239671642063513e-08
and O 0 7.288530334825793e-10
Hp1 O 0 2.111227530576798e-07
/ O 0 1.825287831991318e-08
Hpdel O 0 4.7569390204671436e-08
, O 0 1.1828912849232154e-10
showing O 0 4.028898104024847e-09
an O 0 1.3421644351474527e-10
anomalous O 0 5.9063459900698945e-08
inheritance O 0 4.847495915782929e-07
of O 0 1.845598451843955e-09
Hp O 0 1.6336180408416112e-07
phenotypes O 0 2.599728645691357e-07
in O 0 2.663406162284332e-09
the O 0 2.6062678681881835e-09
child O 0 6.34152925726994e-08
with O 0 9.52053902381067e-09
Hp1 O 0 1.3724152267968748e-05
. O 0 5.940300980000757e-07

The O 0 1.272913436878298e-07
Hp2 O 0 6.4902078520390205e-06
/ O 0 5.671730036738154e-07
Hpdel O 0 2.660717086655495e-07
individuals O 0 2.826822331769563e-09
had O 0 1.6388572277037383e-08
an O 0 6.250415185427016e-10
extremely O 0 6.739728064530937e-08
low O 0 0.00028556748293340206
level O 0 5.172953621013221e-08
of O 0 3.1088151497549177e-10
Hp O 0 4.985523816003479e-08
( O 0 4.6242734641488425e-10
mean O 0 8.212479585267829e-09
+ O 0 1.670063056735671e-07
/ O 0 6.901832989569812e-07
- O 0 6.57360442346544e-06
SD O 0 1.472768508392619e-05
= O 0 5.694265041711333e-07
0 O 0 6.314405887053454e-09
. O 0 1.3737631032739728e-09
049 O 0 8.023532132028777e-07
+ O 0 2.0635923192457994e-07
/ O 0 4.1751940216272487e-07
- O 0 5.288964644023508e-07
0 O 0 2.3582174435432535e-08
. O 0 6.159621257495473e-09
043 O 0 3.5853856843459653e-06
mg O 0 5.144306669535581e-07
/ O 0 1.381937408950762e-07
ml O 0 2.689961320356815e-07
; O 0 3.76149644765178e-09
n O 0 8.435490173042126e-08
= O 0 3.6622729737700865e-08
6 O 0 1.0140240869205286e-09
) O 0 1.243650044058242e-10
, O 0 4.086957508531164e-11
compared O 0 9.266862832646439e-10
with O 0 1.6816156800381066e-10
the O 0 3.0187023991601336e-09
level O 0 2.942999621780018e-08
( O 0 1.7607590385715355e-10
1 O 0 5.009644921116774e-10
. O 0 3.1518149201659185e-10
64 O 0 7.736287721549218e-10
+ O 0 1.5299738365115445e-08
/ O 0 5.000332237159455e-08
- O 0 3.5705622281057003e-07
1 O 0 1.1421749768203426e-08
. O 0 4.345240167680231e-09
07 O 0 1.0347982737357597e-07
mg O 0 7.306353921876507e-08
/ O 0 1.8079081343103098e-08
ml O 0 1.915309510991392e-08
) O 0 5.403485645039119e-11
obtained O 0 3.401761372590073e-10
from O 0 1.5581262668984408e-10
52 O 0 4.0723562300115645e-09
healthy O 0 3.2759706058982374e-09
volunteers O 0 2.0962611646524465e-09
having O 0 1.3556886280241542e-08
phenotype O 0 2.457126413446531e-07
Hp2 O 0 4.667815005632292e-07
, O 0 9.725509286795386e-10
whereas O 0 4.743336834422962e-09
the O 0 4.020252464265184e-10
serum O 0 1.0459721977440495e-07
Hp O 0 7.952375824515912e-08
level O 0 3.5837723899589946e-09
of O 0 2.2404333596681703e-11
an O 0 3.051569413825561e-11
individual O 0 7.609101682071184e-10
with O 0 1.406222804867241e-09
Hp1 O 0 3.4935137591673993e-06
/ O 0 5.463456318466342e-07
Hpdel O 0 2.886434913307312e-06
was O 0 1.2309153873957257e-07
0 O 0 8.158090736287704e-08
. O 0 1.253544468227119e-07

50 O 0 1.9975468603661284e-06
mg O 0 2.6713960323831998e-06
/ O 0 1.3833749790137517e-06
ml O 0 6.485579888249049e-06
, O 0 2.037715551850283e-09
which O 0 1.1290463008961638e-09
was O 0 6.544759734161687e-10
approximately O 0 2.744121874176386e-10
half O 0 4.049900859115496e-09
the O 0 6.618800507673939e-10
level O 0 3.848179552790043e-09
of O 0 4.2203924383033e-11
Hp O 0 1.3821214395193238e-08
in O 0 9.131740918988385e-10
control O 0 1.821982209548878e-07
sera O 0 1.9097687697922083e-07
from O 0 3.5163585931918817e-10
the O 0 5.219151222313201e-10
Hp1 O 0 8.090109986369498e-07
phenotype O 0 1.1671479427377562e-07
( O 0 2.867188431121548e-10
1 O 0 6.194160739880772e-10
. O 0 4.971152378629995e-10
26 O 0 9.876516271489777e-10
+ O 0 5.869899677435342e-09
/ O 0 2.417168154522642e-08
- O 0 6.554409281989138e-08
0 O 0 1.9079504642860456e-09
. O 0 2.6493399141180873e-10
33 O 0 2.4609423388000096e-09
mg O 0 3.5434410960988316e-08
/ O 0 1.8417944502857608e-08
ml O 0 7.53591109514673e-08
; O 0 1.5957403176614093e-09
n O 0 7.91404772826354e-08
= O 0 7.867392781690796e-08
9 O 0 1.6733616714503796e-09
) O 0 1.2548871664019856e-10
, O 0 9.482399587756873e-11
showing O 0 1.0565527119865692e-08
a O 0 1.4584522478600093e-09
gene O 0 4.1490250168862985e-07
- O 0 5.213369149714708e-06
dosage O 0 2.8313588700257242e-05
effect O 0 2.406391558906762e-06
. O 0 3.588172603485873e-07

The O 0 1.1424189594322343e-08
other O 0 3.8470200358631246e-09
allele O 0 2.0110060461320245e-07
( O 0 1.0849218190500665e-09
Hp2 O 0 7.17135222316756e-08
) O 0 2.948013777537284e-10
of O 0 1.4399589159941328e-11
individuals O 0 1.7977691557646835e-10
with O 0 1.7642215466295852e-10
Hp2 O 0 6.13348049682827e-07
/ O 0 8.377799076697556e-08
Hpdel O 0 3.1772111697137007e-07
was O 0 2.2441135616446672e-09
found O 0 2.216631461715579e-10
to O 0 6.578747963059683e-11
have O 0 5.511786582701461e-10
, O 0 8.02527488907856e-11
in O 0 9.236647557919753e-11
all O 0 8.857031080777844e-11
exons O 0 4.346270543464925e-08
, O 0 9.602382222695383e-10
no O 0 2.929434028686728e-09
mutation O 0 2.6728223190275457e-08
, O 0 1.582765724039703e-10
by O 0 5.055874052750653e-10
DNA O 0 3.376368056251522e-07
sequencing O 0 1.018601210489578e-06
. O 0 6.054339110050933e-07

On O 0 3.006912407954587e-08
the O 0 3.8692785087057757e-10
basis O 0 7.02004232522313e-10
of O 0 3.1043341508496525e-11
the O 0 6.476000985466968e-11
present O 0 3.674051063384809e-10
study O 0 5.966816485347692e-10
, O 0 5.4477564820354374e-11
the O 0 2.7786127565487817e-11
mechanism O 0 7.406797397635501e-10
of O 0 2.2234478147531433e-11
anhaptoglobinemia B-Disease 0 1.308921184772771e-07
and O 0 6.902498572713966e-10
the O 0 1.2099339585791569e-10
mechanism O 0 1.5409615805594967e-09
of O 0 6.20652834681934e-11
anomalous O 0 3.818751537210119e-08
inheritance O 0 1.5109937123725103e-07
of O 0 1.4167789164076794e-09
Hp O 0 2.810760122429201e-07
phenotypes O 0 4.271923899068497e-07
were O 0 1.2536802707074912e-08
well O 0 3.04011216201161e-08
explained O 0 8.49304285566177e-07
. O 0 2.703431789541355e-07

However O 0 1.447244670771397e-07
, O 0 6.092157445181101e-09
the O 0 1.4530266989609686e-09
mechanism O 0 2.7227851973066208e-08
of O 0 5.58103829817469e-09
hypohaptoglobinemia B-Disease 0 4.9068319640355185e-05
remains O 0 5.669357051374391e-06
unknown O 0 2.2343221644405276e-05

ATM O 0 0.00032821830245666206
mutations O 0 8.651003008708358e-05
and O 0 1.1308426195455468e-07
phenotypes O 0 1.2193536349514034e-05
in O 0 5.040521955379518e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 1.0249437764286995e-05
in O 0 2.101658935771411e-08
the O 0 7.762261056143416e-09
British O 0 0.0005079146358184516
Isles O 0 3.102199457316601e-07
: O 0 2.6201529834679604e-10
expression O 0 3.485694788363247e-10
of O 0 1.4126894966326464e-11
mutant O 0 3.97137123187008e-09
ATM O 0 1.6078457676371727e-08
and O 0 4.221570037987732e-10
the O 0 8.341882740126039e-10
risk O 0 3.192227211457066e-07
of O 0 1.989456599460482e-09
leukemia B-Disease 1 0.7264982461929321
, O 0 5.977842192805838e-06
lymphoma B-Disease 1 1.0
, O 0 1.1735734517515084e-07
and O 0 7.078062481014058e-06
breast B-Disease 1 0.999703586101532
cancer I-Disease 0 0.0054048895835876465
. O 0 5.470698170029209e-07

We O 0 5.480735012497462e-07
report O 0 1.0096397495829024e-08
the O 0 1.5454700019734702e-10
spectrum O 0 2.642800422947289e-09
of O 0 2.286715677923823e-10
59 O 0 2.7841341676548836e-08
ATM O 0 8.767538588472235e-07
mutations O 0 1.33460673623631e-06
observed O 0 4.10653029803143e-07
in O 0 6.907903866704146e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.07884830236434937
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.4045457180932317e-08
patients O 0 2.4526167763383455e-08
in O 0 7.685136971247175e-10
the O 0 7.211415464780657e-09
British O 0 4.695972893387079e-05
Isles O 0 5.7636470955912955e-06
. O 0 2.9920838073849154e-07

Of O 0 2.1184298759635567e-07
51 O 0 1.8282864857610548e-06
ATM O 0 9.85471524472814e-06
mutations O 0 1.55269799506641e-06
identified O 0 6.903663773982771e-08
in O 0 1.0035798858609724e-09
families O 0 8.63175309007147e-10
native O 0 1.2171608165800762e-09
to O 0 8.451055411029529e-10
the O 0 1.9662864669811597e-09
British O 0 0.0001599245733814314
Isles O 0 3.547783364865609e-07
, O 0 9.995014815800118e-10
11 O 0 1.1847320902091951e-09
were O 0 5.001433711626646e-10
founder O 0 3.241685142540973e-09
mutations O 0 4.102263062577549e-08
, O 0 3.22380205863837e-10
and O 0 4.535956332762936e-10
2 O 0 3.001431325699855e-10
of O 0 9.902649880655368e-12
these O 0 2.6229732275062645e-10
11 O 0 5.883515341587042e-10
conferred O 0 2.0950821078002946e-09
a O 0 5.09533359949188e-10
milder O 0 2.885477670133696e-07
clinical O 0 5.04471529438888e-07
phenotype O 0 1.480248812413265e-07
with O 0 3.179541629982907e-10
respect O 0 9.46007605584498e-10
to O 0 1.4497933964463527e-09
both O 0 2.7821062786870243e-08
cerebellar B-Disease 0 3.879084033542313e-05
degeneration I-Disease 0 2.6056633942062035e-05
and O 0 6.318035161712032e-08
cellular O 0 7.491954647775856e-07
features O 0 2.276966142744641e-06
. O 0 1.3488017884810688e-06

We O 0 4.0649319998919964e-07
report O 0 1.2278102090590437e-08
, O 0 1.7932144658061588e-10
in O 0 1.299040458535572e-10
two O 0 2.3157129547257682e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 6.31577945497952e-09
, O 0 2.5971852446460275e-10
an O 0 2.3183709119134477e-10
ATM O 0 1.349551894236356e-06
mutation O 0 2.2468694282906654e-07
( O 0 1.8877841512221494e-09
7271T O 0 2.5795588953769766e-07
- O 0 4.480064035305986e-07
- O 0 1.988149591625188e-07
> O 0 1.2764505008533433e-08
G O 0 3.0563214181711373e-08
) O 0 1.630207219216473e-10
that O 0 4.141005593982783e-11
may O 0 2.166011148219127e-09
be O 0 4.561348174170199e-11
associated O 0 3.114333096965183e-11
with O 0 1.0687364188077808e-11
an O 0 1.0160719488006009e-10
increased O 0 2.1675043981872477e-08
risk O 0 1.793379169612308e-06
of O 0 8.307934340479051e-10
breast B-Disease 0 0.40776723623275757
cancer I-Disease 0 4.268215889169369e-06
in O 0 8.131192386073849e-10
both O 0 6.57683552063304e-09
homozygotes O 0 2.1007426767027937e-06
and O 0 4.672658704407695e-09
heterozygotes O 0 7.931000141070399e-07
( O 0 1.1851434278398187e-09
relative O 0 1.5293474575628352e-07
risk O 0 7.666004239581525e-05
12 O 0 2.6578950151900926e-09
. O 0 4.79470962932993e-10
7 O 0 2.805872645339491e-09
; O 0 4.90861218338523e-09
P O 0 0.0008042789995670319
= O 0 1.769710848975592e-07
. O 0 1.7686732078914247e-09
0025 O 0 2.706599673274468e-07
) O 0 2.4442453616657644e-10
, O 0 3.203951687291706e-11
although O 0 9.00753152621725e-11
there O 0 7.62077553839724e-11
is O 0 4.700489303344213e-11
a O 0 2.2189494686131184e-10
less O 0 1.0415620366188705e-08
severe O 1 0.9486460089683533
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 2.457239133946132e-06
in O 0 4.755555393920474e-10
terms O 0 2.2428812140873333e-09
of O 0 2.3458500766904145e-11
the O 0 3.770660450541641e-10
degree O 0 4.902046413235439e-08
of O 0 8.695010933479352e-09
cerebellar B-Disease 0 5.547903856495395e-05
degeneration I-Disease 0 0.00039800512604415417
. O 0 1.453636855330842e-06

This O 0 1.0443674369753353e-07
mutation O 0 1.0101417728947126e-06
( O 0 5.828209026503828e-09
7271T O 0 5.933982265560189e-07
- O 0 2.177579517592676e-06
- O 0 9.459504326514434e-07
> O 0 7.517505906662336e-08
G O 0 2.0299354730468622e-07
) O 0 5.421037507780113e-10
also O 0 9.94200069492912e-11
allows O 0 2.9196875472869976e-10
expression O 0 5.06485076101626e-10
of O 0 4.776333148437395e-11
full O 0 4.990782453972997e-09
- O 0 7.639663124336948e-08
length O 0 1.1132378574529866e-08
ATM O 0 7.900369070057423e-08
protein O 0 2.2815587197300147e-09
at O 0 1.0369627378992163e-09
a O 0 2.2352188155938535e-10
level O 0 9.57078527541455e-10
comparable O 0 4.020162425177887e-09
with O 0 1.4068821108104146e-10
that O 0 4.0243955390373287e-10
in O 0 4.269388398370211e-09
unaffected O 0 5.213535132497782e-07
individuals O 0 3.287840755206162e-08
. O 0 1.4301380701908784e-07

In O 0 5.4657260939450225e-09
addition O 0 1.3074629157117101e-09
, O 0 2.2263854648763015e-10
we O 0 2.773615503937066e-10
have O 0 1.854203318663039e-10
studied O 0 2.6255284168996695e-08
18 O 0 2.8742933366743273e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 8.212998068302113e-07
, O 0 4.929379474050144e-11
in O 0 6.129190904813342e-11
15 O 0 1.1624396584197783e-10
families O 0 5.097217092853157e-11
, O 0 5.795336086023006e-11
who O 0 6.425255438813338e-09
developed O 0 5.55642191102379e-06
leukemia B-Disease 1 0.9875298738479614
, O 0 1.050174432748463e-05
lymphoma B-Disease 1 1.0
, O 0 1.458313914071141e-08
preleukemic O 0 1.3234605830803048e-05
T O 0 0.006713220849633217
- O 0 2.2395540781872114e-06
cell O 0 9.640650660003303e-07
proliferation O 0 5.551303274842212e-07
, O 0 3.492757638667854e-09
or O 0 1.8830528460966889e-06
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.3460239972905583e-08
mostly O 0 2.0627002328410526e-08
in O 0 3.8819077730067875e-08
childhood O 0 8.116408025671262e-06
. O 0 9.110322025662754e-07

A O 0 2.25877187176593e-07
wide O 0 3.626323064054304e-08
variety O 0 2.0434924863366177e-08
of O 0 1.6778488598490071e-09
ATM O 0 2.3845200303185266e-06
mutation O 0 4.0972790316118335e-07
types O 0 9.907392239938417e-08
, O 0 2.543403931909438e-09
including O 0 5.53897949728821e-09
missense O 0 3.1122590371523984e-06
mutations O 0 1.6699561911082128e-06
and O 0 5.279145121050988e-09
in O 0 4.430536826305342e-09
- O 0 7.109114221748314e-07
frame O 0 5.933405304858752e-07
deletions O 0 1.2480407463044685e-07
, O 0 9.815331880602685e-10
were O 0 6.585204048725757e-10
seen O 0 1.408451488771334e-08
in O 0 8.477483715019218e-10
these O 0 7.447031880047916e-09
patients O 0 1.5477998260848835e-07
. O 0 6.95146908924471e-08

We O 0 2.750025203113182e-07
also O 0 7.682132707742539e-10
show O 0 1.5153591714778258e-09
that O 0 1.5130766084503477e-10
25 O 0 2.3408053273499263e-10
% O 0 4.211097442974321e-11
of O 0 2.0411755619065275e-11
all O 0 4.604519077133773e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.3249785979496664e-06
carried O 0 8.632054182555748e-09
in O 0 1.7411030395209082e-09
- O 0 1.8269741985932342e-07
frame O 0 4.253382712704479e-07
deletions O 0 1.9834983788769023e-07
or O 0 1.0100462688455991e-08
missense O 0 2.5806664893934794e-07
mutations O 0 7.452874939417597e-08
, O 0 1.848719094477147e-10
many O 0 7.88091258918655e-11
of O 0 1.955732971403723e-11
which O 0 2.8680284813731305e-08
were O 0 1.409346879199802e-07
also O 0 8.623035618882113e-09
associated O 0 2.8106934557570185e-09
with O 0 2.3620594369333503e-10
expression O 0 4.997584124311061e-09
of O 0 5.326812324568664e-10
mutant O 0 3.133075949790509e-07
ATM O 0 2.2746805825590855e-06
protein O 0 8.676201446178311e-07
. O 0 2.605666225008463e-07

The O 0 7.67262164913518e-08
DMPK O 0 3.754198814931442e-06
gene O 0 4.396899271341681e-07
of O 0 5.6432938322359405e-09
severely O 0 0.00033272954169660807
affected O 0 7.022243153187446e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0057937088422477245
is O 0 2.979160695915084e-09
hypermethylated O 0 2.690410099148721e-07
proximal O 0 2.206956679629002e-07
to O 0 1.2399421045472536e-08
the O 0 5.6336797449318965e-09
largely O 0 2.2146058142880065e-07
expanded O 0 6.58325120639347e-07
CTG O 0 2.78713177976897e-05
repeat O 0 7.2221519076265395e-06
. O 0 4.2514483311606455e-07

Using O 0 5.353585947887041e-07
methylation O 0 3.7504630654439097e-06
- O 0 1.7979798940359615e-05
sensitive O 0 6.594661954295589e-07
restriction O 0 1.093327206547201e-08
enzymes O 0 1.8213581753911967e-08
, O 0 3.831924777486506e-10
we O 0 4.784359020071349e-10
characterized O 0 9.064825556848177e-10
the O 0 1.0394018284953788e-10
methylation O 0 9.869929762373886e-09
pattern O 0 5.120425683458052e-08
on O 0 2.737217563719696e-09
the O 0 2.8884916680738115e-10
5 O 0 1.893940559938301e-09
side O 0 3.648090496355394e-09
of O 0 5.5942910026640646e-11
the O 0 5.812320069686905e-10
CTG O 0 3.5416070431892877e-07
repeat O 0 7.397429868660765e-08
in O 0 2.1148260920256234e-10
the O 0 8.654102434668687e-11
DMPK O 0 4.408630260854807e-08
gene O 0 3.7192908752814446e-09
of O 0 2.7424406495724085e-11
normal O 0 1.319931053345158e-09
individuals O 0 2.0533047484505573e-10
and O 0 3.30765054235016e-10
of O 0 1.1537036603836981e-10
patients O 0 4.830329558558333e-08
affected O 0 6.120365547701567e-09
with O 0 4.804241449107849e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
, O 0 3.1336777617241296e-09
showing O 0 1.3435897727731572e-08
expansions O 0 8.940448736893813e-08
of O 0 3.94691807015235e-10
the O 0 3.1259290711460608e-09
repetitive O 0 1.4978074887039838e-06
sequence O 0 1.4748028434041771e-06
. O 0 3.659040714865114e-07

The O 0 1.356609971026046e-07
gene O 0 7.783566502439498e-07
segment O 0 3.811424562627508e-07
analyzed O 0 6.223891801937498e-08
corresponds O 0 2.3454422404256547e-08
to O 0 1.7263019902458154e-09
the O 0 2.955407252258624e-09
genomic O 0 1.26720999560348e-06
SacI O 0 1.657793291087728e-05
- O 0 2.1106750409671804e-06
HindIII O 0 8.816539320832817e-07
fragment O 0 7.103787424966868e-08
carrying O 0 8.04261457432176e-09
exons O 0 5.799291784569505e-07
11 O 0 8.100379744746533e-08
- O 0 2.1287471554387594e-06
15 O 0 5.261154356617226e-08
. O 0 1.3127240094945591e-07

There O 0 2.3183119424174947e-07
is O 0 1.6412565528867162e-08
constitutive O 0 9.105382048346655e-08
methylation O 0 8.746262381009728e-08
in O 0 3.423731964602439e-09
intron O 0 2.2339650058711413e-06
12 O 0 9.419533597565533e-09
at O 0 5.541660463848075e-10
restriction O 0 6.835667587523631e-10
sites O 0 2.1655568449574503e-09
of O 0 8.151887498364374e-11
SacII O 0 1.7519745654226426e-07
and O 0 2.441488344828713e-09
HhaI O 0 1.9430723341429257e-07
, O 0 6.757691628500595e-10
localized O 0 1.64100288913005e-08
1 O 0 3.139301041343856e-09
, O 0 2.73581740595219e-10
159 O 0 1.0098940350644625e-08
- O 0 3.080560304624669e-07
1 O 0 3.903571688113061e-09
, O 0 4.308003676012362e-10
232 O 0 3.9045096045242644e-09
bp O 0 4.154832922154128e-08
upstream O 0 3.5749383453520522e-09
of O 0 7.915198357855147e-11
the O 0 3.9460895662202233e-10
CTG O 0 2.8282971697990433e-07
repeat O 0 1.310707489210472e-07
, O 0 5.899469107673028e-11
whereas O 0 8.978646298674064e-11
most O 0 5.939777142360825e-11
, O 0 5.752200105124672e-11
if O 0 8.594329692357405e-10
not O 0 1.252314363320295e-10
all O 0 1.0012349456467451e-11
, O 0 1.182690057000002e-11
of O 0 1.6602039838373162e-12
the O 0 9.949602773617894e-12
other O 0 5.669224117932359e-11
sites O 0 1.8042385363514768e-09
of O 0 3.0166043274437726e-11
SacII O 0 4.4633296170104586e-08
, O 0 1.9817979202141345e-10
HhaI O 0 1.630159296439615e-08
, O 0 1.1887425765966242e-10
and O 0 1.2446609021221633e-10
HpaII O 0 2.0584829840686325e-08
in O 0 1.3044780533544298e-10
this O 0 1.8222177933235884e-10
region O 0 1.5686562049310737e-09
are O 0 1.8316333172396781e-10
unmethylated O 0 7.508836574743327e-08
, O 0 2.3138385651932936e-10
in O 0 1.055747850253752e-10
normal O 0 6.360844628794382e-10
individuals O 0 1.6525349144647095e-10
and O 0 1.2299303242535586e-10
most O 0 1.5210165071888326e-10
of O 0 9.859045524418519e-11
the O 0 5.812755610179465e-09
patients O 0 3.509929911160725e-07
. O 0 1.0024827190591168e-07

In O 0 1.661018167453676e-08
a O 0 6.173590527680517e-10
number O 0 3.7427871912854016e-10
of O 0 8.49987094597715e-11
young O 0 6.232109939219299e-09
and O 0 1.270211136272792e-08
severely O 0 0.0004766030760947615
affected O 0 3.101095913393692e-08
patients O 0 4.474240000718055e-08
, O 0 3.555908623109616e-10
however O 0 1.7595714885132452e-09
, O 0 2.1240348369033768e-10
complete O 0 1.729214271772861e-10
methylation O 0 2.384931363508258e-09
of O 0 1.0951621554067259e-11
these O 0 3.016719166137882e-11
restriction O 0 5.431035066116863e-10
sites O 0 3.389270197828864e-09
was O 0 1.751962908080884e-09
found O 0 6.781630812469075e-10
in O 0 2.527256182105475e-10
the O 0 2.449810132532093e-09
mutated O 0 1.6491537735419115e-06
allele O 0 6.510937964776531e-06
. O 0 4.239302029418468e-07

In O 0 1.4290114869197623e-08
most O 0 7.228791454316763e-10
of O 0 2.9699100817515145e-11
these O 0 1.211358652275507e-10
patients O 0 3.0434927911215937e-09
, O 0 3.8656324669039677e-11
the O 0 1.1473354905033872e-10
onset O 0 1.1401925092968668e-07
of O 0 4.0253936295364667e-10
the O 0 1.6498714217050292e-07
disease O 0 0.0009756395011208951
was O 0 9.9076351034455e-06
congenital O 1 0.9989547729492188
. O 0 2.2988767796050524e-06

Preliminary O 0 2.832539621522301e-06
in O 0 1.0572969699751411e-07
vivo O 0 7.289730092452373e-06
footprinting O 0 2.0110601326450706e-05
data O 0 2.8890896786037956e-08
gave O 0 1.0342784406702776e-09
evidence O 0 1.4763084088542655e-09
for O 0 1.5690354571162857e-10
protein O 0 5.683542525503071e-09
- O 0 3.991778996237372e-08
DNA O 0 8.141116580873131e-08
contact O 0 2.9724532168984297e-08
in O 0 1.7444936606381134e-09
normal O 0 2.084830263981985e-08
genes O 0 6.453038992049187e-08
at O 0 2.636699392155606e-08
an O 0 1.367770563476256e-09
Sp1 O 0 3.8690171777489013e-07
consensus O 0 2.6947706288638074e-09
binding O 0 5.59863000404448e-09
site O 0 3.5335718795437288e-09
upstream O 0 1.6956915871446654e-09
of O 0 3.783236571242021e-11
the O 0 1.4259714242736976e-10
CTG O 0 8.253405070490771e-08
repeat O 0 4.357176663916107e-08
and O 0 1.8424391179383548e-10
for O 0 3.1153964824559566e-11
a O 0 7.126754048014661e-11
significant O 0 2.338338855878419e-09
reduction O 0 9.337998818637061e-09
of O 0 1.1357645726683963e-11
this O 0 4.6707557960212753e-11
interaction O 0 5.306976524899198e-10
in O 0 3.3837652124724116e-10
cells O 0 6.196551272097395e-09
with O 0 3.7138095376754165e-10
a O 0 2.6778932404880607e-09
hypermethylated O 0 2.318706719961483e-06
DMPK O 0 1.6310694945786963e-06
gene O 0 3.5850874269272026e-07
. O 0 5.3932385668531424e-08
. O 0 2.606757334433496e-07

The O 0 1.095053107746935e-06
hemochromatosis B-Disease 1 0.999931812286377
gene O 0 1.8909115624410333e-06
product O 0 1.471659771823397e-07
complexes O 0 9.735669692645388e-08
with O 0 1.2542226146550206e-09
the O 0 1.448566155914932e-09
transferrin O 0 1.7234279994227109e-06
receptor O 0 4.612738280229678e-07
and O 0 1.9769974102246124e-08
lowers O 0 4.652344784972229e-07
its O 0 6.759702797509703e-10
affinity O 0 6.952924902492441e-09
for O 0 8.612298096899451e-10
ligand O 0 1.276112442383237e-07
binding O 0 6.874649898236385e-07
. O 0 5.874191515431448e-07

We O 0 9.092441359825898e-07
recently O 0 1.219657832507437e-07
reported O 0 1.196026033767339e-08
the O 0 5.97745256070148e-11
positional O 0 7.467770402058704e-09
cloning O 0 3.4185378972040326e-09
of O 0 5.646819817295423e-11
a O 0 9.228006137007583e-10
candidate O 0 8.799673878456815e-08
gene O 0 2.205810915256734e-06
for O 0 7.86630334914662e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.0024313454050570726
HFE O 1 0.9786912202835083
. O 0 5.612946097244276e-06

The O 0 2.379398544860578e-08
gene O 0 8.850457788867061e-08
product O 0 2.6784054085737807e-08
, O 0 6.738385405213876e-10
a O 0 5.900845367889929e-10
member O 0 4.827681032715248e-10
of O 0 8.536280016180342e-11
the O 0 1.0954014362241082e-09
major O 0 4.7050892959532575e-08
histocompatibility O 0 7.333592293434776e-07
complex O 0 2.9230236009425425e-07
class O 0 2.4887944505280757e-07
I O 0 5.022633331464021e-07
- O 0 1.899327983778676e-08
like O 0 7.168297067039475e-10
family O 0 5.756527476918905e-10
, O 0 1.1609307265514346e-10
was O 0 5.670783842504079e-10
found O 0 9.320799687628778e-11
to O 0 1.411725875088976e-10
have O 0 1.863383225497728e-09
a O 0 1.3761257688926776e-09
mutation O 0 1.4506133538816357e-07
, O 0 1.921144132666086e-09
Cys O 0 0.00031757415854372084
- O 0 2.127379275407293e-06
282 O 0 4.835426921090402e-07
- O 0 1.0231819942418952e-05
- O 0 2.753904027485987e-06
> O 0 6.817743525289188e-08
Tyr O 0 1.9584317101362103e-07
( O 0 2.4810423160381845e-10
C282Y O 0 7.05549707546993e-09
) O 0 1.5518740459352642e-10
, O 0 7.295829218545435e-11
in O 0 2.868747739359634e-10
85 O 0 2.9417746016946467e-09
% O 0 6.972456501053159e-10
of O 0 6.275429620394846e-10
patient O 0 2.562672136718902e-07
chromosomes O 0 2.238686874989071e-06
. O 0 7.701871709286934e-07

This O 0 5.885418374873552e-08
mutation O 0 1.1849654129036935e-06
eliminates O 0 1.2939522093802225e-06
the O 0 3.594753383850957e-09
ability O 0 3.125000702652869e-08
of O 0 4.86526707810242e-10
HFE O 0 1.3286760349728866e-06
to O 0 9.619394170101714e-10
associate O 0 8.518154182013404e-09
with O 0 5.427079341480123e-10
beta2 O 0 9.412231520400383e-06
- O 0 1.0156049938814249e-05
microglobulin O 0 2.0761576706718188e-06
( O 0 1.360563106622692e-09
beta2m O 0 1.5187184487785998e-07
) O 0 1.0940817141147363e-09
and O 0 1.4645654689005028e-09
prevents O 0 3.355182442987825e-08
cell O 0 5.189662715565646e-06
- O 0 0.0016121891094371676
surface O 0 2.96911002806155e-06
expression O 0 8.044640367188549e-07
. O 0 3.672219861527992e-07

A O 0 1.6458434970445524e-07
second O 0 1.3850268487658468e-08
mutation O 0 7.192461737304257e-08
that O 0 5.498933530745376e-10
has O 0 8.501594428445003e-10
no O 0 6.819532161195241e-10
effect O 0 9.576980986025774e-09
on O 0 7.280152591881972e-10
beta2m O 0 9.092106267871713e-08
association O 0 2.9559693581759916e-10
, O 0 3.547425200811638e-11
H63D O 0 4.60081430730952e-08
, O 0 7.309786803633145e-11
was O 0 2.7907612332178644e-10
found O 0 1.5088517935080148e-10
in O 0 4.332028832876311e-11
eight O 0 1.9662216299565216e-10
out O 0 1.8584876693150676e-10
of O 0 5.188538487743699e-11
nine O 0 4.798362596147854e-09
patients O 0 8.743105794906114e-09
heterozygous O 0 1.3117223751635265e-08
for O 0 2.2161918133978276e-10
the O 0 1.8072107144107008e-09
C282Y O 0 1.395114622937399e-06
mutant O 0 2.5193667170242406e-06
. O 0 4.653831524592533e-07

In O 0 5.6223896649498784e-08
this O 0 1.1469420968523991e-09
report O 0 5.069917374811439e-09
, O 0 3.5969738299002074e-10
we O 0 4.3351885969933335e-10
demonstrate O 0 8.465348422248553e-10
in O 0 8.008108065560293e-10
cultured O 0 2.591878853763774e-07
293 O 0 6.795077212018441e-08
cells O 0 3.646881907570787e-08
overexpressing O 0 1.4215919463822502e-06
wild O 0 3.9956180586386836e-08
- O 0 7.896263014117721e-06
type O 0 1.0837329682544805e-06
or O 0 2.6808024244928674e-08
mutant O 0 3.243276580633392e-07
HFE O 0 8.97449581316323e-07
proteins O 0 2.5334834230505976e-09
that O 0 8.659550854162035e-11
both O 0 5.890249399342906e-11
the O 0 6.657464163284388e-11
wild O 0 4.708857304080993e-09
- O 0 8.014775085030124e-05
type O 0 1.5888455891399644e-05
and O 0 4.6289553523592986e-08
H63D O 0 7.932596417958848e-06
HFE O 0 8.259471542260144e-06
proteins O 0 3.835562978338203e-08
form O 0 3.04675857876191e-08
stable O 0 4.549573162648812e-08
complexes O 0 3.2995380649936124e-08
with O 0 1.2293633888660338e-09
the O 0 1.6481548570368432e-08
transferrin O 0 8.778182746027596e-06
receptor O 0 1.7216063952218974e-06
( O 0 2.118017228269764e-08
TfR O 0 5.169928499526577e-06
) O 0 2.3107185498361105e-08
. O 0 1.2498833257268416e-07

The O 0 1.1436075908477505e-07
C282Y O 0 4.144427748542512e-06
mutation O 0 5.397168365561811e-07
nearly O 0 1.2322138864817589e-08
completely O 0 5.704626104829913e-08
prevents O 0 3.5757583560780404e-08
the O 0 3.0974453557597315e-10
association O 0 4.308316203793794e-10
of O 0 6.567740101770525e-11
the O 0 2.1066866029428866e-09
mutant O 0 2.630687276905519e-07
HFE O 0 4.405631443660241e-06
protein O 0 3.946477633576251e-08
with O 0 2.0359283148252416e-09
the O 0 3.892064981414478e-08
TfR O 0 5.1156323024770245e-05
. O 0 5.600479653367074e-07

Studies O 0 3.016982645931421e-06
on O 0 3.488764477310724e-08
cell O 0 1.6999205172396614e-06
- O 0 3.616374215198448e-06
associated O 0 2.7128427504408137e-08
transferrin O 0 2.2792116283198993e-07
at O 0 3.745816989919604e-09
37 O 0 1.8624238817821492e-09
degrees O 0 1.7679219865840423e-08
C O 0 4.6864062852591815e-08
suggest O 0 5.9653064710119e-09
that O 0 1.950432870767571e-10
the O 0 2.1870118216416046e-10
overexpressed O 0 2.3805000637366902e-07
wild O 0 3.918492907928339e-08
- O 0 5.760405656474177e-06
type O 0 8.961837352217117e-07
HFE O 0 9.242682608601172e-06
protein O 0 4.9758625664253486e-08
decreases O 0 3.1112506349018076e-08
the O 0 1.7283438569215548e-10
affinity O 0 1.3424192424338344e-08
of O 0 5.411162073976072e-10
the O 0 1.1674690547636146e-08
TfR O 0 6.9397046900121495e-06
for O 0 1.805709537450184e-08
transferrin O 0 8.322647772729397e-06
. O 0 2.1758762613899307e-07

The O 0 5.924296146986308e-07
overexpressed O 0 3.037757778656669e-05
H63D O 0 2.2687033833790338e-06
protein O 0 2.70106550459559e-08
does O 0 4.956867361016748e-09
not O 0 4.398924835502527e-10
have O 0 1.0923589116584864e-10
this O 0 2.1865434809975604e-11
effect O 0 1.914391756230316e-09
, O 0 2.7057484724979375e-11
providing O 0 3.044755420011924e-11
the O 0 6.160105411878725e-12
first O 0 5.642976017017354e-11
direct O 0 8.031875164959956e-11
evidence O 0 1.6004710889916396e-09
for O 0 1.577660085905208e-10
a O 0 7.80415010392943e-10
functional O 0 8.095499026694597e-08
consequence O 0 5.7046477763833536e-08
of O 0 4.5699019568523624e-10
the O 0 1.4881491594564977e-08
H63D O 0 4.101037484360859e-05
mutation O 0 3.461580035946099e-06
. O 0 2.8043365318808355e-07

Addition O 0 1.5836783973099955e-07
of O 0 4.14336387422054e-09
soluble O 0 6.880355840621633e-07
wild O 0 1.5132867758893553e-07
- O 0 0.00012746118591167033
type O 0 2.798632522171829e-05
HFE O 0 0.005281298886984587
/ O 0 8.588489436078817e-06
beta2m O 0 2.293507577633136e-06
heterodimers O 0 8.354610940841667e-07
to O 0 3.2639833058567547e-09
cultured O 0 2.0527788535673608e-07
cells O 0 5.3285756251852945e-08
also O 0 4.190565672246294e-09
decreased O 0 7.908068866413487e-09
the O 0 3.905997469910716e-10
apparent O 0 5.5261684117624554e-09
affinity O 0 1.7538562602226193e-08
of O 0 1.983567615715387e-10
the O 0 1.237658975306033e-09
TfR O 0 4.7227388222381705e-07
for O 0 1.1337739774797129e-10
its O 0 1.0192241495232679e-10
ligand O 0 2.7197317731264548e-09
under O 0 3.739019649451336e-10
steady O 0 3.019953709326728e-08
- O 0 3.618488335632719e-07
state O 0 4.676153242400005e-09
conditions O 0 1.1125798948796728e-08
, O 0 7.722278372312985e-11
both O 0 1.7479434566425311e-10
in O 0 4.0541026091744925e-10
293 O 0 7.128392542909978e-09
cells O 0 7.53309059575713e-09
and O 0 3.213012078617794e-09
in O 0 7.50752970901658e-09
HeLa O 0 2.467308604536811e-06
cells O 0 6.785349455640244e-07
. O 0 3.3881349281728035e-07

Furthermore O 0 5.157181703907554e-07
, O 0 6.276917208225541e-09
at O 0 2.568035339933772e-09
4 O 0 1.276079797385421e-09
degrees O 0 1.7347765890463052e-07
C O 0 1.2728834235531394e-06
, O 0 3.81785936198753e-10
the O 0 6.119708628737897e-10
added O 0 1.5404920006290013e-08
soluble O 0 1.2729692855373287e-07
complex O 0 1.7033555010925738e-08
of O 0 2.1908999059405687e-09
HFE O 0 4.791968603967689e-05
/ O 0 8.784822398411052e-07
beta2m O 0 3.2614386782370275e-06
inhibited O 0 2.49240486027702e-07
binding O 0 8.70754490733816e-08
of O 0 2.0501125241878526e-09
transferrin O 0 6.906823841745791e-07
to O 0 7.0781145389275935e-09
HeLa O 0 1.7722387610774604e-06
cell O 0 4.970598297404649e-07
TfR O 0 1.2037428405164974e-06
in O 0 9.61323132209202e-10
a O 0 3.0221820601639138e-09
concentration O 0 8.420719495916273e-06
- O 0 1.7545928130857646e-05
dependent O 0 2.0811930880881846e-06
manner O 0 1.9126173356198706e-06
. O 0 5.920044259255519e-07

Scatchard O 0 2.283474532305263e-05
plots O 0 1.6356552805518731e-06
of O 0 9.67573798860144e-10
these O 0 4.2177952797040064e-10
data O 0 5.28894128493107e-09
indicate O 0 2.533198317777874e-09
that O 0 3.785541047296448e-10
the O 0 4.863744962335659e-10
added O 0 9.671278000666916e-09
heterodimer O 0 5.289700766297756e-08
substantially O 0 5.3417739565020383e-08
reduced O 0 6.0828915238175796e-09
the O 0 2.4417945443389044e-10
affinity O 0 9.939109979484329e-09
of O 0 9.066987716188635e-10
TfR O 0 2.2364547476172447e-06
for O 0 1.4311499541008743e-08
transferrin O 0 4.6185014070943e-06
. O 0 1.7712980593387329e-07

These O 0 1.4757974042822752e-07
results O 0 1.4098334588652506e-07
establish O 0 1.6039127359590566e-08
a O 0 1.8371762999791486e-09
molecular O 0 6.378199657319783e-08
link O 0 2.964035559216427e-07
between O 0 1.2084729661410165e-08
HFE O 0 0.00018264539539813995
and O 0 1.5026898836367764e-08
a O 0 1.2506059521300017e-09
key O 0 1.1275339772964799e-08
protein O 0 1.3428103073920283e-09
involved O 0 1.926644621619289e-09
in O 0 6.875011115958785e-10
iron O 0 0.00017390624270774424
transport O 0 8.000768048077589e-09
, O 0 1.302290358884406e-10
the O 0 1.7937412666313435e-10
TfR O 0 1.23758454151357e-07
, O 0 8.35351718353472e-11
and O 0 1.1923530218727052e-10
raise O 0 1.9192862577011027e-10
the O 0 3.6371856915184964e-11
possibility O 0 4.242136641963157e-10
that O 0 2.4581860852412873e-11
alterations O 0 4.997088076663658e-09
in O 0 1.0284766094326159e-10
this O 0 9.698644665157019e-11
regulatory O 0 1.2960718720478326e-08
mechanism O 0 2.601956650138959e-09
may O 0 3.897865141766488e-09
play O 0 2.726690540022503e-10
a O 0 7.135962654114536e-11
role O 0 2.087797934535729e-09
in O 0 3.590194808111846e-10
the O 0 2.3782358304913487e-09
pathogenesis O 0 4.883992232862511e-07
of O 0 1.1917454401100258e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.2236007023602724e-05
. O 0 2.1335520159482257e-06

Genomic O 0 2.544637754908763e-05
organization O 0 2.909018803620711e-07
of O 0 5.599762431529598e-09
the O 0 1.2420297679227588e-08
UBE3A O 0 6.0206592024769634e-05
/ O 0 5.680749836756149e-06
E6 O 0 9.982933079299983e-06
- O 0 5.339470226317644e-05
AP O 0 4.1262221202487126e-05
gene O 0 4.906171398033621e-07
and O 0 1.708568220237794e-08
related O 0 3.7267918173711223e-07
pseudogenes O 0 1.962954229384195e-05
. O 0 1.2841593388657202e-06

The O 0 1.4197357813827693e-06
UBE3A O 0 0.00012054981925757602
gene O 0 4.281208475731546e-06
encodes O 0 9.243689191862359e-07
the O 0 4.0685772972892664e-08
E6 O 0 4.819130481337197e-06
- O 0 4.062849984620698e-05
AP O 0 2.228015182481613e-05
ubiquitin O 0 2.861248731278465e-07
- O 0 5.3741491257142116e-08
protein O 0 1.3998938674930628e-09
ligase O 0 1.0258225380255226e-09
and O 0 2.2966029078475003e-10
has O 0 2.0998858207832427e-10
recently O 0 2.0545321000042804e-09
been O 0 5.985244244666177e-11
shown O 0 6.526332252398959e-11
to O 0 4.828801941636485e-11
be O 0 7.274711943949796e-10
mutated O 0 6.75526166560303e-07
in O 0 9.446051080885809e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0007084250100888312
who O 0 6.596197010821925e-08
lack O 0 6.599620405722817e-08
15q11 O 0 5.167784365767147e-06
- O 0 8.15594830783084e-06
q13 O 0 4.69712767880992e-06
deletions O 0 2.3749835236230865e-06
or O 0 3.3575454949641426e-07
chromosome O 0 7.222954445751384e-05
15 O 0 4.279606002910441e-07
paternal O 0 1.7911190298036672e-05
uniparental B-Disease 0 0.004588160663843155
disomy I-Disease 0 0.0010761168086901307
. O 0 5.613047505903523e-06

Previous O 0 2.814831304931431e-06
UBE3A O 0 5.855495692230761e-05
cDNA O 0 1.1116635505459271e-06
analysis O 0 2.89708623313345e-07
has O 0 1.4364225364715821e-08
shown O 0 5.250846424331712e-09
a O 0 1.8680308411234137e-09
coding O 0 1.589358362252824e-06
region O 0 5.808746195157255e-08
of O 0 9.670645395587485e-10
approximately O 0 9.276982737560502e-09
2 O 0 7.853883943198525e-08
. O 0 1.555494577587524e-07

6 O 0 2.8694839784293436e-06
kb O 0 8.810456165520009e-06
and O 0 3.1523050836312905e-08
a O 0 1.9764131664601337e-08
3 O 0 3.172058029576874e-07
- O 0 0.0018696381011977792
untranslated O 0 0.039265990257263184
region O 0 2.7627636427496327e-06
( O 0 7.242070942936607e-09
UTR O 0 3.3724546710800496e-07
) O 0 1.000010629859105e-09
of O 0 4.56839219231675e-11
< O 0 5.724056340028483e-09
50 O 0 5.481237130844363e-10
bp O 0 4.6563172872993164e-08
, O 0 7.195470608234444e-11
whereas O 0 9.452717497637764e-10
Northern O 0 2.1172810171776746e-09
analysis O 0 3.563570771802915e-08
has O 0 7.541687274681408e-09
indicated O 0 4.131148312325195e-09
mRNA O 0 1.5277162868088112e-09
sizes O 0 1.1023899126882952e-08
of O 0 4.4440254254318745e-10
5 O 0 1.699895690876474e-08
- O 0 1.3819106243317947e-05
8 O 0 1.9033249998301471e-07
kb O 0 4.456747319636634e-06
. O 0 3.08297330775531e-07

We O 0 4.5649238700207206e-07
have O 0 4.869706859977896e-09
analyzed O 0 9.05561936548338e-09
additional O 0 9.293236180596409e-10
cDNA O 0 1.973885233041983e-08
clones O 0 1.1573437319611912e-08
and O 0 3.154605465738314e-10
provide O 0 1.0358276042454762e-10
evidence O 0 4.0778339038816114e-10
for O 0 4.7871866193371915e-11
an O 0 9.770387277008297e-11
additional O 0 1.0116059989684345e-08
0 O 0 1.4804294323766953e-07
. O 0 3.722678627582354e-07

5 O 0 1.8657225382412435e-06
kb O 0 5.7299421314382926e-06
of O 0 5.6723878927300575e-09
5 O 0 8.844382648476312e-08
- O 0 2.1951943836029386e-06
UTR O 0 3.7062386581965256e-06
and O 0 1.2852869879509399e-08
> O 0 2.494368445127293e-08
2 O 0 4.600970271440019e-09
kb O 0 2.984693878715916e-07
of O 0 1.510966463058594e-09
3 O 0 2.1054087540051114e-07
- O 0 5.940009214100428e-05
UTR O 0 7.479000487364829e-05
. O 0 7.818861718078551e-07

We O 0 2.3562449769087834e-06
have O 0 9.361216690706442e-09
established O 0 3.0651290394700936e-09
the O 0 2.3661447801082147e-10
genomic O 0 3.1909419107023496e-08
organization O 0 1.2901789636643457e-09
of O 0 1.0820527807098301e-10
UBE3A O 0 2.8480937430686026e-07
and O 0 7.591676731699692e-10
the O 0 8.826253616867064e-11
sequence O 0 4.903156547442222e-09
of O 0 1.086549406004167e-09
intron O 0 2.498158937669359e-05
- O 0 2.95768568321364e-05
exon O 0 1.827626329031773e-05
borders O 0 8.338050974998623e-06
. O 0 1.412351593899075e-06

We O 0 6.604247460018087e-07
have O 0 6.9957457604630235e-09
also O 0 1.2994475495631264e-09
mapped O 0 5.7896439642490805e-08
two O 0 2.5600637165723583e-09
highly O 0 7.688087499957419e-09
homologous O 0 8.72402026175223e-08
processed O 0 2.0361159869253243e-08
pseudogenes O 0 1.7289727338720695e-07
, O 0 1.6055832219308286e-09
UBE3AP1 O 0 2.3794535763954627e-07
and O 0 1.413483330381382e-09
UBE3AP2 O 0 2.1094142255151382e-07
, O 0 1.5753025273124166e-10
to O 0 9.725058952581023e-11
chromosomes O 0 3.6907692457788244e-09
2 O 0 1.4146889215638225e-09
and O 0 7.58406448753135e-10
21 O 0 5.082792520205714e-10
, O 0 5.835121968944534e-11
respectively O 0 6.754731440850037e-09
, O 0 1.166847396483206e-09
and O 0 4.4072829830099636e-09
determined O 0 7.44740447089498e-08
their O 0 9.996068861539698e-09
genomic O 0 1.908980038933805e-06
organization O 0 2.3573817031774524e-07
. O 0 4.95868562211399e-07

These O 0 2.269485399608584e-08
results O 0 5.796925961476518e-08
will O 0 3.532114878357362e-10
form O 0 1.0551258478042058e-10
the O 0 2.2156963763730886e-11
basis O 0 3.5997052560965415e-10
for O 0 1.1896589269255742e-10
studies O 0 3.1771425490489946e-09
of O 0 7.156639864058789e-11
mutation O 0 4.6608221282440354e-08
and O 0 4.540927633911451e-09
imprinting O 0 2.5447138796153013e-06
of O 0 2.9649505961515388e-08
UBE3A O 0 0.00014695794379804283
. O 0 2.099541006828076e-06

Mutation O 0 3.240943988203071e-05
spectrum O 0 2.392542910456541e-06
and O 0 1.6554284343328618e-07
genotype O 0 0.004090289119631052
- O 0 0.1661137342453003
phenotype O 0 1.0346357157686725e-05
analyses O 0 3.6704693684441736e-07
in O 0 1.0989176679743196e-08
Cowden B-Disease 0 9.280441008741036e-05
disease I-Disease 0 3.180162366334116e-06
and O 0 2.6122563667740906e-08
Bannayan B-Disease 1 0.9849270582199097
- I-Disease 1 0.9999951124191284
Zonana I-Disease 1 0.999922513961792
syndrome I-Disease 1 0.9999909400939941
, O 0 2.296482470853789e-08
two O 0 7.193312256958961e-08
hamartoma B-Disease 0 0.268267422914505
syndromes I-Disease 0 0.031495802104473114
with O 0 2.0734654526677332e-07
germline O 0 0.0008652086253277957
PTEN O 0 0.007909543812274933
mutation O 0 0.000501356553286314
. O 0 4.828450073546264e-06

The O 0 6.421211310225772e-06
tumour B-Disease 1 0.9999986886978149
suppressor O 0 0.00012558755406644195
gene O 0 1.0977269084833097e-05
PTEN O 0 6.95862399879843e-05
, O 0 1.1959211398959724e-08
which O 0 6.536874930240799e-10
maps O 0 4.5366530088131185e-08
to O 0 2.570653556688285e-08
10q23 O 0 1.0810720596055035e-05
. O 0 4.6657009988848586e-07

3 O 0 3.7861809687456116e-07
and O 0 7.436925741899358e-09
encodes O 0 6.805971963785851e-08
a O 0 1.7306282629192538e-08
403 O 0 1.733296670636264e-07
amino O 0 6.817977009632159e-07
acid O 0 3.0055359729885822e-06
dual O 0 1.0705744898587e-05
specificity O 0 9.40198606258491e-06
phosphatase O 0 0.0028069799300283194
( O 0 5.4856979403439254e-08
protein O 0 2.460282360061683e-07
tyrosine O 0 1.880312538560247e-06
phosphatase O 0 2.023271554207895e-05
; O 0 1.355316392448458e-08
PTPase O 0 3.0681493967676943e-07
) O 0 1.422820639085387e-09
, O 0 1.8061899198507092e-10
was O 0 6.751958436801431e-10
shown O 0 9.029381686787019e-10
recently O 0 1.1342552674875606e-08
to O 0 1.937189714196208e-10
play O 0 1.3898875383944187e-09
a O 0 3.261753367400644e-10
broad O 0 4.1210905799005104e-09
role O 0 7.626239550972969e-08
in O 0 1.085019540880694e-08
human O 0 1.3994186076615733e-07
malignancy B-Disease 0 0.00027789900195784867
. O 0 6.147851649984659e-07

Somatic O 0 0.0005562680307775736
PTEN O 0 0.000507434131577611
deletions O 0 1.720776162983384e-05
and O 0 7.015444225544343e-08
mutations O 0 4.792300956069084e-07
were O 0 3.615726384964546e-09
observed O 0 2.221420558612408e-08
in O 0 6.828646537115901e-09
sporadic B-Disease 0 0.00010999460209859535
breast I-Disease 1 0.9999433755874634
, I-Disease 0 1.1248236830851965e-07
brain I-Disease 0 0.00025748522602953017
, I-Disease 0 3.475368615113439e-08
prostate I-Disease 0 0.002697492018342018
and I-Disease 0 6.407585715351161e-07
kidney I-Disease 0 4.105702100787312e-05
cancer I-Disease 0 6.9033203544677235e-06
cell O 0 7.787650702084647e-07
lines O 0 2.9678585633519106e-06
and O 0 2.100700058349503e-09
in O 0 3.0863994693319796e-10
several O 0 3.1501337094397286e-09
primary O 0 0.0014961296692490578
tumours B-Disease 1 1.0
such O 0 6.07723249501646e-09
as O 0 1.8631109810485214e-07
endometrial B-Disease 1 0.9997294545173645
carcinomas I-Disease 1 1.0
, O 0 0.12374628335237503
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.8220170140266418
thyroid B-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 7.478929092030739e-06

In O 0 5.398456437433197e-08
addition O 0 1.9585915111974828e-08
, O 0 2.6589801471743613e-09
PTEN O 0 2.9920147426309995e-06
was O 0 7.128351686702672e-09
identified O 0 3.210512744544758e-09
as O 0 1.3956834299388987e-10
the O 0 1.5391160568256623e-10
susceptibility O 0 2.8037128174673853e-08
gene O 0 4.343187498534462e-08
for O 0 5.088372390105178e-09
two O 0 3.692292693813215e-07
hamartoma B-Disease 1 0.9999574422836304
syndromes I-Disease 1 0.9999974966049194
Cowden B-Disease 1 0.9997790455818176
disease I-Disease 1 0.961181640625
( O 0 2.959820122327983e-08
CD B-Disease 0 6.722767693645437e-07
; O 0 3.4402692250523614e-08
MIM O 0 2.673259768926073e-05
158350 O 0 3.000845083533932e-07
) O 0 2.250805319903293e-09
and O 0 4.34832436724264e-09
Bannayan B-Disease 0 0.00020275736460462213
- I-Disease 0 0.017915958538651466
Zonana I-Disease 0 6.537000444950536e-05
( I-Disease 0 1.0851271881051616e-08
BZS I-Disease 0 3.911723524652189e-06
) I-Disease 0 2.267411591816426e-09
or I-Disease 0 2.7438300520543635e-09
Ruvalcaba I-Disease 0 1.3063840924587566e-05
- I-Disease 0 0.00011396339687053114
Riley I-Disease 0 7.396555156446993e-05
- I-Disease 1 0.999839186668396
Smith I-Disease 1 0.9623553156852722
syndrome I-Disease 1 0.9971845746040344
( O 0 1.4926603952858386e-08
MIM O 0 2.4303832105943002e-05
153480 O 0 3.7068039091536775e-06
) O 0 5.945487657754711e-08
. O 0 1.8466246842763212e-07

Constitutive O 0 4.276466825103853e-06
DNA O 0 8.409672318521189e-07
from O 0 4.6370205453172275e-09
37 O 0 5.752425202842915e-09
CD B-Disease 0 2.128579268401154e-08
families O 0 2.909909868620275e-09
and O 0 3.2750897549505e-09
seven O 0 9.252384636226907e-09
BZS B-Disease 0 5.422508820629446e-06
families O 0 4.990954316497209e-09
was O 0 8.32422841767766e-09
screened O 0 2.352306296415918e-07
for O 0 2.233916696070537e-08
germline O 0 2.8972988729947247e-05
PTEN O 0 0.0002538793196436018
mutations O 0 7.051596912788227e-05
. O 0 1.8076067362926551e-06

PTEN O 0 0.0006317207007668912
mutations O 0 9.258412319468334e-06
were O 0 9.413032131533328e-09
identified O 0 7.602751317392631e-09
in O 0 2.8083019243396734e-10
30 O 0 6.763997695280466e-10
of O 0 4.925600899374771e-11
37 O 0 5.187158258479485e-09
( O 0 8.053632205573535e-10
81 O 0 1.3976001689286477e-08
% O 0 1.4520792346317535e-09
) O 0 4.96916119363533e-10
CD B-Disease 0 2.4293841605071975e-08
families O 0 8.973275456014562e-10
, O 0 1.069368968376061e-10
including O 0 2.3155162509613803e-10
missense O 0 2.5041986191354226e-06
and O 0 3.248742785899594e-08
nonsense O 0 7.818354674782313e-07
point O 0 5.370409184024538e-08
mutations O 0 1.8499949305805785e-07
, O 0 3.0357802383029764e-10
deletions O 0 5.466636210371689e-08
, O 0 1.2644405522621582e-09
insertions O 0 2.539983370297705e-07
, O 0 2.893157713401706e-09
a O 0 4.392219921101059e-09
deletion O 0 3.205398343197885e-06
/ O 0 1.1286613244010368e-06
insertion O 0 8.272378977380868e-07
and O 0 5.98644049887298e-08
splice O 0 1.646579767111689e-05
site O 0 3.62561172551068e-06
mutations O 0 2.0315197616582736e-05
. O 0 5.00294163430226e-07

These O 0 4.8111765238445514e-08
mutations O 0 2.9346935548346664e-07
were O 0 2.2981245795250516e-09
scattered O 0 3.0157789598916906e-09
over O 0 4.8600936608522716e-09
the O 0 7.228639908873902e-10
entire O 0 3.896905909073212e-09
length O 0 8.649424287909824e-09
of O 0 1.7311282962673147e-10
PTEN O 0 3.1819777746022737e-07
, O 0 1.1894092655229116e-10
with O 0 3.868383391392172e-11
the O 0 8.410416113546759e-11
exception O 0 1.7835619647854628e-09
of O 0 2.2376404548718476e-11
the O 0 1.0731530941665568e-10
first O 0 2.5005311155013032e-09
, O 0 6.936178853500508e-10
fourth O 0 1.2269464555458853e-08
and O 0 3.738308773648669e-09
last O 0 5.403731151432112e-08
exons O 0 1.9911544768547174e-06
. O 0 3.6661279523286794e-07

A O 0 6.478900900219742e-07
hot O 0 1.8607934180181473e-06
spot O 0 1.097608333111566e-06
for O 0 9.532131528544596e-09
PTEN O 0 1.0292174010828603e-05
mutation O 0 7.425001058436465e-07
in O 0 4.295222844064028e-09
CD B-Disease 0 8.666850703775708e-08
was O 0 4.231762495976454e-09
identified O 0 8.436613185835995e-09
in O 0 4.394480335179196e-10
exon O 0 4.122625796298962e-08
5 O 0 1.6254328993881018e-09
that O 0 8.702568526919308e-11
contains O 0 1.910258062842729e-10
the O 0 3.753553579066704e-10
PTPase O 0 1.2788025571808248e-07
core O 0 2.6134173936043226e-08
motif O 0 2.856318381816436e-08
, O 0 4.2224077012598116e-10
with O 0 6.986310835399578e-11
13 O 0 3.885756161281506e-10
of O 0 2.91314437850243e-11
30 O 0 6.822160614206041e-10
( O 0 1.403537147615097e-10
43 O 0 3.922723479377055e-09
% O 0 1.3244275676171924e-09
) O 0 7.654197275996921e-10
CD B-Disease 0 9.710948489782822e-08
mutations O 0 1.1785510878326022e-07
identified O 0 1.646765923624116e-08
in O 0 6.435529886772429e-10
this O 0 3.5089100514085203e-09
exon O 0 1.9216822693124413e-06
. O 0 5.358387511478213e-07

Seven O 0 1.2773081436989742e-07
of O 0 5.691828119935849e-10
30 O 0 2.692386980029937e-09
( O 0 3.140629145637064e-10
23 O 0 1.3651069163955754e-09
% O 0 2.243950164571018e-10
) O 0 3.9396824691451116e-10
were O 0 1.6607448749539344e-09
within O 0 1.3269983722974388e-10
the O 0 2.8600879997675577e-10
core O 0 2.3149622663254377e-08
motif O 0 1.1384948095383152e-08
, O 0 2.098760470969907e-10
the O 0 6.208896591308743e-11
majority O 0 1.7014292197359282e-09
( O 0 3.240383655844781e-11
five O 0 5.505332648092498e-11
of O 0 5.6016979249617904e-12
seven O 0 1.6710453853985285e-10
) O 0 6.793771101243351e-11
of O 0 1.1083485691731898e-11
which O 0 1.6651093837083408e-09
were O 0 3.2387370563213835e-09
missense O 0 7.829726200725418e-07
mutations O 0 2.3764873446907586e-07
, O 0 5.819963955211449e-10
possibly O 0 6.046581013663399e-09
pointing O 0 4.747122872572618e-08
to O 0 2.2806145860698734e-09
the O 0 7.347587538397704e-10
functional O 0 1.0214943557684819e-08
significance O 0 4.791082641730782e-09
of O 0 1.3735788895186118e-10
this O 0 4.823780930252042e-09
region O 0 7.73745966853312e-07
. O 0 7.593449709020206e-07

Germline O 0 0.002208998426795006
PTEN O 0 0.0004953621537424624
mutations O 0 1.0232775821350515e-05
were O 0 1.1573017211219394e-08
identified O 0 1.1227141882841352e-08
in O 0 2.2247129138897037e-10
four O 0 3.8913186561906343e-10
of O 0 5.109764000810202e-11
seven O 0 2.456951087026482e-09
( O 0 1.0856213705778828e-09
57 O 0 4.3636227076149225e-08
% O 0 6.299945898291526e-09
) O 0 1.4888333232931927e-08
BZS B-Disease 0 2.405166014796123e-05
families O 0 3.5051925806328654e-08
studied O 0 3.1526062116427056e-07
. O 0 1.7461798051954247e-07

Interestingly O 0 3.2551990898355143e-06
, O 0 2.617568206630949e-08
none O 0 6.519222495171562e-09
of O 0 1.0531876759589665e-10
these O 0 6.227259263802409e-10
mutations O 0 1.791654398175524e-07
was O 0 4.488974081340302e-09
observed O 0 1.113547920539304e-08
in O 0 1.5058395641531774e-09
the O 0 5.6864268849210475e-09
PTPase O 0 3.4504826089687413e-06
core O 0 1.3772051943305996e-06
motif O 0 3.689754976221593e-06
. O 0 4.700590920947434e-07

It O 0 1.0957096208130679e-07
is O 0 3.126209291437476e-09
also O 0 6.837766464151684e-10
worthy O 0 1.5833161448597366e-09
of O 0 3.17465567722941e-11
note O 0 1.9894729419434043e-08
that O 0 4.0708242332598843e-10
a O 0 5.588065565831357e-10
single O 0 2.3297122453413976e-08
nonsense O 0 1.3471431259404198e-07
point O 0 1.6701132921070894e-08
mutation O 0 4.14293914730024e-08
, O 0 4.1395309402503244e-10
R233X O 0 4.743583659205797e-08
, O 0 6.108163974616332e-10
was O 0 1.5967388522497572e-09
observed O 0 3.846594154310878e-09
in O 0 5.111257528334079e-10
the O 0 4.4522890929599157e-10
germline O 0 7.806897173168181e-08
DNA O 0 2.5895310784562753e-08
from O 0 1.017297565630848e-10
two O 0 7.908031174341801e-11
unrelated O 0 1.1884581319066001e-08
CD B-Disease 0 9.780245591173298e-08
families O 0 2.6754731763389827e-09
and O 0 2.936460186120371e-09
one O 0 1.8564946913102176e-08
BZS B-Disease 0 4.570594319375232e-05
family O 0 1.9669481332584837e-07
. O 0 2.511387720005587e-07

Genotype O 1 0.8054715991020203
- O 1 0.9910582304000854
phenotype O 0 1.383623657602584e-05
studies O 0 4.878932031715522e-07
were O 0 2.5844473228175957e-09
not O 0 1.899387730430746e-10
performed O 0 9.26949628166085e-10
on O 0 3.834469131103191e-10
this O 0 4.4469081195153137e-10
small O 0 1.7731226265027544e-08
group O 0 8.422307473665569e-08
of O 0 8.711412036177535e-09
BZS B-Disease 0 0.00010187405132455751
families O 0 2.287857370220081e-07
. O 0 2.4809222054500424e-07

However O 0 4.4733525328410906e-07
, O 0 6.710303779300375e-08
genotype O 0 3.6825789720751345e-05
- O 0 5.0133963668486103e-05
phenotype O 0 2.788354322547093e-06
analysis O 0 6.00761325131316e-08
inthe O 0 3.015044057974592e-06
group O 0 5.792571045049044e-08
of O 0 2.4687546451573894e-10
CD B-Disease 0 6.360268400840141e-08
families O 0 2.0446688786535105e-09
revealed O 0 5.109018985649527e-09
two O 0 1.9067782075499196e-10
possible O 0 2.671062704351357e-09
associations O 0 1.072844590943589e-09
worthy O 0 2.2698565249612557e-09
of O 0 5.5590834019403346e-11
follow O 0 6.476983394065883e-09
- O 0 1.3008266250835732e-06
up O 0 1.2427241458112803e-08
in O 0 2.787480246624341e-09
independent O 0 1.2337993382516288e-07
analyses O 0 1.1512844366734498e-06
. O 0 2.491516113423131e-07

The O 0 2.2763524398783375e-08
first O 0 7.72380381874882e-09
was O 0 7.829202175457795e-09
an O 0 9.938777578710756e-11
association O 0 3.607582288456257e-10
noted O 0 1.2221345047080945e-09
in O 0 3.8117106693214e-10
the O 0 8.637154880197784e-10
group O 0 2.804643628451231e-08
of O 0 1.2453590936267744e-10
CD B-Disease 0 1.0151686069548305e-07
families O 0 9.20519216407456e-09
with O 0 4.6458584535002956e-08
breast B-Disease 1 0.9993554949760437
disease I-Disease 0 0.00020149270130787045
. O 0 4.881091513198044e-07

A O 0 4.969783162778185e-07
correlation O 0 1.8099113958669477e-06
was O 0 2.8744523206114536e-08
observed O 0 1.4788342994620507e-08
between O 0 1.138739658124166e-09
the O 0 7.435247972864545e-10
presence O 0 4.0818370905526535e-08
/ O 0 3.4502448897910654e-07
absence O 0 5.9409845931668315e-09
of O 0 8.450406346893757e-11
a O 0 1.4012856430767329e-09
PTEN O 0 2.1453777208080282e-06
mutation O 0 1.241400440221696e-07
and O 0 8.628773806584888e-10
the O 0 3.772516465883058e-10
type O 0 6.233075566797197e-08
of O 0 3.6857044083404844e-09
breast O 0 0.0024010350462049246
involvement O 0 1.7498852002972853e-06
( O 0 1.16192655497116e-08
unaffected O 0 1.5314257097998052e-06
versus O 0 8.362027983821463e-06
benign O 0 0.0020157434046268463
versus O 0 0.00011992198415100574
malignant O 0 0.4821988642215729
) O 0 1.7300746435466863e-07
. O 0 2.7076995934294246e-07

Specifically O 0 1.882360152194451e-07
and O 0 2.6659985330468317e-09
more O 0 5.691977097987966e-11
directly O 0 4.314656409931672e-10
, O 0 6.440822319930817e-10
an O 0 1.825557621737417e-10
association O 0 1.0702346786573003e-09
was O 0 5.8722875451167056e-08
also O 0 1.2421192963074645e-09
observed O 0 1.2167662433171245e-09
between O 0 1.6209861231075706e-10
the O 0 1.0228269620160546e-10
presence O 0 9.606155870756083e-10
of O 0 6.454679152279041e-11
a O 0 4.185932489519928e-09
PTEN O 0 6.37788834865205e-05
mutation O 0 9.257784768124111e-06
and O 0 7.893430620242725e-07
malignant B-Disease 1 0.9996579885482788
breast I-Disease 1 0.9999819993972778
disease I-Disease 0 0.08175011724233627
. O 0 2.331127234356245e-06

Secondly O 0 2.5490166080999188e-05
, O 0 1.3468586246290215e-08
there O 0 9.92478432770838e-10
appeared O 0 3.4321794295522068e-09
to O 0 3.0819877205878754e-10
be O 0 1.0490821544806295e-09
an O 0 4.0233438802772525e-10
interdependent O 0 1.1698718935804209e-06
association O 0 1.2832972462462067e-09
between O 0 6.326554280455809e-10
mutations O 0 2.8866550039197136e-08
upstream O 0 8.926029693157034e-09
and O 0 8.6693552336925e-10
within O 0 1.5544038278747507e-10
the O 0 5.672406988566081e-10
PTPase O 0 2.2239755992359278e-07
core O 0 3.458420749780089e-08
motif O 0 5.104774203346096e-08
, O 0 7.457674477961973e-10
the O 0 3.05308445192054e-10
core O 0 1.0884831702639985e-08
motif O 0 6.514275341373832e-09
containing O 0 8.999208045423757e-10
the O 0 5.122247070943331e-10
majority O 0 8.387499583761837e-09
of O 0 3.3635730312120415e-10
missense O 0 5.702743237634422e-07
mutations O 0 1.8291046899321373e-07
, O 0 9.057636307652217e-10
and O 0 4.4894690742758314e-10
the O 0 1.1230128632577774e-10
involvement O 0 4.04304723033988e-09
of O 0 3.186187425008313e-11
all O 0 3.0783686710833535e-10
major O 0 6.9807768454666075e-09
organ O 0 7.048129191389307e-08
systems O 0 2.8398108042893e-07
( O 0 8.485685487613637e-10
central O 0 1.3688464584049598e-08
nervous O 0 6.921119620528771e-06
system O 0 3.97098709470356e-08
, O 0 4.681633303249555e-09
thyroid O 0 0.0014163277810439467
, O 0 1.1156100931941637e-08
breast O 0 0.01212990190833807
, O 0 1.7819519371187198e-07
skin O 1 0.9998212456703186
and O 0 0.002468537073582411
gastrointestinal O 1 0.8103341460227966
tract O 0 0.04325123131275177
) O 0 6.675090276075935e-07
. O 0 4.620412141775887e-07

However O 0 1.1625432705386629e-07
, O 0 7.314783223577592e-10
these O 0 8.742897378288816e-11
observations O 0 2.2761950102534456e-09
would O 0 6.830467302876286e-10
need O 0 2.348259919848772e-10
to O 0 7.327263101819526e-11
be O 0 3.2673574956731954e-10
confirmed O 0 4.848073609231562e-10
by O 0 1.6883187556326895e-11
studying O 0 1.053156006847189e-09
a O 0 1.1135935923389795e-10
larger O 0 2.4715969271227323e-09
number O 0 2.8753170955297946e-09
of O 0 6.797689078297253e-10
CD B-Disease 0 8.944145974965068e-07
families O 0 9.243004939207822e-08
. O 0 1.2443778985016252e-07

Molecular O 0 0.0014636219711974263
defects O 0 0.19608284533023834
leading O 0 5.9596118262561504e-08
to O 0 2.926585862539355e-09
human O 0 1.6543152625558832e-08
complement B-Disease 0 2.010932576013147e-06
component I-Disease 1 0.9381392002105713
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.017341570516919e-09
an O 0 9.993051941492581e-10
African O 0 1.8599362050508716e-08
- O 0 5.75495164412132e-07
American O 0 5.1022823299717857e-08
family O 0 3.276653259831619e-08
. O 0 6.214450110064718e-08

Complement B-Disease 0 0.000738639326300472
component I-Disease 1 0.9991768002510071
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.0207409079375793e-08
C6D B-Disease 0 1.1450649708422134e-06
) O 0 9.467156836251434e-09
was O 0 2.7663487500717565e-08
diagnosed O 0 4.4480725591711234e-06
in O 0 5.903592059652851e-10
a O 0 8.251430094752266e-10
16 O 0 2.653705921673577e-09
- O 0 1.0766296298925226e-07
year O 0 1.8652119848638904e-08
- O 0 4.54856234455292e-07
old O 0 5.043335136178939e-07
African O 0 4.459906666198776e-09
- O 0 2.611603733271295e-08
American O 0 6.1184279864789914e-09
male O 0 3.533924086696061e-08
with O 0 4.152273902491288e-08
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 0.9999994039535522
. O 0 6.736566433573898e-07

The O 0 1.5936460329157853e-07
patients O 0 7.152637522267469e-07
father O 0 1.4915505275325813e-08
and O 0 1.996428355965918e-09
two O 0 6.317763534546827e-10
brothers O 0 4.86639422092594e-08
also O 0 5.216148402098497e-09
had O 0 2.088538675337759e-09
C6D B-Disease 0 1.8388885791864595e-07
, O 0 6.822989395693924e-11
but O 0 1.2188329512330398e-10
gave O 0 2.41618836049895e-10
no O 0 2.2216387063345167e-10
history O 0 1.1560303825319806e-09
of O 0 8.515096405758982e-10
meningitis B-Disease 1 0.9999876022338867
or O 0 1.505389590761297e-08
other O 0 2.764217832407212e-08
neisserial B-Disease 0 0.00498192198574543
infection I-Disease 0 0.0006716813077218831
. O 0 5.947477461631934e-07

By O 0 1.858975196000756e-08
using O 0 8.251547711779494e-08
exon O 0 3.0256151148932986e-06
- O 0 1.1651666227407986e-06
specific O 0 1.7818152286963596e-08
polymerase O 0 3.0704677556059323e-07
chain O 0 8.006005032257235e-07
reaction O 0 4.222089700078868e-08
( O 0 6.063728963390247e-10
PCR O 0 9.42302307294085e-08
) O 0 8.260704897899984e-10
/ O 0 1.3708347346153005e-08
single O 0 2.437311330538705e-08
- O 0 9.543875876261154e-07
strand O 0 6.958392759770504e-07
conformation O 0 4.05142444037665e-08
polymorphism O 0 8.383057803484917e-08
as O 0 4.872770520414349e-10
a O 0 3.6939085124032545e-10
screening O 0 5.7682685294935254e-09
step O 0 3.3480338501590268e-09
and O 0 1.0715413278905572e-10
nucleotide O 0 3.4644465074507025e-09
sequencing O 0 1.6085441867375039e-09
of O 0 5.003663802738423e-11
target O 0 1.942170424484857e-09
exons O 0 1.3276326704669827e-08
, O 0 5.407220782238653e-10
we O 0 4.10092904079562e-10
determined O 0 6.892565407312645e-10
that O 0 3.4293491657511055e-11
the O 0 6.428141352543548e-11
proband O 0 2.0040906179019657e-07
was O 0 2.5514257373515647e-09
a O 0 4.860360447445089e-10
compound O 0 1.3260585518537482e-08
heterozygote O 0 6.764009299331519e-07
for O 0 1.6231341826156154e-09
two O 0 1.1515767006642363e-08
C6 O 0 6.576269242941635e-06
gene O 0 2.920687393270782e-06
mutations O 0 2.271056655445136e-05
. O 0 5.259449835648411e-07

The O 0 2.7221828347023802e-08
first O 0 7.950219149677196e-09
, O 0 5.047751661102495e-10
1195delC O 0 2.621330175145431e-08
located O 0 8.848659582838536e-10
in O 0 2.6346858028603037e-10
exon O 0 7.925301304112509e-08
7 O 0 1.1842221425695243e-08
, O 0 3.354679867229038e-10
is O 0 1.7967270726781948e-10
a O 0 9.981351162258179e-11
novel O 0 2.6412683151733063e-09
mutation O 0 1.1698721102959553e-08
, O 0 1.2893665302105006e-10
while O 0 4.6287826349633576e-10
the O 0 1.2291563600275168e-10
second O 0 2.480153860062728e-09
, O 0 2.287614264684379e-10
1936delG O 0 1.1010534706201724e-08
in O 0 1.5134173081410296e-10
exon O 0 1.3113195862501925e-08
12 O 0 2.3787756209259214e-09
, O 0 2.217629413436839e-10
has O 0 4.0588687966192083e-10
been O 0 2.1281224005242905e-10
described O 0 4.0737835327320226e-10
before O 0 7.863918960460126e-10
to O 0 1.5877911485606688e-10
cause O 0 1.4012535576313212e-09
C6D B-Disease 0 1.1084583917408963e-07
in O 0 1.6193081597837278e-10
an O 0 9.65996727053664e-11
unrelated O 0 1.4239399881432746e-08
African O 0 1.2953256245396005e-08
- O 0 4.1673220607663097e-07
American O 0 4.453227830936157e-08
individual O 0 3.8624097697947946e-08
. O 0 1.0064600530768075e-07

Both O 0 7.069791649882973e-07
mutations O 0 1.7246893548872322e-05
result O 0 4.992460844732705e-07
in O 0 5.660610113977782e-08
premature O 0 4.621140305971494e-06
termination O 0 1.86604654572875e-06
codons O 0 1.093763239623513e-05
and O 0 2.9929140055173775e-07
C6 O 0 7.162130350479856e-05
null O 0 3.210153226973489e-05
alleles O 0 2.4914999812608585e-05
. O 0 1.9062056253460469e-06

Allele O 0 0.00017464438860770315
- O 0 1.0147994544240646e-05
specific O 0 4.910618045528281e-08
PCR O 0 1.2095633792341687e-06
indicated O 0 2.9664551703945108e-08
that O 0 1.788569015115371e-10
the O 0 1.3388047614970588e-10
probands O 0 1.434265755051456e-07
two O 0 1.679731687076469e-09
brothers O 0 1.389467314538706e-07
also O 0 1.0847609033248773e-08
inherited O 0 7.244891975233259e-08
the O 0 5.871027553006058e-10
1195delC O 0 2.3003674698429677e-07
mutation O 0 6.649263184499432e-08
from O 0 3.028626238688048e-10
their O 0 9.076417395448289e-10
heterozygous O 0 8.022210806757357e-08
mother O 0 6.96842050729174e-08
and O 0 6.054529655408203e-10
the O 0 3.186377273145524e-10
1936delG O 0 2.504365568256617e-07
mutation O 0 5.8668469193889905e-08
from O 0 2.793120457145193e-10
their O 0 2.045378755255456e-09
homozygous O 0 4.437385712208197e-07
father O 0 4.627030847359492e-08
. O 0 2.225007911249577e-08
. O 0 1.625573986530071e-07

PAX6 O 0 0.01566719077527523
mutations O 0 0.0006220662035048008
reviewed O 0 5.1877956138923764e-05
. O 0 7.919006748124957e-06

Mutations O 0 6.09656453889329e-05
in O 0 5.1452236249360794e-08
PAX6 O 0 2.1452060536830686e-06
are O 0 2.19782680943581e-09
responsible O 0 1.9530621564456396e-09
for O 0 1.5527801267012364e-10
human O 0 6.892131865221529e-10
aniridia B-Disease 1 1.0
and O 0 5.678298276023952e-09
have O 0 7.525963185983642e-10
also O 0 2.5390647917511444e-10
been O 0 3.3558958389967586e-10
found O 0 2.754961536677314e-10
in O 0 3.537130310871106e-10
patients O 0 1.0673161021657052e-08
with O 0 2.4868518355702918e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 5.561305194135002e-09
with O 0 1.4593044994626325e-08
congenital B-Disease 1 0.9999992847442627
cataracts I-Disease 1 0.9999890327453613
, O 0 2.2762872475823315e-08
with O 0 3.406738713351842e-08
autosomal B-Disease 1 0.9919812679290771
dominant I-Disease 1 0.6775771379470825
keratitis I-Disease 1 0.9996374845504761
, O 0 2.5325475050408386e-08
and O 0 8.468631129687765e-09
with O 0 2.6023252885920556e-08
isolated B-Disease 0 0.3941754102706909
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 2.7495359972817823e-05

No O 0 5.412415475802845e-07
locus O 0 7.288572305697016e-07
other O 0 3.277245363975112e-09
than O 0 2.635230034186975e-09
chromosome O 0 3.9439424881493323e-07
11p13 O 0 1.0369177516622585e-06
has O 0 7.667454227089365e-09
been O 0 4.6481867244096975e-09
implicated O 0 1.9353560531953917e-08
in O 0 2.5712210138806313e-09
aniridia B-Disease 1 1.0
, O 0 2.0929851185513826e-09
and O 0 9.894297603452173e-10
PAX6 O 0 4.256738748154021e-07
is O 0 1.4449319518661241e-09
clearly O 0 1.675041327864335e-09
the O 0 6.599308599586351e-11
major O 0 1.7939508767383927e-09
, O 0 3.178953489335612e-10
if O 0 3.2014748629904943e-09
not O 0 3.960521632873082e-10
only O 0 1.9651980043278172e-10
, O 0 6.851971212640251e-10
gene O 0 8.789039185330694e-08
responsible O 0 2.499922686638456e-07
. O 0 6.010897095620749e-07

Twenty O 0 1.0927684570560814e-06
- O 0 1.3635583854920696e-05
eight O 0 3.945943305438959e-08
percent O 0 9.473102835499958e-08
of O 0 3.677016746639339e-10
identified O 0 6.938527263855576e-08
PAX6 O 0 4.111571797693614e-06
mutations O 0 7.09429571088549e-07
are O 0 1.1885034290060048e-08
C O 0 6.621775355597492e-06
- O 0 0.003958869259804487
T O 0 1.039578091877047e-05
changes O 0 9.396027067509749e-09
at O 0 1.2012402184069515e-09
CpG O 0 7.255692224816812e-08
dinucleotides O 0 1.3134803111825022e-07
, O 0 7.440383309464949e-10
20 O 0 3.186328978443953e-10
% O 0 4.7002027270259816e-11
are O 0 1.40125220454701e-11
splicing O 0 2.4606853443742693e-08
errors O 0 1.4915762847067526e-08
, O 0 7.181156364000074e-11
and O 0 2.2220400866523882e-11
more O 0 7.330390634774364e-12
than O 0 4.291093869124296e-10
30 O 0 1.3404970466979194e-09
% O 0 2.4770610562718787e-10
are O 0 2.1470072941731644e-10
deletion O 0 5.5319294034461564e-08
or O 0 6.517233419600643e-09
insertion O 0 1.5720392809726036e-07
events O 0 1.1066290284134084e-07
. O 0 3.7190235957496043e-07

There O 0 2.4113805352499185e-07
is O 0 6.149174058833751e-09
a O 0 4.372476158920335e-09
noticeably O 0 2.3523331549313298e-07
elevated O 0 3.0189119115675567e-07
level O 0 1.3735593107355726e-08
of O 0 1.706358387920659e-10
mutation O 0 1.720924558412662e-08
in O 0 5.07541009220347e-10
the O 0 1.870072569021275e-10
paired O 0 1.4263047631857262e-08
domain O 0 2.529050968647084e-09
compared O 0 1.7468777535611935e-09
with O 0 6.759377085829854e-11
the O 0 2.7511126710066947e-10
rest O 0 2.902814211225291e-09
of O 0 7.769659221557035e-11
the O 0 2.2601189808568733e-09
gene O 0 5.490052217282937e-07
. O 0 5.210960694057576e-07

Increased O 0 1.1923654028578312e-06
mutation O 0 1.6380187162212678e-06
in O 0 5.497688526645561e-09
the O 0 1.4778860357722579e-09
homeodomain O 0 6.002476311550708e-07
is O 0 1.001396410238442e-09
accounted O 0 5.878224573763191e-09
for O 0 7.678905428187832e-11
by O 0 3.3093416895724204e-10
the O 0 6.47918252383306e-09
hypermutable O 0 8.011145837372169e-06
CpG O 0 7.4690078690764494e-06
dinucleotide O 0 1.0706643479352351e-05
in O 0 6.06061192343077e-08
codon O 0 4.607089522323804e-06
240 O 0 5.743043516304169e-07
. O 0 3.2748920375524904e-07

Very O 0 6.325799972728419e-08
nearly O 0 1.2113251735001995e-08
all O 0 7.12255865398248e-10
mutations O 0 1.6343216557856977e-08
appear O 0 5.786163992382853e-09
to O 0 1.7368906313208754e-09
cause O 0 1.6200173647007432e-08
loss O 0 5.2001578154659e-08
of O 0 2.9530936723753953e-11
function O 0 1.3212205773882602e-09
of O 0 2.156634766603549e-11
the O 0 1.2522476111609393e-10
mutant O 0 2.0595042116156037e-08
allele O 0 1.8687657643567945e-08
, O 0 5.828647980932189e-11
and O 0 1.999741865155169e-11
more O 0 1.50012190169857e-11
than O 0 1.2659312487173224e-10
80 O 0 5.753519327633683e-10
% O 0 1.8313676963810366e-10
of O 0 4.2645251913109306e-11
exonic O 0 1.962209807970794e-07
substitutions O 0 4.858187097056543e-08
result O 0 3.0417069751820236e-08
in O 0 9.767192388210333e-09
nonsense O 0 2.1895637019042624e-06
codons O 0 6.830825441284105e-06
. O 0 5.673883265444601e-07

In O 0 6.570819266471517e-08
a O 0 3.0646263304845434e-09
gene O 0 1.840902541516698e-08
with O 0 2.1993690202393168e-10
such O 0 1.0011098616757863e-09
extraordinarily O 0 2.352059453869515e-07
high O 0 5.3517577924822035e-08
sequence O 0 1.1983505743273781e-08
conservation O 0 1.3823526767708927e-09
throughout O 0 6.85317358417592e-10
evolution O 0 5.271646452698064e-10
, O 0 3.3456573622636654e-10
there O 0 4.725229652002838e-10
are O 0 1.6350690801303358e-09
presumed O 0 7.636966188329097e-07
undiscovered O 0 1.5595434888382442e-05
missense O 0 5.238662652118364e-06
mutations O 0 6.833202519374026e-07
, O 0 3.777477219912839e-10
these O 0 1.6829151960884303e-10
are O 0 2.1569403207966076e-10
hypothesized O 0 4.185381818899714e-09
to O 0 2.6676144626591736e-10
exist O 0 3.805879167373405e-09
in O 0 3.9966202569630127e-10
as O 0 1.1385122178353413e-08
- O 0 0.0003313954803161323
yet O 0 8.767153758526547e-07
unidentified O 0 1.060958993548411e-06
phenotypes O 0 3.760401341423858e-07
. O 0 1.4506376544431987e-08
. O 0 1.2054644571435347e-07

Genetic O 0 4.904432353214361e-05
heterogeneity O 0 1.9610344679676928e-05
and O 0 6.454306600289783e-08
penetrance O 0 2.027150912908837e-06
analysis O 0 6.102323624190831e-08
of O 0 5.929931545800571e-10
the O 0 4.749194371100884e-09
BRCA1 O 0 1.4316804481495637e-05
and O 0 6.454257572841016e-08
BRCA2 O 0 7.2764360083965585e-06
genes O 0 9.392426818521926e-07
in O 0 2.3739728760574508e-07
breast B-Disease 1 0.9995500445365906
cancer I-Disease 0 0.0696883350610733
families O 0 1.0940071888398961e-06
. O 0 6.550310445163632e-07

The O 0 4.6984543587313965e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.00026490050368011
Consortium O 0 4.4417458411771804e-05
. O 0 3.61056049769104e-06

The O 0 2.1171770114847277e-08
contribution O 0 3.2348246747915255e-08
of O 0 1.5020042987146098e-09
BRCA1 O 0 1.4227393876353744e-06
and O 0 1.2010598737788314e-08
BRCA2 O 0 1.4612321137974504e-05
to O 0 4.0722190419728577e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 8.848109587233921e-07
assessed O 0 3.705866546965808e-08
by O 0 4.830609801054209e-10
linkage O 0 3.1965345215212437e-07
and O 0 8.15146083965601e-09
mutation O 0 2.88511383672585e-08
analysis O 0 3.5955762811568093e-09
in O 0 2.275039184818084e-10
237 O 0 1.4017668137356054e-09
families O 0 2.777999219549798e-10
, O 0 1.895832449361201e-11
each O 0 4.015774518473236e-11
with O 0 4.7775720879439376e-11
at O 0 5.114944023887347e-10
least O 0 1.194893906042438e-10
four O 0 2.8458854717250404e-10
cases O 0 7.580278627017378e-09
of O 0 2.32191221805067e-09
breast B-Disease 1 0.9850563406944275
cancer I-Disease 0 1.520299406365666e-06
, O 0 3.491881783723727e-11
collected O 0 1.0042112974506523e-10
by O 0 1.7719046230268987e-09
the O 0 2.0284647689550184e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 3.7272409826982766e-05
Consortium O 0 4.960472324455623e-06
. O 0 5.541623409044405e-07

Families O 0 3.802928461027477e-07
were O 0 1.9476606993862333e-09
included O 0 3.045616536745399e-10
without O 0 4.560698485533976e-10
regard O 0 3.822114291729406e-10
to O 0 5.393281654608728e-11
the O 0 8.60978094374687e-11
occurrence O 0 1.7640593341639033e-07
of O 0 4.842549472527935e-09
ovarian B-Disease 0 0.05502806231379509
or I-Disease 0 5.595729035690056e-08
other I-Disease 0 1.1089785800777463e-07
cancers I-Disease 1 0.9813226461410522
. O 0 7.069266416692699e-07

Overall O 0 4.751152664539404e-05
, O 0 1.3740839222009527e-07
disease O 0 7.179714316407626e-07
was O 0 5.7170406186912714e-09
linked O 0 9.366399922328128e-08
to O 0 1.372453484194125e-09
BRCA1 O 0 1.6177762063307455e-07
in O 0 3.053562125376885e-10
an O 0 1.1449306780431101e-10
estimated O 0 1.7116529305027939e-09
52 O 0 7.836612248013353e-09
% O 0 4.125650099329192e-10
of O 0 2.6382398002344765e-11
families O 0 4.881635651265981e-10
, O 0 6.789056122835646e-11
to O 0 2.905676532716228e-10
BRCA2 O 0 8.914685167837888e-08
in O 0 5.220345822287698e-10
32 O 0 1.433113294702082e-09
% O 0 1.303249452799804e-10
of O 0 1.881588808372303e-11
families O 0 6.2929295108205e-10
, O 0 2.2174602432034618e-10
and O 0 2.8707453081366907e-10
to O 0 1.2524840886651845e-10
neither O 0 2.7005129243917736e-09
gene O 0 7.346077968151121e-09
in O 0 1.2651184544409944e-09
16 O 0 2.095705609050924e-09
% O 0 2.6215227211245917e-10
( O 0 1.3000318876965622e-10
95 O 0 4.176896162277899e-09
% O 0 7.051192074669643e-09
confidence O 0 5.419486228674941e-07
interval O 0 1.8378192123691406e-07
[ O 0 5.67448985577812e-08
CI O 0 3.9155983699856733e-07
] O 0 1.716164987897173e-08
6 O 0 5.057632090910147e-09
% O 0 1.2967091844728884e-09
- O 0 2.7746773412218317e-06
28 O 0 1.0949257500669773e-08
% O 0 3.953910254761439e-10
) O 0 1.372421343237562e-10
, O 0 8.71612365616059e-11
suggesting O 0 1.5032290079375343e-08
other O 0 5.97377702860058e-09
predisposition O 0 7.48469176414801e-07
genes O 0 1.0912073094004882e-06
. O 0 6.716231837344822e-07

The O 0 9.185097127328845e-08
majority O 0 2.0108525689011003e-07
( O 0 3.1730000848995132e-09
81 O 0 9.519559363013741e-09
% O 0 5.622791676707095e-10
) O 0 1.7867583801400855e-10
of O 0 6.370749761064332e-11
the O 0 2.0787719279269368e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.2479926425612575e-08
were O 0 1.551623274309577e-09
due O 0 1.1753735762454198e-09
to O 0 3.309872098622435e-10
BRCA1 O 0 9.383422394648733e-08
, O 0 9.294099517775933e-11
with O 0 3.2075592182323476e-11
most O 0 5.204617847809345e-10
others O 0 3.733933162664016e-09
( O 0 3.762326838963048e-10
14 O 0 1.364487300925532e-09
% O 0 9.771138342884456e-10
) O 0 1.389527048978323e-09
due O 0 1.0645185177793337e-08
to O 0 2.7007359904018813e-08
BRCA2 O 0 7.300038123503327e-05
. O 0 7.986354262357054e-07

Conversely O 0 1.939008825502242e-06
, O 0 3.8918033240520344e-09
the O 0 2.994889336527251e-10
majority O 0 4.066232239807732e-09
of O 0 7.278566638291295e-11
families O 0 7.1808858859157e-10
with O 0 1.9149348773339625e-10
male B-Disease 0 2.49648451244866e-07
and I-Disease 0 2.95939663885747e-08
female I-Disease 0 1.177704780275235e-05
breast I-Disease 1 0.9524718523025513
cancer I-Disease 0 0.001245716237463057
were O 0 3.8969654170273316e-09
due O 0 5.592696084022464e-09
to O 0 4.915863716092872e-09
BRCA2 O 0 2.904759867305984e-06
( O 0 2.697419176911353e-09
76 O 0 4.6482870885711236e-08
% O 0 5.596889618431078e-09
) O 0 1.9963758646213137e-08
. O 0 2.5158129801639006e-07

The O 0 3.115823332677792e-08
largest O 0 7.443995997391539e-08
proportion O 0 7.206495666878254e-08
( O 0 8.70967964416991e-10
67 O 0 3.5282583521478728e-09
% O 0 2.826928691135322e-10
) O 0 1.341673022681178e-10
of O 0 7.483903774474499e-11
families O 0 2.469565885121483e-09
due O 0 5.908190825465454e-09
to O 0 1.9601406608948935e-10
other O 0 1.5082504689623022e-10
genes O 0 2.5299773387388313e-09
was O 0 6.810826569392248e-09
found O 0 6.849318889834421e-10
in O 0 1.0417041534926952e-10
families O 0 1.6131058988566593e-10
with O 0 2.6884123399684157e-11
four O 0 1.8096175946613613e-10
or O 0 6.763158921785362e-10
five O 0 2.804736998207602e-10
cases O 0 1.280805461689738e-09
of O 0 8.218052904851447e-10
female O 0 0.00037304640864022076
breast B-Disease 1 0.993676483631134
cancer I-Disease 0 6.64906037854962e-05
only O 0 9.753267526946274e-09
. O 0 1.7821763265146728e-07

These O 0 2.5000172598765857e-08
estimates O 0 4.4058733550400575e-08
were O 0 3.3211557948220616e-09
not O 0 1.022487983171061e-09
substantially O 0 1.6472622377250445e-08
affected O 0 1.3956361621936253e-09
either O 0 1.6658135981728606e-10
by O 0 1.5639323169835961e-10
changing O 0 3.02645233318799e-08
the O 0 1.0365455160865622e-09
assumed O 0 7.710030303087478e-08
penetrance O 0 3.38047925652063e-07
model O 0 1.453817599639251e-08
for O 0 3.2781941050608054e-10
BRCA1 O 0 6.479135805648184e-08
or O 0 6.942373342866404e-10
by O 0 3.475827611842952e-11
including O 0 4.984862522761091e-10
or O 0 3.448507257530764e-08
excluding O 0 6.276240583247272e-06
BRCA1 O 0 5.1249877287773415e-05
mutation O 0 3.3553733373992145e-06
data O 0 8.895718792700791e-07
. O 0 5.097944040244329e-07

Among O 0 8.03251509751135e-08
those O 0 1.0337049438646773e-08
families O 0 2.8906039784004633e-09
with O 0 3.867103970378594e-09
disease O 0 4.900695671494759e-07
due O 0 4.860742919277072e-09
to O 0 2.9680935487164106e-10
BRCA1 O 0 1.9598591904923524e-07
that O 0 2.0551620127928771e-10
were O 0 1.8371124066440814e-10
tested O 0 7.987361883010635e-10
by O 0 1.4412420909493129e-11
one O 0 1.1995499038519597e-10
of O 0 7.0040262652171226e-12
the O 0 5.558606352984441e-11
standard O 0 3.186409358590936e-09
screening O 0 2.0689208124480274e-09
methods O 0 5.1225623742823245e-09
, O 0 1.657004117250338e-10
mutations O 0 9.620169549862112e-09
were O 0 6.012422226753245e-10
detected O 0 2.6311530731959465e-08
in O 0 5.701433214433393e-10
the O 0 4.939961217864663e-10
coding O 0 1.4683791960123926e-07
sequence O 0 5.253651291781125e-09
or O 0 7.138388768979098e-10
splice O 0 5.934973401622301e-08
sites O 0 4.829580291243474e-09
in O 0 1.246269198951211e-10
an O 0 5.853358076013393e-11
estimated O 0 2.6905080385830615e-09
63 O 0 1.4105134837905098e-08
% O 0 8.673076701271043e-10
( O 0 2.3784796354675564e-10
95 O 0 5.769732247529191e-09
% O 0 4.860075453194668e-09
CI O 0 1.0338548008803627e-06
51 O 0 7.214554642587245e-08
% O 0 1.5312791035171358e-08
- O 0 0.00015314316260628402
77 O 0 8.494632908195854e-08
% O 0 1.130255622427967e-08
) O 0 1.1837795632629877e-08
. O 0 9.241523457603762e-08

The O 0 3.186586994274876e-08
estimated O 0 8.522541783406723e-09
sensitivity O 0 4.079377902144188e-08
was O 0 2.0899575403632298e-09
identical O 0 2.164458390296886e-09
for O 0 3.394727207672865e-11
direct O 0 1.9457882527440518e-10
sequencing O 0 2.9534688028576284e-09
and O 0 7.130115942111104e-10
other O 0 4.33987096259969e-10
techniques O 0 3.8613941910625726e-07
. O 0 2.0256695165699057e-07

The O 0 1.0036573883098754e-07
penetrance O 0 7.075632765918272e-06
of O 0 6.111313233247984e-09
BRCA2 O 0 3.4259530821145745e-06
was O 0 3.945775706171162e-09
estimated O 0 5.407210235119919e-10
by O 0 3.847135388035383e-10
maximizing O 0 8.775086968171308e-08
the O 0 4.981367762724176e-09
LOD O 0 0.07202667742967606
score O 0 3.090478983835965e-08
in O 0 3.727386843621616e-09
BRCA2 O 0 2.0018487703055143e-05
- O 0 2.816464075294789e-06
mutation O 0 1.4318057139917073e-07
families O 0 1.4335205245075144e-09
, O 0 1.3435783041693128e-10
over O 0 4.3695400075982604e-10
all O 0 9.586315075083007e-10
possible O 0 3.7089993298877744e-08
penetrance O 0 2.9932987217762275e-06
functions O 0 2.2807469690633297e-07
. O 0 5.811494361296354e-07

The O 0 1.8016841352164192e-08
estimated O 0 2.299498014224355e-08
cumulative O 0 2.232839477755988e-07
risk O 0 3.6964113405701937e-06
of O 0 2.939418930480997e-09
breast B-Disease 0 0.3640464246273041
cancer I-Disease 0 0.000296869344310835
reached O 0 4.1689865781791013e-08
28 O 0 7.833996562567336e-09
% O 0 5.879970399469414e-10
( O 0 1.7729145929124002e-10
95 O 0 3.538940696046211e-09
% O 0 4.969050060310565e-09
CI O 0 9.401101124240085e-07
9 O 0 4.572520140300185e-09
% O 0 1.4957691751860125e-09
- O 0 5.992918090669264e-07
44 O 0 2.5844029138966107e-09
% O 0 1.4844253604096025e-10
) O 0 2.7271362251779507e-11
by O 0 4.879482928821233e-11
age O 0 2.1919992487795525e-09
50 O 0 3.154750072287271e-10
years O 0 1.6929705415336116e-09
and O 0 7.239470689590632e-10
84 O 0 2.3388473380236974e-09
% O 0 2.9233207521350835e-10
( O 0 7.29908702923332e-11
95 O 0 2.0331889505342815e-09
% O 0 1.9640749027161064e-09
CI O 0 4.2115658516195253e-07
43 O 0 1.441046393324541e-08
% O 0 2.894774864259375e-09
- O 0 3.9924651673572953e-07
95 O 0 7.308845972886502e-09
% O 0 6.384741624287926e-10
) O 0 1.296639323689064e-10
by O 0 3.5794259223287384e-10
age O 0 2.8956378628208768e-08
70 O 0 7.366506959982644e-09
years O 0 4.208100889968591e-08
. O 0 1.2249967085153912e-07

The O 0 5.682081791746896e-07
corresponding O 1 0.8527718782424927
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 0.3848259150981903
were O 0 2.2710267444381316e-08
0 O 0 1.223354075818861e-07
. O 0 1.6341914488293696e-07

4 O 0 9.737543678056682e-07
% O 0 2.9427472014731393e-08
( O 0 1.645823144436065e-09
95 O 0 1.8894386499823668e-08
% O 0 9.959149060989603e-09
CI O 0 1.7513943930680398e-06
0 O 0 1.380266745343306e-08
% O 0 4.281400123318235e-09
- O 0 2.1455948626680765e-06
1 O 0 1.1955379797257137e-08
% O 0 2.5781243806477505e-10
) O 0 2.213592503741424e-11
by O 0 3.1267249206434755e-11
age O 0 7.246212518907669e-10
50 O 0 1.2553612316335006e-10
years O 0 5.461054941591215e-10
and O 0 7.742945173916382e-10
27 O 0 1.886384159988097e-09
% O 0 1.5366286021389897e-10
( O 0 7.840925131397114e-11
95 O 0 2.086488093411276e-09
% O 0 1.012045558468344e-09
CI O 0 2.143000585874688e-07
0 O 0 6.8178969137022705e-09
% O 0 2.822097666665968e-09
- O 0 1.0125887683898327e-06
47 O 0 3.5112080354338104e-08
% O 0 5.286558413253317e-10
) O 0 1.437925889469227e-10
by O 0 3.8231059984461524e-10
age O 0 2.000278875868844e-08
70 O 0 5.870381514228029e-09
years O 0 1.9976138077026917e-08
. O 0 1.3265447762478288e-07

The O 0 7.484899811061041e-08
lifetime O 0 2.356523737034877e-06
risk O 0 7.130092853913084e-06
of O 0 5.9257518891797645e-09
breast B-Disease 1 0.9537742733955383
cancer I-Disease 0 7.206414738902822e-05
appears O 0 1.1302448754690886e-08
similar O 0 1.2978820240761024e-09
to O 0 1.4821204263881782e-09
the O 0 2.974759993890075e-09
risk O 0 6.512165668937087e-07
in O 0 6.552653419866772e-10
BRCA1 O 0 2.3652137315366417e-07
carriers O 0 3.5379976282001735e-08
, O 0 1.349691192142899e-10
but O 0 1.232575153053972e-09
there O 0 1.62964780558994e-10
was O 0 3.964187311744638e-10
some O 0 2.25713562423957e-11
suggestion O 0 2.925955033816763e-09
of O 0 1.1372371100382139e-10
a O 0 9.66972812932454e-09
lower O 0 2.9798280593240634e-05
risk O 0 7.530790298915235e-06
in O 0 5.672052605376621e-09
BRCA2 O 0 3.4984248031832976e-06
carriers O 0 8.991340649799895e-08
< O 0 2.837573909175717e-08
50 O 0 1.4624969013610212e-09
years O 0 2.163748513694941e-09
of O 0 4.874797232545802e-10
age O 0 5.6819633442728446e-08
. O 0 9.366042519332041e-08

Eye B-Disease 1 0.9956188797950745
movement I-Disease 0 1.9866947695845738e-05
abnormalities I-Disease 0 0.000650943664368242
correlate O 0 5.462039212034142e-07
with O 0 1.7787320061302125e-08
genotype O 0 6.414228118956089e-05
in O 0 1.0437958763986899e-07
autosomal O 1 0.9073724150657654
dominant O 0 0.4699537456035614
cerebellar B-Disease 0 0.14093278348445892
ataxia I-Disease 1 0.9991231560707092
type I-Disease 1 0.9999933242797852
I I-Disease 1 0.635751485824585
. O 0 1.8156715668737888e-06

We O 0 2.3495849745813757e-06
compared O 0 3.1922755283630977e-07
horizontal O 0 2.3337843231274746e-05
eye O 1 0.9724072217941284
movements O 0 1.982905450859107e-05
( O 0 2.773713703163594e-08
visually O 0 4.164417930496711e-07
guided O 0 2.873099163025472e-07
saccades O 0 4.977408934792038e-06
, O 0 6.172887534461324e-09
antisaccades O 0 1.5297032973649038e-07
, O 0 8.68194793834931e-10
and O 0 5.43085909576746e-10
smooth O 0 1.5805893482934152e-08
pursuit O 0 5.974999339741771e-08
) O 0 2.009072241904164e-09
in O 0 4.9959042458525e-10
control O 0 4.8701643606818834e-08
subjects O 0 4.608420312024464e-08
( O 0 4.1851080934129925e-10
n O 0 8.333874745858338e-08
= O 0 9.598599604032643e-08
14 O 0 6.611760028363278e-10
) O 0 1.5550918885942622e-10
and O 0 1.6789716839049618e-10
patients O 0 5.06646391507104e-10
with O 0 7.638016087663235e-12
three O 0 1.4600379238949301e-10
forms O 0 4.978650824938313e-09
of O 0 4.134364406382929e-09
autosomal O 1 0.8704777956008911
dominant O 0 0.0692671537399292
cerebellar B-Disease 0 0.0006268697907216847
ataxias I-Disease 0 0.0009970199316740036
type I-Disease 0 0.002719924319535494
I I-Disease 0 2.4909986677812412e-06
spinocerebellar B-Disease 0 4.916035322821699e-05
ataxias I-Disease 0 1.820695433707442e-05
1 I-Disease 0 4.64349305673295e-08
and I-Disease 0 5.815106174367202e-09
2 I-Disease 0 7.332303209039992e-09
( O 0 1.569006258250738e-09
SCA1 B-Disease 0 9.53145047333237e-07
, O 0 2.1938688643530213e-09
n O 0 2.8365329285406915e-07
= O 0 1.889864620352455e-07
11 O 0 3.2423528306679827e-09
; O 0 9.32446786450214e-10
SCA2 B-Disease 0 1.7821864162215206e-07
, O 0 5.762327281999546e-10
n O 0 6.774358496386412e-08
= O 0 6.362451898667132e-08
10 O 0 7.818140024262732e-10
) O 0 7.063303275600674e-10
and O 0 7.38890904017353e-09
SCA3 B-Disease 1 1.0
/ O 0 9.310290920439002e-07
Machado B-Disease 0 8.954643817560282e-07
- I-Disease 0 4.036410246044397e-06
Joseph I-Disease 0 2.0169825347693404e-06
disease I-Disease 0 5.0418766477378085e-06
( O 0 6.230588933675563e-09
MJD B-Disease 1 0.9999998807907104
) O 0 6.561436727281489e-09
( O 0 4.962522059948071e-10
n O 0 2.4330296355401515e-07
= O 0 1.1755286095649353e-06
16 O 0 2.10825525925884e-08
) O 0 8.9389269319895e-09
. O 0 6.774784822027868e-08

In O 0 2.501169831248262e-07
SCA1 B-Disease 0 4.153912414039951e-06
, O 0 5.15000264655896e-09
saccade O 0 1.188607598123781e-06
amplitude O 0 8.031795317720025e-08
was O 0 2.276908084297702e-08
significantly O 0 3.000100790018223e-08
increased O 0 1.7685561459757082e-08
, O 0 3.444515339623422e-09
resulting O 0 4.633557182387449e-08
in O 0 1.2294389506450898e-08
hypermetria B-Disease 0 9.34796753426781e-06
. O 0 3.620241955104575e-07

The O 0 7.623999920269853e-08
smooth O 0 5.157594387128484e-07
pursuit O 0 1.1727337323463871e-06
gain O 0 2.375853728153743e-05
was O 0 9.060898378265847e-07
decreased O 0 6.022451543685747e-06
. O 0 6.225809556781314e-07

In O 0 3.075731171975349e-07
SCA2 B-Disease 0 8.399930266023148e-06
, O 0 1.072730615447881e-08
saccade O 0 3.062672703890712e-06
velocity O 0 1.0427128245282802e-06
was O 0 2.3364590617802605e-07
markedly O 0 3.07123082166072e-06
decreased O 0 1.611039442650508e-05
. O 0 1.7837587620306294e-06

The O 0 1.7868998725134588e-08
percentage O 0 8.576375165603167e-08
of O 0 1.2216117006857985e-10
errors O 0 7.548652369848696e-09
in O 0 7.156275017017322e-10
antisaccades O 0 3.2410906669610995e-07
was O 0 5.583401740949512e-09
greatly O 0 1.2842057417472574e-09
increased O 0 1.6202792441077918e-09
and O 0 1.2050933584362156e-09
was O 0 2.35268582393644e-09
significantly O 0 3.990056729463731e-09
correlated O 0 5.4033262308905705e-09
with O 0 1.0686396212378213e-09
age O 0 1.1274291011886817e-07
at O 0 1.1102887498282143e-07
disease O 0 1.6365681858587777e-06
onset O 0 1.0529473001952283e-05
. O 0 1.231027340509172e-06

In O 0 2.3085025446789587e-08
addition O 0 8.592170530619114e-09
, O 0 8.051911359885366e-10
a O 0 4.22535617605746e-10
correlation O 0 3.1161324187678474e-08
between O 0 1.97756988562503e-09
smooth O 0 2.2569022206653244e-08
pursuit O 0 9.192650907152711e-08
gain O 0 2.51639880843868e-06
and O 0 1.4277192761369406e-09
the O 0 2.7744623265490986e-10
number O 0 1.5769809902366205e-09
of O 0 1.5695750255062535e-09
trinucleotide O 0 6.878302883706056e-06
repeats O 0 9.87519342743326e-07
was O 0 6.989852607830471e-08
found O 0 2.7371774180551256e-08
. O 0 1.8295303050308576e-07

In O 0 1.1014063829861698e-06
SCA3 B-Disease 1 0.9999996423721313
, O 0 4.2248526455068713e-08
gaze B-Disease 0 2.4917542759794742e-05
- I-Disease 0 1.4997562175267376e-05
evoked I-Disease 0 7.494599003621261e-07
nystagmus I-Disease 0 1.0336977538827341e-05
was O 0 1.6455414808547175e-08
often O 0 1.0032737973730832e-09
present O 0 2.564098933177661e-10
as O 0 6.9811462166669e-10
was O 0 4.612656923086433e-09
saccade O 0 4.1460626221123675e-07
hypometria O 0 4.784702127835772e-07
and O 0 2.7678568326194863e-09
smooth O 0 4.173187306832915e-08
pursuit O 0 3.1778597531229025e-07
gain O 0 7.801494575687684e-06
was O 0 2.973594064314966e-07
markedly O 0 1.7304948869423242e-06
decreased O 0 3.1075462629814865e-06
. O 0 4.234744039877114e-07

Three O 0 3.6005266679239867e-07
major O 0 2.866035799797828e-07
criteria O 0 1.73011088122621e-07
, O 0 2.188135228564647e-09
saccade O 0 7.956643912621075e-07
amplitude O 0 4.354468430278757e-08
, O 0 2.78015299670642e-09
saccade O 0 6.19310412730556e-07
velocity O 0 1.375801588210379e-07
, O 0 1.3062664283580716e-09
and O 0 5.581120565700814e-10
presence O 0 7.130582346803749e-09
of O 0 4.2523601306854175e-10
gaze B-Disease 0 0.008612355217337608
- I-Disease 0 5.427715586847626e-05
evoked I-Disease 0 3.4479816690691223e-07
nystagmus I-Disease 0 5.050010258855764e-07
, O 0 3.1978480974359513e-10
permitted O 0 6.409413000341146e-10
the O 0 7.266166140995622e-11
correct O 0 1.3198359738453291e-08
assignment O 0 9.905214426453313e-09
of O 0 3.7167057626019684e-11
90 O 0 4.450727009164268e-10
% O 0 1.268198185355729e-10
of O 0 1.1454391254939189e-11
the O 0 3.099909773318643e-10
SCA1 B-Disease 0 5.031282057643693e-07
, O 0 4.2431078095539476e-10
90 O 0 4.841993472837203e-10
% O 0 1.3692001699094902e-10
of O 0 1.753378518765114e-11
the O 0 2.0884978468860282e-10
SCA2 B-Disease 0 5.146293915458955e-07
, O 0 3.8277464531333294e-10
and O 0 3.224392419731714e-10
93 O 0 6.851134659591196e-10
% O 0 1.5132498032421893e-10
of O 0 1.1228794803697095e-11
the O 0 7.379694078046839e-10
patients O 0 1.668604099336335e-08
with O 0 4.328727098990015e-10
SCA3 B-Disease 1 1.0
to O 0 1.8291275161175236e-09
their O 0 1.0279535000989881e-09
genetically O 0 1.2918615510670861e-08
confirmed O 0 5.7142855780512036e-08
patient O 0 2.9199412665548152e-08
group O 0 8.8032123812809e-09
and O 0 9.705182213437524e-10
, O 0 2.69445604716978e-10
therefore O 0 6.595323176483703e-10
, O 0 5.025838079042444e-10
may O 0 7.768630183591085e-09
help O 0 4.434798306363064e-09
orient O 0 3.0264669703683467e-07
diagnoses O 0 5.028279019825277e-07
of O 0 1.3219964012378682e-10
SCA1 B-Disease 0 3.194023747710162e-07
, O 0 4.832618749617268e-10
SCA2 B-Disease 0 1.1130515531476703e-07
, O 0 2.7764102128458035e-10
and O 0 2.465019965924853e-09
SCA3 B-Disease 1 1.0
at O 0 2.9701789916458665e-09
early O 0 5.896584553966022e-09
clinical O 0 9.346358353923279e-08
stages O 0 3.694264805176317e-08
of O 0 3.6297997940692994e-10
the O 0 1.2328627008173498e-08
diseases O 0 1.7711945474729873e-06
. O 0 1.2217459044450152e-08
. O 0 1.7923618145232467e-07

Genetic O 0 4.208874088362791e-06
basis O 0 4.748780213503778e-08
and O 0 8.059060085940928e-09
molecular O 0 5.183541702535877e-07
mechanism O 0 6.284829851210816e-06
for O 0 1.3647449122800026e-05
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999988079071045
fibrillation I-Disease 1 1.0
. O 0 9.07468274817802e-05

Ventricular B-Disease 0 0.04544606804847717
fibrillation I-Disease 0 0.005523924250155687
causes O 0 2.518986832455994e-07
more O 0 7.610553853787394e-10
than O 0 4.994827329518614e-10
300 O 0 6.114365125320376e-10
, O 0 2.76298151025145e-10
000 O 0 3.1103233322227197e-09
sudden O 0 1.2527337389656168e-08
deaths O 0 4.563711630822809e-09
each O 0 1.7681909270095275e-09
year O 0 7.3040515857769606e-09
in O 0 3.1436617198288275e-10
the O 0 1.919023606689052e-09
USA O 0 8.216562150664686e-07
alone O 0 1.224485117745644e-07
. O 0 7.485999020673262e-08

In O 0 2.951758304448049e-08
approximately O 0 6.498118043651857e-09
5 O 0 8.904195603065546e-09
- O 0 6.454355911955645e-07
12 O 0 3.1628490937407605e-09
% O 0 1.2157588824557308e-10
of O 0 1.869467905132871e-12
these O 0 3.110254762073161e-11
cases O 0 7.402447543825019e-10
, O 0 5.934160801635002e-11
there O 0 5.003015363103103e-11
are O 0 9.726692368206002e-11
no O 0 1.3058180092784255e-09
demonstrable O 0 2.237747594335815e-06
cardiac O 0 2.375674284849083e-06
or O 0 1.8937741685931542e-07
non O 1 0.8223661184310913
- O 1 0.8523393273353577
cardiac O 0 5.2378589316504076e-05
causes O 0 4.151369470406507e-09
to O 0 9.170380427248048e-11
account O 0 4.926524188597625e-10
for O 0 3.2996400750606725e-11
the O 0 2.98797236952808e-11
episode O 0 4.736583569808772e-09
, O 0 1.4371061285434195e-10
which O 0 1.4114243107599123e-10
is O 0 1.351726508502793e-10
therefore O 0 6.835315646824824e-10
classified O 0 2.004949095635311e-07
as O 0 4.825089945370564e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999822378158569
fibrillation I-Disease 1 1.0
( O 0 3.081035174545832e-06
IVF B-Disease 1 1.0
) O 0 1.0439426887387526e-06
. O 0 6.821528018008394e-07

A O 0 1.662418185333081e-07
distinct O 0 1.713915338541483e-07
group O 0 2.2579140335210468e-08
of O 0 7.698149340207294e-10
IVF B-Disease 1 1.0
patients O 0 4.1023049561772496e-05
has O 0 4.3332226695724785e-09
been O 0 1.4019807537124507e-09
found O 0 2.7368821098328056e-10
to O 0 6.520608358817626e-11
present O 0 1.3246390095922322e-10
with O 0 2.2289901868699502e-10
a O 0 2.8205855429064286e-09
characteristic O 0 6.665999308097525e-07
electrocardiographic O 0 3.3112104574684054e-05
pattern O 0 2.334563214390073e-05
. O 0 1.5721938098067767e-06

Because O 0 7.905657639639685e-07
of O 0 3.5550948296325657e-10
the O 0 3.6445416129460284e-10
small O 0 8.609654100766306e-10
size O 0 4.409166365348938e-09
of O 0 3.5529915815013524e-11
most O 0 2.253291303544458e-10
pedigrees O 0 2.7253364009993675e-08
and O 0 2.1636659131019087e-09
the O 0 6.063162194536176e-10
high O 0 7.333131435416362e-08
incidence O 0 2.377576493017841e-05
of O 0 4.648778584304125e-10
sudden B-Disease 0 4.968995526155595e-08
death I-Disease 0 5.160021743222387e-09
, O 0 3.873960041644864e-10
however O 0 6.81274592295722e-10
, O 0 1.033374705250445e-10
molecular O 0 3.957337568749608e-09
genetic O 0 2.5146992044255967e-08
studies O 0 3.21487569898693e-09
of O 0 7.267648982622887e-11
IVF B-Disease 1 0.9999998807907104
have O 0 1.9867387734961994e-08
not O 0 1.0049227006092565e-09
yet O 0 6.792236550978714e-09
been O 0 5.2266351246998966e-09
done O 0 5.685681614409077e-08
. O 0 7.840472449061053e-08

Because O 0 2.620220766402781e-05
IVF B-Disease 1 0.9999997615814209
causes O 0 2.7622640118352138e-05
cardiac O 0 0.026527749374508858
rhythm O 0 8.928559509513434e-06
disturbance O 0 6.705556643282762e-07
, O 0 3.0798268380038962e-09
we O 0 3.178803220649229e-09
investigated O 0 1.397288240667649e-08
whether O 0 3.2874378774749857e-09
malfunction O 0 2.1853882969935512e-07
of O 0 5.3023092860815524e-11
ion O 0 7.974289673029489e-09
channels O 0 6.749672252226446e-07
could O 0 3.824871328106383e-06
cause O 0 5.646807110792906e-08
the O 0 5.822464288485207e-09
disorder O 0 5.466166612677625e-07
by O 0 1.213722317094934e-10
studying O 0 8.65731397681202e-09
mutations O 0 2.0136428702244302e-07
in O 0 4.6633807926355075e-09
the O 0 1.3088109263037495e-08
cardiac O 0 3.138685542580788e-06
sodium O 0 1.0880721674766392e-06
channel O 0 1.814522306631261e-06
gene O 0 8.090163646556903e-06
SCN5A O 0 0.00010656627273419872
. O 0 1.5544195548500284e-06

We O 0 1.0321997478968115e-06
have O 0 1.1380692832574368e-08
now O 0 8.841410270576944e-09
identified O 0 1.413880390543909e-08
a O 0 4.166686995432656e-09
missense O 0 3.994523922301596e-06
mutation O 0 1.1309132332826266e-06
, O 0 1.980091202113954e-09
a O 0 2.967064816061793e-09
splice O 0 5.7528573961462826e-05
- O 0 7.602681580465287e-05
donor O 0 2.183326017757281e-07
mutation O 0 1.0766650575533276e-06
, O 0 1.9514572180412415e-09
and O 0 1.4019432281742183e-09
a O 0 3.9390681827455865e-09
frameshift O 0 1.5895031538093463e-05
mutation O 0 1.0894801789618214e-06
in O 0 2.764975581825979e-09
the O 0 1.134983995676464e-09
coding O 0 3.139763293802389e-06
region O 0 3.641411794319538e-08
of O 0 4.760138394566127e-10
SCN5A O 0 7.565548116872378e-07
in O 0 2.4516988439415854e-09
three O 0 7.750188935062852e-09
IVF B-Disease 1 0.9999994039535522
families O 0 1.192975815911268e-07
. O 0 1.25010146234672e-07

We O 0 6.780161925235006e-07
show O 0 4.726009805722242e-08
that O 0 5.683377102272402e-10
sodium O 0 2.9833797654532646e-09
channels O 0 3.454087904586345e-09
with O 0 2.739498905501847e-10
the O 0 1.4698098294019246e-09
missense O 0 3.332870164740598e-06
mutation O 0 4.6759240035498806e-07
recover O 0 2.961899383535638e-07
from O 0 4.354630267489057e-10
inactivation O 0 2.2752807637971273e-07
more O 0 1.4342199650130283e-10
rapidly O 0 4.481018667235048e-09
than O 0 7.284639558235995e-10
normal O 0 8.44216607731596e-09
and O 0 1.1294492008318002e-09
that O 0 1.014486494810285e-09
the O 0 4.872810155376328e-09
frameshift O 0 1.0167970685870387e-05
mutation O 0 3.946771869323129e-07
causes O 0 7.3230785879729865e-09
the O 0 2.247891039974803e-10
sodium O 0 1.3051364433636081e-08
channel O 0 2.53875711564433e-08
to O 0 5.239498834797018e-10
be O 0 2.460712522633912e-09
non O 0 3.217883772776986e-07
- O 0 4.793827883986523e-06
functional O 0 1.31643787426583e-06
. O 0 1.225835859486324e-07

Our O 0 1.4551195590684074e-06
results O 0 1.9402669693135977e-07
indicate O 0 3.089005673473366e-08
that O 0 2.002988663818428e-09
mutations O 0 1.0559487151340363e-07
in O 0 1.9909598414358243e-09
cardiac O 0 2.7541983627088484e-07
ion O 0 5.171453949515126e-07
- O 0 1.3308927918842528e-05
channel O 0 2.736742317210883e-07
genes O 0 2.0491441432568536e-08
contribute O 0 1.0564110697330875e-09
to O 0 2.1631367530527967e-10
the O 0 4.800831954199225e-10
risk O 0 4.6972793654731504e-08
of O 0 2.7889573983586047e-10
developing O 0 1.676100822578519e-07
IVF B-Disease 1 0.9999912977218628
. O 0 7.931743795097645e-08
. O 0 1.342932023362664e-07

Molecular O 0 1.8223734514322132e-05
heterogeneity O 0 8.704556421434972e-06
in O 0 4.8891045878463046e-08
mucopolysaccharidosis B-Disease 0 4.347048161434941e-06
IVA I-Disease 0 6.224649951036554e-06
in O 0 6.313731315543691e-09
Australia O 0 5.550358839201408e-09
and O 0 1.0233464076137011e-09
Northern O 0 2.1497303492878927e-08
Ireland O 0 1.9212116342259833e-07
: O 0 3.64330454694084e-10
nine O 0 3.3364938589741655e-10
novel O 0 3.0883915425050645e-09
mutations O 0 6.720573431096e-09
including O 0 9.640511999808865e-11
T312S O 0 4.6638813699928505e-08
, O 0 2.069930338244319e-10
a O 0 2.06820949255615e-10
common O 0 4.030319633585577e-09
allele O 0 1.886158997876919e-07
that O 0 2.7748023878615413e-09
confers O 0 1.7875483138141135e-07
a O 0 1.4548778892731207e-07
mild O 0 3.0117711503407918e-05
phenotype O 0 0.00018100546731147915
. O 0 3.5825828490487766e-06

Mucopolysaccharidosis B-Disease 0 0.0023342182394117117
IVA I-Disease 0 0.005989929661154747
( O 0 9.408922210241144e-07
MPS B-Disease 1 0.9999996423721313
IVA I-Disease 1 1.0
) O 0 6.658563478367796e-09
is O 0 1.6399976932035543e-09
an O 0 6.78442901858034e-09
autosomal B-Disease 1 0.9997244477272034
recessive I-Disease 1 0.9996734857559204
lysosomal I-Disease 1 0.9997904896736145
storage I-Disease 1 0.9999715089797974
disorder I-Disease 1 0.9999998807907104
caused O 0 1.4861573163216235e-06
by O 0 7.497327203509485e-09
a O 0 7.766720386825909e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.5102186995695774e-08
N O 0 0.00022355400142259896
- O 0 3.0373752451851033e-05
acetylgalactosamine O 0 0.00018251777510158718
- O 0 4.192460619378835e-05
6 O 0 5.523594381884323e-07
- O 0 1.1482688023534138e-05
sulfate O 0 1.2012626029900275e-05
sulfatase O 0 1.3671077795152087e-05
( O 0 4.330174441236068e-09
GALNS O 0 6.142682309473457e-07
) O 0 1.2527839210463299e-08
. O 0 7.22116340057255e-08

Previous O 0 6.236952572180599e-07
studies O 0 6.57751542121332e-08
of O 0 1.9024695707692274e-10
patients O 0 7.68248842319963e-09
from O 0 1.6204235175898418e-10
a O 0 9.195852412879901e-10
British O 0 0.0002489513426553458
- O 0 0.0006547602242790163
Irish O 0 3.3743884841896943e-07
population O 0 2.126760101361924e-09
showed O 0 4.443197365588958e-09
that O 0 6.414938025223194e-11
the O 0 1.0293892127588578e-10
I113F O 0 1.0804122929641835e-08
mutation O 0 2.6801567631906664e-09
is O 0 2.5839372308489317e-11
the O 0 1.335142239822229e-11
most O 0 4.657669736007897e-11
common O 0 5.110399881047556e-10
single O 0 1.5920868179364334e-08
mutation O 0 1.093802666218835e-06
among O 0 2.2995382664703357e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.7414282638128498e-06
and O 0 1.0210731149484786e-09
produces O 0 1.9380490101639225e-08
a O 0 5.918728618325986e-08
severe O 0 8.223528857342899e-05
clinical O 0 0.00010010293772211298
phenotype O 0 0.0001364197814837098
. O 0 1.6260776192211779e-06

We O 0 6.333079340947734e-07
studied O 0 3.7808263186889235e-07
mutations O 0 3.014590390648664e-07
in O 0 1.0039533648864563e-09
the O 0 5.440116690458296e-10
GALNS O 0 2.6451976964381174e-07
gene O 0 2.7635641330903127e-08
from O 0 1.9007477813914875e-09
23 O 0 8.326038525297008e-09
additional O 0 7.949903846338202e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 8.056172191572841e-07
( O 0 1.7541620933592128e-10
15 O 0 1.1289230661404304e-10
from O 0 5.697864402520736e-11
Australia O 0 4.660657415556102e-10
, O 0 3.6488801563594464e-11
8 O 0 8.428465564369603e-11
from O 0 4.325489619261269e-11
Northern O 0 3.516051894081329e-09
Ireland O 0 7.874162832877118e-08
) O 0 8.8205824588794e-11
, O 0 8.8098339387499e-12
with O 0 6.736554022945818e-12
various O 0 5.640482525492985e-10
clinical O 0 1.0234308547296678e-06
phenotypes O 0 1.19063599868241e-06
( O 0 9.79495240471806e-09
severe O 0 4.957209512213012e-06
, O 0 3.0867661759970133e-09
16 O 0 1.5823561350103432e-09
cases O 0 4.214975035665702e-09
; O 0 2.1131818517261536e-09
intermediate O 0 9.0662828355903e-09
, O 0 6.418906517424716e-10
4 O 0 1.2123370085603824e-09
cases O 0 8.667392137340357e-09
; O 0 1.4879703691406121e-08
mild O 0 6.194574666551489e-07
, O 0 1.2790916104066241e-09
3 O 0 3.76244368993639e-09
cases O 0 2.0107677300984506e-08
) O 0 1.2059860665658562e-08
. O 0 1.0466846589451961e-07

We O 0 1.2855169870817917e-06
found O 0 6.665603180522339e-09
two O 0 2.9661129108404793e-10
common O 0 1.1223366680468416e-09
mutations O 0 6.924682161013607e-09
that O 0 1.3817239019608962e-11
together O 0 2.4662214978543595e-11
accounted O 0 5.358708476954632e-10
for O 0 6.435404292792768e-11
32 O 0 1.268135929599623e-09
% O 0 1.5447863821460572e-10
of O 0 3.045011118252283e-11
the O 0 1.1770157071211429e-09
44 O 0 3.5039275925186075e-09
unrelated O 0 3.269704862418621e-08
alleles O 0 5.694505134101746e-08
in O 0 2.2509984987095777e-09
these O 0 1.3979067681191282e-08
patients O 0 4.6465851255561574e-07
. O 0 1.338998316668949e-07

One O 0 8.348304447736155e-08
is O 0 1.9917196780738777e-09
the O 0 7.759030085097152e-10
T312S O 0 4.286411297016457e-07
mutation O 0 3.1077991025085794e-07
, O 0 8.649914673419801e-10
a O 0 5.08062147908106e-10
novel O 0 2.2690956669180196e-08
mutation O 0 1.49468107224493e-07
found O 0 3.897255407281364e-09
exclusively O 0 8.888195068834648e-09
in O 0 5.755432574972019e-09
milder O 0 3.1856079658609815e-06
patients O 0 2.651077011250891e-06
. O 0 4.6025877509237034e-07

The O 0 6.209565750481261e-09
other O 0 5.987828011200236e-10
is O 0 3.77361031311807e-10
the O 0 2.77415534988279e-10
previously O 0 1.8085462016870224e-08
described O 0 4.917908302815022e-09
I113F O 0 8.521457317556269e-08
that O 0 1.4097434331006298e-09
produces O 0 2.3919026759244844e-08
a O 0 5.4806360338943705e-08
severe O 0 3.0597115255659446e-05
phenotype O 0 0.00010943863890133798
. O 0 2.7194380436412757e-06

The O 0 1.008860621709573e-07
I113F O 0 1.6152031321325921e-06
and O 0 5.678417736021402e-09
T312S O 0 1.449523665542074e-07
mutations O 0 2.2228913820754315e-08
accounted O 0 3.014346994234529e-09
for O 0 1.6304249617071775e-10
8 O 0 4.917943274840297e-10
( O 0 9.013065987995006e-11
18 O 0 4.5592807307315297e-10
% O 0 1.3737465331953302e-10
) O 0 1.5599639635599516e-10
and O 0 6.453377832116303e-10
6 O 0 6.377366412735341e-10
( O 0 7.17115117288003e-11
14 O 0 4.478521720141515e-10
% O 0 8.328793904555098e-11
) O 0 8.756949332333619e-11
of O 0 6.794471235638255e-11
44 O 0 3.0040558929300687e-09
unrelated O 0 4.97609029537216e-08
alleles O 0 3.200262028713041e-07
, O 0 5.328654406611122e-09
respectively O 0 1.6337583019776503e-07
. O 0 3.964690904467716e-07

The O 0 7.682359637328773e-08
relatively O 0 1.1119820442218042e-07
high O 0 2.1452744647376676e-07
residual O 0 2.6189647996943677e-06
GALNS O 0 1.2529425248430925e-06
activity O 0 3.406927007176819e-08
seen O 0 5.7262106167854654e-08
when O 0 3.651264846027402e-09
the O 0 4.0764183695252143e-10
T312S O 0 6.447920242180771e-08
mutant O 0 2.527008113872853e-08
cDNA O 0 4.255496222071997e-08
is O 0 2.9976112703167246e-09
overexpressed O 0 2.577729674158036e-07
in O 0 7.045555250329016e-10
mutant O 0 2.68924740254306e-08
cells O 0 8.43810887829477e-09
provides O 0 2.177451274842923e-10
an O 0 1.055844040670495e-11
explanation O 0 3.6908803791035893e-10
for O 0 9.547406615295628e-11
the O 0 1.420569994969867e-09
mild O 0 7.467017439921619e-07
phenotype O 0 1.3295619964992511e-06
in O 0 4.2757366536250174e-09
patients O 0 2.5314172091839282e-08
with O 0 2.0629696562135535e-10
this O 0 4.730209557379794e-09
mutation O 0 2.414179334664368e-06
. O 0 4.4315285663287796e-07

The O 0 6.871029967214781e-09
distribution O 0 7.001926149996507e-09
and O 0 1.384564018991341e-09
relative O 0 2.246554942075818e-09
frequencies O 0 8.205809365335881e-09
of O 0 9.155664421056642e-11
the O 0 5.561111571239508e-10
I113F O 0 9.697584602008646e-08
and O 0 1.1332037530564776e-09
T312S O 0 5.57062911354933e-08
mutations O 0 3.11065697644608e-08
in O 0 3.468782483473376e-10
Australia O 0 2.659851228159482e-10
corresponded O 0 3.2275057626485193e-10
to O 0 3.027949072031966e-11
those O 0 6.476655323162106e-11
observed O 0 5.461950891572087e-10
in O 0 3.168317830315459e-10
Northern O 0 2.224935968797581e-08
Ireland O 0 2.636378440001863e-06
and O 0 1.952436434748961e-09
are O 0 6.340902802826065e-11
unique O 0 1.2481675415454418e-10
to O 0 2.0541420994724113e-11
these O 0 5.187034482490027e-11
two O 0 6.089664883468515e-11
populations O 0 1.0279201934082494e-09
, O 0 6.325706625176508e-11
suggesting O 0 1.4951044846611694e-09
that O 0 4.059857658389454e-11
both O 0 1.4205638054765046e-10
mutations O 0 4.768764494400557e-09
were O 0 3.283363025907704e-10
probably O 0 2.676084354114039e-10
introduced O 0 7.042075811369841e-10
to O 0 1.8271599511177072e-10
Australia O 0 4.2772513308975135e-10
by O 0 1.4757897681683119e-10
Irish O 0 1.5009025133849718e-08
migrants O 0 1.3229512596524273e-08
during O 0 2.3324056019902173e-09
the O 0 8.049239608176606e-10
19th O 0 7.008288349652503e-08
century O 0 2.0777292775164824e-07
. O 0 1.9191972455701034e-07

Haplotype O 0 0.0001267743791686371
analysis O 0 3.2314119380316697e-07
using O 0 5.563207139402948e-08
6 O 0 2.5586299301494364e-08
RFLPs O 0 1.2317677544615435e-07
provides O 0 6.718852696430133e-10
additional O 0 2.0348056573027407e-10
data O 0 2.6763766758364227e-09
that O 0 2.6339522229967827e-10
the O 0 3.303130546861155e-10
I113F O 0 2.3676872729083698e-07
mutation O 0 4.425556099363348e-08
originated O 0 4.762074734543376e-09
from O 0 3.929963299231787e-10
a O 0 1.7908364791097142e-09
common O 0 2.5703203121452134e-08
ancestor O 0 4.946207354805665e-07
. O 0 1.0256702580591082e-06

The O 0 3.4411218763352736e-08
other O 0 4.7365293909251704e-09
9 O 0 5.218476761825741e-09
novel O 0 3.640069579091687e-09
mutations O 0 4.4686963462936546e-08
identified O 0 1.2236559321365803e-08
in O 0 1.4871998077481408e-10
these O 0 3.7199274216526135e-10
23 O 0 1.9226948921868825e-09
patients O 0 2.5011321902468353e-09
were O 0 1.1743622740922888e-10
each O 0 2.3115977187959658e-10
limited O 0 2.395467157967346e-09
to O 0 8.47025893868647e-10
a O 0 3.78803477474321e-09
single O 0 1.8810968072102696e-07
family O 0 2.0437700243292056e-07
. O 0 3.4683895933085296e-07

These O 0 1.8682206004427826e-08
data O 0 2.3064119503146685e-08
provide O 0 1.269219951360867e-09
further O 0 5.892938359508548e-10
evidence O 0 1.349820588636419e-09
for O 0 2.603831872338702e-10
extensive O 0 2.7693999982147943e-08
allelic O 0 1.6495471300004283e-06
heterogeneity O 0 3.002304538313183e-06
in O 0 4.651958818158164e-07
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 0.9999998807907104
in O 0 3.019406236148825e-08
British O 0 0.0021630648989230394
- O 0 0.0028468745294958353
Irish O 0 3.283535932041559e-07
patients O 0 1.6609673636480693e-08
and O 0 4.331896646947442e-11
provide O 0 3.416930627331283e-11
evidence O 0 2.282384559126882e-10
for O 0 3.664335501696314e-11
their O 0 7.214242397912685e-11
transmission O 0 4.462672009708513e-09
to O 0 4.3455034015593696e-10
Australia O 0 4.794554198106482e-10
by O 0 1.585315767549389e-10
British O 0 4.650504251912935e-06
- O 0 3.578369387469138e-06
Irish O 0 1.0854298437834586e-07
migrants O 0 1.7914864258727903e-08
. O 0 4.500256167716543e-09
. O 0 3.544847260172901e-08

Identification O 0 8.780868370195094e-07
of O 0 7.344928665276029e-09
constitutional O 0 2.4610287141513254e-07
WT1 O 0 2.881369618989993e-05
mutations O 0 2.218597728642635e-06
, O 0 1.7923331707692114e-09
in O 0 1.4028794792508847e-09
patients O 0 3.4728639519698845e-08
with O 0 1.1878320549385535e-09
isolated O 0 1.0392053809482604e-05
diffuse B-Disease 1 0.9621755480766296
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 9.153229285630005e-09
and O 0 9.815632751042358e-10
analysis O 0 1.2624435719033045e-08
of O 0 1.5673851105901804e-09
genotype O 0 0.00014256012218538672
/ O 0 1.5161458577495068e-05
phenotype O 0 7.348581902988371e-07
correlations O 0 5.6503193235357685e-08
by O 0 9.359333447145346e-11
use O 0 2.6737285718780868e-09
of O 0 1.6338524977399516e-10
a O 0 4.270773068526523e-09
computerized O 0 7.162342171795899e-06
mutation O 0 3.279278189438628e-06
database O 0 1.6804842744022608e-06
. O 0 4.590077651300817e-07

Constitutional O 0 5.2261775635997765e-06
mutations O 0 4.396565145725617e-06
of O 0 4.379788087760517e-09
the O 0 6.752927994568836e-09
WT1 O 0 4.856496161664836e-06
gene O 0 1.6255306434231898e-07
, O 0 1.412658545696388e-09
encoding O 0 1.3877744287071891e-08
a O 0 1.129923710152525e-08
zinc O 0 0.004093394614756107
- O 0 1.0530640111028333e-06
finger O 0 8.176555752470449e-07
transcription O 0 1.2503994639700977e-07
factor O 0 7.676808166934279e-08
involved O 0 9.372525866524484e-09
in O 0 8.236292536878409e-09
renal O 0 0.003824331099167466
and O 0 2.6720119450374114e-08
gonadal O 1 0.7472599148750305
development O 0 1.918840641934594e-09
, O 0 7.248447675411995e-11
are O 0 2.547343586067896e-11
found O 0 1.1153621776172074e-10
in O 0 3.747886029303871e-11
most O 0 3.353503030822935e-10
patients O 0 9.620682916988699e-09
with O 0 7.641189014861993e-09
Denys B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
Drash I-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999990463256836
( O 0 2.9175916793633405e-08
DDS B-Disease 1 1.0
) O 0 1.2164884211074423e-08
, O 0 1.97238647636766e-09
or O 0 2.2856023917938728e-07
diffuse B-Disease 1 0.9790498614311218
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 7.913132549219881e-07
DMS B-Disease 0 0.49765563011169434
) O 0 9.298434910931519e-09
associated O 0 5.955483661779226e-09
with O 0 2.136200327740312e-09
pseudohermaphroditism B-Disease 1 1.0
and O 0 7.438247280333599e-07
/ O 0 7.31484942662064e-06
or O 0 1.1060609494961682e-06
Wilms B-Disease 1 0.7579843401908875
tumor I-Disease 0 0.004845464136451483
( O 0 2.0111288279167638e-07
WT B-Disease 1 0.9999998807907104
) O 0 1.7425864484721387e-07
. O 0 3.926116676211677e-07

Most O 0 8.80027641869674e-07
mutations O 0 4.268196789780632e-05
in O 0 4.652988252473733e-07
DDS B-Disease 1 1.0
patients O 0 0.0002986503823194653
lie O 0 7.374395636361442e-07
in O 0 3.873489529127028e-09
exon O 0 3.05620801555051e-07
8 O 0 8.345021562661259e-09
or O 0 3.847628882169829e-09
exon O 0 2.0474023187944113e-07
9 O 0 8.357892156141133e-09
, O 0 4.350828031185472e-10
encoding O 0 2.9049424199456553e-08
zinc O 0 0.00026465990231372416
finger O 0 1.0732936971180607e-05
2 O 0 1.374938118914315e-08
or O 0 2.4020888389486572e-08
zinc O 0 0.00028993107844144106
finger O 0 8.82299427757971e-05
3 O 0 9.59363610775199e-09
, O 0 2.1699633756533387e-10
respectively O 0 4.082567173213647e-09
, O 0 1.7910199712201091e-10
with O 0 1.7693167764232243e-10
a O 0 2.9814288815543932e-09
hot O 0 5.042771817898029e-07
spot O 0 1.2268502587176044e-06
( O 0 1.0559517704678e-09
R394W O 0 6.763745119542364e-08
) O 0 1.067319566061542e-09
in O 0 3.737959275440517e-09
exon O 0 1.771454776644532e-06
9 O 0 3.5832346156894346e-07
. O 0 3.7614523762385943e-07

We O 0 6.673950991853417e-08
analyzed O 0 1.7736436319637505e-08
a O 0 3.667512127325523e-10
series O 0 1.457645670832619e-09
of O 0 1.9444489074427196e-10
24 O 0 7.424963310853627e-09
patients O 0 2.8983343725030863e-08
, O 0 4.799375896702429e-10
10 O 0 7.42929384678348e-10
with O 0 2.3614257216308943e-09
isolated B-Disease 0 7.057234324747697e-05
DMS I-Disease 1 0.9809935092926025
( O 0 1.1290318013834622e-08
IDMS B-Disease 0 9.944440535036847e-06
) O 0 2.066282478452308e-09
, O 0 2.7419400083772416e-10
10 O 0 3.6971084527159803e-10
with O 0 7.67700569781482e-10
DDS B-Disease 1 1.0
, O 0 5.033169880874766e-09
and O 0 1.9416335206301483e-09
4 O 0 4.968007782935047e-09
with O 0 5.660024005038622e-09
urogenital B-Disease 0 0.0004208926693536341
abnormalities I-Disease 1 0.9997515082359314
and O 0 8.1893620063056e-07
/ O 0 0.0006513352855108678
or O 0 0.0010053670266643167
WT B-Disease 1 1.0
. O 0 2.506860710127512e-06

We O 0 5.0116605052608065e-06
report O 0 8.822797212815203e-07
WT1 O 0 2.5211278625647537e-05
heterozygous O 0 2.3533593775937334e-06
mutations O 0 8.599632224104425e-07
in O 0 7.973483207024401e-09
16 O 0 1.1034081204286394e-08
patients O 0 4.393059782614728e-08
, O 0 4.025877131663691e-10
4 O 0 1.3119143549289447e-09
of O 0 1.961812517992101e-10
whom O 0 9.43068343417508e-08
presented O 0 3.33433405330652e-08
with O 0 1.1422211088074619e-07
IDMS B-Disease 0 0.056234028190374374
. O 0 1.8732821445155423e-06

One O 0 3.9867808254712145e-07
male O 0 4.2922852117044386e-07
and O 0 8.662301986817056e-09
two O 0 1.1263217913892731e-08
female O 0 3.4953366139234276e-06
IDMS B-Disease 0 0.22560633718967438
patients O 0 2.9885811727581313e-06
with O 0 4.4512489694170654e-08
WT1 O 0 0.0003097065491601825
mutations O 0 8.431238529738039e-05
underwent O 0 1.3123252756486181e-05
normal O 0 7.403014933515806e-06
puberty O 0 8.165781036950648e-05
. O 0 1.5195035985016148e-06

Two O 0 1.1306879059702624e-06
mutations O 0 3.4116430924768792e-06
associated O 0 6.016270504005661e-08
with O 0 2.76792011533189e-09
IDMS B-Disease 0 4.729382271762006e-05
are O 0 5.723758689235581e-10
different O 0 4.103518636000558e-10
from O 0 2.363857720677487e-10
those O 0 1.0121072868685133e-09
described O 0 4.9753687392239954e-08
in O 0 2.0657324739659089e-07
DDS B-Disease 1 1.0
patients O 0 6.407930777641013e-05
. O 0 6.670323386970267e-07

No O 0 1.3369009366215323e-06
WT1 O 0 3.1369709176942706e-05
mutations O 0 1.435407170902181e-06
were O 0 3.3975420254961364e-09
detected O 0 2.3899234591340246e-08
in O 0 2.1764877400354266e-10
the O 0 1.7024508192076127e-10
six O 0 1.6214756204391279e-09
other O 0 2.46280662530296e-09
IDMS B-Disease 0 0.0003125907969661057
patients O 0 5.007681380675422e-08
, O 0 2.7444932437781233e-10
suggesting O 0 2.1860007137775028e-08
genetic O 0 1.9086108693500137e-07
heterogeneity O 0 5.191848231334006e-07
of O 0 1.8231157694614808e-09
this O 0 8.409433860379067e-08
disease O 0 1.709800199023448e-05
. O 0 7.350228656832769e-07

We O 0 2.4322553144884296e-06
analyzed O 0 4.200810053589521e-06
genotype O 0 6.3632833189331e-05
/ O 0 6.996694537519943e-06
phenotype O 0 1.3647206742462004e-06
correlations O 0 8.788752552391088e-07
, O 0 1.767631041538209e-09
on O 0 3.151165717252269e-10
the O 0 5.942927400193199e-11
basis O 0 4.929531782771335e-10
of O 0 4.157624938772031e-11
the O 0 8.115496608063211e-10
constitution O 0 3.610075793858414e-09
of O 0 8.84217699059775e-11
a O 0 2.367211315856821e-09
WT1 O 0 2.275253336847527e-06
mutation O 0 1.0364041713728511e-07
database O 0 7.460965179006962e-09
of O 0 2.0543389211979957e-10
84 O 0 1.222093093389276e-08
germ O 0 6.847966142231598e-05
- O 0 0.001197999226860702
line O 0 4.81370591387531e-07
mutations O 0 8.356285974286948e-08
, O 0 3.4475419047330647e-11
to O 0 1.2938421167785208e-11
compare O 0 1.184845110913102e-09
the O 0 3.3859973852523595e-11
distribution O 0 5.269544800512449e-10
and O 0 1.0259927352151976e-09
type O 0 2.4277813537310067e-08
of O 0 5.2421546270498e-11
mutations O 0 7.573937921279139e-08
, O 0 1.3665781006810818e-10
according O 0 9.805522366290731e-11
to O 0 2.343472360610832e-10
the O 0 7.649205713278207e-10
different O 0 8.111155835877071e-08
symptoms O 0 4.710908797278535e-06
. O 0 1.851120856599664e-07

This O 0 4.8142332786937914e-08
demonstrated O 0 9.321167482312376e-08
( O 0 9.956921953602205e-10
1 O 0 1.6208818731655583e-09
) O 0 3.8778044664233846e-10
the O 0 4.276941301117887e-10
association O 0 1.4279317728238539e-09
between O 0 1.2417307182488457e-09
mutations O 0 6.426274978821311e-08
in O 0 4.27772456346176e-10
exons O 0 6.002184704811953e-08
8 O 0 3.229527312242908e-09
and O 0 7.017431635780724e-10
9 O 0 2.264598064627421e-09
and O 0 2.002423116209684e-09
DMS B-Disease 0 6.362091426126426e-06
; O 0 5.517655776721142e-10
( O 0 6.342609076837036e-11
2 O 0 3.6495015343085413e-10
) O 0 3.453216324000863e-10
among O 0 6.390004636536162e-10
patients O 0 4.608251114035511e-09
with O 0 2.2471452476580112e-10
DMS B-Disease 0 0.0013468693941831589
, O 0 2.852036662392976e-10
a O 0 2.817820143885541e-10
higher O 0 3.291936501170767e-09
frequency O 0 1.706236396614713e-08
of O 0 7.108633126584607e-10
exon O 0 3.8853454498166684e-07
8 O 0 1.4445165064103094e-08
mutations O 0 1.042103079385015e-07
among O 0 5.805022240679136e-09
46 O 0 2.5771143441488675e-08
, O 0 9.030403091969674e-09
XY O 0 4.187254944554297e-06
patients O 0 7.593552453499797e-08
with O 0 4.210392867687318e-10
female O 0 9.291489533325148e-08
phenotype O 0 1.6098380228868336e-07
than O 0 1.6270644831450909e-09
among O 0 4.681882881385491e-09
46 O 0 5.6744251963891656e-08
, O 0 1.7288467546450192e-08
XY O 0 3.9425060094799846e-05
patients O 0 6.623631065849622e-08
with O 0 2.85666434951537e-10
sexual O 0 2.1086172807827097e-08
ambiguity O 0 1.2442473007467925e-07
or O 0 4.852426727097736e-08
male O 0 3.37166028430147e-07
phenotype O 0 4.988815476281161e-07
; O 0 4.170957357274574e-09
and O 0 1.8538400814449574e-09
( O 0 1.3882177352098068e-10
3 O 0 4.670464570644128e-10
) O 0 1.7266106600022368e-10
statistically O 0 6.04154326566686e-09
significant O 0 2.9807123436143e-09
evidence O 0 2.1901158220316574e-08
that O 0 4.149335097736184e-09
mutations O 0 6.207898195498274e-08
in O 0 5.36722943866863e-10
exons O 0 1.4343532939165016e-07
8 O 0 5.5722630953880525e-09
and O 0 1.2036369678725123e-09
9 O 0 5.025649230105955e-09
preferentially O 0 1.1815220801736359e-07
affect O 0 9.285217572596594e-08
amino O 0 1.757325307494284e-08
acids O 0 5.0130308792972755e-09
with O 0 4.395525610156881e-11
different O 0 2.1382208503784028e-10
functions O 0 2.9861524364349634e-09
. O 0 1.425369156038414e-08
. O 0 1.3455277780849428e-07

The O 0 5.271722329780459e-07
185delAG O 0 1.588572922628373e-05
BRCA1 O 0 7.753283171041403e-06
mutation O 0 1.9541852225302137e-07
originated O 0 7.372045196518684e-09
before O 0 1.8715113903056135e-09
the O 0 1.1651944686885685e-10
dispersion O 0 2.0223987817757916e-08
of O 0 4.066576936301303e-11
Jews O 0 1.2098105628410849e-08
in O 0 4.0032349657437294e-10
the O 0 1.0296110491969657e-10
diaspora O 0 7.566526960545161e-09
and O 0 9.20343246058053e-10
is O 0 1.731570858920506e-10
not O 0 9.015855839678011e-10
limited O 0 3.1144491430268317e-09
to O 0 5.8877396291734385e-09
Ashkenazim O 0 7.846926564525347e-06
. O 0 2.872386914987146e-07

The O 0 2.447028748520097e-07
185delAG O 0 8.69974337547319e-06
mutation O 0 1.724550998005725e-06
in O 0 1.0016031559700878e-08
BRCA1 O 0 1.5844353811189649e-06
is O 0 6.144706965471869e-09
detected O 0 6.467011104405174e-08
in O 0 1.512379332879732e-09
Ashkenazi O 0 2.7995776008538087e-07
Jews O 0 6.798185125944656e-09
both O 0 5.780733669524807e-10
in O 0 2.8053053213739076e-09
familial B-Disease 1 0.9931545257568359
breast I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.5383796398159575e-08
in O 0 6.063913815523847e-10
the O 0 8.17783729623045e-10
general O 0 5.583146389653848e-09
population O 0 6.183224598999004e-08
. O 0 1.703830747601387e-07

All O 0 2.083499452965043e-07
tested O 0 1.50437824686378e-06
Ashkenazi O 0 6.087599558668444e-06
mutation O 0 2.789705604300252e-07
carriers O 0 1.066189199150358e-07
share O 0 1.1940065824944668e-08
the O 0 3.787397340193621e-10
same O 0 5.508016709399044e-09
allelic O 0 3.2046418141362665e-07
pattern O 0 1.8443628277964308e-06
at O 0 5.28418482304005e-08
the O 0 1.8364168852258445e-08
BRCA1 O 0 4.6040026063565165e-05
locus O 0 2.5607896532164887e-05
. O 0 7.285104288712319e-07

Our O 0 8.048085646805703e-07
previous O 0 9.043005633202483e-08
study O 0 6.813399178184909e-09
showed O 0 1.3962997869043647e-08
that O 0 4.832361177875555e-10
this O 0 1.6699627236604897e-09
Ashkenazi O 0 4.3068766899523325e-06
mutation O 0 1.1736652538729686e-07
also O 0 1.6139901637401977e-09
occurs O 0 1.3645862217970262e-09
in O 0 5.121543744657231e-10
Iraqi O 0 3.9218953418185265e-08
Jews O 0 1.2479759448069672e-08
with O 0 1.8782442268161503e-10
a O 0 2.861268111331583e-09
similar O 0 8.952768126846422e-08
allelic O 0 9.62219201028347e-06
pattern O 0 2.0062272596987896e-05
. O 0 2.649484713401762e-06

We O 0 4.4818673927693453e-07
extended O 0 9.477780338329467e-09
our O 0 1.0275241768553656e-09
analysis O 0 9.518537069652666e-10
to O 0 1.544986777402002e-10
other O 0 8.129455442151823e-10
non O 0 1.4349321020290517e-07
- O 0 7.183755315054441e-07
Ashkenazi O 0 8.096917554212268e-07
subsets O 0 2.2072761396429996e-08
354 O 0 1.173299946088946e-08
of O 0 2.1383922410578293e-10
Moroccan O 0 5.608263009548864e-08
origin O 0 7.271275581643977e-09
, O 0 4.1641506909328996e-10
200 O 0 1.0072754852430421e-09
Yemenites O 0 2.6990423407369235e-07
and O 0 2.114371344674737e-09
150 O 0 3.3674583121978685e-09
Iranian O 0 6.702641286437938e-08
Jews O 0 1.029392606710644e-07
. O 0 9.7836036161425e-08

Heteroduplex O 0 4.390704634715803e-05
analysis O 0 4.0432578884974646e-07
complemented O 0 4.6659099695034456e-08
by O 0 5.604215425059067e-10
direct O 0 4.7938435443484195e-09
DNA O 0 7.938766088955163e-08
sequencing O 0 2.859387393527868e-08
of O 0 4.888950355663724e-10
abnormally O 0 4.7807702685531694e-08
migrating O 0 1.2173076768817737e-08
bands O 0 8.641480064852658e-08
were O 0 2.2366368312987106e-08
employed O 0 6.861118322376569e-07
. O 0 2.4617821736683254e-07

Four O 0 2.778395185032423e-07
of O 0 3.6005241010883537e-09
Moroccan O 0 4.987064698980248e-07
origin O 0 6.6679302079819536e-09
( O 0 2.4153176680918875e-10
1 O 0 1.672422755838454e-10
. O 0 1.357628037768066e-10
1 O 0 4.0299641401730923e-10
% O 0 6.493106052829489e-11
) O 0 5.819550050190081e-11
and O 0 2.933212006617225e-10
none O 0 1.196929000357727e-09
of O 0 9.474530535125147e-12
the O 0 1.4602440090438762e-10
Yemenites O 0 7.429130732816702e-08
or O 0 2.3853774511195525e-09
Iranians O 0 1.8915516264428334e-08
was O 0 2.0925501331703344e-09
a O 0 4.077600479490684e-10
carrier O 0 1.5367239925012655e-08
of O 0 1.2303009999659054e-10
the O 0 3.104301704581758e-09
185delAG O 0 3.751028089027386e-06
mutation O 0 2.235273541373317e-06
. O 0 3.669622117286053e-07

BRCA1 O 0 0.00025978710618801415
allelic O 0 1.6494559531565756e-05
patterns O 0 5.336875688044529e-07
were O 0 3.1092555197176353e-09
determined O 0 4.744495463171461e-09
for O 0 7.638966542655723e-11
four O 0 9.32449811807956e-11
of O 0 4.147698243889275e-12
these O 0 5.405320288587312e-11
individuals O 0 8.022994768541736e-11
and O 0 1.3817140487315527e-10
for O 0 1.2861194054192282e-10
12 O 0 2.786128827647616e-10
additional O 0 1.7589105727466858e-09
non O 0 7.105283202690771e-06
- O 0 2.3130673071136698e-05
Ashkenazi O 0 6.884911272209138e-06
185delAG O 0 3.3715349445628817e-07
mutation O 0 1.548405066387204e-07
carriers O 0 5.938959191098547e-08
who O 0 4.84961404367823e-08
had O 0 1.2508997997429105e-06
breast B-Disease 1 0.9999964237213135
/ I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.9381359379622154e-06

Six O 0 3.1397723887494067e-06
non O 0 0.0001628570316825062
- O 0 0.012167912907898426
Ashkenazi O 0 2.247816155431792e-05
individuals O 0 3.543709548026186e-09
shared O 0 2.8239233174076617e-09
the O 0 7.180639971515745e-10
common O 0 1.8889918962372576e-08
Ashkenazi O 0 2.1363455289247213e-06
haplotype O 0 5.659292696691409e-07
, O 0 2.8812296992697384e-09
four O 0 4.341810910801769e-09
had O 0 1.1363600727065659e-08
a O 0 2.832336587488271e-10
closely O 0 7.09252034880592e-09
related O 0 8.799418971250361e-09
pattern O 0 9.144409318651014e-07
, O 0 3.317926600132637e-09
and O 0 1.759259404821023e-09
the O 0 5.322089990933421e-10
rest O 0 4.0481937801928325e-09
( O 0 4.876777870421733e-10
n O 0 3.458487469742977e-07
= O 0 7.210344961094961e-07
6 O 0 9.96937377095719e-09
) O 0 6.913948857878438e-10
displayed O 0 3.5454401636769717e-09
a O 0 1.242790492739232e-08
distinct O 0 2.0302427401475143e-06
BRCA1 O 0 0.00014633942919317633
allelic O 0 3.9050279156072065e-05
pattern O 0 6.128869426902384e-05
. O 0 3.234749556213501e-06

We O 0 7.796404588589212e-07
conclude O 0 9.107674969754953e-08
that O 0 1.0138964112726967e-09
the O 0 1.5595422730996233e-09
185delAG O 0 7.18841533853265e-07
BRCA1 O 0 2.3561192392662633e-06
mutation O 0 8.93708929083914e-08
occurs O 0 3.1359319585533285e-09
in O 0 1.6016214743341806e-10
some O 0 2.3980578633953087e-10
non O 0 1.097608583222609e-05
- O 0 0.025474058464169502
Ashkenazi O 0 0.00048057519597932696
populations O 0 3.457345343349516e-08
at O 0 3.816448934657046e-09
rates O 0 6.722445267115518e-09
comparable O 0 4.0009315860345396e-09
with O 0 1.0876727296604827e-10
that O 0 4.5990375396876004e-10
of O 0 1.6996679619296629e-09
Ashkenazim O 0 6.216006568138255e-06
. O 0 1.7624131487536943e-07

The O 0 1.246769016916005e-07
majority O 0 8.345121216279949e-08
of O 0 1.370062951977502e-09
Jewish O 0 1.9453528921076213e-07
185delAG O 0 1.5364008731921786e-06
mutation O 0 3.6117862123319355e-07
carriers O 0 1.6929850232827448e-07
have O 0 3.3985076974829553e-09
a O 0 1.056350673600548e-09
common O 0 2.0259275146372602e-08
allelic O 0 5.960407065686013e-07
pattern O 0 9.70172550296411e-07
, O 0 3.6400626957089344e-09
supporting O 0 1.6760775878310596e-08
the O 0 7.101125798492092e-10
founder O 0 1.1525655096988885e-08
effect O 0 1.2332390220137768e-08
notion O 0 4.675333009629412e-09
, O 0 2.203954657664653e-10
but O 0 2.913184693476012e-10
dating O 0 1.1916995390492957e-08
the O 0 1.6519643986079302e-10
mutations O 0 3.2906937175170015e-09
origin O 0 3.351296740117249e-10
to O 0 9.479560886260785e-11
an O 0 4.533333777811954e-11
earlier O 0 2.5508808398910787e-09
date O 0 1.3843798107870953e-08
than O 0 1.650129477503981e-09
currently O 0 1.8880481178484843e-08
estimated O 0 2.31014549711972e-08
. O 0 2.0377714804453717e-07

However O 0 1.8470755946964346e-07
, O 0 1.4515973978390662e-09
the O 0 3.3135735821865353e-10
different O 0 2.4250219610166823e-09
allelic O 0 1.7588786249689292e-07
pattern O 0 5.016922273171076e-07
at O 0 7.986573180573941e-09
the O 0 1.2598377896466673e-09
BRCA1 O 0 3.582995589113125e-07
locus O 0 9.589944482968349e-08
even O 0 6.121323004038004e-09
in O 0 2.485067707169719e-10
some O 0 1.5598033975550152e-10
Jewish O 0 3.751481969516135e-08
mutation O 0 4.6381732232703143e-08
carriers O 0 1.8903039133988386e-08
, O 0 1.8847289007251078e-10
might O 0 2.6051545365390893e-09
suggest O 0 3.924863989368532e-09
that O 0 4.894866179050439e-10
the O 0 1.2437051388758391e-09
mutation O 0 1.0100428227133307e-07
arose O 0 2.395514009378985e-08
independently O 0 3.5169655632216745e-08
. O 0 2.7305549821221575e-08
. O 0 2.7824893322758726e-07

Crystal O 0 0.0003535870637279004
structure O 0 1.6975196786006563e-06
of O 0 2.069813653804431e-08
the O 0 1.0349660328756727e-07
hemochromatosis B-Disease 1 0.9999994039535522
protein O 0 1.84442274075991e-06
HFE O 0 2.3434746253769845e-05
and O 0 5.8814544345864306e-09
characterization O 0 1.0086471036174771e-07
of O 0 3.9385103511868635e-10
its O 0 2.7096556109995618e-09
interaction O 0 1.0785838888693888e-08
with O 0 7.069331342535179e-09
transferrin O 0 1.2658677405852359e-05
receptor O 0 4.133919901505578e-06
. O 0 6.568563435394026e-07

HFE O 0 0.00373167940415442
is O 0 5.90787806231674e-07
an O 0 2.567096402117386e-08
MHC O 0 2.8767381081706844e-05
- O 0 1.7399738680978771e-06
related O 0 8.309728904976055e-09
protein O 0 3.6234586442418504e-09
that O 0 6.882275999098297e-11
is O 0 5.623582155500628e-11
mutated O 0 5.475513820130118e-09
in O 0 4.3447823117048756e-10
the O 0 2.4105970553023326e-09
iron B-Disease 1 0.9986248016357422
- I-Disease 1 0.9999980926513672
overload I-Disease 1 0.994744062423706
disease I-Disease 1 0.9995840191841125
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 5.442403198685497e-05

HFE O 0 0.0011651491513475776
binds O 0 1.0116840712726116e-05
to O 0 1.1860219473192046e-07
transferrin O 0 6.128362656454556e-06
receptor O 0 6.36786694485636e-07
( O 0 7.161713000414238e-09
TfR O 0 1.3759383818978677e-06
) O 0 5.5574984614281675e-09
and O 0 4.369475004040169e-09
reduces O 0 3.6062647978951645e-08
its O 0 3.8372052757473796e-10
affinity O 0 7.82702169743743e-09
for O 0 1.2951766326096958e-09
iron O 0 1.6284850062220357e-05
- O 0 1.1767415344365872e-05
loaded O 0 9.295406044884658e-08
transferrin O 0 7.906366477072879e-07
, O 0 6.433078958423266e-09
implicating O 0 1.7509669305582065e-06
HFE O 0 7.705420284764841e-05
in O 0 1.1725084902991512e-07
iron O 0 2.6285495550837368e-05
metabolism O 0 1.715395410428755e-05
. O 0 5.730612997467688e-07

The O 0 5.437486834125593e-07
2 O 0 7.54849736495089e-07
. O 0 6.020127898409555e-07

6 O 0 7.019163604127243e-06
A O 0 1.2774287938555062e-07
crystal O 0 3.6115970942773856e-06
structure O 0 2.4378468310715107e-07
of O 0 1.4866163855487002e-09
HFE O 0 4.199916475045029e-06
reveals O 0 2.5955836591151638e-08
the O 0 1.4015308358317213e-10
locations O 0 1.5024491872850376e-08
of O 0 2.4288639988157e-09
hemochromatosis B-Disease 1 1.0
mutations O 0 0.055913057178258896
and O 0 3.930694347786812e-08
a O 0 5.522691637338539e-09
patch O 0 2.18076729652239e-05
of O 0 1.0705566294566538e-10
histidines O 0 9.653349763993901e-08
that O 0 1.2769994783834449e-10
could O 0 7.588579209460988e-10
be O 0 3.9414388419700686e-11
involved O 0 4.3410300354373987e-10
in O 0 1.414071193472921e-09
pH O 0 1.6874606671990477e-06
- O 0 1.0110764378623571e-05
dependent O 0 8.295889983855886e-07
interactions O 0 2.820985969265166e-07
. O 0 2.769297964277939e-07

We O 0 5.303510874909989e-07
also O 0 5.953938675418158e-09
demonstrate O 0 2.08647339405843e-08
that O 0 4.021006194676602e-09
soluble O 0 8.925707675189187e-07
TfR O 0 2.617294057927211e-06
and O 0 5.004127334728992e-09
HFE O 0 1.6283340755762765e-06
bind O 0 1.6698020033345529e-07
tightly O 0 1.6881996600659477e-07
at O 0 6.949530728661557e-09
the O 0 1.8680547386740187e-10
basic O 0 7.110725785963723e-09
pH O 0 2.3209839383753206e-08
of O 0 2.0890306845489093e-11
the O 0 2.4133053888597544e-10
cell O 0 2.4187551161958254e-07
surface O 0 3.8007154216757044e-05
, O 0 2.566316714691652e-09
but O 0 9.9574402057101e-09
not O 0 5.3044186820727646e-09
at O 0 4.993658375695986e-09
the O 0 7.052644690475063e-09
acidic O 0 8.862854201652226e-07
pH O 0 5.748687499362859e-07
of O 0 7.367574550443123e-09
intracellular O 0 6.987985671003116e-06
vesicles O 0 2.5624214686104096e-05
. O 0 1.1541492312971968e-06

TfR O 0 0.12313452363014221
HFE O 0 0.0018284267280250788
stoichiometry O 0 2.9968585295137018e-05
( O 0 7.258557843670133e-08
2 O 0 2.0373434495013498e-08
1 O 0 5.7387268270758796e-09
) O 0 1.130444848840284e-09
differs O 0 1.073657873718048e-08
from O 0 7.932618117933998e-09
TfR O 0 5.766726189904148e-06
transferrin O 0 8.055549756136315e-07
stoichiometry O 0 1.024988307563035e-07
( O 0 7.347811248337166e-10
2 O 0 9.443166248956913e-10
2 O 0 6.220599035877683e-10
) O 0 2.074989902123292e-10
, O 0 7.380338007401122e-11
implying O 0 2.1463368859997445e-09
a O 0 3.918352448062379e-11
different O 0 1.9416360186319537e-10
mode O 0 2.7351405584852273e-09
of O 0 3.8537725094434094e-11
binding O 0 2.0361003549851375e-08
for O 0 1.464828147668129e-09
HFE O 0 2.287517872900935e-06
and O 0 2.5282747007082662e-09
transferrin O 0 1.1000148703033119e-07
to O 0 1.6687974335738431e-09
TfR O 0 8.224394036915328e-07
, O 0 5.43922462625801e-10
consistent O 0 4.294469668764123e-09
with O 0 3.3011085531775564e-10
our O 0 1.943396998882463e-09
demonstration O 0 4.845488010829513e-09
that O 0 4.9401116530845e-10
HFE O 0 4.338543249104987e-07
, O 0 4.292125266314173e-10
transferrin O 0 7.761612863532719e-08
, O 0 1.3594062542310326e-09
and O 0 5.289546578524096e-09
TfR O 0 9.880421885100077e-07
form O 0 1.1404877930942803e-08
a O 0 5.031125294152616e-09
ternary O 0 7.053521358102444e-07
complex O 0 1.413297354702081e-06
. O 0 1.0409086144136381e-06

Identification O 0 3.928678893316828e-07
of O 0 1.806838456630544e-09
three O 0 1.4905715550739274e-09
novel O 0 1.0790077276112697e-08
mutations O 0 1.3917643570948712e-07
and O 0 2.8628841519662274e-09
a O 0 1.1335496985509508e-09
high O 0 6.28512353273436e-09
frequency O 0 3.153790473220397e-08
of O 0 8.725538347409412e-11
the O 0 1.023893192453329e-09
Arg778Leu O 0 1.127889845520258e-06
mutation O 0 2.5756258992259973e-07
in O 0 3.115304680889608e-09
Korean O 0 8.060355582983902e-08
patients O 0 4.8949456044056205e-08
with O 0 4.199375069902089e-09
Wilson B-Disease 0 2.9231005100882612e-06
disease I-Disease 0 2.721775899772183e-06
. O 0 2.9019196290391847e-07

Four O 0 5.886647045372229e-07
mutations O 0 1.2625281669897959e-05
- O 0 0.0012847485486418009
- O 0 2.6981673727277666e-05
R778L O 0 1.235678041666688e-06
, O 0 1.7884060898865073e-09
A874V O 0 7.423833636721611e-08
, O 0 2.0023839530924903e-10
L1083F O 0 1.5147241683166612e-08
, O 0 1.4699688688502022e-10
and O 0 1.258160936545849e-10
2304delC O 0 6.417039344341902e-08
- O 0 4.6178794832485437e-07
- O 0 3.5403073184170353e-07
in O 0 1.1870799898616724e-09
the O 0 3.96779553657467e-10
copper O 0 1.180175672743644e-06
- O 0 1.0141565098820138e-07
transporting O 0 1.9865076694713935e-08
enzyme O 0 2.83560428471219e-08
, O 0 7.89575183013369e-10
P O 0 7.08958032191731e-06
- O 0 4.842200951316045e-07
type O 0 3.0470090450762655e-07
ATPase O 0 1.8449926528774085e-06
( O 0 5.909517875046788e-10
ATP7B O 0 5.363980548622749e-08
) O 0 2.1327872801180092e-10
, O 0 3.179212448856106e-11
were O 0 3.0694569108646874e-10
identified O 0 1.048550490878597e-08
in O 0 2.280323263548212e-09
Korean O 0 1.4000326586938172e-07
Patients O 0 1.5747094295193165e-08
with O 0 1.664575810522706e-09
Wilson B-Disease 0 1.7101646108130808e-06
disease I-Disease 0 1.7628227624300052e-06
. O 0 2.643351990627707e-07

Arg778Leu O 0 3.850722350762226e-05
, O 0 1.2915313263306416e-08
the O 0 4.263941422166795e-10
most O 0 9.786973453884684e-10
frequently O 0 5.991444140818203e-08
reported O 0 8.854375010969306e-08
mutation O 0 3.7043399458980275e-08
of O 0 4.3406389593769745e-11
this O 0 5.721638440814303e-11
enzyme O 0 1.7812095132185846e-09
, O 0 5.384791224027907e-11
was O 0 2.1010396200615844e-10
found O 0 3.0086760860470463e-10
in O 0 1.0237481695707373e-10
six O 0 3.8636147059456505e-10
of O 0 3.3913358232773305e-11
eight O 0 1.0673969486063584e-09
unrelated O 0 2.6757398075005767e-08
patients O 0 2.332255455428367e-08
studied O 0 6.407314234735395e-09
, O 0 1.3253290132020368e-10
an O 0 1.2075408728495773e-10
allele O 0 1.0685344875582814e-07
frequency O 0 2.632870916841057e-07
of O 0 6.548533715289295e-09
37 O 0 2.174838868995721e-07
. O 0 1.9915843552098522e-07

5 O 0 4.274120328773279e-07
% O 0 1.521850911956335e-08
, O 0 4.5303452655964804e-10
which O 0 2.745352001287671e-10
is O 0 6.645158728835199e-11
considerably O 0 9.442482351573744e-10
higher O 0 1.2414299588314748e-09
than O 0 7.614948949186129e-11
those O 0 1.5372912665068128e-10
in O 0 1.9372672910300537e-10
other O 0 2.0384307575227467e-09
Asian O 0 8.851537813825416e-08
populations O 0 1.7305465860317781e-07
. O 0 1.460034440015079e-07

The O 0 3.7853641998708554e-08
novel O 0 7.009171554273053e-08
single O 0 3.089630240538099e-08
nucleotide O 0 4.1805409978223906e-07
deletion O 0 3.5231229844612244e-07
, O 0 1.5975857303729413e-09
2304delC O 0 1.3130971865393803e-07
, O 0 1.823881046192355e-09
was O 0 5.638398636875763e-09
found O 0 2.6036492961623026e-09
in O 0 6.452417489200002e-10
one O 0 2.0100697994962502e-08
patient O 0 5.332022396942193e-07
. O 0 1.9131194051169587e-07

Since O 0 1.4049442143004853e-06
a O 0 3.219295052758753e-08
mutation O 0 5.732100021305087e-07
at O 0 1.9301619857969854e-08
cDNA O 0 8.065550787250686e-07
nucleotide O 0 1.1740603440557607e-05
2302 O 0 3.874152389471419e-05
( O 0 3.6618101884045018e-09
2302insC O 0 7.448270622489872e-08
) O 0 1.0555329943429115e-09
had O 0 2.214181726856168e-09
been O 0 1.4145782323282674e-09
previously O 0 6.076281700018171e-09
described O 0 1.9642847348677606e-09
, O 0 1.2049915232292818e-10
this O 0 9.744331730399125e-11
region O 0 3.2986555709157983e-09
of O 0 5.671884489855117e-11
the O 0 3.7745315206727525e-10
ATP7B O 0 2.5828921934589744e-07
gene O 0 2.184291680862316e-08
may O 0 3.1382951792835456e-09
be O 0 2.30025026803915e-10
susceptible O 0 1.6638814770431054e-08
to O 0 1.2579025598924432e-09
gene O 0 5.69861128951743e-07
rearrangements O 0 9.032496564032044e-06
causing O 0 7.942126103444025e-06
Wilson B-Disease 0 1.7738955648383126e-05
disease I-Disease 0 4.6116882003843784e-05
. O 0 9.770267297426471e-07

Disruption O 0 2.275032238685526e-05
of O 0 4.477960224846811e-09
splicing O 0 2.8588729605871777e-07
regulated O 0 1.0687118390251271e-07
by O 0 1.0237486414155228e-09
a O 0 8.438237664165626e-09
CUG O 0 9.252347808796912e-06
- O 0 1.0366942433392978e-06
binding O 0 3.2428715712740086e-07
protein O 0 3.3537051535859064e-07
in O 0 8.94728842126824e-08
myotonic B-Disease 1 0.999995231628418
dystrophy I-Disease 1 0.9999939203262329
. O 0 5.21496031069546e-06

Myotonic B-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999997615814209
( O 0 0.00012690149014815688
DM B-Disease 1 1.0
) O 0 7.778709004924167e-06
is O 0 4.346146198486167e-08
caused O 0 1.9802882889052853e-08
by O 0 3.2768501800894967e-10
a O 0 1.093564350185261e-09
CTG O 0 2.354029930984325e-07
expansion O 0 6.581792000304176e-09
in O 0 8.504545956355969e-10
the O 0 7.480425723294104e-10
3 O 0 3.5695826294812605e-09
untranslated O 0 8.152690611495927e-07
region O 0 2.0385133581157788e-08
of O 0 1.044956232654215e-09
the O 0 5.877532061049351e-08
DM B-Disease 1 0.9999998807907104
gene O 0 5.161962235433748e-06
. O 0 4.0768506437416363e-07

One O 0 3.243697506150056e-07
model O 0 8.685225907356653e-07
of O 0 1.4332425024576878e-08
DM B-Disease 1 0.9999998807907104
pathogenesis O 0 1.4426600500883069e-06
suggests O 0 9.036367742965012e-08
that O 0 7.566292592464663e-10
RNAs O 0 4.559267807735523e-08
from O 0 1.2535283921977225e-10
the O 0 4.4309885621762746e-11
expanded O 0 2.6469422209629556e-09
allele O 0 1.4453819474624652e-08
create O 0 1.1883486417119116e-09
a O 0 3.590790720320314e-10
gain O 0 1.5658446272937e-07
- O 0 4.0623007180329296e-07
of O 0 6.784710016027873e-10
- O 0 6.215635153239418e-07
function O 0 1.1148825862505873e-08
mutation O 0 5.14638909265841e-09
by O 0 5.060946453583348e-11
the O 0 9.393867628215702e-11
inappropriate O 0 3.5388394437063653e-09
binding O 0 4.658473606866664e-09
of O 0 6.068261171332523e-11
proteins O 0 1.2643633917619468e-09
to O 0 6.867567625690185e-10
the O 0 2.0805868139461836e-09
CUG O 0 5.192187472857768e-06
repeats O 0 2.637696297824732e-06
. O 0 3.9265887608053163e-07

Data O 0 7.34818229375378e-07
presented O 0 3.598157505280142e-08
here O 0 3.070032228436048e-09
indicate O 0 4.019840460500745e-09
that O 0 2.358835904381351e-10
the O 0 1.9466792067213134e-10
conserved O 0 1.4004206683182474e-08
heterogeneous O 0 9.437107451049087e-08
nuclear O 0 7.13575445843162e-07
ribonucleoprotein O 0 1.323952915299742e-06
, O 0 3.166132467313787e-09
CUG O 0 1.5709962326582172e-06
- O 0 2.0569177650031634e-07
binding O 0 1.2026259810227202e-07
protein O 0 3.620393584924386e-08
( O 0 1.055045828479706e-09
CUG O 0 1.2829574416173273e-06
- O 0 1.0013663995778188e-06
BP O 0 1.943160896189511e-06
) O 0 7.792429479458463e-10
, O 0 2.981598024032195e-10
may O 0 1.4892103106234345e-09
mediate O 0 1.3425881739692613e-08
the O 0 1.012358308294381e-09
trans O 0 3.770485079712671e-07
- O 0 8.191768188225979e-07
dominant O 0 2.1190251118241576e-06
effect O 0 7.475284036218e-08
of O 0 2.9086763553287653e-10
the O 0 3.1079154805269127e-09
RNA O 0 3.142412481338397e-07
. O 0 5.713685879982222e-08

CUG O 0 0.000705416954588145
- O 0 0.127450630068779
BP O 0 2.8910499167977832e-05
was O 0 2.268726762011397e-09
found O 0 1.3133658050001884e-10
to O 0 3.5928714864352784e-11
bind O 0 6.520515682950645e-09
to O 0 4.1981076948083285e-10
the O 0 1.2641607760599527e-09
human O 0 4.3432041962887524e-08
cardiac O 0 4.9381428652850445e-06
troponin O 0 1.6364716429961845e-05
T O 0 2.4733724330872064e-06
( O 0 1.3552898803226299e-09
cTNT O 0 9.000589074048548e-08
) O 0 3.2651412684714387e-09
pre O 0 2.135779141099192e-06
- O 0 9.538188123769942e-07
messenger O 0 4.077137560898336e-08
RNA O 0 1.5222253679780806e-08
and O 0 7.866198803441193e-10
regulate O 0 1.5764042515797883e-08
its O 0 4.6886481364083465e-09
alternative O 0 9.017325197646642e-08
splicing O 0 4.5648030209122226e-06
. O 0 4.4660976072918857e-07

Splicing O 0 1.8449434719514102e-05
of O 0 2.041202051827895e-08
cTNT O 0 1.9595465801103273e-06
was O 0 1.0890110502259631e-07
disrupted O 0 1.7974097090700525e-06
in O 0 5.863266849814863e-08
DM B-Disease 1 1.0
striated O 0 9.219965431839228e-05
muscle O 0 8.506308950018138e-05
and O 0 4.542931364426295e-08
in O 0 8.151289421221009e-09
normal O 0 1.403780203190763e-07
cells O 0 1.9276258456102369e-07
expressing O 0 1.263623961023086e-08
transcripts O 0 8.475196011659136e-08
that O 0 3.5872056436403454e-09
contain O 0 6.291075038689087e-08
CUG O 0 8.092431926343124e-06
repeats O 0 3.0150208658596966e-06
. O 0 2.1828138585533452e-07

Altered O 0 3.044358527404256e-05
expression O 0 4.798474719791557e-07
of O 0 5.223416366106903e-09
genes O 0 2.009740711628183e-07
regulated O 0 2.2916962905128457e-07
posttranscriptionally O 0 3.770247474221833e-07
by O 0 2.630087925226121e-09
CUG O 0 1.4994300727266818e-05
- O 0 1.687694930296857e-05
BP O 0 4.202700893074507e-06
therefore O 0 1.1290189227963765e-08
may O 0 5.830343763335577e-09
contribute O 0 5.232231092833217e-09
to O 0 1.1883176220806035e-08
DM B-Disease 1 0.9999978542327881
pathogenesis O 0 8.716284014553821e-07
. O 0 3.0223219482650165e-08
. O 0 2.1177470443944912e-07

Identification O 0 2.2139815882837866e-06
of O 0 1.2349007150191937e-08
a O 0 1.4667270953339084e-08
novel O 0 1.324734313357112e-07
nonsense O 0 1.505213390373683e-06
mutation O 0 1.1509506521178992e-06
and O 0 7.495225773368475e-09
a O 0 1.896427459513461e-09
missense O 0 5.367571702663554e-07
substitution O 0 8.692690123268676e-09
in O 0 1.4926397895465016e-09
the O 0 1.5044155921017932e-09
vasopressin O 0 1.0910855507972883e-06
- O 0 2.0503032374108443e-06
neurophysin O 0 9.576342563377693e-07
II O 0 2.1374809477947565e-08
gene O 0 1.1419484025054771e-08
in O 0 1.0029522767851518e-09
two O 0 2.8243594130117344e-09
Spanish O 0 4.269227815711929e-07
kindreds O 0 9.635681635700166e-06
with O 0 1.1625033380369132e-07
familial B-Disease 1 0.9976339340209961
neurohypophyseal I-Disease 1 0.9996553659439087
diabetes I-Disease 1 0.999984622001648
insipidus I-Disease 1 0.9921531081199646
. O 0 1.0145923624804709e-05

Familial B-Disease 1 0.9999939203262329
neurohypophyseal I-Disease 1 0.999935507774353
diabetes I-Disease 1 0.9999992847442627
insipidus I-Disease 1 0.9997105002403259
( O 0 2.0382624370540725e-06
FNDI B-Disease 1 1.0
) O 0 2.9607688745159066e-08
is O 0 1.9328392220074875e-09
an O 0 6.289908593970495e-09
autosomal B-Disease 1 0.9990481734275818
dominant I-Disease 1 0.9999896287918091
disease I-Disease 1 0.9996747970581055
caused O 0 4.076911864103749e-06
by O 0 9.045455584555384e-08
deficiency O 0 0.35471224784851074
in O 0 4.934200159567581e-09
the O 0 1.8437908977375628e-08
antidiuretic O 0 7.345301855821162e-05
hormone O 0 7.341258879023371e-06
arginine O 0 1.3722182075071032e-06
vasopressin O 0 9.574333716955152e-07
( O 0 4.265847231010866e-09
AVP O 0 1.1241459674238286e-07
) O 0 1.239122970897455e-10
encoded O 0 1.8004732427190362e-10
by O 0 1.8333530527048225e-10
the O 0 1.09964670702567e-09
AVP O 0 7.767173883621581e-06
- O 0 2.8457202461140696e-06
neurophysin O 0 4.890997843176592e-06
II O 0 2.401567371634883e-07
( O 0 2.0054655713863667e-09
AVP O 0 2.007335979214986e-06
- O 0 8.758028684496821e-07
NPII O 0 1.7236319536095834e-06
) O 0 2.5756041743818514e-09
gene O 0 5.583117257401682e-08
on O 0 2.265528031841768e-08
chromosome O 0 8.332463949045632e-06
20p13 O 0 1.9561261069611646e-05
. O 0 5.340297093425761e-07

In O 0 4.249250906696034e-08
this O 0 1.0605660794027472e-09
study O 0 1.8615360364293565e-09
, O 0 4.799787789444565e-10
we O 0 6.699938381871107e-10
analyzed O 0 5.303852024240996e-09
two O 0 5.395373592342878e-10
families O 0 1.1153457046830795e-09
with O 0 3.74137415493081e-10
FNDI B-Disease 1 0.9999613761901855
using O 0 2.1290815777064154e-09
direct O 0 1.6477894604349785e-09
automated O 0 1.0637679537239819e-07
fluorescent O 0 1.2342465538495162e-07
, O 0 1.2339771426894686e-09
solid O 0 3.509474311158556e-08
phase O 0 2.727671244429075e-08
, O 0 8.788779704005378e-10
single O 0 4.4198028348318985e-08
- O 0 1.3762113439952373e-06
stranded O 0 1.2352588285580168e-08
DNA O 0 8.825404407275528e-09
sequencing O 0 6.9121988133247214e-09
of O 0 3.3563826717930567e-10
PCR O 0 1.5129720623008325e-06
- O 0 8.631824357507867e-07
amplified O 0 1.745353529258864e-06
AVP O 0 1.3513198609871324e-05
- O 0 2.7596615836955607e-06
NPII O 0 5.744178452005144e-06
DNA O 0 1.3150663562555565e-06
. O 0 2.6688138632380287e-07

In O 0 1.1960534784805077e-08
one O 0 8.852711341766906e-10
of O 0 3.0734564199219605e-11
the O 0 1.361325496773702e-10
families O 0 9.397349565176683e-10
, O 0 2.3697940831901576e-10
affected O 0 7.550536307299183e-10
individuals O 0 2.1044126163882737e-10
presented O 0 1.900660739906357e-09
a O 0 1.584597120185549e-09
novel O 0 3.68012855744837e-08
nonsense O 0 1.5664151931105152e-07
mutation O 0 4.188530056126183e-08
in O 0 3.2730584909046456e-10
exon O 0 2.9574273696653108e-08
3 O 0 2.134721510671511e-09
of O 0 4.167486147843569e-11
the O 0 8.06109623496809e-11
gene O 0 6.215206127535566e-09
, O 0 3.114738467147049e-10
consisting O 0 4.2139117195638676e-10
in O 0 1.0015033247157135e-09
a O 0 2.777386098884449e-09
G O 0 5.633252158077084e-07
to O 0 6.386012163517307e-09
T O 0 1.3299919601195143e-06
transition O 0 2.2280657319129205e-08
at O 0 2.0392629807020057e-09
nucleotide O 0 1.0865338140320091e-07
2101 O 0 2.346234708738848e-07
, O 0 6.135568719756179e-10
which O 0 3.3850433567295113e-10
produces O 0 1.4967366235296709e-09
a O 0 9.676919265899642e-10
stop O 0 3.607516774195574e-08
signal O 0 8.629210412891553e-08
in O 0 9.299960801456564e-09
codon O 0 7.700637638663466e-07
82 O 0 6.318071399391556e-08
( O 0 5.312985162930772e-09
Glu O 0 1.5692082797613693e-06
) O 0 5.988973317272439e-09
of O 0 3.384489799529433e-09
NPII O 0 3.119622851954773e-05
. O 0 8.785752356743615e-07

The O 0 2.2992817605427263e-07
premature O 0 1.330116219833144e-06
termination O 0 3.6962174476684595e-07
eliminates O 0 4.0456106376041134e-07
part O 0 4.1616439183655984e-09
of O 0 1.6568714455988953e-10
the O 0 8.36037572504722e-10
C O 0 1.3248396726339706e-06
- O 0 4.3250426529084507e-07
terminal O 0 3.3256576159601536e-08
domain O 0 3.999016673361666e-09
of O 0 7.393723133741759e-11
NPII O 0 1.890513487978751e-07
, O 0 8.848047988729846e-11
including O 0 7.231518162065242e-11
a O 0 8.242286714255087e-11
cysteine O 0 3.1371822917236614e-09
residue O 0 2.1111121739636474e-08
in O 0 3.1470215322570994e-10
position O 0 2.9673323354018066e-08
85 O 0 1.1593845883339782e-09
, O 0 5.5888512567880966e-11
which O 0 2.5612836851429677e-10
could O 0 6.275815866985113e-09
be O 0 2.8855345890477224e-10
involved O 0 9.890466223794192e-10
in O 0 4.0612385676652707e-10
the O 0 1.0782172932266576e-09
correct O 0 4.477014670101198e-07
folding O 0 3.2811789196784957e-07
of O 0 1.0406123740480666e-09
the O 0 2.0362712405130878e-08
prohormone O 0 5.549575143959373e-05
. O 0 4.5456528141585295e-07

In O 0 7.413164127001437e-08
the O 0 2.649139130284084e-09
second O 0 8.057200240330076e-09
family O 0 4.000809461501831e-09
, O 0 2.3722002140402765e-10
a O 0 1.7998895429638395e-10
G279A O 0 1.2039039098965532e-08
substitution O 0 9.748092333339287e-10
at O 0 7.737792628859097e-10
position O 0 1.0526849791858695e-07
- O 0 2.940341232715582e-07
1 O 0 1.3200317505734915e-09
of O 0 1.6803194252679177e-11
the O 0 1.0524767168895721e-10
signal O 0 3.990422214883438e-09
peptide O 0 4.191101243833373e-09
was O 0 4.208353665546838e-10
observed O 0 7.47279627066888e-10
in O 0 2.2957094558684332e-10
all O 0 7.264867041278933e-10
affected O 0 1.5033206679504474e-08
individuals O 0 7.482912067757752e-09
. O 0 7.365864007624623e-08

This O 0 1.7975452237806167e-07
missense O 0 3.92535439459607e-05
mutation O 0 6.6037023316312116e-06
, O 0 2.744035576540682e-08
which O 0 3.499000200690716e-08
replaces O 0 1.0338153515476733e-06
Ala O 0 4.475810726489726e-07
with O 0 1.3073306881494773e-09
Thr O 0 4.944801275996724e-06
, O 0 9.962868308122097e-10
is O 0 4.5393491743261905e-10
frequent O 0 5.629987143151993e-08
among O 0 3.720782615346252e-08
FNDI B-Disease 1 1.0
patients O 0 5.138347660249565e-06
and O 0 6.029360899439951e-10
is O 0 2.245367086706196e-10
thought O 0 3.0262545802628438e-09
to O 0 6.61621313291505e-10
reduce O 0 1.1473934691252907e-08
the O 0 4.444762891075982e-10
efficiency O 0 6.372748995175925e-09
of O 0 9.13157952031618e-11
cleavage O 0 2.3408216520692804e-07
by O 0 3.670656001375505e-09
signal O 0 4.295868620829424e-07
peptidases O 0 2.387960876149009e-06
. O 0 3.827713612736261e-08
. O 0 2.6772622163662163e-07

Genetic O 0 6.018844942445867e-05
heterogeneity O 0 2.5427334549021907e-05
of O 0 7.418609726528302e-08
Saethre B-Disease 1 0.9709553718566895
- I-Disease 1 0.999996542930603
Chotzen I-Disease 1 0.9999775886535645
syndrome I-Disease 1 0.999998927116394
, O 0 3.96870580843256e-09
due O 0 5.45314682298681e-09
to O 0 1.184325415515275e-09
TWIST O 0 4.647533842216944e-06
and O 0 7.85592106922195e-08
FGFR O 0 2.1998001102474518e-05
mutations O 0 5.884839538339293e-06
. O 0 3.589363757328101e-07

Thirty O 0 1.0785616723296698e-05
- O 0 0.0011741900816559792
two O 0 7.695892811909744e-09
unrelated O 0 8.254097849658137e-08
patients O 0 3.139464510582002e-08
with O 0 3.6163298050562176e-11
features O 0 2.3127675330414377e-09
of O 0 7.985122008058454e-10
Saethre B-Disease 1 0.9988406300544739
- I-Disease 1 0.9999964237213135
Chotzen I-Disease 1 0.9999617338180542
syndrome I-Disease 1 0.9999576807022095
, O 0 3.631351053190457e-10
a O 0 6.476102432095843e-10
common O 0 1.3708823587421648e-07
autosomal B-Disease 1 0.8541033864021301
dominant I-Disease 1 0.9921624064445496
condition I-Disease 0 0.011667964048683643
of O 0 5.158486970913145e-09
craniosynostosis B-Disease 1 0.6964524984359741
and O 0 2.098404934258724e-07
limb B-Disease 0 0.00359245203435421
anomalies I-Disease 0 0.016063811257481575
, O 0 1.8806038948326886e-09
were O 0 1.3953727062698817e-09
screened O 0 1.2402313132042764e-07
for O 0 7.019921866024958e-10
mutations O 0 8.256711225840263e-08
in O 0 1.133739879755069e-09
TWIST O 0 8.990703577183012e-07
, O 0 5.044395123832146e-09
FGFR2 O 0 7.429853212670423e-07
, O 0 2.617317029773858e-09
and O 0 1.3628987716174379e-08
FGFR3 O 0 1.0453191862325184e-05
. O 0 3.28408077621134e-07

Nine O 0 2.819463702508074e-07
novel O 0 1.2985591979486344e-07
and O 0 2.1384433779303436e-08
three O 0 6.82216372283051e-09
recurrent O 0 8.809245628071949e-06
TWIST O 0 1.331733164988691e-05
mutations O 0 3.1368811050924705e-06
were O 0 4.235105155458996e-09
found O 0 2.7222331056009352e-09
in O 0 1.6906922528647783e-09
12 O 0 9.427550295981746e-09
families O 0 3.140722171224297e-08
. O 0 1.2415459593739797e-07

Seven O 0 2.4152859623427503e-07
families O 0 1.0699862329488496e-08
were O 0 7.366306453704397e-10
found O 0 5.652458501259616e-10
to O 0 2.0347162843492583e-10
have O 0 9.440627168899596e-10
the O 0 2.343427674134091e-10
FGFR3 O 0 4.134659263854701e-07
P250R O 0 6.343839942246632e-08
mutation O 0 9.644456788748812e-09
, O 0 1.809755539872171e-10
and O 0 1.0607374700821737e-10
one O 0 1.4626497235603608e-10
individual O 0 4.273704168333836e-10
was O 0 2.4483901572835975e-09
found O 0 3.3489006012743516e-10
to O 0 2.1471548150575614e-10
have O 0 1.1540916000640777e-09
an O 0 9.944907120029711e-10
FGFR2 O 0 3.4495778891141526e-06
VV269 O 0 2.3384259293379728e-06
- O 0 2.1399505385488737e-06
270 O 0 5.879011837350845e-07
deletion O 0 8.59497049532365e-06
. O 0 7.236853889480699e-07

To O 0 4.614066995145549e-08
date O 0 1.0123379468041094e-07
, O 0 1.3368763873700118e-09
our O 0 6.121553264293311e-10
detection O 0 5.0634234582958015e-09
rate O 0 1.8900612186456556e-09
for O 0 2.8583415148664137e-11
TWIST O 0 8.894915026758099e-08
or O 0 4.7422603621782855e-09
FGFR O 0 2.631194035984663e-07
mutations O 0 5.6790376845583523e-08
is O 0 8.490153580176241e-10
68 O 0 8.316896504823035e-09
% O 0 3.482332200377414e-10
in O 0 2.802223730835607e-10
our O 0 1.8692578152013084e-08
Saethre B-Disease 1 0.8900141716003418
- I-Disease 1 0.9999630451202393
Chotzen I-Disease 1 0.9992064833641052
syndrome I-Disease 1 0.9977864027023315
patients O 0 8.027185316450414e-08
, O 0 4.183127108592366e-11
including O 0 7.18706275049108e-11
our O 0 1.2838333729447982e-09
five O 0 1.6168925087711727e-09
patients O 0 8.902565795665396e-09
elsewhere O 0 1.90058919713465e-08
reported O 0 5.8751783882371456e-08
with O 0 4.9194843754207795e-09
TWIST O 0 0.0001569097803439945
mutations O 0 4.833615093957633e-05
. O 0 5.740874371440441e-07

More O 0 1.783869052474074e-08
than O 0 5.258904867133651e-09
35 O 0 5.660952595576418e-09
different O 0 2.0503316822129136e-09
TWIST O 0 6.250206183722185e-07
mutations O 0 2.4946641019596427e-07
are O 0 1.1183450832064068e-09
now O 0 3.9394589812502545e-09
known O 0 1.3364226392198475e-09
in O 0 5.112564260834063e-10
the O 0 1.159072726686361e-09
literature O 0 9.375980170034381e-08
. O 0 1.2588732545282255e-07

The O 0 1.3326407533043039e-08
most O 0 2.1633814739629997e-09
common O 0 3.2243818726129803e-09
phenotypic O 0 1.4175830642670917e-07
features O 0 5.82307890795164e-08
, O 0 4.250090002155815e-10
present O 0 8.650471311488772e-11
in O 0 1.6606417629905224e-11
more O 0 7.170258310706945e-12
than O 0 1.266298316204839e-10
a O 0 1.1090686147241513e-09
third O 0 1.7774542016013584e-07
of O 0 4.025853816980174e-10
our O 0 2.9544279911419835e-08
patients O 0 9.615765961257239e-09
with O 0 2.44687631267837e-10
TWIST O 0 3.93420850741677e-06
mutations O 0 8.189018103621493e-07
, O 0 7.007239788414665e-10
are O 0 9.054008653919254e-10
coronal B-Disease 0 7.274198310369684e-07
synostosis I-Disease 0 1.2239077022968559e-06
, O 0 2.431385537349229e-09
brachycephaly B-Disease 0 9.521493780084711e-07
, O 0 4.500155270648065e-08
low B-Disease 0 0.013853917829692364
frontal I-Disease 1 0.9999985694885254
hairline I-Disease 1 1.0
, O 0 8.834618370201497e-07
facial B-Disease 1 0.9985684156417847
asymmetry I-Disease 0 0.0002164437173632905
, O 0 1.4473798159997386e-07
ptosis B-Disease 1 0.9574763178825378
, O 0 3.707421925014387e-08
hypertelorism B-Disease 0 2.4012653739191592e-05
, O 0 1.203768373869707e-08
broad B-Disease 0 6.266368757223972e-08
great I-Disease 0 4.2611816297721816e-08
toes I-Disease 0 9.031654917635024e-05
, O 0 6.255201245863873e-09
and O 0 1.9567917064478024e-08
clinodactyly B-Disease 0 7.136868589441292e-06
. O 0 4.4796968268201454e-07

Significant O 0 5.084328222437762e-06
intra O 0 5.051640982856043e-05
- O 0 0.0036160186864435673
and O 0 2.6732198676882035e-08
interfamilial O 0 9.616995839678566e-07
phenotypic O 0 3.4607182897161692e-06
variability O 0 4.631732792859111e-07
is O 0 7.512840349832572e-10
present O 0 3.710163010151035e-10
for O 0 2.964902490187882e-10
either O 0 2.2290731038765443e-08
TWIST O 0 1.900603274407331e-05
mutations O 0 1.1929242646147031e-05
or O 0 2.1978577535719523e-07
FGFR O 0 4.911012001684867e-05
mutations O 0 2.3931243049446493e-05
. O 0 5.736989123761305e-07

The O 0 3.055027519849318e-08
overlap O 0 4.4726999703925685e-07
in O 0 5.6012683380401995e-09
clinical O 0 3.740007770147713e-08
features O 0 1.0701168839943875e-08
and O 0 2.424762834962735e-09
the O 0 1.0272493272678318e-10
presence O 0 3.79851838872014e-09
, O 0 1.0145711354381248e-10
in O 0 5.768240399217639e-11
the O 0 3.520799277123565e-11
same O 0 1.560696155644692e-10
genes O 0 8.626453440463422e-10
, O 0 9.222792668461821e-11
of O 0 8.545904435497409e-12
mutations O 0 1.5361928396018243e-09
for O 0 1.3175150206934383e-11
more O 0 9.015021368297127e-12
than O 0 2.1095725166730972e-10
one O 0 2.4129844788944865e-09
craniosynostotic B-Disease 0 1.6094669263111427e-05
condition I-Disease 0 1.2544968512884225e-06
- O 0 5.379348877454504e-08
such O 0 3.3183425451888127e-10
as O 0 1.5746305370711866e-09
Saethre B-Disease 0 9.195471761813678e-07
- I-Disease 0 2.8568450716193183e-07
Chotzen I-Disease 0 1.7369785609844257e-07
, I-Disease 0 5.980363981805681e-10
Crouzon I-Disease 0 6.648553352306408e-08
, I-Disease 0 5.288595672503504e-10
and I-Disease 0 3.6323088981049523e-09
Pfeiffer I-Disease 0 4.502406227402389e-05
syndromes I-Disease 0 2.4344220946659334e-05
- O 0 7.924513170110004e-07
support O 0 1.688803541455286e-09
the O 0 2.0562128388856848e-10
hypothesis O 0 2.8597078038927748e-09
that O 0 1.0256166055322424e-10
TWIST O 0 3.226462652605733e-08
and O 0 3.0227223501988476e-10
FGFRs O 0 1.0195556399139605e-08
are O 0 7.638005505850032e-11
components O 0 1.2330361176537963e-09
of O 0 1.946633826355182e-11
the O 0 1.0784738380120729e-10
same O 0 8.306967891336114e-10
molecular O 0 1.2604777666069822e-08
pathway O 0 2.312295688255972e-09
involved O 0 1.6556906956566309e-09
in O 0 1.1193773685747033e-10
the O 0 1.0145652373783065e-10
modulation O 0 5.198531738415113e-08
of O 0 5.11283737569812e-10
craniofacial O 0 0.006061792839318514
and O 0 1.6295909688324173e-07
limb O 0 2.694266731850803e-05
development O 0 2.5757074251231415e-09
in O 0 8.141853857779324e-10
humans O 0 4.725160263063799e-09
. O 0 8.046726840404972e-09
. O 0 5.396325519768652e-08

Mutation O 0 6.916073471074924e-05
analysis O 0 7.843057687750843e-07
of O 0 6.801197116601543e-08
UBE3A O 0 0.004276455845683813
in O 0 0.00056428526295349
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.019148411229252815
. O 0 1.5629011613782495e-06

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.949401828635018e-06
AS B-Disease 1 1.0
) O 0 4.2916713738350154e-08
is O 0 8.930917339000644e-09
caused O 0 2.9180982963339375e-08
by O 0 3.3839862023654632e-09
chromosome O 0 8.267076736956369e-06
15q11 O 0 9.078708899323829e-06
- O 0 5.060479907115223e-06
q13 O 0 8.047679216360848e-07
deletions O 0 2.275541248764057e-07
of O 0 9.566587522158443e-10
maternal O 0 1.0537938521792967e-07
origin O 0 5.0388585748351034e-08
, O 0 1.6520377288387067e-09
by O 0 3.1823581547740787e-09
paternal O 0 7.561058282590238e-06
uniparental B-Disease 0 0.029947429895401
disomy I-Disease 0 0.002007278148084879
( O 0 9.733145134305232e-08
UPD B-Disease 1 1.0
) O 0 1.5635162498028876e-08
15 O 0 7.996797668496924e-10
, O 0 5.026957322629144e-11
by O 0 5.178515949388895e-10
imprinting O 0 0.0003379022527951747
defects O 1 0.9996323585510254
, O 0 3.1368712072321614e-09
and O 0 9.86578485573375e-10
by O 0 1.2917721337046828e-09
mutations O 0 4.559867932130146e-07
in O 0 5.967423000186045e-09
the O 0 7.888650621623583e-09
UBE3A O 0 2.0082046830793843e-05
gene O 0 2.063760803139303e-06
. O 0 7.044029644021066e-07

UBE3A O 0 0.0017134674126282334
encodes O 0 1.0941555046883877e-05
a O 0 1.3115176500377856e-07
ubiquitin O 0 1.804117573556141e-06
- O 0 1.3746517879553721e-06
protein O 0 6.90303210149068e-08
ligase O 0 6.53827711971644e-08
and O 0 5.744761111259322e-09
shows O 0 1.3375024821016268e-07
brain O 0 1.0718678822740912e-05
- O 0 4.000699846073985e-06
specific O 0 2.9234863063720695e-07
imprinting O 0 4.180679388809949e-05
. O 0 1.5522093690378824e-06

Here O 0 5.340419306776312e-07
we O 0 4.249721285987107e-08
describe O 0 3.5631231298793864e-07
UBE3A O 0 3.359650509082712e-05
coding O 0 0.00038613355718553066
- O 0 0.011109585873782635
region O 0 1.9088088265561964e-06
mutations O 0 1.2564844382723095e-06
detected O 0 9.486284113791044e-08
by O 0 4.5338544030215644e-10
SSCP O 0 2.4229339601333777e-07
analysis O 0 8.307320165101828e-09
in O 0 1.1747772754588937e-09
13 O 0 2.759591000156547e-09
AS B-Disease 1 0.9995865225791931
individuals O 0 3.3393539045079024e-09
or O 0 3.035992079958305e-08
families O 0 3.526127301256565e-08
. O 0 1.4234420575576223e-07

Two O 0 3.982440830441192e-07
identical O 0 8.055242233240278e-07
de O 0 1.90952619050222e-06
novo O 0 8.987394721771125e-07
5 O 0 4.612711990148455e-08
- O 0 7.838990541131352e-07
bp O 0 8.797900932222547e-07
duplications O 0 2.888897370212362e-07
in O 0 3.4407134918978954e-09
exon O 0 1.503166373595377e-07
16 O 0 1.3503827389627077e-08
were O 0 3.0977600484760615e-09
found O 0 3.051061625569673e-08
. O 0 1.504537578966847e-07

Among O 0 8.541195484212949e-08
the O 0 1.4121575020453747e-09
other O 0 6.788477002750426e-10
11 O 0 1.264276572321421e-09
unique O 0 1.5941370445915481e-09
mutations O 0 1.2216577260915074e-07
, O 0 1.031105201221294e-09
8 O 0 8.441324861330202e-10
were O 0 2.5635316092120775e-10
small O 0 1.2065514143344558e-09
deletions O 0 1.1069772654082044e-07
or O 0 1.475053856836439e-08
insertions O 0 1.4838544757367345e-06
predicted O 0 4.346457274095883e-07
to O 0 3.7140308606353756e-09
cause O 0 1.9128886918906574e-08
frameshifts O 0 9.302693229074066e-07
, O 0 7.897468790041273e-10
1 O 0 3.6685909865497024e-09
was O 0 3.296384942785835e-09
a O 0 2.6250052131970847e-10
mutation O 0 7.5500636853576e-09
to O 0 2.419605904524502e-10
a O 0 4.1657238769587934e-10
stop O 0 9.611878404314211e-09
codon O 0 4.522199859025022e-08
, O 0 2.1234353164700792e-10
1 O 0 4.82416495639626e-10
was O 0 9.407894463464572e-10
a O 0 5.68724844995927e-10
missense O 0 3.616749495449767e-07
mutation O 0 1.1084922135751185e-07
, O 0 4.5952849858643674e-10
and O 0 4.981421941607778e-10
1 O 0 4.048124058186886e-09
was O 0 2.406298449386668e-08
predicted O 0 2.412079247449128e-08
to O 0 6.434965338364407e-10
cause O 0 1.2159449003235068e-09
insertion O 0 9.735963146795257e-09
of O 0 1.8181907368575168e-10
an O 0 8.624512215504865e-10
isoleucine O 0 8.084455657808576e-06
in O 0 1.9600818745857396e-09
the O 0 3.0105590242968105e-10
hect O 0 8.416927244070393e-08
domain O 0 4.77423389710907e-09
of O 0 9.557864916187597e-11
the O 0 5.932850877243823e-10
UBE3A O 0 2.2851402547985344e-07
protein O 0 2.970485191156058e-09
, O 0 1.298188362364172e-10
which O 0 1.1003154637423407e-10
functions O 0 7.786189470948557e-10
in O 0 6.864869783740346e-10
E2 O 0 4.154935950850813e-08
binding O 0 2.107893415370654e-08
and O 0 1.6170436101248242e-09
ubiquitin O 0 3.3996180093254225e-08
transfer O 0 5.1942599554877233e-08
. O 0 1.764002064419401e-07

Eight O 0 7.662091405791216e-08
of O 0 1.8452948891134469e-10
the O 0 2.0990809090903895e-10
cases O 0 2.1571142649889907e-09
were O 0 1.072695265946777e-09
familial O 0 1.4957690837036353e-06
, O 0 3.85891008036765e-09
and O 0 7.004170132773879e-09
five O 0 6.456151613321026e-09
were O 0 2.242891028458871e-08
sporadic O 0 3.895945610565832e-06
. O 0 2.0548916381812887e-06

In O 0 1.1920023013090031e-07
two O 0 5.738113539877077e-09
familial O 0 2.4452328943880275e-06
cases O 0 9.978623438655632e-08
and O 0 3.4893552491865876e-09
one O 0 1.8737973395133167e-09
sporadic O 0 1.5306021339256404e-07
case O 0 1.0776157921554841e-07
, O 0 2.223606854201421e-09
mosaicism O 0 9.97766846921877e-07
for O 0 1.9123735928161523e-09
UBE3A O 0 2.6746436105895555e-06
mutations O 0 7.887936703809828e-07
was O 0 9.642139531251814e-09
detected O 0 2.74809988098923e-08
in O 0 4.4227838058574775e-10
the O 0 2.1891946588858957e-10
mother O 0 3.464395348373728e-08
of O 0 3.8867620927307556e-11
three O 0 8.982218524522523e-09
AS B-Disease 1 1.0
sons O 0 1.4543618931384117e-07
, O 0 2.5396265646016047e-10
in O 0 2.024967693525781e-10
the O 0 2.559183698291889e-10
maternal O 0 1.214916256486731e-08
grandfather O 0 2.0591349070286924e-08
of O 0 4.392835400990336e-11
two O 0 4.611944159904624e-09
AS B-Disease 1 1.0
first O 0 1.7388993578393297e-09
cousins O 0 6.504196647938443e-08
, O 0 6.310020284061579e-10
and O 0 6.340447056274456e-10
in O 0 3.4233713086528894e-10
the O 0 5.247969836474908e-10
mother O 0 1.4115771307388059e-07
of O 0 8.678036761411434e-11
an O 0 5.070516895244737e-09
AS B-Disease 1 1.0
daughter O 0 0.0001940569345606491
. O 0 5.449884383779136e-07

The O 0 9.044969218052756e-09
frequencies O 0 3.938363946076606e-08
with O 0 7.581967276237833e-10
which O 0 2.22377227743209e-09
we O 0 3.0450835186712766e-09
detected O 0 1.7604989466235565e-08
mutations O 0 1.2201832433333948e-08
were O 0 5.469352193365751e-10
5 O 0 2.583095681796266e-10
( O 0 5.774239766886957e-11
14 O 0 2.728677839236582e-10
% O 0 9.061882494387774e-11
) O 0 6.909581934388953e-11
of O 0 1.5058322644367905e-11
35 O 0 8.419649422108932e-10
in O 0 3.2727026644252533e-10
sporadic O 0 6.954691400551383e-08
cases O 0 2.410543515907193e-07
and O 0 7.024479220518742e-09
8 O 0 6.504339289392647e-10
( O 0 4.4609656246752394e-11
80 O 0 1.9330631539915544e-10
% O 0 1.0461343596945838e-10
) O 0 5.848091455540327e-11
of O 0 3.040310364577081e-11
10 O 0 1.4165248973796452e-09
in O 0 1.4527912206574456e-09
familial O 0 2.6814577722689137e-06
cases O 0 2.7714827410818543e-07
. O 0 5.7067481407102605e-08
. O 0 1.5616869575296732e-07

The O 0 8.05180116003612e-06
hemochromatosis B-Disease 1 0.9999911785125732
845 O 0 3.526788714225404e-05
G O 0 1.991718090721406e-05
- O 0 1.738567698339466e-05
- O 0 1.6332517134287627e-06
> O 0 1.2202577615028076e-08
A O 0 7.078016506234519e-10
and O 0 3.975416107415697e-10
187 O 0 3.864264908060022e-09
C O 0 4.043326384817192e-08
- O 0 1.5341211678787658e-07
- O 0 3.3514319852656627e-07
> O 0 7.063862028644508e-08
G O 0 3.878526513290126e-07
mutations O 0 8.335639734013967e-08
: O 0 1.5348631254852307e-09
prevalence O 0 6.40963904174896e-08
in O 0 2.774543039762989e-09
non O 0 3.3868020636873553e-06
- O 0 1.8970285964314826e-05
Caucasian O 0 9.152967322734185e-06
populations O 0 1.723462673908216e-06
. O 0 5.115125532029197e-07

Hemochromatosis B-Disease 0 0.0068139852955937386
, O 0 1.2278276244614972e-06
the O 0 1.3342223610379733e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 4.318767121702649e-09
iron I-Disease 0 0.0016724715242162347
metabolism I-Disease 0 1.5586736481054686e-05
, O 0 1.4298832118342375e-09
leads O 0 1.817851758012523e-09
, O 0 3.5417752064503816e-10
if O 0 6.8126455587957935e-09
untreated O 0 1.31628169697251e-07
, O 0 1.6844020622741596e-10
to O 0 5.663217672591259e-10
progressive O 0 3.5083905913779745e-07
iron B-Disease 1 0.9731153845787048
overload I-Disease 0 0.004140435717999935
and O 0 2.1833301389051485e-07
premature B-Disease 0 1.3133993661540444e-06
death I-Disease 0 1.0115176252156743e-07
. O 0 2.5936492420441937e-07

The O 0 2.016034386542742e-06
hemochromatosis B-Disease 1 0.9999817609786987
gene O 0 6.291120371315628e-06
, O 0 4.2722742676915004e-08
HFE O 0 7.776906386425253e-06
, O 0 8.897507619565204e-09
recently O 0 6.731185067110346e-07
has O 0 4.59222926352254e-09
been O 0 2.2041197755839903e-09
identified O 0 3.91642851482743e-09
, O 0 1.002427793550531e-10
and O 0 1.2033700425018168e-10
characterization O 0 1.3328543602142418e-08
of O 0 4.569655764896652e-11
this O 0 1.1821402190470565e-10
gene O 0 1.0157862107007531e-08
has O 0 4.167497902329842e-09
shown O 0 6.628287918530873e-10
that O 0 5.38417505024924e-11
it O 0 6.750126846366555e-11
contains O 0 4.066103703737056e-11
two O 0 2.463608761438252e-10
mutations O 0 2.0447558313207992e-08
that O 0 6.977951549913541e-10
result O 0 5.644585687747394e-09
in O 0 1.5957555277168467e-09
amino O 0 4.901280092894922e-08
acid O 0 5.008159575936588e-08
substitutions O 0 2.538582855038385e-08
- O 0 8.042571408850563e-08
cDNA O 0 2.4496438300047885e-07
nucleotides O 0 1.8667356016521808e-07
845 O 0 1.9469750611733616e-07
G O 0 4.7418834014933964e-07
- O 0 4.5229072043184715e-07
- O 0 2.9642163212884043e-07
> O 0 1.2106646352094685e-08
A O 0 1.4751937449375419e-09
( O 0 1.3850175173413248e-10
C282Y O 0 1.2025681783711661e-08
) O 0 1.80226666923744e-10
and O 0 2.1270672723172623e-10
187 O 0 6.031307897558236e-09
C O 0 7.601507689969367e-08
- O 0 3.340681189456518e-07
- O 0 7.999693139026931e-07
> O 0 1.0396868077577892e-07
G O 0 4.4581574343283137e-07
( O 0 2.7871824848091364e-09
H63D O 0 1.1161271231685532e-06
) O 0 2.3163490681099574e-08
. O 0 9.211694163013817e-08

Although O 0 1.266553681489313e-05
hemochromatosis B-Disease 1 0.9999998807907104
is O 0 4.681063714429001e-08
common O 0 1.9074020585208018e-08
in O 0 5.201226560558325e-09
Caucasians O 0 8.470038892482989e-07
, O 0 3.204333909323509e-09
affecting O 0 2.1142877670854432e-08
> O 0 1.821691597569952e-08
= O 0 3.689919481075776e-08
1 O 0 1.082565259657997e-09
/ O 0 4.159628197442089e-09
300 O 0 7.455196182615254e-11
individuals O 0 3.939214579529171e-11
of O 0 8.8467948244908e-12
northern O 0 1.1896798923771712e-07
European O 0 7.837765991780543e-08
origin O 0 6.42615904933308e-10
, O 0 6.264830321178749e-11
it O 0 2.3029150808540066e-10
has O 0 1.974901131518436e-09
not O 0 3.112719526576768e-10
been O 0 4.097137074055013e-10
recognized O 0 8.094688808135686e-10
in O 0 2.409621113752536e-10
other O 0 1.5962943189506973e-09
populations O 0 1.8418688796373317e-07
. O 0 2.340082829732637e-07

The O 0 2.79560676830215e-08
present O 0 3.834924822143648e-09
study O 0 1.4749125254454043e-09
used O 0 1.079274780657613e-09
PCR O 0 2.1430128072097432e-07
and O 0 8.460441791591222e-10
restriction O 0 1.2891538503367883e-08
- O 0 4.454603796943957e-08
enzyme O 0 1.8472688267934245e-08
digestion O 0 8.82089423726029e-09
to O 0 1.241517028072181e-10
analyze O 0 3.5368490358678173e-09
the O 0 7.141027352774998e-11
frequency O 0 8.480059321414046e-09
of O 0 4.7768435040840274e-11
the O 0 4.2739406458380813e-10
845 O 0 4.4923083919456985e-08
G O 0 3.077943802054506e-07
- O 0 5.009420647184015e-07
- O 0 2.5223499733328936e-07
> O 0 4.283426058293571e-09
A O 0 3.5221581207167674e-10
and O 0 1.9336901524447114e-10
187 O 0 2.3324677744795963e-09
C O 0 2.0559717484047724e-08
- O 0 1.1232415175754795e-07
- O 0 1.903608222164621e-07
> O 0 3.503254220049712e-08
G O 0 2.40369814719088e-07
mutations O 0 8.046468735756207e-08
in O 0 1.3352072780747903e-09
HLA O 0 1.0551735840635956e-07
- O 0 2.3022804995775914e-08
typed O 0 1.594791854131472e-08
samples O 0 2.0471155881551795e-09
from O 0 2.2158663792737343e-10
non O 0 9.210781115598365e-08
- O 0 3.336688507715735e-07
Caucasian O 0 2.870979187719058e-07
populations O 0 1.86814563818416e-08
, O 0 2.1188312215869587e-10
comprising O 0 8.696317554957034e-10
Australian O 0 8.014255037380735e-09
Aboriginal O 0 3.1649731724314734e-09
, O 0 5.906404532129983e-11
Chinese O 0 3.942641699228311e-11
, O 0 1.3407698562506454e-10
and O 0 1.2619877365338539e-09
Pacific O 0 1.5068861713984916e-08
Islanders O 0 4.5413844418362714e-07
. O 0 2.0466801231577847e-07

Results O 0 1.1940919648623094e-05
showed O 0 1.7857047396319103e-07
that O 0 1.0185464693890367e-09
the O 0 8.131828543866959e-10
845 O 0 7.905357790605194e-08
G O 0 8.103731374831113e-07
- O 0 2.3929489998408826e-06
- O 0 1.4290993703980348e-06
> O 0 4.4385068065366795e-08
A O 0 3.937025372380276e-09
mutation O 0 4.924105567738479e-08
was O 0 2.4098154582929965e-09
present O 0 2.0662538346982728e-10
in O 0 9.652065952048261e-11
these O 0 3.330936360068648e-10
populations O 0 6.447291145406098e-09
( O 0 1.5038410794421253e-10
allele O 0 1.0760400570575257e-08
frequency O 0 2.2039778002636012e-08
0 O 0 1.6168246741443681e-09
. O 0 2.3462631837389836e-10
32 O 0 1.0475065259640814e-09
% O 0 9.541035322913061e-11
) O 0 5.83701420531213e-11
, O 0 6.606071245585099e-11
and O 0 4.200895187267406e-10
, O 0 1.1031228708269225e-10
furthermore O 0 1.9663315420359595e-09
, O 0 8.884033092515509e-11
it O 0 1.7297825394280153e-09
was O 0 3.164498423302575e-07
always O 0 1.9794462957634096e-08
seen O 0 1.256776016589356e-08
in O 0 2.1534504734965765e-10
conjunction O 0 4.633219141680911e-09
with O 0 6.692942200459129e-09
HLA O 0 9.566794005877455e-07
haplotypes O 0 4.2215503981424263e-07
common O 0 1.6872911956511416e-08
in O 0 1.5529466601549302e-09
Caucasians O 0 7.6913174495985e-08
, O 0 4.338480685817103e-10
suggesting O 0 9.423379410122834e-09
that O 0 1.0240923664639467e-09
845 O 0 5.2090925350967154e-08
G O 0 4.3638806346280035e-07
- O 0 8.052262501223595e-07
- O 0 4.2003145495073113e-07
> O 0 8.614093438552572e-09
A O 0 1.1807033128974354e-09
may O 0 4.215706450594325e-09
have O 0 1.7837040178214636e-10
been O 0 1.5021583976704278e-10
introduced O 0 7.831647552691834e-10
into O 0 3.089815625578751e-10
these O 0 8.007572938062424e-10
populations O 0 2.257173470354701e-08
by O 0 1.1829218493630833e-08
Caucasian O 0 1.0146504791919142e-05
admixture O 0 1.4739233847649302e-05
. O 0 1.0014293820859166e-06

187 O 0 7.2757147790980525e-06
C O 0 6.580616627616109e-06
- O 0 2.7475293791212607e-06
- O 0 9.374260230288201e-07
> O 0 5.364901056736926e-08
G O 0 1.5284841481388867e-07
was O 0 9.854067561931856e-10
present O 0 6.051040224441806e-11
at O 0 2.2487187112396612e-10
an O 0 5.522159118864778e-11
allele O 0 2.8184361511307543e-08
frequency O 0 1.5543497511316673e-07
of O 0 2.835375934040485e-09
2 O 0 5.282713644305659e-08
. O 0 2.0520840848803346e-07

68 O 0 2.8807810394937405e-06
% O 0 2.2177967906600315e-08
in O 0 4.958576327318553e-10
the O 0 2.337552651443531e-10
two O 0 6.844891875523729e-10
populations O 0 9.41500744033874e-09
analyzed O 0 3.4417585226265146e-08
( O 0 4.5347020583008657e-10
Australian O 0 5.204977782113929e-09
Aboriginal O 0 1.061582555195173e-08
and O 0 1.994213238987186e-09
Chinese O 0 1.4017186300563367e-09
) O 0 4.9456199135988754e-09
. O 0 3.623183886247716e-08

In O 0 3.9140410024174344e-08
the O 0 2.7685429504487047e-09
Australian O 0 8.751682045726739e-09
Aboriginal O 0 7.740940333178514e-09
samples O 0 2.492712036783473e-09
, O 0 1.738951621588214e-10
187 O 0 3.367740974979938e-09
C O 0 4.15446059776059e-08
- O 0 1.1655706089186424e-07
- O 0 9.714913318248364e-08
> O 0 7.596257844966203e-09
G O 0 5.2997091160023047e-08
was O 0 3.312651264408828e-10
found O 0 5.9146569586499e-11
to O 0 1.2108804237076498e-10
be O 0 8.824743158442061e-10
associated O 0 4.907282580290939e-09
with O 0 1.769716040378455e-09
HLA O 0 4.4351136807563307e-07
haplotypes O 0 2.57119381785742e-07
common O 0 1.0296711039359252e-08
in O 0 8.222788006051474e-10
Caucasians O 0 8.448211019640439e-08
, O 0 3.3858052472801603e-10
suggesting O 0 3.7372105410327094e-09
that O 0 1.5674082864958194e-10
it O 0 7.646113742154625e-10
was O 0 1.4486490895748716e-09
introduced O 0 1.3039562762884316e-09
by O 0 6.815006892146869e-10
recent O 0 9.847068582757856e-08
admixture O 0 8.429332410742063e-06
. O 0 6.043891858098505e-07

In O 0 6.531658414132835e-08
the O 0 1.2292601381247437e-09
Chinese O 0 2.384957509260488e-10
samples O 0 9.048726212768088e-10
analyzed O 0 2.4961994693484257e-09
, O 0 5.875797071119848e-11
187 O 0 2.5614996790324085e-09
C O 0 1.69709348796232e-08
- O 0 1.0437640440841278e-07
- O 0 7.746113794837584e-08
> O 0 1.1537268918004884e-08
G O 0 1.3433802337203815e-07
was O 0 2.031049106676619e-09
present O 0 5.428301141918723e-10
in O 0 9.46337896934324e-10
association O 0 3.978222751221949e-10
with O 0 7.686818542795848e-11
a O 0 2.255467063116967e-10
wide O 0 1.4815777493737414e-09
variety O 0 6.6354894912024065e-09
of O 0 7.934489731908911e-10
HLA O 0 1.6777896405528736e-07
haplotypes O 0 8.861081823852146e-08
, O 0 3.3709587898833604e-10
showing O 0 5.472151620722343e-09
this O 0 6.688061215953667e-11
mutation O 0 3.3886495831580987e-09
to O 0 9.301726056065718e-11
be O 0 9.785511984050643e-11
widespread O 0 4.1924103078017083e-10
and O 0 1.4117534918867136e-09
likely O 0 3.3070406413315823e-09
to O 0 7.703316456941778e-11
predate O 0 1.6058505636351583e-08
the O 0 8.769384524098811e-11
more O 0 8.57330387238342e-11
genetically O 0 6.77554501393729e-09
restricted O 0 3.2532805338547632e-09
845 O 0 5.1929621491808575e-08
G O 0 3.3069102300942177e-07
- O 0 1.1960851225012448e-06
- O 0 7.588049584228429e-07
> O 0 8.923480265821127e-08
A O 0 2.104816054782077e-08
mutation O 0 1.1683266620821087e-06
. O 0 2.3084504618964274e-07

Genotype O 1 0.9201480746269226
- O 1 0.9881733059883118
phenotype O 0 0.0005935803055763245
correlations O 0 0.000180821938556619
in O 0 5.37474124939763e-06
attenuated B-Disease 1 0.9978556036949158
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 1.0
. O 0 0.00010556215420365334

Germ O 0 0.01042893435806036
- O 1 0.7439024448394775
line O 0 1.992854777199682e-06
mutations O 0 6.416170776901708e-07
of O 0 6.197186652734388e-10
the O 0 1.8912258425984874e-09
tumor B-Disease 0 1.226578888235963e-06
suppressor O 0 4.091073151357705e-06
APC O 0 8.646028391012806e-07
are O 0 1.8619026320720877e-08
implicated O 0 4.349291430116864e-06
in O 0 1.302487589782686e-06
attenuated B-Disease 1 0.9999643564224243
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 2.3879267700976925e-06
AAPC B-Disease 1 1.0
) O 0 1.9332384582071427e-08
, O 0 5.824983273505779e-10
a O 0 2.712546187666476e-09
variant O 0 8.123824227368459e-05
of O 0 7.519508471887093e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.4105621782364324e-05
FAP B-Disease 0 0.0003053020336665213
) O 0 4.7114249923652096e-07
. O 0 6.024055778652837e-07

AAPC B-Disease 1 0.9999998807907104
is O 0 1.1261052179634135e-07
recognized O 0 1.591995690830572e-08
by O 0 6.158654697330235e-10
the O 0 6.265359342449983e-10
occurrence O 0 1.0983669085362635e-07
of O 0 1.247577929852639e-09
< O 0 1.2532886728422454e-07
100 O 0 3.928309233458549e-09
colonic B-Disease 0 6.598783102162997e-07
adenomas I-Disease 0 2.5008716875163373e-06
and O 0 5.699617444676619e-10
a O 0 4.399209607708343e-10
later O 0 2.570869384044272e-08
onset O 0 9.207158655044623e-06
of O 0 0.00011503665882628411
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 9.152548052782095e-09
age O 0 1.4079842181047297e-08
> O 0 1.5378441631241913e-08
40 O 0 7.221367059884187e-09
years O 0 2.3771665524918717e-08
) O 0 1.2551756967127403e-08
. O 0 1.2555808837078075e-07

The O 0 2.0639319586734928e-08
aim O 0 6.596197010821925e-08
of O 0 4.620330507076886e-11
this O 0 3.1610124240355475e-11
study O 0 4.569675471355339e-10
was O 0 4.753261118040086e-10
to O 0 7.047235017765274e-10
assess O 0 6.051556624697696e-07
genotype O 0 5.050157415098511e-05
- O 0 7.604168058605865e-05
phenotype O 0 8.467571205983404e-06
correlations O 0 5.7722227211343125e-06
in O 0 4.6417483190452913e-07
AAPC B-Disease 1 0.9999985694885254
families O 0 1.2531970696727512e-06
. O 0 6.851127523077594e-07

By O 0 8.118399108525409e-08
protein O 0 8.198114187507599e-07
- O 0 5.05397883898695e-06
truncation O 0 8.651382813695818e-06
test O 0 5.288889042276423e-07
( O 0 1.5044557821752846e-09
PTT O 0 9.207865048210806e-08
) O 0 1.301024149524821e-10
assay O 0 1.242802305512214e-08
, O 0 1.0320569399091539e-10
the O 0 7.493002052161302e-11
entire O 0 5.003153891181e-09
coding O 0 3.0491357847495237e-06
region O 0 3.304097973000353e-08
of O 0 1.7440603128360266e-10
the O 0 4.790769447815535e-10
APC B-Disease 0 1.4062289110938764e-08
gene O 0 8.241634930072905e-09
was O 0 1.988212483539087e-09
screened O 0 1.2676432348257549e-08
in O 0 4.603759318211331e-10
affected O 0 1.8127862544403683e-09
individuals O 0 5.412194026277461e-10
from O 0 2.344117122632383e-09
11 O 0 1.1793639487223118e-07
AAPC B-Disease 1 0.9999998807907104
kindreds O 0 3.357984678586945e-05
, O 0 6.163193955188717e-09
and O 0 1.7859926870755771e-09
their O 0 2.96775537478311e-09
phenotypic O 0 2.00146178030991e-06
differences O 0 2.025522553594783e-05
were O 0 5.006822334507888e-08
examined O 0 8.195049190362624e-07
. O 0 1.827232125606315e-07

Five O 0 2.8775633609257056e-07
novel O 0 4.3664243776220246e-07
germ O 0 7.075833127601072e-05
- O 0 0.0006340214749798179
line O 0 9.715976148072514e-07
APC B-Disease 0 2.48522752599456e-07
mutations O 0 1.7022000520228175e-07
were O 0 1.991582898597244e-09
identified O 0 1.5562211075348387e-08
in O 0 7.173963201267952e-09
seven O 0 8.775589321885491e-08
kindreds O 0 4.577424988383427e-05
. O 0 6.485465746663976e-07

Mutations O 0 1.844048165366985e-05
were O 0 1.561427076524069e-08
located O 0 4.462919367398399e-09
in O 0 5.250242463006316e-10
three O 0 1.8967739878750223e-10
different O 0 5.08033115576012e-10
regions O 0 6.386572160010928e-09
of O 0 1.4124261482617584e-10
the O 0 1.123527604285357e-09
APC B-Disease 0 1.8961355152669057e-08
gene O 0 5.7065494551977736e-09
( O 0 1.1044302972162967e-10
1 O 0 2.6747981607400106e-10
) O 0 1.2435409646460727e-10
at O 0 6.093002768992051e-10
the O 0 3.8000672053506435e-10
5 O 0 8.015228480928727e-10
end O 0 3.747089305505824e-09
spanning O 0 1.058359888617133e-08
exons O 0 2.0870331240985251e-07
4 O 0 3.4885698774189677e-09
and O 0 6.595385904084594e-10
5 O 0 4.4415679467668667e-10
, O 0 1.577347141790142e-10
( O 0 6.28711943617688e-11
2 O 0 2.1839938191270392e-10
) O 0 9.242938359133035e-11
within O 0 1.1432069180195015e-10
exon O 0 1.4256846370130916e-08
9 O 0 1.4814308668675835e-09
, O 0 3.9906387222510276e-11
and O 0 1.2536192917078637e-10
( O 0 3.694371544793462e-11
3 O 0 2.2815183076119183e-10
) O 0 9.704898690232611e-11
at O 0 4.973086942250404e-10
the O 0 3.4092118017525763e-10
3 O 0 2.6917192919029276e-09
distal O 0 1.0739223910150031e-07
end O 0 8.815538876660867e-07
of O 0 8.712953136758017e-10
the O 0 3.903169343288937e-09
gene O 0 9.960460829461226e-07
. O 0 4.983270969205478e-07

Variability O 0 8.004501978575718e-06
in O 0 6.3797540583721e-09
the O 0 2.661470210885142e-10
number O 0 3.554215144419004e-09
of O 0 6.34103329844038e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 4.044810793857323e-06
most O 0 1.0051585119796869e-09
apparent O 0 1.0936316741094743e-08
in O 0 5.284421233930914e-10
individuals O 0 3.5555830502076446e-10
with O 0 3.0795901939661974e-10
mutations O 0 1.650448950840655e-07
in O 0 2.0035846315380468e-09
region O 0 3.435744133639673e-08
1 O 0 2.263588783080195e-08
, O 0 1.0624530144554e-09
and O 0 1.7486787129428194e-08
upper O 0 0.03281722962856293
- O 1 0.9990265369415283
gastrointestinal O 0 2.4761553504504263e-05
manifestations O 0 2.7314726480653917e-07
were O 0 1.6386437762250239e-09
more O 0 5.822650694931042e-10
severe O 0 7.657488936274603e-07
in O 0 1.960990481109093e-09
them O 0 7.53996154401193e-09
. O 0 1.0129425476179676e-07

In O 0 4.4466581528013194e-08
individuals O 0 6.313780165356775e-09
with O 0 1.3779986041129177e-09
mutations O 0 1.905104767274679e-07
in O 0 1.8730541562206326e-09
either O 0 9.742186612982096e-09
region O 0 4.2706446379270346e-08
2 O 0 9.04448604899244e-09
or O 0 2.502068596754725e-08
region O 0 1.9450036248258584e-08
3 O 0 2.366014939525485e-09
, O 0 1.2713854968815497e-10
the O 0 9.099639791676495e-11
average O 0 2.1655568449574503e-09
number O 0 2.644498231507697e-10
of O 0 4.5733705017481086e-11
adenomas B-Disease 0 2.8809378704863775e-07
tended O 0 9.59813917233987e-09
to O 0 2.5616353482860177e-10
be O 0 6.85211498652194e-10
lower O 0 6.799491525377732e-10
than O 0 1.0061938088279376e-10
those O 0 9.373803816492554e-11
in O 0 8.994055500366471e-11
individuals O 0 2.090307232860411e-10
with O 0 7.976608956683506e-11
mutations O 0 2.5858984287197018e-08
in O 0 6.233580873704625e-10
region O 0 1.1196176430416926e-08
1 O 0 3.886736266167645e-09
, O 0 1.9371158843650704e-10
although O 0 4.443214240978932e-09
age O 0 6.006315889095504e-09
at O 0 4.360516836499073e-09
diagnosis O 0 5.075106628282811e-07
was O 0 7.602433349518378e-09
similar O 0 4.3272372352021193e-08
. O 0 5.411971528701542e-07

In O 0 5.920907710788015e-07
all O 0 3.468740317202901e-07
AAPC B-Disease 1 0.9999984502792358
kindreds O 0 3.12681331706699e-05
, O 0 5.764242860806235e-09
a O 0 1.2771048663040574e-09
predominance O 0 2.172848638792857e-07
of O 0 2.2327568682811716e-09
right O 0 0.024017008021473885
- O 1 0.999998927116394
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 1.9054739823332056e-05
rectal B-Disease 1 0.9991484880447388
polyp I-Disease 0 0.00033635005820542574
sparing O 0 1.0568277275524451e-06
was O 0 4.850576118542449e-08
observed O 0 3.9497655279774335e-07
. O 0 2.2132756782866636e-07

No O 0 9.058660907612648e-06
desmoid B-Disease 0 0.09147429466247559
tumors I-Disease 1 1.0
were O 0 5.71703289153902e-08
found O 0 1.3068651938397124e-08
in O 0 5.120940560487952e-09
these O 0 1.762535006832877e-08
kindreds O 0 5.7256402214989066e-05
. O 0 6.915550443409302e-07

Our O 0 3.343645289533015e-07
data O 0 4.172327905394013e-08
suggest O 0 2.0601799377573116e-08
that O 0 1.0879429579446764e-09
, O 0 9.680426460434433e-10
in O 0 3.8875818120232e-09
AAPC B-Disease 1 0.9999998807907104
families O 0 8.658403771732992e-09
, O 0 2.121637865393211e-10
the O 0 4.8432466370762484e-11
location O 0 8.59781046358421e-09
of O 0 2.9149188618404764e-10
the O 0 7.881837404966063e-09
APC B-Disease 0 9.040433610607579e-07
mutation O 0 3.818609911832027e-06
may O 0 2.868341084649728e-07
partially O 0 5.915658789490408e-07
predict O 0 2.5886430421451223e-07
specific O 0 2.6701727051658963e-08
phenotypic O 0 7.088680831657257e-06
expression O 0 3.920073595509166e-06
. O 0 1.965820729310508e-06

This O 0 1.0206919753841248e-08
should O 0 6.486490455870353e-09
help O 0 2.084006522906634e-09
in O 0 1.4061979358714893e-10
the O 0 6.116274847700609e-11
design O 0 1.0258720095634999e-08
of O 0 1.006535479963766e-10
tailored O 0 8.493109504570384e-08
clinical O 0 3.495203372949618e-06
- O 0 4.418089702085126e-06
management O 0 5.182569928763314e-09
protocols O 0 1.5178989176689583e-09
in O 0 5.92852711367442e-11
this O 0 4.114064991456168e-11
subset O 0 8.235742754436615e-09
of O 0 9.703718939491068e-10
FAP B-Disease 0 1.012463258120988e-06
patients O 0 1.2779564428910817e-07
. O 0 7.36628225084246e-09
. O 0 1.3305357526860462e-07

Wilms B-Disease 0 0.11603605002164841
' I-Disease 0 3.075911081396043e-05
tumor I-Disease 0 6.89182252244791e-06
1 O 0 2.5052775853851017e-08
and O 0 2.878763449842836e-09
Dax O 0 0.00012516111019067466
- O 0 6.449618012993596e-07
1 O 0 3.3279596856061744e-09
modulate O 0 6.47666453801321e-08
the O 0 3.067292864145088e-09
orphan O 0 3.2151507411981584e-07
nuclear O 0 4.396932808958809e-07
receptor O 0 1.5407455578042573e-07
SF O 0 2.071697417704854e-05
- O 0 2.829424943229242e-07
1 O 0 1.4868262177003544e-09
in O 0 1.457759052359009e-10
sex O 0 2.7789031520342178e-08
- O 0 3.763600986417259e-08
specific O 0 4.564695288422627e-09
gene O 0 2.9907602083767415e-07
expression O 0 3.7797448726450966e-07
. O 0 2.416191478005203e-07

Products O 0 7.415804248012137e-06
of O 0 2.8465615642403463e-08
steroidogenic O 0 1.1689859093166888e-05
factor O 0 4.1738644540600944e-07
1 O 0 1.5215114501643257e-08
( O 0 4.492691552115957e-09
SF O 0 0.04177633672952652
- O 0 3.5648565244628116e-05
1 O 0 1.8737267737378716e-08
) O 0 1.461203269492728e-09
and O 0 1.0789809934408368e-08
Wilms B-Disease 0 8.94974436960183e-06
tumor I-Disease 0 9.790825288291671e-07
1 O 0 9.198488193362664e-09
( O 0 1.1407853550693403e-09
WT1 O 0 5.72625879158295e-07
) O 0 7.998063877856509e-10
genes O 0 3.419815985949981e-09
are O 0 1.9543727747262096e-10
essential O 0 8.369853143896933e-10
for O 0 1.5686284215998825e-10
mammalian O 0 3.294809047815761e-08
gonadogenesis O 0 2.263502949517715e-07
prior O 0 8.151864960836974e-09
to O 0 2.4206825433026324e-09
sexual O 0 1.8065539109102247e-07
differentiation O 0 1.1653932006083778e-06
. O 0 3.406888708923361e-07

In O 0 1.372347497863302e-07
males O 0 2.453094509746734e-07
, O 0 9.788714727676506e-09
SF O 0 0.044455062597990036
- O 0 1.9820772649836726e-05
1 O 0 9.908465159469415e-09
participates O 0 2.5801032421668424e-09
in O 0 2.1479001910407192e-10
sexual O 0 8.487271441204314e-10
development O 0 1.4919530888501953e-10
by O 0 7.150868092109519e-11
regulating O 0 8.438978404967656e-09
expression O 0 3.102052614778472e-09
of O 0 1.905891000575366e-10
the O 0 5.352470022756961e-09
polypeptide O 0 1.0269417543895543e-05
hormone O 0 8.749415428610519e-06
Mullerian O 0 1.3600701095128898e-05
inhibiting O 0 1.3604233117803233e-06
substance O 0 5.232668058852141e-07
( O 0 1.3238826923611668e-08
MIS O 0 2.066551496682223e-05
) O 0 4.139321774232485e-08
. O 0 1.4744384202458605e-07

Here O 0 1.9238370896346169e-07
, O 0 4.786077312246562e-09
we O 0 5.181660434061541e-09
show O 0 4.774318540512468e-08
that O 0 1.2574568941658981e-08
WT1 O 0 4.531845115707256e-05
- O 0 8.121858627418987e-06
KTS O 0 1.4563117474608589e-05
isoforms O 0 2.103520131413461e-07
associate O 0 5.1505455900269226e-08
and O 0 2.2693888990232836e-09
synergize O 0 7.085816378094023e-07
with O 0 4.176099910324638e-09
SF O 1 0.636817455291748
- O 0 8.770599379204214e-05
1 O 0 1.5648348394847744e-08
to O 0 2.479340288630283e-09
promote O 0 4.1839310682689757e-08
MIS O 0 1.1277413250354584e-05
expression O 0 2.949845452349109e-07
. O 0 1.8994843742348166e-07

In O 0 1.038109544992949e-07
contrast O 0 3.297462569662457e-07
, O 0 2.9262411160857482e-08
WT1 O 0 3.596510214265436e-05
missense O 0 1.657420398260001e-05
mutations O 0 3.4447125472070184e-06
, O 0 2.517529296142129e-09
associated O 0 5.3204689542951655e-09
with O 0 2.0711001802453666e-09
male B-Disease 0 3.529058631102089e-06
pseudohermaphroditism I-Disease 1 1.0
in O 0 9.030043912616748e-08
Denys B-Disease 1 0.9999973773956299
- I-Disease 1 0.9999990463256836
Drash I-Disease 1 0.9999774694442749
syndrome I-Disease 1 0.9999988079071045
, O 0 1.3842213597570208e-08
fail O 0 7.041490448500554e-07
to O 0 8.383337357642517e-10
synergize O 0 1.118290015256207e-06
with O 0 1.4103493484185492e-08
SF O 1 0.9878004789352417
- O 0 0.00010162459511775523
1 O 0 2.2545106048710295e-07
. O 0 1.6255275170351524e-07

Additionally O 0 1.288106432184577e-06
, O 0 4.834105560291846e-09
the O 0 1.1244987163649967e-09
X O 0 0.0005555860698223114
- O 0 4.805216667591594e-05
linked O 0 3.527854232743266e-06
, O 0 1.1157287316265752e-09
candidate O 0 3.0015147700623857e-08
dosage O 0 1.6209219211305026e-06
- O 0 1.8528376699578075e-07
sensitive O 0 4.328285854171554e-07
sex O 0 1.2538673388462485e-07
- O 0 9.294360125977619e-08
reversal O 0 4.3896424273270895e-08
gene O 0 1.1454386772413727e-08
, O 0 8.306049181783237e-10
Dax O 0 7.644000106665771e-06
- O 0 4.2659070231820806e-07
1 O 0 9.378945620142076e-09
, O 0 1.2261200943441963e-09
antagonizes O 0 3.407577651159954e-07
synergy O 0 4.270294695629673e-08
between O 0 4.547263010579172e-09
SF O 0 0.005034969188272953
- O 0 1.3602883655039477e-06
1 O 0 3.911322377092574e-09
and O 0 3.636653755911823e-10
WT1 O 0 7.106877575324688e-08
, O 0 1.3127572640048157e-10
most O 0 1.219684075959293e-10
likely O 0 9.677620926851205e-10
through O 0 9.07478536760209e-11
a O 0 1.7644403993433144e-10
direct O 0 2.2272954591784355e-09
interaction O 0 6.8567205246949925e-09
with O 0 1.1538545230393993e-08
SF O 1 0.9853622913360596
- O 0 0.0002534454397391528
1 O 0 2.7980294703411346e-07
. O 0 3.22427951005011e-07

We O 0 7.037166938062001e-07
propose O 0 7.518573283959995e-07
that O 0 8.838409115696777e-09
WT1 O 0 1.1260273140578647e-06
and O 0 5.607157849141231e-09
Dax O 0 6.960800965316594e-05
- O 0 7.082255706336582e-07
1 O 0 2.630509365886269e-09
functionally O 0 3.6815659409938917e-09
oppose O 0 2.21747842310549e-09
each O 0 1.1150069062493273e-10
other O 0 1.9514599658432275e-10
in O 0 1.2506536917200606e-09
testis O 0 3.184898389463342e-07
development O 0 1.2027877582809765e-09
by O 0 8.90069407066818e-10
modulating O 0 1.7195617374454741e-06
SF O 1 0.8026837706565857
- O 0 2.547607073211111e-05
1 O 0 1.1253064968741455e-07
- O 0 1.2106573876735638e-06
mediated O 0 1.7332035895378795e-06
transactivation O 0 1.2553127817227505e-05
. O 0 4.857121282952903e-08
. O 0 1.7589725587185967e-07

A O 0 2.2921379638773942e-07
mouse O 0 1.199160919895803e-06
model O 0 1.0713871461121016e-06
for O 0 3.2073751299321884e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
imprinting O 0 0.2989862859249115
- O 1 0.995272696018219
centre O 0 7.887471838330384e-06
mutations O 0 4.1693758248584345e-05
. O 0 1.131586486735614e-06

Imprinting O 0 2.9410095521598123e-05
in O 0 4.5998142184089374e-08
the O 0 8.411980445544032e-09
15q11 O 0 3.624253167799907e-06
- O 0 2.128682353941258e-06
q13 O 0 9.583998235029867e-07
region O 0 1.9886307711658446e-08
involves O 0 6.0207909768905665e-09
an O 0 1.1544064593138614e-09
imprinting O 0 1.2868123349107918e-06
centre O 0 6.94863189210082e-08
( O 0 5.313650630611733e-10
IC O 0 3.883670629534208e-08
) O 0 2.5204302533943235e-10
, O 0 3.57674896644955e-11
mapping O 0 2.841125112951204e-09
in O 0 2.573319612952929e-10
part O 0 5.963619043036772e-10
to O 0 2.1675723715919304e-10
the O 0 9.620874930060808e-11
promoter O 0 2.964215539691395e-08
and O 0 2.064230120168986e-09
first O 0 3.405762338815066e-09
exon O 0 2.1276380834933661e-07
of O 0 7.738343299479311e-09
SNRPN O 0 2.5315985112683848e-05
. O 0 3.7114202200427826e-07

Deletion O 0 1.9373526811250485e-05
of O 0 1.1287088597100592e-08
this O 0 1.9279102758673616e-08
IC O 0 6.45661202725023e-06
abolishes O 0 1.848010811045242e-06
local O 0 2.4261057163244004e-08
paternally O 0 7.587593700009165e-07
derived O 0 1.0532469119084453e-08
gene O 0 2.6203355929510508e-08
expression O 0 4.789237006974645e-09
and O 0 4.554476795703977e-09
results O 0 1.8778059995838703e-07
in O 0 1.1466221394584863e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.167350314470241e-06
PWS B-Disease 1 0.9999998807907104
) O 0 9.867859489531838e-07
. O 0 9.480058906774502e-07

We O 0 7.035408771116636e-07
have O 0 3.1679205925172482e-09
created O 0 9.88047310634954e-10
two O 0 6.077090497491611e-10
deletion O 0 1.6966718874300568e-07
mutations O 0 1.5286008192560985e-07
in O 0 4.5275980187220455e-10
mice O 0 4.094656702591237e-08
to O 0 3.948546378751416e-09
understand O 0 2.5796450131565507e-07
PWS B-Disease 1 1.0
and O 0 1.1482341299995369e-08
the O 0 6.309033295792688e-10
mechanism O 0 9.182571147903218e-09
of O 0 4.629577554648989e-10
this O 0 7.310909211355465e-09
IC O 0 8.660860657982994e-06
. O 0 3.280499640823109e-07

Mice O 0 0.00014786214160267264
harbouring O 0 3.917755020665936e-05
an O 0 5.75403813485309e-09
intragenic O 0 7.579573093607905e-07
deletion O 0 3.510572810228041e-07
in O 0 2.292450895780007e-09
Snrpn O 0 3.651765325685119e-07
are O 0 1.0584966236848459e-09
phenotypically O 0 1.1941482114252722e-07
normal O 0 2.6315998269410557e-08
, O 0 8.81932527008189e-10
suggesting O 0 9.70553770685001e-09
that O 0 4.989542667921398e-10
mutations O 0 1.3166678414222588e-08
of O 0 8.114625638100392e-11
SNRPN O 0 1.360995156574063e-07
are O 0 3.233704692906514e-10
not O 0 7.264423507180595e-10
sufficient O 0 5.248062873164372e-09
to O 0 1.4577131501880558e-08
induce O 0 4.927417194267036e-06
PWS B-Disease 1 0.9999949932098389
. O 0 3.3500207337056054e-06

Mice O 0 1.9273391444585286e-05
with O 0 7.4038064568071604e-09
a O 0 3.469551757007139e-09
larger O 0 1.3672573295764323e-08
deletion O 0 2.387650397395191e-07
involving O 0 1.0567704045172377e-08
both O 0 1.2144431016380963e-09
Snrpn O 0 3.526000114106864e-07
and O 0 4.136194053927511e-09
the O 0 7.187686446030739e-09
putative O 0 0.00014793493028264493
PWS O 1 1.0
- O 1 0.9984246492385864
IC O 0 0.00012094705016352236
lack O 0 7.189252215766828e-08
expression O 0 1.6797772062204785e-08
of O 0 3.8170946958793195e-10
the O 0 2.1241373104885497e-09
imprinted O 0 1.0202452358498704e-06
genes O 0 2.0240626952272578e-07
Zfp127 O 0 5.569916652348184e-07
( O 0 2.2537349764206738e-09
mouse O 0 6.10490786812079e-08
homologue O 0 3.7198321933828993e-07
of O 0 1.5755378113269103e-09
ZNF127 O 0 1.968424157894333e-06
) O 0 3.387215175010283e-09
, O 0 1.5268364350617958e-09
Ndn O 0 7.230382834677584e-07
and O 0 1.543894678768254e-09
Ipw O 0 6.805815928601078e-07
, O 0 1.663109649996386e-09
and O 0 1.9507575554911227e-09
manifest O 0 1.8318166539188496e-08
several O 0 3.9957988029470926e-09
phenotypes O 0 7.195040439000877e-07
common O 0 5.881748279534804e-07
to O 0 3.024686293429113e-06
PWS B-Disease 1 1.0
infants O 0 0.023752912878990173
. O 0 6.089174462431401e-07

These O 0 1.0425519114676263e-08
data O 0 5.246761691779511e-09
demonstrate O 0 1.8696417747321448e-09
that O 0 1.0921630266835791e-10
both O 0 2.0435995951029184e-10
the O 0 2.3452698116877e-10
position O 0 5.73820386762236e-07
of O 0 8.124258210617796e-11
the O 0 7.498796583682577e-10
IC O 0 6.826474532317661e-07
and O 0 9.119557331516148e-10
its O 0 6.08951722380624e-10
role O 0 2.5877437082044707e-08
in O 0 3.0536262407565573e-10
the O 0 1.5476883663545493e-10
coordinate O 0 5.2285198393065e-09
expression O 0 7.561564707714297e-09
of O 0 1.080170120015822e-10
genes O 0 3.5121641150936966e-09
is O 0 7.692303738426887e-11
conserved O 0 3.949583715634475e-10
between O 0 2.174939811583343e-10
mouse O 0 4.165108435927323e-08
and O 0 1.6572072603082688e-09
human O 0 2.8752827896383337e-10
, O 0 1.4536082060256916e-10
and O 0 1.3970363754722825e-10
indicate O 0 1.4943604131900656e-09
that O 0 1.386349646192997e-10
the O 0 4.926709734620616e-11
mouse O 0 1.9872011591814953e-08
is O 0 5.555036985960271e-10
a O 0 2.2109902797495806e-10
suitable O 0 1.0917808879185031e-08
model O 0 7.983013006196416e-08
system O 0 1.4829970584884222e-09
in O 0 6.660906548550116e-11
which O 0 1.6039355954511336e-10
to O 0 1.1011615924649831e-10
investigate O 0 2.6013213805242685e-09
the O 0 9.494163094592167e-11
molecular O 0 5.321869167573823e-09
mechanisms O 0 1.3414536148559364e-09
of O 0 3.131153322732949e-11
imprinting O 0 5.340276487686424e-08
in O 0 9.169789927376826e-10
this O 0 2.6797261631905656e-10
region O 0 9.271516887565667e-09
of O 0 1.6059009677604763e-10
the O 0 4.996990599082096e-10
genome O 0 8.640784088242981e-09
. O 0 4.560544386578158e-09
. O 0 9.175379034331854e-08

Mutations O 0 2.3756047085043974e-05
of O 0 3.324362563006389e-09
the O 0 2.8128761542234315e-09
ATM O 0 4.1189008470610133e-07
gene O 0 1.7204231994583097e-07
detected O 0 2.5584353124941117e-07
in O 0 8.067273071787895e-09
Japanese O 0 4.1820825572358444e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.99400794506073
: O 0 4.079204973805872e-09
possible O 0 4.238790207722332e-09
preponderance O 0 1.2378053781958442e-07
of O 0 1.0029709701653289e-10
the O 0 4.274348375243875e-10
two O 0 2.8895232873082932e-09
founder O 0 1.6468641206301982e-07
mutations O 0 8.358803142982651e-07
4612del165 O 0 1.2625273484445643e-06
and O 0 3.013216343106251e-08
7883del5 O 0 5.543988208955852e-06
. O 0 3.8399002733058296e-07

The O 0 5.899365973505155e-08
ATM O 0 5.542085546039743e-06
( O 0 9.572985248951227e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 2.006720789538008e-09
mutated O 0 6.220783177468547e-08
) O 0 8.725742350890187e-10
gene O 0 1.6131414426467927e-08
on O 0 4.510619877606814e-09
human O 0 3.650486846140666e-08
chromosome O 0 7.5209004535281565e-06
11q22 O 0 1.273022462555673e-05
. O 0 7.47050080462941e-07

3 O 0 7.836971462893416e-07
has O 0 2.4586118030356374e-08
recently O 0 4.125048391756536e-08
been O 0 3.050001362581156e-09
identified O 0 5.669013258824407e-09
as O 0 1.263220222869066e-10
the O 0 2.6886789669666733e-11
gene O 0 1.5665752028937163e-09
responsible O 0 4.445890600113245e-10
for O 0 4.6140247872417106e-11
the O 0 4.1503855907620846e-10
human O 0 8.361101322407194e-08
recessive B-Disease 1 0.9999958276748657
disease I-Disease 1 0.999966025352478
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.24356813728809357
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.1049835886042274e-07
. O 0 4.2740387584672135e-07

In O 0 2.1794560822741005e-08
order O 0 1.4800525249825114e-09
to O 0 1.7590404133294157e-10
define O 0 8.272850848811686e-09
the O 0 2.469371651603325e-10
types O 0 7.379247435324032e-09
of O 0 9.34209154479504e-10
disease O 0 1.8626896007845062e-06
- O 0 0.0008430405869148672
causing O 0 3.133327197701874e-07
ATM O 0 1.1852479246954317e-06
mutations O 0 1.0026229801951558e-06
in O 0 2.61674815149604e-09
Japanese O 0 4.881268523604376e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.120764848878025e-07
as O 0 1.3657520947507606e-10
well O 0 5.064210509275746e-11
as O 0 3.643691945387495e-11
to O 0 7.868416335155004e-11
look O 0 5.462183150228839e-09
for O 0 1.9718250643396829e-10
possible O 0 6.491824855459072e-09
mutational O 0 6.054160053281521e-07
hotspots O 0 1.772852868953123e-07
, O 0 1.7567715060451405e-09
reverse O 0 1.5228649772325298e-06
- O 0 3.3854090020213334e-07
transcribed O 0 4.8703594046628496e-08
RNA O 0 1.1991736492689142e-08
derived O 0 1.3551243460696583e-09
from O 0 5.881527209705695e-11
ten O 0 4.45878195476368e-10
patients O 0 1.3821390698609548e-09
belonging O 0 2.8509597460590896e-10
to O 0 1.4915178814245422e-10
eight O 0 4.1447134613292747e-10
unrelated O 0 2.3634724399812512e-08
Japanese O 0 4.96096872666385e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.3304565449345773e-08
was O 0 1.5651266949134879e-09
analyzed O 0 3.3960516621078796e-09
for O 0 1.3510022267571031e-10
mutations O 0 7.071799146274316e-09
by O 0 7.151018666107234e-11
the O 0 3.3146357880653454e-10
restriction O 0 1.501859081542989e-08
endonuclease O 0 6.615632059947529e-07
fingerprinting O 0 4.447362584869552e-07
method O 0 3.793358587245166e-07
. O 0 3.2430043006570486e-07

As O 0 8.001519091749287e-08
has O 0 1.3273642629485494e-08
been O 0 3.930579861588512e-09
reported O 0 3.177099916484849e-09
by O 0 1.258924353653157e-10
others O 0 2.050488001614781e-09
, O 0 1.1410524608512773e-10
mutations O 0 1.552017714345766e-08
that O 0 2.268111254366545e-10
lead O 0 1.0864458221959694e-09
to O 0 1.8710072380301312e-10
exon O 0 5.386309709365378e-08
skipping O 0 2.8709683874694747e-07
or O 0 5.576742267976442e-08
premature O 0 8.929677619562426e-08
protein O 0 1.1177911041215793e-08
truncation O 0 9.7546852373398e-08
were O 0 7.741974172859045e-09
also O 0 3.521501534820004e-09
predominant O 0 1.9968678088844172e-07
in O 0 7.328975204501376e-09
our O 0 3.827874195394543e-08
mutants O 0 1.1013432867912343e-06
. O 0 1.5469808545276464e-07

Six O 0 3.4097232060048555e-07
different O 0 1.0080273504797788e-08
mutations O 0 1.7912921634888335e-07
were O 0 2.9100539755688715e-09
identified O 0 1.1205277594683594e-08
on O 0 1.3831807921249606e-09
12 O 0 1.1623226825463462e-09
of O 0 6.273679492574402e-11
the O 0 3.349649890793671e-09
16 O 0 3.7601640912043877e-08
alleles O 0 6.873515303595923e-07
examined O 0 2.333636302864761e-06
. O 0 4.741887664749811e-07

Four O 0 1.3117403341311729e-07
were O 0 3.4571459028853724e-09
deletions O 0 3.5254011265806184e-08
involving O 0 9.926019117756368e-09
a O 0 4.6063091119208366e-09
loss O 0 3.497886069681044e-08
of O 0 6.051663337114377e-11
a O 0 6.355266313207153e-10
single O 0 1.407388072749427e-08
exon O 0 1.8979343963110296e-07
exon O 0 4.2062552552124544e-07
7 O 0 6.2597962369181914e-09
, O 0 5.710890649268663e-10
exon O 0 1.5347490034400835e-07
16 O 0 7.111783162372376e-09
, O 0 5.406395331419844e-10
exon O 0 6.99988618180214e-08
33 O 0 2.1514942716294172e-08
or O 0 2.0896155916716452e-08
exon O 0 1.9140168205922237e-06
35 O 0 4.3635975544020766e-07
. O 0 3.3431288670726644e-07

The O 0 2.6286800292041335e-08
others O 0 1.0225002178287923e-08
were O 0 6.844003697104029e-10
minute O 0 3.950143323550037e-09
deletions O 0 3.640113277469936e-08
, O 0 1.5045877876929126e-09
4649delA O 0 5.627582666534181e-08
in O 0 1.0921760162929672e-09
exon O 0 7.409841629169023e-08
33 O 0 1.3036909329855462e-08
and O 0 2.0513328813365206e-09
7883del5 O 0 1.0386046511712266e-07
in O 0 3.5195542036348115e-09
exon O 0 8.528300554644375e-07
55 O 0 3.085258697410609e-07
. O 0 2.1358758317546744e-07

The O 0 1.9035864795569069e-07
mutations O 0 2.0495485841820482e-06
4612del165 O 0 6.068976290407591e-07
and O 0 3.6240324075009767e-09
7883del5 O 0 7.037248650476613e-08
were O 0 1.0234089131699875e-09
found O 0 2.2773488650429385e-10
in O 0 1.6603472069443015e-11
more O 0 1.1307887785860782e-11
than O 0 7.779594329848649e-11
two O 0 1.729029558417139e-10
unrelated O 0 5.9548250774810185e-09
families O 0 5.821562676366909e-10
; O 0 2.201186177774872e-10
44 O 0 3.4209171606569555e-10
% O 0 8.4303793113083e-11
( O 0 2.2510006011944306e-11
7 O 0 2.1930479654486135e-10
of O 0 3.653002553227758e-11
16 O 0 3.867308140392822e-10
) O 0 4.424182201145932e-11
of O 0 7.083451880607328e-12
the O 0 6.452709894189113e-11
mutant O 0 2.9264867862366373e-08
alleles O 0 3.304393914049797e-08
had O 0 2.439227486661366e-08
one O 0 5.810779635240237e-10
of O 0 5.3457713949933705e-11
the O 0 7.315229533233492e-10
two O 0 1.9888583224769718e-08
mutations O 0 6.382339961419348e-06
. O 0 4.411170948515064e-07

The O 0 7.752675657002328e-08
4612del165 O 0 1.0390062925580423e-06
mutations O 0 1.3071210958059964e-07
in O 0 1.9420212660214986e-10
three O 0 5.611324946364071e-11
different O 0 7.481305852596876e-11
families O 0 3.787924696130318e-10
were O 0 1.3300441303876198e-10
all O 0 2.7425558352112134e-11
ascribed O 0 1.8752990271764247e-09
to O 0 1.5891121751820947e-10
the O 0 9.447143761720511e-11
same O 0 2.3567954254843926e-09
T O 0 1.0181322068092413e-05
- O 0 6.045534632903582e-07
- O 0 1.3212797966843937e-07
> O 0 2.655888398095385e-09
A O 0 2.108188901228658e-10
substitution O 0 9.535855438613794e-10
at O 0 3.8642483657369553e-10
the O 0 1.9820095564782036e-10
splice O 0 2.4298111611642526e-07
donor O 0 1.3419660938041034e-08
site O 0 2.748807759189731e-08
in O 0 1.0953685958270398e-08
intron O 0 2.8672831831499934e-05
33 O 0 1.8081791495205835e-06
. O 0 7.909111445769668e-07

Microsatellite O 0 0.00026234061806462705
genotyping O 0 2.709071122808382e-05
around O 0 4.82245852140295e-08
the O 0 1.8590664563333803e-09
ATM O 0 4.27454040163866e-07
locus O 0 3.9759063952260476e-07
also O 0 1.0836793684632084e-08
indicated O 0 1.4561681638269874e-08
that O 0 3.694937411591326e-10
a O 0 4.759384553132406e-10
common O 0 4.5183696784079075e-09
haplotype O 0 1.3435254686555709e-06
was O 0 1.4682414395394972e-08
shared O 0 1.1904311980615034e-09
by O 0 1.200953225755086e-10
the O 0 6.074818426071715e-10
mutant O 0 1.2435806695521023e-07
alleles O 0 7.131890100708915e-08
in O 0 3.2146303396984877e-09
both O 0 1.7225403325937805e-08
mutations O 0 4.070738214068115e-06
. O 0 2.0289057545141986e-07

This O 0 3.133619586037639e-08
suggests O 0 3.479387800098266e-08
that O 0 2.6372448669320647e-10
these O 0 1.5875609160609372e-10
two O 0 4.278312148997543e-10
founder O 0 4.042732726361464e-08
mutations O 0 6.20504522430565e-07
may O 0 4.79359876237595e-08
be O 0 8.37528213448735e-10
predominant O 0 1.1700789315227667e-07
among O 0 4.1826044849813115e-09
Japanese O 0 2.7669818436493188e-08
ATM O 0 1.7148387314591673e-06
mutant O 0 2.2466304017143557e-06
alleles O 0 1.0312874110240955e-05
. O 0 6.095571620789997e-07

W474C O 0 0.00010139837831957266
amino O 0 5.7968873079516925e-06
acid O 0 8.664335950925306e-07
substitution O 0 2.419857736413178e-08
affects O 0 3.417333616084761e-08
early O 0 2.3334558729715127e-09
processing O 0 4.21261159289088e-09
of O 0 3.960942684955171e-11
the O 0 1.4354897825974433e-10
alpha O 0 1.8568834248000599e-09
- O 0 6.0861173878379304e-09
subunit O 0 2.5358184441159892e-09
of O 0 4.175538040329663e-11
beta O 0 5.694643423481693e-09
- O 0 3.561654793315938e-08
hexosaminidase O 0 9.123618127659938e-08
A O 0 9.589716798430459e-10
and O 0 3.3089886386505896e-10
is O 0 2.5037988349296825e-10
associated O 0 2.4494690720189283e-09
with O 0 2.2596533533203456e-09
subacute O 0 2.538011540309526e-05
G B-Disease 0 7.306392035388853e-06
( I-Disease 0 1.2417266326281151e-08
M2 I-Disease 0 9.737554137245752e-06
) I-Disease 0 1.0801901595414165e-07
gangliosidosis I-Disease 0 1.3615729585580993e-05
. O 0 1.00932606983406e-06

Mutations O 0 0.0001495187170803547
in O 0 6.169864974481243e-08
the O 0 1.6444182904251647e-08
HEXA O 0 2.2895561414770782e-05
gene O 0 2.1042144737748458e-07
, O 0 1.0640307523956949e-09
encoding O 0 1.1202200056459333e-08
the O 0 1.0274027184564716e-09
alpha O 0 1.4822116867208024e-08
- O 0 2.598748949367291e-08
subunit O 0 2.0616736762235632e-08
of O 0 3.138425352933183e-10
beta O 0 8.469152135148761e-08
- O 0 7.026089292594406e-07
hexosaminidase O 0 9.08270067156991e-07
A O 0 2.488047323723208e-09
( O 0 3.149867588980726e-10
Hex O 0 2.1681328732370275e-08
A O 0 2.1653327741955053e-10
) O 0 8.912479088074576e-11
, O 0 4.502827277708121e-11
that O 0 2.3434945650713246e-10
abolish O 0 7.79636124548233e-08
Hex O 0 2.259500035961537e-07
A O 0 1.4537475667708577e-09
enzyme O 0 6.306223809815492e-08
activity O 0 3.269455817189737e-07
cause O 0 0.004456284921616316
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 0 0.002290366915985942
( O 0 1.6847048200929748e-09
TSD B-Disease 0 1.687446228970657e-06
) O 0 1.6274122049964035e-09
, O 0 3.3975142144093695e-10
the O 0 2.944255728110079e-09
fatal O 0 0.0003718711086548865
infantile B-Disease 0 1.8112269799530623e-06
form I-Disease 0 5.8375132283572384e-08
of I-Disease 0 1.6256685997362297e-09
G I-Disease 0 1.6095874570964952e-06
( I-Disease 0 1.4193620723190747e-09
M2 I-Disease 0 9.436492405257013e-07
) I-Disease 0 5.465455199527014e-09
gangliosidosis I-Disease 0 5.161147100807284e-07
, I-Disease 0 3.9387750838670854e-09
Type I-Disease 0 2.2326884163703653e-07
1 I-Disease 0 1.2053770603870362e-07
. O 0 1.5942116249334504e-07

Less O 0 2.959289304271806e-06
severe O 0 5.398142457124777e-05
, O 0 2.2227895968285338e-08
subacute O 0 1.963892464118544e-05
( O 0 2.0068059214395362e-08
juvenile O 0 0.00019348161004018039
- O 1 0.9859758019447327
onset O 0 0.13315871357917786
) O 0 3.782200224122789e-07
and O 0 1.2717973731923848e-06
chronic O 0 0.09966502338647842
( O 0 1.3247029029272994e-09
adult O 0 4.395919404487358e-06
- O 1 0.9525081515312195
onset O 0 0.00033176346914842725
) O 0 1.6613626030448359e-09
variants O 0 9.005548307072786e-09
are O 0 3.249371605118512e-10
characterized O 0 9.643108533907707e-10
by O 0 7.421415565422862e-11
a O 0 5.918384116121445e-10
broad O 0 5.379571454966481e-09
spectrum O 0 4.833829336803319e-09
of O 0 8.505384591073195e-11
clinical O 0 2.8845249744335888e-08
manifestations O 0 1.8101509624557366e-08
and O 0 1.5080067194972457e-09
are O 0 3.3925151576852386e-10
associated O 0 3.972962403508973e-09
with O 0 1.5895494920314945e-09
residual O 0 0.2261238694190979
levels O 0 1.4671533108412405e-06
of O 0 9.876045536927336e-10
Hex O 0 7.242397828122193e-07
A O 0 7.953919300973666e-09
enzyme O 0 1.7476492075729766e-07
activity O 0 3.714698948442674e-07
. O 0 3.20788899443869e-07

We O 0 1.1040239087378723e-06
identified O 0 1.3102899742989393e-07
a O 0 1.7154057729840133e-08
1422 O 0 3.891311280312948e-06
G O 0 3.749239795070025e-06
- O 0 1.0221773663943168e-05
- O 0 4.365921995486133e-06
> O 0 2.146297646277162e-07
C O 0 9.486211638431996e-08
( O 0 3.933765535535372e-10
amino O 0 5.28609733763119e-09
acid O 0 5.470962349818365e-09
W474C O 0 6.1960427899521164e-09
) O 0 2.142236735225289e-11
substitution O 0 4.186271815309617e-11
in O 0 2.6488786858402946e-11
the O 0 3.342899915215192e-11
first O 0 4.862288904838863e-10
position O 0 8.850419952466382e-09
of O 0 1.175639724459998e-10
exon O 0 4.565550781876482e-08
13 O 0 2.3320585462727195e-09
of O 0 1.3518321184680104e-10
HEXA O 0 1.6076547808552277e-06
of O 0 2.0931796573808725e-10
a O 0 3.5630933759023264e-09
non O 0 1.222423975377751e-06
- O 0 9.407926313542703e-07
Jewish O 0 1.684523311951125e-07
proband O 0 1.0085275334859034e-06
who O 0 8.0522690737439e-09
manifested O 0 4.145120513499023e-08
a O 0 3.71729069748028e-09
subacute O 0 2.136716375389369e-06
variant O 0 1.5918005829007598e-06
of O 0 7.421989689504471e-09
G B-Disease 0 3.170538548147306e-06
( I-Disease 0 9.635704678601087e-09
M2 I-Disease 0 8.458530828647781e-06
) I-Disease 0 8.627251446569062e-08
gangliosidosis I-Disease 0 8.155559044098482e-06
. O 0 3.832477375453891e-07

On O 0 3.387307145885643e-08
the O 0 3.0348323853957027e-09
second O 0 2.508519436617007e-08
maternally O 0 1.5829235735509428e-06
inherited O 0 2.206554796657656e-07
allele O 0 2.0940530021107406e-07
, O 0 1.5306738099241102e-09
we O 0 7.308159077901166e-10
identified O 0 3.098232559395342e-09
the O 0 1.093651946781904e-09
common O 0 2.891427755002951e-07
infantile O 0 0.0017532517667859793
disease O 0 0.08410836011171341
- O 0 0.03435003384947777
causing O 0 1.960454937943723e-06
4 O 0 6.012588471548952e-08
- O 0 1.8352163806412136e-06
bp O 0 1.7691316998025286e-06
insertion O 0 1.463943988255778e-07
, O 0 5.103836908659787e-09
+ O 0 1.1331421490012872e-07
TATC O 0 1.2052614692947827e-06
1278 O 0 6.192236128299555e-07
, O 0 2.420197819930081e-09
in O 0 6.4190568416222504e-09
exon O 0 1.4028314581082668e-06
11 O 0 2.1135221572876617e-07
. O 0 2.5750316012818075e-07

Pulse O 0 0.0008322874782606959
- O 0 0.0003819966223090887
chase O 0 3.2449829632241745e-06
analysis O 0 4.0625288022511086e-08
using O 0 3.155716044034307e-08
proband O 0 1.0699167205530102e-06
fibroblasts O 0 1.639123752283922e-07
revealed O 0 1.3942032239810942e-07
that O 0 7.017699199529659e-10
the O 0 4.800630448720256e-10
W474C O 0 1.9712935284132982e-07
- O 0 2.658651787612598e-08
containing O 0 1.9396864114895607e-09
alpha O 0 3.917519197926822e-09
- O 0 1.175450314860882e-08
subunit O 0 1.2383491565515214e-08
precursor O 0 1.686049344584717e-08
was O 0 8.799212469767781e-10
normally O 0 2.911806906702452e-10
synthesized O 0 1.2393456261250435e-09
, O 0 8.169694781789971e-11
but O 0 1.5074451409358147e-10
not O 0 8.137083368220388e-11
phosphorylated O 0 1.7465112689407647e-09
or O 0 3.457025499198352e-10
secreted O 0 2.8469455681801037e-09
, O 0 5.970516858688768e-10
and O 0 1.3600131021362927e-09
the O 0 9.338100293021512e-10
mature O 0 4.429465860766868e-08
lysosomal O 0 5.003151954952045e-07
alpha O 0 2.0892928276339262e-08
- O 0 4.154238553155665e-08
subunit O 0 7.096163301412162e-08
was O 0 1.1424146073579777e-08
not O 0 3.837609785506402e-09
detected O 0 2.8190174816700164e-07
. O 0 1.1104645381010414e-07

When O 0 1.575697183398006e-06
the O 0 1.3668063125749086e-08
W474C O 0 1.4252979099182994e-06
- O 0 1.634605979461412e-07
containing O 0 9.46136147206289e-09
alpha O 0 2.3170207086309347e-08
- O 0 7.12169523353623e-08
subunit O 0 1.3421099254173896e-07
was O 0 2.677445110066401e-08
transiently O 0 4.969110136698873e-07
co O 0 3.647400944828405e-06
- O 0 5.133020408720768e-07
expressed O 0 1.7510543015575308e-09
with O 0 1.588839337873793e-10
the O 0 1.6035747729681304e-10
beta O 0 9.543647649934428e-09
- O 0 1.0424325402880186e-08
subunit O 0 9.216787333343746e-09
to O 0 6.234567861973517e-10
produce O 0 2.7879376585104865e-09
Hex O 0 1.2575414132243168e-07
A O 0 8.092496117662051e-10
( O 0 2.4889004746064813e-10
alphabeta O 0 3.0371040793397697e-08
) O 0 5.810114611648487e-10
in O 0 7.104241639410702e-10
COS O 0 7.932156586321071e-05
- O 0 2.156931714125676e-06
7 O 0 6.255547191358346e-09
cells O 0 9.019196944848318e-09
, O 0 2.0638393771754693e-10
the O 0 9.632662723024765e-11
mature O 0 1.5448520240823882e-09
alpha O 0 1.2614655986453727e-09
- O 0 1.8324238792999381e-09
subunit O 0 2.055264847200533e-09
was O 0 6.954857800778314e-10
present O 0 9.183279831015412e-11
, O 0 7.000583446270525e-11
but O 0 5.577640571630127e-10
its O 0 3.7100356120589595e-10
level O 0 3.793906078186637e-09
was O 0 1.3212407834473083e-09
much O 0 7.24057203083106e-11
lower O 0 1.0262433125518555e-09
than O 0 2.183073444239625e-10
that O 0 1.148066641754042e-10
from O 0 1.4384114732646225e-10
normal O 0 2.0318706717148416e-09
alpha O 0 1.7027277365855298e-09
- O 0 5.219353393925985e-09
subunit O 0 5.556078264135067e-09
transfections O 0 1.0905030656260806e-08
, O 0 3.1704923408870656e-11
although O 0 9.511236243042731e-11
higher O 0 3.255190283990572e-10
than O 0 9.283062513132379e-11
in O 0 6.048296863347957e-10
those O 0 1.6395630408894135e-09
cells O 0 7.387274791881282e-09
transfected O 0 6.343670122532785e-08
with O 0 3.7554154230790004e-10
an O 0 3.6082151155802933e-10
alpha O 0 1.126094062442462e-08
- O 0 1.6059370011589635e-07
subunit O 0 2.3176178842732043e-07
associated O 0 8.050399458170432e-08
with O 0 2.249377217822257e-08
infantile O 0 3.796744567807764e-05
TSD B-Disease 0 0.000329852569848299
. O 0 5.216479621594772e-07

Furthermore O 0 8.387789307562343e-07
, O 0 7.085787068206173e-09
the O 0 3.3151667522268724e-10
precursor O 0 3.1861436156077616e-08
level O 0 1.5354700622083328e-08
of O 0 1.6904559696495625e-10
the O 0 9.715979132352004e-10
W474C O 0 5.989695495145497e-08
alpha O 0 4.96616037182207e-09
- O 0 1.344579469986229e-08
subunit O 0 1.054627851715395e-08
was O 0 1.359914514331706e-09
found O 0 8.79449360557949e-11
to O 0 6.253894624386191e-11
accumulate O 0 2.6212538806191787e-09
in O 0 4.071326609178527e-11
comparison O 0 3.0879085954893526e-09
to O 0 1.1307467184806796e-09
the O 0 7.396180889962523e-10
normal O 0 1.1242828001911676e-08
alpha O 0 2.5952321180966464e-08
- O 0 1.0908197367598405e-07
subunit O 0 3.339935972235253e-07
precursor O 0 5.881647666683421e-07
levels O 0 6.381959565260331e-07
. O 0 1.36187949806299e-07

We O 0 5.812863150822523e-07
conclude O 0 9.413071211383794e-08
that O 0 1.0742594591661714e-09
the O 0 1.313897657340135e-09
1422 O 0 6.541689003825013e-07
G O 0 8.191432243620511e-07
- O 0 1.5773388213347062e-06
- O 0 9.820581681196927e-07
> O 0 4.320491342468813e-08
C O 0 3.993469732677113e-08
mutation O 0 6.797459040086551e-09
is O 0 1.063376955934281e-10
the O 0 1.0388865462340746e-10
cause O 0 1.202127286603627e-09
of O 0 2.1357998702953296e-10
Hex B-Disease 0 0.0008088478352874517
A I-Disease 0 2.837389956766856e-06
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.4599919313270675e-09
the O 0 9.749752116761101e-09
proband O 0 1.2799320757039823e-05
. O 0 5.935810349910753e-07

The O 0 1.4812202664415963e-07
resulting O 0 2.0121456145716365e-07
W474C O 0 1.7615153637962067e-06
substitution O 0 1.1839617997111418e-07
clearly O 0 4.72343266721964e-08
interferes O 0 9.49727336774231e-08
with O 0 4.2983597237089555e-10
alpha O 0 6.301724919666185e-09
- O 0 5.354940935120567e-09
subunit O 0 2.6481186132798484e-09
processing O 0 5.640668376827307e-09
, O 0 1.531972743107346e-10
but O 0 1.4349040011740755e-10
because O 0 1.9143579776947917e-10
the O 0 1.4899702999171538e-11
base O 0 4.0288192226789477e-10
substitution O 0 7.448903160955922e-10
falls O 0 9.153721691745886e-08
at O 0 3.2861321996868753e-10
the O 0 6.652259992856457e-11
first O 0 8.153354102979904e-10
position O 0 8.073723023471757e-09
of O 0 4.680057036354768e-11
exon O 0 2.299195500654605e-08
13 O 0 1.1086688234129838e-09
, O 0 1.3925217923205224e-10
aberrant O 0 6.338745084377706e-09
splicing O 0 1.1355122353506886e-07
may O 0 2.1761414004117796e-08
also O 0 6.716776579374084e-10
contribute O 0 6.422862242061456e-10
to O 0 8.879718071952425e-10
Hex B-Disease 0 1.4272772205004003e-05
A I-Disease 0 1.5711400180862256e-07
deficiency I-Disease 0 2.169466597479186e-06
in O 0 3.24059529210885e-10
this O 0 2.921408948086679e-10
proband O 0 3.1061370009410894e-07
. O 0 1.06616440120888e-08
. O 0 1.3288541822475963e-07

Two O 0 4.451767381397076e-07
frequent O 0 1.4500766155833844e-05
missense O 0 0.0009122872143052518
mutations O 0 0.01747756265103817
in O 0 4.815065040020272e-05
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.0542685231484938e-05

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 3.537725660862634e-06
an O 0 8.05883391876705e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 5.4565229220315814e-05
by O 0 5.599465779937418e-08
early O 0 1.5887850167928264e-05
childhood O 1 0.9968358874320984
deafness B-Disease 1 1.0
and O 0 0.3264019787311554
goiter B-Disease 1 1.0
. O 0 1.3401239812083077e-05

A O 0 9.250130261762024e-08
century O 0 3.381381219469404e-08
after O 0 8.847483634610853e-09
its O 0 3.578422280714477e-10
recognition O 0 8.1680200381129e-09
as O 0 6.0108540367309615e-09
a O 0 3.8012959890920683e-08
syndrome O 0 0.0005955472006462514
by O 0 7.134686730303486e-10
Vaughan O 0 8.191363320975142e-08
Pendred O 0 4.4264470488997176e-07
, O 0 2.1209389799992096e-09
the O 0 5.3833693058891186e-09
disease O 0 2.8177004196550115e-07
gene O 0 1.4610499476930272e-07
( O 0 3.305785423179941e-09
PDS O 0 3.6770558153875754e-07
) O 0 1.5765718730520462e-09
was O 0 1.1196769067467471e-09
mapped O 0 8.884131119657468e-08
to O 0 8.894995850994292e-09
chromosome O 0 5.408708148024743e-06
7q22 O 0 1.6297559341182932e-05
- O 0 4.8508201871300116e-05
q31 O 0 1.425807840860216e-05
. O 0 6.29725775525003e-07

1 O 0 6.447416467381117e-07
and O 0 8.853088040439161e-09
, O 0 8.893023539791045e-10
recently O 0 1.8431228099302643e-08
, O 0 1.8203351326295802e-10
found O 0 4.5498291245671396e-10
to O 0 1.710460939552405e-10
encode O 0 1.514828085191766e-08
a O 0 2.47655300711358e-08
putative O 0 9.279406185669359e-06
sulfate O 0 0.00014323569484986365
transporter O 0 4.225382144795731e-05
. O 0 9.045710953614616e-07

We O 0 5.875155011381139e-07
performed O 0 3.75760471627018e-08
mutation O 0 7.087830766749903e-08
analysis O 0 7.946792557333993e-09
of O 0 7.551683584017255e-11
the O 0 3.129125014655898e-10
PDS B-Disease 0 9.644809750852801e-08
gene O 0 2.403371901493756e-08
in O 0 1.2373994051628756e-09
patients O 0 2.4197468917463993e-08
from O 0 3.4332187093255584e-10
14 O 0 1.3594114722792483e-09
Pendred B-Disease 0 2.6992578838758163e-08
families O 0 1.9665516437505914e-10
originating O 0 2.368212570491579e-10
from O 0 9.68141886104057e-11
seven O 0 4.2857770110593663e-10
countries O 0 4.6297893296909365e-10
and O 0 9.846008452996102e-10
identified O 0 1.5435803746299825e-08
all O 0 3.7255674101288605e-09
mutations O 0 6.609477054553281e-07
. O 0 1.3892181982555485e-07

The O 0 8.253468308794254e-08
mutations O 0 2.5316762730653863e-07
include O 0 2.2867954196925666e-09
three O 0 8.41313185784287e-10
single O 0 6.157013565655234e-09
base O 0 9.758105434798381e-09
deletions O 0 7.791515344024447e-08
, O 0 1.7345666014634276e-09
one O 0 1.5401153685701274e-09
splice O 0 8.788299510342767e-07
site O 0 1.3015124977755477e-07
mutation O 0 1.3309156656760024e-06
and O 0 2.5693399408055484e-08
10 O 0 4.323046809417974e-08
missense O 0 2.7042209694627672e-05
mutations O 0 2.0824672901653685e-05
. O 0 1.16638057079399e-06

One O 0 2.915355707955314e-06
missense O 0 0.00010742164886323735
mutation O 0 6.933235454198439e-06
( O 0 1.2167947538443968e-08
L236P O 0 2.162821886031452e-07
) O 0 3.456869013263031e-09
was O 0 1.8355020836580138e-09
found O 0 5.393973601108826e-10
in O 0 8.558370678812821e-11
a O 0 9.496988612189838e-11
homozygous O 0 2.4896626982240377e-08
state O 0 5.262644764414404e-10
in O 0 4.0759051689320813e-10
two O 0 4.940206022041593e-10
consanguineous O 0 3.5529842534742784e-07
families O 0 2.529519038674266e-09
and O 0 2.9964777881197335e-10
in O 0 7.673429947008259e-11
a O 0 8.484094676797227e-11
heterozygous O 0 2.7918434231111178e-09
state O 0 9.308771808935745e-11
in O 0 9.154057373228497e-11
five O 0 3.182684393809865e-10
additional O 0 5.148362625106984e-09
non O 0 4.0843092392606195e-06
- O 0 3.305550853838213e-05
consanguineous O 0 4.84842385048978e-05
families O 0 2.136258672180702e-07
. O 0 2.0241940035248263e-07

Another O 0 2.19375874621619e-06
missense O 0 6.731956818839535e-05
mutation O 0 6.908194336574525e-06
( O 0 1.826712470176517e-08
T416P O 0 3.080880333072855e-07
) O 0 4.775754902652807e-09
was O 0 2.301932422454911e-09
found O 0 9.54974321842883e-10
in O 0 1.2761033896246943e-10
a O 0 1.2559790707467045e-10
homozygous O 0 1.6611004127753404e-08
state O 0 6.93747559399327e-10
in O 0 3.113942714794149e-10
one O 0 7.969009341302069e-10
family O 0 7.025895976120466e-10
and O 0 5.163622862625061e-10
in O 0 1.6502103850069005e-10
a O 0 3.4114819302821786e-10
heterozygous O 0 2.09672208484335e-08
state O 0 1.7534137475294642e-09
in O 0 1.253667725187313e-09
four O 0 1.2137026494940528e-08
families O 0 5.401360780865616e-08
. O 0 1.1971745550454216e-07

Pendred B-Disease 0 0.00010393722914159298
patients O 0 5.12958331455593e-06
in O 0 2.1279855655365054e-09
three O 0 3.4546479010799658e-09
non O 0 7.075633448039298e-07
- O 0 6.096809670452785e-07
consanguineous O 0 1.0147094826606917e-06
families O 0 1.6246333167657667e-09
were O 0 1.276239808278845e-10
shown O 0 1.819807360359249e-10
to O 0 1.0084571372415141e-10
be O 0 1.9009968599270621e-10
compound O 0 3.771590151302462e-09
heterozygotes O 0 7.624218056889731e-08
for O 0 5.950961390333021e-10
L236P O 0 4.0262003153657133e-07
and O 0 1.5574741496493516e-08
T416P O 0 3.4649090139282634e-06
. O 0 2.63318213455932e-07

In O 0 2.5159851091416385e-08
total O 0 1.9456112276827753e-09
, O 0 5.526482049766912e-10
one O 0 2.4040067159170064e-10
or O 0 1.0391446592095122e-09
both O 0 2.0391453803281223e-10
of O 0 3.15432124864401e-11
these O 0 3.23237270283272e-10
mutations O 0 1.64948517067387e-08
were O 0 5.180887385769495e-10
found O 0 5.497507449270245e-10
in O 0 3.5141325960275083e-10
nine O 0 1.0014956641768435e-09
of O 0 1.0618973755871508e-10
the O 0 1.7479108160856072e-09
14 O 0 6.79390810276459e-09
families O 0 2.5804822723074494e-09
analyzed O 0 2.8482105562943616e-07
. O 0 1.285763175928878e-07

The O 0 4.529396857577694e-09
identification O 0 1.4477187448846962e-08
of O 0 2.0586538029832013e-10
two O 0 1.2990956088643202e-09
frequent O 0 1.749266687056661e-07
PDS B-Disease 0 7.921831638668664e-06
mutations O 0 1.5548049532299046e-06
will O 0 6.200874813622193e-10
facilitate O 0 5.28379617836805e-10
the O 0 4.8633275184784e-10
molecular O 0 6.110587946750456e-07
diagnosis O 0 0.0002527748001739383
of O 0 5.173644694878021e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 8.41920973471133e-06

Insertional O 0 0.0005267205415293574
mutation O 0 9.70213659456931e-06
by O 0 1.6536400693212272e-08
transposable O 0 6.5619792621873785e-06
element O 0 3.811213673543534e-07
, O 0 5.06452435544702e-09
L1 O 0 8.497142403030011e-07
, O 0 5.630797494937667e-10
in O 0 4.358618743705023e-10
the O 0 4.297435740596711e-09
DMD B-Disease 1 1.0
gene O 0 7.158150765462779e-07
results O 0 1.975648586949319e-07
in O 0 2.4526821462700354e-08
X B-Disease 1 0.9999980926513672
- I-Disease 1 0.9999996423721313
linked I-Disease 1 0.9999992847442627
dilated I-Disease 1 0.999920129776001
cardiomyopathy I-Disease 1 0.9999998807907104
. O 0 3.7452018659678288e-06

X B-Disease 1 0.9999992847442627
- I-Disease 1 1.0
linked I-Disease 1 0.9999971389770508
dilated I-Disease 1 0.9999730587005615
cardiomyopathy I-Disease 1 1.0
( O 0 6.301138455455657e-08
XLDCM B-Disease 0 5.520721060747746e-06
) O 0 2.8463864598649025e-09
is O 0 3.2351482603942827e-10
a O 0 9.597658223725603e-10
clinical O 0 5.024060669711616e-07
phenotype O 0 2.101651404018412e-07
of O 0 1.172265340354528e-10
dystrophinopathy B-Disease 0 3.5930872854805784e-06
which O 0 1.9010995000456887e-09
is O 0 3.318133823260183e-10
characterized O 0 3.887448141171035e-09
by O 0 1.2485229516912e-09
preferential O 0 9.841376140684588e-07
myocardial B-Disease 0 1.8178572645410895e-05
involvement I-Disease 0 9.441446024993638e-08
without O 0 3.4818026239946676e-09
any O 0 3.3561089463063354e-09
overt O 0 3.0547425922122784e-07
clinical O 0 1.139096184488153e-06
signs O 0 7.149520229177142e-07
of O 0 1.3432828893655824e-07
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 4.109132714802399e-05

To O 0 1.703186569557147e-08
date O 0 4.701249878280578e-08
, O 0 5.718401308030252e-10
several O 0 9.219648933189717e-10
mutations O 0 5.906728972604469e-08
in O 0 9.51196788001596e-10
the O 0 1.5250209983719287e-08
Duchenne B-Disease 0 7.684360025450587e-05
muscular I-Disease 0 5.131540547154145e-06
dystrophy I-Disease 0 2.0709669570351252e-06
gene O 0 5.462684953272401e-07
, O 0 2.037541690924627e-08
DMD O 1 1.0
, O 0 4.7867709795923474e-09
have O 0 2.173593305343502e-09
been O 0 1.6056904694750074e-09
identified O 0 9.929749467119109e-09
in O 0 7.640573729261746e-10
patients O 0 9.123111155417973e-09
with O 0 8.548255853169096e-11
XLDCM B-Disease 0 5.286117811920121e-06
, O 0 5.320872076275407e-10
but O 0 1.0252337867555639e-09
a O 0 3.4295211115420443e-10
pathogenic O 0 1.3747859739510204e-08
correlation O 0 1.7430011212127283e-08
of O 0 6.981368955161216e-11
these O 0 8.772433890413822e-10
cardiospecific O 0 1.008173626360076e-06
mutations O 0 3.557486820682243e-07
in O 0 3.942292714498308e-09
DMD O 1 1.0
with O 0 8.70931493590632e-10
the O 0 2.101822271782794e-09
XLDCM B-Disease 0 0.0006034841644577682
phenotype O 0 4.7732006350997835e-05
has O 0 4.759189309311296e-08
remained O 0 2.152528466581316e-08
to O 0 8.22338475092721e-10
be O 0 4.919859630803103e-09
elucidated O 0 2.88475644083519e-06
. O 0 1.9072498957939388e-07

We O 0 3.702063168020686e-06
report O 0 1.8552487546230623e-08
here O 0 3.16938142397305e-10
the O 0 4.4240302393694364e-11
identification O 0 3.094476674903035e-09
of O 0 2.581913571830796e-10
a O 0 3.5874039294725435e-09
unique O 0 6.979009015140036e-08
de O 0 9.226040447174455e-07
novo O 0 7.639005730197823e-07
L1 O 0 4.812645215679368e-07
insertion O 0 3.701056172644712e-08
in O 0 1.9489390101767867e-09
the O 0 8.636166226594355e-10
muscle O 0 1.0618847312571233e-07
exon O 0 2.904677671722311e-07
1 O 0 2.1580618181360478e-08
in O 0 5.808078906710534e-09
DMD O 1 1.0
in O 0 6.106279926143543e-09
three O 0 6.437104627110557e-09
XLDCM B-Disease 0 7.157439540605992e-06
patients O 0 7.594914563924249e-08
from O 0 2.7164021032533014e-10
two O 0 8.953204289063876e-10
unrelated O 0 1.576949273385253e-07
Japanese O 0 2.161741292638908e-07
families O 0 9.209744433746891e-08
. O 0 2.2507126118398446e-07

The O 0 3.016729621663217e-08
insertion O 0 2.1416686024622322e-07
was O 0 1.2184925068936536e-08
a O 0 1.687901929336988e-09
5 O 0 5.350020426675428e-09
- O 0 8.852889266108832e-08
truncated O 0 4.0855340444068133e-07
form O 0 3.33417489173371e-08
of O 0 1.0071927736277075e-09
human O 0 1.2326604625911841e-08
L1 O 0 7.111073614396446e-07
inversely O 0 6.842613231583528e-08
integrated O 0 2.2930255738629057e-07
in O 0 1.2516176983723426e-09
the O 0 6.868091095846296e-10
5 O 0 7.590783113187172e-09
- O 0 1.9882482149569114e-07
untranslated O 0 2.7521291485754773e-06
region O 0 5.7770797923240025e-08
in O 0 1.5660881480528133e-09
the O 0 5.751654152952312e-10
muscle O 0 1.9908167558924106e-08
exon O 0 3.2054664700353896e-08
1 O 0 2.8569600019068275e-09
, O 0 1.85810838937428e-10
which O 0 4.3273071237415195e-10
affected O 0 7.067184060183251e-10
the O 0 2.279190204623749e-11
transcription O 0 8.327400435881316e-10
or O 0 3.3761209383698088e-09
the O 0 5.795328106295017e-10
stability O 0 1.4884273369375478e-08
of O 0 5.738239397534706e-11
the O 0 5.496196830989675e-10
muscle O 0 6.22429539021141e-08
form O 0 1.904972402044791e-09
of O 0 6.426057602704205e-11
dystrophin O 0 1.8810638380273303e-08
transcripts O 0 8.001821427683353e-09
but O 0 4.4646705776862916e-10
not O 0 5.2598422145555546e-11
that O 0 1.5579650416985835e-11
of O 0 5.760805027454907e-12
the O 0 3.334852116676501e-10
brain O 0 1.9881950663602765e-07
or O 0 6.181288370044058e-09
Purkinje O 0 5.213634608480788e-07
cell O 0 4.674506328683492e-07
form O 0 2.6983416390180537e-08
, O 0 6.2134284384285365e-09
probably O 0 2.777165946099558e-07
due O 0 1.993807252631541e-08
to O 0 6.640347716135864e-10
its O 0 5.284381265902027e-10
unique O 0 2.4592485825536414e-09
site O 0 1.0238389691608063e-08
of O 0 9.831671032856093e-10
integration O 0 2.3248125557984167e-07
. O 0 1.748362734588227e-07

We O 0 2.0795927468952868e-07
speculate O 0 5.0255650307917676e-08
that O 0 9.713158055646431e-11
this O 0 2.3993742756522884e-11
insertion O 0 1.4071886988986648e-09
of O 0 7.482048314244594e-11
an O 0 5.578523754046216e-10
L1 O 0 6.68756001687143e-07
sequence O 0 3.155186334424798e-08
in O 0 1.3637387219489483e-08
DMD O 1 1.0
is O 0 2.4173836266072612e-09
responsible O 0 6.080313474932098e-10
for O 0 2.0991559185334907e-11
some O 0 1.0046629327076229e-11
of O 0 8.532353643064816e-12
the O 0 7.505460836165767e-11
population O 0 1.0463863109322347e-09
of O 0 1.131479632210386e-10
Japanese O 0 1.7083799264128174e-07
patients O 0 1.0473912404052044e-08
with O 0 5.426747939907273e-10
XLDCM B-Disease 0 1.7170840465041692e-06
. O 0 1.8890638386892533e-08
. O 0 1.946134204899863e-07

Severe O 0 0.004631150979548693
early O 0 3.1654228223487735e-05
- O 1 0.9998878240585327
onset O 1 0.9997449517250061
obesity B-Disease 1 1.0
, O 0 1.4305297781902482e-06
adrenal B-Disease 1 0.9999998807907104
insufficiency I-Disease 1 1.0
and O 0 1.0578920495163402e-07
red O 0 1.4949847582101938e-06
hair O 1 0.9999914169311523
pigmentation O 1 0.9949411153793335
caused O 0 1.6641914726278628e-06
by O 0 3.2747852429793056e-08
POMC O 0 9.732927719596773e-05
mutations O 0 4.887733666691929e-06
in O 0 1.1204422278865422e-08
humans O 0 1.5096513550361124e-07
. O 0 2.604712108222884e-07

Sequential O 0 1.8399236068944447e-05
cleavage O 0 2.991538895003032e-05
of O 0 5.639699818260624e-09
the O 0 8.842180876378336e-10
precursor O 0 2.4255550457041863e-08
protein O 0 4.009635290458391e-08
pre O 0 3.87052614314598e-06
- O 0 7.867398380767554e-06
pro O 0 2.2277229163591983e-06
- O 0 1.2663846064242534e-05
opiomelanocortin O 0 2.4060518626356497e-06
( O 0 4.474698389600462e-09
POMC O 0 1.980074785024044e-06
) O 0 1.4953241977977427e-09
generates O 0 7.037701976742028e-09
the O 0 4.041643908436754e-09
melanocortin O 0 5.1026895562245045e-06
peptides O 0 1.4702611679240363e-06
adrenocorticotrophin O 0 4.961238573741866e-06
( O 0 1.2589880249436192e-08
ACTH O 0 3.4093241083610337e-06
) O 0 1.874208566121638e-09
, O 0 1.5163016398034301e-09
melanocyte O 0 8.44221176521387e-06
- O 0 1.6171317838598043e-05
stimulating O 0 2.009619265663787e-06
hormones O 0 7.534415544796502e-07
( O 0 1.2844996177818757e-09
MSH O 0 5.305949457579118e-07
) O 0 4.042211843025001e-10
alpha O 0 3.788220848122137e-10
, O 0 3.3573605701109344e-11
beta O 0 8.398061690506609e-10
and O 0 8.561538283879955e-11
gamma O 0 8.290253483700383e-10
as O 0 7.770489113267942e-11
well O 0 7.962912967895974e-11
as O 0 9.849121518357151e-11
the O 0 1.748983735616605e-10
opioid O 0 1.669633036271989e-07
- O 0 2.8366602577989397e-07
receptor O 0 2.0414712764704745e-07
ligand O 0 1.8590820616282144e-07
beta O 0 1.2218552001286298e-06
- O 0 7.7479462561314e-06
endorphin O 0 0.00035418791230767965
. O 0 1.196845005324576e-06

While O 0 9.324919147957189e-08
a O 0 1.3211096661081e-09
few O 0 4.1520502591652075e-09
cases O 0 6.971649035847349e-09
of O 0 1.346205591445937e-09
isolated O 0 0.0012032120721414685
ACTH B-Disease 1 0.99993896484375
deficiency I-Disease 1 0.9461573362350464
have O 0 1.1459674986724622e-08
been O 0 2.734166670848026e-08
reported O 0 8.300909115632749e-08
( O 0 4.239324002952571e-09
OMIM O 0 1.3879704056307673e-05
201400 O 0 2.816394726323779e-07
) O 0 2.8723352585302564e-09
, O 0 6.973134847321205e-10
an O 0 1.8574005666849303e-09
inherited O 0 0.00040621243533678353
POMC O 0 0.09021515399217606
defect O 0 0.47139087319374084
has O 0 4.51490862474202e-08
not O 0 2.078698546625901e-09
been O 0 9.404664824685938e-10
described O 0 2.174381119601776e-09
so O 0 2.3739030741154465e-09
far O 0 2.2189603043898387e-08
. O 0 2.109885031131853e-07

Recent O 0 2.016324742726283e-06
studies O 0 1.2909529800708697e-07
in O 0 1.3100091011963855e-09
animal O 0 5.960335780486048e-09
models O 0 1.0435311281753457e-07
elucidated O 0 1.5801558106431912e-07
a O 0 1.331987076191865e-09
central O 0 3.97134103380381e-09
role O 0 1.8290691627953493e-08
of O 0 4.1635236924797425e-10
alpha O 0 2.1130782457134956e-08
- O 0 2.0753846285970212e-07
MSH O 0 2.0787213088624412e-06
in O 0 2.8989283196168003e-10
the O 0 7.360628773156463e-11
regulation O 0 9.622181940116548e-10
of O 0 4.201694547845136e-11
food O 0 9.22272702652549e-10
intake O 0 1.0020574370273039e-09
by O 0 3.5034027762170794e-11
activation O 0 1.0539799033537633e-09
of O 0 4.364539632484288e-11
the O 0 1.916858005657218e-09
brain O 0 1.4727030475114589e-06
melanocortin O 0 7.737511623417959e-06
- O 0 8.551710379833821e-06
4 O 0 5.793013002630687e-08
- O 0 7.380601232398476e-07
receptor O 0 3.7007109199294064e-07
( O 0 4.511050200051159e-09
MC4 O 0 4.198915121378377e-06
- O 0 4.5637833068212785e-07
R O 0 2.1409640282854525e-07
; O 0 9.104922926717052e-10
refs O 0 3.3823681633293745e-08
3 O 0 1.3307858148792207e-09
- O 0 1.4619343069455226e-08
5 O 0 2.648986308084744e-10
) O 0 4.152964777626167e-11
and O 0 2.499059986726948e-11
the O 0 4.176032089575621e-11
linkage O 0 2.3840321716761537e-08
of O 0 3.5674710407995747e-10
human O 0 1.2457927134335023e-08
obesity B-Disease 1 0.999998927116394
to O 0 9.420696445161525e-10
chromosome O 0 4.561094613109162e-08
2 O 0 2.2320756354332616e-09
in O 0 1.8927732992057855e-10
close O 0 2.9051072658603516e-09
proximity O 0 1.1411645850500918e-08
to O 0 3.1389417731730873e-09
the O 0 1.2224654621917352e-09
POMC O 0 5.567766265812679e-07
locus O 0 5.2334115707708406e-08
, O 0 2.9077332208693463e-10
led O 0 1.4115211777188108e-10
to O 0 3.393633291048914e-11
the O 0 6.924966156063306e-11
proposal O 0 5.0631334680417694e-09
of O 0 6.720399930992826e-11
an O 0 3.487410360492049e-10
association O 0 1.7250052497530532e-09
of O 0 4.149040000456239e-10
POMC O 0 3.6767160054296255e-06
with O 0 1.3336121540419299e-08
human O 0 6.017481268827396e-07
obesity B-Disease 1 0.9999996423721313
. O 0 1.7738349242790719e-06

The O 0 1.0330569466532324e-07
dual O 0 2.972328502437449e-06
role O 0 1.625974022090304e-07
of O 0 1.858803999610359e-09
alpha O 0 1.5553256105249602e-07
- O 0 2.0283346202631947e-06
MSH O 0 1.4181162441673223e-05
in O 0 1.29478638921654e-09
regulating O 0 3.268457859917362e-08
food O 0 5.726917606807547e-09
intake O 0 1.1939724764431503e-08
and O 0 4.1757150515131514e-10
influencing O 0 8.579679899867187e-08
hair O 0 0.0033735584001988173
pigmentation O 0 4.91450691697537e-06
predicts O 0 1.636390436488e-07
that O 0 4.752327420476377e-10
the O 0 3.947550342164874e-10
phenotype O 0 1.4719010721364612e-07
associated O 0 7.520514877512596e-09
with O 0 4.666795838659255e-10
a O 0 1.4401643433359368e-08
defect O 0 1.0224367542832624e-05
in O 0 7.921641120844924e-09
POMC O 0 5.216825684328796e-06
function O 0 4.9089702969240534e-08
would O 0 6.448287237503791e-09
include O 0 1.0579420894885061e-08
obesity B-Disease 1 0.9999996423721313
, O 0 3.1301294889374276e-09
alteration O 0 5.854204232491611e-07
in O 0 7.91047156667446e-08
pigmentation O 1 0.6976596713066101
and O 0 0.00023782678181305528
ACTH B-Disease 1 0.9989635944366455
deficiency I-Disease 0 0.2746224105358124
. O 0 6.967490548959177e-07

The O 0 3.7677523323509376e-08
observation O 0 1.3104225615734322e-07
of O 0 3.295760886423693e-10
these O 0 4.934407105139371e-09
symptoms O 0 2.263887068920667e-07
in O 0 2.3002327820265123e-10
two O 0 5.627082688697271e-10
probands O 0 1.415462236309395e-07
prompted O 0 3.6909522105332826e-09
us O 0 8.775145610151469e-10
to O 0 3.925998068310399e-11
search O 0 1.7055847845171002e-09
for O 0 9.233885878145998e-10
mutations O 0 1.7260600770896417e-07
within O 0 9.11470987574603e-09
their O 0 5.6152309468870953e-08
POMC O 0 0.00010181626566918567
genes O 0 5.185684585740091e-06
. O 0 8.605325660937524e-07

Patient O 0 3.935511995223351e-05
1 O 0 3.040031231194007e-07
was O 0 4.169231182515887e-09
found O 0 2.87326551440259e-10
to O 0 1.3538112297872829e-10
be O 0 2.7643626276940836e-10
a O 0 1.5529222352483885e-10
compound O 0 7.250225309007874e-09
heterozygote O 0 1.6457305207495665e-07
for O 0 6.407310793044019e-10
two O 0 1.1983933845272077e-09
mutations O 0 5.77952690150596e-08
in O 0 7.246102051716719e-10
exon O 0 1.0974267183883057e-07
3 O 0 4.898744521142362e-09
( O 0 3.7382494322280024e-10
G7013T O 0 2.102476948095955e-08
, O 0 5.087487098265342e-10
C7133delta O 0 9.388417510081126e-08
) O 0 3.7178421452566113e-10
which O 0 2.261980741602443e-10
interfere O 0 3.633438439010206e-09
with O 0 1.1189440346504043e-10
appropriate O 0 3.703271689303733e-09
synthesis O 0 1.746139055569529e-08
of O 0 2.01028349522403e-09
ACTH O 0 4.559104127110913e-06
and O 0 1.2248981384743729e-08
alpha O 0 4.298512124023546e-07
- O 0 1.1879652447532862e-05
MSH O 0 0.0003172049764543772
. O 0 3.1026877422846155e-07

Patient O 0 4.597828956320882e-05
2 O 0 7.433822446500926e-08
was O 0 5.264283675643355e-09
homozygous O 0 7.581106586940223e-08
for O 0 6.044260647541932e-10
a O 0 3.4125313685962055e-09
mutation O 0 1.4155430960727244e-07
in O 0 4.212965531991131e-09
exon O 0 5.276289130051737e-07
2 O 0 3.3524447218269415e-08
( O 0 2.824968259318439e-09
C3804A O 0 5.114939654049522e-07
) O 0 1.4504080603217062e-08
which O 0 3.773419976482728e-08
abolishes O 0 6.077413218008587e-06
POMC O 0 4.120598896406591e-05
translation O 0 7.083060040713463e-07
. O 0 6.554321885232639e-07

These O 0 2.3706238749809927e-08
findings O 0 5.990663964894338e-09
represent O 0 3.5745956195043505e-10
the O 0 8.554698616158873e-11
first O 0 1.7863664714123928e-10
examples O 0 5.620882648216252e-10
of O 0 8.066294854280898e-11
a O 0 6.453002043826928e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 6.366394522672181e-09
the O 0 9.82248615777337e-10
POMC O 0 1.4804987813477055e-06
gene O 0 2.6647693829318087e-08
and O 0 6.628553816945271e-10
define O 0 3.51413582677651e-08
a O 0 3.892048461295872e-09
new O 0 1.7741722047048825e-07
monogenic B-Disease 1 0.8609444499015808
endocrine I-Disease 1 0.9718219637870789
disorder I-Disease 0 0.08738844841718674
resulting O 0 5.30228732031901e-08
in O 0 6.733879232001527e-09
early O 0 6.367323749145726e-06
- O 1 0.9999122619628906
onset O 1 0.9998452663421631
obesity B-Disease 1 1.0
, O 0 7.526999070250895e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 9.656756105869135e-08
red O 0 9.123198196903104e-07
hair O 1 0.8735215067863464
pigmentation O 0 0.0001426950329914689
. O 0 8.333493894951971e-08
. O 0 2.8669410312431864e-07

A O 0 2.815959305735305e-06
European O 0 2.4711562218726613e-06
multicenter O 0 5.1502884161891416e-05
study O 0 5.10008362653025e-07
of O 0 2.1648338588420302e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 3.553620331331331e-08
classification O 0 4.322090063624273e-08
of O 0 1.213669026389752e-10
105 O 0 4.074578008328444e-09
mutations O 0 1.4878432352816162e-07
and O 0 1.324162224314307e-09
a O 0 4.965731714712263e-10
general O 0 4.2958928081482384e-10
system O 0 5.313329776157616e-09
for O 0 4.4300615953396516e-10
genotype O 0 8.523778660673997e-07
- O 0 2.996104058183846e-07
based O 0 1.4959068650455265e-08
prediction O 0 8.535055684433246e-08
of O 0 1.5200833924922108e-09
metabolic O 0 2.658144148881547e-05
phenotype O 0 2.703898644540459e-05
. O 0 6.769772085135628e-07

Phenylketonuria B-Disease 0 0.005747681949287653
( O 0 6.183036020956933e-07
PKU B-Disease 0 1.4981852473283652e-05
) O 0 2.2439136770913137e-08
and O 0 1.5546813614264465e-08
mild B-Disease 0 2.0071745893801562e-05
hyperphenylalaninemia I-Disease 1 1.0
( O 0 3.4869890441768803e-07
MHP B-Disease 1 1.0
) O 0 7.755930653274845e-08
are O 0 3.5246749519046716e-08
allelic B-Disease 0 0.006819445174187422
disorders I-Disease 1 0.9996474981307983
caused O 0 6.53959943974769e-08
by O 0 1.0384155757492408e-09
mutations O 0 4.360668981462368e-07
in O 0 1.2738085031216428e-09
the O 0 1.7196603030456004e-09
gene O 0 8.894573397810746e-07
encoding O 0 3.394258328626165e-06
phenylalanine O 0 0.0005490640178322792
hydroxylase O 0 0.01703573949635029
( O 0 3.597180295855651e-07
PAH O 0 0.0001366821670671925
) O 0 2.1292599683420121e-07
. O 0 3.435738449297787e-07

Previous O 0 3.242546711135219e-07
studies O 0 8.341365287378721e-08
have O 0 8.681617091887972e-10
suggested O 0 7.754828446060458e-10
that O 0 6.27772486772038e-11
the O 0 1.1449700909604843e-10
highly O 0 7.266256485394251e-09
variable O 0 1.5880463024586788e-06
metabolic O 0 0.00043458491563796997
phenotypes O 0 4.201153933536261e-05
of O 0 2.746067764292093e-07
PAH B-Disease 1 0.999806821346283
deficiency I-Disease 1 0.9969883561134338
correlate O 0 5.870210770808626e-06
with O 0 5.754469043495192e-07
PAH O 0 0.06683166325092316
genotypes O 0 0.00041260491707362235
. O 0 2.638747901073657e-06

We O 0 1.0239540415568626e-06
identified O 0 8.928553540954454e-08
both O 0 6.0019180736503586e-09
causative O 0 1.363497744932829e-06
mutations O 0 7.635313181708625e-07
in O 0 3.517701907540527e-09
686 O 0 1.6618838571957895e-07
patients O 0 7.212229746755838e-08
from O 0 6.934459118035363e-10
seven O 0 5.971088956613357e-09
European O 0 1.5794960006587644e-07
centers O 0 2.544827850670117e-07
. O 0 3.453530155184126e-07

On O 0 2.679263744198579e-08
the O 0 3.8981456951248106e-10
basis O 0 1.256252990522455e-09
of O 0 7.1244982136065e-11
the O 0 7.015129588339164e-10
phenotypic O 0 3.846868423806882e-07
characteristics O 0 5.84084283161701e-08
of O 0 1.3936862774954761e-09
297 O 0 6.921766981804467e-08
functionally O 0 1.2417437744716153e-07
hemizygous O 0 8.205075232581294e-07
patients O 0 1.36183658128175e-07
, O 0 1.2885527367334504e-10
105 O 0 2.422482769937062e-10
of O 0 3.59310463327045e-11
the O 0 2.0637015707425377e-10
mutations O 0 2.1816978446054236e-08
were O 0 3.4620670219531746e-10
assigned O 0 1.3420167199740263e-09
to O 0 1.281684480769485e-10
one O 0 1.690868833836845e-10
of O 0 2.219244753243199e-11
four O 0 1.102818392162419e-09
arbitrary O 0 7.563486548178844e-08
phenotype O 0 2.7995454729534686e-05
categories O 0 4.1194134610123e-06
. O 0 4.817117655875336e-07

We O 0 2.522255897474679e-07
proposed O 0 2.0181216697778837e-08
and O 0 4.467748393466309e-09
tested O 0 1.1321240833694901e-08
a O 0 7.566837434413998e-11
simple O 0 4.5027609418824e-10
model O 0 5.422777782371213e-09
for O 0 1.0883326184707443e-10
correlation O 0 2.2924739440099984e-08
between O 0 1.1345582251465203e-08
genotype O 0 1.8416350258121383e-06
and O 0 1.6951135606291245e-08
phenotypic O 0 4.242357590555912e-06
outcome O 0 3.951422058889875e-06
. O 0 9.765609547685017e-07

The O 0 7.473872187802044e-08
observed O 0 2.612461287299084e-07
phenotype O 0 9.77449872152647e-07
matched O 0 1.5843991718611505e-07
the O 0 1.6643026956586482e-09
predicted O 0 5.911778799827516e-08
phenotype O 0 1.5159372424022877e-07
in O 0 7.474463825651867e-10
79 O 0 5.057689822507427e-09
% O 0 2.814211086388241e-10
of O 0 8.981073697233999e-12
the O 0 6.470148028459022e-11
cases O 0 3.184021712954177e-09
, O 0 3.332156217616955e-10
and O 0 2.0138439527084273e-10
in O 0 8.53125139976818e-11
only O 0 1.2098232138324505e-10
5 O 0 8.17979850520345e-11
of O 0 7.300837885637623e-12
184 O 0 7.478570540619955e-10
patients O 0 2.376377850055178e-08
was O 0 2.7010693681717157e-09
the O 0 1.9860207922661743e-10
observed O 0 6.801505580966705e-09
phenotype O 0 5.70890090756393e-09
more O 0 1.685133803330796e-11
than O 0 6.17527279311858e-11
one O 0 1.533940474640616e-10
category O 0 3.4216691702226854e-09
away O 0 1.9897945513491777e-09
from O 0 1.3197892778649134e-10
that O 0 1.24444321514261e-09
expected O 0 2.3688523143050588e-08
. O 0 9.515641608004444e-08

Among O 0 8.341699953007264e-08
the O 0 1.3798764353367687e-09
seven O 0 5.415291548516166e-10
contributing O 0 8.907827253601397e-10
centers O 0 1.0499608960046203e-09
, O 0 7.455551453983134e-11
the O 0 6.360453136400324e-11
proportion O 0 1.1416043221856853e-08
of O 0 6.232614424561689e-11
patients O 0 4.4942516375101604e-09
for O 0 3.8983517802737566e-11
whom O 0 1.5763614857888797e-09
the O 0 1.1748932382538158e-10
observed O 0 8.718526345319333e-09
phenotype O 0 3.05985032866829e-08
did O 0 3.8911869282287626e-09
not O 0 9.600586992064564e-10
match O 0 7.329786111398562e-09
the O 0 4.497662520197565e-10
predicted O 0 6.079031322769879e-08
phenotype O 0 1.190180327625967e-07
was O 0 2.3784534342041752e-09
4 O 0 1.5575505329934458e-09
% O 0 2.031072421360136e-09
- O 0 9.61223995545879e-05
23 O 0 5.2148084961345376e-08
% O 0 2.2805755062194066e-09
( O 0 1.8397853240870177e-09
P O 0 1.659193185332697e-05
< O 0 3.474586307561367e-08
. O 0 1.4781454948931128e-09
0001 O 0 8.5475349465014e-08
) O 0 1.3148145072694462e-10
, O 0 5.780002865218847e-11
suggesting O 0 2.9711764160111898e-09
that O 0 1.7288087628131166e-10
differences O 0 2.190640779886621e-09
in O 0 1.9570426876280855e-11
methods O 0 4.276941301117887e-10
used O 0 3.6355024546352865e-10
for O 0 6.45059283765903e-11
mutation O 0 1.2478189148623642e-08
detection O 0 2.5572441941790203e-08
or O 0 1.888833267571499e-08
phenotype O 0 2.1903513243159978e-06
classification O 0 3.223034639177058e-07
may O 0 7.233153187513608e-09
account O 0 1.490540246784633e-09
for O 0 1.134509430844588e-10
a O 0 4.347012194649835e-10
considerable O 0 5.117620549555113e-09
proportion O 0 1.5743948722501955e-07
of O 0 4.233312367318831e-09
genotype O 0 0.3651588261127472
- O 1 0.867575466632843
phenotype O 0 0.00015847095346543938
inconsistencies O 0 1.2416610843501985e-05
. O 0 6.043896974006202e-07

Our O 0 6.222788329068862e-07
data O 0 1.0875621825334747e-07
indicate O 0 3.3058878301517325e-08
that O 0 2.342838589797225e-09
the O 0 2.8075481939282554e-09
PAH O 0 1.1595394425967243e-05
- O 0 1.131653448283032e-06
mutation O 0 1.6943579339567805e-07
genotype O 0 3.00420680332536e-07
is O 0 5.140049497143195e-10
the O 0 9.65945101683019e-11
main O 0 3.225206102186462e-09
determinant O 0 1.0880913947630688e-07
of O 0 8.535388507091568e-10
metabolic O 0 7.40711084290524e-06
phenotype O 0 9.513061627330899e-07
in O 0 1.2094545365215481e-09
most O 0 1.3233853124461348e-08
patients O 0 1.5449506918230327e-06
with O 0 4.361376113592996e-07
PAH B-Disease 1 0.99950110912323
deficiency I-Disease 1 0.9962092638015747
. O 0 9.037847803483601e-07

In O 0 3.8705664451299526e-08
the O 0 7.294023718351639e-10
present O 0 5.244538137105792e-10
study O 0 8.116053940021573e-10
, O 0 1.1837647528878392e-10
the O 0 2.2052118464621628e-10
classification O 0 9.326250882679687e-09
of O 0 2.2241444797010956e-10
105 O 0 2.3572956919792887e-08
PAH O 0 6.813596883148421e-06
mutations O 0 2.5774986056603666e-07
may O 0 2.263449427886144e-09
allow O 0 2.301637214152663e-10
the O 0 5.138997560827363e-11
prediction O 0 3.273297410899545e-09
of O 0 2.299016706175383e-11
the O 0 7.395659085140949e-10
biochemical O 0 7.341611762967659e-07
phenotype O 0 2.172751436546605e-07
in O 0 6.724109047340221e-10
> O 0 6.5602354659688444e-09
10 O 0 3.319849395388985e-10
, O 0 1.3061013381943098e-10
000 O 0 1.6608336927959044e-09
genotypes O 0 6.622140347189998e-08
, O 0 3.4430092110682153e-10
which O 0 3.923110447612288e-10
may O 0 9.382520316236764e-10
be O 0 1.3605721584097896e-11
useful O 0 1.1134215077701626e-10
for O 0 2.3466915910486108e-11
the O 0 2.2256042842005996e-10
management O 0 4.148068555309692e-09
of O 0 2.992605330209841e-10
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.685588356143853e-07
newborns O 0 4.4942560634808615e-05
. O 0 2.636644751419226e-07

Somatic O 0 0.00030747122946195304
instability O 0 5.711314588552341e-05
of O 0 1.2050709763400391e-08
the O 0 7.599475715380777e-09
CTG O 0 9.659805982664693e-06
repeat O 0 7.949355449454742e-07
in O 0 1.2642380475824666e-09
mice O 0 2.0964181501881285e-08
transgenic O 0 1.6095578203589866e-08
for O 0 3.7015820963937074e-10
the O 0 2.912919461195429e-09
myotonic B-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999995231628418
region O 0 1.3377668892644579e-06
is O 0 9.484742768961496e-09
age O 0 5.7970335198831435e-09
dependent O 0 1.6295187421633273e-08
but O 0 2.357631867511145e-09
not O 0 2.3337839993864407e-10
correlated O 0 2.01546646039219e-09
to O 0 2.9158087055947135e-10
the O 0 2.9695942926899477e-10
relative O 0 3.1015691348557084e-08
intertissue O 0 1.1217625797144137e-06
transcription O 0 3.2450711273668276e-07
levels O 0 4.34299749940692e-07
and O 0 1.1876313976699748e-07
proliferative O 0 0.0003422855807002634
capacities O 0 9.83007612376241e-06
. O 0 8.34311379094288e-07

A O 0 1.8028621298071812e-06
( O 0 5.917532064358966e-08
CTG O 0 3.2129883038578555e-06
) O 0 6.541468255960581e-09
nexpansion O 0 3.8771284494032443e-07
in O 0 1.287457696008687e-09
the O 0 2.3435358098566894e-09
3 O 0 1.0445088349797516e-07
- O 0 0.0009312672191299498
untranslated O 0 0.02398010715842247
region O 0 6.560875362993102e-07
( O 0 2.4410506949124056e-09
UTR O 0 2.0966626834706403e-07
) O 0 1.0313550014018347e-09
of O 0 1.2312401098668602e-10
the O 0 2.3581545605111387e-08
DM O 1 0.9999998807907104
protein O 0 2.692278542326676e-07
kinase O 0 3.846024583253893e-07
gene O 0 1.0144061235450863e-07
( O 0 1.644210323448192e-09
DMPK O 0 1.4560798433649325e-07
) O 0 3.1006669454214375e-10
is O 0 1.711910058155297e-10
responsible O 0 2.9891042974128368e-09
for O 0 8.71453575967962e-09
causing O 0 1.2925738701596856e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.4832261260598898e-05
DM B-Disease 1 1.0
) O 0 1.5043279972815071e-06
. O 0 8.00809800693969e-07

Major O 0 1.0090517207572702e-05
instability O 0 7.872877176851034e-06
, O 0 4.039054424254118e-09
with O 0 2.5546967319378666e-10
very O 0 5.68419034063794e-10
large O 0 1.5386852902921078e-09
expansions O 0 5.449677331625935e-08
between O 0 1.0637061231832945e-09
generations O 0 2.6217351845048142e-08
and O 0 1.4683002369508813e-08
high O 0 1.71126863790505e-08
levels O 0 3.757982813823446e-09
of O 0 5.396193908380198e-11
somatic O 0 2.6863046898029097e-08
mosaicism O 0 1.2290917084101238e-06
, O 0 8.315321764484906e-10
is O 0 3.0152366714553125e-10
observed O 0 1.693216589160329e-08
in O 0 8.298388642913324e-09
patients O 0 5.803032081530546e-07
. O 0 2.2214889838778618e-07

There O 0 1.472973991667459e-07
is O 0 5.1195145900351235e-09
a O 0 1.5883310222619684e-09
good O 0 7.966308501750063e-09
correlation O 0 1.4779883095172863e-08
between O 0 2.10365524999645e-09
repeat O 0 4.338485268817749e-07
size O 0 2.5295156191873502e-08
( O 0 2.3161787765513253e-10
at O 0 3.1814706424881933e-10
least O 0 1.682007033654287e-10
in O 0 2.773551943668906e-10
leucocytes O 0 1.6162434235411638e-07
) O 0 6.422630205449309e-10
, O 0 3.020117766983077e-10
clinical O 0 3.6755690047129974e-08
severity O 0 1.390640562703993e-07
and O 0 1.5295304578444302e-08
age O 0 2.7629685206420618e-08
of O 0 2.5904285383404613e-09
onset O 0 1.3250582924229093e-05
. O 0 9.993515277528786e-07

The O 0 4.621835785201256e-07
trinucleotide O 0 0.0007492179283872247
repeat O 0 3.3881380659295246e-05
instability O 0 1.1360900771251181e-06
mechanisms O 0 2.7446320771673527e-08
involved O 0 1.2449518749235722e-08
in O 0 9.66250102152344e-09
DM B-Disease 1 1.0
and O 0 4.049869772870807e-09
other O 0 1.0809765305097585e-09
human O 0 2.7879282882281586e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 3.0085757884990016e-08
unknown O 0 9.048834499481018e-07
. O 0 2.9346009000619233e-07

We O 0 1.43411136832583e-06
studied O 0 4.992346589460794e-07
somatic O 0 1.5854677712923149e-06
instability O 0 3.061975633045222e-07
by O 0 1.4416202676059697e-09
measuring O 0 2.188391619029062e-07
the O 0 3.3836506929674215e-09
CTG O 0 1.2464818155422108e-06
repeat O 0 1.2779879909885494e-07
length O 0 5.494533272809576e-09
at O 0 8.653677219250255e-10
several O 0 1.3317449920613456e-10
ages O 0 1.9773436221726115e-09
in O 0 1.4628422084772552e-10
various O 0 3.026218442503392e-10
tissues O 0 7.766230325501056e-09
of O 0 1.1008213784968746e-10
transgenic O 0 6.174808930836662e-08
mice O 0 8.13340292893372e-08
carrying O 0 1.8138479607188174e-09
a O 0 9.04675834245694e-10
( O 0 1.048613973431145e-09
CTG O 0 2.3470090582122793e-07
) O 0 1.1522660603446866e-09
55expansion O 0 7.514451993984039e-08
surrounded O 0 1.0844071418603107e-08
by O 0 9.072920748032232e-10
45 O 0 3.0662870020847777e-09
kb O 0 1.616369758039582e-07
of O 0 2.6104207684340963e-10
the O 0 2.791316067174421e-09
human O 0 1.5807376030352316e-07
DM B-Disease 1 1.0
region O 0 1.5653610319077416e-07
, O 0 2.351522865318145e-10
using O 0 2.9727180717031843e-09
small O 0 8.375146620664964e-08
- O 0 0.00015158066526055336
pool O 0 2.0208854039083235e-06
PCR O 0 1.2029019671899732e-05
. O 0 3.014751541741134e-07

These O 0 4.877489345744834e-08
mice O 0 3.0069958256717655e-07
have O 0 1.7067692814620727e-09
been O 0 5.107320677488758e-10
shown O 0 5.556319293553713e-10
to O 0 9.870635558906216e-11
reproduce O 0 4.691074551033125e-08
the O 0 4.676597442632158e-10
intergenerational O 0 5.912680478559196e-08
and O 0 1.5640045925024992e-09
somatic O 0 1.4986862595378625e-07
instability O 0 1.2813100624953222e-07
of O 0 2.851873459608356e-10
the O 0 9.680353185714807e-10
55 O 0 2.128567011538962e-08
CTG O 0 4.929076453663583e-07
repeat O 0 1.370072197914851e-07
suggesting O 0 7.988157690874687e-09
that O 0 7.854322053857388e-11
surrounding O 0 2.179811470215398e-10
sequences O 0 5.315518691872967e-09
and O 0 1.5481025350538857e-09
the O 0 2.955664879511488e-10
chromatin O 0 1.4062397468705967e-08
environment O 0 6.711248001778358e-09
are O 0 3.202914600208828e-10
involved O 0 3.873991349934158e-09
in O 0 9.271304612923359e-09
instability O 0 7.025942068139557e-07
mechanisms O 0 3.2841651886883483e-07
. O 0 3.492087330414506e-07

As O 0 2.377103136552705e-08
observed O 0 1.208124889018336e-08
in O 0 2.9991081840208267e-10
some O 0 7.856090084024103e-11
of O 0 3.9841439175569704e-11
the O 0 2.8722352274357377e-10
tissues O 0 3.643746282477878e-08
of O 0 2.277289246066516e-09
DM B-Disease 1 1.0
patients O 0 0.0033920842688530684
, O 0 2.1105303615875926e-10
there O 0 2.0817210455437163e-10
is O 0 2.62640714732143e-10
a O 0 1.8379324451256451e-10
tendency O 0 2.1415413442582576e-08
for O 0 3.214297439324554e-10
repeat O 0 6.620170012183735e-08
length O 0 3.253429525784668e-09
and O 0 6.581500344715607e-10
somatic O 0 2.2597838267301995e-08
mosaicism O 0 2.210061325058632e-07
to O 0 1.233746549367254e-09
increase O 0 1.5751352444581812e-09
with O 0 1.579014696773129e-10
the O 0 7.67961250147664e-10
age O 0 5.806129799168502e-09
of O 0 6.484615622248668e-11
the O 0 1.3653047581385636e-09
mouse O 0 7.679201416976866e-07
. O 0 4.710998382506659e-07

Furthermore O 0 1.8564295487522031e-06
, O 0 1.3649826158257383e-08
we O 0 2.19171103488236e-09
observed O 0 2.3311823582616853e-09
no O 0 2.183906527841728e-10
correlation O 0 3.105107060363821e-09
between O 0 2.429048351348939e-10
the O 0 5.786160439669175e-10
somatic O 0 3.532442462983454e-07
mutation O 0 1.014079657579714e-06
rate O 0 1.2943879710292094e-06
and O 0 2.56896761641201e-08
tissue O 0 4.18777426602901e-06
proliferation O 0 1.4347065189213026e-05
capacity O 0 2.258347393535587e-07
. O 0 1.2566613349918043e-07

The O 0 1.2677526228799252e-07
somatic O 0 4.975225692760432e-06
mutation O 0 3.3033340969268465e-06
rates O 0 2.7333746288604743e-07
in O 0 4.748005322241511e-10
different O 0 5.498723698593722e-10
tissues O 0 1.2073486210795181e-08
were O 0 1.7370894722645858e-09
also O 0 6.800399687811876e-10
not O 0 2.6931148977560326e-10
correlated O 0 2.0153050339644096e-09
to O 0 1.5949422338401575e-10
the O 0 2.7096130894577186e-10
relative O 0 4.477723436480119e-08
inter O 0 2.409050466667395e-06
- O 0 6.57146028970601e-06
tissue O 0 3.075813594932697e-07
difference O 0 3.037694895624554e-08
in O 0 2.0224200092400224e-10
transcriptional O 0 3.161722617051055e-08
levels O 0 1.3954318589526338e-08
of O 0 4.586718851951055e-11
the O 0 2.0007347167894096e-10
three O 0 4.766088634866605e-10
genes O 0 8.819598384945948e-09
( O 0 3.013523597328316e-10
DMAHP O 0 9.734370109981683e-08
, O 0 3.952861926670437e-10
DMPK O 0 2.42183659793227e-07
and O 0 3.3469738092151147e-09
59 O 0 5.7930766850233795e-09
) O 0 3.339881149422297e-10
surrounding O 0 1.8923300704187795e-09
the O 0 2.9000692958192076e-09
repeat O 0 5.453759968077065e-06
. O 0 1.787097581029684e-08
. O 0 1.2274477967366693e-07

A O 0 7.133971280381957e-07
novel O 0 1.3330293313629227e-06
missense O 0 4.718984564533457e-05
mutation O 0 6.602996563742636e-06
in O 0 2.134620835647638e-08
patients O 0 2.729050834204827e-07
from O 0 9.099332953788064e-10
a O 0 2.1007040551523914e-09
retinoblastoma B-Disease 0 8.230647949858394e-07
pedigree O 0 7.63470416131895e-06
showing O 0 9.547017043587402e-07
only O 0 1.8024953973849733e-08
mild O 0 2.423981015908794e-07
expression O 0 1.6913897837866898e-08
of O 0 8.272057483438289e-10
the O 0 1.4717489449367349e-08
tumor B-Disease 0 2.3046628484735265e-05
phenotype O 0 3.135451697744429e-05
. O 0 1.3091275832266547e-06

We O 0 3.326581463625189e-07
have O 0 3.276614313207915e-09
used O 0 6.604754965167103e-09
single O 0 1.952258621429337e-08
strand O 0 5.560915496971575e-07
conformation O 0 8.784598293232193e-08
polymorphism O 0 1.6228354127179045e-07
analysis O 0 1.0101753211699815e-08
to O 0 3.7183525702921827e-10
study O 0 8.990920785656442e-10
the O 0 2.2896486095991264e-10
27 O 0 1.1660042931183057e-09
exons O 0 2.634095608300413e-08
of O 0 1.2476938926475611e-10
the O 0 5.406426972776046e-10
RB1 O 0 3.851765200124646e-07
gene O 0 7.798083956345181e-09
in O 0 1.353862993935806e-10
individuals O 0 1.6100412669750597e-10
from O 0 9.473506007440236e-11
a O 0 4.838254241690265e-10
family O 0 1.218615608422624e-08
showing O 0 2.7704836611519568e-06
mild O 0 4.950067591380503e-07
expression O 0 1.5025179322947224e-08
of O 0 1.1727668836059024e-09
the O 0 1.0653309345798334e-08
retinoblastoma B-Disease 0 1.8100003217114136e-05
phenotype O 0 5.4173622629605234e-05
. O 0 1.1626801779129892e-06

In O 0 8.860114419917409e-09
this O 0 4.665148822802223e-10
family O 0 1.4630913147684055e-09
affected O 0 3.871916121056529e-09
individuals O 0 9.628222663593533e-10
developed O 0 3.36384573529358e-08
unilateral B-Disease 1 0.9968754053115845
tumors I-Disease 1 1.0
and O 0 1.846994592824558e-07
, O 0 5.379938716743027e-10
as O 0 3.4074695842711833e-10
a O 0 5.506112787934114e-10
result O 0 3.217943245203969e-09
of O 0 2.8437080815124638e-11
linkage O 0 7.245500199815069e-08
analysis O 0 2.8131996288038863e-08
, O 0 1.2904914914457777e-09
unaffected O 0 6.598865098794704e-08
mutation O 0 8.750684798997099e-08
carriers O 0 1.6072148412149545e-07
were O 0 4.639479911361377e-09
also O 0 3.016400240696271e-09
identified O 0 1.2070630717175845e-08
within O 0 1.677493588481127e-09
the O 0 5.094014543516323e-09
pedigree O 0 1.3069584383629262e-05
. O 0 7.708896418989752e-07

A O 0 9.080180234377622e-07
single O 0 7.338770302567355e-08
band O 0 3.950891169779425e-08
shift O 0 4.710638634719544e-08
using O 0 8.490967928764803e-09
SSCP O 0 1.213385303344694e-06
was O 0 3.810324500364004e-09
identified O 0 5.587577955878942e-09
in O 0 2.9855701244585475e-10
exon O 0 5.9418940878686044e-08
21 O 0 4.878696557852891e-09
which O 0 6.744866332120125e-10
resulted O 0 3.612486532134085e-09
in O 0 2.041329327795438e-09
a O 0 7.76325315143822e-09
missense O 0 4.110070676688338e-06
mutation O 0 5.537830247703823e-07
converting O 0 1.4661208069810527e-07
a O 0 2.0820049684289188e-08
cys O 0 0.00032403707155026495
- O 0 5.418569799076067e-06
- O 0 2.6646330297808163e-06
> O 0 2.951992712496576e-07
arg O 0 5.831642511111568e-07
at O 0 1.5524135310585052e-09
nucleotide O 0 6.381886663575642e-08
position O 0 1.0181471310488632e-07
28 O 0 4.880511994542758e-09
in O 0 5.120039392458864e-10
the O 0 3.7103491390411136e-09
exon O 0 2.1081282284285408e-06
. O 0 3.7671566133212764e-07

The O 0 2.909889929014753e-07
mutation O 0 3.971914793510223e-06
destroyed O 0 1.295540187129518e-06
an O 0 3.1982096970750717e-09
NdeI O 0 1.5048259456307278e-06
restriction O 0 8.472561319194938e-08
enzyme O 0 6.40243627003656e-07
site O 0 2.91972497734605e-07
. O 0 3.004573443377012e-07

Analysis O 0 4.091449170573469e-07
of O 0 1.1216990669637994e-09
all O 0 8.280249819136998e-10
family O 0 1.0803787864333003e-09
members O 0 3.133389103737727e-10
demonstrated O 0 1.684961947745478e-09
that O 0 1.6054292617528887e-10
the O 0 1.2261551773917745e-09
missense O 0 6.641178060817765e-06
mutation O 0 5.632819011225365e-06
co O 0 6.410497735487297e-05
- O 0 5.646694717142964e-06
segregated O 0 1.005471901294186e-07
with O 0 7.334062246400208e-10
patients O 0 2.927050424261779e-08
with O 0 1.587858511342688e-09
tumors B-Disease 1 1.0
or O 0 2.2963963601796422e-06
who O 0 1.223028647245883e-07
, O 0 1.2673276317265447e-10
as O 0 3.108032442522557e-10
a O 0 5.229215394031428e-10
result O 0 5.092771093728743e-09
of O 0 2.1764369820265195e-11
linkage O 0 1.528917970006205e-08
analysis O 0 1.8730336392991376e-08
had O 0 2.5230107780771505e-08
been O 0 5.028765404091473e-09
predicted O 0 5.036271399916359e-09
to O 0 2.2997415083381156e-10
carry O 0 4.653891494399431e-09
the O 0 5.267196012681552e-09
predisposing O 0 3.5814043712889543e-06
mutation O 0 4.017354513052851e-06
. O 0 5.908013349653629e-07

These O 0 7.295057447009867e-09
observations O 0 1.030480500929798e-08
point O 0 6.177339972879281e-09
to O 0 3.270874404659452e-10
another O 0 7.671590029900699e-10
region O 0 1.1559824208973168e-08
of O 0 4.211051229940921e-10
the O 0 4.885186921654849e-09
RB1 O 0 2.070878053928027e-06
gene O 0 3.5935144637733174e-08
where O 0 4.272597831089797e-09
mutations O 0 2.790003073016578e-08
only O 0 3.284847671647384e-10
modify O 0 1.7499665716513846e-08
the O 0 1.6996280771675032e-10
function O 0 7.518574651754761e-10
of O 0 2.153026194828822e-11
the O 0 6.511485795002159e-11
gene O 0 6.537825392172181e-09
and O 0 8.819274199822758e-10
raise O 0 3.8420389092408413e-10
important O 0 2.113777486378865e-10
questions O 0 4.523851571125448e-10
for O 0 1.6306232406004817e-11
genetic O 0 3.5093921102458125e-09
counseling O 0 9.302799419685925e-09
in O 0 2.9852398331087215e-10
families O 0 6.934961493954006e-10
with O 0 1.721073700222675e-10
these O 0 4.374511863858288e-09
distinctive O 0 8.565500593249453e-07
phenotypes O 0 1.4374331840372179e-06
. O 0 5.782922585240158e-08
. O 0 2.594663612853765e-07

Maternal B-Disease 0 0.0003085227217525244
disomy I-Disease 0 0.0035836193710565567
and O 0 0.0006217577029019594
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 2.988236644796416e-07
with O 0 6.580022304802924e-09
gamete O 0 2.1572238892986206e-06
complementation O 0 5.65997925150441e-06
in O 0 1.6944758929327008e-09
a O 0 8.615798074984582e-10
case O 0 7.222992870481448e-09
of O 0 5.125198598854297e-10
familial O 0 2.339594630029751e-06
translocation O 0 6.941497758816695e-07
( O 0 4.9860351403197e-09
3 O 0 3.384683422424928e-09
; O 0 2.4387796226932323e-09
15 O 0 2.3136410565172127e-09
) O 0 9.089514696469791e-10
( O 0 1.9310217314050249e-10
p25 O 0 3.896045797091574e-08
; O 0 2.8979016963859294e-09
q11 O 0 1.2534680138287513e-07
. O 0 3.163440176479071e-09
2 O 0 6.598233071031245e-09
) O 0 1.0191085308974834e-08
. O 0 1.1708033298418741e-07

Maternal B-Disease 0 0.004815034568309784
uniparental I-Disease 0 0.01475436333566904
disomy I-Disease 0 0.0010276150424033403
( I-Disease 0 2.5770069100872206e-07
UPD I-Disease 1 0.9999997615814209
) I-Disease 0 1.4350642452143347e-08
for I-Disease 0 3.673280568605719e-10
chromosome I-Disease 0 2.034893498148449e-07
15 I-Disease 0 3.4617120281410507e-09
is O 0 1.1748843564696188e-10
responsible O 0 2.6171362299542977e-10
for O 0 2.366947089715854e-11
an O 0 1.4219673181992132e-11
estimated O 0 5.191441165841582e-10
30 O 0 5.002225855754716e-10
% O 0 8.391188438539032e-11
of O 0 2.5075877138625025e-11
cases O 0 4.040805379190715e-08
of O 0 1.8248827018396696e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.850498160318239e-06
PWS B-Disease 1 0.9999997615814209
) O 0 6.426140544135706e-07
. O 0 3.9093933423828275e-07

We O 0 1.1774382073781453e-06
report O 0 1.4331604347717075e-08
on O 0 1.951095257579638e-10
an O 0 1.8725770933869512e-11
unusual O 0 7.880946450988802e-10
case O 0 4.675618114902136e-09
of O 0 1.320967918383431e-10
maternal B-Disease 0 3.654004743225414e-08
disomy I-Disease 0 1.869840843937709e-06
15 I-Disease 0 7.82554376854705e-09
in O 0 6.372797400899799e-09
PWS B-Disease 1 1.0
that O 0 2.272082966214839e-09
is O 0 1.847133002108592e-10
most O 0 2.461161829891978e-10
consistent O 0 2.1787192050481963e-09
with O 0 1.0704423458740564e-10
adjacent O 0 4.858705793253648e-08
- O 0 0.0007557756616733968
1 O 0 1.6136246117071096e-08
segregation O 0 4.4452335146161204e-08
of O 0 6.101825988924503e-11
a O 0 1.0735917710391618e-09
paternal O 0 1.6744552056024986e-07
t O 0 2.7815181624646357e-07
( O 0 3.756618904837694e-10
3 O 0 6.603341207167546e-10
; O 0 1.0268972339133597e-09
15 O 0 1.1302767610743558e-09
) O 0 4.45111753011318e-10
( O 0 2.450687708321908e-10
p25 O 0 1.604426813628379e-08
; O 0 6.923780437873006e-10
q11 O 0 2.24963478956397e-08
. O 0 4.2718703574529115e-10
2 O 0 3.2168059882486943e-10
) O 0 1.2635407997674264e-10
with O 0 2.0342545703488923e-10
simultaneous O 0 2.0167831848993956e-07
maternal O 0 7.880846624175319e-07
meiotic O 0 6.599395419470966e-06
nondisjunction O 0 4.411264853843022e-06
for O 0 1.2827179318719573e-08
chromosome O 0 4.833932962355902e-06
15 O 0 2.412887170066824e-07
. O 0 2.629678874654928e-07

The O 0 2.829608263255068e-07
patient O 0 1.765044885360112e-06
( O 0 7.195011697547216e-09
J O 0 1.7954052964341827e-06
. O 0 1.1723336967861542e-08
B O 0 5.7916871298857586e-08
. O 0 2.36266312070299e-10
) O 0 1.216668293890777e-10
, O 0 4.527734090431501e-11
a O 0 9.610439527518722e-11
17 O 0 1.6033461225362089e-09
- O 0 1.4058298347663367e-07
year O 0 9.376051934850693e-08
- O 0 3.911222665919922e-05
old O 0 1.628904283279553e-05
white O 0 6.637846183821239e-08
male O 0 2.0660273492012493e-08
with O 0 1.7851548017588925e-09
PWS B-Disease 1 1.0
, O 0 1.37861366766856e-09
was O 0 7.594704309887845e-10
found O 0 2.2548303502123446e-10
to O 0 1.9290376240821416e-10
have O 0 2.22181784081954e-09
47 O 0 1.6994863294428342e-09
chromosomes O 0 1.049723152846127e-08
with O 0 4.2078238116083355e-10
a O 0 3.541114956817637e-09
supernumerary O 0 6.456267328758258e-06
, O 0 3.397554904083222e-09
paternal O 0 1.7428041587663756e-07
der O 0 1.951862395799253e-05
( O 0 7.836608029165859e-10
15 O 0 5.234534472542407e-10
) O 0 4.815925089274309e-11
consisting O 0 5.248958559467276e-11
of O 0 2.8721242398277447e-11
the O 0 4.393256314294547e-10
short O 0 6.10334654993494e-06
arm O 0 0.009851749055087566
and O 0 1.5898343752596134e-09
the O 0 5.711511819050941e-10
proximal O 0 2.2212009298527846e-07
long O 0 0.0008645043708384037
arm O 0 0.0008489139145240188
of O 0 7.750450836674361e-10
chromosome O 0 1.1397862635931233e-06
15 O 0 9.55566914484507e-09
, O 0 2.249933794828962e-09
and O 0 1.154417983428857e-08
distal O 0 2.1691437723347917e-05
chromosome O 1 0.979482889175415
arm O 1 0.9687711596488953
3p O 0 0.001002129982225597
. O 0 3.086979177169269e-06

The O 0 3.2251159609586466e-07
t O 0 2.277565499753109e-06
( O 0 2.50915932475948e-09
3 O 0 1.3853881375425203e-09
; O 0 6.981439315545401e-10
15 O 0 3.125903702549948e-10
) O 0 1.524112364093e-10
was O 0 4.4595985237982916e-10
present O 0 1.121779752422114e-10
in O 0 2.196907933349479e-10
the O 0 1.5958795396286973e-10
balanced O 0 4.300944933532946e-09
state O 0 7.711493665851776e-10
in O 0 3.3713959401993066e-10
the O 0 9.328754435600217e-10
patients O 0 2.7745391761868632e-08
father O 0 4.3601842136808955e-09
and O 0 2.65984256841989e-09
a O 0 1.0529435989781177e-08
sister O 0 5.769443305325694e-06
. O 0 4.802805619874562e-07

Fluorescent O 0 5.237253844825318e-06
in O 0 1.5560370769662768e-08
situ O 0 1.8818612090854003e-07
hybridization O 0 1.1559983192910295e-07
analysis O 0 2.5587958418782364e-08
demonstrated O 0 1.466503274372144e-08
that O 0 7.661295486904862e-10
the O 0 4.771457451369088e-09
PWS B-Disease 1 0.9999997615814209
critical O 0 2.913583330155234e-07
region O 0 6.211996605998138e-08
resided O 0 1.6998575347315636e-07
on O 0 4.564425282183038e-09
the O 0 5.744572040278229e-10
derivative O 0 1.0027447672200651e-07
chromosome O 0 6.096006899269923e-08
3 O 0 2.9302780202300482e-09
and O 0 8.103679394189101e-10
that O 0 1.200962385095039e-10
there O 0 2.8148766650915036e-10
was O 0 2.3843493845987496e-09
no O 0 4.5855924613036336e-10
deletion O 0 3.426255545946333e-08
of O 0 4.0462230788129716e-10
the O 0 1.7334892632447918e-08
PWS B-Disease 1 1.0
region O 0 2.595153603124345e-07
on O 0 3.868903863946116e-09
the O 0 8.44332159743999e-10
normal O 0 1.6250927714622776e-08
pair O 0 1.7293347198688025e-08
of O 0 4.333948200319071e-10
15s O 0 6.182068545967923e-08
present O 0 7.039823390897482e-09
in O 0 2.0214153906294996e-08
J O 0 9.500816668150946e-05
. O 0 3.0706314646522515e-07

B O 0 0.00881539098918438
. O 0 1.586625694471877e-05

Methylation O 0 1.2951180906384252e-05
analysis O 0 8.637111363896111e-07
at O 0 1.933338111825833e-08
exon O 0 1.6208277031637408e-07
alpha O 0 1.201440191778147e-08
of O 0 1.7231562010611157e-10
the O 0 6.007596642376711e-10
small O 0 5.943231684568673e-08
nuclear O 0 1.4308669051388279e-05
ribonucleoprotein O 0 1.1754415936593432e-05
- O 0 1.2472499975046958e-06
associated O 0 1.0113942039424728e-07
polypeptide O 0 2.4545925043639727e-06
N O 0 1.3285923614603234e-06
( O 0 1.732747945126789e-09
SNRPN O 0 1.4185866348270793e-07
) O 0 2.2409218924934748e-10
gene O 0 9.236286402369842e-09
showed O 0 2.49038460964357e-08
a O 0 7.591416384400418e-10
pattern O 0 3.9184627098620695e-08
characteristic O 0 5.0182375588292416e-08
of O 0 2.2504050012361887e-10
only O 0 1.2367741275554067e-09
the O 0 1.2953890182743066e-09
maternal O 0 1.6944031244747748e-07
chromosome O 0 6.891533303132746e-06
15 O 0 6.379281813906346e-08
in O 0 2.9910218302120484e-08
J O 0 0.0013528603594750166
. O 0 6.521413524751551e-07

B O 0 0.004366022534668446
. O 0 9.234595381713007e-06

Maternal B-Disease 0 0.0006973641575314105
disomy I-Disease 0 0.08609803020954132
was O 0 1.73173157236306e-06
confirmed O 0 3.0735257894320966e-08
by O 0 6.996596080277584e-10
polymerase O 0 1.290756159733064e-07
chain O 0 8.658537353767315e-07
reaction O 0 4.594588176587422e-08
analysis O 0 2.3208688304521274e-08
of O 0 4.1947140205778055e-10
microsatellite O 0 9.811969903239515e-07
repeats O 0 3.381430246918171e-07
at O 0 2.9655373712245137e-09
the O 0 9.388785304764724e-10
gamma O 0 5.356537826628482e-07
- O 0 2.78880415862659e-05
aminobutyric O 0 1.957607855729293e-05
acid O 0 1.3925915709478431e-06
receptor O 0 5.62197044473578e-07
beta3 O 0 9.454101927985903e-07
subunit O 0 1.1680281204462517e-06
( O 0 1.89849860277036e-08
GABRB3 O 0 1.8723247876550886e-06
) O 0 2.7709271321896267e-08
locus O 0 3.0849896575091407e-06
. O 0 5.043320356890035e-07

A O 0 3.611951342463726e-07
niece O 0 1.4366108871399774e-06
( O 0 1.1884648820625898e-08
B O 0 1.5673687414619053e-07
. O 0 2.8163440468631507e-09
B O 0 2.258482467709655e-08
. O 0 1.6617961173803764e-10
) O 0 8.818294705559282e-11
with O 0 6.633065624539469e-11
45 O 0 2.846319846483425e-10
chromosomes O 0 5.4094719814656855e-09
and O 0 5.640364286740862e-10
the O 0 5.580926346060444e-11
derivative O 0 2.524045505936101e-08
3 O 0 6.949129049971248e-10
but O 0 1.0461368438186014e-09
without O 0 8.810061569164418e-10
the O 0 4.908515816026693e-10
der O 0 1.573207669025578e-06
( O 0 1.6105235201013812e-10
15 O 0 2.3250266989460755e-10
) O 0 9.9093053207433e-11
demonstrated O 0 1.2207412858344924e-09
a O 0 4.8669929197942e-10
phenotype O 0 3.6872322084491316e-08
consistent O 0 1.5955881060847332e-09
with O 0 5.1769529635370404e-11
that O 0 2.2529214604993797e-10
reported O 0 9.41669586751459e-09
for O 0 3.7043154654803345e-10
haploinsufficiency O 0 1.5359832161720988e-07
of O 0 4.392954611187605e-10
distal O 0 8.959461865742924e-07
3 O 0 1.4290872059063986e-06
p O 0 0.0040753367356956005
. O 0 9.692126923255273e-07

Uniparental B-Disease 1 0.9999980926513672
disomy I-Disease 1 0.9999984502792358
associated O 0 2.566984676377615e-06
with O 0 1.6294505300606943e-08
unbalanced O 0 2.627452886372339e-06
segregation O 0 9.578735671311733e-07
of O 0 1.098009905220465e-09
non O 0 5.016907493882172e-07
- O 0 2.2849486924769735e-07
Robertsonian O 0 2.1826140539360495e-07
translocations O 0 5.0495094683356e-07
has O 0 8.505199211583658e-09
been O 0 9.534310008163516e-10
reported O 0 3.138702409088978e-09
previously O 0 9.830438685298759e-09
but O 0 8.839150744677227e-09
has O 0 2.261438369899338e-09
not O 0 4.724851065951441e-10
, O 0 7.226223786016561e-11
to O 0 4.817376705879006e-11
our O 0 1.2044905350894197e-10
knowledge O 0 1.3416166788626782e-10
, O 0 7.418386738233806e-11
been O 0 3.041291940508728e-10
observed O 0 1.1416582124113006e-09
in O 0 1.8242278521096722e-10
a O 0 6.958891796138289e-10
case O 0 6.629078086461959e-08
of O 0 2.2596889692749755e-08
PWS B-Disease 1 0.9999996423721313
. O 0 1.3502818774213665e-06

Furthermore O 0 7.239253136503976e-06
, O 0 5.011694526046995e-08
our O 0 1.0326230537316405e-08
findings O 0 3.0791629246351704e-09
are O 0 1.590549358887472e-10
best O 0 1.4657475233548212e-09
interpreted O 0 2.0044865767232523e-09
as O 0 1.1594929461011816e-09
true O 0 1.2588439624039438e-08
gamete O 0 1.6537968576813e-06
complementation O 0 4.010287739220075e-06
resulting O 0 2.755270145371469e-07
in O 0 8.353163138963282e-08
maternal B-Disease 0 0.001008851919323206
UPD I-Disease 1 1.0
15 I-Disease 0 1.1542412721610162e-05
and O 0 8.251047802332323e-06
PWS B-Disease 1 0.9999991655349731

Schwartz B-Disease 1 0.9996922016143799
- I-Disease 1 0.9999979734420776
Jampel I-Disease 1 0.9996703863143921
syndrome I-Disease 1 0.9999768733978271
type I-Disease 0 1.5655775769118918e-06
2 I-Disease 0 5.1566207304176714e-08
and O 0 4.85955844453656e-08
Stuve B-Disease 1 0.9999595880508423
- I-Disease 1 1.0
Wiedemann I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999798536300659
: O 0 8.970161280430489e-10
a O 0 1.9863087563631865e-10
case O 0 4.087086225013081e-09
for O 0 3.800625369976274e-10
" O 0 2.7837079308312696e-09
lumping O 0 2.5098648848143057e-07
" O 0 1.2893757173060294e-07
. O 0 1.8091037645717734e-07

Recent O 0 1.149406216427451e-06
studies O 0 2.0243446385848074e-07
demonstrated O 0 1.122341597437071e-08
the O 0 1.396479598625433e-10
existence O 0 9.86766668376049e-10
of O 0 1.6435377364620862e-11
a O 0 1.459336401721245e-10
genetically O 0 1.4493787281466552e-09
distinct O 0 1.8357927400458607e-09
, O 0 7.788309580591957e-11
usually O 0 2.0086037000321966e-10
lethal O 0 8.54306070330324e-10
form O 0 1.552152295580811e-10
of O 0 3.142593130167626e-11
the O 0 4.322294078207278e-09
Schwartz B-Disease 1 0.9999080896377563
- I-Disease 1 0.9999967813491821
Jampel I-Disease 1 0.9999836683273315
syndrome I-Disease 1 0.999993085861206
( O 0 3.876758114529366e-08
SJS B-Disease 1 0.996380627155304
) O 0 5.764331234558995e-09
of O 0 9.467548967023731e-10
myotonia B-Disease 1 0.8800855278968811
and O 0 2.6114747697647545e-07
skeletal B-Disease 0 0.020822463557124138
dysplasia I-Disease 1 0.9805083870887756
, O 0 1.4515151747218624e-08
which O 0 1.2251458514356273e-08
we O 0 2.5156202454468257e-08
called O 0 9.11250523927265e-08
SJS B-Disease 1 0.9963853359222412
type I-Disease 0 1.987286395888077e-06
2 I-Disease 0 1.473010513564077e-07
. O 0 1.8491694220301724e-07

This O 0 3.4065769227709097e-07
disorder O 0 0.00015969965897966176
is O 0 1.0190807087084863e-09
reminiscent O 0 9.012576462907873e-09
of O 0 9.274602613684735e-11
another O 0 1.03850661403726e-09
rare O 0 1.2473476473928713e-08
condition O 0 1.901401986970086e-07
, O 0 3.483660859782134e-10
the O 0 3.682654625691839e-09
Stuve B-Disease 1 0.9999494552612305
- I-Disease 1 0.9999998807907104
Wiedemann I-Disease 1 0.9999982118606567
syndrome I-Disease 1 0.9999747276306152
( O 0 6.412644637521225e-09
SWS B-Disease 0 7.360732979577733e-06
) O 0 1.0081576684584093e-09
, O 0 1.2318249198450815e-10
which O 0 2.5643678847053764e-10
comprises O 0 9.906571118989405e-10
campomelia B-Disease 0 7.891104587542941e-07
at O 0 8.968727982505698e-09
birth O 0 2.735141890752857e-08
with O 0 3.747832710843113e-09
skeletal B-Disease 0 0.010499817319214344
dysplasia I-Disease 1 0.9975074529647827
, O 0 3.359408751180126e-08
contractures B-Disease 0 0.0003714870545081794
, O 0 1.024944840111175e-08
and O 0 7.323427642091929e-09
early B-Disease 0 1.4159482475406548e-07
death I-Disease 0 2.7430789373283915e-07
. O 0 2.9886101060583314e-07

To O 0 3.366002232496612e-08
test O 0 1.4180908891603394e-08
for O 0 1.2636033885904396e-10
possible O 0 1.5145904530555754e-09
nosologic O 0 1.5047957901970221e-07
identity O 0 2.8594147494231947e-08
between O 0 1.1918398490351478e-09
these O 0 6.468809932158592e-09
disorders O 0 6.170692813611822e-06
, O 0 9.691067948125465e-10
we O 0 6.305785338334147e-10
reviewed O 0 1.1126302101871488e-09
the O 0 5.3826249013511074e-11
literature O 0 5.069895614440156e-10
and O 0 9.049170440755816e-11
obtained O 0 6.278182973495916e-10
a O 0 4.246287349518596e-11
follow O 0 9.875273931925221e-10
- O 0 5.1979469617435825e-08
up O 0 1.4239718293396209e-09
of O 0 1.0505186998077676e-11
the O 0 4.281314192056129e-11
only O 0 1.5137116560204333e-10
two O 0 1.4650089474876893e-10
surviving O 0 6.606660463148728e-08
patients O 0 1.0728472332743877e-08
, O 0 4.3052908460516903e-11
one O 0 1.9208647172863635e-10
with O 0 9.774157039288411e-10
SJS B-Disease 1 0.7991313338279724
type I-Disease 0 1.8314540284336545e-07
2 I-Disease 0 3.0473787937523866e-09
at O 0 2.9133861989549814e-09
age O 0 2.096701035014803e-09
10 O 0 1.0654559179368306e-10
years O 0 5.168785954801081e-10
and O 0 1.0253603521803711e-10
another O 0 2.354799133463814e-10
with O 0 1.3142334998050842e-09
SWS B-Disease 0 0.00013061999925412238
at O 0 2.150558842117789e-08
age O 0 1.0644860992670147e-08
7 O 0 6.118999973381278e-09
years O 0 2.8034989441039215e-08
. O 0 8.315155497484739e-08

Patients O 0 0.0002378360804868862
reported O 0 3.986130536759447e-07
as O 0 4.8819641662589675e-09
having O 0 1.4645361545717606e-07
either O 0 1.8192872630606871e-06
neonatal O 1 0.9999713897705078
SJS B-Disease 1 0.9999998807907104
or O 0 1.907185719574045e-06
SWS B-Disease 0 4.428727334016003e-05
presented O 0 1.220650469591078e-09
a O 0 1.756579465217456e-10
combination O 0 3.0942346462836667e-09
of O 0 2.8367848001198404e-11
a O 0 7.118484135482106e-10
severe O 0 1.7395015561305627e-07
, O 0 2.0572887837744247e-09
prenatal O 1 0.9793095588684082
- O 1 0.9993404746055603
onset O 1 0.7684836387634277
neuromuscular B-Disease 1 0.9999477863311768
disorder I-Disease 1 0.9999699592590332
( O 0 1.0947712070219495e-08
with O 0 8.946926755015738e-09
congenital B-Disease 1 0.9999890327453613
joint I-Disease 0 0.0014941433910280466
contractures I-Disease 1 0.9998375177383423
, O 0 4.929104875373014e-07
respiratory O 0 0.0020645984914153814
and O 0 3.425547845381516e-09
feeding O 0 1.2681903172051534e-07
difficulties O 0 4.0469753912475426e-06
, O 0 6.115508099924227e-10
tendency O 0 1.229903379140751e-08
to O 0 8.603678880447774e-10
hyperthermia B-Disease 0 9.569093890604563e-07
, O 0 8.551097607778502e-10
and O 0 4.806787190503314e-10
frequent O 0 4.9463960039020094e-08
death O 0 2.645182028970794e-08
in O 0 6.630466842239002e-09
infancy O 0 2.1670430214726366e-06
) O 0 4.674947651217565e-10
with O 0 6.523407508618462e-11
a O 0 8.353330249732949e-10
distinct O 0 1.4285460281371343e-07
campomelic B-Disease 0 0.12490862607955933
- I-Disease 1 0.8563641309738159
metaphyseal I-Disease 0 0.007134718354791403
skeletal I-Disease 0 0.0067847310565412045
dysplasia I-Disease 0 0.40758180618286133
. O 0 2.4618743736937176e-06

The O 0 1.4023425087827945e-08
similarity O 0 2.8929440176739263e-08
of O 0 1.5681379805787543e-10
the O 0 3.955192562354881e-10
clinical O 0 8.386144401129059e-08
and O 0 1.372422064882528e-09
radiographic O 0 0.0003904291079379618
findings O 0 3.523062019894496e-08
is O 0 4.2699152547065466e-10
so O 0 3.902333733929453e-10
extensive O 0 3.3902400886631767e-09
that O 0 1.21589860402338e-09
these O 0 3.39662831194687e-09
disorders O 0 2.918338566360035e-07
appear O 0 2.2073591843252416e-09
to O 0 5.721149665127712e-10
be O 0 8.251351268917517e-10
a O 0 1.1721988935065042e-09
single O 0 9.472542927824179e-08
entity O 0 9.220312676916365e-06
. O 0 1.4107953347775037e-06

The O 0 1.0631388214221715e-08
follow O 0 2.0141571965837102e-08
- O 0 3.794256144828978e-07
up O 0 2.9373565801904533e-09
observation O 0 3.771885026537802e-09
of O 0 2.144428037920143e-11
an O 0 2.8391070744371305e-11
identical O 0 7.809664026581231e-09
and O 0 1.1101162211701876e-09
unique O 0 3.968524175945731e-09
pattern O 0 9.028061072058335e-07
of O 0 5.258684154796356e-09
progressive O 0 2.9109992283338215e-06
bone B-Disease 1 0.9949460625648499
dysplasia I-Disease 1 0.9994335770606995
in O 0 1.4657763003356195e-08
the O 0 1.4096386280471052e-09
two O 0 5.20926812797029e-09
patients O 0 3.148453586732103e-08
( O 0 8.197322681757768e-11
one O 0 5.822861637305721e-10
with O 0 7.228781129242634e-09
SJS B-Disease 1 0.9998319149017334
type I-Disease 0 5.423881361821259e-07
2 I-Disease 0 2.5893616140137965e-09
, O 0 2.1325431698304698e-10
one O 0 1.8148861302691444e-09
with O 0 5.461599617007096e-09
SWS B-Disease 0 0.0010840250179171562
) O 0 1.953632144946482e-09
surviving O 0 5.766456467881653e-08
beyond O 0 2.1826341622954715e-08
infancy O 0 2.2277986033714114e-07
adds O 0 1.6228563382014727e-08
to O 0 6.113989176048662e-11
the O 0 2.0298427869103186e-11
evidence O 0 1.3960461675566194e-09
in O 0 2.7322505369298256e-10
favor O 0 4.33946745204139e-09
of O 0 8.970366116578532e-10
identity O 0 1.1433561439844198e-06
. O 0 3.142982052395382e-07

The O 0 6.919165684848849e-08
hypothesis O 0 3.241752040139545e-07
that O 0 2.075585747718378e-08
SWS B-Disease 0 4.683048609877005e-05
and O 0 5.920501422451707e-08
SJS B-Disease 1 0.9193422198295593
type I-Disease 0 2.2087549211846635e-07
2 I-Disease 0 1.2837354512740262e-09
are O 0 9.49438028197136e-11
the O 0 2.2936874621848347e-10
same O 0 1.0539687167465672e-07
disorder O 0 0.00011793562589446083
should O 0 2.879740668149111e-09
be O 0 2.8908231364255244e-10
testable O 0 1.0577625886298847e-08
by O 0 2.5256657876226996e-10
molecular O 0 2.0530954714104155e-08
methods O 0 1.0066693079124889e-07
. O 0 2.3714154195886294e-08
. O 0 1.453186087019276e-07

A O 0 1.4142263182748138e-07
mouse O 0 7.522611440435867e-07
model O 0 2.621415831072227e-07
of O 0 1.574625230205129e-08
severe O 1 0.9987446069717407
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.08256880193948746
defects O 1 0.9999884366989136
in O 0 3.429047694680776e-07
hemostasis O 1 0.9874442219734192
and O 0 8.12729740573559e-06
thrombosis B-Disease 0 0.0932953730225563
. O 0 1.1648354529825156e-06

von B-Disease 1 0.913371741771698
Willebrand I-Disease 0 0.07904483377933502
factor I-Disease 0 0.000191080616787076
( I-Disease 0 5.000762257623137e-07
vWf I-Disease 0 0.006787774618715048
) I-Disease 0 0.00023212333326227963
deficiency I-Disease 1 0.9997615218162537
causes O 0 0.001291551161557436
severe O 1 0.9999979734420776
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 8.281645023089368e-07
humans O 0 2.6998400244337972e-06
. O 0 1.355641643385752e-06

We O 0 9.367399655957342e-08
generated O 0 7.110589894665509e-09
a O 0 9.398675171468085e-10
mouse O 0 2.5626544442047816e-08
model O 0 2.0869309835802596e-08
for O 0 4.3706233077145384e-10
this O 0 1.7566073040597985e-09
disease O 0 1.127456528138282e-08
by O 0 4.637405390250926e-11
using O 0 1.1308163294643236e-08
gene O 0 4.642293163215072e-07
targeting O 0 6.095418939366937e-06
. O 0 8.366658335035027e-07

vWf B-Disease 1 0.90700364112854
- I-Disease 1 0.9999656677246094
deficient I-Disease 0 0.20090514421463013
mice O 0 1.6271096683340147e-05
appeared O 0 1.249672436642868e-07
normal O 0 2.5535888070749024e-08
at O 0 1.1765038943067907e-09
birth O 0 7.874065288682175e-10
; O 0 3.2269026339903917e-10
they O 0 1.343086974969765e-09
were O 0 3.3669251831014435e-09
viable O 0 1.2897314718429698e-06
and O 0 3.2151348250408773e-08
fertile O 0 6.237606271497498e-07
. O 0 7.361810503425659e-07

Neither O 0 9.603599028196186e-05
vWf O 0 0.001458735205233097
nor O 0 4.455792804947123e-05
vWf O 0 0.0007530280272476375
propolypeptide O 0 0.00030061264988034964
( O 0 6.851728926449141e-07
von B-Disease 0 0.009172625839710236
Willebrand I-Disease 0 0.013839964754879475
antigen O 0 0.0008676775614731014
II O 0 2.033721648331266e-05
) O 0 1.687278228246214e-08
were O 0 3.2754956524883028e-09
detectable O 0 5.164110916666687e-07
in O 0 1.548953076913051e-09
plasma O 0 1.573794321529931e-07
, O 0 2.226760331680566e-09
platelets O 0 1.4939001857783296e-07
, O 0 2.259735509824168e-09
or O 0 8.54467785416091e-09
endothelial O 0 3.0521444926989716e-08
cells O 0 1.8825820902179657e-08
of O 0 2.6667243413491803e-10
the O 0 3.1454685522902537e-09
homozygous O 0 2.219685711679631e-06
mutant O 0 3.544482751749456e-06
mice O 0 8.293806786241475e-06
. O 0 3.793626319748e-07

The O 0 1.879208753052808e-07
mutant O 0 8.12998041510582e-06
mice O 0 1.2834741937695071e-05
exhibited O 0 3.3319106478302274e-06
defects O 0 0.43548384308815
in O 0 7.257336509525203e-09
hemostasis O 0 1.0632699741108809e-05
with O 0 1.7205823432675516e-09
a O 0 8.054603206630873e-09
highly O 0 1.6778631106717512e-07
prolonged O 0 0.0003854869573842734
bleeding O 0 0.2708418369293213
time O 0 3.1588655247105635e-08
and O 0 5.232939859212138e-09
spontaneous O 0 1.6535707914044906e-08
bleeding O 0 2.4317637326021213e-06
events O 0 2.3728257136923503e-09
in O 0 5.769190125626267e-10
approximately O 0 1.2684843175847504e-09
10 O 0 2.7410158587315436e-09
% O 0 1.7650167993821242e-09
of O 0 2.030119627960403e-09
neonates O 0 1.7502625269116834e-05
. O 0 4.248400671258423e-07

As O 0 4.500146744135236e-08
in O 0 2.1052766197016126e-09
the O 0 7.698208737139112e-10
human O 0 4.494388861076004e-09
disease O 0 7.670675472581934e-08
, O 0 2.0287795055029534e-10
the O 0 3.421628258504228e-10
factor O 0 4.691611366069992e-08
VIII O 0 4.151934547280689e-07
level O 0 1.6005389014139837e-08
in O 0 2.59197940888356e-10
these O 0 3.467816589441952e-10
mice O 0 4.919017726479069e-08
was O 0 1.3045790225874043e-08
reduced O 0 2.019838296618559e-09
strongly O 0 7.866994278238337e-10
as O 0 5.45029521514806e-10
a O 0 2.6278301756832434e-10
result O 0 3.189382757895487e-09
of O 0 5.978467720879621e-11
the O 0 9.516886168015048e-10
lack O 0 9.014724966505128e-09
of O 0 1.4796228131608302e-10
protection O 0 2.9685085500830155e-09
provided O 0 3.278646021342979e-09
by O 0 9.306295289945865e-09
vWf O 0 1.6846895960043184e-05
. O 0 8.912081739254063e-07

Defective O 0 0.053915541619062424
thrombosis B-Disease 0 0.004233601037412882
in O 0 3.27057811944087e-08
mutant O 0 9.360860531160142e-07
mice O 0 5.3902876970823854e-05
was O 0 2.2822590040050272e-07
also O 0 3.475830734345209e-09
evident O 0 6.763188231673212e-09
in O 0 4.3418746376033823e-10
an O 0 1.9696785868994482e-10
in O 0 1.908853297649671e-09
vivo O 0 1.1211283208467648e-06
model O 0 1.5707205136550328e-07
of O 0 6.54209175721121e-09
vascular B-Disease 0 0.019743410870432854
injury I-Disease 0 0.16799679398536682
. O 0 8.442659122920304e-07

In O 0 2.2035827385025186e-08
this O 0 4.5401110648768395e-10
model O 0 1.0844547482236067e-08
, O 0 1.8430226789156734e-10
the O 0 2.458173387065443e-10
exteriorized O 0 4.031137450510869e-07
mesentery O 0 2.6335339953220682e-06
was O 0 1.863213583419565e-08
superfused O 0 1.646232874463749e-07
with O 0 4.6139567166925133e-10
ferric O 0 1.0613035783535452e-07
chloride O 0 1.2128306536851596e-07
and O 0 1.0978926656690646e-09
the O 0 3.14481329866112e-10
accumulation O 0 1.165291152460668e-08
of O 0 9.730185546175107e-10
fluorescently O 0 6.487664904852863e-06
labeled O 0 1.6073142887762515e-06
platelets O 0 7.519608971051639e-06
was O 0 2.3404192361908827e-08
observed O 0 1.8222197084583058e-08
by O 0 5.618763232462243e-09
intravital O 0 3.6794872357859276e-06
microscopy O 0 2.5125812044279883e-06
. O 0 8.143078389366565e-07

We O 0 4.183404769264598e-07
conclude O 0 3.9532050521984274e-08
that O 0 1.8683077307457552e-10
these O 0 2.1826072893471604e-10
mice O 0 1.4064274189706794e-08
very O 0 4.672531250804468e-10
closely O 0 5.587879314816746e-08
mimic O 0 2.327043875993695e-05
severe O 0 0.0004259211418684572
human O 0 6.252053026400972e-06
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.011713719926774502
will O 0 5.189694363139097e-08
be O 0 3.533347781026208e-10
very O 0 3.984158836178864e-11
useful O 0 3.7868191915535476e-10
for O 0 3.603000883756202e-11
investigating O 0 1.4207434118063134e-09
the O 0 9.827016284047474e-11
role O 0 3.845105123190251e-09
of O 0 1.6801153523982038e-10
vWf O 0 2.6414846843181294e-07
in O 0 1.8629924269930598e-09
normal O 0 2.131256415793814e-08
physiology O 0 2.3252995973166435e-08
and O 0 3.2992031329115434e-09
in O 0 1.512178116058749e-08
disease O 0 3.370284389347944e-07
models O 0 2.7327700991008896e-07
. O 0 2.077677052625404e-08
. O 0 1.7547972674947232e-07

Oral O 0 3.50749814970186e-06
contraceptives O 0 3.939188172807917e-05
and O 0 2.071543647730323e-08
the O 0 7.82160380907726e-09
risk O 0 6.42537052044645e-05
of O 0 2.46827767114155e-07
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.82579263614025e-06

Hereditary B-Disease 1 0.9999996423721313
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9995239973068237
Clinical O 0 0.00030931705259718
Study O 0 2.874874780900427e-06
Group O 0 2.2363608422892867e-06
. O 0 1.57834108449606e-06

BACKGROUND O 0 8.052311750361696e-05
Women O 0 3.0853760790705564e-07
with O 0 2.2433219726281095e-09
mutations O 0 7.17722272725041e-08
in O 0 3.717714192053023e-10
either O 0 1.8838599569193093e-09
the O 0 9.391579736117706e-10
BRCA1 O 0 1.3722469702770468e-06
or O 0 7.320565043045235e-09
the O 0 5.807300196281062e-10
BRCA2 O 0 2.392174565102323e-07
gene O 0 1.757935308432934e-08
have O 0 1.9805896922520105e-09
a O 0 8.751243618654314e-10
high O 0 7.49834541124983e-08
lifetime O 0 1.713048959572916e-06
risk O 0 0.0042003365233540535
of O 0 3.3953783713513985e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.2978008423233405e-06

Oral O 0 1.2901662557851523e-05
contraceptives O 0 0.0004200617258902639
protect O 0 3.810146517935209e-05
against O 1 0.7796859741210938
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.0004265194041295e-09
general O 0 2.901229534391092e-10
, O 0 3.722233909986272e-10
but O 0 6.1380887039774734e-09
it O 0 5.03733499357395e-10
is O 0 9.235678194441377e-11
not O 0 3.180158220095208e-11
known O 0 8.78998263065256e-11
whether O 0 2.045420777196938e-10
they O 0 6.042301103903469e-10
also O 0 4.015248411537442e-10
protect O 0 3.874878196086229e-09
against O 0 4.7267465497213834e-09
hereditary B-Disease 0 4.286356215743581e-06
forms I-Disease 0 2.5763115445442963e-06
of I-Disease 0 0.0009325685095973313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.706087560814922e-07

METHODS O 0 2.0699856122519122e-06
We O 0 5.770417388362148e-08
enrolled O 0 1.0965667485152153e-07
207 O 0 8.556147435001549e-08
women O 0 9.580784876561665e-08
with O 0 1.4077672005896602e-07
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.7065488577827637e-08
161 O 0 3.907102197331369e-09
of O 0 1.0455339372050787e-10
their O 0 1.5511586459737714e-09
sisters O 0 3.7746511338809796e-07
as O 0 1.3847039070924438e-09
controls O 0 1.1538153188439537e-07
in O 0 4.012484788873394e-10
a O 0 4.3139980476780693e-10
case O 0 1.1264918953202141e-07
- O 0 0.00024515760014764965
control O 0 8.373163495889457e-07
study O 0 1.3372600449201855e-07
. O 0 9.853268778670099e-08

All O 0 3.3801821786028086e-08
the O 0 3.1395166466552382e-09
patients O 0 4.6230169914451835e-08
carried O 0 6.589579992777317e-09
a O 0 2.5148323423707097e-09
pathogenic O 0 1.4934840919522685e-07
mutation O 0 6.78412064303302e-08
in O 0 8.66713978364686e-10
either O 0 1.0567240416037293e-08
BRCA1 O 0 2.345036364204134e-06
( O 0 2.815060629046684e-09
179 O 0 1.299636576135299e-08
women O 0 9.321875715784245e-09
) O 0 8.157896025373645e-10
or O 0 5.371143974031156e-09
BRCA2 O 0 5.472229531733319e-06
( O 0 3.775973755892892e-09
28 O 0 2.3609088017906288e-08
women O 0 7.276717184367953e-08
) O 0 1.520710668501124e-08
. O 0 1.1205047201201523e-07

The O 0 2.222297723619704e-08
control O 0 3.417881657696853e-07
women O 0 1.427134677101094e-08
were O 0 2.1055768240074713e-10
enrolled O 0 1.4381652535533362e-09
regardless O 0 6.142301667289018e-10
of O 0 4.948018123701603e-12
whether O 0 3.201815201858693e-10
or O 0 1.5478278658775935e-09
not O 0 1.2583321051806706e-09
they O 0 3.056896957787103e-09
had O 0 1.5817503751236472e-08
either O 0 5.0727830824826015e-08
mutation O 0 3.5446723813947756e-06
. O 0 3.5034790357713064e-07

Lifetime O 0 7.2420702963427175e-06
histories O 0 9.530933198220737e-07
of O 0 1.4164412975858909e-09
oral O 0 1.4723502772540087e-07
- O 0 1.0390390343673062e-06
contraceptive O 0 1.1556978734006407e-06
use O 0 5.380125678300374e-09
were O 0 2.307188468053667e-10
obtained O 0 1.1645906461410505e-09
by O 0 1.9221253755308254e-10
interview O 0 3.5850046486984866e-08
or O 0 4.893223048973994e-10
by O 0 1.6391110690960886e-11
written O 0 1.502579588530395e-10
questionnaire O 0 3.2189990673003877e-09
and O 0 1.5756872195904492e-10
were O 0 1.6487756993033287e-10
compared O 0 6.680631603472875e-10
between O 0 4.1348197088453276e-10
patients O 0 2.187694114752503e-08
and O 0 1.594426035644858e-09
control O 0 3.194815860751987e-07
women O 0 8.93338736318583e-09
, O 0 5.756249643606992e-11
after O 0 3.1473273987003836e-10
adjustment O 0 3.9483354363767376e-09
for O 0 4.0123064593000635e-11
year O 0 3.203629583836687e-10
of O 0 2.7654687567713054e-11
birth O 0 5.962371485424001e-09
and O 0 5.019785920268305e-09
parity O 0 3.789959635014384e-07
. O 0 1.1675631839125344e-07

RESULTS O 0 1.6967460396699607e-06
The O 0 4.495897876211075e-09
adjusted O 0 1.4235699836717686e-06
odds O 0 0.00010804111661855131
ratio O 0 0.0006205420359037817
for O 0 0.03868129849433899
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 2.099195128835163e-08
with O 0 1.8412026070446785e-10
any O 0 5.641246914045439e-10
past O 0 1.0792419180560842e-09
use O 0 1.782936243088784e-09
of O 0 1.5677550924131367e-10
oral O 0 5.668097102784486e-08
contraceptives O 0 1.8566861399449408e-05
was O 0 5.125164648234204e-08
0 O 0 5.6477983179092917e-08
. O 0 1.4231693512556376e-07

5 O 0 3.7229835925245425e-07
( O 0 8.739220902498346e-09
95 O 0 3.8431934967775305e-08
percent O 0 3.31623755300825e-06
confidence O 0 1.5536710407104692e-07
interval O 0 2.999706083528508e-08
, O 0 1.768216961739455e-10
0 O 0 2.1689330886864866e-10
. O 0 3.9591000616789884e-11
3 O 0 1.8760350217750243e-10
to O 0 1.1533384663975355e-10
0 O 0 1.0359308966201297e-09
. O 0 1.7624869341759108e-09
8 O 0 8.801214868014995e-09
) O 0 6.386036144334639e-09
. O 0 8.658258821014897e-08

The O 0 3.3966631463044905e-07
risk O 0 2.7144860723637976e-05
decreased O 0 1.294930882522749e-07
with O 0 4.887085736093866e-10
increasing O 0 2.8534745677433193e-09
duration O 0 2.749725247497281e-08
of O 0 3.770442638661997e-11
use O 0 3.919761848436565e-09
( O 0 4.713303081160802e-10
P O 0 8.204057735383685e-07
for O 0 3.594504693893441e-10
trend O 0 9.339265716334921e-08
, O 0 6.645238248559338e-10
< O 0 1.2525831927234776e-08
0 O 0 1.1681168254895624e-09
. O 0 2.499013496137792e-10
001 O 0 1.9846357890429545e-09
) O 0 9.113393199811082e-12
; O 0 4.1107217456370915e-12
use O 0 3.767222298001194e-11
for O 0 2.774513778447396e-11
six O 0 9.661606931166133e-11
or O 0 4.226355931891135e-10
more O 0 4.918334836623295e-11
years O 0 4.646438753752591e-07
was O 0 1.8479877184063298e-08
associated O 0 5.013564008393701e-10
with O 0 5.133687919212093e-11
a O 0 6.850651157463972e-10
60 O 0 9.380395127323027e-09
percent O 0 5.202415422900231e-07
reduction O 0 6.641480609914652e-08
in O 0 2.8282800101919747e-08
risk O 0 8.608891221228987e-06
. O 0 1.2353865486147697e-07

Oral O 0 1.615086875972338e-05
- O 0 1.154338133346755e-05
contraceptive O 0 8.952015377872158e-06
use O 0 5.1831854364081664e-08
protected O 0 9.779980700841406e-07
against O 0 0.10652194917201996
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
both O 0 1.9370159642928542e-10
for O 0 8.265176737465296e-11
carriers O 0 2.364125117892968e-09
of O 0 3.3279056593782386e-11
the O 0 1.659225090655525e-09
BRCA1 O 0 7.77273908170173e-06
mutation O 0 4.1706582010192506e-07
( O 0 1.1665960419904309e-09
odds O 0 2.074871190416161e-06
ratio O 0 7.344987551505255e-08
, O 0 2.51183962518553e-10
0 O 0 3.7592853829870876e-10
. O 0 3.900977457726995e-11
5 O 0 5.665764732376566e-11
; O 0 1.2680143046672754e-10
95 O 0 1.4553094285219004e-09
percent O 0 1.0464685828992515e-06
confidence O 0 2.9208880647502156e-08
interval O 0 8.40623926023909e-09
, O 0 1.0895206958849712e-10
0 O 0 2.0337539985426645e-10
. O 0 5.870622044046314e-11
3 O 0 8.335659940073015e-11
to O 0 7.353247871710877e-11
0 O 0 1.4775075607431631e-10
. O 0 1.0997300986526071e-10
9 O 0 1.1938049160331587e-10
) O 0 3.165453316134048e-11
and O 0 2.579018248960452e-11
for O 0 3.378449256463689e-11
carriers O 0 1.3179536351159982e-09
of O 0 4.502329065125821e-11
the O 0 2.0036305947712663e-09
BRCA2 O 0 8.032045116124209e-06
mutation O 0 1.0883279344398034e-07
( O 0 1.038661157082288e-09
odds O 0 2.6001380319939926e-06
ratio O 0 7.713898497740956e-08
, O 0 2.690188627418877e-10
0 O 0 3.220108624191198e-10
. O 0 8.985498456404173e-11
4 O 0 9.576477805195438e-11
; O 0 1.24271579138302e-10
95 O 0 8.131735285132891e-10
percent O 0 1.219785076500557e-06
confidence O 0 1.9867918865656975e-08
interval O 0 6.133173524602853e-09
, O 0 1.224205598004957e-10
0 O 0 1.863816045943878e-10
. O 0 7.815229019492165e-11
2 O 0 3.0088137537021e-10
to O 0 1.3083154004611686e-10
1 O 0 8.332611822758906e-10
. O 0 4.772019446264153e-10
1 O 0 2.2758128714883696e-09
) O 0 2.4417490251948948e-09
. O 0 3.199474107873357e-08

CONCLUSIONS O 0 5.777101250714622e-07
Oral O 0 4.1519183469063137e-07
- O 0 6.367915261762391e-07
contraceptive O 0 4.399692556944501e-07
use O 0 4.85731366239861e-09
may O 0 5.631423327656648e-09
reduce O 0 9.091634112223801e-09
the O 0 1.0861475052692526e-09
risk O 0 8.981458449852653e-06
of O 0 2.3786180136653456e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.394420883788939e-09
women O 0 1.2829234563582759e-08
with O 0 5.49803202964938e-10
pathogenic O 0 4.548150300820453e-08
mutations O 0 9.225585273497927e-08
in O 0 9.909727483048414e-10
the O 0 1.0196023580988367e-08
BRCA1 O 0 2.9896478736191057e-05
or O 0 9.966599918698194e-07
BRCA2 O 0 0.00037132384022697806
gene O 0 0.0003141053894069046

A O 0 4.918323384117684e-07
Japanese O 0 1.4223334687812894e-07
family O 0 7.864553452918699e-09
with O 0 1.9821617680548798e-09
adrenoleukodystrophy B-Disease 1 0.9999998807907104
with O 0 6.733943180847746e-09
a O 0 1.2188015929837093e-08
codon O 0 8.370944328817131e-07
291 O 0 3.324072395116673e-08
deletion O 0 1.7535525387302187e-07
: O 0 1.1635160612755158e-09
a O 0 3.230240241958171e-10
clinical O 0 7.176894456506488e-08
, O 0 4.858089486248218e-10
biochemical O 0 1.3481019323080545e-07
, O 0 1.165441743111728e-09
pathological O 0 7.896361609027736e-08
, O 0 2.4915616236853566e-09
and O 0 7.967037696232637e-09
genetic O 0 4.09665199185838e-06
report O 0 1.2608836641447851e-06
. O 0 4.538747759852413e-07

We O 0 2.4367966489080573e-06
report O 0 6.668695107236999e-08
a O 0 2.7196020990771785e-09
Japanese O 0 3.1311817139112463e-08
family O 0 1.7272943964030674e-08
with O 0 2.628574691243557e-08
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.64571787308887e-07
ALD B-Disease 1 1.0
) O 0 7.709997085214582e-09
with O 0 2.208351973509437e-10
a O 0 4.3819836648140154e-10
three O 0 1.7747728842110178e-09
base O 0 1.5746554282713987e-08
pair O 0 4.805040987321263e-08
deletion O 0 6.341674065879488e-07
( O 0 1.3304255475077298e-09
delGAG O 0 7.473273910818534e-08
291 O 0 1.621371303883734e-08
) O 0 1.0762202240499619e-09
in O 0 1.3485751404473945e-09
the O 0 5.341804509839676e-08
ALD B-Disease 1 0.9999997615814209
gene O 0 8.68542610987788e-06
. O 0 1.1081598358941847e-06

A O 0 1.2000390370303649e-07
variety O 0 3.464560549559792e-08
of O 0 7.11180725421201e-10
phenotypes O 0 3.2191115906243795e-07
were O 0 4.806349540587007e-09
observed O 0 1.2232101553877328e-08
within O 0 1.45114897875942e-09
this O 0 3.0100897330243015e-09
family O 0 8.922884120465824e-08
. O 0 2.76687188716096e-07

While O 0 5.10754034621641e-07
the O 0 9.64144053483551e-09
proband O 0 8.691407060723577e-07
( O 0 2.331814075162697e-09
patient O 0 2.3273939220302964e-08
1 O 0 1.7731690560296443e-09
) O 0 4.284934906895188e-10
was O 0 2.6523788720922425e-10
classified O 0 1.2174486974103615e-09
as O 0 3.1159685942583337e-10
having O 0 1.0422134266718786e-09
a O 0 7.510529698162571e-11
rare O 0 7.767944620873379e-10
intermediate O 0 3.9981773447550495e-09
type O 0 6.402601115951256e-08
of O 0 8.599216339000293e-10
adult O 0 1.1956483376707183e-06
cerebral O 0 0.0003871078079100698
and O 0 3.3179219371959334e-08
cerebello O 1 0.699923574924469
- O 1 0.9571380019187927
brain O 0 9.346088336315006e-05
stem O 0 1.2621551093161543e-07
forms O 0 1.1494152296620541e-08
, O 0 9.013860768902759e-10
his O 0 8.985743260581103e-10
younger O 0 1.144211481118873e-08
brother O 0 7.4277113348841795e-09
( O 0 7.386989353541651e-10
patient O 0 2.7701290150616842e-08
2 O 0 2.8347704184028544e-09
) O 0 1.5894644489478083e-09
and O 0 1.7167928190175985e-09
nephew O 0 3.9660744022285144e-08
( O 0 1.330988985692727e-09
patient O 0 4.445148604759197e-08
3 O 0 4.585498203368843e-09
) O 0 2.210746696817978e-09
had O 0 3.608962373391478e-08
a O 0 5.443683193107063e-08
childhood O 0 0.00038688594941049814
ALD B-Disease 1 1.0
type O 0 0.07358979433774948
. O 0 3.217449602743727e-06

Another O 0 5.871839334758988e-07
nephew O 0 6.014010409671755e-07
( O 0 1.2141355476558147e-08
patient O 0 8.204685997270644e-08
4 O 0 1.8658656841807897e-09
) O 0 1.0550539331077857e-09
of O 0 1.5377135675898046e-10
patient O 0 1.5468185665667988e-07
1 O 0 1.2326417220265284e-08
was O 0 3.120579794568812e-09
classified O 0 1.298031282459533e-08
as O 0 2.9107978249953703e-09
having O 0 3.250379521091418e-08
an O 0 3.1368470043702246e-09
adolescent O 0 1.5017035366327036e-06
form O 0 4.097391865798272e-07
. O 0 6.131696181910229e-07

The O 0 5.5317187275250035e-08
tau O 0 9.840459114229816e-08
level O 0 3.823955552206826e-08
in O 0 2.5522435276315036e-09
the O 0 1.2271594407309294e-08
cerebrospinal O 0 1.3398273949860595e-05
fluid O 0 4.931893045068136e-07
( O 0 1.0600771815916232e-08
CSF O 0 1.3125906662025955e-05
) O 0 8.170291110332073e-10
in O 0 2.451080172161113e-10
patient O 0 1.2406329297220964e-08
1 O 0 1.3360664574690873e-08
was O 0 1.1949611966599605e-08
as O 0 4.672460196530892e-10
high O 0 9.129580980093976e-10
as O 0 6.892654502710371e-11
that O 0 1.0589606275202001e-10
of O 0 2.003388704929776e-10
patients O 0 5.285031434709708e-08
with O 0 1.3447486679751819e-08
Alzheimers B-Disease 1 0.9980900883674622
disease I-Disease 0 4.639796679839492e-05
( O 0 5.861821694708169e-09
AD B-Disease 0 2.0272671008569887e-06
) O 0 3.819130256488279e-08
. O 0 1.3211462146500708e-07

His O 0 2.805545875617099e-07
brain O 0 7.825075954315253e-06
magnetic O 0 2.2201292892987112e-07
resonance O 0 2.0225434127496555e-06
image O 0 1.8149115703636198e-06
( O 0 2.2680302080857473e-09
MRI O 0 2.725528929659049e-06
) O 0 7.169681293106578e-09
showed O 0 1.299338379112669e-07
abnormalities B-Disease 0 0.00013693484652321786
in I-Disease 0 8.956176356100798e-10
the I-Disease 0 1.7599072199558918e-09
bilateral I-Disease 0 1.9330141753926e-07
cerebellar I-Disease 0 2.9673039989575045e-06
hemispheres I-Disease 0 6.823677540523931e-05
and O 0 4.593326252688712e-08
brain O 0 2.876169844512333e-07
stem O 0 2.570227053411145e-08
, O 0 2.150622180341344e-10
but O 0 6.379263783884426e-10
not O 0 2.240178181844854e-10
in O 0 2.0903311026554405e-10
the O 0 8.542946350331704e-10
cerebral O 0 4.02672640120727e-07
white O 0 1.4318543684055385e-08
matter O 0 8.353218672318974e-10
, O 0 5.2887343809926435e-11
where O 0 1.4425162453424178e-10
marked O 0 2.6881383785593016e-09
reductions O 0 5.166564065461898e-08
of O 0 7.203902058217082e-11
the O 0 3.222291322657611e-09
cerebral O 0 2.9743443974439288e-06
blood O 0 1.865091405761632e-07
flow O 0 8.688102326459557e-08
and O 0 2.3564911799667243e-08
oxygen O 0 6.518749984252281e-09
metabolism O 0 3.209520649249953e-09
were O 0 2.9690844227658886e-10
clearly O 0 1.2084999667649754e-09
demonstrated O 0 4.684239107710653e-10
by O 0 1.587134174085847e-10
positron O 0 1.801908240395278e-07
emission O 0 9.366042519332041e-08
tomography O 0 1.0664165301932371e-06
( O 0 1.0411647544117386e-08
PET O 0 3.3158346468553646e-07
) O 0 2.7151099146749402e-08
. O 0 1.1787894038661761e-07

In O 0 5.72236672269355e-07
patients O 0 1.4233879710445763e-06
2 O 0 1.0658798288432081e-08
and O 0 1.612303957010397e-09
3 O 0 2.721049607856685e-09
, O 0 2.8968721865751945e-10
the O 0 4.470874503947897e-10
autopsy O 0 1.9216476232486457e-07
findings O 0 3.383329527650858e-08
showed O 0 3.57778446868906e-08
massive O 0 7.959462777762383e-08
demyelination B-Disease 1 1.0
of I-Disease 0 4.791987695540456e-09
the I-Disease 0 2.509936081196429e-08
cerebral I-Disease 0 3.0378592782653868e-05
white I-Disease 0 5.711811823516655e-08
matter I-Disease 0 9.799731026660652e-10
with O 0 5.096691818584631e-11
sparing O 0 2.459210834970804e-09
of O 0 4.9516557520945526e-11
the O 0 7.076653152360279e-10
U O 0 8.424430234299507e-06
- O 0 0.00036478263791650534
fibers O 0 1.6278732800856233e-05
, O 0 2.725951964155371e-10
compatible O 0 7.150435243907793e-10
with O 0 6.495298049413734e-11
the O 0 6.857449608155264e-10
findings O 0 4.3659866832967964e-08
of O 0 8.585798738636186e-09
childhood O 0 3.226883563911542e-05
ALD B-Disease 1 0.9999997615814209
. O 0 3.6807998640142614e-06

Oleic O 0 0.3458442986011505
and O 0 2.4723819933569757e-06
erucic O 0 0.00015352667833212763
acids O 0 7.866609621487441e-07
( O 0 1.9892556490930247e-09
Lorenzos O 0 2.0864699479261617e-07
Oil O 0 6.334964552934252e-08
) O 0 3.635169387727899e-10
were O 0 1.6756444842780382e-10
administered O 0 8.58862758690293e-10
to O 0 1.7476899094592824e-10
patients O 0 3.7690441878623915e-09
1 O 0 4.70955552334118e-10
and O 0 3.056254138655845e-10
4 O 0 6.457933632297852e-10
, O 0 1.817441752649529e-10
but O 0 9.862247685177294e-10
sufficient O 0 2.3635300383517688e-09
effectiveness O 0 1.9042539989300167e-08
was O 0 2.0166508463148602e-09
not O 0 1.071098543192761e-09
obtained O 0 3.523693692386587e-08
. O 0 7.487341235901113e-08

The O 0 3.42571304656758e-08
findings O 0 2.4797767395057235e-08
in O 0 5.488235421680088e-10
this O 0 9.450171201130786e-11
family O 0 4.428439281944918e-10
suggest O 0 8.53613790763319e-10
that O 0 3.5616901788992905e-11
delGAG291 O 0 7.67203278684292e-09
is O 0 3.996732458877439e-11
part O 0 1.3756842887069354e-10
of O 0 2.2811471461769983e-11
the O 0 1.202177690728945e-09
cause O 0 7.94389798386419e-09
of O 0 6.664455654004087e-10
Japanese O 0 4.453331712284125e-06
ALD B-Disease 1 1.0
with O 0 1.073459277023403e-08
phenotypic O 0 5.529605004994664e-06
variations O 0 6.643255801463965e-06
. O 0 1.3452715847961372e-06

Moreover O 0 7.159093229347491e-07
, O 0 5.300534677843416e-09
although O 0 1.089620949024095e-09
the O 0 9.45772626881336e-11
scale O 0 4.326989611058707e-08
of O 0 3.576053342335683e-11
the O 0 9.761912111994064e-11
study O 0 5.959366888852458e-10
is O 0 5.789514007092933e-11
limited O 0 5.057128049656967e-10
, O 0 8.812123253321147e-11
there O 0 6.751543074612343e-11
is O 0 4.6566035749595613e-11
a O 0 4.448449941740762e-11
possibility O 0 1.5005353626307283e-09
that O 0 1.9769956505211184e-10
PET O 0 6.645267447424885e-09
can O 0 2.0030648251179173e-09
detect O 0 3.394726491023903e-07
an O 0 3.89669574385465e-10
insidious B-Disease 0 1.7326869055978023e-05
lesion I-Disease 1 0.9291377663612366
which O 0 8.926561179123382e-08
is O 0 4.151020860376775e-09
undetectable O 0 1.1724056037110131e-07
by O 0 1.9748774837680116e-10
computed O 0 3.823110006351271e-08
tomogram O 0 6.328140784717107e-07
( O 0 1.0030173358543948e-09
CT O 0 0.0005942153511568904
) O 0 4.5924633540472826e-10
or O 0 5.327676078081822e-10
MRI O 0 2.26883230425301e-07
analysis O 0 4.152208799013124e-09
, O 0 1.8622524355915715e-10
and O 0 3.253266267488897e-10
that O 0 2.473350135812069e-10
the O 0 4.039329704053074e-10
higher O 0 3.1812072620596155e-07
level O 0 1.3845857793626237e-08
of O 0 5.840065236961678e-11
tau O 0 7.917256295009167e-10
reflects O 0 6.074170055825334e-10
the O 0 5.221399354549128e-11
process O 0 1.9623749292208004e-09
of O 0 3.5748817794889476e-10
neuronal B-Disease 0 1.147533339462825e-06
degeneration I-Disease 0 2.5519524569972418e-05
in O 0 1.0568550123934983e-06
ALD B-Disease 1 1.0
. O 0 3.287093477410963e-06

Lorenzos O 0 5.0115184421883896e-05
Oil O 0 7.190224096120801e-06
should O 0 9.897188846252902e-09
be O 0 1.9115264926483633e-10
given O 0 1.5819751064682919e-10
in O 0 1.7312340450104102e-10
the O 0 3.881074628342418e-10
early O 0 6.609042202398996e-08
stage O 0 5.668085805154988e-07
. O 0 2.767467321973527e-08
. O 0 1.8084534758600057e-07

Nonsense O 0 8.369811985176057e-05
mutation O 0 7.208824172266759e-06
in O 0 1.8780811572582934e-08
exon O 0 3.5366085171517625e-07
4 O 0 1.963866225196398e-08
of O 0 3.802075321246434e-10
human O 0 4.228905670089489e-09
complement O 0 6.334155244758222e-08
C9 O 0 7.327552680180816e-07
gene O 0 3.68838541930927e-08
is O 0 8.401361828447307e-10
the O 0 5.106639000551638e-10
major O 0 8.657577765802671e-09
cause O 0 1.3011198340961982e-08
of O 0 1.3719509972531796e-09
Japanese O 0 1.7395392433172674e-06
complement B-Disease 0 1.7567575923749246e-05
C9 I-Disease 0 0.007418124005198479
deficiency I-Disease 0 0.030609698966145515
. O 0 4.9012425051842e-07

Deficiency B-Disease 1 0.9992135763168335
of I-Disease 0 5.248403489588327e-09
the I-Disease 0 1.8247439115270936e-09
ninth I-Disease 0 1.5060930280696994e-08
component I-Disease 0 6.417823072979445e-08
of I-Disease 0 2.171404167583546e-10
human I-Disease 0 1.4460098674007327e-09
complement I-Disease 0 7.361590892429604e-09
( O 0 4.0141379109570607e-10
C9 O 0 4.598393132937417e-08
) O 0 1.3475331961387838e-10
is O 0 3.97567222198969e-11
the O 0 2.963583545234627e-11
most O 0 9.531964106912483e-10
common O 0 1.4793387208555941e-06
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.3021643763266866e-09
Japan O 0 8.436789933341515e-09
but O 0 1.2084445666360466e-09
is O 0 3.000399581565283e-11
rare O 0 1.8072236762645133e-10
in O 0 1.4333693953982873e-10
other O 0 4.066493808352334e-10
countries O 0 1.1295789192899974e-08
. O 0 1.0426060725876596e-07

We O 0 5.425511062639998e-07
studied O 0 4.2873026018241944e-08
the O 0 4.153172805665406e-10
molecular O 0 1.260220550136637e-08
basis O 0 1.203963595486357e-08
of O 0 9.468637429677074e-09
C9 B-Disease 0 0.30403196811676025
deficiency I-Disease 0 0.2750757932662964
in O 0 3.243874502345534e-09
four O 0 6.522120621355043e-09
Japanese O 0 1.989469637919683e-07
C9 B-Disease 0 0.00028091450803913176
- I-Disease 0 0.00011009585432475433
deficient I-Disease 0 1.9517133296176326e-06
patients O 0 3.6231149636023474e-08
who O 0 1.1366375396448802e-08
had O 0 7.91960488299992e-08
suffered O 0 0.0008427435532212257
from O 0 2.630815174597956e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.724926162045449e-06

Direct O 0 6.595203103643144e-07
sequencing O 0 9.586063924871269e-07
of O 0 1.7001420715700988e-08
amplified O 0 5.865934440407727e-07
C9 O 0 3.6522637856251094e-06
cDNA O 0 1.8469363283202256e-07
and O 0 1.0499555003207206e-08
DNA O 0 1.4475482146281138e-07
revealed O 0 6.936184604455775e-08
a O 0 1.4311628548924205e-09
nonsense O 0 1.1656751297550727e-07
substitution O 0 1.2530994020210073e-08
( O 0 1.0592156041155931e-09
CGA O 0 2.611738807445363e-07
- O 0 3.769531986108632e-06
- O 0 6.729798656124331e-07
> O 0 4.73735397577002e-08
TGA O 0 8.439495218226511e-07
) O 0 5.844325023929287e-10
at O 0 6.931682450250776e-10
codon O 0 1.3723338021520703e-08
95 O 0 7.062144202762966e-10
in O 0 7.943495861084671e-11
exon O 0 1.1361433571721591e-08
4 O 0 1.0211510526048073e-09
in O 0 1.1630450769128942e-10
the O 0 4.0430600534158145e-10
four O 0 1.7828996945468134e-08
C9 B-Disease 0 0.000363086408469826
- I-Disease 0 0.0001180717590614222
deficient I-Disease 0 5.188722298044013e-06
individuals O 0 2.7219597242833515e-08
. O 0 1.0185104315496574e-07

An O 0 2.576515498731169e-07
allele O 0 1.3600441889138892e-05
- O 0 3.879794348904397e-06
specific O 0 6.158014542734236e-08
polymerase O 0 3.5458285196909856e-07
chain O 0 1.5816287941561313e-06
reaction O 0 8.134504270174148e-08
system O 0 5.227273724983661e-09
designed O 0 5.816615189502272e-09
to O 0 1.8111506738804906e-10
detect O 0 1.7527192142097192e-08
exclusively O 0 4.3135620075851477e-10
only O 0 7.473575924787923e-11
one O 0 7.585970740464631e-11
of O 0 6.891152145444002e-12
the O 0 1.1472238437004734e-10
normal O 0 4.08658751283042e-09
and O 0 1.053015341589969e-09
mutant O 0 3.0776554638123343e-08
alleles O 0 2.399886156467801e-08
indicated O 0 7.136922164363568e-09
that O 0 1.06975248104213e-10
all O 0 2.4127474324009412e-11
the O 0 3.0394350231111034e-11
four O 0 2.0393553512576545e-10
patients O 0 1.142265837472678e-09
were O 0 5.90709217651586e-11
homozygous O 0 7.681140168358525e-09
for O 0 1.0169561026618368e-10
the O 0 1.8665267942363784e-10
mutation O 0 5.825164350881096e-09
in O 0 1.5183469759261214e-10
exon O 0 9.843271975285006e-09
4 O 0 2.4906967599491736e-09
and O 0 4.952263044089023e-10
that O 0 1.0068542527497115e-10
the O 0 1.6497414545568745e-10
parents O 0 5.625883758852979e-09
of O 0 1.7162091192624018e-10
patient O 0 2.4105153428877202e-08
2 O 0 5.0230806181161824e-09
were O 0 8.067565282487976e-09
heterozygous O 0 2.2449855805461993e-06
. O 0 3.0668240924569545e-07

The O 0 5.8173725392407505e-08
common O 0 8.045088151220625e-08
mutation O 0 3.6676593140327896e-07
at O 0 7.114062672286536e-09
codon O 0 1.0648987824879441e-07
95 O 0 3.233188383688912e-09
in O 0 2.287452866012174e-10
exon O 0 2.4762320194327003e-08
4 O 0 2.518403485751719e-09
might O 0 3.7021135046444442e-09
be O 0 2.168449170225628e-10
responsible O 0 5.478665854319331e-10
for O 0 2.0590346094806478e-10
most O 0 1.051233944338037e-08
Japanese O 0 4.912683834845666e-06
C9 B-Disease 0 0.012639197520911694
deficiency I-Disease 0 0.0006034689140506089
. O 0 2.1415004880509514e-08
. O 0 8.433495679582848e-08

BRCA1 O 0 6.377256067935377e-05
required O 0 1.5424538446495717e-07
for O 0 5.464350305572907e-09
transcription O 0 4.835933964386641e-07
- O 0 0.005127298180013895
coupled O 0 3.903576725861058e-06
repair O 0 3.2530260796193033e-05
of O 0 3.760807665287302e-09
oxidative O 0 2.595435717012151e-06
DNA O 0 1.1794650163210463e-05
damage O 0 3.0460108973784372e-05
. O 0 7.511643502766674e-07

The O 0 1.0830873407030595e-06
breast B-Disease 1 0.9999761581420898
and I-Disease 1 0.9999319314956665
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 0.0001112854151870124
gene O 0 4.092344897799194e-05
BRCA1 O 0 0.00010710527567425743
encodes O 0 2.087860138999531e-06
a O 0 2.2369829366652993e-07
zinc O 0 0.00046641661901958287
finger O 0 1.2423314728948753e-05
protein O 0 3.4498927448112227e-07
of O 0 1.8675425650371835e-09
unknown O 0 2.2303369462406408e-07
function O 0 5.451963716041064e-07
. O 0 1.0477037903910968e-06

Association O 0 1.188931832984963e-06
of O 0 5.39574607216764e-09
the O 0 5.275420544847975e-09
BRCA1 O 0 1.014821691569523e-06
protein O 0 1.3089806571997542e-08
with O 0 5.424885540783464e-10
the O 0 1.7506400773470432e-09
DNA O 0 4.347804463122884e-07
repair O 0 1.159668045147555e-06
protein O 0 2.6939755315424918e-08
Rad51 O 0 8.30741726076667e-07
and O 0 3.757251842984033e-09
changes O 0 2.130999154914548e-09
in O 0 1.9534188155923005e-10
the O 0 4.1835736264150825e-11
phosphorylation O 0 2.025007272976609e-09
and O 0 1.516041403526458e-09
cellular O 0 2.340115834442713e-08
localization O 0 5.480382814226914e-09
of O 0 3.7942277791858103e-11
the O 0 5.890586629586636e-11
protein O 0 2.411443045247097e-09
after O 0 1.7161837506662891e-09
exposure O 0 3.592054653722698e-08
to O 0 1.4360977684813037e-10
DNA O 0 2.16740161818052e-07
- O 0 8.402273010688077e-07
damaging O 0 4.944735820799906e-08
agents O 0 7.4437940256188995e-09
are O 0 7.122731571218566e-11
consistent O 0 7.436963822549103e-10
with O 0 4.0308770210550904e-11
a O 0 3.7714589784521024e-10
role O 0 1.8162584325409625e-08
for O 0 1.8240270405200931e-09
BRCA1 O 0 9.95852360574645e-07
in O 0 1.4408128024001599e-08
DNA O 0 1.2359713764453772e-05
repair O 0 0.0001889980776468292
. O 0 6.577251383532712e-07

Here O 0 1.1973754965310945e-07
, O 0 1.2494854040312475e-09
it O 0 3.246521940170055e-10
is O 0 9.491736563393971e-11
shown O 0 7.263689649761318e-10
that O 0 1.5832035682450396e-10
mouse O 0 5.0896272085765304e-08
embryonic O 0 1.2746529876039858e-07
stem O 0 7.857941568545357e-07
cells O 0 8.228685715039319e-07
deficient B-Disease 0 1.5435266504937317e-06
in I-Disease 0 1.1605106875478555e-09
BRCA1 I-Disease 0 1.7333907464944787e-07
are O 0 6.443980349324363e-10
defective O 0 3.900194656125677e-08
in O 0 3.554308514175375e-10
the O 0 1.1456165877055113e-10
ability O 0 1.8375198029829676e-09
to O 0 1.0808172412613004e-10
carry O 0 1.5062876501659161e-09
out O 0 4.596144020929671e-10
transcription O 0 1.594332488252803e-08
- O 0 3.164961981383385e-06
coupled O 0 3.447284768753889e-07
repair O 0 1.1242547088841093e-06
of O 0 2.1311079290153856e-10
oxidative O 0 5.347186871063059e-08
DNA O 0 3.5593092206909205e-07
damage O 0 9.593559298082255e-06
, O 0 3.9406292118293607e-10
and O 0 2.8498073345595287e-10
are O 0 8.798352324479453e-11
hypersensitive O 0 4.4789533859557196e-08
to O 0 3.641819734667706e-09
ionizing O 0 1.2854496844738605e-06
radiation O 0 3.3190315207320964e-06
and O 0 1.5384189921974212e-08
hydrogen O 0 3.10689841853673e-07
peroxide O 0 3.185640161973424e-05
. O 0 3.9561024323120364e-07

These O 0 1.7317054812338029e-07
results O 0 1.866639536274306e-07
suggest O 0 5.176615047730593e-08
that O 0 2.3325568143661712e-09
BRCA1 O 0 3.7781950368298567e-07
participates O 0 6.7787118140927305e-09
, O 0 1.6253669243848634e-10
directly O 0 3.701151329860153e-10
or O 0 2.2685753275908382e-09
indirectly O 0 3.265678572006436e-08
, O 0 5.980591577525729e-10
in O 0 7.186613526499741e-10
transcription O 0 3.3230426765840093e-07
- O 0 0.056755390018224716
coupled O 0 1.59591745614307e-05
repair O 0 1.4941416338842828e-05
of O 0 1.3553932420862225e-09
oxidative O 0 6.171749191707931e-07
DNA O 0 2.4493031105521368e-06
damage O 0 7.162533620430622e-06
. O 0 4.4083527939164924e-08
. O 0 3.012188187767606e-07

Truncation O 0 5.8357447414891794e-05
mutations O 0 1.3814956218993757e-05
in O 0 9.346587503955561e-09
the O 0 3.341348087104734e-09
transactivation O 0 6.260882855713135e-06
region O 0 1.8763238074370747e-07
of O 0 8.744335255883584e-10
PAX6 O 0 3.0387927836272866e-06
result O 0 3.056863562278522e-08
in O 0 3.095090406191048e-09
dominant O 0 0.00014804358943365514
- O 0 0.010595917701721191
negative O 0 3.42409111908637e-06
mutants O 0 3.830756213574205e-06
. O 0 1.6813903869206115e-07

PAX6 O 0 0.00024111253151204437
is O 0 7.663465595442176e-08
a O 0 2.5826143446039396e-09
transcription O 0 4.235672790287026e-08
factor O 0 2.2211281702766428e-08
with O 0 1.1897768881219406e-10
two O 0 7.247857869430163e-10
DNA O 0 1.3322286349648493e-06
- O 0 9.36839478526963e-06
binding O 0 1.0503303826681076e-07
domains O 0 1.100461801684105e-07
( O 0 1.271303728955786e-09
paired O 0 5.169343708644192e-08
box O 0 1.545631533872438e-07
and O 0 5.997432772630873e-09
homeobox O 0 2.806940244681755e-07
) O 0 1.3878954652213338e-09
and O 0 6.960710341452625e-10
a O 0 2.058128556470251e-09
proline O 0 1.3130636489222525e-06
- O 0 2.4500930067006266e-06
serine O 0 6.846059932286153e-06
- O 0 3.134719008812681e-06
threonine O 0 1.6986856508083292e-06
( O 0 3.783889646058469e-09
PST O 0 5.044244062446523e-07
) O 0 1.3343296245693637e-08
- O 0 4.1591948729546857e-07
rich O 0 1.7802466345528956e-07
transactivation O 0 1.599862844159361e-05
domain O 0 1.5459131645911839e-06
. O 0 6.907271199452225e-07

PAX6 O 0 0.0006704379920847714
regulates O 0 5.342088115867227e-05
eye O 0 0.07139186561107635
development O 0 1.8804469092970066e-08
in O 0 5.229943700335582e-10
animals O 0 5.842185624160834e-10
ranging O 0 1.2585552600086203e-09
from O 0 3.445374263666423e-10
jellyfish O 0 6.6990089031548905e-09
to O 0 1.5528511809748125e-10
Drosophila O 0 2.912474927896369e-09
to O 0 5.529961488726087e-10
humans O 0 2.0555246393882953e-08
. O 0 9.818917590109777e-08

Heterozygous O 0 0.00025304153678007424
mutations O 0 2.079028490697965e-05
in O 0 2.541615629070293e-08
the O 0 2.4343043136809683e-09
human O 0 5.387313706251007e-09
PAX6 O 0 1.3373103229241678e-06
gene O 0 1.0500480129849166e-07
result O 0 1.0556080454193761e-08
in O 0 8.858044853177205e-11
various O 0 1.2956281880693865e-10
phenotypes O 0 2.999688675231482e-08
, O 0 1.1396712740197046e-10
including O 0 1.0218524915117655e-09
aniridia B-Disease 1 1.0
, O 0 1.3472266857661452e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.2572093055496225e-07
autosomal B-Disease 0 0.006659167818725109
dominant I-Disease 0 0.0025510748382657766
keratitis I-Disease 1 0.9959858059883118
, O 0 2.2368932661720464e-07
and O 0 4.7250048851310567e-07
familial B-Disease 1 0.998126208782196
foveal I-Disease 1 0.9914029240608215
dysplasia I-Disease 1 0.9991875290870667
. O 0 1.866250931925606e-05

It O 0 6.161079824096305e-08
is O 0 2.800761178534117e-09
believed O 0 3.7259226814967406e-09
that O 0 9.405431294906563e-11
the O 0 2.527256182105475e-10
mutated O 0 1.0858646248834702e-07
allele O 0 2.233902449688685e-07
of O 0 8.127409301117439e-10
PAX6 O 0 2.2612987322645495e-06
produces O 0 2.0833038405498883e-08
an O 0 2.5571439410398966e-10
inactive O 0 1.726309584171304e-08
protein O 0 4.799387554044188e-09
and O 0 3.5975655787723326e-09
aniridia B-Disease 1 1.0
is O 0 5.862764140829313e-08
caused O 0 3.320169028597775e-08
due O 0 8.47305869910997e-09
to O 0 5.8299542970985385e-09
genetic O 0 2.800808260872145e-06
haploinsufficiency O 0 1.584460369485896e-05
. O 0 3.311871523692389e-07

However O 0 1.6044459982822445e-07
, O 0 1.611200284301617e-09
several O 0 8.134155016215061e-10
truncation O 0 9.140828183262784e-08
mutations O 0 2.6438789291205467e-07
have O 0 4.866382408152958e-09
been O 0 1.0053655685737795e-09
found O 0 2.3024099293778022e-10
to O 0 9.958112806573993e-11
occur O 0 7.295373749549583e-10
in O 0 1.1553398515662394e-10
the O 0 5.637589284290812e-10
C O 0 6.519293833662232e-07
- O 0 1.7117787365350523e-07
terminal O 0 7.045669292438106e-08
half O 0 2.1938439953572697e-09
of O 0 7.564903564682979e-11
PAX6 O 0 1.2505712732036045e-07
in O 0 4.0350328633920185e-10
patients O 0 1.0335472033773385e-08
with O 0 1.0844086739680847e-09
Aniridia B-Disease 1 1.0
resulting O 0 4.013100962652061e-08
in O 0 3.305739570969024e-10
mutant O 0 8.28646307127201e-09
proteins O 0 1.3949176258520879e-09
that O 0 2.6447757872638533e-10
retain O 0 9.601837547279501e-09
the O 0 1.259952558951838e-10
DNA O 0 4.790856422687284e-08
- O 0 3.8676439828577713e-08
binding O 0 2.1180726061942323e-09
domains O 0 4.090018101976511e-09
but O 0 2.9051514527367317e-09
have O 0 1.1752704365264321e-09
lost O 0 2.689052536197778e-08
most O 0 2.0504399567133902e-10
of O 0 1.8138299195946672e-10
the O 0 6.7046719287588985e-09
transactivation O 0 5.817688361275941e-06
domain O 0 9.111911936088291e-07
. O 0 2.126011509062664e-07

It O 0 3.670258763577294e-08
is O 0 1.0876359812783676e-09
not O 0 4.271194231630915e-10
clear O 0 4.769926120751222e-10
whether O 0 2.38605857294516e-10
such O 0 1.890330669773732e-10
mutants O 0 1.267174809527205e-07
really O 0 1.4845685569753186e-08
behave O 0 2.9070472695735816e-09
as O 0 1.512222708166533e-10
loss O 0 9.147975710277478e-09
- O 0 1.1061857918548412e-07
of O 0 5.720015572308057e-10
- O 0 3.2984642075462034e-06
function O 0 1.416436568035806e-08
mutants O 0 1.3750671712386975e-07
as O 0 3.1281837120644695e-09
predicted O 0 2.8616188529895226e-08
by O 0 4.1830192643033115e-09
haploinsufficiency O 0 6.35580909147393e-06
. O 0 2.649838677371008e-07

Contrary O 0 2.1119505788647075e-07
to O 0 3.130338432910662e-09
this O 0 2.8663793560923523e-10
theory O 0 7.866994278238337e-10
, O 0 2.0446212778413297e-10
our O 0 2.317433744902786e-10
data O 0 2.1737425193180115e-09
showed O 0 1.5802960051658488e-09
that O 0 1.3399179335515932e-11
these O 0 3.186557961942782e-11
mutants O 0 3.851424956735627e-09
are O 0 2.2712628999776996e-10
dominant O 0 4.789532113136374e-07
- O 0 0.00022344637545756996
negative O 0 4.867174538958352e-07
in O 0 2.4388029373767495e-09
transient O 0 7.41292396355675e-08
transfection O 0 1.099950395655469e-06
assays O 0 8.356164471479133e-07
when O 0 6.008011421698711e-09
they O 0 3.70574987362815e-10
are O 0 9.539961876026126e-11
coexpressed O 0 1.1936991839434086e-08
with O 0 1.97338645424594e-10
wild O 0 2.218820682742262e-08
- O 0 6.841869617346674e-05
type O 0 6.262751867325278e-06
PAX6 O 0 0.00016068671538960189
. O 0 1.2485758134062053e-06

We O 0 1.7516170203180081e-07
found O 0 2.8202089552564757e-09
that O 0 2.1852106235620283e-10
the O 0 2.568210366593604e-10
dominant O 0 1.0805883903231006e-06
- O 0 0.0001188831593026407
negative O 0 2.3596855953655904e-06
effects O 0 1.0155846439374727e-06
result O 0 3.0948310580924954e-09
from O 0 8.40956609904353e-11
the O 0 1.6919979306528887e-10
enhanced O 0 7.908657728705748e-09
DNA O 0 3.777661561343848e-08
binding O 0 1.9851364996270604e-08
ability O 0 6.9007124459119495e-09
of O 0 1.1194947746595574e-10
these O 0 4.729677094417184e-09
mutants O 0 1.3799582347928663e-06
. O 0 1.8439094162658876e-07

Kinetic O 0 4.442141744220862e-06
studies O 0 2.0730266214741278e-07
of O 0 3.304283513472228e-10
binding O 0 3.439757279011246e-08
and O 0 8.312217580908055e-09
dissociation O 0 8.808540741256365e-08
revealed O 0 1.8080665853403843e-08
that O 0 1.1999434779141893e-10
various O 0 1.7562713783281225e-10
truncation O 0 3.408499793522424e-08
mutants O 0 7.501692778077995e-08
have O 0 1.6830348226193337e-09
3 O 0 1.1938647848097617e-09
- O 0 6.598411772529289e-08
5 O 0 5.2714272946730034e-09
- O 0 1.1231215069074096e-07
fold O 0 2.8342211066956224e-07
higher O 0 4.352771920679288e-09
affinity O 0 1.6451452422572288e-09
to O 0 4.680146201141433e-11
various O 0 8.76540506844492e-11
DNA O 0 1.514342784503242e-08
- O 0 5.828742377644858e-09
binding O 0 7.117288980396097e-10
sites O 0 1.0875176315039425e-09
when O 0 3.5354510985463605e-10
compared O 0 8.730881989604811e-11
with O 0 1.5578283454886765e-11
the O 0 2.2859916737338892e-10
wild O 0 2.5586981422520694e-08
- O 0 3.202502557542175e-05
type O 0 4.499152510106796e-06
PAX6 O 0 0.00010248888429487124
. O 0 5.9331733837098e-07

These O 0 6.150489895162536e-08
results O 0 3.537039461321001e-08
provide O 0 1.2128527071553208e-09
a O 0 2.7924595968897847e-10
new O 0 1.2343349675703053e-09
insight O 0 2.483922179052911e-09
into O 0 1.6932473478892263e-10
the O 0 1.5837563205334249e-10
role O 0 1.2604224330914349e-08
of O 0 3.96229743460097e-10
mutant O 0 2.520419002394192e-07
PAX6 O 0 3.4167419471486937e-06
in O 0 1.8066740992139785e-08
causing O 0 7.175156042649178e-07
aniridia B-Disease 1 0.9999998807907104
. O 0 1.3659911246577394e-07
. O 0 2.778233465505764e-07

Reversal O 0 5.7620542065706104e-05
of O 0 2.027281311711704e-07
severe O 0 0.00509323226287961
hypertrophic B-Disease 1 0.9929549098014832
cardiomyopathy I-Disease 1 1.0
and O 0 4.282570387204032e-07
excellent O 0 2.0337218131771806e-07
neuropsychologic O 0 3.5808679967885837e-06
outcome O 0 1.1140412681243106e-07
in O 0 3.2366436197861503e-09
very B-Disease 0 2.1018113471882316e-08
- I-Disease 0 0.00014299986651167274
long I-Disease 0 9.229972420143895e-06
- I-Disease 0 9.955750101653393e-06
chain I-Disease 0 2.229566962341778e-05
acyl I-Disease 0 2.2106287360657007e-05
- I-Disease 0 8.875864295987412e-06
coenzyme I-Disease 0 3.6054236716154264e-06
A I-Disease 0 8.898815622160328e-07
dehydrogenase I-Disease 0 0.0001798615703592077
deficiency I-Disease 0 0.00029291841201484203
. O 0 3.0756521596231323e-07

Very B-Disease 0 2.399887307547033e-06
- I-Disease 0 0.00024430922348983586
long I-Disease 0 3.7628583413606975e-06
- I-Disease 0 1.234419960383093e-05
chain I-Disease 0 5.231588147580624e-06
acyl I-Disease 0 1.3717805813939776e-05
- I-Disease 0 2.9764300961687695e-06
coenzyme I-Disease 0 2.668111278580909e-07
A I-Disease 0 1.0533975469684265e-08
dehydrogenase I-Disease 0 8.657844432491402e-07
( I-Disease 0 2.2203943128573655e-09
VLCAD I-Disease 0 1.8242562873638235e-06
) I-Disease 0 1.9982389076744766e-08
deficiency I-Disease 0 2.422079887764994e-06
is O 0 7.104566934756917e-10
a O 0 8.310728105698217e-09
disorder O 0 0.0015642025973647833
of O 0 9.438322345900474e-10
fatty O 0 5.587011855823221e-06
acid O 0 3.537681152465666e-07
beta O 0 2.6324983082304243e-08
oxidation O 0 7.827619441513889e-09
that O 0 1.0748497647483646e-09
reportedly O 0 2.090668544951768e-07
has O 0 6.091831483701071e-09
high O 0 3.860642650010959e-08
rates O 0 4.353887277375179e-07
of O 0 1.497664658955955e-09
morbidity O 0 1.6442634660052136e-05
and O 0 1.0619393719935033e-07
mortality O 0 3.67273491974629e-06
. O 0 2.2417798106744158e-07

We O 0 3.665540475594753e-07
describe O 0 3.321930108768356e-08
the O 0 6.12823569667853e-10
outcome O 0 3.704705653362339e-09
of O 0 3.0987736682197564e-11
a O 0 1.7640869320878494e-10
5 O 0 8.930026718090289e-10
- O 0 1.288375131025532e-07
year O 0 7.946371738398739e-08
- O 0 1.081986010831315e-05
old O 0 3.955901320296107e-06
girl O 0 2.775948075850465e-07
with O 0 9.75159331062514e-09
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.123952575454723e-08
was O 0 4.236719031158742e-10
first O 0 1.1722542381242818e-10
seen O 0 3.454344810194243e-09
at O 0 2.4934523890074445e-10
5 O 0 3.4248260477598436e-11
months O 0 2.612776939248107e-10
of O 0 1.9347074289854937e-11
age O 0 8.118132832635183e-09
with O 0 1.976450825225129e-08
severe O 1 0.6474640369415283
hypertrophic B-Disease 1 0.9998372793197632
cardiomyopathy I-Disease 1 1.0
, O 0 5.337727998266928e-06
hepatomegaly B-Disease 1 1.0
, O 0 3.9034770793477946e-07
encephalopathy B-Disease 0 0.0001426743547199294
, O 0 1.854579956273028e-08
and O 0 6.102975191879523e-08
hypotonia B-Disease 0 0.00014383763482328504
. O 0 1.7414015474059852e-06

Biochemical O 0 0.0001270624197786674
studies O 0 3.821482096100226e-05
indicated O 0 0.18920587003231049
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.3730455066252034e-06
by O 0 2.0924104671138366e-09
a O 0 2.3183691411077234e-08
stable O 0 1.548799559714098e-06
yet O 0 6.278278306126595e-07
inactive O 0 3.80024880541896e-06
enzyme O 0 4.79316940982244e-06
. O 0 2.9993574912623444e-07

Molecular O 0 1.4848743376205675e-05
genetic O 0 2.5734163955348777e-06
analysis O 0 1.5021834087747266e-07
of O 0 1.8344415986248919e-09
her O 0 8.552035524189705e-08
VLCAD O 0 1.0924809430434834e-05
gene O 0 9.61672071753128e-07
revealed O 0 5.821956392537686e-07
a O 0 1.0208554890311916e-08
T1372C O 0 1.1125915762022487e-06
( O 0 7.437322757652964e-09
F458L O 0 6.10339498052781e-07
) O 0 2.2504071495177413e-08
missense O 0 1.253335449291626e-05
mutation O 0 1.1199506843695417e-05
and O 0 3.153454315452109e-07
a O 0 8.262097708211513e-07
1668 O 0 0.1325550228357315
ACAG O 0 0.0019022722262889147
1669 O 0 3.0972805689089e-05
splice O 0 3.160813866998069e-05
site O 0 2.394144985373714e-06
mutation O 0 3.94216003769543e-05
. O 0 1.3175870208215201e-06

After O 0 5.667512823492871e-07
initial O 0 1.262342834706942e-07
treatment O 0 4.944471854173571e-08
with O 0 5.033705119394938e-10
intravenous O 0 5.8336059538532936e-08
glucose O 0 4.308215466153342e-06
and O 0 3.1575448922183114e-09
carnitine O 0 3.7956166920594114e-07
, O 0 5.528801860776866e-10
the O 0 1.8387460998248173e-10
patient O 0 1.4073398446612373e-08
has O 0 6.746886382913431e-10
thrived O 0 2.7598030527542505e-08
on O 0 1.4090042466108343e-09
a O 0 2.4842348178566453e-09
low O 0 6.268580250434752e-07
- O 0 5.537967240343278e-07
fat O 0 6.132567165195724e-08
diet O 0 5.7678835041485854e-09
supplemented O 0 5.177086315200086e-09
with O 0 7.471556151550374e-10
medium O 0 1.4610148355131969e-05
- O 0 2.5146139250864508e-06
chain O 0 1.4220692037270055e-06
triglyceride O 0 1.1307342902000528e-06
oil O 0 1.8325162898236158e-07
and O 0 1.763576507052278e-09
carnitine O 0 2.6068119041156024e-07
and O 0 1.112766101485363e-09
avoidance O 0 3.9445588129183307e-08
of O 0 1.5437592315592497e-09
fasting O 0 1.3430950502879568e-06
. O 0 3.483465604858793e-07

Her O 0 0.00013233997742645442
ventricular O 0 6.426240724977106e-05
hypertrophy O 0 2.757981746981386e-05
resolved O 0 9.694751952338265e-07
significantly O 0 1.0068344380442795e-07
over O 0 2.0169970138539384e-09
1 O 0 3.567921957881026e-09
year O 0 1.5763313987449123e-09
, O 0 1.0913801112844013e-10
and O 0 5.373375078221443e-10
cognitively O 0 3.858051300653642e-08
, O 0 3.2685418260847143e-10
she O 0 1.958599682438944e-07
is O 0 1.4124693081818407e-10
in O 0 7.702934123887673e-11
the O 0 2.499175588699387e-10
superior O 0 1.5721704826887617e-08
range O 0 1.7364808257980258e-08
for O 0 3.5990757041304278e-09
age O 0 6.381228701002328e-08
. O 0 1.2342889021965675e-07

Clinical O 0 5.1974460802739486e-05
recognition O 0 1.6630555137453484e-06
of O 0 3.7128646113160357e-07
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 8.842012677590105e-10
important O 0 1.2290532480641048e-10
because O 0 7.786709610435594e-10
it O 0 1.3394536868549523e-10
is O 0 3.9759907172198794e-11
one O 0 3.8111562516984776e-11
of O 0 3.6299693719626935e-12
the O 0 7.93589360892355e-11
few O 0 1.3760031336573775e-08
directly O 0 1.1778207209545144e-07
treatable O 0 0.3774697184562683
causes O 0 3.987890195844557e-08
of O 0 2.6909903194649587e-09
cardiomyopathy B-Disease 1 1.0
in O 0 5.736059804917204e-08
children O 0 7.666506718351229e-08
. O 0 2.3473038623933462e-08
. O 0 2.495930004897673e-07

Cloning O 0 8.605957759755256e-07
of O 0 2.2923853926215543e-09
a O 0 1.05572228736861e-09
novel O 0 9.415204615947914e-09
member O 0 1.6847885309090316e-09
of O 0 6.551600928439427e-11
the O 0 2.401858489875508e-09
low O 0 0.3321603238582611
- O 1 0.8603755831718445
density O 0 3.005954567925073e-06
lipoprotein O 0 0.00031414732802659273
receptor O 0 1.1222773537156172e-05
family O 0 1.1023541901522549e-06
. O 0 9.940949894371442e-07

A O 0 5.661948421220586e-07
gene O 0 1.234933506566449e-06
encoding O 0 3.360527784934675e-07
a O 0 2.3043718044846173e-08
novel O 0 1.5316592794079043e-07
transmembrane O 0 1.6200688151002396e-06
protein O 0 3.57328417521785e-07
was O 0 1.5930558205923262e-08
identified O 0 6.921644590818232e-09
by O 0 2.0348638052336554e-10
DNA O 0 2.5830294347883864e-08
sequence O 0 9.566410774652923e-09
analysis O 0 5.279860104678846e-09
within O 0 1.0015319684697488e-09
the O 0 9.775952491963835e-09
insulin B-Disease 1 0.9998855590820312
- I-Disease 1 0.9999985694885254
dependent I-Disease 1 0.9999971389770508
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 2.0306285364313226e-07
IDDM B-Disease 0 1.6162623069249094e-05
) O 0 3.3935279475372226e-08
locus O 0 3.2223904327111086e-06
IDDM4 O 0 1.525487459730357e-05
on O 0 1.3033979939791607e-07
chromosome O 0 3.3657659514574334e-05
11q13 O 0 2.8064447178621776e-05
. O 0 9.57794100031606e-07

Based O 0 9.549311243972625e-07
on O 0 2.5675468862118578e-08
its O 0 5.376371792209511e-09
chromosomal O 0 0.0027176516596227884
position O 0 2.4463608497171663e-05
, O 0 3.3100805429953084e-10
this O 0 4.006074291740269e-11
gene O 0 3.880159304969766e-09
is O 0 1.7385337613973206e-10
a O 0 7.144842356643366e-11
candidate O 0 2.5765183320203278e-09
for O 0 2.026903506147093e-10
conferring O 0 8.876153856363089e-08
susceptibility O 0 1.0637477316777222e-05
to O 0 1.9318010799906915e-06
diabetes B-Disease 1 0.9356868863105774
. O 0 2.725063723119092e-06

The O 0 1.9145350194094135e-08
gene O 0 2.93124742256623e-07
, O 0 8.27360757682527e-09
termed O 0 5.203412456467049e-07
low O 0 0.0008950696210376918
- O 0 0.03966571390628815
density O 0 1.7121066093750414e-06
lipoprotein O 0 0.00010545319673838094
receptor O 0 3.0218952815630473e-06
related O 0 1.1448690173665454e-07
protein O 0 1.1839200197982791e-07
5 O 0 7.458859307973853e-09
( O 0 5.480578213479248e-10
LRP5 O 0 3.403199855256389e-07
) O 0 8.465251832845411e-10
, O 0 2.0726245719693281e-10
encodes O 0 5.246191037144854e-09
a O 0 2.287502187670043e-09
protein O 0 3.435449258404333e-08
of O 0 1.1056786597407608e-09
1615 O 0 6.975149062782293e-07
amino O 0 8.959840158695442e-08
acids O 0 6.891875159453775e-08
that O 0 1.381819519918892e-10
contains O 0 8.457146094542622e-11
conserved O 0 8.036016296841808e-10
modules O 0 2.9277804625138515e-09
which O 0 2.0912722942245665e-10
are O 0 5.123680646423878e-11
characteristic O 0 2.144871835696449e-09
of O 0 9.81731224092286e-11
the O 0 2.4853534785762577e-09
low O 0 0.03686689957976341
- O 1 0.8588963747024536
density O 0 5.5589075600437354e-06
lipoprotein O 0 0.026397667825222015
( O 0 1.4026534245203948e-07
LDL O 0 0.00015986818470992148
) O 0 5.130250002594039e-08
receptor O 0 6.852970386717061e-07
family O 0 2.937073304565274e-07
. O 0 3.9737832935315964e-07

These O 0 7.500577225982852e-08
modules O 0 9.612028861738509e-08
include O 0 4.5355865729845846e-09
a O 0 1.7805368290879642e-09
putative O 0 1.2627594969671918e-07
signal O 0 3.809018522815677e-08
peptide O 0 1.6013695258720873e-08
for O 0 1.1567046626081989e-10
protein O 0 2.02164218698897e-09
export O 0 3.706593032504202e-09
, O 0 3.6333394626275606e-10
four O 0 1.941226068780111e-09
epidermal O 0 7.597665785397112e-07
growth O 0 3.5371280660001503e-07
factor O 0 1.0391079285909655e-07
( O 0 3.5776737128401237e-09
EGF O 0 2.0634538486774545e-06
) O 0 3.1876921102735878e-09
repeats O 0 4.375423756641794e-08
with O 0 5.038603423379584e-10
associated O 0 1.3020184930212508e-08
spacer O 0 1.713109327283746e-06
domains O 0 4.5113708324606705e-07
, O 0 4.635499539773491e-09
three O 0 1.8511839172674627e-08
LDL O 0 0.00423018354922533
- O 0 0.00017409138672519475
receptor O 0 1.0339060736441752e-06
( O 0 2.4624591254962525e-09
LDLR O 0 3.332827702706709e-07
) O 0 4.671399933542375e-10
repeats O 0 8.668482820439749e-09
, O 0 4.3921336012608947e-10
a O 0 8.818466512572343e-10
single O 0 1.790577819349437e-08
transmembrane O 0 1.667108051606192e-07
spanning O 0 2.4388274511011332e-08
domain O 0 1.1225989737795317e-07
, O 0 4.830852162740484e-09
and O 0 4.52031745368231e-09
a O 0 8.097101655835104e-09
cytoplasmic O 0 4.18489162257174e-06
domain O 0 3.490845983833424e-06
. O 0 6.445154667744646e-07

The O 0 1.2910880364813693e-08
encoded O 0 3.433313722212006e-08
protein O 0 5.732843888495154e-08
has O 0 3.730174835681055e-09
a O 0 4.809740383748817e-10
unique O 0 3.9697582998599046e-09
organization O 0 7.66509966609874e-09
of O 0 7.636785648301725e-10
EGF O 0 8.212597094825469e-06
and O 0 3.940180626216261e-09
LDLR O 0 5.694553237844957e-07
repeats O 0 1.936142624003878e-08
; O 0 4.133195452560301e-10
therefore O 0 2.623178063654308e-10
, O 0 1.1203726835162797e-10
LRP5 O 0 1.5918249118840322e-07
likely O 0 1.6347416753603738e-09
represents O 0 2.0645520015794006e-10
a O 0 1.6926919588211575e-10
new O 0 2.639833018847071e-09
category O 0 3.02644060923285e-08
of O 0 9.512838294867265e-10
the O 0 2.1510757619580545e-08
LDLR O 0 5.957117537036538e-05
family O 0 1.4776479417832888e-07
. O 0 2.1411170791907352e-07

Both O 0 6.477578295971398e-08
human O 0 2.370339124979637e-08
and O 0 8.31845081705751e-09
mouse O 0 1.454580882409573e-07
LRP5 O 0 1.239613197867584e-06
cDNAs O 0 2.2764659490803751e-07
have O 0 8.528363792947857e-09
been O 0 5.1102562181881694e-09
isolated O 0 6.058392898466991e-08
and O 0 1.3775570684160243e-09
the O 0 6.414277442523542e-11
encoded O 0 1.6654395640358644e-09
mature O 0 5.027106286803473e-09
proteins O 0 3.4045199992505104e-10
are O 0 1.5231182981523261e-10
95 O 0 7.747628094634251e-10
% O 0 1.3049608615922637e-10
identical O 0 5.3865534255237435e-09
, O 0 5.109913048251258e-10
indicating O 0 2.132382626029994e-08
a O 0 5.763066468489342e-09
high O 0 9.010396695430245e-08
degree O 0 4.836598677115944e-08
of O 0 8.681977359259463e-11
evolutionary O 0 6.611308833726071e-09
conservation O 0 9.79738068451752e-09
. O 0 1.3164519252484297e-08
. O 0 1.5826050514533563e-07

The O 0 1.8396112011487276e-07
APC B-Disease 0 1.1926975957976538e-06
variants O 0 1.2718092534669267e-07
I1307K O 0 3.029718698144279e-07
and O 0 1.540520710996418e-09
E1317Q O 0 7.692226944300273e-08
are O 0 8.330641176890197e-10
associated O 0 2.0788702315144292e-08
with O 1 0.5635858178138733
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.4787245163461193e-05
but O 0 1.1067682947896174e-07
not O 0 7.150697811653117e-09
always O 0 6.438209521064664e-09
with O 0 1.3505564722127161e-10
a O 0 1.9117900595944093e-09
family O 0 3.660275638139865e-08
history O 0 3.6578475715032255e-07
. O 0 5.681181960426329e-07

Classical O 1 0.6688272953033447
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 7.586669653392164e-06
FAP B-Disease 0 6.105402007960947e-06
) O 0 8.150030872400293e-09
is O 0 3.3967365031806196e-10
a O 0 4.275687803811934e-09
high O 0 0.0014800725039094687
- O 1 0.9999703168869019
penetrance O 1 0.9991821646690369
autosomal B-Disease 1 0.9996349811553955
dominant I-Disease 1 0.8483675122261047
disease I-Disease 0 2.330375173187349e-05
that O 0 2.9925939504238386e-10
predisposes O 0 2.984092617452916e-08
to O 0 1.4293152772459905e-10
hundreds O 0 3.036174089920962e-10
or O 0 4.731380287559261e-10
thousands O 0 1.872575650097019e-09
of O 0 4.176579437853434e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.4435535669326782
carcinoma I-Disease 1 1.0
and O 0 1.8137421875508153e-07
that O 0 8.916020144411618e-10
results O 0 8.426208175649208e-09
from O 0 3.0003438622472345e-10
truncating O 0 3.513875412863854e-07
mutations O 0 3.8406730595852423e-07
in O 0 4.879841419835884e-09
the O 0 8.11355072016795e-09
APC B-Disease 0 6.958831022529921e-07
gene O 0 1.616645590729604e-06
. O 0 8.081473197307787e-07

A O 0 5.458924761114758e-07
variant O 0 2.1624023247568402e-06
of O 0 1.7434233612334538e-08
FAP B-Disease 0 2.6688503567129374e-05
is O 0 6.950341457923059e-07
attenuated B-Disease 1 0.9442331790924072
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 1.0
, O 0 1.343792916941311e-07
which O 0 5.525831348052179e-09
results O 0 8.131754825058124e-09
from O 0 2.9214647367936664e-10
germ O 0 2.909739578171866e-06
- O 0 3.478437292869785e-06
line O 0 7.27122255739232e-08
mutations O 0 3.030854145436024e-08
in O 0 2.8099522708657787e-10
the O 0 1.4908237144783953e-10
5 O 0 8.042012056286296e-10
and O 0 5.504453559623812e-10
3 O 0 1.0150768003924782e-09
regions O 0 3.813305227140518e-09
of O 0 2.9546110003053627e-10
the O 0 6.631478477459041e-09
APC B-Disease 0 4.2160223756582127e-07
gene O 0 7.464247460120532e-07
. O 0 4.450116364296264e-07

Attenuated B-Disease 1 0.9999821186065674
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9981369972229004
have O 0 6.055562096207723e-08
" O 0 1.1496783081099693e-08
multiple O 0 1.4001288946019486e-06
" O 1 0.8673298358917236
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 3.801976067308033e-09
typically O 0 2.5528277269870614e-09
fewer O 0 1.4226361200186943e-09
than O 0 2.404359766838837e-10
100 O 0 4.802333530840031e-10
) O 0 5.096461030973387e-10
without O 0 2.859996905968387e-09
the O 0 2.8775446470064026e-09
florid O 0 6.28584257356124e-06
phenotype O 0 2.4924029276007786e-06
of O 0 4.526391705894639e-09
classical O 0 1.525561401649611e-06
FAP B-Disease 0 1.99547521333443e-05
. O 0 6.022803518135333e-07

Another O 0 2.1094021462886303e-07
group O 0 5.259208180063979e-08
of O 0 3.403468340490434e-10
patients O 0 1.8855649486226866e-08
with O 0 2.1935414595830593e-10
multiple O 0 1.4892827948642662e-07
adenomas B-Disease 1 0.9662074446678162
has O 0 1.209482775266224e-06
no O 0 1.437853480723561e-08
mutations O 0 1.409134569030357e-07
in O 0 7.096996323951998e-10
the O 0 3.275169302430214e-10
APC B-Disease 0 4.7706021355509165e-09
gene O 0 2.585334835103481e-09
, O 0 1.6581137851634509e-10
and O 0 2.603325333083717e-10
their O 0 6.067083502259152e-10
phenotype O 0 2.1021405416377092e-07
probably O 0 2.4286196165235197e-08
results O 0 2.6021949040000436e-09
from O 0 4.4121317710477115e-11
variation O 0 4.66968286261249e-09
at O 0 1.0736537880973174e-08
a O 0 1.7092322002199012e-09
locus O 0 2.92617528430128e-07
, O 0 1.2340642951969016e-09
or O 0 2.5911353063179376e-09
loci O 0 1.277405203836679e-08
, O 0 3.4210148602831225e-10
elsewhere O 0 1.2658794901199144e-08
in O 0 9.065067585467546e-10
the O 0 2.8432609600059777e-09
genome O 0 1.8432851334182487e-07
. O 0 3.413594811263465e-07

Recently O 0 7.822129191481508e-06
, O 0 8.281944019472576e-09
however O 0 3.0110545168327008e-09
, O 0 4.92205332047746e-10
a O 0 2.234503693188117e-09
missense O 0 1.3074705975668621e-06
variant O 0 1.0233488865196705e-06
of O 0 2.637306595332234e-09
APC B-Disease 0 1.4522134961225674e-07
( O 0 1.0480462053763517e-09
I1307K O 0 1.2071255639511946e-07
) O 0 1.524473547398486e-09
was O 0 6.384912043522206e-10
described O 0 2.853832448135307e-10
that O 0 1.7522218051513327e-11
confers O 0 8.679266194633328e-10
an O 0 1.1917164477459607e-10
increased O 0 6.260945184521916e-08
risk O 0 0.09443940222263336
of O 0 0.023383362218737602
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.7331849733182025e-08
including O 0 1.731244814173749e-09
multiple O 0 2.974365429508907e-07
adenomas B-Disease 0 0.011952918954193592
, O 0 2.1129007876652395e-08
in O 0 5.780673006938741e-08
Ashkenazim O 0 9.411716018803418e-05
. O 0 1.2127443369536195e-06

We O 0 1.2231686241648276e-07
have O 0 9.097875230956731e-10
studied O 0 1.0228253799482445e-09
a O 0 1.1204689259747269e-10
set O 0 2.114922820206644e-10
of O 0 3.5271043030693505e-11
164 O 0 7.3201880113060724e-09
patients O 0 1.126884718871679e-08
with O 0 2.3528023973540257e-09
multiple O 1 0.9999805688858032
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.001020821277052164
/ I-Disease 0 0.07819191366434097
or I-Disease 0 0.03287852182984352
carcinoma I-Disease 1 1.0
and O 0 3.6642751410909113e-07
analyzed O 0 1.8875009573093848e-06
codons O 0 1.1270929462625645e-05
1263 O 0 1.4699902749271132e-05
- O 0 7.980446753208525e-06
1377 O 0 7.313245532714063e-06
( O 0 9.434494074866961e-09
exon O 0 5.043772262069979e-07
15G O 0 1.6300680272252066e-06
) O 0 2.635893503466491e-09
of O 0 7.821104180960603e-11
the O 0 5.246799106295441e-10
APC B-Disease 0 1.5547080067790375e-08
gene O 0 1.6525870449868307e-08
for O 0 1.6332208918612423e-09
germ O 0 8.244692253356334e-06
- O 0 1.2961856555193663e-05
line O 0 8.063612995101721e-07
variants O 0 1.2076488928869367e-06
. O 0 3.2330177646144875e-07

Three O 0 2.0068257811090007e-07
patients O 0 3.664802932235034e-07
with O 0 8.212020508047146e-10
the O 0 4.779999174253646e-10
I1307K O 0 2.43978888647689e-07
allele O 0 1.2777151425780175e-07
were O 0 1.0799955374451997e-09
detected O 0 1.1210535610928218e-08
, O 0 3.2883895606516944e-10
each O 0 1.7197390178580463e-09
of O 0 8.635511861143641e-09
Ashkenazi O 0 0.0003271529858466238
descent O 0 1.8112452380592003e-05
. O 0 1.455553842788504e-06

Four O 0 5.550419359678926e-07
patients O 0 1.719109263831342e-06
had O 0 1.653895687070417e-08
a O 0 5.847561546090674e-09
germ O 0 5.434152626548894e-05
- O 0 9.864741878118366e-05
line O 0 9.415456929673383e-07
E1317Q O 0 1.1635008831945015e-06
missense O 0 8.340122690242424e-07
variant O 0 1.01035297461749e-07
of O 0 2.1140839079336615e-10
APC O 0 7.245221311791283e-09
that O 0 1.6063421426348867e-10
was O 0 5.998653795913356e-10
not O 0 1.417586464880216e-10
present O 0 4.573413869835008e-11
in O 0 9.228142555661734e-11
controls O 0 7.093630127741335e-09
; O 0 4.86911011510216e-10
one O 0 5.3514026543410864e-11
of O 0 3.4218335630276098e-12
these O 0 2.8722337008790788e-11
individuals O 0 1.4720562269143755e-10
had O 0 1.769818247510102e-08
an O 0 5.1564256337011116e-11
unusually O 0 3.099934975381302e-09
large O 0 2.3258350800858807e-09
number O 0 2.993463033007515e-09
of O 0 6.007390140894131e-10
metaplastic B-Disease 0 1.5404648365802132e-06
polyps I-Disease 0 3.143841013297788e-06
of I-Disease 0 4.819529220156937e-10
the I-Disease 0 8.868754619584251e-09
colorectum I-Disease 0 1.64127595780883e-05
. O 0 4.7069295305846026e-07

There O 0 1.2716661501599447e-07
is O 0 2.4851163349381977e-09
increasing O 0 1.9127019967868364e-09
evidence O 0 4.929703756317849e-09
that O 0 8.113794081054948e-10
there O 0 8.864606826364252e-10
exist O 0 1.657846659952611e-08
germ O 0 1.8140896145268925e-06
- O 0 4.5414321903081145e-07
line O 0 2.7972710370249843e-08
variants O 0 8.581426236276002e-09
of O 0 7.312310479345996e-11
the O 0 3.466335274371346e-10
APC B-Disease 0 4.459209002050102e-09
gene O 0 3.819551341877059e-09
that O 0 1.4286012650632784e-10
predispose O 0 3.490772781944429e-09
to O 0 4.4922929959279045e-11
the O 0 3.795313716081772e-11
development O 0 2.2063899318691682e-10
of O 0 8.480443014491357e-10
multiple O 1 0.9999775886535645
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9671406745910645
carcinoma I-Disease 1 1.0
, O 0 2.7305967265078834e-08
but O 0 5.9090026205410595e-09
without O 0 1.1070967476101146e-09
the O 0 3.997573105873897e-10
florid O 0 1.132923102886707e-06
phenotype O 0 6.898095534779713e-07
of O 0 1.987764119970592e-10
classical O 0 1.3711250801407004e-08
FAP B-Disease 0 8.6704886825828e-08
, O 0 1.1263377730497126e-10
and O 0 5.4031765173157e-11
possibly O 0 3.2804084448834203e-10
with O 0 3.558050729046691e-11
importance O 0 6.210181702215323e-09
for O 0 0.02251732163131237
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.7919626832008362
in O 0 1.0204773692734648e-09
the O 0 3.2344449341081827e-10
general O 0 1.560030216118946e-09
population O 0 4.552973997817844e-09
. O 0 1.3286104660892306e-08
. O 0 3.242775505896134e-07

Genomic O 0 1.1395284673199058e-05
structure O 0 1.7142831154615124e-07
of O 0 1.1128700183604678e-09
the O 0 5.555696791503806e-09
human O 0 3.8253060097304115e-07
congenital B-Disease 1 0.999998927116394
chloride I-Disease 1 0.9999961853027344
diarrhea I-Disease 1 1.0
( O 0 9.884059863907169e-07
CLD B-Disease 0 0.00929226167500019
) O 0 9.37172544013265e-08
gene O 0 3.8127004700072575e-06
. O 0 7.755943443044089e-07

Congenital B-Disease 1 0.9999996423721313
chloride I-Disease 1 0.9999947547912598
diarrhea I-Disease 1 1.0
( O 0 3.1338252028945135e-06
CLD B-Disease 1 0.8486817479133606
) O 0 5.90419460877456e-07
is O 0 3.3771080154565425e-08
caused O 0 3.5139887444302076e-08
by O 0 2.1975878894409107e-09
mutations O 0 1.0524395293032285e-06
in O 0 2.672418286664424e-09
a O 0 1.929111981269216e-09
gene O 0 9.635873965407882e-08
which O 0 6.3389506976818666e-09
encodes O 0 1.194720056219012e-07
an O 0 2.5969205452724964e-08
intestinal O 0 7.026720413705334e-05
anion O 0 0.00016220085672102869
transporter O 0 0.00029405500390566885
. O 0 2.6668901682569413e-06

We O 0 8.579139830544591e-06
report O 0 6.265711505193394e-08
here O 0 1.1684755385488188e-09
the O 0 1.1977506486626766e-10
complete O 0 9.433985814766288e-10
genomic O 0 4.089240235316538e-08
organization O 0 2.2939685706546697e-09
of O 0 1.5649348483748327e-10
the O 0 1.6789692969254588e-09
human O 0 1.5736794978238322e-08
CLD B-Disease 0 8.45668364490848e-06
gene O 0 5.565627247960947e-08
which O 0 1.4715995089176204e-09
spans O 0 1.838625074412903e-08
approximately O 0 1.4891023969454409e-09
39kb O 0 1.130895952883293e-06
, O 0 5.521448631640169e-09
and O 0 7.4080444001367596e-09
comprises O 0 1.522271908527273e-08
21 O 0 3.4846610930117095e-08
exons O 0 3.5776083677774295e-06
. O 0 6.303866939560976e-07

All O 0 3.416327274408104e-07
exon O 0 1.2415332093951292e-05
/ O 0 4.2675446820794605e-06
intron O 0 2.7899053748114966e-05
boundaries O 0 5.581359232564864e-07
conform O 0 5.704081331714406e-07
to O 0 4.012899790239999e-09
the O 0 1.1774115016294218e-08
GT O 0 2.7879368644789793e-06
/ O 0 5.295775736158248e-06
AG O 1 0.9993582367897034
rule O 0 1.3032007473157137e-06
. O 0 4.616963451553602e-07

An O 0 2.0026762470592985e-08
analysis O 0 2.766670448295372e-08
of O 0 4.156866240112578e-10
the O 0 7.138498125947024e-10
putative O 0 1.4939570291971904e-07
promoter O 0 3.521739131429058e-07
region O 0 8.175318555458944e-08
sequence O 0 4.274532017234378e-08
shows O 0 1.8358431930209917e-07
a O 0 1.5617814597135293e-08
putative O 0 2.767357045740937e-06
TATA O 0 1.1882156286446843e-05
box O 0 2.853906835298403e-07
and O 0 1.7794819839878073e-08
predicts O 0 1.267310238972641e-07
multiple O 0 3.319694386050287e-08
transcription O 0 2.9260411338327685e-07
factor O 0 2.1380645875979098e-07
binding O 0 2.963718941373372e-07
sites O 0 8.019247843549238e-07
. O 0 7.750974191367277e-07

The O 0 1.635189192938924e-07
genomic O 0 2.550241106291651e-06
structure O 0 3.275029314409039e-07
was O 0 1.6034480410098695e-08
determined O 0 6.7650844925992715e-09
using O 0 2.538523391493186e-09
DNA O 0 2.3308501795327174e-08
from O 0 1.6365690747033312e-10
several O 0 1.6971209160221434e-10
sources O 0 8.871964829459955e-10
including O 0 1.5804971220667596e-10
multiple O 0 7.01009117420881e-09
large O 0 1.8409416213671648e-07
- O 0 0.0014220746234059334
insert O 0 1.6760318430897314e-06
libaries O 0 9.61683099376387e-07
and O 0 1.5906109762653386e-09
genomic O 0 8.805702123027004e-08
DNA O 0 2.2078324946050998e-07
from O 0 1.1278093126065869e-08
Finnish O 0 3.581701321309083e-06
CLD B-Disease 0 0.0001822687336243689
patients O 0 1.444992676624679e-06
and O 0 1.5995349045283547e-08
controls O 0 4.202328454994131e-06
. O 0 1.5720272585895145e-06

Exon O 0 5.340845018508844e-05
- O 0 1.3734640560869593e-05
specific O 0 4.859410296376154e-08
primers O 0 7.231955123643274e-07
developed O 0 1.2763969436946354e-08
in O 0 2.0799112432356992e-10
this O 0 6.876751945661397e-11
study O 0 4.364625050268245e-10
will O 0 7.793019701773929e-11
facilitate O 0 7.837669402377401e-10
mutation O 0 1.508507985192864e-08
screening O 0 2.2875425997881393e-08
studies O 0 4.347544990679353e-09
of O 0 1.0672803613109849e-10
patients O 0 1.4846420981484698e-08
with O 0 6.006771191557903e-10
the O 0 4.3384350334463306e-08
disease O 0 1.1069282663811464e-05
. O 0 3.4378888358332915e-07

Genomic O 0 8.233755579567514e-06
sequencing O 0 3.0891712299307983e-07
of O 0 6.901159199657059e-09
a O 0 2.8043332989113878e-08
BAC O 0 7.024165370239643e-06
clone O 0 4.4375183279043995e-06
H O 1 0.9999998807907104
_ O 0 5.96554770027069e-08
RG364P16 O 0 1.7204429525463638e-07
revealed O 0 2.6545627918039827e-08
the O 0 2.2067223048871654e-10
presence O 0 2.832754253390135e-09
of O 0 4.443921272634377e-11
another O 0 4.922851570832165e-10
, O 0 2.86481616207368e-10
highly O 0 2.111868235843417e-09
homologous O 0 2.6099753469566167e-08
gene O 0 4.177790557946537e-08
3 O 0 3.591066555230782e-09
of O 0 1.743055838554497e-10
the O 0 1.9382144778035126e-09
CLD B-Disease 0 2.3969184894667706e-06
gene O 0 2.9580141003293647e-08
, O 0 7.361025677887767e-10
with O 0 1.3378910479477923e-10
a O 0 6.356466464296773e-10
similar O 0 8.745057122894195e-09
genomic O 0 3.3970519552894984e-07
structure O 0 4.868910536970361e-07
, O 0 2.194521675491501e-09
recently O 0 2.5193079622454206e-08
identified O 0 1.9006508367169772e-08
as O 0 8.351231706171802e-09
the O 0 2.296681032021297e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 5.1483343668223824e-06
( O 0 1.036504571061414e-08
PDS B-Disease 0 6.698812740069116e-07
) O 0 1.1404595490205338e-08
. O 0 2.1397326577243803e-08
. O 0 2.600673667529918e-07

The O 0 1.4959445593376586e-07
APCI1307K O 0 1.7256963474210352e-05
allele O 0 1.5573512428090908e-05
and O 0 1.064514322024479e-06
cancer B-Disease 0 0.004457850009202957
risk O 0 0.00016036376473493874
in O 0 1.3486934902218195e-09
a O 0 1.1460893345471845e-09
community O 0 8.40197422746769e-09
- O 0 6.342242500068096e-07
based O 0 2.03304235668611e-08
study O 0 8.420777852791161e-09
of O 0 1.7382892902872982e-09
Ashkenazi O 0 2.595029855001485e-06
Jews O 0 4.0084503893922374e-07
. O 0 1.6652663248351018e-07

Mutations O 0 0.0001285357284359634
in O 0 6.332983559786953e-08
APC O 0 3.1891474350231874e-07
are O 0 3.797352210455074e-09
classically O 0 1.3418936759990174e-05
associated O 0 1.4564509456249652e-06
with O 0 0.00017296131409239024
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 5.516837063623825e-06
FAP B-Disease 0 1.0293704690411687e-05
) O 0 4.211149651212054e-09
, O 0 6.04891914335326e-10
a O 0 6.420453058098019e-09
highly O 0 1.7678010408417322e-05
penetrant O 1 0.9999932050704956
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 6.4322866819566116e-06
by O 0 1.9910217474716774e-08
multiple O 0 3.8796092667325865e-06
intestinal O 0 0.01349855400621891
polyps B-Disease 0 0.008441095240414143
and O 0 2.6360846838713314e-09
, O 0 1.8368601084617353e-10
without O 0 7.88852649868943e-10
surgical O 0 9.516040933021941e-08
intervention O 0 7.5918258346519e-09
, O 0 1.6003054437163655e-10
the O 0 2.927164899357848e-10
development O 0 1.4564069950040448e-08
of O 0 6.836677493993193e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.921423541441982e-08
CRC B-Disease 0 9.64865193964215e-07
) O 0 4.729851355023129e-08
. O 0 1.3984832492042187e-07

APC B-Disease 0 3.191213545505889e-05
is O 0 1.6462799123928562e-07
a O 0 2.1657486115600477e-07
tumour O 1 1.0
- O 0 1.5461724615306593e-05
suppressor O 0 1.1448596524132881e-06
gene O 0 1.246834386847695e-07
, O 0 2.107795937789092e-09
and O 0 3.629960998452475e-09
somatic O 0 7.864553595027246e-07
loss O 0 7.984365879565303e-07
occurs O 0 1.44522815048731e-07
in O 0 3.408767383916711e-07
tumours B-Disease 1 1.0
. O 0 3.5077925986115588e-06

The O 0 3.801459911301208e-07
germline O 0 3.201665822416544e-05
T O 0 1.5956982679199427e-05
- O 0 5.871581834071549e-07
to O 0 4.695565714030181e-09
- O 0 9.41475946092396e-08
A O 0 2.082111150158994e-09
transversion O 0 4.087625882220891e-08
responsible O 0 1.5751862036950115e-09
for O 0 1.0558626889478617e-10
the O 0 3.5817138144267346e-10
APC O 0 4.199857883691038e-08
I1307K O 0 3.096893053111671e-08
allele O 0 1.2055490827833637e-08
converts O 0 4.3588039844166815e-09
the O 0 1.1034321373282197e-10
wild O 0 1.3266600040751086e-09
- O 0 4.092275673883705e-08
type O 0 5.240640810200148e-09
sequence O 0 3.6139751191655023e-09
to O 0 3.9670844387273974e-10
a O 0 1.4272456549946355e-09
homopolymer O 0 1.9348819932929473e-06
tract O 0 1.6891898440007935e-06
( O 0 2.187880765447403e-09
A8 O 0 9.171238843919127e-07
) O 0 2.666993847988408e-10
that O 0 1.2328074672218747e-10
is O 0 6.036909860895889e-10
genetically O 0 6.966401144836709e-08
unstable O 0 8.63399327499792e-05
and O 0 3.6575819706285984e-08
prone O 0 9.13523081180756e-07
to O 0 1.4902964196039648e-08
somatic O 0 7.280823865585262e-06
mutation O 0 2.8137363187852316e-05
. O 0 7.222546969387622e-07

The O 0 1.4863825015254406e-07
I1307K O 0 4.621677817340242e-06
allele O 0 3.251928546887939e-06
was O 0 3.901772060999065e-08
found O 0 1.0251951287898464e-08
in O 0 6.395946439141653e-09
6 O 0 7.69726185012587e-08
. O 0 2.0976067105493712e-07

1 O 0 2.2154092675918946e-06
% O 0 4.7726068430620217e-08
of O 0 1.7171858379683158e-09
unselected O 0 3.415250830585137e-05
Ashkenazi O 0 1.877411523310002e-05
Jews O 0 1.1494113749677126e-07
and O 0 6.9055046125754416e-09
higher O 0 2.5961975680388605e-08
proportions O 0 2.810738521930034e-07
of O 0 5.928122437381944e-10
Ashkenazim O 0 2.273845666422858e-06
with O 0 9.249398469357573e-10
family O 0 5.7341096315610685e-09
or O 0 1.0721598719953818e-08
personal O 0 2.7407400793322267e-08
histories O 0 7.280930276465369e-07
of O 0 2.6832105426422004e-09
CRC B-Disease 0 8.972467639978277e-07
( O 0 3.1779787690311423e-09
ref O 0 8.256694172814605e-07
. O 0 2.7433226801321098e-09
2 O 0 8.08272027086332e-09
) O 0 5.839580818900458e-09
. O 0 5.327234475771547e-08

To O 0 4.4433519974518276e-08
evaluate O 0 1.9856011590491107e-07
the O 0 5.422186033499088e-10
role O 0 5.574867234514613e-09
of O 0 2.0572209213920445e-10
I1307K O 0 7.207760432947907e-08
in O 0 1.758464374113089e-09
cancer B-Disease 0 1.217995730939947e-07
, O 0 3.654649360917972e-10
we O 0 2.4786310781621523e-09
genotyped O 0 2.894567785460822e-07
5 O 0 6.6888201644133005e-09
, O 0 2.9476272533912606e-09
081 O 0 2.8188339911139337e-06
Ashkenazi O 0 2.6386624085716903e-06
volunteers O 0 1.6619054576949566e-08
in O 0 7.261652945622643e-10
a O 0 2.617936312176994e-09
community O 0 3.211996713048393e-08
survey O 0 8.439060934506415e-07
. O 0 2.6200413572041725e-07

Risk O 0 0.007667227648198605
of O 0 1.541506122748615e-08
developing O 0 3.4311224226257764e-06
colorectal B-Disease 1 1.0
, I-Disease 0 3.1706061776048955e-08
breast I-Disease 0 0.00021778060181532055
and I-Disease 0 1.366488344700656e-08
other I-Disease 0 5.751613407767309e-09
cancers I-Disease 0 0.28903916478157043
were O 0 1.520936043775123e-09
compared O 0 2.565411216792768e-09
between O 0 1.13097531340145e-09
genotyped O 0 1.9908551962544152e-07
I1307K O 0 1.5433558075983456e-07
carriers O 0 2.2191210646838044e-08
and O 0 1.3980793189816154e-09
non O 0 4.5205613474763595e-08
- O 0 4.0446386151415936e-07
carriers O 0 2.2353487949544615e-08
and O 0 1.2658782355678966e-10
their O 0 1.0182623494392473e-10
first O 0 4.629385319532275e-09
- O 0 5.131660145707428e-07
degree O 0 1.5405075259877776e-07
relatives O 0 1.0713507947457401e-07
. O 0 1.4467312325905368e-07

Sperm O 0 2.5861560061457567e-05
DNA O 0 1.8430441741656978e-06
analysis O 0 2.207184053304445e-07
in O 0 1.073100985848896e-08
a O 0 4.601376346613506e-08
Friedreich B-Disease 0 0.00019564875401556492
ataxia I-Disease 0 0.0005407247226685286
premutation O 0 0.0026614023372530937
carrier O 0 2.021826912823599e-05
suggests O 0 2.504619089904736e-07
both O 0 4.661175889708602e-09
meiotic O 0 1.2006702263533953e-06
and O 0 4.624443494805064e-09
mitotic O 0 1.5735422209672834e-07
expansion O 0 6.143712738548857e-08
in O 0 3.4678051541447985e-09
the O 0 4.800650987846211e-09
FRDA B-Disease 0 6.2940312091086525e-06
gene O 0 1.2719854112219764e-06
. O 0 4.3836939767061267e-07

Friedreich B-Disease 0 0.05523867905139923
ataxia I-Disease 1 0.9806424975395203
is O 0 1.672632060945034e-05
usually O 0 2.442077857267577e-06
caused O 0 2.4025560207974195e-08
by O 0 1.1557299561815171e-10
an O 0 8.970019171883337e-11
expansion O 0 1.5735384550907838e-08
of O 0 7.916229893822901e-10
a O 0 2.5371113210326257e-08
GAA O 0 1.189537442769506e-06
trinucleotide O 0 1.8331351384404115e-05
repeat O 0 5.797677431473858e-07
in O 0 2.1949824180467203e-09
intron O 0 1.2728700085062883e-06
1 O 0 1.5118953200499163e-08
of O 0 5.060833419001654e-10
the O 0 4.160961353250059e-09
FRDA B-Disease 0 6.712762569804909e-06
gene O 0 3.1734819003759185e-06
. O 0 7.020342422947579e-07

Occasionally O 0 2.973394430227927e-06
, O 0 1.0993285393112728e-08
a O 0 3.0030991027274467e-09
fully O 0 1.532865745446088e-08
expanded O 0 5.967787153338122e-09
allele O 0 7.610429975102306e-08
has O 0 2.3232591406241454e-09
been O 0 5.489366183830668e-10
found O 0 2.4550339539075594e-10
to O 0 1.7300852417356793e-10
arise O 0 1.318260389737702e-09
from O 0 2.6032150393651143e-11
a O 0 9.371926151802157e-11
premutation O 0 2.834555345998524e-08
of O 0 8.153847042002837e-11
100 O 0 9.184826232910837e-10
or O 0 8.158444586570113e-09
less O 0 3.5156244138079273e-08
triplet O 0 6.40664147795178e-05
repeats O 0 2.6160016204812564e-05
. O 0 8.147063113028707e-07

We O 0 9.706724313218729e-07
have O 0 3.4899274581334794e-09
examined O 0 1.648576031243465e-08
the O 0 3.8014008607589744e-10
sperm O 0 1.12545421870891e-08
DNA O 0 1.6751796394487428e-08
of O 0 1.9517652771749994e-10
a O 0 3.1775724274041295e-09
premutation O 0 3.964157258451451e-06
carrier O 0 2.334869577680365e-06
. O 0 2.1840861563759972e-07

This O 0 6.313685929626445e-08
mans O 0 7.511492867706693e-07
leucocyte O 0 1.1979698228969937e-06
DNA O 0 4.356151350748405e-07
showed O 0 5.2206704737045584e-08
one O 0 1.039204167163632e-09
normal O 0 5.53897949728821e-09
allele O 0 8.795395700644804e-08
and O 0 3.193777908805373e-09
one O 0 1.3657840414182942e-09
allele O 0 5.8633787602957455e-08
of O 0 5.631474175871176e-10
approximately O 0 3.1396245603332318e-09
100 O 0 1.1684270440071032e-08
repeats O 0 3.5953153201262467e-06
. O 0 3.391206178093853e-07

His O 0 3.753958210950259e-08
sperm O 0 3.0721841426384344e-07
showed O 0 2.458832248919407e-08
an O 0 1.374422797795205e-10
expanded O 0 4.883714765924196e-09
allele O 0 1.089038050849922e-07
in O 0 1.407392757890591e-09
a O 0 1.4983732032902708e-09
tight O 0 7.493370191014037e-08
range O 0 3.631068778986446e-09
centering O 0 3.547604876530386e-09
on O 0 2.2131851906692646e-09
a O 0 1.1383727294145274e-09
size O 0 1.3670409693133934e-08
of O 0 8.359881120689749e-10
approximately O 0 1.2782826352975007e-08
320 O 0 3.783358124564984e-07
trinucleotide O 0 0.00019272651115898043
repeats O 0 6.44330502836965e-05
. O 0 1.7237026668226463e-06

His O 0 7.102080417098477e-07
affected O 0 1.1404908946133219e-06
son O 0 3.1647007858737197e-07
has O 0 4.236238737576059e-08
repeat O 0 7.144483333831886e-07
sizes O 0 2.1218185963789438e-07
of O 0 1.3699898993024817e-09
1040 O 0 3.9121903228078736e-07
and O 0 2.0597083150164508e-08
540 O 0 4.4328260173642775e-07
. O 0 3.1736436767459963e-07

These O 0 1.9975642473468724e-08
data O 0 2.2848171354894475e-08
suggest O 0 9.413750667874865e-09
that O 0 7.115996680795433e-11
expansion O 0 9.621778929158609e-10
occurs O 0 3.9910288962552443e-10
in O 0 3.243642507366751e-11
two O 0 1.239737479341585e-10
stages O 0 6.410663111466874e-09
, O 0 1.6409981706821952e-10
the O 0 3.996976360998161e-11
first O 0 1.9327719980033464e-10
during O 0 2.9442318028038983e-10
meiosis O 0 2.821242128803192e-09
followed O 0 6.764191429198263e-10
by O 0 1.2139700356073035e-10
a O 0 1.5151740972996208e-09
second O 0 1.4891088362389837e-08
mitotic O 0 8.606638743913209e-07
expansion O 0 5.041810595685092e-07
. O 0 5.135419769430882e-07

We O 0 9.741202120494563e-07
also O 0 3.6352405530237775e-09
show O 0 4.486774507483915e-09
that O 0 7.842585608708319e-11
in O 0 4.9345715014137426e-11
all O 0 5.6704349549185906e-11
informative O 0 6.35064090204196e-09
carrier O 0 2.277594468580446e-08
father O 0 1.4379074597670183e-09
to O 0 3.3922306630351784e-10
affected O 0 2.8167361776354483e-09
child O 0 4.740867698416196e-09
transmissions O 0 5.2732303856828366e-08
, O 0 2.1325229082602704e-10
with O 0 5.3728806126418505e-11
the O 0 8.232466791602278e-11
notable O 0 2.8161133425186335e-09
exception O 0 6.359622606311177e-09
of O 0 2.3870678003690138e-11
the O 0 1.413746897327428e-10
premutation O 0 8.18405339941819e-07
carrier O 0 7.163492199424581e-08
, O 0 7.238417504273897e-11
the O 0 6.529233403940182e-11
expansion O 0 5.7532045794062014e-09
size O 0 3.724069941313246e-08
decreases O 0 2.4420353383902693e-07
. O 0 1.0132473526880403e-08
. O 0 1.0937196748272981e-07

The O 0 1.114789469625066e-07
R496H O 0 2.4524351829313673e-06
mutation O 0 3.218328856746666e-07
of O 0 4.5008033411342296e-10
arylsulfatase O 0 3.358038327405666e-07
A O 0 1.3792193165329536e-08
does O 0 1.0955528040312856e-07
not O 0 9.808042733538969e-08
cause O 0 1.6090965573312133e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999998807907104
. O 0 5.233718638919527e-06

Deficiency B-Disease 1 0.9993778467178345
of I-Disease 0 2.8763389892105806e-08
arylsulfatase I-Disease 0 1.641914786887355e-05
A I-Disease 0 1.2610145461167122e-07
( O 0 2.6965409460899536e-08
ARSA O 0 6.414595554815605e-05
) O 0 2.7297843985252257e-08
enzyme O 0 7.418878453790967e-07
activity O 0 2.485862978574005e-06
causes O 0 2.0246108761057258e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 6.866302555863513e-06
MLD B-Disease 1 0.9999985694885254
) O 0 6.07100218985579e-07
. O 0 4.233920378737821e-07

A O 0 4.460760010260856e-07
number O 0 2.9164901604872284e-08
of O 0 9.373080089858377e-09
ARSA O 0 5.332717773853801e-05
gene O 0 1.3563038692154805e-06
mutations O 0 1.5596999674016843e-06
responsible O 0 7.830040971157359e-08
for O 0 2.537696985882576e-08
MLD B-Disease 1 1.0
have O 0 2.9647083010786446e-07
been O 0 6.370952831957766e-08
identified O 0 6.48109448775358e-07
. O 0 2.8233168336555536e-07

Recently O 0 4.9010736802301835e-06
, O 0 6.71014710462714e-09
the O 0 1.5203038827849014e-09
R496H O 0 2.8036521371177514e-07
mutation O 0 1.1183012560422867e-07
of O 0 3.2189234611124107e-10
ARSA O 0 4.531638751359424e-06
was O 0 7.293662340757123e-10
proposed O 0 2.1098139901809532e-10
to O 0 1.7061892176872817e-10
be O 0 1.1610752359558774e-09
a O 0 2.150606803752453e-09
cause O 0 5.9164488419582995e-08
of O 0 1.3408761212474474e-08
MLD B-Disease 1 0.9999998807907104
( O 0 2.0862145788669295e-08
Draghia O 0 1.505311047367286e-06
et O 0 9.250567245544516e-07
al O 0 9.593944014341105e-06
. O 0 2.6326189228598196e-08
, O 0 5.436603611741475e-09
1997 O 0 6.945438713046315e-08
) O 0 1.6607328845452685e-08
. O 0 8.405745433037737e-08

We O 0 1.0119072157976916e-06
have O 0 3.521474667422808e-09
investigated O 0 1.6748696651802675e-08
the O 0 3.9846931310094647e-10
R496H O 0 8.269982032516054e-08
mutation O 0 2.269156418321927e-08
and O 0 5.064425545597828e-10
found O 0 2.5468346875889836e-10
this O 0 4.983690890525416e-11
mutation O 0 8.575830712231891e-09
at O 0 8.13358103091133e-10
a O 0 2.0740560657817042e-10
relatively O 0 2.7337949681793816e-09
high O 0 7.139727031812981e-09
frequency O 0 6.585273126802349e-08
in O 0 1.1815773914847227e-09
an O 0 4.863513480835024e-10
African O 0 2.1619581680454303e-09
American O 0 4.241192286258411e-09
population O 0 7.313303851397279e-10
( O 0 2.4088031569391433e-10
f O 0 1.5891924221023146e-08
= O 0 1.4163230588337683e-08
0 O 0 2.9884144048253347e-09
. O 0 2.1937853755815695e-09
09 O 0 2.7513936018408458e-08
, O 0 7.488248354725613e-10
n O 0 2.053421184200488e-07
= O 0 3.200131004632567e-07
61 O 0 2.768755713589144e-08
subjects O 0 5.595793339807642e-08
) O 0 1.9561873898510385e-08
. O 0 8.807448637071502e-08

The O 0 5.48861748939089e-07
ARSA O 0 9.208103438140824e-05
enzyme O 0 5.06625724483456e-07
activity O 0 4.194654223965699e-08
in O 0 4.3994111131873126e-10
subjects O 0 5.085199816790009e-09
with O 0 1.3740032722697748e-10
and O 0 9.882716867082308e-10
without O 0 1.657453840842038e-09
the O 0 4.74595029942293e-10
R496H O 0 8.28822095400028e-08
mutation O 0 5.141907877259655e-08
was O 0 4.252881602440084e-09
determined O 0 1.9346881430237772e-08
and O 0 5.305781924924702e-10
found O 0 8.483339031251091e-10
to O 0 3.5117270202889017e-10
be O 0 4.0993120009602535e-09
normal O 0 7.226523024428388e-08
. O 0 2.5466678721386415e-07

It O 0 9.191072791736588e-08
is O 0 1.5916610252020291e-09
therefore O 0 1.0896106239499659e-09
concluded O 0 3.5922997909665355e-09
that O 0 9.65799593077854e-11
the O 0 3.17096571222919e-10
R496H O 0 2.0010197943065577e-07
mutation O 0 6.544053121615434e-08
of O 0 5.637868505381505e-10
ARSA O 0 6.579951786989113e-06
does O 0 2.601352733222484e-08
not O 0 7.975152760408832e-10
negatively O 0 1.4258850766779574e-09
influence O 0 3.094559275496067e-09
the O 0 3.215180621740643e-10
activity O 0 9.540644718697422e-09
of O 0 3.9491920844625383e-10
ARSA O 0 1.819445787987206e-05
and O 0 3.3576519342659594e-09
is O 0 8.729921230354876e-10
not O 0 3.755431965402067e-09
a O 0 5.6013007565525186e-09
cause O 0 1.4696765049393434e-07
of O 0 4.0377398136115517e-07
MLD B-Disease 1 0.9999988079071045

Down O 0 2.0579767806339078e-05
- O 0 9.07502089830814e-06
regulation O 0 2.907978569055558e-07
of O 0 6.005571151490585e-09
transmembrane O 0 3.779654434765689e-06
carbonic O 0 1.180619619844947e-05
anhydrases O 0 1.6506266547366977e-05
in O 0 2.7006979053112445e-07
renal B-Disease 1 0.9915987253189087
cell I-Disease 1 0.9999485015869141
carcinoma I-Disease 1 1.0
cell O 0 0.47089728713035583
lines O 0 1.2777970823663054e-06
by O 0 3.966836636948301e-09
wild O 0 2.8988327471779485e-07
- O 1 0.9886941313743591
type O 1 0.9668038487434387
von B-Disease 1 0.9997689127922058
Hippel I-Disease 1 0.9986183643341064
- I-Disease 1 0.9910694360733032
Lindau I-Disease 0 0.4468636214733124
transgenes O 0 0.000793540442828089
. O 0 3.6031788113177754e-06

To O 0 1.6953924841800472e-07
discover O 0 5.454355687106727e-07
genes O 0 2.687781375243503e-07
involved O 0 8.667727513511636e-08
in O 0 1.4639063294907828e-07
von B-Disease 1 0.9998142123222351
Hippel I-Disease 1 0.9999871253967285
- I-Disease 1 0.9999970197677612
Lindau I-Disease 1 0.9999266862869263
( O 0 1.7672854824013484e-07
VHL B-Disease 0 2.636591307236813e-05
) O 0 3.658021441310666e-08
- O 0 1.9006001821253449e-06
mediated O 0 1.285805183215416e-06
carcinogenesis O 0 3.7603974760713754e-06
, O 0 3.995890285324322e-09
we O 0 8.47779535462223e-09
used O 0 2.1366133751143934e-07
renal B-Disease 0 0.028621498495340347
cell I-Disease 1 0.9994682669639587
carcinoma I-Disease 1 1.0
cell O 1 0.9995999932289124
lines O 0 0.0041628312319517136
stably O 0 1.9282178982393816e-05
transfected O 0 3.34155879500031e-06
with O 0 6.929834928115497e-09
wild O 0 2.2421559719987272e-07
- O 0 0.03529072552919388
type O 0 0.0003126408555544913
VHL O 0 0.0033938707783818245
- O 0 3.557060335879214e-05
expressing O 0 4.848032517656975e-07
transgenes O 0 4.363093466963619e-05
. O 0 9.192718835038249e-07

Large O 0 1.819252588575182e-06
- O 0 0.00032191528589464724
scale O 0 1.1144126119688735e-06
RNA O 0 1.8460612238868634e-07
differential O 0 6.067470792459062e-08
display O 0 5.5613371685581114e-09
technology O 0 1.0456266963387861e-08
applied O 0 1.4537002712700087e-09
to O 0 1.8861205652864754e-10
these O 0 4.570425149452717e-10
cell O 0 7.327944473445314e-08
lines O 0 2.2195153803750145e-07
identified O 0 2.0198466899046252e-08
several O 0 8.858505040620912e-10
differentially O 0 1.9043127963414008e-07
expressed O 0 1.4679243376392037e-09
genes O 0 7.251939937447105e-09
, O 0 3.1424626789622323e-10
including O 0 3.1175201309352474e-10
an O 0 1.0677899675570757e-09
alpha O 0 1.9518533633799962e-07
carbonic O 0 3.775820914597716e-06
anhydrase O 0 6.162647423479939e-06
gene O 0 5.278906201056088e-07
, O 0 1.8784323430054428e-08
termed O 0 1.7667442762103747e-06
CA12 O 0 6.395891978172585e-05
. O 0 9.832408522925107e-07

The O 0 1.607821928928388e-07
deduced O 0 1.6187532025924156e-07
protein O 0 2.0849418191914992e-08
sequence O 0 1.3823217237529661e-08
was O 0 1.131592486380839e-09
classified O 0 4.4229717666155466e-09
as O 0 3.311690643936771e-10
a O 0 4.665959285610199e-10
one O 0 7.048449379709609e-09
- O 0 0.0001056723267538473
pass O 0 8.262130535285905e-08
transmembrane O 0 3.783791271416703e-07
CA O 0 2.1471821298746363e-07
possessing O 0 1.1912449693340932e-08
an O 0 1.4186908314783864e-09
apparently O 0 1.4737945264187147e-07
intact O 0 8.950036090027425e-08
catalytic O 0 6.733534974046052e-08
domain O 0 7.05859619642979e-08
in O 0 4.739782788476532e-09
the O 0 8.831062103809018e-09
extracellular O 0 2.2597248516831314e-06
CA O 0 8.610568329459056e-05
module O 0 1.0834880868060282e-06
. O 0 1.7401470131517272e-07

Reintroduced O 0 4.068363068654435e-06
wild O 0 8.469635304209078e-07
- O 0 9.316545765614137e-05
type O 0 3.4953766316903057e-06
VHL B-Disease 0 1.9033979697269388e-05
strongly O 0 6.305766930836398e-08
inhibited O 0 8.482764712880453e-08
the O 0 3.700636186376727e-10
overexpression O 0 7.5542700983533e-09
of O 0 8.019904185196935e-11
the O 0 2.711980917613488e-10
CA12 O 0 6.303314137312555e-08
gene O 0 1.1536168464942875e-08
in O 0 1.50335144333269e-09
the O 0 1.6362710297812555e-08
parental O 0 0.0026154324878007174
renal B-Disease 1 0.999713122844696
cell I-Disease 1 0.9999724626541138
carcinoma I-Disease 1 1.0
cell O 1 0.9992656111717224
lines O 0 0.10758745670318604
. O 0 3.0352391604537843e-06

Similar O 0 3.7669192920475325e-07
results O 0 2.1240254000076675e-07
were O 0 9.35980182248386e-10
obtained O 0 8.553777242070737e-09
with O 0 4.413962528815318e-09
CA9 O 0 7.9462377470918e-05
, O 0 2.5071980047641773e-09
encoding O 0 6.154057530238788e-08
another O 0 7.257477818711777e-08
transmembrane O 0 3.0063964004511945e-05
CA O 0 0.0074898055754601955
with O 0 2.5433846140288097e-09
an O 0 3.1910012410207855e-09
intact O 0 1.0438968729431508e-06
catalytic O 0 2.1605717392958468e-06
domain O 0 1.6373392099922057e-06
. O 0 7.496285547858861e-07

Although O 0 2.1841715636128356e-07
both O 0 5.520595536268047e-09
domains O 0 4.380776630341643e-08
of O 0 4.825692623278144e-10
the O 0 1.4889944832674473e-09
VHL B-Disease 0 6.180771947583708e-07
protein O 0 5.9977982580505795e-09
contribute O 0 3.2311647801819277e-10
to O 0 2.383320485410678e-10
regulation O 0 3.930864966861236e-09
of O 0 1.9329048084326672e-10
CA12 O 0 2.8693753506559005e-07
expression O 0 6.28053387075056e-09
, O 0 3.365678014066731e-10
the O 0 1.139034422337204e-10
elongin O 0 1.285830535380228e-07
binding O 0 2.2660422871467745e-08
domain O 0 3.945431359397844e-08
alone O 0 6.926758544523182e-08
could O 0 1.8227899190037533e-08
effectively O 0 1.469048811486573e-07
regulate O 0 1.934498186528799e-06
CA9 O 0 0.00013901977217756212
expression O 0 2.274561438753153e-06
. O 0 7.05572801962262e-07

We O 0 2.825465571731911e-06
mapped O 0 1.4046631804376375e-05
CA12 O 0 6.874582322780043e-05
and O 0 2.1024251850576547e-07
CA9 O 0 0.00010705209570005536
loci O 0 9.445594741919194e-07
to O 0 1.1600864269212252e-08
chromosome O 0 1.2085049547749804e-06
bands O 0 6.98934570664278e-07
15q22 O 0 4.256415650161216e-06
and O 0 7.296870307982317e-08
17q21 O 0 9.224076165992301e-06
. O 0 4.207450672311097e-07

2 O 0 2.2789856757299276e-07
respectively O 0 7.000099344622868e-08
, O 0 2.387671393933033e-09
regions O 0 3.7974121624984036e-08
prone O 0 8.138940188473498e-07
to O 0 1.4690474392509145e-09
amplification O 0 5.546467463091176e-08
in O 0 4.3622450096592047e-10
some O 0 6.687707054808811e-10
human O 0 8.447678823131355e-08
cancers B-Disease 1 0.5979917645454407
. O 0 4.968328539689537e-07

Additional O 0 2.835366608167078e-08
experiments O 0 2.8701572674094677e-08
are O 0 7.091651155199941e-10
needed O 0 2.194145087841548e-09
to O 0 6.781394890076342e-11
define O 0 5.268010028203207e-09
the O 0 3.544681215217338e-10
role O 0 1.0554389362482652e-08
of O 0 6.26287410820936e-10
CA O 0 7.391889539576368e-06
IX O 0 2.120376336733898e-07
and O 0 1.532649385183049e-08
CA O 0 4.642107001018303e-07
XII O 0 1.1563440871498187e-08
enzymes O 0 2.632537299263049e-09
in O 0 1.139082300705141e-10
the O 0 5.2759990820661073e-11
regulation O 0 1.763549639655082e-09
of O 0 7.984950894934784e-11
pH O 0 1.8470785789759248e-08
in O 0 1.796041787516245e-10
the O 0 2.497850815075253e-10
extracellular O 0 1.0475590173086857e-08
microenvironment O 0 2.312306150997756e-07
and O 0 1.7281270858759967e-09
its O 0 1.0080000167889125e-09
potential O 0 5.2192962840535984e-08
impact O 0 3.474109178114304e-08
on O 0 1.4508452217398826e-08
cancer B-Disease 0 7.765668783576984e-07
cell O 0 8.963564255282108e-07
growth O 0 8.829716193758941e-07
. O 0 4.3341182731637673e-07

A O 0 1.4069914300307573e-07
gene O 0 2.856954210983531e-07
encoding O 0 1.9522498462265503e-07
a O 0 2.1704913422126992e-08
transmembrane O 0 3.8253133993748634e-07
protein O 0 1.5509110440348195e-08
is O 0 4.717143342602981e-10
mutated O 0 9.937255640579679e-08
in O 0 5.4114948078165526e-09
patients O 0 1.5307803096220596e-06
with O 0 7.193330930022057e-06
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.00032417738111689687
optic B-Disease 1 0.9999983310699463
atrophy I-Disease 1 0.9999496936798096
( O 0 0.0006102427141740918
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 4.065730649926991e-07
. O 0 3.119123732631124e-07

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.109745976980776e-06
WFS B-Disease 0 0.0772053524851799
; O 0 1.7877221125672804e-07
OMIM O 0 7.662218558834866e-05
222300 O 0 5.581498498941073e-07
) O 0 1.2437360030759237e-09
is O 0 7.714391347946048e-10
an O 0 5.525494284341903e-09
autosomal B-Disease 1 0.9999727010726929
recessive I-Disease 1 0.9999940395355225
neurodegenerative I-Disease 1 0.9998774528503418
disorder I-Disease 1 0.9999711513519287
defined O 0 4.2644543896130926e-07
by O 0 1.6042861261666985e-08
young O 0 5.975033445793088e-07
- O 0 0.00031782948644831777
onset O 0 0.0030335576739162207
non O 0 0.002266758121550083
- O 0 0.002896364778280258
immune O 0 0.00024633004795759916
insulin B-Disease 1 0.9994692206382751
- I-Disease 1 0.9994086027145386
dependent I-Disease 1 0.9983909130096436
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 7.840171178941091e-07
progressive O 0 1.4882625691825524e-05
optic B-Disease 1 0.9992146492004395
atrophy I-Disease 0 0.007351217791438103
. O 0 5.955298092885641e-06

Linkage O 0 1.7854670659289695e-05
to O 0 3.065095555143671e-08
markers O 0 3.46489173352893e-07
on O 0 1.4545914694963358e-08
chromosome O 0 6.96193774274434e-06
4p O 0 0.030545346438884735
was O 0 4.815243528355495e-07
confirmed O 0 4.6836809985961736e-08
in O 0 3.648250590515545e-09
five O 0 3.089500566488823e-08
families O 0 7.290304182561158e-08
. O 0 1.5540355491339142e-07

On O 0 4.5867430742418946e-08
the O 0 7.713523153540791e-10
basis O 0 2.3424455708465075e-09
of O 0 3.304106988011313e-10
meiotic O 0 1.4925088862582925e-06
recombinants O 0 4.181408803560771e-05
and O 0 3.035853524124832e-07
disease O 0 2.472809501341544e-05
- O 0 0.0001686691539362073
associated O 0 3.0202707534954243e-07
haplotypes O 0 6.052946446288843e-06
, O 0 6.251670736645565e-09
the O 0 1.56666779549397e-09
WFS B-Disease 0 6.155422852316406e-06
gene O 0 5.820946569201624e-08
was O 0 4.171713197109739e-09
localized O 0 2.2348627837232016e-08
to O 0 3.8371634758505024e-09
a O 0 1.823196704719976e-08
BAC O 0 3.185085461154813e-06
/ O 0 1.9797414552158443e-07
P1 O 0 3.603796869811049e-07
contig O 0 6.751887582367999e-08
of O 0 4.591130253750464e-11
less O 0 4.0143524615565696e-10
than O 0 1.1204011052257101e-09
250 O 0 1.8427011028165907e-08
kb O 0 7.82152437750483e-06
. O 0 4.374164177534112e-07

Mutations O 0 0.00025657087098807096
in O 0 8.278314567178313e-08
a O 0 1.4278835003267432e-08
novel O 0 1.6621724796550552e-07
gene O 0 8.984480359686131e-07
( O 0 1.5043475798393047e-08
WFS1 O 0 1.8073687897413038e-06
) O 0 3.841066131826665e-09
encoding O 0 2.3432153994917826e-08
a O 0 6.05516792262506e-09
putative O 0 2.747071050634986e-07
transmembrane O 0 7.750266206585366e-08
protein O 0 1.1345538730722637e-08
were O 0 7.852617445180954e-10
found O 0 3.878085352848615e-10
in O 0 1.2391465631367282e-10
all O 0 2.236191093407669e-10
affected O 0 9.264440881118219e-10
individuals O 0 1.7898009463390707e-10
in O 0 7.817484437566691e-10
six O 0 1.0775393910478215e-08
WFS B-Disease 0 4.0061213439912535e-06
families O 0 5.106444156410817e-10
, O 0 8.167918424950571e-11
and O 0 1.2775135116438463e-10
these O 0 3.3743488558890533e-10
mutations O 0 3.54179903183649e-08
were O 0 8.046016075624607e-10
associated O 0 3.122294423008043e-09
with O 0 1.880238187368377e-09
the O 0 1.812846477378116e-07
disease O 0 3.496295539662242e-05
phenotype O 0 4.52359818154946e-05
. O 0 1.0565355523795006e-06

WFS1 O 0 8.804554090602323e-05
appears O 0 4.602034948675282e-07
to O 0 3.832321571195507e-09
function O 0 1.578365882437538e-08
in O 0 5.7004569953278406e-09
survival O 0 1.3673300145455869e-06
of O 0 6.966793253404546e-10
islet O 0 2.1084573745611124e-05
beta O 0 1.7065640349755995e-06
- O 0 9.44232215260854e-06
cells O 0 9.48248555232567e-08
and O 0 5.994550633658946e-09
neurons O 0 5.246764445132612e-08
. O 0 1.5853355961326088e-08
. O 0 1.697090965535608e-07

Stable O 0 4.77396815767861e-06
interaction O 0 3.403114590128098e-08
between O 0 2.6278716980243644e-09
the O 0 2.355823591759787e-10
products O 0 4.516241158825096e-09
of O 0 8.957180136492937e-11
the O 0 2.4240229823391246e-09
BRCA1 O 0 1.2145257642259821e-05
and O 0 7.529042989062873e-08
BRCA2 O 0 2.449983912811149e-05
tumor B-Disease 0 1.565065417707956e-06
suppressor O 0 2.073026053039939e-06
genes O 0 6.971292236812587e-07
in O 0 2.292211576104819e-08
mitotic O 0 6.4727646531537175e-06
and O 0 2.1327697652395727e-07
meiotic O 0 5.430712553788908e-05
cells O 0 2.0189196220599115e-05
. O 0 1.7009033399517648e-06

BRCA1 O 0 0.0003789199108723551
and O 0 2.693642215945147e-07
BRCA2 O 0 2.90649450107594e-06
account O 0 9.183587224015355e-09
for O 0 1.0981957704325751e-10
most O 0 9.961399760616274e-11
cases O 0 2.6333859537430726e-09
of O 0 1.8362156239959404e-10
familial O 0 1.2736732969642617e-05
, O 0 2.1641530789651142e-09
early O 0 5.59154713641874e-08
onset O 0 9.314711860497482e-06
breast B-Disease 1 0.7594691514968872
and I-Disease 0 1.7101059484048164e-06
/ I-Disease 1 0.957514226436615
or I-Disease 1 0.9999933242797852
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.894809557676183e-10
encode O 0 2.5327973052213792e-09
products O 0 1.2144945493730575e-08
that O 0 2.2057082549320484e-10
each O 0 3.6495781396972404e-10
interact O 0 1.930809068184658e-09
with O 0 2.629496176353996e-09
hRAD51 O 0 3.3933911254280247e-06
. O 0 3.506999064484262e-07

Results O 0 7.767949909975869e-07
presented O 0 1.199272059437817e-08
here O 0 1.2532206383752964e-09
show O 0 1.0545917028537133e-08
that O 0 1.457987730546506e-09
BRCA1 O 0 8.723452538106358e-07
and O 0 7.348137653906406e-09
BRCA2 O 0 1.299316522818117e-06
coexist O 0 1.2811560168302094e-07
in O 0 4.764470484808214e-10
a O 0 4.977907530623327e-10
biochemical O 0 7.602378104820673e-08
complex O 0 1.24993411176888e-08
and O 0 3.640250101355491e-09
colocalize O 0 4.645096396416193e-07
in O 0 4.5800438996934645e-09
subnuclear O 0 7.379574071819661e-07
foci O 0 5.122579977978603e-07
in O 0 7.806651436403911e-10
somatic O 0 8.95792666710804e-08
cells O 0 1.0118689175442341e-07
and O 0 2.3029995688261806e-09
on O 0 7.567880766501389e-10
the O 0 1.275305416825745e-10
axial O 0 1.8778054666768185e-08
elements O 0 1.8357409814484527e-08
of O 0 2.449810132532093e-09
developing O 0 3.108881116986595e-07
synaptonemal O 0 3.652329723990988e-06
complexes O 0 2.566208650023327e-06
. O 0 3.740700265097985e-07

Like O 0 1.2174700714240316e-05
BRCA1 O 0 0.0003013141977135092
and O 0 6.57148973459698e-07
RAD51 O 0 0.00015975144924595952
, O 0 6.204773228546401e-08
BRCA2 O 0 7.101231858541723e-06
relocates O 0 1.6251939314315678e-06
to O 0 4.351413096514989e-08
PCNA O 0 1.2684006833296735e-05
+ O 0 1.2035049223868555e-07
replication O 0 1.2651650393991076e-08
sites O 0 1.1035638181056129e-08
following O 0 1.2786141923015748e-08
exposure O 0 1.8465627817931818e-06
of O 0 1.0427582131100621e-09
S O 0 1.0497251423657872e-06
phase O 0 3.0723473543048385e-08
cells O 0 1.4747331356090854e-08
to O 0 1.007277372622184e-09
hydroxyurea O 0 3.670007231448835e-07
or O 0 1.879826605488688e-08
UV O 0 3.7269305721565615e-06
irradiation O 0 1.7065543715943932e-06
. O 0 2.289297924562561e-07

Thus O 0 7.388784979411867e-07
, O 0 1.7744488545190507e-08
BRCA1 O 0 2.0978277461836115e-06
and O 0 7.575234661771901e-09
BRCA2 O 0 5.451755669128033e-07
participate O 0 2.1445978326539716e-09
, O 0 2.1205212585861943e-10
together O 0 3.830682715477707e-10
, O 0 3.286733940566222e-10
in O 0 3.3628802520446754e-10
a O 0 1.5728174318496713e-09
pathway O 0 1.3933707521118777e-08
( O 0 1.012624761820291e-09
s O 0 3.3246752195736917e-07
) O 0 1.7654613326811841e-09
associated O 0 3.2949707406970674e-09
with O 0 1.721641856855527e-10
the O 0 1.4625492483766322e-10
activation O 0 1.40107181412219e-09
of O 0 8.902625164841638e-11
double O 0 4.5010440885562275e-07
- O 0 0.0003927723446395248
strand O 0 0.009114460088312626
break O 0 0.0001038067857734859
repair O 0 9.873491762846243e-06
and O 0 7.0429662102355906e-09
/ O 0 7.447546579442132e-08
or O 0 1.306182362270647e-08
homologous O 0 1.6505841813341249e-06
recombination O 0 3.043052856810391e-06
. O 0 7.988920742718619e-07

Dysfunction O 0 0.0002894822391681373
of O 0 2.783538066708502e-09
this O 0 5.501514799277629e-10
pathway O 0 8.983999322254022e-09
may O 0 6.01469878347416e-08
be O 0 3.5626293581891844e-10
a O 0 8.944153750967132e-11
general O 0 7.632471044072275e-11
phenomenon O 0 8.882314439517813e-09
in O 0 2.1197608945922042e-10
the O 0 2.2030342827772387e-10
majority O 0 3.011249471995825e-09
of O 0 2.7477289540889238e-11
cases O 0 3.3166864810141305e-09
of O 0 6.705819233232546e-10
hereditary B-Disease 1 0.9195979237556458
breast I-Disease 1 0.9999761581420898
and I-Disease 0 0.00135318364482373
/ I-Disease 1 0.998849630355835
or I-Disease 1 0.9999911785125732
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.012025887182972e-08
. O 0 3.348566224303795e-07

A O 0 5.812880203848181e-07
novel O 0 6.010707807035942e-07
Arg362Ser O 0 4.6988211579446215e-06
mutation O 0 6.75773605962604e-07
in O 0 2.920975683551319e-09
the O 0 5.0913238069938416e-09
sterol O 0 1.6181193132069893e-05
27 O 0 1.9952688035118626e-07
- O 0 6.500699214484484e-07
hydroxylase O 0 7.070411811582744e-06
gene O 0 2.536517058615573e-07
( O 0 2.9843816307106863e-09
CYP27 O 0 3.736093958650599e-07
) O 0 4.98845798002634e-10
: O 0 1.2091772028099967e-10
its O 0 6.885772507736476e-10
effects O 0 1.8369938459272817e-07
on O 0 9.387822963446979e-09
pre O 0 5.611393589788349e-06
- O 0 1.339542308187447e-07
mRNA O 0 2.9085517994076326e-08
splicing O 0 9.170952353088069e-08
and O 0 3.358458844360257e-09
enzyme O 0 5.150781490215195e-08
activity O 0 1.3673178500539507e-07
. O 0 1.3611392546408752e-07

A O 0 1.6546155734431522e-07
novel O 0 1.6849330108925642e-07
C O 0 2.7100870170215785e-07
to O 0 1.1537747424128497e-09
A O 0 2.3918875768913495e-09
mutation O 0 4.0065085471496786e-08
in O 0 1.602043941950626e-09
the O 0 2.2796968757177183e-09
sterol O 0 4.5873879571445286e-05
27 O 0 2.1461440269376908e-07
- O 0 6.293163323789486e-07
hydroxylase O 0 3.7669731227651937e-06
gene O 0 1.5151582033468003e-07
( O 0 1.1156563450853696e-09
CYP27 O 0 3.067122520405974e-07
) O 0 9.974884251917615e-10
was O 0 5.317158935369548e-10
identified O 0 1.159448648202499e-09
by O 0 9.838230924374969e-11
sequencing O 0 1.8009627567039388e-08
amplified O 0 9.42083104860103e-08
CYP27 O 0 1.5331822567077324e-07
gene O 0 1.3679746224681821e-08
products O 0 7.930802681244131e-09
from O 0 1.2743012200999715e-10
a O 0 8.280313101849401e-10
patient O 0 8.048832711438081e-08
with O 0 3.373702384124044e-08
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.5853467516535602e-07
CTX B-Disease 0 0.0005171472439542413
) O 0 2.50113401989438e-07
. O 0 5.505046374310041e-07

The O 0 1.2362987433789385e-07
mutation O 0 1.4251075981519534e-06
changed O 0 1.3453853853206965e-07
the O 0 2.4186659342007033e-09
adrenodoxin O 0 5.779845650977222e-07
cofactor O 0 3.144384947972867e-07
binding O 0 2.178974511934939e-07
residue O 0 5.335643891157815e-07
362Arg O 0 4.932782076139119e-07
to O 0 2.893505213208414e-09
362Ser O 0 6.883453806949547e-07
( O 0 2.3069299803779586e-09
CGT O 0 3.422157703880657e-07
362Arg O 0 2.7484045972414606e-07
to O 0 2.2292887535968475e-09
AGT O 0 6.536295131809311e-07
362Ser O 0 7.98618131625517e-08
) O 0 1.6639083166847257e-10
, O 0 3.5490225341883175e-11
and O 0 2.8815197450349217e-10
was O 0 2.498562023944828e-09
responsible O 0 1.1843351188645102e-08
for O 0 1.092503776334297e-08
deficiency O 0 1.403338865202386e-05
in O 0 7.764981435620655e-10
the O 0 3.135710802126823e-09
sterol O 0 1.3809159099764656e-05
27 O 0 4.280569498860132e-08
- O 0 1.3136056509210903e-07
hydroxylase O 0 7.750819008833787e-07
activity O 0 1.9983227517172963e-08
, O 0 5.794465463004883e-10
as O 0 8.156448849661047e-10
confirmed O 0 3.28293858764539e-09
by O 0 1.3706581702965792e-10
expression O 0 2.482813732385125e-09
of O 0 1.3387768671435651e-10
mutant O 0 2.7856215112365135e-08
cDNA O 0 5.652065482308899e-08
into O 0 7.433210047480543e-09
COS O 0 3.3255204471061006e-05
- O 0 2.3664058517169906e-06
1 O 0 4.130961173132164e-08
cells O 0 2.152935536514633e-07
. O 0 1.1919613740474233e-07

Quantitative O 0 3.039369630641886e-06
analysis O 0 3.490941935524461e-07
showed O 0 9.075213824871753e-08
that O 0 9.550599200380816e-10
the O 0 2.0311953508045377e-10
expression O 0 5.117874568583147e-09
of O 0 2.946793919988977e-10
CYP27 O 0 2.4417090571660083e-07
gene O 0 2.875236404520365e-08
mRNA O 0 1.653454084760142e-08
in O 0 1.3361115547283475e-09
the O 0 2.9515316857242624e-09
patient O 0 8.395074502232092e-08
represented O 0 4.882087623059306e-08
52 O 0 4.867642928729765e-07
. O 0 2.272552848125997e-07

5 O 0 8.069736168181407e-07
% O 0 1.3029676004805424e-08
of O 0 3.3697888923711616e-10
the O 0 6.9392784851629585e-09
normal O 0 6.617960366384068e-07
level O 0 1.4153084748613765e-06
. O 0 7.009451223893848e-07

As O 0 1.4957790028802265e-07
the O 0 7.048690964239768e-09
mutation O 0 1.2365134693936852e-07
occurred O 0 3.0751969859466044e-08
at O 0 3.0832945085990104e-09
the O 0 4.2034281610980884e-10
penultimate O 0 3.310595175776143e-08
nucleotide O 0 6.059525503587793e-08
of O 0 3.6426792138222197e-10
exon O 0 4.1682632456740976e-08
6 O 0 4.3339336563974484e-09
( O 0 5.759404619887221e-10
- O 0 5.026533145269241e-08
2 O 0 2.6339133096797696e-09
position O 0 8.453461930457706e-09
of O 0 3.146637117534823e-10
exon O 0 1.600036085847023e-07
6 O 0 2.8319290024114707e-08
- O 0 3.1214389650813246e-07
intron O 0 5.433772457763553e-06
6 O 0 1.0885870871391035e-08
splice O 0 2.9088246833453013e-07
site O 0 1.7687719733316953e-08
) O 0 4.540856024526363e-10
of O 0 8.310034084468843e-12
the O 0 4.259013627883057e-11
gene O 0 3.934060188726107e-09
, O 0 3.8777744904017197e-10
we O 0 2.850285840683142e-10
hypothesized O 0 1.3784664520954948e-09
that O 0 7.081807362752102e-11
the O 0 8.759693526094736e-10
mutation O 0 4.1668573658171226e-07
may O 0 1.2017775929962227e-07
partially O 0 4.250868528288265e-07
affect O 0 2.1812901707107812e-08
the O 0 3.2318178688761634e-10
normal O 0 5.520732315744681e-09
splicing O 0 1.2430470519575465e-07
efficiency O 0 1.5401630193423443e-08
in O 0 7.575968186124271e-10
exon O 0 9.496584851831358e-08
6 O 0 1.029547291864219e-08
and O 0 1.021599138617546e-09
cause O 0 1.2124826698212132e-09
alternative O 0 2.177709568229602e-09
splicing O 0 4.0034223047769046e-08
elsewhere O 0 6.675746533346683e-08
, O 0 2.8218488656861496e-10
which O 0 6.217242276562729e-10
resulted O 0 3.5322578195717824e-09
in O 0 8.932770079184138e-10
decreased O 0 2.6724297441660383e-08
transcript O 0 4.534404141054438e-08
in O 0 1.893377232775606e-09
the O 0 3.7244871631259002e-09
patient O 0 7.352612101385603e-07
. O 0 1.7716359934638604e-07

Transfection O 0 0.00017981800192501396
of O 0 1.0394266780622274e-08
constructed O 0 1.0169283370942139e-07
minigenes O 0 1.553722995595308e-06
, O 0 7.556053560620057e-10
with O 0 1.0185283866315231e-10
or O 0 4.419092647367506e-09
without O 0 4.4371502028184295e-09
the O 0 3.6086006405255944e-10
mutation O 0 5.639272870894274e-08
, O 0 4.1794923077986823e-10
into O 0 2.2428472412627798e-09
COS O 0 9.192251309286803e-05
- O 0 1.9074986994382925e-06
1 O 0 5.908664668652364e-09
cells O 0 5.546845205373074e-09
confirmed O 0 2.059911574647799e-09
that O 0 2.1891851179067778e-11
the O 0 5.233782851554736e-11
mutant O 0 7.465377649396032e-09
minigene O 0 1.2502565027716628e-07
was O 0 2.8591460310423145e-09
responsible O 0 1.8903965059990924e-09
for O 0 2.5220747712495495e-10
a O 0 3.6164557459805735e-10
mRNA O 0 5.4682289807317375e-09
species O 0 2.519603414796734e-10
alternatively O 0 9.815767754162152e-09
spliced O 0 8.901073442757479e-07
at O 0 2.1782675219128578e-08
an O 0 8.844070475966248e-10
activated O 0 5.2670582562086565e-08
cryptic O 0 6.617860037749779e-08
5 O 0 4.712146228769143e-09
splice O 0 4.19433433762606e-07
site O 0 6.8336653669121e-08
88 O 0 1.1747241401849351e-08
bp O 0 1.0875871225834999e-07
upstream O 0 7.517230393716545e-09
from O 0 3.108115709249404e-10
the O 0 1.424313444964298e-10
3 O 0 7.166683357873183e-10
end O 0 2.2100006269454298e-09
of O 0 4.038852030596729e-10
exon O 0 5.000361511520168e-07
6 O 0 8.04047033398092e-08
. O 0 1.1824147350125713e-07

Our O 0 2.7867594099006965e-07
data O 0 5.7416205123672626e-08
suggest O 0 6.804152352657411e-09
that O 0 1.9066907774867303e-10
the O 0 2.088609424300003e-10
C O 0 9.39072375416572e-09
to O 0 1.2861782472395333e-10
A O 0 6.376831285237472e-10
mutation O 0 1.1762891105604467e-08
at O 0 5.78865566591702e-10
the O 0 2.0716522941555127e-10
penultimate O 0 1.510886349365137e-08
nucleotide O 0 2.6791614260446295e-08
of O 0 1.2047847441909454e-10
exon O 0 3.245485302727502e-08
6 O 0 1.562057816428819e-09
of O 0 1.8194317580322306e-11
the O 0 1.31634508848677e-10
CYP27 O 0 6.114254347266979e-08
gene O 0 1.0177565457070159e-08
not O 0 1.1856544634980537e-09
only O 0 3.4800018422487256e-10
causes O 0 1.3437358781231978e-08
the O 0 1.6733178398453674e-08
deficiency B-Disease 0 0.00014663611364085227
in I-Disease 0 6.208757397097031e-10
the I-Disease 0 1.3380881958013902e-09
sterol I-Disease 0 5.562587375607109e-06
27 I-Disease 0 3.68598733757608e-08
- I-Disease 0 9.814835522092835e-08
hydroxylase I-Disease 0 4.2031436464640137e-07
activity I-Disease 0 2.0384707255516332e-08
, O 0 1.2000058724481732e-09
but O 0 4.740596803998187e-09
also O 0 3.132853088061438e-09
partially O 0 6.798304497124263e-08
leads O 0 1.123321879958894e-09
to O 0 3.0283836549571674e-10
alternative O 0 1.64893467768934e-08
pre O 0 1.2591797258210136e-06
- O 0 6.666762430995732e-08
mRNA O 0 1.2966530071878424e-08
splicing O 0 4.8471356706158986e-08
of O 0 3.8851630246306e-10
the O 0 2.204893378987549e-09
gene O 0 6.25455299996247e-07
. O 0 3.557880461357854e-07

To O 0 7.875199514728592e-08
our O 0 3.927769665068581e-09
knowledge O 0 1.1569214475315448e-09
, O 0 1.2015352601757456e-10
this O 0 2.4824609382023688e-11
is O 0 8.157176323297932e-11
the O 0 7.557923037415648e-11
first O 0 6.489568327161521e-10
report O 0 1.7290965326210994e-09
regarding O 0 5.455818019584058e-10
effects O 0 2.1752034840005763e-08
on O 0 1.0080306589443921e-09
pre O 0 2.7412897907197475e-07
- O 0 1.2299221197054067e-08
mRNA O 0 1.433290930386022e-09
splicing O 0 5.7047429002921035e-09
of O 0 2.658647781095258e-11
a O 0 1.6194286189818996e-10
mutation O 0 2.5019957217153888e-09
at O 0 2.0296463121294295e-10
the O 0 1.3914809582349363e-10
- O 0 1.092900856747292e-05
2 O 0 8.299037901338124e-09
position O 0 3.2943884775704646e-07
of O 0 1.8421159042603108e-10
a O 0 2.6773570027671667e-09
5 O 0 5.132929636886274e-09
splice O 0 1.3484004739439115e-06
site O 0 4.479773849652702e-07
. O 0 4.6116826979414327e-07

ATM O 0 0.000414694455685094
germline O 0 0.0003876797272823751
mutations O 0 1.563650948810391e-05
in O 0 4.605309911198674e-08
classical O 0 3.867486157105304e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.998890221118927
in O 0 2.369236362653737e-08
the O 0 1.3041983493167209e-08
Dutch O 0 2.5396699129487388e-05
population O 0 1.1688577217228158e-07
. O 0 3.4610906141097075e-07

Germline O 0 0.0005572349764406681
mutations O 0 1.241778318217257e-05
in O 0 3.4621476796559136e-09
the O 0 1.6984615103243783e-10
ATM O 0 1.340421018625193e-08
gene O 0 2.676218358033111e-09
are O 0 6.31290644759197e-11
responsible O 0 6.298717103447871e-10
for O 0 1.5533969666137182e-09
the O 0 8.528530997864436e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9050095677375793
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.3724248876533238e-07
. O 0 1.6384593948259862e-07

In O 0 1.3276104482429218e-07
our O 0 9.103416687139543e-09
study O 0 1.0178783371728173e-09
, O 0 1.4820632221468344e-10
we O 0 4.0203598783428163e-10
have O 0 1.1484345419088271e-10
determined O 0 9.376651677328596e-10
the O 0 1.283382289329893e-10
ATM O 0 3.847572216386652e-08
mutation O 0 7.813776292664443e-09
spectrum O 0 4.396846442489277e-09
in O 0 1.1404155397798377e-09
19 O 0 1.9741854817567628e-09
classical O 0 2.74833126923113e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.9862283668080636e-07
, O 0 2.118329123224072e-11
including O 0 1.3003264263955483e-11
some O 0 9.808889117612907e-11
immigrant O 0 7.338014995639242e-08
populations O 0 1.0337167566376593e-08
, O 0 1.6380119483017097e-10
as O 0 8.738296197741136e-11
well O 0 4.389269780968874e-10
as O 0 6.299654131680654e-10
12 O 0 5.117949952726519e-10
of O 0 1.6590565032892357e-10
Dutch O 0 5.980762580293231e-06
ethnic O 0 1.551763801899142e-07
origin O 0 1.0035480499936966e-06
. O 0 5.834106673319184e-07

Both O 0 1.0375909198501176e-07
the O 0 6.189794454769526e-09
protein O 0 2.269043797298309e-08
truncation O 0 6.123866000962153e-07
test O 0 2.6373035666438227e-07
( O 0 1.6435456329233489e-09
PTT O 0 2.1324525789623294e-07
) O 0 3.4977357121768193e-10
and O 0 1.2499709600710673e-10
the O 0 1.4314760488076672e-10
restriction O 0 6.311371869571758e-09
endonuclease O 0 1.52824796373352e-07
fingerprinting O 0 3.8558926007681293e-07
( O 0 8.720850153132176e-10
REF O 0 4.397133679390208e-08
) O 0 3.27103483188651e-11
method O 0 2.3389890024816395e-10
were O 0 4.9495404302879464e-11
used O 0 7.369510557353465e-10
and O 0 1.6232756805401038e-10
compared O 0 5.272500769315513e-10
for O 0 3.217184851855848e-11
their O 0 2.2263939303268643e-10
detection O 0 1.973471164262719e-08
efficiency O 0 1.985074993271496e-09
, O 0 4.4786216402137313e-11
identifying O 0 1.836430119084298e-09
76 O 0 2.214815442158624e-09
% O 0 3.0491623115302957e-10
and O 0 4.759638794205046e-10
60 O 0 2.0232815423071315e-09
% O 0 5.36275746032544e-10
of O 0 4.113296162011615e-11
the O 0 1.0386452808930358e-09
mutations O 0 1.3199414752307348e-06
, O 0 5.0150776864654745e-09
respectively O 0 2.968912724554684e-07
. O 0 3.622521091983799e-07

Most O 0 1.151900121953986e-07
patients O 0 4.934918251819909e-07
were O 0 9.645186871409805e-10
found O 0 8.263541517727901e-10
to O 0 7.791924327982258e-10
be O 0 4.393275521152873e-09
compound O 0 2.5568692763044965e-07
heterozygote O 0 3.828982517006807e-05
. O 0 5.084524445919669e-07

Seventeen O 0 3.932816525775706e-06
mutations O 0 2.6467876068636542e-06
were O 0 7.350843045372812e-09
distinct O 0 1.1086863871412334e-08
, O 0 1.5825946109160327e-09
of O 0 6.331114799085213e-11
which O 0 1.563068119381228e-09
10 O 0 6.445369793439681e-10
were O 0 1.0703938846390315e-09
not O 0 9.198277695077195e-09
reported O 0 1.5041214851407858e-07
previously O 0 4.1717638055160933e-07
. O 0 2.547936048813426e-07

Mutations O 0 4.2276751628378406e-05
are O 0 1.589398657131369e-08
small O 0 7.929229717262842e-09
deletions O 0 2.970889738662663e-07
or O 0 1.296163958386387e-07
point O 0 2.7718476758309407e-07
mutations O 0 4.931935109198093e-06
frequently O 0 6.744550660187087e-07
affecting O 0 3.356924196395994e-07
splice O 0 1.1954546607739758e-05
sites O 0 2.337834985155496e-06
. O 0 8.973981948656728e-07

Moreover O 0 1.5470337530132383e-05
, O 0 6.081211978425927e-08
a O 0 4.374764728254377e-08
16 O 0 1.6980672512545425e-07
. O 0 3.578187772745878e-07

7 O 0 6.606372608075617e-06
- O 0 8.25936149340123e-06
kb O 0 2.0728678009618307e-06
genomic O 0 3.2727129450904613e-07
deletion O 0 3.3657332210168533e-07
of O 0 3.557272254539612e-10
the O 0 2.2650634146081927e-10
3 O 0 1.4036823925422937e-09
end O 0 2.531483467294038e-09
of O 0 1.2332911601686813e-11
the O 0 3.9825635844703555e-11
gene O 0 1.2715606345636843e-09
, O 0 9.624454011536443e-11
most O 0 3.960098915456456e-10
likely O 0 5.218517173943837e-09
a O 0 6.23267715216258e-10
result O 0 3.5282110566470237e-09
of O 0 2.8631104431742216e-11
recombination O 0 2.0537760381245107e-09
between O 0 5.308869455156184e-10
two O 0 1.3845824486935498e-09
LINE O 0 1.7607381153084134e-07
elements O 0 1.668728266679409e-08
, O 0 3.92555277173301e-09
was O 0 1.975467078807469e-08
identified O 0 2.721191947330226e-07
. O 0 3.4423831607455213e-07

The O 0 6.1065832390738706e-09
most O 0 8.72031835630338e-10
frequently O 0 1.2509596025722658e-08
found O 0 1.6933128232921035e-09
mutation O 0 1.540045424519576e-08
, O 0 1.524007586795051e-10
identified O 0 2.53424681240233e-09
in O 0 1.6267098779110256e-10
three O 0 9.691474289752477e-10
unrelated O 0 2.7384785994399863e-07
Turkish O 0 0.17952248454093933
A B-Disease 1 1.0
- I-Disease 1 0.9999985694885254
T I-Disease 1 1.0
individuals O 0 2.735839998990741e-09
, O 0 3.8777081545759984e-10
was O 0 1.8608898866290247e-09
previously O 0 2.4179094282317237e-09
described O 0 3.468808851270211e-10
to O 0 1.4275960968923584e-10
be O 0 1.3156882250342505e-09
a O 0 3.448755725443675e-09
Turkish O 0 9.371407941216603e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
founder O 0 3.3778023862396367e-06
mutation O 0 1.1678582268359605e-05
. O 0 5.984043696116714e-07

The O 0 3.4659684899907006e-08
presence O 0 4.6430592703927687e-08
of O 0 4.025285660347322e-10
a O 0 1.1771683627870289e-09
founder O 0 3.531121350874855e-08
mutation O 0 5.7957539212338816e-08
among O 0 6.404158314765596e-10
relatively O 0 1.5854102475287846e-09
small O 0 6.251038797699948e-09
ethnic O 0 4.77998582937289e-08
population O 0 9.89488668778904e-09
groups O 0 2.7493358700780846e-09
in O 0 9.485733309944067e-10
Western O 0 1.2995126752457509e-08
Europe O 0 2.686346363134362e-07
could O 0 4.0902135012288454e-09
indicate O 0 2.3393291748163847e-09
a O 0 5.638965960841347e-10
high O 0 7.11402181607923e-09
carrier O 0 1.559682871743462e-08
frequency O 0 1.2408269967068009e-08
in O 0 6.715777933763434e-10
such O 0 1.959420181663063e-09
communities O 0 1.596993257635404e-07
. O 0 2.167616486303814e-07

In O 0 1.1707631841773036e-07
patients O 0 3.581785961159767e-07
of O 0 5.656934920494905e-10
Dutch O 0 9.30228125071153e-05
ethnic O 0 1.870909116519215e-08
origin O 0 4.9252513178998925e-08
, O 0 1.3326858505635641e-09
however O 0 1.283804063056948e-09
, O 0 1.9330265166317417e-10
no O 0 2.614561622760192e-10
significant O 0 1.1247003328662686e-09
founder O 0 8.211445745587298e-09
effect O 0 5.322075224967193e-08
could O 0 2.862683423643375e-08
be O 0 4.3808578986670454e-09
identified O 0 1.313365061150762e-07
. O 0 2.0029786185205012e-07

The O 0 8.58657216440406e-08
observed O 0 1.6027452431899292e-07
genetic O 0 2.544880999266752e-07
heterogeneity O 0 2.2547472156020376e-07
including O 0 3.526515524043816e-09
the O 0 1.253792070166071e-09
relative O 0 1.312228334882093e-07
high O 0 1.5496105731926946e-07
percentage O 0 7.650831435057626e-07
of O 0 4.126720354324931e-10
splice O 0 6.390149792423472e-05
- O 0 2.873212179110851e-05
site O 0 7.24805744312107e-08
mutations O 0 7.758118840683892e-07
had O 0 2.4512511132002146e-08
no O 0 1.814145500489417e-09
reflection O 0 7.928367296017313e-09
on O 0 5.102795519462688e-09
the O 0 1.8424199055289137e-08
phenotype O 0 8.25625829747878e-06
. O 0 4.319642528116674e-07

All O 0 3.9957942021828785e-07
patients O 0 8.955668704402342e-07
manifested O 0 1.4179373408751417e-07
classical O 0 3.9676979213254526e-07
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.999998927116394
T I-Disease 1 1.0
and O 0 4.7928217838943965e-08
increased O 0 2.1907089475803332e-08
cellular O 0 4.414891350279504e-07
radioresistant O 0 1.1553837566680158e-06
DNA O 0 6.745644327565969e-07
synthesis O 0 5.503035822584934e-07
. O 0 2.1956539342227188e-07

Determination O 0 3.7369457004388096e-06
of O 0 4.609895132290376e-09
the O 0 1.281272088426988e-09
genomic O 0 1.1763165019829103e-07
structure O 0 2.7060570673143047e-08
of O 0 1.1359602147820169e-10
the O 0 2.0362499186799e-10
COL4A4 O 0 1.2370819035822933e-07
gene O 0 1.157246565242076e-08
and O 0 3.408236470825443e-10
of O 0 2.2432482260636988e-10
novel O 0 1.4825334346824093e-06
mutations O 0 0.16247251629829407
causing O 0 0.0006046796916052699
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.379048212082125e-05

Autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 7.766653311591654e-07
a O 0 2.7478859010443557e-07
progressive O 0 5.067360325483605e-05
hematuric B-Disease 1 0.9992339611053467
glomerulonephritis I-Disease 1 1.0
characterized O 0 2.1189087419770658e-05
by O 0 3.037127669358597e-07
glomerular B-Disease 1 0.9581236243247986
basement I-Disease 1 0.9995282888412476
membrane I-Disease 1 0.9861950874328613
abnormalities I-Disease 1 0.9999991655349731
and O 0 5.320816853782162e-08
associated O 0 2.23368239460342e-08
with O 0 5.813418080258259e-10
mutations O 0 1.1811175681941677e-07
in O 0 9.295381131479985e-10
either O 0 5.793407975573928e-09
the O 0 9.521679000812355e-10
COL4A3 O 0 1.4459880048889318e-06
or O 0 5.43632339145006e-09
the O 0 3.8360492560229886e-10
COL4A4 O 0 1.8111806809884e-07
gene O 0 1.063875121332103e-08
, O 0 1.0208506956432828e-10
which O 0 8.482736041370842e-11
encode O 0 2.117676700663651e-09
the O 0 4.4832051959708963e-10
alpha3 O 0 7.927944807306631e-07
and O 0 1.1012486922368225e-08
alpha4 O 0 4.072159299539635e-06
type O 0 5.567400876316242e-06
IV O 0 1.3139781458448851e-06
collagen O 0 2.2139522570796544e-06
chains O 0 2.9194146918598562e-05
, O 0 3.083719235519311e-08
respectively O 0 5.161560920896591e-07
. O 0 7.564523798464506e-07

To O 0 3.305471807379945e-08
date O 0 3.41094548161891e-08
, O 0 7.31539717691021e-10
mutation O 0 1.7021799081362587e-08
screening O 0 3.080251076426066e-08
in O 0 3.906072132409122e-10
the O 0 5.3307632613686096e-11
two O 0 1.9752241509074508e-10
genes O 0 1.0355401869333036e-08
has O 0 7.440262805857856e-08
been O 0 7.296786463939497e-08
hampered O 0 7.377140320841136e-08
by O 0 2.745613736365726e-10
the O 0 1.5083748694522114e-09
lack O 0 8.816352092821944e-09
of O 0 2.6139232445210325e-10
genomic O 0 2.7347621767148667e-07
structure O 0 1.8394570133750676e-07
information O 0 4.783269247354838e-08
. O 0 1.6429360982783692e-07

We O 0 2.521885789974476e-06
report O 0 2.3035454432829283e-08
here O 0 3.654063718272482e-10
the O 0 6.144899866722398e-11
complete O 0 2.4806731668824966e-10
characterization O 0 1.0869852573591743e-08
of O 0 9.66580981920373e-11
the O 0 4.926881125300042e-10
48 O 0 5.8883911080442886e-09
exons O 0 4.2762934526763274e-08
of O 0 1.8626646058894636e-10
the O 0 7.518187183919167e-10
COL4A4 O 0 2.930375444520905e-07
gene O 0 1.45149297026137e-08
, O 0 4.1970507624888853e-10
a O 0 1.901413887450687e-10
comprehensive O 0 3.0015472329836257e-09
gene O 0 1.2123145154419035e-08
screen O 0 2.3436532501364127e-05
, O 0 1.4638364964625339e-09
and O 0 4.761000482744748e-10
the O 0 4.481783694165742e-11
subsequent O 0 1.4693640748575376e-09
detection O 0 1.3916125141122393e-08
of O 0 3.4043885765999704e-11
10 O 0 1.3804417331453323e-10
novel O 0 2.846180180426927e-09
mutations O 0 5.639509481625282e-08
in O 0 1.6181174178342417e-09
eight O 0 2.4433157719272458e-08
patients O 0 1.2677588756559999e-06
diagnosed O 0 0.0008025311981327832
with O 0 4.972617944076774e-07
autosomal B-Disease 1 0.9999991655349731
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.9947939512785524e-05

Furthermore O 0 1.46286959079589e-06
, O 0 1.77673147305768e-08
we O 0 6.372068206417225e-09
identified O 0 5.103184985699727e-09
a O 0 5.255292312433824e-10
glycine O 0 4.254830798799958e-08
to O 0 7.980721639100352e-10
alanine O 0 2.2157422563395812e-07
substitution O 0 1.775105573642577e-08
in O 0 1.8052883632435623e-09
the O 0 1.446644359859306e-09
collagenous O 0 3.947803008941264e-07
domain O 0 1.474106081644777e-08
that O 0 3.0128108341465065e-10
is O 0 3.2776439895521037e-10
apparently O 0 4.791703922535362e-09
silent O 0 1.1353980866601887e-08
in O 0 2.576104052298689e-10
the O 0 2.353461314719141e-10
heterozygous O 0 4.043418755372841e-08
carriers O 0 2.4102211781951155e-08
, O 0 6.578726452488581e-10
in O 0 3.804558446063311e-09
11 O 0 5.0227189518636806e-08
. O 0 2.1985916021094454e-07

5 O 0 9.720881877228749e-08
% O 0 2.8213227309947797e-09
of O 0 4.279338688961687e-11
all O 0 1.771038871112296e-10
control O 0 6.705848321075791e-09
individuals O 0 5.106746137073515e-10
, O 0 1.5692540322742587e-10
and O 0 3.542410254020467e-10
in O 0 2.2547444467058142e-10
one O 0 8.24527890408433e-10
control O 0 9.777406440036884e-09
individual O 0 1.2082648215283598e-09
homozygous O 0 1.818591321978147e-08
for O 0 1.4956400007370974e-10
this O 0 5.877077713378753e-10
glycine O 0 2.420044893369777e-07
substitution O 0 1.1474946148837262e-07
. O 0 2.3212588473597862e-07

There O 0 7.068862117876051e-08
has O 0 1.372977731506353e-08
been O 0 5.910310019174858e-09
no O 0 8.295741871222617e-10
previous O 0 4.201850867247003e-09
finding O 0 3.745188603687666e-09
of O 0 2.254984046712316e-11
a O 0 7.702405380172195e-11
glycine O 0 7.887507535997429e-09
substitution O 0 9.933722733279637e-10
that O 0 1.8088548714434438e-10
is O 0 1.0634540470455534e-10
not O 0 8.748134855407486e-11
associated O 0 1.256386522596742e-10
with O 0 6.228752236214774e-11
any O 0 4.338292391992127e-09
obvious O 0 1.3747262528340798e-07
phenotype O 0 3.231353105093149e-07
in O 0 3.880928911570436e-09
homozygous O 0 1.2448234656403656e-06
individuals O 0 4.964505606608327e-08
. O 0 2.4118958208418917e-07

Founder O 0 6.61485901218839e-05
BRCA1 O 0 0.0002904027351178229
and O 0 4.5901214207333396e-07
BRCA2 O 0 3.98779047827702e-05
mutations O 0 2.296571665283409e-06
in O 0 1.635715562997575e-08
French O 0 4.744407306134235e-06
Canadian O 0 1.0466468665981665e-05
breast B-Disease 1 0.9999954700469971
and I-Disease 1 0.9999899864196777
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.638313602205017e-07
. O 0 7.107223041202815e-07

We O 0 1.0975016948577831e-06
have O 0 4.033403833147986e-09
identified O 0 4.741374404204635e-09
four O 0 2.941537569078889e-10
mutations O 0 7.72395125636649e-09
in O 0 8.501135906335833e-11
each O 0 2.3585028374739636e-10
of O 0 1.0572531738972657e-10
the O 0 4.2707341663117404e-08
breast B-Disease 1 0.9999721050262451
cancer I-Disease 1 0.9252931475639343
- O 0 0.00024154785205610096
susceptibility O 0 5.147382125869626e-06
genes O 0 1.0104645298270043e-06
, O 0 7.710703187058243e-09
BRCA1 O 0 1.708805029920768e-06
and O 0 5.120745605324828e-09
BRCA2 O 0 9.009852988128841e-07
, O 0 7.905395782437097e-10
in O 0 2.8710973598577993e-09
French O 0 1.4658428426628234e-06
Canadian O 0 1.2837982694691163e-06
breast B-Disease 1 0.6465728282928467
cancer I-Disease 0 0.005724834743887186
and O 0 1.1316833479213528e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4719938690177514e-07
from O 0 1.5320152257913833e-08
Quebec O 0 1.7828371028372203e-06
. O 0 6.272479140534415e-07

To O 0 1.2080170108674793e-07
identify O 0 5.10066740844195e-07
founder O 0 2.0500047526184062e-07
effects O 0 4.928559064865112e-06
, O 0 1.2460826148696924e-08
we O 0 5.877484277050371e-09
examined O 0 2.7241044975312434e-08
independently O 0 2.646393326699581e-08
ascertained O 0 5.486754162120633e-07
French O 0 3.597825184442627e-07
Canadian O 0 5.606444730688054e-08
cancer B-Disease 0 1.7143861441581976e-07
families O 0 5.007714798388463e-10
for O 0 4.377128173804756e-11
the O 0 6.89483747873254e-11
distribution O 0 7.530931989130352e-10
of O 0 1.1344229028376063e-10
these O 0 2.4806363629892303e-09
eight O 0 3.985502772252403e-08
mutations O 0 4.297038231015904e-06
. O 0 3.083825959038222e-07

Mutations O 0 2.7480022254167125e-05
were O 0 2.941495580444098e-08
found O 0 5.5722098046828705e-09
in O 0 8.459409284178321e-10
41 O 0 1.1349434281271442e-08
of O 0 7.507783839066917e-10
97 O 0 1.478070714711066e-07
families O 0 8.100843729152984e-08
. O 0 3.7415387055261817e-07

Six O 0 2.7886841280633234e-07
of O 0 9.090277419687709e-10
eight O 0 4.157438837637528e-09
mutations O 0 7.692300840744792e-08
were O 0 1.2779308722343785e-09
observed O 0 5.166442829107609e-09
at O 0 3.845780138789223e-09
least O 0 6.31204599699231e-09
twice O 0 3.1579384085489437e-07
. O 0 2.059432091527924e-07

The O 0 2.793832436509547e-07
BRCA1 O 0 3.064983320655301e-05
C4446T O 0 5.425529252534034e-06
mutation O 0 1.2198921695016907e-06
was O 0 1.8618564467942633e-08
the O 0 1.9672494189215683e-10
most O 0 5.483861698074577e-10
common O 0 5.198786734439409e-09
mutation O 0 1.0472158606944504e-07
found O 0 3.6180580753608638e-09
, O 0 2.5928001412545143e-10
followed O 0 1.1680699740779232e-09
by O 0 1.3184464631166293e-09
the O 0 2.8550768860213793e-08
BRCA2 O 0 8.731918933335692e-05
8765delAG O 0 1.8711552911554463e-05
mutation O 0 1.9339382561156526e-05
. O 0 5.520461172636715e-07

Together O 0 5.420340087880504e-08
, O 0 1.9452994770574605e-09
these O 0 3.497942768770912e-10
mutations O 0 1.3065262649547549e-08
were O 0 5.366573851972589e-10
found O 0 5.301321048811758e-10
in O 0 2.769323381723865e-10
28 O 0 1.3396740383697647e-09
of O 0 6.01034361169539e-11
41 O 0 4.07995193185684e-09
families O 0 7.66929297846275e-10
identified O 0 4.4915267061185205e-09
to O 0 1.1490222107113368e-09
have O 0 1.5158194699438354e-08
a O 0 1.5724765489721904e-08
mutation O 0 3.5751081668422557e-06
. O 0 5.06620835949434e-07

The O 0 4.1463305677780227e-08
odds O 0 1.2821965356124565e-06
of O 0 2.0953207224838621e-10
detection O 0 1.728154508384705e-08
of O 0 2.7472990896115768e-11
any O 0 5.304274242057261e-10
of O 0 3.503335815890907e-11
the O 0 4.355062144245636e-10
four O 0 1.4188051622454623e-08
BRCA1 O 0 5.238187895884039e-06
mutations O 0 1.6470067976115388e-06
was O 0 9.010465618075614e-08
18 O 0 4.221703164830615e-08
. O 0 1.7285475450989907e-07

7x O 0 6.929475057404488e-05
greater O 0 7.007633939792868e-08
if O 0 7.059670181774891e-09
one O 0 8.17839476696669e-11
or O 0 8.343421786793925e-11
more O 0 2.3109705121759916e-11
cases O 0 1.3164319412339864e-08
of O 0 6.649453325735522e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.394280531030745e-07
also O 0 2.558101508398636e-09
present O 0 8.224074754537014e-10
in O 0 1.5585788215588536e-09
the O 0 2.071329330277649e-09
family O 0 8.431275944076333e-08
. O 0 3.3558487189111474e-07

The O 0 3.389116898233624e-08
odds O 0 9.286613931180909e-07
of O 0 2.930455322847081e-10
detection O 0 1.6016382886618885e-08
of O 0 4.978854828419088e-11
any O 0 1.9254176031324732e-09
of O 0 1.59092572449282e-10
the O 0 1.2239657065649112e-09
four O 0 5.0422617192680264e-08
BRCA2 O 0 1.0578134606475942e-05
mutations O 0 1.6889290463950601e-06
was O 0 5.4054318354701536e-08
5 O 0 5.004502057204263e-08
. O 0 2.1787542436868534e-07

3x O 0 4.5438755478244275e-05
greater O 0 9.08045976188987e-08
if O 0 4.021659805175659e-08
there O 0 4.505888440142769e-10
were O 0 2.1535161154329074e-10
at O 0 1.2007859984120017e-10
least O 0 4.2330576544014065e-11
five O 0 3.441328610964689e-10
cases O 0 5.349857001846203e-09
of O 0 2.7719881945387215e-09
breast B-Disease 1 0.9908217191696167
cancer I-Disease 0 0.0005251687252894044
in O 0 5.602561081730073e-09
the O 0 6.567896893017178e-09
family O 0 1.9346850876900135e-07
. O 0 2.949733186596859e-07

Interestingly O 0 2.31153103413817e-06
, O 0 9.381915688777553e-09
the O 0 4.1693326569003375e-10
presence O 0 5.479253939455475e-09
of O 0 3.4691530204078447e-10
a O 0 2.489102257641207e-08
breast B-Disease 0 0.0007679957780055702
cancer I-Disease 0 9.858453040578752e-07
case O 0 8.814216911900985e-09
< O 0 1.956582806883489e-08
36 O 0 1.3565829570794108e-09
years O 0 1.1469771798999773e-09
of O 0 5.6961692307400114e-11
age O 0 4.199038450281023e-09
was O 0 7.410669300433881e-10
strongly O 0 3.029394790576845e-10
predictive O 0 2.5707320716605864e-08
of O 0 3.8479920638767595e-11
the O 0 5.717699924634445e-11
presence O 0 7.586046235630306e-10
of O 0 1.0898360339184343e-11
any O 0 2.4587312741353173e-10
of O 0 3.9006797791785175e-11
the O 0 6.407310793044019e-10
eight O 0 1.4831929462388871e-08
mutations O 0 8.445373396170908e-07
screened O 0 1.7370492741974886e-06
. O 0 3.245733353196556e-07

Carriers O 0 3.1517756724497303e-06
of O 0 1.0421536966731537e-09
the O 0 2.223427691960822e-10
same O 0 6.742345570742714e-10
mutation O 0 7.45220418707504e-09
, O 0 1.5160897537391804e-10
from O 0 5.3003580691157737e-11
different O 0 6.330694302114637e-10
families O 0 2.710312196896325e-09
, O 0 3.3416777678318965e-10
shared O 0 1.7026465792824297e-09
similar O 0 4.2640251329828516e-09
haplotypes O 0 2.2857376791307615e-07
, O 0 8.61622495573755e-10
indicating O 0 3.7110283734875793e-09
that O 0 6.904417315656275e-11
the O 0 6.025265009146352e-11
mutant O 0 4.032665312792005e-09
alleles O 0 6.1766098902182875e-09
were O 0 6.452036127591043e-10
likely O 0 9.501740505513112e-10
to O 0 1.0453864163206816e-10
be O 0 1.0649195414380586e-10
identical O 0 7.668356505341478e-10
by O 0 1.730138116107227e-10
descent O 0 1.1150297041240265e-07
for O 0 1.2068737120785045e-09
a O 0 4.182700408250639e-09
mutation O 0 2.467510284986929e-07
in O 0 3.0524105465445928e-09
the O 0 6.041889211161333e-09
founder O 0 3.778360735395836e-07
population O 0 1.3252120822926372e-07
. O 0 2.3194576215246343e-07

The O 0 1.173273123100671e-08
identification O 0 4.422028965223035e-08
of O 0 1.6850905115717296e-09
common O 0 1.4783245205762796e-07
BRCA1 O 0 2.4021515855565667e-05
and O 0 7.715532035490469e-08
BRCA2 O 0 9.427843906451017e-06
mutations O 0 6.194161414896371e-07
will O 0 1.1436196434289059e-09
facilitate O 0 2.2029345014829005e-09
carrier O 0 7.21755526456036e-08
detection O 0 4.3168583374608716e-08
in O 0 2.7487383480462313e-09
French O 0 6.8895087679266e-07
Canadian O 0 3.2963998819468543e-07
breast B-Disease 0 0.08394192904233932
cancer I-Disease 0 0.0006689728470519185
and O 0 1.571386746945791e-05
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.08872119805892e-06
. O 0 1.4859559769320185e-06

Are O 0 6.837706791884557e-07
Dp71 O 0 3.2761763577582315e-05
and O 0 2.2483784789528727e-07
Dp140 O 0 1.8875671230489388e-05
brain O 0 7.1682602538203355e-06
dystrophin O 0 3.4948834581882693e-06
isoforms O 0 3.673193873510172e-07
related O 0 5.2512096004875275e-08
to O 0 1.3392863706940261e-08
cognitive B-Disease 0 4.575376351567684e-06
impairment I-Disease 0 7.273342362168478e-06
in O 0 1.5591288615723897e-07
Duchenne B-Disease 0 0.002531342674046755
muscular I-Disease 0 0.0012739112135022879
dystrophy I-Disease 0 0.004070211201906204
? O 0 0.00010715729149524122

Molecular O 0 9.082042197405826e-06
study O 0 3.9662413087171444e-07
and O 0 1.9164859921261268e-08
neuropsychological O 0 3.269318540333188e-07
analysis O 0 8.394702710745605e-09
were O 0 3.546750670935239e-10
performed O 0 5.12869913205094e-10
concurrently O 0 1.6484212883582927e-09
on O 0 3.4141849347690822e-09
49 O 0 1.4215714827514603e-07
patients O 0 9.203088779941027e-08
with O 0 1.2173611452226396e-08
Duchenne B-Disease 0 0.0054930709302425385
muscular I-Disease 0 7.542076491517946e-05
dystrophy I-Disease 0 8.224815246649086e-05
( O 0 1.548616381796819e-07
DMD B-Disease 1 1.0
) O 0 3.889141098056825e-08
in O 0 7.483151320819559e-10
order O 0 9.784342225316323e-10
to O 0 5.519718571100896e-10
find O 0 4.0771279685714035e-09
a O 0 9.749463042441064e-11
molecular O 0 2.295229117876829e-09
explanation O 0 1.111578162849014e-09
for O 0 2.4244195540035207e-10
the O 0 1.4611056808888634e-09
cognitive B-Disease 0 8.439085377176525e-07
impairment I-Disease 0 2.513774575163552e-07
observed O 0 2.5988876828364482e-08
in O 0 1.2906842705717736e-08
most O 0 7.594753128614684e-07
DMD B-Disease 1 1.0
patients O 0 0.00013846412184648216
. O 0 4.867926577389881e-07

Complete O 0 2.155717595542228e-07
analysis O 0 6.17389090962206e-08
of O 0 6.224361026596625e-10
the O 0 7.776260191327822e-10
dystrophin O 0 3.093327904934995e-07
gene O 0 5.30373363005765e-08
was O 0 3.251592994857333e-09
performed O 0 1.8195931428266476e-09
to O 0 2.6513519157944643e-10
define O 0 1.9650725491260346e-08
the O 0 7.270328783448576e-10
localization O 0 1.3905193441132724e-08
of O 0 7.061144724485047e-11
deletions O 0 4.404310516292753e-08
and O 0 2.248835562213003e-09
duplications O 0 9.285253810276117e-08
in O 0 1.6431945804029624e-09
relation O 0 7.084867803541783e-09
to O 0 7.854685235564318e-10
the O 0 2.190406966917635e-09
different O 0 9.321203009449164e-08
DMD B-Disease 1 0.9999996423721313
promoters O 0 1.8989254385815002e-05
. O 0 5.371596785153088e-07

Qualitative O 0 7.654256478417665e-06
analysis O 0 1.4718786189860111e-07
of O 0 4.762735206220725e-10
the O 0 3.5645053575450447e-10
Dp71 O 0 3.2097794644414535e-08
transcript O 0 1.3013084831925426e-08
and O 0 4.510617712671916e-10
testing O 0 1.2886762768005156e-09
for O 0 8.630789659347382e-12
the O 0 4.518095533118105e-12
specific O 0 1.244433028846359e-10
first O 0 1.412523153998535e-10
exon O 0 4.792179542079111e-09
of O 0 4.512146906110459e-11
Dp140 O 0 7.3464448746563e-08
were O 0 3.106730428470428e-09
also O 0 1.2246732516985048e-09
carried O 0 2.46355007504917e-08
out O 0 1.6882987452504494e-08
. O 0 8.188801814412727e-08

Neuropsychological O 0 0.0002574125537648797
analysis O 0 1.8588281136544538e-06
assessed O 0 1.0555877452134155e-06
verbal O 0 2.1319899587979307e-06
and O 0 1.94006464226959e-08
visuospatial O 0 2.8751928766723722e-06
intelligence O 0 8.398451427638065e-07
, O 0 2.0701285130542146e-09
verbal O 0 8.929234951438048e-08
memory O 0 4.853611699218163e-07
, O 0 1.939682636731277e-09
and O 0 4.4076444716267815e-09
reading O 0 1.1792019449785585e-07
skills O 0 1.2342766240180936e-06
. O 0 3.9400100604325416e-07

Comparison O 0 1.0397596952316235e-06
of O 0 2.6436222100301165e-09
molecular O 0 3.624366229360021e-07
and O 0 1.2504253632528162e-08
psychometric O 0 3.6521694255498005e-06
findings O 0 5.3217604545352515e-08
demonstrated O 0 9.970134051684454e-09
that O 0 7.427335135812285e-11
deletions O 0 1.3014474831152256e-08
and O 0 6.778811401098039e-10
duplications O 0 6.513469941182848e-08
that O 0 1.0607521527816743e-09
were O 0 5.248500523080679e-10
localized O 0 1.5581932188979408e-08
in O 0 1.0553075080466101e-09
the O 0 1.6315013229295516e-10
distal O 0 1.79390386989553e-08
part O 0 8.579692512000747e-09
of O 0 5.144921641497824e-11
the O 0 7.479251246111929e-11
gene O 0 6.233405347444432e-09
seemed O 0 4.238483342078325e-09
to O 0 9.34447519362891e-11
be O 0 2.489123629434431e-10
preferentially O 0 1.2013989802994729e-08
associated O 0 1.0581620912830658e-08
with O 0 9.09338648824587e-09
cognitive B-Disease 0 6.95386870575021e-06
impairment I-Disease 0 9.557461453368887e-06
. O 0 8.601617196291045e-07

Two O 0 2.8676572583208326e-07
altered O 0 1.6993078588711796e-06
Dp71 O 0 1.0945121857730555e-06
transcripts O 0 1.1371453467745596e-07
and O 0 1.9220640634642905e-09
two O 0 4.3478828870568975e-10
deleted O 0 7.178989136491509e-08
Dp140 O 0 3.056420538882776e-08
DNA O 0 3.780073587478228e-09
sequences O 0 1.5844460188318976e-09
were O 0 1.4963162653369722e-10
found O 0 1.630630214188855e-10
in O 0 9.258642463816358e-11
four O 0 2.0408039702601855e-09
patients O 0 5.687687831823496e-08
with O 0 3.0897130187668154e-08
severe O 1 0.9882036447525024
cerebral B-Disease 1 0.9994106292724609
dysfunction I-Disease 1 0.8353497385978699
. O 0 3.3610931495786645e-06

These O 0 5.0757833491843485e-08
findings O 0 2.4299495748891786e-08
suggest O 0 1.1788991116645775e-08
that O 0 5.741852132645775e-11
some O 0 1.5034501421595792e-11
sequences O 0 1.360879742229315e-09
located O 0 2.582446700927221e-09
in O 0 7.466997575811263e-10
the O 0 3.067373299803222e-10
distal O 0 4.282627230622893e-08
part O 0 9.467481909553044e-09
of O 0 1.1287099033197023e-10
the O 0 8.875294943422318e-11
gene O 0 3.985538565842717e-09
and O 0 1.1234847496766065e-09
, O 0 6.354353848658789e-11
in O 0 8.548810270792018e-11
particular O 0 8.98579544106326e-10
, O 0 3.498016043490537e-10
some O 0 1.7736562218928498e-09
DMD B-Disease 1 0.999998927116394
isoforms O 0 4.398711084263596e-08
expressed O 0 2.2030353097335365e-09
in O 0 8.296105469263182e-10
the O 0 9.258611655127424e-10
brain O 0 1.2123673513997346e-06
may O 0 3.976358797785906e-09
be O 0 3.177927018760407e-11
related O 0 1.8460974415823728e-10
to O 0 3.0668820261148255e-10
the O 0 5.703763683584384e-09
cognitive B-Disease 0 5.734107162425062e-06
impairment I-Disease 0 1.2177174539829139e-06
associated O 0 6.572837918383811e-08
with O 0 8.939289131149053e-08
DMD B-Disease 1 1.0
. O 0 3.4170867024840845e-07
. O 0 5.948390935373027e-07

I1307K O 0 0.0001683378650341183
APC O 0 5.900996711716289e-06
and O 0 2.3304588481209976e-08
hMLH1 O 0 8.191252049982722e-07
mutations O 0 2.2442782210418954e-07
in O 0 1.2636641733010379e-09
a O 0 1.7684674835649616e-09
non O 0 7.477232429664582e-06
- O 0 1.114244878408499e-05
Jewish O 0 9.887344276648946e-08
family O 0 6.280138631353793e-09
with O 0 5.270613279151348e-09
hereditary B-Disease 1 0.9995225667953491
non I-Disease 1 0.999997615814209
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.863553153380053e-06

We O 0 2.2174420166720665e-07
describe O 0 1.928061692524352e-07
a O 0 1.891356760097551e-08
French O 0 1.0671042218746152e-06
Canadian O 0 8.921929293137509e-07
hereditary B-Disease 1 0.9922342300415039
non I-Disease 1 0.9999972581863403
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.6353449154848931e-06
HNPCC B-Disease 0 0.098838672041893
) O 0 1.0830206065293169e-07
kindred O 0 1.921511739055859e-06
which O 0 1.4073666676495122e-08
carries O 0 1.3473623106108334e-08
a O 0 2.497585249727763e-09
novel O 0 1.0057404864483033e-07
truncating O 0 7.118814210116398e-06
mutation O 0 5.9771869018732104e-06
in O 0 7.715767225136005e-08
hMLH1 O 0 1.6284850062220357e-05
. O 0 4.248756795277586e-07

Interestingly O 0 6.177005161589477e-06
, O 0 3.661406822175195e-08
the O 0 8.371709547816408e-09
I1307K O 0 1.060901354321686e-06
APC O 0 1.30613543092295e-07
polymorphism O 0 2.616280880829436e-07
, O 0 4.52477499912618e-10
associated O 0 6.195059465419206e-10
with O 0 5.98398899875896e-11
an O 0 1.8693842307460073e-10
increased O 0 8.801570317018559e-08
risk O 0 0.0321468748152256
of O 0 1.3926653082307894e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 9.07817394590893e-08
is O 0 2.8735518409206406e-09
also O 0 1.561226814494887e-09
present O 0 8.700414833029413e-10
in O 0 1.1934184751538623e-09
this O 0 2.7464219787276534e-09
family O 0 7.649679645282959e-08
. O 0 1.714238919703348e-07

The O 0 3.667445369615052e-08
I1307K O 0 7.298998525584466e-07
polymorphism O 0 4.194702398763184e-07
has O 0 3.419529104320418e-09
previously O 0 2.1071366873570696e-09
only O 0 1.272812133468193e-10
been O 0 2.9588462235885515e-10
identified O 0 1.3501193496523456e-09
in O 0 6.401053298521475e-11
individuals O 0 1.1361594998149371e-10
of O 0 3.714198948401304e-10
self O 0 0.4873773455619812
- O 1 0.9987480640411377
reported O 0 0.0012316673528403044
Ashkenazi O 0 4.151657049078494e-05
Jewish O 0 6.547336965923023e-07
origins O 0 2.1606829250231385e-06
. O 0 8.2758901953639e-07

In O 0 3.32275398307047e-08
addition O 0 9.1544869462723e-09
, O 0 1.1252089260338494e-09
in O 0 2.488122208266219e-10
this O 0 1.4850060070514814e-10
family O 0 6.942849628543968e-10
, O 0 1.7893400650059732e-10
there O 0 1.0991618726308161e-10
appears O 0 1.8123437195427528e-09
to O 0 2.935708343088095e-10
be O 0 2.2844413027911514e-09
no O 0 3.523071834266034e-10
relationship O 0 1.6719643447515864e-09
between O 0 5.6567157208364804e-11
the O 0 6.282995651529788e-11
I1307K O 0 1.1431338542422509e-08
polymorphism O 0 2.6219053594900288e-08
and O 0 5.168756533890928e-10
the O 0 1.1586124420981392e-10
presence O 0 1.2983920605336152e-09
or O 0 3.949337301634159e-09
absence O 0 6.327958157470448e-09
of O 0 6.353133574776848e-10
cancer B-Disease 0 6.273298822634388e-07
. O 0 1.21661365426462e-08
. O 0 2.800239826683537e-07

Identification O 0 9.472828992329596e-07
of O 0 3.4147971117448606e-09
a O 0 2.7916249312198715e-09
novel O 0 3.096155154480584e-08
mutation O 0 6.744357250454414e-08
of O 0 1.743734184822543e-10
the O 0 8.685824282039789e-10
CPO O 0 2.3828053485885903e-07
gene O 0 4.003154785436891e-08
in O 0 2.1528641092061207e-09
a O 0 9.539043333006703e-09
Japanese O 0 1.4457839370152215e-06
hereditary B-Disease 0 0.001744016190059483
coproporphyria I-Disease 0 0.0001286249898839742
family O 0 8.448498647339875e-07
. O 0 3.6110972700953425e-07

Hereditary B-Disease 1 0.9919809103012085
coproporphyria I-Disease 0 0.0018553414847701788
( O 0 9.59479251605444e-08
HCP B-Disease 0 5.147627234691754e-06
) O 0 3.6535496850120808e-09
is O 0 7.46961825726089e-10
an O 0 3.9334522305978226e-09
autosomal B-Disease 1 0.9999644756317139
dominant I-Disease 1 0.9999958276748657
disease I-Disease 0 0.3495086133480072
characterized O 0 1.7226592774477467e-07
by O 0 9.796745636947435e-09
a O 0 2.8871292556686967e-07
deficiency B-Disease 0 0.08702682703733444
of I-Disease 0 4.972328104813073e-10
coproporphyrinogen I-Disease 0 3.086979177169269e-06
oxidase I-Disease 0 6.428641086131393e-07
( O 0 1.6361204613346558e-09
CPO O 0 4.2010915990431386e-07
) O 0 3.038910234565151e-09
caused O 0 2.9159212822094105e-09
by O 0 1.7998552648279542e-10
a O 0 3.411359861260621e-09
mutation O 0 1.7951845165953273e-07
in O 0 1.630954593601075e-09
the O 0 5.624768206757835e-09
CPO O 0 5.3549565564026125e-06
gene O 0 1.4288500551629113e-06
. O 0 4.093783161351894e-07

Only O 0 2.775683469735668e-07
11 O 0 2.450877190085521e-08
mutations O 0 4.206961179420432e-08
of O 0 6.487164277979574e-11
the O 0 1.0711877912461532e-10
gene O 0 1.3315940350366873e-08
have O 0 1.1959530255012396e-08
been O 0 2.829742307142169e-08
reported O 0 8.438225762574803e-08
in O 0 3.186234920349307e-08
HCP B-Disease 0 0.0007349741063080728
patients O 0 7.222723979793955e-06
. O 0 3.312181036108086e-07

We O 0 1.8830006638381747e-06
report O 0 5.687644843987982e-08
another O 0 2.8522559869514907e-09
mutation O 0 8.261626049943516e-08
in O 0 2.293041090339898e-09
a O 0 3.756606581362121e-09
Japanese O 0 2.5399035052942054e-07
family O 0 3.9968952592062124e-07
. O 0 4.543676368484739e-07

Polymerase O 0 8.450072346022353e-05
chain O 0 4.2014664359157905e-05
reaction O 0 4.037253347632941e-06
- O 0 2.1395841031335294e-05
single O 0 2.7870305530086625e-07
strand O 0 2.72271813628322e-06
conformational O 0 3.526296268319129e-07
polymorphism O 0 5.13988823058753e-07
and O 0 2.3788526704038304e-09
direct O 0 2.2513932940171344e-09
sequence O 0 9.301682091233943e-09
analyses O 0 6.112458095230977e-08
demonstrated O 0 1.1078155282007174e-08
a O 0 7.062588847084328e-10
C O 0 1.964233220519418e-08
to O 0 4.210408965921175e-10
T O 0 2.7845644012813864e-08
substitution O 0 3.8685993297704613e-10
in O 0 1.701087465333373e-10
exon O 0 8.779167615102779e-09
1 O 0 9.81548176071101e-10
of O 0 3.3839570034999156e-11
the O 0 3.481893662282687e-10
CPO O 0 6.594649448743439e-08
gene O 0 6.53765086511271e-09
at O 0 3.79629300217843e-10
nucleotide O 0 2.240569330069775e-08
position O 0 4.477159620819293e-08
85 O 0 3.052474717435416e-09
, O 0 5.824217219618788e-10
which O 0 1.3818833854983836e-09
lies O 0 9.909165044064139e-09
in O 0 8.111845084535219e-10
the O 0 5.545319203825727e-10
putative O 0 6.74103972642115e-08
presequence O 0 6.608702562971303e-08
for O 0 3.408795745674098e-10
targeting O 0 5.400958968948544e-08
to O 0 8.268591145110804e-09
mitochondria O 0 8.266826512226544e-07
. O 0 4.43973476649262e-07

This O 0 5.814399983705698e-08
mutation O 0 2.462935242419917e-07
changes O 0 8.643091575777362e-09
the O 0 2.8291621823051116e-10
codon O 0 3.832001738146573e-08
for O 0 9.060966560392458e-11
glutamine O 0 1.6243799194626263e-08
to O 0 4.535030961871911e-10
a O 0 4.1625409785694956e-09
termination O 0 4.6298561073854216e-07
codon O 0 8.860691309564572e-07
at O 0 1.7696123677524156e-08
amino O 0 1.5728549840332562e-07
acid O 0 5.328444103724905e-07
position O 0 4.180963628641621e-07
29 O 0 2.6864208280130697e-07
. O 0 1.5904092265373038e-07

MaeI O 0 2.175613735744264e-05
restriction O 0 1.7639818850057054e-07
analysis O 0 4.748200410631398e-08
showed O 0 1.1439103886345947e-08
two O 0 9.350856894352333e-11
other O 0 2.5908525325135656e-10
carriers O 0 1.967037555061779e-08
in O 0 4.6447992674281124e-10
the O 0 1.9946202467480134e-09
family O 0 5.967869043388419e-08
. O 0 4.10931960459493e-07

The O 0 4.6468954906231374e-07
C O 0 0.0008906653965823352
- O 0 0.026752037927508354
T O 0 7.396021101158112e-05
mutation O 0 6.354665771368673e-08
is O 0 2.1601929967030031e-10
located O 0 5.095848187863794e-10
within O 0 2.2342511174500146e-10
a O 0 8.08573874522267e-10
recently O 0 1.7394144791182953e-08
proposed O 0 3.7570222488625404e-09
putative O 0 4.9675367819190797e-08
alternative O 0 1.0208165868164087e-08
translation O 0 1.535549110087686e-08
initiation O 0 2.850223168593402e-08
codon O 0 4.5431477246893337e-07
( O 0 1.875256172567674e-09
TIC O 0 4.6069001768955786e-07
- O 0 1.4064306697036955e-07
1 O 0 1.6544722258871047e-09
) O 0 1.0139501044337251e-10
, O 0 3.912788495985531e-11
supporting O 0 1.4456679187091481e-09
that O 0 2.78973399936433e-10
TIC O 0 2.8891153647236933e-07
- O 0 1.8562086268048006e-07
1 O 0 2.84917844872723e-09
is O 0 2.33721403342102e-10
the O 0 4.0398459577595247e-10
real O 0 3.502305290226104e-08
TIC O 0 4.310506795945912e-08
rather O 0 3.113752589101182e-10
than O 0 5.425651039558943e-10
TIC O 0 5.184016345083364e-07
- O 0 1.727038068111142e-07
2 O 0 4.206574200082969e-09
. O 0 5.3367710250995515e-09
. O 0 6.782568107155384e-08

Human B-Disease 0 6.561557484019431e-07
complement I-Disease 0 6.268787274166243e-06
factor I-Disease 0 0.0005999676650390029
H I-Disease 1 1.0
deficiency I-Disease 1 0.9997230172157288
associated O 0 3.5763766845775535e-06
with O 0 3.911327075911686e-05
hemolytic B-Disease 1 0.9999998807907104
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.5445502615184523e-05

This O 0 1.427338958137625e-08
study O 0 4.948393694803599e-09
reports O 0 1.4365477696287599e-09
on O 0 3.0947583384843824e-10
six O 0 1.0103560210694695e-09
cases O 0 7.180863015321393e-09
of O 0 1.5526090413331417e-09
deficiency B-Disease 0 2.4449778720736504e-05
in I-Disease 0 4.769235006918393e-10
the I-Disease 0 6.263674579010114e-10
human I-Disease 0 1.4451744245747022e-09
complement I-Disease 0 1.5207685777340885e-08
regulatory I-Disease 0 1.3728971737236861e-07
protein I-Disease 0 7.118544687045869e-08
Factor I-Disease 0 2.986359390888538e-07
H I-Disease 1 0.9999997615814209
( O 0 3.0562441466486234e-09
FH O 0 3.7646352666342864e-06
) O 0 2.329465509376405e-10
in O 0 1.825807387223488e-11
the O 0 1.4568271936021837e-11
context O 0 7.984620187251323e-10
of O 0 1.6523331314299838e-10
an O 0 7.457795447862736e-08
acute B-Disease 1 0.9998049139976501
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.686469765147194e-06

Five O 0 3.825502048471208e-08
of O 0 7.016370817680695e-11
the O 0 3.642024529182386e-11
cases O 0 7.686735137291123e-10
were O 0 1.3836867762684335e-10
observed O 0 8.934814554883985e-10
in O 0 1.3120637909480592e-10
children O 0 8.659308270431154e-10
presenting O 0 1.5715050594167224e-08
with O 0 7.646017365914304e-07
idiopathic O 1 0.9999979734420776
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.0543491700664163e-05
HUS B-Disease 1 0.9999650716781616
) O 0 3.3121666547231143e-06
. O 0 1.3869761232854216e-06

Two O 0 1.8085703601400382e-08
of O 0 2.8376900829130136e-10
the O 0 6.799815710500923e-10
children O 0 2.6178663681264425e-09
exhibited O 0 2.832372025807217e-08
a O 0 2.0516939258641287e-08
homozygous O 0 0.020839745178818703
deficiency O 0 0.0009768132586032152
characterized O 0 4.692467747702267e-09
by O 0 3.469450560178444e-10
the O 0 8.03736577292824e-10
absence O 0 3.836387652000894e-09
of O 0 3.341255397359966e-11
the O 0 1.6956842874282785e-10
150 O 0 1.0616629797510768e-09
- O 0 2.57447112517184e-08
kD O 0 1.684443020621984e-07
form O 0 1.1352806472686439e-09
of O 0 1.7759639592274112e-10
Factor O 0 6.485763037744618e-08
H O 1 1.0
and O 0 4.570950729032575e-09
the O 0 1.8328773221387706e-10
presence O 0 1.5378081030803514e-09
, O 0 4.270320555499474e-11
upon O 0 7.932488693684903e-11
immunoblotting O 0 2.3125791059896983e-08
, O 0 1.4289691652180636e-10
of O 0 1.9587009097987718e-11
the O 0 4.121905872178644e-10
42 O 0 9.98347360336993e-09
- O 0 1.5970664435371873e-07
kD O 0 2.7319256332702935e-06
Factor O 0 2.7824361836792377e-07
H O 1 0.9999998807907104
- O 0 3.400876948944642e-07
like O 0 5.327719154735178e-09
protein O 0 9.52101153472995e-09
1 O 0 1.4483449994884268e-09
( O 0 2.198106696660318e-10
FHL O 0 5.652426011693024e-07
- O 0 7.34123446477497e-08
1 O 0 7.666586809840226e-10
) O 0 4.534751740781218e-11
and O 0 7.531129192495101e-11
other O 0 1.159090490254755e-09
FH O 0 0.057220589369535446
- O 0 1.260576851791484e-07
related O 0 1.0892495794223578e-08
protein O 0 1.1158419965795474e-08
( O 0 2.8332874935088626e-10
FHR O 0 9.396551092777372e-08
) O 0 1.3832704981453503e-09
bands O 0 7.493227371924149e-08
. O 0 1.311515234192484e-07

Southern O 0 6.462686087616021e-06
blot O 0 2.1320760424714535e-05
and O 0 1.1610558736663279e-08
PCR O 0 2.1873525213322864e-07
analysis O 0 2.2119530651565356e-09
of O 0 1.6724729240413794e-11
DNA O 0 3.919955915421269e-09
of O 0 2.1423347471016818e-11
one O 0 5.657323498553524e-10
patient O 0 1.0071798506317009e-08
with O 0 1.1064802407645402e-09
homozygous O 0 8.228989463532344e-05
deficiency O 0 0.0006179941119626164
ruled O 0 5.4660521442428944e-08
out O 0 1.1470384642109366e-09
the O 0 1.2442692709502268e-10
presence O 0 6.451777445626306e-10
of O 0 1.1546078329538467e-11
a O 0 8.225247566384652e-11
large O 0 5.09140896109983e-10
deletion O 0 9.764253405819545e-08
of O 0 1.0759897139944741e-10
the O 0 6.401813523737587e-10
FH O 0 2.100692654494196e-06
gene O 0 6.4238339092526076e-09
as O 0 5.642387113091729e-10
the O 0 2.450369629425353e-10
underlying O 0 1.8403956403290067e-07
defect O 0 7.072866878843342e-07
for O 0 2.4474284820996672e-09
the O 0 7.688384329185283e-08
deficiency O 0 0.0018052274826914072
. O 0 1.1848066350239606e-07

The O 0 4.343227111291981e-09
other O 0 3.645056201317942e-10
four O 0 5.435003558318385e-10
children O 0 4.718925250557504e-10
presented O 0 6.811368691295172e-10
with O 0 4.153507315862726e-09
heterozygous O 0 0.0011047943262383342
deficiency O 0 0.0015283323591575027
and O 0 1.5116957685634702e-09
exhibited O 0 3.0891353475226424e-08
a O 0 2.811390453771878e-09
normal O 0 8.394081163487499e-08
immunoblotting O 0 8.187355433619814e-07
pattern O 0 2.8982523758713796e-07
of O 0 4.2102640818164616e-10
proteins O 0 6.865894075502865e-09
of O 0 8.987080524214264e-10
the O 0 1.9481074531313425e-08
FH O 0 0.14800924062728882
family O 0 3.778786208386009e-07
. O 0 3.0267182182797114e-07

Factor B-Disease 1 0.9993051290512085
H I-Disease 1 1.0
deficiency I-Disease 1 0.9985309839248657
is O 0 4.678312404138296e-09
the O 0 1.3490922823322649e-09
only O 0 1.319760940532433e-07
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 5.498445716511924e-07
with O 0 1.3216779848335136e-07
HUS B-Disease 1 0.9754410982131958
. O 0 2.2510139388032258e-06

These O 0 1.383139380806142e-08
observations O 0 2.3386833802874207e-08
suggest O 0 1.2548453831584538e-08
a O 0 6.565488708254463e-10
role O 0 1.1839602187535547e-08
for O 0 2.524901399070245e-09
FH O 0 4.180491669103503e-05
and O 0 5.422281290634601e-09
/ O 0 1.265171505338003e-07
or O 0 4.289379873512189e-08
FH O 0 0.0003294117050245404
receptors O 0 1.3387939645781444e-07
in O 0 9.203168782612181e-10
the O 0 1.1784804243575309e-09
pathogenesis O 0 2.2879795835706318e-07
of O 0 4.374361761705359e-09
idiopathic O 0 0.0003606123791541904
HUS B-Disease 1 0.9963927865028381
. O 0 4.70903984250981e-07
. O 0 9.382882240061008e-07

Further O 0 2.5539833359289332e-08
evidence O 0 3.120996572292256e-09
for O 0 1.1469240834838246e-10
a O 0 2.073739652219686e-10
major O 0 2.3549036054504313e-09
ancient O 0 2.9046434590895842e-08
mutation O 0 2.42079531744821e-05
underlying O 0 2.3332300770562142e-05
myotonic B-Disease 1 0.9999977350234985
dystrophy I-Disease 1 0.9999854564666748
from O 0 2.535718124363484e-08
linkage O 0 5.5891114243422635e-06
disequilibrium O 0 8.729079127078876e-06
studies O 0 1.2018004724723141e-07
in O 0 9.752723073574998e-10
the O 0 1.1519275533444784e-09
Japanese O 0 1.0445327802699467e-07
population O 0 4.652269325333691e-08
. O 0 2.3760294709518348e-07

The O 0 5.035120921093039e-06
myotonic B-Disease 1 0.9999980926513672
dystrophy I-Disease 1 0.9999997615814209
( O 0 2.014945675909985e-05
DM B-Disease 1 1.0
) O 0 4.37014449516937e-07
mutation O 0 1.6406075928898645e-06
is O 0 9.709610893082754e-09
an O 0 3.758441557977221e-09
unstable O 0 0.00040077074663713574
( O 0 1.7021926979055024e-08
CTG O 0 1.6099667163871345e-06
) O 0 3.0337790057899383e-09
n O 0 2.335006854536914e-07
repeat O 0 1.1381546755728777e-05
, O 0 3.5344596693853703e-10
present O 0 2.9076391294680093e-10
at O 0 7.431547044411957e-10
a O 0 7.355464154423785e-11
copy O 0 5.3095101648636955e-09
number O 0 5.011116521735914e-10
of O 0 7.855940203915779e-11
5 O 0 3.6451277551918793e-09
- O 0 9.374332421430154e-07
37 O 0 6.220993942207542e-09
repeats O 0 3.338502096994489e-08
on O 0 2.0661681254807718e-09
normal O 0 4.085823235300268e-09
chromosomes O 0 8.420006913922862e-09
but O 0 2.173924817938655e-09
amplified O 0 5.920193668629281e-09
to O 0 3.971429574090024e-10
50 O 0 1.5690422294767359e-09
- O 0 2.5593816843638706e-08
3000 O 0 1.9099358539165223e-08
copies O 0 4.5139181281683705e-08
on O 0 3.672422792533325e-07
DM B-Disease 1 0.9999948740005493
chromosomes O 0 7.192596967797726e-06
. O 0 5.69920359794196e-07

Previous O 0 1.273228235731949e-06
findings O 0 2.1909600889102876e-07
in O 0 9.484941720927509e-09
Caucasian O 0 1.148242745330208e-06
populations O 0 1.254934431926813e-07
of O 0 1.8031204307433768e-09
a O 0 1.196877690290421e-07
DM B-Disease 1 1.0
founder O 0 4.8710468547596975e-08
chromosome O 0 3.412182252304774e-07
raise O 0 7.565156501243564e-09
a O 0 3.025658612543225e-10
question O 0 3.210598453762259e-09
about O 0 6.885243764020998e-11
the O 0 3.030011658244902e-11
molecular O 0 1.4252189428631823e-09
events O 0 7.27443438819364e-10
involved O 0 1.891842904555574e-09
in O 0 6.661913798389207e-10
the O 0 1.697260887389973e-09
expansion O 0 4.2901285723928595e-07
mutation O 0 5.154829068487743e-06
. O 0 2.542147399253736e-07

To O 0 4.321983126942541e-08
investigate O 0 8.53841015668877e-08
whether O 0 9.329489181197914e-09
a O 0 1.1184900783334228e-09
founder O 0 1.9178756360815896e-08
chromosome O 0 9.359934693975447e-08
for O 0 1.8790082823016974e-09
the O 0 1.8361857812010385e-08
DM B-Disease 1 1.0
mutation O 0 4.668474105073983e-07
exists O 0 5.439248162986132e-09
in O 0 1.6864208640665623e-10
the O 0 1.224018802981064e-10
Japanese O 0 7.012899150282692e-09
population O 0 3.838054596361218e-10
, O 0 2.3716797969974834e-10
we O 0 6.428438892314148e-10
genotyped O 0 2.6952141851666056e-08
families O 0 3.08074177279849e-10
using O 0 8.027192244242087e-10
polymorphic O 0 8.778719262636514e-08
markers O 0 2.770452169897908e-07
near O 0 8.10663962624858e-08
the O 0 7.714498373445622e-09
( O 0 6.270216346138113e-09
CTG O 0 1.7425296618966968e-06
) O 0 6.695725751626469e-09
n O 0 8.512731710652588e-07
repeat O 0 0.00018728368740994483
region O 0 4.841711529479653e-07
and O 0 2.3921490566181092e-08
constructed O 0 2.0424890863068867e-06
haplotypes O 0 1.5091838577063754e-05
. O 0 4.384563396797603e-07

Six O 0 1.21062114999404e-07
different O 0 6.907902250219422e-09
haplotypes O 0 2.2026335955160903e-07
were O 0 4.4815657851415835e-09
found O 0 1.1608566552467892e-08
and O 0 1.584057542913797e-07
DM B-Disease 1 1.0
alleles O 0 1.7831687273428543e-06
were O 0 3.339342669050893e-08
always O 0 9.40203648269744e-08
haplotype O 0 3.236638349335408e-06
A O 0 2.1740800093539292e-07
. O 0 3.8651819522783626e-07

To O 0 1.2791947945345328e-08
find O 0 1.5518313745133128e-08
an O 0 5.884073783768429e-11
origin O 0 1.2133547500070563e-09
of O 0 5.462666777256153e-11
the O 0 8.500377624010014e-10
( O 0 1.2132251869800825e-09
CTG O 0 3.134887549549603e-07
) O 0 1.1576233305277128e-09
n O 0 7.981064698014961e-08
repeat O 0 2.965972498714109e-07
mutation O 0 5.321100715605098e-08
and O 0 4.090453253891013e-10
to O 0 7.82056711057244e-11
investigate O 0 7.296848680837797e-10
the O 0 6.428656218471218e-11
mechanism O 0 3.6205691222868097e-10
of O 0 9.706801334941062e-12
the O 0 5.0110277038939444e-11
expansion O 0 2.2241881669771146e-09
mutation O 0 1.8947969859794966e-09
in O 0 2.834497046799722e-11
the O 0 3.458764871733244e-11
Japanese O 0 1.6826560145233316e-09
population O 0 1.486797213123836e-10
we O 0 2.3695953532687497e-10
have O 0 1.5440852763060064e-10
studied O 0 1.6322149187786295e-09
90 O 0 1.0326817179162617e-09
Japanese O 0 7.640741728209832e-08
DM B-Disease 1 0.9999998807907104
families O 0 2.701332046939342e-09
comprising O 0 1.2366113688599967e-09
190 O 0 3.505993273478225e-09
affected O 0 1.0799549698958799e-08
and O 0 5.0648334415370755e-09
130 O 0 2.446132363331799e-08
unaffected O 0 8.584030979363888e-07
members O 0 5.234429778511185e-08
. O 0 3.069999081617425e-07

The O 0 8.843269228009376e-08
results O 0 1.2766091117555334e-07
suggest O 0 1.0924246396371018e-08
that O 0 4.350296789468189e-10
a O 0 3.8385741807367424e-10
few O 0 2.8439877119978973e-09
common O 0 1.3951676480772335e-09
ancestral O 0 1.7144573760674575e-08
mutations O 0 2.813541186696966e-07
in O 0 1.4076450005617858e-09
both O 0 4.556822474910405e-09
Caucasian O 0 2.8774147722288035e-06
and O 0 6.479676795123623e-09
Japanese O 0 9.62618962319084e-09
populations O 0 5.2086717161614615e-09
have O 0 1.3742969262597882e-10
originated O 0 1.439042635054122e-10
by O 0 1.567293864135344e-11
expansion O 0 9.206311823994895e-10
of O 0 2.1850760784092316e-11
an O 0 7.72880578980839e-11
ancestral O 0 1.9006289875278526e-08
n O 0 1.3175330195736024e-06
= O 0 1.4780735568820091e-07
5 O 0 3.7466318936196785e-09
repeat O 0 8.950360808057667e-08
to O 0 1.6500097954619264e-09
n O 0 2.0573729386796913e-07
= O 0 2.198985811219245e-07
19 O 0 1.3818103994367448e-08
- O 0 1.411326735478724e-07
37 O 0 1.2669446824986608e-08
copies O 0 7.219662023771889e-08
. O 0 2.0509041576133313e-07

These O 0 2.5561423200315403e-08
data O 0 2.535060517061538e-08
support O 0 3.2738343147542537e-09
multistep O 0 2.676965777936857e-07
models O 0 4.522372520909812e-08
of O 0 1.3933747211591907e-10
triplet O 0 2.936308476364502e-07
repeat O 0 1.2276399274924188e-07
expansion O 0 2.5983857288025547e-09
that O 0 4.941013917458825e-11
have O 0 1.451502529281612e-10
been O 0 6.154060594454336e-11
proposed O 0 9.943043610682878e-11
for O 0 1.3054561598391246e-10
both O 0 3.462697861777997e-08
DM B-Disease 1 1.0
and O 0 1.8522017342093022e-07
Friedreichs B-Disease 0 6.4008331719378475e-06
ataxia I-Disease 0 1.5126277503441088e-05
. O 0 8.510655646887244e-08
. O 0 5.103908051751205e-07

The O 0 2.8941691709860606e-08
molecular O 0 3.487255071377149e-07
basis O 0 3.2598109100945294e-07
of O 0 4.7075312181732443e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.2289237950067218e-09
the O 0 3.4694175310434616e-10
western O 0 9.915479104449787e-09
Cape O 0 2.3702215301568685e-08
, O 0 2.192513504084559e-09
South O 0 3.3055350456834276e-08
Africa O 0 5.232143607258877e-08
. O 0 8.334351520034033e-08

Deficiency B-Disease 1 0.999229907989502
of I-Disease 0 2.528896869691266e-09
the I-Disease 0 2.572584811844081e-09
sixth I-Disease 0 2.6270511099824034e-08
component I-Disease 0 4.2679737077833124e-08
of I-Disease 0 3.304018725280855e-10
human I-Disease 0 2.56858889713385e-09
complement I-Disease 0 3.9741010482430283e-08
( O 0 9.113575449859468e-10
C6 O 0 9.84244934443268e-08
) O 0 3.982246477018947e-10
has O 0 7.458911821522918e-10
been O 0 2.368792273443887e-09
reported O 0 2.205376992137076e-09
in O 0 9.803951400710886e-11
a O 0 1.0814935752501142e-10
number O 0 3.095242673278875e-10
of O 0 5.6895346073337905e-11
families O 0 2.40352987512793e-10
from O 0 7.603397078614904e-11
the O 0 1.6398686575325172e-10
western O 0 1.5100740213824793e-08
Cape O 0 3.446679386343021e-08
, O 0 2.021487865988547e-09
South O 0 2.323286985017603e-08
Africa O 0 5.903170219312415e-08
. O 0 1.0063602928767068e-07

Meningococcal B-Disease 1 0.9895564913749695
disease I-Disease 0 0.07048048824071884
is O 0 2.110790298104348e-08
endemic O 0 1.4091608768751485e-08
in O 0 5.657819213134019e-10
the O 0 1.9503659798303374e-10
Cape O 0 2.2317565573359843e-09
and O 0 1.1399233640352335e-10
almost O 0 9.745745183087351e-11
all O 0 4.456050459178407e-11
pedigrees O 0 3.091776079600095e-08
of O 0 3.173980633874862e-09
total O 0 0.028253920376300812
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 9.489479202429152e-10
C6Q0 O 0 7.757409292707962e-08
) O 0 1.4712675522332574e-10
have O 0 1.5455289825716534e-10
been O 0 5.454590112918822e-10
ascertained O 0 3.020443273271667e-08
because O 0 5.494837029829114e-09
of O 0 2.513000696424683e-09
recurrent O 0 0.15177980065345764
disease O 0 0.00010674526129150763
. O 0 6.001514520903584e-07

We O 0 8.541665579286928e-07
have O 0 7.591897777103895e-09
sequenced O 0 1.973275409739017e-08
the O 0 4.4718806435639635e-10
expressed O 0 9.121888244756349e-10
exons O 0 5.242672784788738e-08
of O 0 1.907120017463626e-10
the O 0 9.106451148710448e-10
C6 O 0 9.174801363087681e-08
gene O 0 3.7086438364752894e-09
from O 0 5.627069296632037e-11
selected O 0 1.081541037284417e-10
cases O 0 3.13581660638107e-10
and O 0 4.684578280844676e-10
have O 0 5.323003704482687e-10
found O 0 8.886580360467633e-10
three O 0 6.521532203151992e-10
molecular O 0 4.897485723631689e-07
defects O 0 0.42805561423301697
leading O 0 1.4447975260623025e-08
to O 0 3.1793732091500715e-09
total O 0 1.5070384051796282e-08
deficiency O 0 1.2122992302465718e-05
879delG O 0 2.395880187577859e-07
, O 0 4.1522860150244867e-10
which O 0 2.4858926028770156e-10
is O 0 1.6727354223977642e-10
the O 0 1.3690121258846943e-10
common O 0 4.304704148694327e-09
defect O 0 2.653829369592131e-07
in O 0 6.213140557598251e-10
the O 0 5.79747250206708e-10
Cape O 0 1.1815643574664136e-08
and O 0 4.022346622445383e-10
hitherto O 0 2.9810550472575414e-08
unreported O 0 3.915967639045448e-08
, O 0 3.570098661143106e-10
and O 0 2.73368938596974e-10
1195delC O 0 1.6557514470605383e-08
and O 0 1.8311650806790425e-10
1936delG O 0 2.1224090929194972e-08
, O 0 8.467960360691862e-11
which O 0 1.4076174947863507e-10
have O 0 6.27183971424472e-10
been O 0 1.5951621135101846e-09
previously O 0 1.1123464815909756e-08
reported O 0 7.215185782172284e-09
in O 0 1.2725553943937484e-09
African O 0 2.1146506767877327e-08
- O 0 2.6688571779232007e-06
Americans O 0 4.2191919646938914e-07
. O 0 9.612596585384381e-08

We O 0 8.784612646195455e-07
also O 0 3.7080991610594083e-09
show O 0 4.067612913161156e-09
that O 0 1.4526990721464017e-10
the O 0 1.8327935003004114e-10
879delG O 0 1.4153299332519964e-07
and O 0 5.192424268329887e-09
1195delC O 0 7.033771453279769e-06
defects O 0 0.1327117383480072
are O 0 1.726269238666589e-09
associated O 0 1.6606886532599674e-08
with O 0 9.338390505320149e-09
characteristic O 0 0.033528152853250504
C6 O 1 0.9971983432769775
/ O 0 0.0007200038526207209
C7 O 0 3.648556230473332e-05
region O 0 2.6921321705231094e-07
DNA O 0 5.70297686408594e-07
marker O 0 2.676965777936857e-07
haplotypes O 0 7.033477800177934e-07
, O 0 2.4951665178463145e-09
although O 0 5.926531265743051e-09
small O 0 5.79574033210406e-09
variations O 0 1.2096090529212233e-07
were O 0 2.779894536786287e-08
observed O 0 3.156514196689386e-07
. O 0 3.007451709891029e-07

The O 0 1.3649049890318565e-07
1936delG O 0 4.623070708476007e-06
defect O 0 2.0135307750024367e-06
was O 0 4.244615325887935e-09
observed O 0 1.898403656497294e-09
only O 0 2.271652727037221e-10
once O 0 7.204568941432399e-09
in O 0 4.696558142391893e-10
the O 0 8.142289065204977e-10
Cape O 0 1.2412388450400158e-08
, O 0 3.6174077622241896e-10
but O 0 9.499511177679665e-10
its O 0 5.993278651139633e-10
associated O 0 7.218433850653128e-09
haplotype O 0 3.581860994472663e-07
could O 0 3.380672097819115e-08
be O 0 5.784696277544299e-09
deduced O 0 3.9706694110464014e-07
. O 0 7.806986701552887e-08

The O 0 6.87488377337786e-09
data O 0 6.712579381229489e-09
from O 0 2.005939025995218e-10
the O 0 1.2768679169550268e-10
haplotypes O 0 4.9145914005066516e-08
indicate O 0 9.997460637123368e-09
that O 0 1.1932040078210804e-10
these O 0 3.490178701603952e-10
three O 0 5.493859811522839e-10
molecular O 0 9.035279049385281e-07
defects O 0 0.0004943451494909823
account O 0 5.557879934059429e-09
for O 0 7.135612101194511e-10
the O 0 1.853178943633793e-09
defects O 0 0.03235451132059097
in O 0 3.4801012072094295e-10
all O 0 1.22174229066907e-10
the O 0 1.875240795978783e-10
38 O 0 1.8172762183965574e-09
unrelated O 0 6.0077827157556385e-09
C6Q0 O 0 1.5088971849763766e-07
individuals O 0 8.506103599259518e-10
we O 0 1.0670794248213156e-09
have O 0 1.718207104373093e-10
studied O 0 2.1153798712703065e-09
from O 0 2.995986236875581e-10
the O 0 2.288689238127972e-09
Cape O 0 1.5362383010142366e-07
. O 0 1.2759640810600104e-07

We O 0 1.2443629202607553e-06
have O 0 8.804756923552759e-09
also O 0 9.339917728112823e-10
observed O 0 2.4199393600099484e-09
the O 0 6.189000423262314e-10
879delG O 0 4.339163979238947e-07
defect O 0 3.345642198837595e-07
in O 0 1.638409519166828e-09
two O 0 2.463297050780966e-07
Dutch O 1 0.9999991655349731
C6 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 1.0
kindreds O 0 7.3072005761787295e-06
, O 0 1.0274184836234213e-09
but O 0 6.041309674742479e-10
the O 0 2.393269193934344e-10
879delG O 0 1.3643895613313362e-07
defect O 0 8.338469825730499e-08
in O 0 2.4082794092272763e-10
the O 0 1.2390898029845943e-10
Cape O 0 1.9270489648448574e-09
probably O 0 7.586741235243721e-10
did O 0 3.728294895033457e-10
not O 0 1.070205521425116e-10
come O 0 1.544441657896911e-10
from O 0 1.0055626470384382e-10
The O 0 3.364727940713408e-10
Netherlands O 0 2.3388467695895088e-07
. O 0 6.480764369598546e-09
. O 0 6.505933924927376e-08

Complement B-Disease 1 0.9934647679328918
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 7.15703194487105e-08
seven O 0 6.532914653689659e-09
further O 0 8.400068196579014e-09
molecular O 0 6.299147935351357e-05
defects O 1 0.9999351501464844
and O 0 4.1513395387937635e-08
their O 0 1.5729623825677663e-08
associated O 0 5.996131449137465e-07
marker O 0 1.772059295035433e-05
haplotypes O 0 0.0001500966609455645
. O 0 1.8865705442294711e-06

Seven O 0 2.761378254945157e-07
further O 0 2.4895962624782442e-08
molecular O 0 2.4451205149489397e-07
bases O 0 8.995969551506278e-07
of O 0 1.1704254347932874e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 4.9904709698012084e-08
described O 0 2.990742871133989e-07
. O 0 3.572855007405451e-07

All O 0 2.385879049882078e-08
these O 0 5.373050004919833e-09
new O 0 2.3015076067167684e-08
molecular O 0 5.813456596115429e-07
defects O 0 4.683110091718845e-06
involve O 0 2.930877229800899e-08
single O 0 5.08436848178917e-08
- O 0 3.4590152608870994e-07
nucleotide O 0 1.7797373175199027e-07
events O 0 3.080531829624533e-09
, O 0 1.1517248960091209e-10
deletions O 0 3.004365423109334e-09
and O 0 2.0914397991234068e-10
substitutions O 0 8.277549756741109e-10
, O 0 7.631015958020626e-11
some O 0 2.469648270608804e-11
of O 0 4.3962215812154426e-11
which O 0 2.116296027310227e-09
alter O 0 2.3593295850332652e-07
splice O 0 1.6763469545821863e-07
sites O 0 3.1570404956937637e-08
, O 0 1.3991517944234033e-09
and O 0 3.1186460081045198e-09
others O 0 2.7725446827275846e-08
codons O 0 2.0726286038552644e-06
. O 0 2.0975386405552854e-07

They O 0 8.850457788867061e-08
are O 0 5.495117139098227e-10
distributed O 0 6.815344955057867e-10
along O 0 2.1252921644787648e-09
the O 0 1.316049602628766e-09
C7 O 0 2.0481269302763394e-07
gene O 0 1.8147417790714826e-08
, O 0 8.405112161824491e-10
but O 0 1.0076866008290608e-09
predominantly O 0 3.2234841462752684e-09
towards O 0 2.092705786438387e-09
the O 0 2.3070136911940153e-09
3 O 0 1.2433997831351462e-08
end O 0 1.618007701154056e-07
. O 0 1.6965957172487833e-07

All O 0 2.8239083960102107e-08
were O 0 5.0738551138351795e-09
found O 0 1.9433006315239254e-09
in O 0 1.0718158582889714e-09
compound O 0 1.0027523700273377e-07
heterozygous O 0 1.4216882391338004e-06
individuals O 0 5.636068323155996e-08
. O 0 3.570729347757151e-07

The O 0 7.374983397312462e-06
C6 O 0 0.006042391061782837
/ O 0 0.0003022763703484088
C7 O 0 5.080376286059618e-05
marker O 0 2.0477941689023282e-06
haplotypes O 0 2.931310746134841e-06
associated O 0 7.979953409176233e-08
with O 0 6.156496645814968e-09
most O 0 2.1923061410689115e-07
C7 B-Disease 0 0.14220328629016876
defects I-Disease 1 0.9576032161712646
are O 0 8.380080629422082e-09
tabulated O 0 6.084466690481349e-07
. O 0 2.7845855399277752e-08
. O 0 1.8051761685455858e-07

A O 0 1.508249738435552e-07
genome O 0 4.026258011435857e-07
- O 0 1.2522102679213276e-06
wide O 0 1.9939555784276308e-08
search O 0 2.6850752732343608e-08
for O 0 2.873929982882828e-09
chromosomal O 0 5.469615189213073e-06
loci O 0 1.0365815796831157e-06
linked O 0 9.30001351662213e-06
to O 0 1.265191968968793e-07
mental O 0 0.004637574311345816
health O 0 2.7806112257167115e-07
wellness O 0 4.6258396224629905e-08
in O 0 2.20927026672868e-10
relatives O 0 1.5173750034236377e-09
at O 0 2.4212782889776463e-09
high O 0 2.2184227788102362e-08
risk O 0 5.484625376084296e-07
for O 0 3.78060027728111e-09
bipolar B-Disease 1 0.6421160697937012
affective I-Disease 0 0.19548918306827545
disorder I-Disease 1 0.9574875831604004
among O 0 3.2345962353019786e-08
the O 0 5.342270625874335e-09
Old O 0 3.2814555197546724e-06
Order O 0 9.951101986871436e-08
Amish O 0 5.871207122254418e-06
. O 0 5.753486789217277e-07

Bipolar B-Disease 1 0.9999927282333374
affective I-Disease 1 0.9998660087585449
disorder I-Disease 1 0.999980092048645
( O 0 9.447721254218777e-07
BPAD B-Disease 1 1.0
; O 0 3.0556850106222555e-05
manic B-Disease 1 0.9999992847442627
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 0.9997839331626892
) O 0 5.492922383609766e-08
is O 0 1.0606165945503676e-09
characterized O 0 2.462759551846716e-09
by O 0 2.0784994558820102e-10
episodes O 0 3.865387299128997e-08
of O 0 5.832876959210864e-10
mania B-Disease 0 4.273853392078308e-06
and O 0 1.765536161713044e-08
/ O 0 4.484706153107254e-07
or O 0 2.6264649122254013e-08
hypomania B-Disease 0 3.85485918741324e-06
interspersed O 0 1.1435497526690597e-07
with O 0 2.4782245144905346e-09
periods O 0 4.76513918101773e-07
of O 0 2.6706157285616428e-08
depression B-Disease 0 2.72559864242794e-05
. O 0 7.838728492970404e-07

Compelling O 0 1.0450722811583546e-06
evidence O 0 7.640682753162764e-08
supports O 0 3.226973532832744e-08
a O 0 1.0305193365311993e-09
significant O 0 1.6143163472648325e-09
genetic O 0 2.0178175574869783e-08
component O 0 2.393888109963882e-08
in O 0 5.49492840118404e-10
the O 0 1.1411944722539147e-09
susceptibility O 0 3.17642331992829e-07
to O 0 4.320103741406456e-08
develop O 0 4.476601588976337e-06
BPAD B-Disease 1 0.9999992847442627
. O 0 9.201226021104958e-07

To O 0 2.2125153265051267e-08
date O 0 4.811589704445396e-08
, O 0 3.6145661463926615e-10
however O 0 4.088924199230348e-10
, O 0 8.440064619419374e-11
linkage O 0 5.70241454056486e-09
studies O 0 1.958747608554745e-09
have O 0 1.5771967065703052e-10
attempted O 0 8.138733575968615e-10
only O 0 8.837287845953057e-11
to O 0 3.2167632446622463e-10
identify O 0 5.229420452224076e-08
chromosomal O 0 2.6790344236360397e-06
loci O 0 4.5943078674781646e-08
that O 0 1.0801604055643566e-09
cause O 0 1.997597642855453e-09
or O 0 5.317567275398005e-09
increase O 0 2.581472990925704e-08
the O 0 1.1474985406323412e-08
risk O 0 7.723268936388195e-06
of O 0 3.1896383312357557e-09
developing O 0 3.963060862588463e-06
BPAD B-Disease 1 1.0
. O 0 2.205703594881925e-06

To O 0 1.1921269305048554e-08
determine O 0 1.296526974670087e-08
whether O 0 1.4894802058407208e-09
there O 0 2.561449385929393e-10
could O 0 1.815834926865989e-09
be O 0 2.083862249424584e-10
protective O 0 4.3945327377059584e-09
alleles O 0 5.6691211725024004e-09
that O 0 2.0034000847157785e-10
prevent O 0 8.257873496120283e-09
or O 0 2.0006375223147188e-08
reduce O 0 1.1287738743703812e-07
the O 0 1.4695630268235504e-09
risk O 0 5.405761882570914e-08
of O 0 3.184322250326943e-11
developing O 0 2.3143265082126163e-08
BPAD B-Disease 1 1.0
, O 0 4.13002548826924e-11
similar O 0 4.154066327033412e-11
to O 0 3.8633179988423194e-11
what O 0 1.4403277182051255e-10
is O 0 4.351273508174103e-11
observed O 0 3.5594507896696825e-10
in O 0 7.515058714213652e-11
other O 0 3.545697291329475e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 5.88951110103153e-10
we O 0 9.224099262183927e-10
used O 0 4.25791562008726e-08
mental O 0 7.0948349275568034e-06
health O 0 2.3286904848873746e-08
wellness O 0 1.1895489038238338e-08
( O 0 1.245306913144617e-10
absence O 0 6.305280186857942e-10
of O 0 6.245943345861704e-11
any O 0 5.806785807749293e-08
psychiatric B-Disease 1 0.677249014377594
disorder I-Disease 0 0.00045764754759147763
) O 0 1.2334877563802138e-09
as O 0 4.671052433735667e-10
the O 0 1.2098698709550604e-09
phenotype O 0 1.216116970681469e-06
in O 0 3.2985045805844493e-09
our O 0 5.486155529865755e-09
genome O 0 9.457519212219268e-09
- O 0 1.0232439962010176e-07
wide O 0 7.290105852320039e-09
linkage O 0 1.1994498549938726e-07
scan O 0 8.236011126427911e-07
of O 0 8.506163134969214e-11
several O 0 5.193560581595591e-10
large O 0 8.111044280667556e-09
multigeneration O 0 4.422447818797082e-05
Old O 0 8.636345683044055e-07
Order O 0 6.345458825052219e-09
Amish O 0 2.2121867004898377e-07
pedigrees O 0 1.2620057532330975e-07
exhibiting O 0 2.954349120898314e-08
an O 0 1.9180868005008733e-09
extremely O 0 7.24704847243629e-08
high O 0 1.2665407211898128e-06
incidence O 0 0.0008957743411883712
of O 0 1.940972254033113e-07
BPAD B-Disease 1 1.0
. O 0 1.7722488792060176e-06

We O 0 1.2286956234675017e-06
have O 0 4.263212005639616e-09
found O 0 1.7651952122221815e-09
strong O 0 1.447232222950845e-09
evidence O 0 2.5048845220254634e-09
for O 0 2.9042082627661614e-10
a O 0 2.0160433322757854e-09
locus O 0 8.491099379170919e-07
on O 0 1.0288626128840406e-07
chromosome O 0 3.644696334959008e-05
4p O 0 0.0006018135463818908
at O 0 2.7814007097504145e-08
D4S2949 O 0 1.629827295346331e-07
( O 0 9.871581330145318e-10
maximum O 0 3.579864849001524e-09
GENEHUNTER O 0 3.8613975448242854e-06
- O 0 1.2755082252624561e-06
PLUS O 0 1.0946003214939992e-07
nonparametric O 0 3.223194369184057e-07
linkage O 0 1.5059644908888004e-07
score O 0 3.227398437388729e-08
= O 0 5.2029260899644214e-08
4 O 0 1.9783772398085375e-09
. O 0 1.4716134977277306e-09
05 O 0 1.9660741656934988e-07
, O 0 1.707889607516222e-09
P O 0 1.1413710581109626e-06
= O 0 5.147108339542683e-08
5 O 0 1.3428000933402018e-09
. O 0 4.293050359649442e-10
22 O 0 3.728138353586985e-10
x O 0 1.6403175706614093e-08
10 O 0 8.318257194162015e-10
( O 0 3.2837763064286207e-10
- O 0 4.992032245354494e-07
4 O 0 3.6437235451103334e-09
) O 0 6.50102749411019e-10
; O 0 1.326839638160493e-09
SIBPAL O 0 3.141435911402368e-07
Pempirical O 0 9.467629524806398e-08
value O 0 6.33393515414582e-09
< O 0 7.347955577330367e-09
3 O 0 3.894660149939e-10
x O 0 1.3023313982785112e-08
10 O 0 1.1162650803697716e-09
( O 0 2.596284021105788e-10
- O 0 8.710684795687484e-08
5 O 0 6.26442731022081e-10
) O 0 1.009833397458415e-10
) O 0 5.276804340703656e-11
and O 0 4.588591312471024e-11
suggestive O 0 6.3353731150073145e-09
evidence O 0 2.575383239999951e-09
for O 0 1.1720596715392162e-10
a O 0 6.072223834863166e-10
locus O 0 3.755097282009956e-07
on O 0 4.068670378387651e-08
chromosome O 0 5.124934250488877e-05
4q O 1 0.9075866341590881
at O 0 2.1995852250711323e-08
D4S397 O 0 2.879281737477868e-07
( O 0 7.953248060132978e-10
maximum O 0 4.221040850183044e-09
GENEHUNTER O 0 2.081050070046331e-06
- O 0 5.932957947152318e-07
PLUS O 0 4.176587609094895e-08
nonparametric O 0 2.3920011926747975e-07
linkage O 0 1.4405989645638329e-07
score O 0 2.017536715470669e-08
= O 0 2.782382502175551e-08
3 O 0 8.061500356149054e-10
. O 0 4.0757031083415995e-10
29 O 0 3.5267577747077894e-09
, O 0 6.383962802836152e-10
P O 0 1.2085303069397924e-06
= O 0 3.277372329080208e-08
2 O 0 9.614368190469236e-10
. O 0 2.630066719966351e-10
57 O 0 1.2284256944994354e-09
x O 0 2.9584880323341167e-08
10 O 0 7.678675473243857e-10
( O 0 5.600079844292338e-10
- O 0 8.11050369975419e-07
3 O 0 7.393110124098712e-09
) O 0 9.417499002850604e-10
; O 0 1.0577539955036741e-09
SIBPAL O 0 1.2910798830034764e-07
Pempirical O 0 7.976346694249514e-08
value O 0 4.037052026006904e-09
< O 0 7.605188478976288e-09
1 O 0 2.901030526913928e-10
x O 0 1.0712237319410178e-08
10 O 0 4.5289796912761915e-10
( O 0 9.74089420235913e-11
- O 0 3.1444564285720844e-08
3 O 0 4.3676484651200553e-10
) O 0 3.956948310679387e-11
) O 0 1.174959868982528e-11
that O 0 1.1367354106617267e-11
are O 0 1.0201615940896858e-10
linked O 0 1.1485632711583094e-07
to O 0 2.62237520587405e-08
mental O 0 1.448177863494493e-05
health O 0 5.013750978832832e-07
wellness O 0 1.8586508758744458e-06
. O 0 2.657745028500358e-07

These O 0 3.6506538236835695e-08
findings O 0 1.967322660334503e-08
are O 0 1.5735548974937785e-10
consistent O 0 6.405599939363071e-10
with O 0 2.5579819512566715e-11
the O 0 3.411434676414693e-11
hypothesis O 0 1.9630561620687104e-09
that O 0 2.9429500503219685e-11
certain O 0 1.2596641785211915e-10
alleles O 0 1.1116295439705937e-08
could O 0 8.086900038506428e-09
prevent O 0 5.440503603182378e-09
or O 0 1.519155912177439e-09
modify O 0 2.2511628117172222e-08
the O 0 3.446149754449124e-10
clinical O 0 3.688871075269162e-08
manifestations O 0 1.1150697254436182e-08
of O 0 2.366695450728429e-10
BPAD B-Disease 1 1.0
and O 0 1.010105554755114e-09
perhaps O 0 1.900903656704145e-09
other O 0 1.197545618225604e-09
related O 0 6.566283445863519e-07
affective B-Disease 0 0.00975810457020998
disorders I-Disease 0 0.032759662717580795
. O 0 8.250318046520988e-07

Segregation O 0 0.00027845066506415606
distortion O 0 0.00014578957052435726
in O 0 3.178133965775487e-06
myotonic B-Disease 1 0.9999924898147583
dystrophy I-Disease 1 0.9999939203262329
. O 0 1.8923614334198646e-05

Myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999997615814209
( O 0 3.9126211049733683e-05
DM B-Disease 1 1.0
) O 0 1.5189863233899814e-07
is O 0 3.754457633675656e-09
an O 0 4.541845566308211e-09
autosomal B-Disease 1 0.5932750701904297
dominant I-Disease 1 0.999143123626709
disease I-Disease 0 0.010774560272693634
which O 0 1.2374188784747275e-08
, O 0 2.9500554776795695e-10
in O 0 1.8814388935695092e-10
the O 0 1.8723959882560592e-10
typical O 0 7.1956014480178965e-09
pedigree O 0 5.487178214025334e-07
, O 0 2.875809312907762e-10
shows O 0 3.186366948071395e-09
a O 0 6.979308797561146e-10
three O 0 2.8231958992819273e-09
generation O 0 1.1515881226387137e-07
anticipation O 0 2.647888379669894e-07
cascade O 0 3.5196444514440373e-06
. O 0 7.382164426417148e-07

This O 0 2.697230172543641e-08
results O 0 1.4428016470446892e-07
in O 0 1.763826418255121e-08
infertility B-Disease 0 0.01952335052192211
and O 0 6.58292435673502e-07
congenital B-Disease 1 0.999988317489624
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.791414317471208e-07
CDM B-Disease 0 2.4788034806988435e-06
) O 0 1.5193761804255246e-09
with O 0 9.20757151079421e-11
the O 0 3.3734418036779346e-10
disappearance O 0 6.85171599457135e-08
of O 0 3.0253313187955655e-09
DM B-Disease 1 1.0
in O 0 1.529889281925989e-08
that O 0 8.11319456062165e-09
pedigree O 0 5.744857844547369e-06
. O 0 2.835962220615329e-07

The O 0 1.745359767824084e-08
concept O 0 1.55281725255918e-08
of O 0 6.067199520565225e-10
segregation O 0 4.145571352864863e-08
distortion O 0 8.023740605267449e-08
, O 0 1.171849561831806e-10
where O 0 1.2024109485864187e-10
there O 0 4.108748410946994e-11
is O 0 5.6981905305342195e-11
preferential O 0 5.5840514434635224e-09
transmission O 0 9.901153674718444e-09
of O 0 3.129302372784082e-11
the O 0 9.07478536760209e-11
larger O 0 6.4478693495573225e-09
allele O 0 9.259061783950528e-08
at O 0 6.797952423198694e-09
the O 0 3.460642439279127e-09
DM B-Disease 1 1.0
locus O 0 6.792976705582987e-07
, O 0 2.4280486510264154e-09
has O 0 2.661435960504832e-09
been O 0 2.222593442624543e-09
put O 0 1.897161983066553e-09
forward O 0 2.0061925454228913e-09
to O 0 4.998573222003699e-10
explain O 0 1.7226847504048237e-08
partially O 0 1.271234566502244e-07
the O 0 6.085766335317544e-10
maintenance O 0 2.9957664793300864e-08
of O 0 9.097909647870495e-10
DM B-Disease 1 1.0
in O 0 6.906953675667182e-09
the O 0 5.4718807263043345e-09
population O 0 9.094291186784176e-08
. O 0 2.0419345503341901e-07

In O 0 9.336523731917623e-08
a O 0 6.42358877200877e-09
survey O 0 6.407280039866237e-08
of O 0 1.3643832730281247e-09
DM B-Disease 1 1.0
in O 0 2.458011749695288e-08
Northern O 0 5.924946435698075e-07
Ireland O 0 3.237076498407987e-06
, O 0 5.743917341760607e-09
59 O 0 2.942618060330915e-08
pedigrees O 0 6.018175895405875e-07
were O 0 6.829886700643328e-08
ascertained O 0 5.037512892158702e-06
. O 0 4.351641678113083e-07

Sibships O 0 3.174722223775461e-05
where O 0 1.0891004365021217e-07
the O 0 4.5016274041742577e-10
status O 0 2.386687736333215e-09
of O 0 2.205698818036339e-11
all O 0 1.824581978560058e-11
the O 0 1.1423169701818559e-11
members O 0 5.5775738194707714e-11
had O 0 1.5367642713925989e-09
been O 0 7.714259231406118e-10
identified O 0 1.1810253885968791e-09
were O 0 1.5704845757191777e-10
examined O 0 2.4510347085282547e-09
to O 0 7.799949575115761e-11
determine O 0 1.1113406861440467e-09
the O 0 8.481441243768373e-11
transmission O 0 9.537115097657534e-09
of O 0 3.127846592843042e-11
the O 0 2.5870363629110216e-09
DM B-Disease 1 1.0
expansion O 0 1.1822181456011549e-08
from O 0 4.3929379578422356e-10
affected O 0 4.479933313206175e-09
parents O 0 2.4416839661256518e-09
to O 0 3.0841046383400794e-10
their O 0 5.523018042907779e-09
offspring O 0 5.906199476157781e-07
. O 0 2.3385190672797762e-07

Where O 0 2.9914332344560535e-07
the O 0 9.258440236692422e-09
transmitting O 0 4.87869010612485e-06
parent O 0 3.921524694305845e-06
was O 0 8.086085045988511e-08
male O 0 2.114618951054581e-07
, O 0 1.5391117713647873e-08
58 O 0 1.9651069749215822e-07
. O 0 2.1968708097119816e-07

3 O 0 4.402891136123799e-07
% O 0 1.0401643990576304e-08
of O 0 5.355507703974638e-11
the O 0 1.8704469917363298e-10
offspring O 0 9.030368453011306e-09
were O 0 3.217114574738389e-09
affected O 0 1.061885801512119e-09
, O 0 1.2133033466810161e-10
and O 0 1.6972891148103741e-10
in O 0 7.767673310121737e-11
the O 0 7.09649145003155e-11
case O 0 1.7822527897948248e-09
of O 0 3.448883539869385e-11
a O 0 1.3724823499927652e-09
female O 0 1.1715315650917546e-07
transmitting O 0 7.091575298545649e-06
parent O 0 8.982578378891048e-07
, O 0 6.4945742117572536e-09
68 O 0 2.0947439338669938e-07
. O 0 2.7696648885466857e-07

7 O 0 3.5179361930204323e-06
% O 0 1.0129965488658854e-07
were O 0 2.13759516753953e-08
affected O 0 2.0214797302742227e-07
. O 0 5.778771310360753e-07

Studies O 0 1.4939100765332114e-06
on O 0 9.634804065683511e-09
meiotic O 0 6.566734782609274e-07
drive O 0 8.264683515335491e-08
in O 0 1.298982343911348e-08
DM B-Disease 1 1.0
have O 0 4.319821389486833e-09
shown O 0 1.3663572495659082e-09
increased O 0 5.512396650253493e-10
transmission O 0 5.324285456964617e-09
of O 0 2.8025965229105942e-11
the O 0 7.546183816709018e-11
larger O 0 6.274068375944353e-09
allele O 0 1.7489431058947957e-07
at O 0 8.463867828822913e-09
the O 0 6.005193231573003e-09
DM B-Disease 1 0.9999998807907104
locus O 0 1.78638038050849e-06
in O 0 1.8021344416752072e-08
non O 0 4.6375491365324706e-05
- O 0 0.03195158392190933
DM O 1 0.9999994039535522
heterozygotes O 0 5.418641649157507e-06
for O 0 9.826989000316644e-09
CTGn O 0 4.434992661117576e-06
. O 0 2.6212509851575305e-07

This O 0 2.2954315781475998e-08
study O 0 9.295562541922209e-09
provides O 0 1.1321019677268396e-09
further O 0 1.54642534888616e-10
evidence O 0 7.412153113506292e-10
that O 0 3.342787158189253e-10
the O 0 1.615887534889282e-09
DM B-Disease 1 1.0
expansion O 0 2.1856754628402086e-08
tends O 0 1.4443952700560203e-08
to O 0 1.5797227415070836e-10
be O 0 5.315232143310311e-10
transmitted O 0 2.3296680140560966e-08
preferentially O 0 2.3938886783980706e-07
. O 0 1.0933985095107346e-07

Diagnosis O 0 0.48368358612060547
of O 0 4.626590452971868e-06
hemochromatosis B-Disease 1 0.9999994039535522
. O 0 3.7346275348681957e-05

If O 0 2.4160863176803105e-06
untreated O 0 6.516516805277206e-06
, O 0 1.738508892401569e-08
hemochromatosis B-Disease 1 1.0
can O 0 0.00015207898104563355
cause O 0 2.708089368752553e-06
serious O 0 0.0007817120058462024
illness O 0 0.0002082052087644115
and O 0 1.2278167371704285e-09
early B-Disease 0 4.8129087382164926e-09
death I-Disease 0 2.1549964035472158e-09
, O 0 5.406787795259049e-10
but O 0 6.6678920163099065e-09
the O 0 1.4777705725776968e-09
disease O 0 9.009004742210891e-08
is O 0 6.439704325345019e-10
still O 0 1.886730416345017e-08
substantially O 0 7.21458235375394e-08
under O 0 1.326835672443849e-07
- O 1 0.9582301378250122
diagnosed O 0 0.0005560910212807357
. O 0 1.5568244293717726e-07

The O 0 1.950446026910413e-08
cornerstone O 0 7.743676633253926e-08
of O 0 2.2560951717931488e-10
screening O 0 1.1739849981040607e-08
and O 0 1.427931106690039e-10
case O 0 3.9904274329316536e-10
detection O 0 4.572310974282345e-09
is O 0 1.5284323806596944e-10
the O 0 2.037209290151054e-10
measurement O 0 8.825711006466008e-08
of O 0 1.1514004194523864e-09
serum O 0 2.153268354732063e-07
transferrin O 0 5.838269885316549e-07
saturation O 0 2.5462162511757924e-07
and O 0 3.3900331430913866e-09
the O 0 2.4186472824538896e-09
serum O 0 3.520805478274269e-07
ferritin O 0 1.107623211282771e-05
level O 0 7.358336233664886e-07
. O 0 3.0495030500787834e-07

Once O 0 1.0115367103935569e-06
the O 0 5.985935747077065e-09
diagnosis O 0 2.2331641957862303e-06
is O 0 1.7606122115765288e-09
suspected O 0 3.5237212614447344e-07
, O 0 1.5074430592676435e-09
physicians O 0 1.2205510380169926e-08
must O 0 3.625387323680229e-09
use O 0 2.6282739540306466e-08
serum O 0 1.0592959824862191e-06
ferritin O 0 4.239580812281929e-05
levels O 0 3.423313955863705e-06
and O 0 4.596534353140669e-08
hepatic O 0 1.069596783054294e-05
iron O 0 2.0300052710808814e-05
stores O 0 2.1111259229655843e-06
on O 0 8.486887637104701e-09
liver O 0 1.3386980413088168e-07
biopsy O 0 4.568608460431278e-07
specimens O 0 6.245556516404349e-09
to O 0 6.441412403468405e-10
assess O 0 6.24971789875417e-08
patients O 0 1.6420203863276583e-08
for O 0 1.411548239405036e-10
the O 0 3.997222552953872e-10
presence O 0 4.5169066709149774e-08
of O 0 6.840065847057986e-09
iron B-Disease 0 0.014668836258351803
overload I-Disease 0 3.557344825821929e-05
. O 0 5.973688530502841e-07

Liver O 0 0.0008351189317181706
biopsy O 1 0.7729704976081848
is O 0 1.2595500642476054e-08
also O 0 2.2814790334724222e-10
used O 0 5.731132235453629e-10
to O 0 9.438984316378907e-11
establish O 0 8.697096376408808e-10
the O 0 5.6201938936073503e-11
presence O 0 1.2818808237113899e-09
or O 0 1.2401597970779221e-08
absence O 0 6.16282935794743e-09
of O 0 2.2778179342708427e-10
cirrhosis B-Disease 0 7.720874464212102e-07
, O 0 3.8860376028182486e-10
which O 0 3.6901075528561478e-09
can O 0 8.423287312098182e-08
affect O 0 2.2673053479138616e-07
prognosis O 0 2.9516343147406587e-06
and O 0 1.4477078202901339e-08
management O 0 2.1519051074392337e-07
. O 0 2.4482613980580936e-07

A O 0 2.490549206868309e-07
DNA O 0 7.819361371730338e-07
- O 0 1.4423217180592474e-06
based O 0 1.974902019696856e-08
test O 0 2.4681074961563354e-08
for O 0 8.053873540303513e-11
the O 0 1.2940797045057906e-10
HFE O 0 2.96300100899316e-07
gene O 0 6.814308672886682e-09
is O 0 8.704809095760879e-11
commercially O 0 4.38682778991506e-09
available O 0 2.5290800564903293e-09
, O 0 5.140517178592319e-11
but O 0 2.1449034215414997e-10
its O 0 9.572569820148757e-11
place O 0 1.1626308804579821e-09
in O 0 9.091972313912677e-11
the O 0 2.9637828302675473e-10
diagnosis O 0 6.405386443475436e-07
of O 0 1.1099848817863744e-09
hemochromatosis B-Disease 1 1.0
is O 0 1.0819944407103321e-07
still O 0 1.577265180685572e-07
being O 0 4.041584134029108e-08
evaluated O 0 4.5005418769505923e-07
. O 0 2.1469814726060577e-07

Currently O 0 5.000485430173285e-07
, O 0 1.9230028680539135e-09
the O 0 3.469793202759419e-11
most O 0 3.850326654730729e-11
useful O 0 2.6025309685095976e-10
role O 0 1.904365776184136e-09
for O 0 8.218488389832856e-11
this O 0 9.203270090463178e-11
test O 0 7.122453737906653e-09
is O 0 3.4447944496918126e-11
in O 0 2.0548904591799477e-11
the O 0 2.341406929451395e-11
detection O 0 3.4885698774189677e-09
of O 0 1.8941022361662618e-10
hemochromatosis B-Disease 1 1.0
in O 0 7.734565876660326e-09
the O 0 3.993457786677368e-10
family O 0 1.0467395838986704e-09
members O 0 1.5316484192062774e-10
of O 0 3.5772398931932514e-11
patients O 0 3.2918048287200463e-09
with O 0 5.1124646183176026e-11
a O 0 3.668617354346537e-10
proven O 0 1.6320010232107052e-08
case O 0 3.5142415644173752e-09
of O 0 2.01485036988025e-10
the O 0 2.9319007666117614e-08
disease O 0 2.978326847369317e-06
. O 0 4.0855499605640944e-07

It O 0 2.361512407844657e-08
is O 0 2.0532198163891735e-09
crucial O 0 3.936336412380115e-08
to O 0 2.119868369732103e-08
diagnose O 0 0.3260807991027832
hemochromatosis B-Disease 1 1.0
before O 0 0.0004395884752739221
hepatic B-Disease 1 0.9989866614341736
cirrhosis I-Disease 1 0.5635336637496948
develops O 0 2.8224653760844376e-06
because O 0 8.246591676197568e-08
phlebotomy O 0 7.676340828766115e-06
therapy O 0 1.827866185521998e-06
can O 0 9.656922372869303e-08
avert O 0 0.00014934629143681377
serious O 1 0.6585119962692261
chronic O 1 0.9999903440475464
disease O 0 0.000249113974859938
and O 0 3.0680886720091394e-09
can O 0 4.568318612285793e-09
even O 0 8.942696361202707e-09
lead O 0 1.3231782780565027e-08
to O 0 9.590008787085935e-10
normal O 0 1.6182015727395083e-08
life O 0 2.281516309210474e-08
expectancy O 0 1.7857695411294117e-07
. O 0 6.918477346573582e-09
. O 0 8.536748907772562e-08

Prevalence O 0 0.023711467161774635
of O 0 1.4990314767260315e-08
the O 0 1.0749036327695194e-08
I1307K O 0 1.6052479168138234e-06
APC B-Disease 0 1.247807404070045e-07
gene O 0 7.986638195234264e-08
variant O 0 2.0313297000029706e-07
in O 0 3.099509315873661e-09
Israeli O 0 5.791526973553118e-07
Jews O 0 1.3266985732229841e-08
of O 0 3.0229284353477937e-11
differing O 0 4.563859512529689e-09
ethnic O 0 1.441926222867096e-08
origin O 0 4.3722117482047906e-08
and O 0 5.813047110336811e-08
risk O 0 7.843908679205924e-05
for O 0 1.4679309060738888e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.387232370892889e-06

BACKGROUND O 0 0.0004646185552701354
& O 0 2.1937081328360364e-05
AIMS O 0 2.0969514480384532e-06
Israeli O 0 3.187984475516714e-06
Jews O 0 1.43209248903986e-07
of O 0 4.629277239320828e-10
European O 0 2.9658838940349597e-08
birth O 0 1.307962360641568e-08
, O 0 4.466646497114368e-10
i O 0 4.049576229903096e-09
. O 0 1.3758286177001366e-10
e O 0 2.0038750658812887e-09
. O 0 4.489184024514259e-11
, O 0 3.188625058436756e-11
Ashkenazim O 0 1.0933980831850931e-08
, O 0 5.229242733273409e-11
have O 0 3.012425864312718e-10
the O 0 2.281036470819231e-09
highest O 1 0.9999414682388306
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.2684273421764374
of O 0 6.20425877340125e-10
any O 0 3.3647637565081823e-07
Israeli O 1 0.763480544090271
ethnic O 0 2.4952592866611667e-05
group O 0 1.2280359442229383e-05
. O 0 7.280353884198121e-07

The O 0 4.0829905856298865e-07
I1307K O 0 1.0594822924758773e-05
APC B-Disease 0 8.755807243687741e-07
gene O 0 3.101433492247452e-07
variant O 0 2.3261925434781006e-06
was O 0 4.2708727221452136e-08
found O 0 1.740081323475806e-08
in O 0 1.1433040292274654e-08
6 O 0 1.9167863740676694e-07
. O 0 2.3772535939770023e-07

1 O 0 2.3126413850604877e-07
% O 0 3.130398162909387e-09
of O 0 2.0934583927489925e-11
American O 0 5.51677203919354e-10
Jews O 0 3.4110474445014916e-09
, O 0 1.4329348818620247e-10
28 O 0 2.637199625343811e-10
% O 0 4.3192074916653667e-11
of O 0 2.4599777076472762e-11
their O 0 3.263517101004254e-06
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.476769168424653e-06
, O 0 5.620946486040168e-10
but O 0 1.7313603883906126e-09
not O 0 8.846938737150367e-10
in O 0 2.3648103475437665e-09
non O 0 1.284945938095916e-06
- O 0 2.852665375030483e-06
Jews O 0 1.2779530607076595e-06
. O 0 2.679762758361903e-07

We O 0 5.512600864676642e-07
assessed O 0 1.511218670202652e-07
the O 0 2.3617272582043825e-09
I1307K O 0 3.8208432329156494e-07
prevalence O 0 5.124744575368823e-07
in O 0 1.157985596300648e-09
Israeli O 0 1.4913491952484037e-07
Jews O 0 6.640845207073198e-09
of O 0 2.5754740354266836e-11
differing O 0 1.7547319153266017e-09
ethnic O 0 6.06248296008971e-09
origin O 0 1.9027764253110035e-08
and O 0 4.333680081458624e-08
risk O 0 2.8121643481426872e-05
for O 0 7.066556008794578e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.7819689876196207e-06

METHODS O 0 6.116703730185691e-07
DNA O 0 1.5935275143874605e-07
samples O 0 4.625978267114306e-09
from O 0 9.234797648804971e-11
500 O 0 1.1492803930757134e-10
unrelated O 0 5.6476201493183e-10
Jews O 0 8.30545054952836e-09
of O 0 9.206622963997546e-11
European O 0 2.24988365715717e-08
or O 0 2.406114774089474e-08
non O 0 3.057684443774633e-05
- O 0 8.122864528559148e-05
European O 0 1.8874935392432235e-08
origin O 0 1.427969964495901e-09
, O 0 9.576788667642333e-11
with O 0 3.1795337196438567e-11
or O 0 1.969807428281456e-09
without O 0 2.4654243091504213e-09
a O 0 2.351155103941238e-10
personal O 0 5.138846237429107e-09
and O 0 4.085324967206816e-09
/ O 0 6.528457419108236e-08
or O 0 1.1711357217336626e-08
family O 0 2.751428862524108e-09
history O 0 5.86069281993673e-09
of O 0 1.770964486169646e-10
neoplasia B-Disease 0 9.987875273509417e-07
, O 0 1.7135336205509333e-10
were O 0 2.0843074488574587e-10
examined O 0 6.431766230718949e-09
for O 0 8.734629686202311e-11
the O 0 1.4763132383244226e-10
I1307K O 0 3.335815890181948e-08
variant O 0 9.742483264574275e-09
by O 0 1.5467085945353176e-10
the O 0 6.61963373005392e-10
allele O 0 3.9189234257719363e-07
- O 0 3.846317895295215e-07
specific O 0 3.849554275348055e-08
oligonucleotide O 0 3.006011866091285e-06
( O 0 5.279809922598133e-09
ASO O 0 2.4221438366112125e-07
) O 0 2.6394755270331416e-09
method O 0 7.727137329993639e-08
. O 0 1.2120698045237077e-07

RESULTS O 0 1.122555545407522e-06
In O 0 1.40967626460764e-09
persons O 0 1.4708333440083265e-09
at O 0 2.6313726753102173e-09
average O 0 8.217888591843803e-08
risk O 0 0.0025478601455688477
for O 0 0.006500138435512781
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.0230854385895327e-08
I1307K O 0 7.70635324442992e-07
was O 0 2.9494282571818076e-08
found O 0 5.514291689934225e-09
in O 0 3.6865339669844843e-09
5 O 0 3.590437813727476e-08
. O 0 1.9367934100955608e-07

0 O 0 1.2109160252293805e-06
% O 0 2.5441961426508897e-08
of O 0 1.7091955628600886e-10
120 O 0 4.694133082239205e-09
European O 0 1.1433731827992233e-07
and O 0 1.1308766367790213e-08
1 O 0 4.076406767694607e-08
. O 0 9.41488522698819e-08

6 O 0 9.720693014969584e-07
% O 0 1.2902756196808696e-08
of O 0 3.29435950741086e-10
188 O 0 2.3089560485800575e-08
non O 0 1.5321049886551918e-06
- O 0 2.0017379938508384e-05
European O 0 2.0334612216288406e-08
Jews O 0 2.545263910747053e-08
( O 0 5.942080716359044e-10
P O 0 3.993478117081395e-07
= O 0 3.341336807238804e-08
0 O 0 3.5218643557044516e-09
. O 0 1.6376190403732949e-09
08 O 0 3.367838630197184e-08
) O 0 4.852054313886356e-09
. O 0 3.3182949721322075e-08

It O 0 1.9828478059480403e-07
occurred O 0 2.3125841153159854e-07
in O 0 1.4171607887192295e-08
15 O 0 5.846426986977349e-08
. O 0 1.8612179530919093e-07

4 O 0 2.685183631001564e-07
% O 0 1.401008375978563e-08
of O 0 1.050543874114851e-09
52 O 0 2.442934317059553e-07
Ashkenazi O 0 0.0033755535259842873
Israelis O 0 0.0008141482248902321
with O 0 5.12768743021752e-08
familial O 1 0.9940428137779236
cancer B-Disease 1 0.5954506993293762
( O 0 5.324552532215421e-08
P O 0 0.00880880281329155
= O 0 1.0972222526106634e-06
0 O 0 3.5688898947228154e-08
. O 0 3.335439258123074e-09
02 O 0 2.168306423300237e-08
) O 0 1.2447605446386234e-10
and O 0 3.286269867341929e-10
was O 0 1.5346436343932623e-09
not O 0 3.6725938956649884e-10
detected O 0 5.5178901448016404e-09
in O 0 4.485600224590769e-10
51 O 0 1.0453195642412538e-08
non O 0 2.061603510128407e-07
- O 0 1.2204158110762364e-06
European O 0 9.456833538479259e-09
Jews O 0 5.962769389356026e-09
at O 0 5.260158530973058e-09
increased O 0 9.983972404370434e-08
cancer B-Disease 0 5.9372819123382214e-06
risk O 0 2.3246734599524643e-06
. O 0 2.652038233463827e-07

Colorectal B-Disease 1 0.9994304776191711
neoplasia I-Disease 0 0.0018629231490194798
occurred O 0 2.072523784590885e-06
personally O 0 1.907515496668566e-07
or O 0 9.850295690227995e-09
in O 0 3.591489328158559e-10
the O 0 1.8123740008757494e-10
families O 0 7.802691825986585e-10
of O 0 7.925003014941367e-11
13 O 0 1.3886580774169488e-09
of O 0 2.4342147741940323e-10
20 O 0 4.7269268499405825e-09
Ashkenazi O 0 3.740539682439703e-07
I1307K O 0 4.1785082061096546e-08
carriers O 0 9.407611578637898e-09
, O 0 8.564543518829737e-11
8 O 0 9.79408290580075e-11
of O 0 4.232869697112784e-12
whom O 0 2.8632133108885682e-08
also O 0 1.850302027150974e-07
had O 0 1.7935930429757718e-07
a O 0 4.476471970882301e-10
personal O 0 1.2655970493824498e-08
or O 0 1.3737635917721036e-08
family O 0 7.833055093442454e-09
history O 0 5.1882494744859287e-08
of O 0 1.2831632645315949e-08
noncolonic O 0 0.0004708089691121131
neoplasia B-Disease 0 0.0013710558414459229
. O 0 1.2801439197573927e-06

CONCLUSIONS O 0 4.840963356400607e-06
The O 0 2.508093821518287e-08
I1307K O 0 3.053541377084912e-06
APC O 0 3.3541849120410916e-07
variant O 0 3.674188349123142e-07
may O 0 1.2768205159829904e-08
represent O 0 6.812979624903903e-10
a O 0 7.443591298894603e-10
susceptibility O 0 5.153690452175397e-08
gene O 0 1.1886704953667504e-07
for O 0 1.9563886510809425e-08
colorectal B-Disease 1 1.0
, I-Disease 0 1.5958103727342632e-09
or I-Disease 0 2.346675964659539e-09
other I-Disease 0 5.012227966005867e-09
, I-Disease 0 1.193086092143858e-07
cancers I-Disease 1 0.9616516828536987
in O 0 1.864685472696692e-08
Ashkenazi O 0 3.7269459426170215e-05
Jews O 0 1.397082343146394e-07
, O 0 2.005461796628083e-09
and O 0 1.4986876184508446e-09
partially O 0 1.3256214970169822e-07
explains O 0 1.8234853627063785e-08
the O 0 4.2416672951794965e-10
higher O 0 4.162566824561509e-08
incidence O 0 0.0011071828193962574
of O 0 1.0202354133070912e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 9.825006230812505e-08
European O 0 6.419190412998432e-06
Israelis O 0 0.0001551862951600924
. O 0 1.0399837719887728e-06

Systematic O 0 1.4422034837480169e-06
analysis O 0 3.22020781595711e-07
of O 0 4.246477836034046e-09
coproporphyrinogen O 0 4.132887170271715e-06
oxidase O 0 6.344411758618662e-06
gene O 0 3.109444151050411e-05
defects O 1 0.9971688389778137
in O 0 6.971359312046843e-08
hereditary B-Disease 0 0.03134656324982643
coproporphyria I-Disease 0 0.04067748785018921
and O 0 2.3344458099927579e-07
mutation O 0 1.1129215636174195e-05
update O 0 1.2599757610587403e-05
. O 0 7.6805270055047e-07

Hereditary B-Disease 1 0.7494333982467651
coproporphyria I-Disease 0 0.0003530674730427563
( O 0 8.050368194290058e-08
HC B-Disease 0 3.0082144348853035e-06
) O 0 1.2705770657817084e-08
is O 0 4.051492030754389e-09
an O 0 4.414916432438076e-08
acute O 0 0.053104400634765625
hepatic B-Disease 1 0.9981696605682373
porphyria I-Disease 1 0.9999721050262451
with O 0 5.403276759352593e-07
autosomal O 1 0.9997740387916565
dominant O 1 0.94443279504776
inheritance O 1 0.6735444664955139
caused O 0 7.383843694697134e-06
by O 0 1.3425140110712164e-08
deficient B-Disease 0 2.9020855436101556e-05
activity I-Disease 0 1.857880391753497e-07
of I-Disease 0 5.475869091497998e-09
coproporphyrinogen I-Disease 0 4.01517390855588e-05
III I-Disease 0 2.035236548181274e-06
oxidase I-Disease 0 2.328820755792549e-06
( O 0 1.5663189856240933e-08
CPO O 0 5.110569418320665e-06
) O 0 3.2873767707997104e-08
. O 0 1.3920310948378756e-07

Clinical O 0 2.9187911422923207e-05
manifestations O 0 6.050494789633376e-07
of O 0 1.3050162062100412e-09
the O 0 8.582752286656614e-09
disease O 0 2.520226587421348e-07
are O 0 3.8108022293315e-10
characterized O 0 8.416731311911008e-09
by O 0 1.2604393084814092e-08
acute O 0 7.283878221642226e-05
attacks O 1 0.9731614589691162
of O 0 7.214183739279179e-08
neurological B-Disease 1 0.9999632835388184
dysfunction I-Disease 0 0.00010102583473781124
often O 0 5.446528561492414e-08
precipitated O 0 5.6516341828682926e-08
by O 0 1.3238912743851472e-10
drugs O 0 8.953072061501643e-09
, O 0 7.572121402121823e-11
fasting O 0 1.6316771933588825e-08
, O 0 8.713934018800273e-10
cyclical O 0 4.057807927893009e-06
hormonal O 0 1.5565705098197213e-06
changes O 0 1.9705675313730353e-08
, O 0 3.2626574775207473e-09
or O 0 1.5327464097936172e-07
infectious B-Disease 0 5.3404774007503875e-06
diseases I-Disease 0 1.8575894500827417e-05
. O 0 6.468923743341293e-07

Skin O 1 0.9997159838676453
photosensitivity O 1 0.9957162737846375
may O 0 0.0009942055912688375
also O 0 1.0333698341469244e-08
be O 0 2.8743081248450153e-09
present O 0 1.5592009461329326e-08
. O 0 1.5371644224160264e-07

The O 0 5.820235671194496e-08
seven O 0 1.0643033121482404e-08
exons O 0 2.39576138483244e-07
, O 0 1.0978905562453178e-09
the O 0 3.326352526755727e-10
exon O 0 1.920955128298374e-07
/ O 0 7.703959425953144e-08
intron O 0 1.0978282034557196e-06
boundaries O 0 3.738310283551982e-08
and O 0 3.835319617451205e-09
part O 0 2.096953055641393e-09
of O 0 2.349657690636775e-10
3 O 0 1.4383902957604278e-09
noncoding O 0 1.9004575335657137e-07
sequence O 0 1.5121663921036088e-08
of O 0 3.7445008205239105e-10
the O 0 9.291091784824346e-10
CPO O 0 2.2487473927412793e-07
gene O 0 2.545758981398194e-08
were O 0 1.488426493168049e-09
systematically O 0 4.607348103036202e-08
analyzed O 0 7.67721441974345e-09
by O 0 6.70131519719952e-11
an O 0 1.1353450124484965e-10
exon O 0 5.8572648953258977e-08
- O 0 6.518602901905979e-08
by O 0 2.905810925213359e-09
- O 0 9.979401056625647e-07
exon O 0 3.181169404342654e-06
denaturing O 0 3.7686659197788686e-05
gradient O 0 6.1200521486171056e-06
gel O 0 6.0100694099674e-05
electrophoresis O 0 3.940986061934382e-06
( O 0 1.5443423206917828e-09
DGGE O 0 1.8004035950980324e-07
) O 0 7.465174589604828e-10
strategy O 0 4.510189999251679e-09
followed O 0 2.0738347150661696e-10
by O 0 1.0734801068890132e-11
direct O 0 1.86872115004455e-10
sequencing O 0 3.7753973280985065e-09
in O 0 7.821973624366763e-10
seven O 0 3.6730722907662994e-09
unrelated O 0 9.441625792305786e-08
heterozygous O 0 8.113327680803195e-07
HC B-Disease 0 1.3198407486925134e-06
patients O 0 2.471492734912317e-07
from O 0 1.4687644434019376e-09
France O 0 5.05852256083017e-07
, O 0 1.2782623848295316e-09
Holland O 0 2.1177248754611355e-07
, O 0 1.0645179182589004e-09
and O 0 9.787966881447119e-09
Czech O 0 1.59792325575836e-05
Republic O 0 5.580380388892081e-07
. O 0 4.4160958623251645e-07

Seven O 0 6.267629828471399e-07
novel O 0 2.165257058095449e-07
mutations O 0 6.207578735484276e-07
and O 0 1.5334965519642196e-09
two O 0 8.512595628396014e-10
new O 0 8.9541476455679e-09
polymorphisms O 0 1.7759947468221071e-06
were O 0 1.8823094194431178e-08
detected O 0 7.644428023922956e-07
. O 0 1.6553133264096687e-07

Among O 0 1.7190519940868398e-07
these O 0 6.246200001669422e-09
mutations O 0 8.065014611702281e-08
two O 0 1.0032431552176035e-09
are O 0 2.412988919786585e-09
missense O 0 1.1469862783997087e-06
( O 0 2.0722856763910613e-09
G197W O 0 9.962534619489816e-08
, O 0 5.202017705485673e-10
W427R O 0 3.180733543217684e-08
) O 0 3.6949937554098256e-10
, O 0 7.00362892680495e-11
two O 0 1.2909660840332293e-10
are O 0 1.139032979047272e-09
nonsense O 0 6.37040571405123e-08
( O 0 3.072116172564421e-10
Q306X O 0 2.6274621589550406e-08
, O 0 1.5627514560190292e-10
Q385X O 0 1.532611371146686e-08
) O 0 1.995814347122149e-10
, O 0 5.09595317332856e-11
two O 0 1.067101129681447e-10
are O 0 2.4952889754459306e-10
small O 0 2.3131865312109312e-09
deletions O 0 2.3153381789597915e-07
( O 0 9.061714156821665e-10
662de14bp O 0 6.304047417415859e-08
; O 0 1.2851196773411289e-09
1168del3bp O 0 7.231335530377692e-08
removing O 0 1.6974333050256973e-08
a O 0 4.899162187044226e-10
glycine O 0 9.663868638654094e-08
at O 0 5.0928194994526166e-09
position O 0 1.509618918760225e-08
390 O 0 7.135870783159248e-10
) O 0 1.2492559764432087e-10
, O 0 3.601660983343358e-11
and O 0 2.056083359125438e-10
one O 0 8.773672344197792e-10
is O 0 3.9694911246890285e-10
a O 0 1.336585730982165e-09
splicing O 0 2.2052536223782226e-06
mutation O 0 1.0380615549365757e-06
( O 0 6.943515540314138e-09
IVS1 O 0 4.393086328491336e-06
- O 0 1.6050780686782673e-06
15c O 0 1.0237265996693168e-05
- O 0 1.6462954590679146e-06
- O 0 5.764938464380975e-07
> O 0 3.893490685413781e-08
g O 0 5.5279215871451015e-08
) O 0 4.440721124154834e-10
which O 0 5.261862057182043e-10
creates O 0 3.6081759802186752e-09
a O 0 1.2473518884448254e-09
new O 0 1.7615603198350982e-08
acceptor O 0 1.986769859740889e-07
splice O 0 1.3036523341725115e-05
site O 0 1.8405078208161285e-06
. O 0 8.269539080174582e-07

The O 0 2.519875152984241e-08
pathological O 0 1.6896075294425827e-07
significance O 0 2.690909894909055e-08
of O 0 2.980108382288904e-10
the O 0 1.3515931707175355e-09
point O 0 6.945398922653112e-08
mutations O 0 2.1789995230392378e-07
G197W O 0 1.534928912860778e-07
, O 0 4.842621303957628e-10
W427R O 0 3.108225499204309e-08
, O 0 3.463493658539818e-10
and O 0 3.300353046409299e-10
the O 0 1.4146424309746664e-10
in O 0 2.0650650078835042e-09
- O 0 5.466974357659637e-07
frame O 0 1.7914355794346193e-06
deletion O 0 2.290175586949772e-07
390delGly O 0 6.669382912605215e-08
were O 0 2.0437788961213954e-10
assessed O 0 1.0559155771971973e-09
by O 0 3.88399035156084e-11
their O 0 3.6708291961673467e-10
respective O 0 5.889019938365436e-09
expression O 0 5.429443117321853e-09
in O 0 6.873961955200514e-10
a O 0 3.612236620931242e-10
prokaryotic O 0 3.4704847884370338e-09
system O 0 9.88254700295954e-10
using O 0 1.8247996447229298e-09
site O 0 5.695384786008617e-08
- O 0 9.313824875789578e-07
directed O 0 2.4934271891652315e-07
mutagenesis O 0 3.1207471238303697e-06
. O 0 4.602122771757422e-07

These O 0 1.3674535637164809e-07
mutations O 0 4.368569364032737e-07
resulted O 0 1.5311709233856163e-08
in O 0 1.2435178442515848e-09
the O 0 6.538770080943834e-10
absence O 0 6.754885983895065e-09
or O 0 5.532538427388545e-09
a O 0 1.72474856618976e-09
dramatic O 0 7.426870638482796e-07
decrease O 0 1.2320680298216757e-06
of O 0 7.879116914466522e-09
CPO O 0 1.3856321857019793e-05
activity O 0 1.4901848999215872e-06
. O 0 3.2429238672193605e-07

The O 0 3.986521335264115e-08
two O 0 8.345276469867713e-09
polymorphisms O 0 1.2419681070241495e-06
were O 0 9.014311963539967e-09
localized O 0 8.991168698457841e-08
in O 0 6.361684956601721e-09
noncoding O 0 1.2331117886787979e-06
part O 0 1.0646607151443277e-08
of O 0 1.1094890978169403e-10
the O 0 1.7864006107704e-10
gene O 0 6.370925564880281e-09
1 O 0 1.4755596744464583e-09
) O 0 6.015255515912088e-10
a O 0 2.8101252436130153e-09
C O 0 1.9198050438262726e-07
/ O 0 6.15647550716858e-08
G O 0 9.426923952560173e-08
polymorphism O 0 1.138221676910689e-07
in O 0 2.553042000030814e-09
the O 0 2.1591726184766458e-09
promotor O 0 1.4585442613679334e-06
region O 0 5.7540962217217384e-08
, O 0 2.3059887332976814e-09
142 O 0 8.857614197665953e-09
bp O 0 1.1220102180686808e-07
upstream O 0 4.759986182989451e-09
from O 0 2.1063319144420944e-10
the O 0 2.1444822306815325e-10
transcriptional O 0 2.576612878613105e-08
initiation O 0 6.324868628837521e-09
site O 0 1.072339816943213e-08
( O 0 1.123163229088675e-09
- O 0 8.133510931429555e-08
142C O 0 3.36333329187255e-07
/ O 0 4.299569411614357e-08
G O 0 2.4826492861507177e-08
) O 0 3.7069938785272427e-10
, O 0 1.5117727902858036e-10
and O 0 4.29487667652495e-10
2 O 0 7.555938652537009e-10
) O 0 3.8608743979651194e-10
a O 0 6.329692880946425e-10
6 O 0 6.100738580983034e-09
bp O 0 1.1029182189759013e-07
deletion O 0 2.491296768880602e-08
polymorphism O 0 6.09615824487264e-08
in O 0 9.267551726033219e-10
the O 0 3.125212311161363e-10
3 O 0 1.1155627532843937e-09
noncoding O 0 2.3147110539412097e-07
part O 0 3.401185777462956e-09
of O 0 2.978710333945145e-10
the O 0 1.6737925490062366e-09
CPO O 0 3.435594351230975e-07
gene O 0 3.0463983335948797e-08
, O 0 5.870154362597191e-10
574 O 0 1.5102036954317555e-08
bp O 0 5.0372058524317254e-08
downstream O 0 1.9760693081849467e-09
of O 0 1.3707856898192983e-11
the O 0 6.566387711348654e-11
last O 0 1.7580081834722705e-09
base O 0 7.702967708134167e-10
of O 0 4.490186000793983e-11
the O 0 1.5690960752934302e-09
normal O 0 1.369575670651102e-07
termination O 0 4.1684390339469246e-07
codon O 0 9.321075822299463e-07
( O 0 4.2769272567966254e-09
+ O 0 9.301738401745752e-08
574 O 0 3.4003190307885234e-07
delATTCTT O 0 5.367746211959457e-07
) O 0 5.208704934034358e-08
. O 0 1.4686089855331375e-07

Five O 0 2.867247133053752e-07
intragenic O 0 4.495151188166346e-06
dimorphisms O 0 1.5710486422904069e-06
are O 0 2.558423695120382e-09
now O 0 5.3151643086835065e-09
well O 0 4.74264738592467e-10
characterized O 0 2.1209267675459387e-09
and O 0 1.6648870060365084e-09
the O 0 3.480552790424696e-10
high O 0 7.353731845682887e-09
degree O 0 7.248704303464137e-09
of O 0 2.1815416140213983e-10
allelic O 0 1.4563798345079704e-07
heterogeneity O 0 2.0913108755848953e-07
in O 0 3.552331095946215e-09
HC B-Disease 0 1.5413083929161076e-06
is O 0 1.1078888917381846e-09
demonstrated O 0 2.0639387976473245e-09
with O 0 7.542672736393641e-11
seven O 0 1.4474495213523397e-10
new O 0 1.3267756338031234e-10
different O 0 1.1459007354108763e-10
mutations O 0 1.8093767595317445e-09
making O 0 1.8069618024085798e-10
a O 0 1.2632106471954785e-10
total O 0 2.0214829810072388e-10
of O 0 1.3882918425967006e-10
nineteen O 0 3.6372819067764794e-07
CPO O 0 0.0007345976773649454
gene B-Disease 0 1.0426272638142109e-05
defects I-Disease 1 0.9900529980659485
reported O 0 5.7017217613974935e-08
so O 0 5.9325371282170636e-09
far O 0 1.95475511333143e-08
. O 0 1.9398168404904936e-08
. O 0 2.3966984485923604e-07

Coincidence O 0 1.7713499573801528e-06
of O 0 1.1418693768305843e-09
two O 0 1.4565507688857338e-09
novel O 0 3.3443082969597526e-08
arylsulfatase O 0 1.1195789966222947e-06
A O 0 1.443128549993844e-08
alleles O 0 5.342528766050236e-07
and O 0 4.793004748648855e-08
mutation O 0 3.128674052277347e-06
459 O 0 8.032206437746936e-07
+ O 0 7.5346451922087e-07
1G O 0 4.084153715666616e-06
> O 0 1.7538702934416506e-07
A O 0 5.2310333842342516e-09
within O 0 1.0263685457090332e-09
a O 0 2.814341204526727e-09
family O 0 3.24702078557948e-08
with O 0 1.7491366577360168e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 4.1177610654585806e-08
molecular O 0 6.170206034994408e-08
basis O 0 1.66193085959776e-08
of O 0 9.754904439773782e-09
phenotypic O 0 3.854385795420967e-05
heterogeneity O 0 0.0002881296968553215
. O 0 4.62011757917935e-06

In O 0 3.399112102897561e-08
a O 0 1.9732444567210905e-09
family O 0 2.511467256383071e-09
with O 0 3.09816033938759e-10
three O 0 1.7291030829369447e-09
siblings O 0 1.1867619065242252e-07
, O 0 4.657031982269189e-10
one O 0 9.017093738350468e-10
developed O 0 1.103862778961684e-08
classical O 0 1.2438214014309779e-07
late O 0 3.4268548461113824e-06
infantile O 1 0.9548001885414124
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.1908728936305124e-07
MLD B-Disease 1 0.9999980926513672
) O 0 7.535159163296612e-09
, O 0 6.935332308444231e-10
fatal O 0 3.772851755456941e-07
at O 0 9.337090212113708e-09
age O 0 2.8134394813861263e-09
5 O 0 4.029864220100876e-10
years O 0 3.487838018401135e-09
, O 0 2.0784834964260313e-10
with O 0 9.982841220335104e-10
deficient O 0 1.2354222235444468e-05
arylsulfatase O 0 1.4979502793721622e-06
A O 0 1.0864546595712454e-08
( O 0 1.5530828845200517e-09
ARSA O 0 1.825115759856999e-06
) O 0 6.522365425531973e-10
activity O 0 6.026627641375626e-09
and O 0 4.15011847110236e-09
increased O 0 2.2078276984416334e-08
galactosylsulfatide O 0 8.589553544879891e-06
( O 0 3.2525129256555374e-08
GS O 1 0.9999994039535522
) O 0 5.1746901874594187e-08
excretion O 0 3.636928340711165e-07
. O 0 1.685506845205964e-07

The O 0 1.3528860698386325e-08
two O 0 1.4277111715088608e-09
other O 0 7.059450801705225e-10
siblings O 0 1.1908615960010138e-07
, O 0 1.903370794309467e-09
apparently O 0 1.3061131198810472e-07
healthy O 0 1.1552903522726865e-08
at O 0 1.2054749420897792e-09
12 O 0 2.2122219334175242e-10
( O 0 5.0451594291178736e-11
1 O 0 3.301599549310197e-10
/ O 0 4.240892970130972e-09
2 O 0 4.4132786314321493e-10
) O 0 1.3063704284999034e-10
and O 0 3.958030014850067e-10
15 O 0 1.801792465228047e-10
years O 0 6.243218719781396e-10
, O 0 3.158734385166895e-11
respectively O 0 2.467235526992795e-09
, O 0 1.7437641608442078e-10
and O 0 4.314277823880275e-10
their O 0 2.4648777463553984e-10
father O 0 2.0672532130561194e-08
, O 0 1.5601908653906094e-09
apparently O 0 8.56700665963217e-08
healthy O 0 2.440533997116745e-09
as O 0 3.5069211423710556e-10
well O 0 1.2258464243686262e-09
, O 0 4.4241338370554217e-10
presented O 0 6.298047416919417e-09
ARSA O 0 9.087318176170811e-06
and O 0 4.1873640554968006e-08
GS O 1 0.9999983310699463
values O 0 7.512571897905218e-09
within O 0 1.6093658350424533e-10
the O 0 2.6766000527089773e-10
range O 0 1.860755816096571e-08
of O 0 1.4499433653725191e-08
MLD B-Disease 1 0.9999973773956299
patients O 0 2.656148581081652e-06
. O 0 1.4562770900283795e-07

Mutation O 0 3.364668373251334e-05
screening O 0 5.294059064908652e-06
and O 0 1.0160361441080568e-08
sequence O 0 1.4202346854119696e-08
analysis O 0 1.2170035645908683e-08
disclosed O 0 4.353272586854473e-08
the O 0 1.681708661216419e-10
involvement O 0 7.60988960735176e-09
of O 0 1.3277630384056494e-10
three O 0 8.699751474772199e-10
different O 0 1.1161016999494677e-08
ARSA O 0 0.0001458933111280203
mutations O 0 4.712211421065149e-07
being O 0 4.191764713112889e-09
the O 0 9.55737294860981e-11
molecular O 0 1.0723030463566374e-08
basis O 0 3.712614216055954e-09
of O 0 2.6470783343057747e-09
intrafamilial O 0 9.709940059110522e-06
phenotypic O 0 2.985152787005063e-05
heterogeneity O 0 9.303257684223354e-05
. O 0 2.7240739655098878e-06

The O 0 3.263826613419951e-07
late O 0 1.0227166740151006e-06
infantile O 0 7.900729542598128e-05
patient O 0 1.6622007024125196e-05
inherited O 0 1.3565595509135164e-05
from O 0 3.4634752843487604e-09
his O 0 3.3877254335124007e-09
mother O 0 1.4242745294268389e-07
the O 0 5.70128111387902e-10
frequent O 0 3.9655000705351995e-07
0 O 0 9.307911454925488e-07
- O 0 0.0007772608078084886
type O 0 0.00011127065226901323
mutation O 0 4.925434495817171e-06
459 O 0 1.766965453953162e-07
+ O 0 1.2843389640693204e-07
1G O 0 3.644772164079768e-07
> O 0 2.2514203834589352e-08
A O 0 2.1874175804015294e-09
, O 0 3.54700768756544e-10
and O 0 5.289987892176384e-10
from O 0 1.9666904216286696e-10
his O 0 6.633612548156975e-10
father O 0 6.1018443631155606e-09
a O 0 3.2518518433555244e-10
novel O 0 5.524440016557719e-09
, O 0 6.100642213624496e-10
single O 0 5.3557176471485946e-09
basepair O 0 2.2763398987990513e-07
microdeletion O 0 8.67377991653484e-08
of O 0 8.608073281957118e-11
guanine O 0 2.8299634635686743e-08
at O 0 1.1538495714447095e-09
nucleotide O 0 5.6893590283380036e-08
7 O 0 1.9669204043282207e-09
in O 0 7.683422231785642e-10
exon O 0 2.2932310628220876e-07
1 O 0 1.5921962415177404e-08
( O 0 2.0133532618871186e-09
7delG O 0 4.829711883758137e-07
) O 0 1.1864695004248915e-08
. O 0 1.3432803314117336e-07

The O 0 6.068246705126512e-08
two O 0 4.55771989038567e-08
clinically O 0 2.4538951493013883e-06
unaffected O 0 2.2098513454693602e-06
siblings O 0 5.214768634687061e-07
carried O 0 6.367478277979899e-08
the O 0 1.364995583230666e-08
maternal O 0 2.243692733827629e-06
mutation O 0 3.7152271943341475e-06
459 O 0 5.498897053257679e-07
+ O 0 3.559539720754401e-07
1G O 0 1.1140884907945292e-06
> O 0 5.879315168044741e-08
A O 0 5.015192261481616e-09
and O 0 1.9146839669303972e-09
, O 0 2.065229515180178e-10
on O 0 7.737748775049624e-10
their O 0 1.116495118580474e-09
paternal O 0 8.110583138432048e-08
allele O 0 2.2206735650343035e-07
, O 0 7.400555723791058e-10
a O 0 5.073039210934382e-10
novel O 0 1.7640148897157815e-08
cytosine O 0 1.0648764003917677e-07
to O 0 1.1998411153513189e-09
thymidine O 0 5.153523261469672e-07
transition O 0 5.955498494358835e-08
at O 0 6.6313901037062806e-09
nucleotide O 0 3.687598280066595e-07
2435 O 0 1.6533332427570713e-06
in O 0 2.8356463843692836e-09
exon O 0 1.6410866976457328e-07
8 O 0 6.818443143430386e-09
, O 0 2.9118515931791933e-10
resulting O 0 1.4576122531195779e-09
in O 0 3.3697761248063784e-10
substitution O 0 5.0505368776043724e-09
of O 0 9.797301858682772e-10
alanine O 0 1.9990295641036937e-06
464 O 0 1.0703213604301709e-07
by O 0 1.0002267458730785e-08
valine O 0 4.3608099076664075e-05
( O 0 1.1021586310278053e-08
A464V O 0 1.195799995912239e-06
) O 0 6.37366355249469e-08
. O 0 2.619576378037891e-07

The O 0 2.941429215752578e-07
fathers O 0 2.8728409233735874e-06
genotype O 0 1.1961492418777198e-05
thus O 0 2.3433187834598357e-07
was O 0 1.531630147155738e-07
7delG O 0 5.908925686526345e-06
/ O 0 3.0153030365909217e-06
A464V O 0 1.6043821233324707e-05
. O 0 5.849873332408606e-07

Mutation O 0 3.9994560211198404e-05
A464V O 0 4.42761802332825e-06
was O 0 2.0708165848759563e-08
not O 0 1.0943176365074692e-09
found O 0 6.199870061784907e-10
in O 0 1.3819889677080255e-09
18 O 0 1.0156195884292174e-08
unrelated O 0 8.821148185234051e-07
MLD B-Disease 1 0.9999997615814209
patients O 0 2.851789531632676e-06
and O 0 3.98606303519955e-09
50 O 0 9.114310195457165e-09
controls O 0 1.6799940567580052e-06
. O 0 8.705185337021248e-07

A464V O 0 2.7461948775453493e-05
, O 0 5.33107673561517e-08
although O 0 1.4676477810837696e-08
clearly O 0 6.177295119869086e-08
modifying O 0 7.190650990196445e-07
ARSA O 0 6.113674317020923e-05
and O 0 4.4437547330744565e-07
GS O 1 1.0
levels O 0 3.87601943430127e-07
, O 0 1.1708447544833689e-09
apparently O 0 8.772772730480938e-09
bears O 0 4.765982275500846e-09
little O 0 5.60262225501873e-10
significance O 0 3.493657141362405e-09
for O 0 6.121623208343863e-10
clinical O 0 5.560852400776639e-08
manifestation O 0 6.697414534073687e-08
of O 0 8.175766730289524e-09
MLD B-Disease 1 0.9999984502792358
, O 0 8.129195983030968e-09
mimicking O 0 9.82535880211799e-07
the O 0 7.257173706420872e-08
frequent O 0 1.749866896716412e-05
ARSA O 0 0.007052546367049217
pseudodeficiency O 0 0.0001448616967536509
allele O 0 0.00013503950322046876
. O 0 3.234657242501271e-06

Our O 0 4.2727833715616725e-07
results O 0 2.2992438175606367e-08
demonstrate O 0 3.744631271729304e-09
that O 0 1.0638558090025896e-10
in O 0 1.0838290681602913e-10
certain O 0 9.343338325251693e-10
genetic O 0 5.064179617875197e-07
conditions O 0 6.782399282201368e-07
MLD B-Disease 1 0.9999992847442627
- O 0 9.006613254314288e-06
like O 0 1.1351126971703707e-07
ARSA O 0 8.075766527326778e-05
and O 0 3.207992449461017e-08
GS O 1 0.9999986886978149
values O 0 3.1154889779116957e-09
need O 0 3.4417485528237535e-10
not O 0 3.626801636791299e-11
be O 0 1.4658187857952143e-11
paralleled O 0 8.139369733761725e-10
by O 0 5.071278952328839e-10
clinical O 0 1.3736322443946847e-06
disease O 0 1.1314337911016992e-07
, O 0 2.8186858402889925e-10
a O 0 3.1663544008964095e-10
finding O 0 9.312421056506537e-09
with O 0 3.5876230874976045e-09
serious O 0 3.1212604767461016e-07
diagnostic O 0 4.26673886977369e-06
and O 0 4.193502434191032e-08
prognostic O 0 7.981291855685413e-05
implications O 0 7.705818461545277e-06
. O 0 1.0598566859698622e-06

Moreover O 0 7.697987712163012e-06
, O 0 9.355687069501073e-08
further O 0 1.369246547255898e-07
ARSA O 0 0.0007487932452932
alleles O 0 1.7649355186222238e-06
functionally O 0 1.5326558866490814e-07
similar O 0 8.236669124528362e-09
to O 0 9.487181040768178e-10
A464V O 0 1.3328929071576567e-07
might O 0 9.363985142840647e-09
exist O 0 7.904645826783963e-09
which O 0 3.8124597923072656e-10
, O 0 3.808809517780176e-11
together O 0 1.0415888984649513e-10
with O 0 2.4282004185138817e-10
0 O 0 5.6984816865224275e-08
- O 0 3.300217940704897e-05
type O 0 5.793449417978991e-06
mutations O 0 3.4770939691952663e-06
, O 0 6.0810703139679845e-09
may O 0 5.198294061870001e-08
cause O 0 4.6511956952599576e-08
pathological O 0 8.848092534208263e-07
ARSA O 0 0.052447643131017685
and O 0 5.555345978791593e-06
GS O 1 1.0
levels O 0 1.4195393305271864e-07
, O 0 1.671287552795775e-10
but O 0 2.8561630838197516e-10
not O 0 9.792108235373576e-10
clinical O 0 3.7253840901030344e-08
outbreak O 0 1.1741080996330311e-08
of O 0 5.7460373265039166e-11
the O 0 8.556714448104685e-09
disease O 0 2.3200105658816028e-07
. O 0 1.5731064451074417e-08
. O 0 1.9495557523896423e-07

Human O 0 6.794665387133136e-05
MLH1 O 0 0.4907892048358917
deficiency O 0 0.06456945091485977
predisposes O 0 7.384420314338058e-05
to O 0 7.283819059011876e-07
hematological B-Disease 1 0.9358137249946594
malignancy I-Disease 1 0.9995868802070618
and O 0 7.724925694674312e-07
neurofibromatosis B-Disease 0 0.0208757221698761
type I-Disease 0 0.0007615413633175194
1 I-Disease 0 2.274127382406732e-06
. O 0 8.145074730236956e-07

Heterozygous O 0 0.0001945065159816295
germ O 0 0.001175774377770722
- O 0 0.055897049605846405
line O 0 9.076197784452233e-07
mutations O 0 8.038014698286133e-07
in O 0 2.167565238408997e-09
the O 0 1.8273490498543765e-09
DNA O 0 1.0619216936902376e-06
mismatch O 0 1.4762614227947779e-05
repair O 0 2.243868038931396e-06
genes O 0 2.41000577716477e-07
lead O 0 1.88945719514777e-07
to O 0 6.485527848099082e-08
hereditary B-Disease 1 0.9998908042907715
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.4822569937678054e-05

The O 0 1.3292117273522308e-07
disease O 0 7.549382985416742e-07
susceptibility O 0 1.4243696000448836e-07
of O 0 2.6436358657733194e-10
individuals O 0 6.1294547215595685e-09
who O 0 6.699445975755225e-08
constitutionally O 0 1.2269282478882815e-07
lack O 0 2.082762629029844e-09
both O 0 3.8620895370655717e-10
wild O 0 1.7935377627509297e-08
- O 0 0.0026408310513943434
type O 0 7.82177085056901e-06
alleles O 0 6.792795375076821e-07
is O 0 3.903625511725295e-08
unknown O 0 1.1550389444892062e-06
. O 0 8.749597100177198e-07

We O 0 3.667452972422325e-07
have O 0 3.1836147051933494e-09
identified O 0 5.785280698944462e-09
three O 0 2.9571481374723874e-10
offspring O 0 6.30639007681566e-09
in O 0 6.514917494371275e-10
a O 0 3.397472170263427e-08
hereditary B-Disease 1 0.9999959468841553
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.6995120404317277e-06
who O 0 1.3496274675617315e-07
developed O 0 1.7752044811913947e-07
hematological B-Disease 0 0.2688123881816864
malignancy I-Disease 1 0.9961687922477722
at O 0 2.1825011131682004e-08
a O 0 4.1044972975967653e-10
very O 0 5.408478664925553e-10
early O 0 2.105811880426245e-08
age O 0 1.301760210736802e-08
, O 0 9.038372134062556e-11
and O 0 1.6317315554292833e-10
at O 0 2.4784976848657436e-10
least O 0 1.7161789350739198e-11
two O 0 5.574457909163222e-11
of O 0 1.368296188158924e-11
them O 0 2.0928564437028285e-10
displayed O 0 1.0360341029524989e-08
signs O 0 1.3707098389659222e-07
of O 0 1.951550254730705e-09
neurofibromatosis B-Disease 0 0.00033442743006162345
type I-Disease 0 3.6527726479107514e-05
1 I-Disease 0 2.2397452426048403e-07
( O 0 2.601412241176604e-08
NF1 B-Disease 0 3.068141813855618e-05
) O 0 8.143383922742942e-08
. O 0 1.4270101189595152e-07

DNA O 0 4.4542402974911965e-06
sequence O 0 2.412829758213775e-07
analysis O 0 7.996988671266081e-08
and O 0 5.633851163366899e-09
allele O 0 2.428256777875504e-07
- O 0 1.8927721612271853e-07
specific O 0 6.78905021089804e-09
amplification O 0 4.221059057840648e-08
in O 0 6.205016500615557e-10
two O 0 1.5260445129783307e-09
siblings O 0 1.8811434188137355e-07
revealed O 0 1.4155189376197086e-07
a O 0 3.1534778344166625e-08
homozygous O 0 2.6618808988132514e-05
MLH1 O 0 0.0001242726284544915
mutation O 0 3.4743197829811834e-06
( O 0 7.692047887530862e-09
C676T O 0 1.8166554127674317e-06
- O 0 2.3479644369217567e-05
- O 0 1.456001973565435e-05
> O 0 5.900716359974467e-07
Arg226Stop O 0 2.92529807666142e-06
) O 0 5.376742961971104e-08
. O 0 1.5911615491859266e-07

Thus O 0 3.1808613698558474e-07
, O 0 3.1377687115252684e-09
a O 0 2.2286468226440093e-09
homozygous O 0 2.1266289422783302e-06
germ O 0 0.0002509727783035487
- O 0 0.000525698356796056
line O 0 5.005178991268622e-06
MLH1 O 0 0.00018186078523285687
mutation O 0 5.5410919230780564e-06
and O 0 3.696717598700161e-08
consequent O 0 1.9660154066514224e-05
mismatch O 1 0.9923291802406311
repair O 1 0.9984373450279236
deficiency O 1 0.9841877222061157
results O 0 4.6510979956337906e-08
in O 0 1.4726411201593237e-09
a O 0 8.334841261614656e-09
mutator O 0 0.00012042481830576435
phenotype O 0 1.1483695743663702e-05
characterized O 0 1.5379768569800945e-07
by O 0 3.805010351243254e-08
leukemia B-Disease 0 0.21391895413398743
and O 0 4.47026536676276e-07
/ O 1 0.9871690273284912
or O 1 0.9999380111694336
lymphoma B-Disease 1 1.0
associated O 0 0.0021724074613302946
with O 0 1.0209436140939943e-07
neurofibromatosis B-Disease 0 0.47563496232032776
type I-Disease 0 0.001769496826454997
1 I-Disease 0 2.5612135345909337e-07
. O 0 6.079657310920084e-08
. O 0 4.7329962171716033e-07

Missense O 0 0.00026459709624759853
mutations O 0 1.0030668818217237e-05
in O 0 1.2245664038346149e-08
the O 0 3.124282499378239e-10
most O 0 1.450611297748594e-10
ancient O 0 1.0876359812783676e-09
residues O 0 4.155300459274258e-08
of O 0 1.9079059165871826e-10
the O 0 1.4065661968487575e-09
PAX6 O 0 2.280808530485956e-06
paired O 0 1.0173531705959249e-07
domain O 0 3.68594541555467e-08
underlie O 0 9.145588819592376e-08
a O 0 9.429703684560309e-10
spectrum O 0 1.4081399157817032e-08
of O 0 2.24410512394968e-09
human O 0 4.819782475351531e-07
congenital B-Disease 1 0.9999971389770508
eye I-Disease 1 0.9999872446060181
malformations I-Disease 1 0.9993194341659546
. O 0 4.312762030167505e-06

Mutations O 0 5.649717422784306e-05
of O 0 1.0272406036904158e-08
the O 0 9.508344334108187e-09
human O 0 3.916549928817403e-08
PAX6 O 0 4.051668292959221e-05
gene O 0 1.1417389032430947e-05
underlie O 0 0.0004992215544916689
aniridia B-Disease 1 1.0
( O 0 5.827466793562053e-07
congenital B-Disease 1 0.9999291896820068
absence I-Disease 0 2.096354876357509e-07
of I-Disease 0 2.5318494523141055e-10
the I-Disease 0 4.30611407642445e-10
iris I-Disease 0 2.914588321800693e-06
) O 0 3.1340243733524176e-09
, O 0 3.4901920242802476e-10
a O 0 9.34565647092711e-10
rare O 0 8.322993494402908e-08
dominant O 1 0.949461817741394
malformation B-Disease 1 0.9775620102882385
of I-Disease 0 2.1541211037146013e-09
the I-Disease 0 2.473739435515654e-08
eye I-Disease 1 0.9842780232429504
. O 0 3.194820465068915e-06

The O 0 1.0673938533045657e-07
spectrum O 0 4.236315476191521e-07
of O 0 1.032361218733513e-08
PAX6 O 0 2.866610884666443e-05
mutations O 0 4.386944965517614e-06
in O 0 3.156763739298185e-08
aniridia B-Disease 1 1.0
patients O 0 2.3783675715094432e-05
is O 0 1.21486931625725e-09
highly O 0 2.985605762617638e-09
biased O 0 6.223606874300458e-08
, O 0 2.9902830211980813e-10
with O 0 1.3888321048760588e-10
92 O 0 3.8957246317750105e-09
% O 0 3.352946531531842e-10
of O 0 3.198456430264507e-11
all O 0 1.9068373546815565e-09
reported O 0 1.4860592045806698e-07
mutations O 0 2.441821038701164e-07
leading O 0 1.3323484537863806e-08
to O 0 4.2527434906958206e-09
premature O 0 4.4736427895486486e-08
truncation O 0 1.5433809608111915e-07
of O 0 5.074248798919712e-10
the O 0 8.544152607647959e-10
protein O 0 1.5131561781345226e-08
( O 0 6.431382093552429e-10
nonsense O 0 2.283166189442909e-08
, O 0 1.7227158588539737e-10
splicing O 0 3.0191642963472987e-08
, O 0 2.6664243035767754e-10
insertions O 0 2.4537770926258418e-08
and O 0 3.024360206715926e-10
deletions O 0 7.115827038717271e-09
) O 0 4.319044843992259e-10
and O 0 2.2045894276789824e-10
just O 0 4.149230126149206e-10
2 O 0 6.045701161916384e-10
% O 0 8.876141488478595e-11
leading O 0 2.0034994496764824e-10
to O 0 3.5059496972245086e-11
substitution O 0 3.380436486288829e-10
of O 0 3.830315231656556e-11
one O 0 2.66530686410249e-09
amino O 0 3.120319291838314e-08
acid O 0 1.3159247913563377e-08
by O 0 2.2473464755812245e-10
another O 0 2.7305069316696517e-09
( O 0 4.892450888860367e-09
missense O 0 2.3704533305135556e-06
) O 0 5.702286998143791e-08
. O 0 1.8644263377609605e-07

The O 0 3.248563373858815e-08
extraordinary O 0 2.7159646975860596e-08
conservation O 0 4.032111533547322e-09
of O 0 1.1742391781144335e-10
the O 0 9.69576419151963e-10
PAX6 O 0 9.289465765505156e-07
protein O 0 2.437385759890276e-08
at O 0 3.772647527711115e-09
the O 0 9.8001795567626e-10
amino O 0 9.461528094334426e-08
acid O 0 3.2286794748870307e-07
level O 0 6.136426033975795e-09
amongst O 0 3.5989313751372265e-09
vertebrates O 0 2.5657060476191873e-08
predicts O 0 6.810932973166928e-08
that O 0 8.801764317389882e-10
pathological O 0 5.477156506117353e-08
missense O 0 1.5585281971652876e-06
mutations O 0 7.457310289282759e-07
should O 0 3.625249211935966e-09
in O 0 1.0586455323480237e-10
fact O 0 7.666675072570683e-10
be O 0 1.5672349529260998e-10
common O 0 2.3555762895810517e-10
even O 0 3.0183325283594797e-10
though O 0 6.793230422630359e-10
they O 0 2.3123826464743757e-10
are O 0 2.1831152163809264e-10
hardly O 0 1.3511453289538622e-08
ever O 0 3.75910289562853e-08
seen O 0 4.739658621133458e-08
in O 0 3.2199832133983364e-08
aniridia B-Disease 1 1.0
patients O 0 4.048230039188638e-06
. O 0 1.4497061329166172e-07

This O 0 2.135415044790534e-08
indicates O 0 3.490941224981725e-08
that O 0 2.806465337901187e-10
there O 0 2.2353295603405599e-10
is O 0 2.7672852898064093e-10
a O 0 2.3713733199315357e-09
heavy O 0 4.7801049731788225e-06
ascertainment O 0 1.5885592802078463e-05
bias O 0 6.812941137468442e-06
in O 0 1.8344030738859374e-09
the O 0 3.337588538876446e-10
selection O 0 1.3292739131642861e-09
of O 0 3.2143221417868517e-10
patients O 0 2.0344000262184636e-08
for O 0 6.01874383665546e-10
PAX6 O 0 1.410975755788968e-06
mutation O 0 8.911658966326286e-08
analysis O 0 7.266242718628746e-09
and O 0 6.714009903596718e-10
that O 0 2.2981541669686578e-10
the O 0 2.8673761143238607e-09
missing O 0 6.89454395796929e-07
PAX6 O 0 8.536864334018901e-05
missense O 0 7.896383613115177e-05
mutations O 0 2.2578837160835974e-05
frequently O 0 4.359153081168188e-06
may O 0 7.407178372886847e-07
underlie O 0 6.479422609118046e-06
phenotypes O 0 4.467066446522949e-06
distinct O 0 4.30679648388832e-07
from O 0 6.931701790335865e-08
textbook O 0 8.483570127282292e-05
aniridia B-Disease 1 0.9999992847442627
. O 0 4.393103608890669e-06

Here O 0 4.5257377223606454e-07
we O 0 3.263399506181486e-08
present O 0 1.0538939498871969e-08
four O 0 6.8735199754144105e-09
novel O 0 1.8308480775885982e-07
PAX6 O 0 1.936580883921124e-05
missense O 0 7.099979484337382e-06
mutations O 0 1.4508225376630435e-06
, O 0 2.5233075628960933e-09
two O 0 9.992899840938207e-10
in O 0 2.052389591611359e-09
association O 0 3.945226367818577e-09
with O 0 5.297897232026116e-09
atypical O 0 4.475888545130147e-06
phenotypes O 0 2.738226430665236e-05
ectopia B-Disease 0 2.4075272449408658e-05
pupillae I-Disease 0 1.2872055776824709e-05
( O 0 1.0924954274571519e-08
displaced B-Disease 0 1.2709628549600893e-07
pupils I-Disease 0 9.729179737405502e-07
) O 0 3.6123367408436025e-08
and O 0 3.764807843253948e-07
congenital B-Disease 1 0.999825656414032
nystagmus I-Disease 0 9.059196599991992e-06
( O 0 2.441982172030066e-09
searching B-Disease 0 3.741006793234192e-08
gaze I-Disease 0 8.932809691941657e-07
) O 0 1.7465913160208402e-09
, O 0 1.7383414152583043e-10
and O 0 6.616655001678851e-10
two O 0 9.157292701900133e-10
in O 0 1.4863329456105134e-09
association O 0 4.681595111577508e-10
with O 0 1.0243302039913971e-10
more O 0 1.3499081852330619e-09
recognizable O 0 0.008023533970117569
aniridia B-Disease 1 1.0
phenotypes O 0 0.0001283290039282292
. O 0 2.0464431145228446e-06

Strikingly O 0 1.0668641152733471e-06
, O 0 1.3276884480717399e-08
all O 0 1.0621086232731614e-09
four O 0 2.292096512590547e-09
mutations O 0 3.241847679191778e-08
are O 0 2.454149106156933e-10
located O 0 1.118812265055169e-09
within O 0 1.2050979103506165e-09
the O 0 3.1021116786433822e-09
PAX6 O 0 1.7565129155627801e-06
paired O 0 1.240661902102147e-07
domain O 0 5.116276469152581e-08
and O 0 1.5381315776608062e-08
affect O 0 3.1607761741270224e-08
amino O 0 1.622769829623394e-08
acids O 0 2.151018385632142e-08
which O 0 6.455876944144734e-10
are O 0 1.2796132209391686e-10
highly O 0 3.022468941793477e-10
conserved O 0 1.0295526653436582e-09
in O 0 3.502061696192271e-10
all O 0 2.6248045403853837e-10
known O 0 3.898868783380749e-09
paired O 0 9.720547211600206e-08
domain O 0 9.479555984626131e-08
proteins O 0 6.664816964985221e-08
. O 0 1.4154973371205415e-07

Our O 0 8.918611911212793e-07
results O 0 1.5783004414515744e-07
support O 0 3.285657301788092e-09
the O 0 1.4766794731446709e-10
hypothesis O 0 1.7528853923920451e-09
that O 0 3.542476034734676e-11
the O 0 2.812862616441425e-11
under O 0 3.371460333134735e-10
- O 0 2.0411007994880492e-08
representation O 0 1.7448540390319067e-08
of O 0 9.494892649897224e-10
missense O 0 5.469667485158425e-06
mutations O 0 2.2787169200455537e-06
is O 0 7.624883835433138e-09
caused O 0 1.1120494747274279e-08
by O 0 9.407105094894064e-10
ascertainment O 0 1.8819487195287365e-06
bias O 0 6.491099156846758e-06
and O 0 2.380059926920808e-09
suggest O 0 4.479660198342117e-09
that O 0 9.276460155582811e-11
a O 0 4.3478082245584915e-10
substantial O 0 1.514917613576472e-08
burden O 0 7.177893053267326e-07
of O 0 8.573357024310724e-10
PAX6 B-Disease 0 0.00014320373884402215
- I-Disease 1 0.5698664784431458
related I-Disease 0 1.5965584680088796e-05
disease I-Disease 0 5.605702426692005e-06
remains O 0 5.856402029991159e-09
to O 0 5.571548222782496e-10
be O 0 1.2888778933017875e-09
uncovered O 0 4.167004306054878e-07
. O 0 1.0913603354367751e-08
. O 0 8.496738956864647e-08

The O 0 1.4118195679202472e-07
chromosomal O 0 8.896024155546911e-06
order O 0 2.0372269204926852e-08
of O 0 3.0319494137565073e-10
genes O 0 4.466710734618573e-08
controlling O 0 6.382154538187024e-07
the O 0 8.385069527605538e-09
major O 0 5.531581592777002e-08
histocompatibility O 0 9.30570138280018e-07
complex O 0 3.932449388344139e-08
, O 0 1.631875634622304e-09
properdin O 0 3.0092823521954415e-07
factor O 0 1.3911618168549467e-07
B O 0 1.2339941122263554e-06
, O 0 1.0165648323123833e-09
and O 0 2.486075167951185e-08
deficiency B-Disease 0 3.450843735208764e-07
of I-Disease 0 1.5154355201274505e-11
the I-Disease 0 1.3879503102387503e-10
second I-Disease 0 7.876171714826796e-09
component I-Disease 0 7.478278263306493e-08
of I-Disease 0 1.1498203500437398e-09
complement I-Disease 0 1.4003984460941865e-07
. O 0 1.867611700845373e-07

The O 0 6.323725187939999e-08
relationship O 0 8.452610700260266e-08
of O 0 2.649410690835907e-10
the O 0 4.3268616467528886e-10
genes O 0 1.2512961333754902e-08
coding O 0 9.2393385386913e-08
for O 0 3.9113354222131136e-10
HLA O 0 1.2299643969981844e-08
to O 0 1.8992246664240042e-10
those O 0 3.4398914272593117e-10
coding O 0 4.7376161660395155e-08
for O 0 4.830757460716484e-10
properdin O 0 2.8083030656489427e-07
Factor O 0 9.643154896821216e-08
B O 0 8.274968621435619e-08
allotypes O 0 6.99142645999018e-08
and O 0 1.455495390878525e-09
for O 0 1.2116989633881303e-09
deficiency B-Disease 0 5.26076320284119e-08
of I-Disease 0 3.74966464128379e-12
the I-Disease 0 3.7545255099358243e-11
second I-Disease 0 2.2892481243985685e-09
component I-Disease 0 1.6179763306922723e-08
of I-Disease 0 9.318239929667627e-11
complement I-Disease 0 8.811847251877225e-09
( O 0 3.907979495565428e-10
C2 O 0 3.799759440425987e-08
) O 0 7.120788680925472e-11
was O 0 1.4210407850434592e-10
studied O 0 9.64533453107208e-10
in O 0 5.590397242349887e-11
families O 0 3.0997326927462154e-10
of O 0 1.1311818842729693e-10
patients O 0 3.776883161776823e-08
with O 0 1.2280984229562364e-08
connective O 0 0.27349767088890076
tissue O 1 0.9997532963752747
disorders O 1 0.9995520710945129
. O 0 1.5393223975479486e-06

Patients O 0 1.6194653653656133e-05
were O 0 2.568378176803776e-09
selected O 0 7.710875826738572e-10
because O 0 8.762099934500611e-10
they O 0 2.5433008477016017e-10
were O 0 1.8394509526675762e-10
heterozygous O 0 2.038836122153498e-08
or O 0 5.1670343559351295e-09
homozygous O 0 9.071006388694514e-06
for O 0 8.670678653288633e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.0213638006462133e-06

12 O 0 5.305534500621434e-07
families O 0 2.6592351431986572e-08
with O 0 1.4362080413832246e-09
15 O 0 3.861229558310697e-09
matings O 0 8.925401289161528e-07
informative O 0 1.800930590434291e-06
for O 0 0.00023600323766004294
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 4.688525478968586e-08
found O 0 8.961190900436122e-08
. O 0 3.807740540651139e-07

Of O 0 5.882275644353285e-08
57 O 0 9.252829613615177e-08
informative O 0 7.35776168880875e-08
meioses O 0 4.818918455384846e-07
, O 0 3.8725120332649965e-10
two O 0 6.730598023363399e-11
crossovers O 0 2.5462011166155207e-08
were O 0 1.7717288747221005e-09
noted O 0 3.5655134400514044e-09
between O 0 6.501837290784351e-09
the O 0 0.0002540219575166702
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 7.787043188045573e-08
and O 0 1.4958148053523246e-09
the O 0 9.06167918479639e-10
HLA O 0 7.487111588488915e-07
- O 0 4.795931090484373e-06
B O 0 9.030388525843591e-08
gene O 0 4.896791860886651e-09
, O 0 6.959684911711506e-11
with O 0 1.0385730470074961e-11
a O 0 7.655156369912319e-11
recombinant O 0 1.7098061855236324e-09
fraction O 0 9.225264996359783e-09
of O 0 7.823793835015636e-10
0 O 0 5.242642941993836e-08
. O 0 1.1184783232920381e-07

035 O 0 0.05756213515996933
. O 0 0.00012514022819232196

A O 0 5.211457505538419e-07
lod O 0 5.78343024244532e-05
score O 0 4.1272045336882e-08
of O 0 2.36838437750464e-10
13 O 0 4.548579568552924e-10
was O 0 2.8286009645661636e-10
calculated O 0 3.1644180609191608e-09
for O 0 9.098673481311437e-10
linkage O 0 1.235356194229098e-05
between O 0 0.08723705261945724
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.072052917081237e-09
HLA O 0 3.0247619520196167e-07
- O 0 6.5195749812119175e-06
B O 0 1.0565188546252102e-07
at O 0 1.392481963069514e-10
a O 0 7.647801836263568e-11
maximum O 0 3.283839034029512e-10
likelihood O 0 2.4479980265113e-09
value O 0 2.821100575367552e-10
of O 0 7.0789814982097354e-12
the O 0 1.8077915900360786e-11
recombinant O 0 8.472520462987632e-10
fraction O 0 3.584469832063064e-09
of O 0 5.153802939972252e-10
0 O 0 5.060915597709936e-08
. O 0 7.009679592329121e-08

04 O 0 0.0018666487885639071
. O 0 9.809239600144792e-06

18 O 0 1.1893536111529102e-06
families O 0 1.2884458833184453e-08
with O 0 7.586669070747121e-10
21 O 0 1.3825557365620966e-09
informative O 0 6.847284517164098e-09
matings O 0 2.261655822621833e-07
for O 0 1.1563964230631996e-09
both O 0 2.7955786574551666e-09
properdin O 0 1.627789060876239e-06
Factor O 0 1.9456646782600728e-07
B O 0 1.5490520866023871e-07
allotype O 0 1.1697743218519463e-07
and O 0 3.0178848309247996e-09
HLA O 0 1.3505548395187361e-06
- O 0 0.0004029088595416397
B O 0 4.881017048319336e-06
were O 0 3.767765210938023e-09
found O 0 1.4210909782264025e-08
. O 0 4.287760191346024e-08

Of O 0 2.292954803806424e-08
72 O 0 7.852625572013494e-08
informative O 0 3.0417186991371636e-08
meioses O 0 3.675155824112153e-07
, O 0 7.86526899165807e-10
three O 0 3.8371467114828306e-10
recombinants O 0 1.6979164740860142e-07
were O 0 1.5722056989631028e-09
found O 0 7.652211642117379e-10
, O 0 3.9063682844009406e-11
giving O 0 9.801184169822008e-11
a O 0 5.2294720637169334e-11
recombinant O 0 2.0927655164371117e-09
fraction O 0 1.0389271665189881e-08
of O 0 2.1099679781144687e-09
0 O 0 1.1381988684888711e-07
. O 0 1.725089049386952e-07

042 O 0 0.0018217309843748808
. O 0 1.5851495845708996e-05

A O 0 4.521449454841786e-07
lod O 0 5.475245779962279e-05
score O 0 5.1020101921039895e-08
of O 0 4.3887840583956006e-10
16 O 0 1.3334765514017022e-09
between O 0 3.971687423387493e-10
HLA O 0 4.276130312064197e-07
- O 0 3.2825246307766065e-05
B O 0 7.666513397452945e-07
and O 0 1.6435048877383451e-09
Factor O 0 1.068468957754476e-08
B O 0 9.220796570730272e-09
allotypes O 0 1.768218815811906e-08
was O 0 3.4626349010302704e-10
calculated O 0 2.5922870516836838e-09
at O 0 5.290290427950595e-10
a O 0 8.150799479800241e-11
maximum O 0 5.361683874660628e-10
likelihood O 0 4.671242059828273e-09
value O 0 8.047643107467195e-10
of O 0 1.9224875164036703e-11
the O 0 5.5198425691349584e-11
recombinant O 0 3.2334350752449836e-09
fraction O 0 6.12592465643047e-09
of O 0 1.141669092596942e-09
0 O 0 7.230053000739645e-08
. O 0 1.1024661006331371e-07

04 O 0 0.001999468309804797
. O 0 1.165956291515613e-05

A O 0 8.317788768863466e-08
crossover O 0 1.5872514325110387e-07
was O 0 6.182667711129852e-09
shown O 0 7.688230052593781e-10
to O 0 1.5041221046452335e-10
have O 0 3.6382424850600614e-10
occurred O 0 9.903510234110513e-10
between O 0 3.387515268293839e-11
genes O 0 2.2846418090693987e-09
for O 0 7.281374947432084e-10
Factor O 0 2.56397445497214e-08
B O 0 4.704039469061172e-08
and O 0 1.8117146671770001e-09
HLA O 0 3.2692003060219577e-07
- O 0 6.403067800420104e-06
D O 0 5.516857982001966e-06
, O 0 2.1109088088611117e-10
in O 0 1.527129811496053e-10
which O 0 4.896325123127099e-09
HLA O 0 7.162357746892667e-07
- O 0 3.2785965231596492e-06
D O 0 1.0482204970685416e-06
segregared O 0 6.055331880361337e-08
with O 0 4.16987333551333e-10
HLA O 0 2.6179782253166195e-07
- O 0 1.0853175353986444e-06
A O 0 1.7411935004929546e-08
and O 0 4.655331764524817e-08
B O 0 1.1568711215659278e-06
. O 0 9.296097402966552e-08

These O 0 2.779666452568108e-08
studies O 0 1.691351059207591e-08
suggest O 0 2.3667419135620094e-09
that O 0 2.6774409078722528e-11
the O 0 1.9845430854203983e-11
genes O 0 2.6223241356149174e-09
for O 0 9.554078639339991e-10
Factor O 0 3.027243110409472e-06
B O 1 0.9909150004386902
and O 1 0.9951007962226868
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.8563101883705144e-10
located O 0 1.0758932633692098e-10
outside O 0 3.085163791105572e-10
those O 0 1.6559804916216336e-10
for O 0 6.3036180442122e-11
HLA O 0 8.261339168313953e-09
, O 0 1.1389410942141964e-10
that O 0 5.375740477764346e-11
the O 0 7.151823577800087e-11
order O 0 3.0374483483974757e-10
of O 0 2.5863877012310965e-11
genese O 0 6.706119393129484e-08
is O 0 5.819363879666639e-10
HLA O 0 7.079076169702603e-08
- O 0 1.2826865258830367e-07
A O 0 1.1245373521262536e-09
, O 0 5.813129977383369e-10
- O 0 1.4578974116830068e-07
B O 0 6.122843387856847e-08
, O 0 2.96563773538594e-10
- O 0 1.1243303532637583e-07
D O 0 2.522900786061655e-07
, O 0 8.526082062587648e-10
Factor O 0 4.383133500596159e-08
B O 0 3.3600917959120125e-07
allotype O 0 5.117192358738976e-06
, O 0 3.0157975743350107e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 6.576452576956271e-11
that O 0 2.1634121577518428e-11
the O 0 4.0473787515926674e-11
genes O 0 8.232491133242092e-09
coding O 0 7.008428383414866e-06
for O 0 1.054090830621135e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.5655006180281816e-08
Factor O 0 4.921852081452016e-08
B O 0 9.16283937613116e-08
allotypes O 0 6.486591530574515e-08
are O 0 2.0057325245126378e-10
approximately O 0 2.654681474645315e-10
3 O 0 2.10138928480319e-09
- O 0 1.1783627087424975e-06
- O 0 3.6414260762285267e-07
5 O 0 1.071206789937662e-09
centimorgans O 0 1.8321662409448436e-08
from O 0 9.341694778841614e-11
the O 0 2.5761090483022997e-10
HLA O 0 6.462671109375151e-08
- O 0 7.738420038094773e-08
A O 0 1.3530350173596162e-09
and O 0 2.133374366053431e-09
HLA O 0 1.6532291624571371e-07
- O 0 5.25850680332951e-07
B O 0 1.3762289974295072e-08
loci O 0 1.0236939074204088e-09
, O 0 3.7900543814473053e-11
and O 0 3.139214235781118e-11
that O 0 4.443514653451608e-11
the O 0 1.1517952563933065e-10
apparent O 0 2.4963769718056028e-08
lack O 0 1.867517696041432e-09
of O 0 4.733020919633901e-11
recombinants O 0 3.2778597613969396e-08
between O 0 5.466890828920157e-10
the O 0 1.4109836632414385e-09
Factor O 0 1.6520345980097773e-07
B O 0 6.194734396558488e-07
gene O 0 1.8942830593005056e-06
and O 0 0.4166971743106842
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 8.654396310703305e-08
suggests O 0 1.4714655272030086e-08
that O 0 1.0540637807032738e-10
these O 0 1.0248656784339616e-10
two O 0 2.269102128416023e-10
genes O 0 1.724828457838612e-08
lie O 0 1.4036355366897624e-07
in O 0 7.035484417272642e-10
close O 0 3.6251939228293395e-09
proximity O 0 1.707196872757777e-08
to O 0 2.426974621272393e-09
one O 0 6.784894868161473e-09
another O 0 3.182948660196416e-08
. O 0 1.907409910018032e-07

Distribution O 0 5.509285188054491e-07
of O 0 1.3808776344603757e-08
emerin O 0 3.666708380478667e-06
and O 0 2.0518818644177372e-08
lamins O 0 6.191932698129676e-06
in O 0 4.433284406246685e-09
the O 0 1.4662788760944068e-09
heart O 0 4.8703594046628496e-08
and O 0 8.136498141908532e-10
implications O 0 4.62813396495676e-08
for O 0 2.731334936001417e-09
Emery B-Disease 0 1.479446655139327e-05
- I-Disease 0 0.0006161315250210464
Dreifuss I-Disease 0 0.001681602792814374
muscular I-Disease 0 9.000308637041599e-05
dystrophy I-Disease 0 0.0002738701878115535
. O 0 2.4658925212861504e-06

Emerin O 0 0.00016082498768810183
is O 0 1.5554056176370068e-07
a O 0 2.360404671719607e-08
nuclear O 0 6.513719199574552e-07
membrane O 0 1.6466497498868193e-08
protein O 0 9.97820048809217e-09
which O 0 5.520877643938604e-10
is O 0 4.244127549402066e-10
missing O 0 5.983424866684572e-09
or O 0 4.166313960496382e-09
defective O 0 2.324541839016092e-07
in O 0 7.0983672273428056e-09
Emery B-Disease 0 0.009603200480341911
- I-Disease 0 0.08767827600240707
Dreifuss I-Disease 0 0.11014463007450104
muscular I-Disease 0 0.00018811767222359776
dystrophy I-Disease 0 0.00012068451178492978
( O 0 3.4501132972764026e-07
EDMD B-Disease 1 0.9999998807907104
) O 0 3.1324489668804745e-07
. O 0 5.241657845544978e-07

It O 0 1.3574434376550926e-07
is O 0 3.475684851039773e-09
one O 0 1.2091754264531573e-09
member O 0 4.61114146865782e-10
of O 0 4.6806104131436044e-11
a O 0 1.0762694069299528e-09
family O 0 1.5025237942722924e-08
of O 0 1.4573844353549248e-09
lamina O 1 0.7573100328445435
- O 1 0.7832406163215637
associated O 0 1.1111975339872515e-07
proteins O 0 7.2473773649051054e-09
which O 0 1.2450699360400108e-09
includes O 0 1.358024914743794e-09
LAP1 O 0 6.496546802736702e-07
, O 0 1.289964912665198e-09
LAP2 O 0 1.3220868595453794e-06
and O 0 4.130898290100049e-08
lamin O 0 5.497046731761657e-05
B O 0 2.3400110876536928e-05
receptor O 0 1.783318339221296e-06
( O 0 2.621745132103115e-08
LBR O 0 6.742183904862031e-05
) O 0 1.1448778280964689e-07
. O 0 2.1777363201636035e-07

A O 0 5.568631422647741e-07
panel O 0 5.344658688954951e-07
of O 0 3.2326765708745597e-09
16 O 0 1.787663528318717e-08
monoclonal O 0 2.8211528046995227e-07
antibodies O 0 8.620835956207884e-08
( O 0 8.70825134224873e-10
mAbs O 0 1.2773691082657024e-07
) O 0 9.890843699622565e-10
has O 0 3.470039811048764e-10
been O 0 2.6623739324271867e-10
mapped O 0 1.6496581878300276e-08
to O 0 2.3640697732751903e-10
six O 0 1.4717867202751478e-10
specific O 0 9.20609630195024e-11
sites O 0 3.3167875113093714e-09
throughout O 0 2.5188262586794963e-09
the O 0 8.155531805442706e-10
emerin O 0 1.4353685173773556e-07
molecule O 0 6.654247375337263e-09
using O 0 9.023567670851662e-09
phage O 0 3.081609349919745e-07
- O 0 2.851642477708083e-08
displayed O 0 1.2815336569715896e-09
peptide O 0 3.936229120427015e-09
libraries O 0 8.809423190925258e-10
and O 0 1.6092185917138124e-10
has O 0 1.1013632367218307e-10
been O 0 1.0111574771931586e-10
used O 0 3.8136815927458656e-10
to O 0 3.385650371168225e-10
localize O 0 9.402610601227934e-08
emerin O 0 3.3904299812093086e-07
in O 0 1.1820912027005193e-09
human O 0 5.039557660069249e-09
and O 0 1.3493168360412255e-08
rabbit O 0 6.491408839792712e-06
heart O 0 3.103371273027733e-05
. O 0 6.575633619831933e-07

Several O 0 1.9990591226815013e-07
mAbs O 0 4.8591782615403645e-06
against O 0 1.5678912390626465e-08
different O 0 5.627472265956612e-09
emerin O 0 8.109846021397971e-07
epitopes O 0 2.1599330466415267e-06
did O 0 5.44450315942413e-08
not O 0 2.1707511344004615e-09
recognize O 0 1.1594669224734844e-08
intercalated O 0 2.7546283476453937e-08
discs O 0 5.0472849011384824e-08
in O 0 6.021534937339368e-10
the O 0 3.2575506181409253e-10
heart O 0 4.0737486273201284e-08
, O 0 1.327398468919938e-10
though O 0 1.1017083911823988e-09
they O 0 4.898059735580773e-10
recognized O 0 3.6806251380028243e-09
cardiomyocyte O 0 3.3441040159232216e-08
nuclei O 0 3.845215257314294e-09
strongly O 0 2.43167774804931e-09
, O 0 3.560863270912762e-10
both O 0 7.620052921986087e-10
at O 0 4.861002267375625e-09
the O 0 4.0561293213059457e-10
rim O 0 4.432280320543214e-08
and O 0 1.97756988562503e-09
in O 0 1.2844457719651814e-09
intranuclear O 0 4.518660716712475e-07
spots O 0 4.0268724887937424e-07
or O 0 8.77097079410305e-08
channels O 0 2.105331532220589e-06
. O 0 3.876928929003043e-07

A O 0 3.2471807571710087e-06
polyclonal O 0 6.600718916160986e-05
rabbit O 0 1.6026113371481188e-05
antiserum O 0 2.3075372155290097e-05
against O 0 7.97820263187532e-08
emerin O 0 2.032381189565058e-06
did O 0 1.3942426768664973e-08
recognize O 0 1.8168682558439286e-08
both O 0 2.2254524889575578e-09
nuclear O 0 1.453169460319259e-07
membrane O 0 5.6642250889638035e-09
and O 0 2.8297231224883035e-10
intercalated O 0 5.874906339187191e-09
discs O 0 2.5796813574174848e-08
but O 0 8.620745783893824e-10
, O 0 2.5062438235856632e-11
after O 0 1.0567612757084177e-10
affinity O 0 7.371661614463676e-10
purification O 0 1.2163949847376898e-09
against O 0 4.419646593145643e-10
a O 0 2.850003011367619e-10
pure O 0 1.721863540637969e-08
- O 0 7.935796588753874e-07
emerin O 0 5.900366772948473e-07
band O 0 1.1091707108334958e-08
on O 0 5.125550539553103e-10
a O 0 2.340818650026222e-10
western O 0 6.410443287307999e-09
blot O 0 3.2170974009204656e-05
, O 0 2.3582613639661076e-09
it O 0 2.061861348323646e-09
stained O 0 4.641031409846619e-05
only O 0 2.709841684378489e-09
the O 0 3.948207094595091e-09
nuclear O 0 6.777549970138352e-07
membrane O 0 3.500643401821435e-07
. O 0 1.4372891143921152e-07

These O 0 2.5771733191959356e-08
results O 0 2.2270205235486173e-08
would O 0 3.863253605906891e-10
not O 0 1.4060451414277253e-10
be O 0 9.7579090641009e-11
expected O 0 2.716246672029854e-10
if O 0 9.413853030437735e-10
immunostaining O 0 1.5654677554266527e-08
at O 0 1.4999995689990442e-10
intercalated O 0 2.0943708989307197e-09
discs O 0 5.269329506063514e-08
were O 0 1.0296533403675312e-08
due O 0 3.2239759750751773e-09
to O 0 1.7192332280036027e-10
a O 0 3.0296604114354864e-10
product O 0 4.792417129806381e-09
of O 0 3.012303601002131e-11
the O 0 1.04882158513675e-10
emerin O 0 3.5192673664141694e-08
gene O 0 1.0638547820462918e-08
and O 0 1.4178224150285246e-09
, O 0 1.566667073849004e-10
therefore O 0 2.181791275424061e-10
, O 0 5.1673346157521394e-11
cast O 0 1.4767759237699352e-09
some O 0 6.615970271628413e-11
doubt O 0 9.58377377457964e-10
upon O 0 3.251440783280657e-11
the O 0 4.6430696093446855e-11
hypothesis O 0 1.5965875732604218e-08
that O 0 3.6923746282724323e-09
cardiac B-Disease 0 3.6355038446345134e-06
defects I-Disease 0 0.07142387330532074
in O 0 9.238894982388501e-09
EDMD B-Disease 1 1.0
are O 0 7.696747417185179e-08
caused O 0 9.68006208523775e-09
by O 0 4.759475591420426e-10
absence O 0 1.1609850858462778e-08
of O 0 2.7221280785028057e-10
emerin O 0 8.764570793573512e-07
from O 0 3.338264775720745e-09
intercalated O 0 1.1812510365416529e-06
discs O 0 3.1512463465332985e-06
. O 0 3.8318123074532195e-07

Although O 0 6.121372280176729e-07
emerin O 0 4.977304342901334e-06
was O 0 9.009895052258798e-09
abundant O 0 2.223466744055713e-09
in O 0 6.963923881997403e-10
the O 0 5.541861969327044e-10
membranes O 0 4.0432649228705486e-08
of O 0 1.3004088084134224e-10
cardiomyocyte O 0 9.708911363759398e-08
nuclei O 0 8.789958094723715e-09
, O 0 6.7371647149983e-10
it O 0 1.3379070074037713e-09
was O 0 4.464732583642217e-09
absent O 0 5.142709369465592e-09
from O 0 1.960129281108891e-10
many O 0 1.7386407868968945e-09
non O 0 5.502264457390993e-07
- O 0 7.904858421170502e-07
myocyte O 0 1.9583098946895916e-06
cells O 0 4.594816260805601e-08
in O 0 1.6716071860045645e-09
the O 0 9.023739977465084e-09
heart O 0 1.8370496945863124e-06
. O 0 1.9875277246228507e-07

This O 0 1.3006087762335028e-08
distribution O 0 9.47566558551216e-09
of O 0 1.474529248701728e-10
emerin O 0 2.3018640149530256e-07
was O 0 1.5497865213376372e-09
similar O 0 3.1096691888166106e-10
to O 0 1.6605350428022803e-10
that O 0 7.498878601408521e-11
of O 0 3.953922952937283e-11
lamin O 0 2.8213199243509735e-07
A O 0 3.035121931560525e-09
, O 0 1.6440088179692225e-10
a O 0 9.150392249468453e-11
candidate O 0 3.4478608856858273e-09
gene O 0 1.3456569192271672e-08
for O 0 8.208466684145321e-10
an O 0 1.120488701822353e-09
autosomal O 0 2.1396819647634402e-05
form O 0 4.2447877035556303e-07
of O 0 2.184721523690314e-07
EDMD B-Disease 1 1.0
. O 0 4.926585461362265e-06

In O 0 1.9533990780473687e-07
contrast O 0 1.1296930324533605e-06
, O 0 8.713908528079628e-08
lamin O 0 0.00012488036009017378
B1 O 0 0.0020389207638800144
was O 0 3.181388663620055e-08
absent O 0 1.7048897404947638e-08
from O 0 4.962834587729503e-10
cardiomyocyte O 0 7.517018474345605e-08
nuclei O 0 1.70445719760437e-08
, O 0 6.335780233790445e-10
showing O 0 3.985730501199214e-08
that O 0 5.695132365701738e-09
lamin O 0 1.4089953765505925e-05
B1 O 0 2.075795055134222e-05
is O 0 4.809079801049165e-10
not O 0 2.3436599883019937e-10
essential O 0 6.651489914411002e-10
for O 0 4.619713292464134e-11
localization O 0 3.13551318242844e-09
of O 0 7.540212898504706e-11
emerin O 0 1.0445926079682977e-07
to O 0 1.6912856670714405e-09
the O 0 7.238770471929001e-09
nuclear O 0 2.3209368009702303e-06
lamina O 0 1.9755743778659962e-05
. O 0 8.357224601240887e-07

Lamin O 1 0.8019580841064453
B1 O 1 0.9395388960838318
is O 0 4.767002437233714e-08
also O 0 8.56102477797549e-09
almost O 0 5.628008725722111e-09
completely O 0 4.508282813731057e-07
absent O 0 3.0474214440801006e-07
from O 0 1.5142937570544746e-08
skeletal O 0 1.7539754480822012e-05
muscle O 0 3.182482032570988e-05
nuclei O 0 7.807782822055742e-06
. O 0 1.0036455933004618e-06

In O 0 7.37576044684829e-07
EDMD B-Disease 1 0.9999979734420776
, O 0 5.5659428177534664e-09
the O 0 5.018653270738582e-10
additional O 0 3.551010152591516e-09
absence O 0 1.4485944888065205e-08
of O 0 2.0764081565260994e-09
lamin O 0 8.803949458524585e-05
B1 O 0 0.0011078728130087256
from O 0 4.5580135221712226e-09
heart O 0 9.898228654492414e-07
and O 0 9.908880826969835e-09
skeletal O 0 7.438754437316675e-06
muscle O 0 1.0460934163347702e-06
nuclei O 0 7.373285626499637e-08
which O 0 4.630695116247807e-08
already O 0 8.281205055027385e-08
lack O 0 2.7794424539706597e-09
emerin O 0 1.4477443244231836e-07
may O 0 2.718175906579745e-09
offer O 0 3.201088560889076e-10
an O 0 9.747227330825226e-12
alternative O 0 1.1616755335452922e-09
explanation O 0 9.70109104159178e-10
of O 0 3.4750716193521214e-11
why O 0 2.6205939640533416e-09
these O 0 2.3554999617481087e-10
tissues O 0 6.442251176963509e-09
are O 0 6.027682242226717e-10
particularly O 0 4.533044162258193e-09
affected O 0 1.7134176744093566e-08
. O 0 9.511645693294213e-09
. O 0 1.339493849172868e-07

Genetic O 0 1.5078504475241061e-05
mapping O 0 1.998758762056241e-06
of O 0 1.0065672739756337e-08
the O 0 1.3824271505313845e-08
copper B-Disease 0 1.1152951628901064e-05
toxicosis I-Disease 0 0.00015103905752766877
locus O 0 1.9911185518139973e-06
in O 0 1.3775026452833572e-08
Bedlington O 0 1.9330266241013305e-06
terriers O 0 1.0256136420139228e-06
to O 0 3.388287872496676e-09
dog O 0 4.592310531847943e-08
chromosome O 0 5.92483843320224e-07
10 O 0 2.819047439928113e-09
, O 0 2.0623715235590367e-10
in O 0 2.2438643998423657e-10
a O 0 1.374460212311135e-09
region O 0 3.509701684833999e-08
syntenic O 0 8.431483138338081e-07
to O 0 2.7072484254375695e-09
human O 0 1.3423910871779299e-08
chromosome O 0 3.0738826808374142e-06
region O 0 3.9631788695260184e-07
2p13 O 0 1.3904636034567375e-05
- O 0 1.192468153021764e-05
p16 O 0 1.3988468708703294e-05
. O 0 3.683338434257166e-07

Abnormal O 0 0.01964220032095909
hepatic B-Disease 0 0.3346942663192749
copper I-Disease 0 4.3024178012274206e-05
accumulation I-Disease 0 2.186789345159923e-07
is O 0 1.47134116001979e-09
recognized O 0 4.828097921460994e-09
as O 0 4.873442094321945e-09
an O 0 1.4389031832706678e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 5.3376801645299565e-08
man O 0 7.495999625461991e-07
, O 0 1.7135441954252428e-09
mouse O 0 2.75325021448225e-07
, O 0 1.1095663055016303e-08
rat O 0 2.137030151061481e-06
and O 0 4.681795928718202e-08
dog O 0 3.4421573218423873e-06
. O 0 1.398244876327226e-06

The O 0 9.554196367389522e-08
major O 0 2.3253312519955216e-07
cause O 0 2.014857045651297e-07
of O 0 3.5323792779706764e-09
hepatic B-Disease 0 0.00012572246487252414
copper I-Disease 0 5.608149149338715e-05
accumulation I-Disease 0 1.0247146065012203e-07
in O 0 3.0989539823167433e-09
man O 0 1.568235887816627e-07
is O 0 3.3023570544798986e-09
a O 0 6.657750351024561e-09
dysfunctional O 0 1.9821002297248924e-06
ATP7B O 0 1.7677032246865565e-06
gene O 0 5.853556785950786e-07
, O 0 1.780279745844382e-08
causing O 0 9.047540174833557e-07
Wilson B-Disease 0 3.0039602279430255e-05
disease I-Disease 0 3.8789879909018055e-05
( O 0 9.291790092902374e-08
WD B-Disease 1 0.9999936819076538
) O 0 4.136469158311229e-07
. O 0 4.922509333482594e-07

Mutations O 0 4.357940997579135e-05
in O 0 2.4740129944689215e-08
the O 0 1.3250212038684595e-09
ATP7B O 0 1.954114594582279e-07
genes O 0 1.8477022578622382e-08
have O 0 2.8175743960190403e-09
also O 0 7.281291680705237e-10
been O 0 1.5058969626835506e-09
demonstrated O 0 2.436408408357238e-09
in O 0 3.732521514088205e-10
mouse O 0 2.853890634924028e-07
and O 0 5.567984473486831e-08
rat O 0 1.2511344721133355e-05
. O 0 4.665002393267059e-07

The O 0 1.0739879741095137e-07
ATP7B O 0 1.721488160910667e-06
gene O 0 1.3034613743911905e-07
has O 0 7.542910296365335e-09
been O 0 1.9655026495257744e-09
excluded O 0 7.227581200197619e-09
in O 0 8.407834151125115e-11
the O 0 3.717996396868095e-11
much O 0 3.1795899246844783e-10
rarer O 0 9.936706391044936e-08
human O 0 7.651705047351243e-09
copper B-Disease 0 4.968539997207699e-06
overload I-Disease 0 2.987668949572253e-06
disease O 0 2.7299772682454204e-06
non B-Disease 0 1.2641558896575589e-05
- I-Disease 0 0.003917025402188301
Indian I-Disease 0 7.773166998958914e-07
childhood I-Disease 0 1.287511349801207e-05
cirrhosis I-Disease 0 2.154769390472211e-05
, O 0 4.7502632938289935e-09
indicating O 0 1.8482244001916115e-07
genetic O 0 3.5737818961933954e-06
heterogeneity O 0 4.3292522605042905e-05
. O 0 3.0587732453568606e-06

By O 0 5.1231900499715266e-08
investigating O 0 5.373051976675924e-07
the O 0 1.7185628919946794e-08
common O 0 9.083956342692545e-07
autosomal O 1 0.9418283700942993
recessive O 1 0.9650428295135498
copper B-Disease 0 0.013569602742791176
toxicosis I-Disease 0 0.043378595262765884
( O 0 3.69022217228121e-08
CT B-Disease 0 0.24510763585567474
) O 0 7.9940418729052e-09
in O 0 8.989378130763725e-10
Bedlington O 0 2.7849529260493e-07
terriers O 0 4.911901783088979e-07
, O 0 2.5249060620069486e-09
we O 0 1.9165764530981733e-09
have O 0 1.5581499979155922e-10
identified O 0 1.00749630860264e-09
a O 0 1.2883757949389008e-10
new O 0 1.8660792910907276e-09
locus O 0 1.4049291507944872e-07
involved O 0 3.6741948150620374e-08
in O 0 8.430648534840657e-08
progressive O 1 0.9697626829147339
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.4027104902634164e-06

We O 0 5.828562166243501e-07
examined O 0 1.6983311468266038e-07
whether O 0 3.257125413824724e-08
the O 0 8.159082298675457e-09
WD B-Disease 0 0.20257942378520966
gene O 0 5.264216724754078e-07
ATP7B O 0 4.437788902578177e-06
was O 0 5.672723180083494e-09
also O 0 3.5085603866669146e-10
causative O 0 3.394136527390401e-08
for O 0 2.6893884341738783e-10
CT B-Disease 0 5.589675492956303e-05
by O 0 4.866612668408266e-10
investigating O 0 3.3011307465358186e-08
the O 0 4.482839877084643e-09
chromosomal O 1 0.6705072522163391
co O 0 0.11402001231908798
- O 0 1.2183761100459378e-05
localization O 0 9.717469851011629e-08
of O 0 4.74805084138552e-10
ATP7B O 0 8.179933388419158e-07
and O 0 1.2691038220324913e-09
C04107 O 0 2.8645841254615334e-08
, O 0 7.419207609382639e-11
using O 0 7.231190646272978e-10
fluorescence O 0 2.4286428867981158e-08
in O 0 2.055833503433746e-09
situ O 0 1.59081409378814e-07
hybridization O 0 2.789349196063995e-07
( O 0 7.968436577243665e-09
FISH O 0 2.020398426338943e-07
) O 0 4.418740928713305e-08
. O 0 1.049135107678012e-07

C04107 O 0 0.00010028333053924143
is O 0 7.857014594492284e-08
an O 0 1.7327016488266622e-09
anonymous O 0 1.0372387038160014e-07
microsatellite O 0 9.009431778395083e-06
marker O 0 7.532216841354966e-07
closely O 0 3.1408006861965987e-07
linked O 0 2.025427193075302e-06
to O 0 3.419439664753554e-08
CT B-Disease 1 0.9941695928573608
. O 0 9.526334565634897e-07

However O 0 4.317774710216327e-06
, O 0 2.0003747636110347e-07
BAC O 0 2.960746087410371e-06
clones O 0 9.201597350738666e-08
containing O 0 4.734705072451106e-09
ATP7B O 0 8.23283016870846e-07
and O 0 1.6619490228464429e-09
C04107 O 0 7.3190882687868e-08
mapped O 0 6.360814097661205e-08
to O 0 9.5051844173355e-10
the O 0 1.6102326139133538e-09
canine O 0 1.468264713366807e-06
chromosome O 0 4.040473413624568e-06
regions O 0 1.5625688831732987e-07
CFA22q11 O 0 1.6612231092949514e-06
and O 0 3.3852385339372404e-09
CFA10q26 O 0 1.652155958709045e-07
, O 0 4.772792716600804e-10
respectively O 0 2.0737209727172967e-09
, O 0 1.4081706634083702e-10
demonstrating O 0 2.684618305437425e-09
that O 0 2.891419992323563e-09
WD B-Disease 1 0.9992733597755432
cannot O 0 1.3062825132692524e-07
be O 0 9.400935585546222e-10
homologous O 0 2.5270466608162678e-08
to O 0 6.78197054071461e-09
CT B-Disease 0 0.020801642909646034
. O 0 3.721578138993209e-07

The O 0 2.454081879932346e-07
copper O 0 1.6127464732562657e-06
transport O 0 3.477278198715794e-08
genes O 0 5.5396476739133504e-08
CTR1 O 0 8.04680439614458e-07
and O 0 1.30544941523425e-09
CTR2 O 0 2.7294777282804716e-07
were O 0 1.3294768619331876e-09
also O 0 8.822908514893868e-10
excluded O 0 1.0139491912752874e-08
as O 0 1.963032791874042e-10
candidate O 0 2.9095768017128876e-09
genes O 0 3.0355618019228814e-09
for O 0 3.007425419809806e-10
CT B-Disease 0 0.0661439374089241
since O 0 2.2920715991858742e-08
they O 0 6.547668518486205e-10
both O 0 3.5021416322500443e-10
mapped O 0 2.027764622880568e-07
to O 0 1.5115695362055703e-08
canine O 0 5.9849730860150885e-06
chromosome O 0 3.3722619264153764e-05
region O 0 8.77506045071641e-06
CFA11q22 O 0 0.00012994109420105815
. O 0 1.5406088778036064e-06

2 O 0 1.5924191757221706e-05
- O 0 0.0032124521676450968
22 O 0 1.2484590570238652e-06
. O 0 3.3065444426938484e-07

5 O 0 2.108242188114673e-05
. O 0 5.7573629419493955e-06

A O 0 1.926223660575488e-07
transcribed O 0 2.2812776023783954e-07
sequence O 0 6.185170775552251e-08
identified O 0 4.900241989957976e-08
from O 0 6.675765495955943e-10
the O 0 4.5005629778493983e-10
C04107 O 0 2.2830144530416874e-07
- O 0 5.505288669382935e-08
containing O 0 4.472207049133203e-09
BAC O 0 4.040181806885812e-07
was O 0 1.3801028098114898e-09
found O 0 2.342694649382082e-10
to O 0 4.883626142371256e-11
be O 0 5.800190883142875e-11
homologous O 0 1.4316625662758042e-09
to O 0 1.6947142300605123e-10
a O 0 3.860918251774592e-10
gene O 0 1.8875944363117014e-08
expressed O 0 9.777588738657528e-10
from O 0 3.491616717976598e-10
human O 0 2.548235400468002e-09
chromosome O 0 3.608955978506856e-07
2p13 O 0 8.160438369486656e-07
- O 0 2.531405982608703e-07
p16 O 0 1.073291784337016e-07
, O 0 1.511940794785005e-09
a O 0 8.252673544539846e-10
region O 0 2.2673306787623915e-08
devoid O 0 4.5285439398412564e-08
of O 0 2.3715712726968263e-10
any O 0 1.9237071935407357e-09
positional O 0 2.354317132358119e-07
candidate O 0 4.832061790693842e-07
genes O 0 2.829526465575327e-06
. O 0 1.0213052519247867e-06

Molecular O 0 5.683870767825283e-06
analysis O 0 2.4519343355677847e-07
of O 0 1.3992558223208107e-09
the O 0 1.900367196938646e-09
APC B-Disease 0 3.6727517027657086e-08
gene O 0 4.165593026073111e-08
in O 0 1.5018295496105338e-09
205 O 0 1.0190521315678325e-08
families O 0 3.880899157593376e-09
: O 0 1.322198683872955e-09
extended O 0 1.523515180679169e-08
genotype O 0 0.0004388944653328508
- O 0 0.00044313690159469843
phenotype O 0 2.347340796404751e-06
correlations O 0 2.842612332187855e-07
in O 0 1.2167847840416357e-09
FAP B-Disease 0 2.468310000836027e-08
and O 0 1.8892350184263051e-10
evidence O 0 4.646119322604392e-10
for O 0 3.425975822479721e-11
the O 0 5.56746593272095e-11
role O 0 6.6478786919788035e-09
of O 0 1.8409146429476664e-10
APC B-Disease 0 3.120628733199737e-08
amino O 0 2.8544505425998068e-08
acid O 0 4.990575774854733e-08
changes O 0 1.6358441712327476e-07
in O 0 4.177965456619859e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.006388077978044748
. O 0 3.9148280848166905e-06

BACKGROUND O 0 5.0646893214434385e-05
/ O 0 3.321948315715417e-05
AIMS O 0 4.1512851112202043e-07
The O 0 1.0469551892100526e-09
development O 0 5.2357549407133774e-09
of O 0 1.0338493439121521e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.1072071259832228e-08
a O 0 1.2032467244793565e-09
variable O 0 4.914853590776147e-08
range O 0 2.1428203211826258e-08
of O 0 2.0805153155833978e-09
extracolonic O 0 2.0049246813869104e-05
manifestations O 0 4.008394535048865e-05
in O 0 2.1864359950996004e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 9.009242489810276e-07
FAP B-Disease 0 2.6770296699396567e-06
) O 0 4.0222332131634175e-09
is O 0 2.6845603517955396e-10
the O 0 1.2583289965562017e-10
result O 0 1.2776286695270755e-09
of O 0 3.6940828868070597e-11
the O 0 9.4477958789696e-10
dominant O 0 2.542098081903532e-05
inheritance O 0 0.05164264887571335
of O 0 6.355287951009814e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 8.379698215321696e-07
APC B-Disease 0 2.6026884825114394e-06
) O 0 4.712382306593099e-08
gene O 0 2.895475290642935e-06
mutations O 0 3.1893301638774574e-05
. O 0 1.8201689044872182e-06

In O 0 1.8191290251934333e-08
this O 0 3.238543877515099e-10
study O 0 9.133500067370903e-10
, O 0 8.774136278644207e-11
direct O 0 8.987663946413704e-10
mutation O 0 2.5212932186491344e-08
analysis O 0 8.585601563027012e-09
of O 0 1.0067121442025595e-10
the O 0 3.3129418652855236e-10
APC B-Disease 0 5.830299354414592e-09
gene O 0 6.598296131699044e-09
was O 0 7.624763598279571e-10
performed O 0 1.118037884495493e-09
to O 0 3.0867880473905984e-10
determine O 0 1.1232843633024459e-07
genotype O 0 1.104351304093143e-05
- O 0 7.741970875940751e-06
phenotype O 0 3.779232997658255e-07
correlations O 0 7.767581422513103e-08
for O 0 5.986846018934955e-10
nine O 0 1.823849626880758e-09
extracolonic O 0 7.111284361371872e-08
manifestations O 0 1.3983361135672112e-08
and O 0 5.282889126156931e-10
to O 0 1.9925242011886724e-10
investigate O 0 5.7793689833829376e-09
the O 0 6.365480920145217e-10
incidence O 0 9.061304240276513e-07
of O 0 7.007213143062074e-10
APC B-Disease 0 9.0542243924574e-08
mutations O 0 2.4287547262247244e-07
in O 0 1.290310081003554e-08
non O 0 0.01620146632194519
- O 1 0.9999703168869019
FAP O 1 0.9998953342437744
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.8064416710549267e-06

METHODS O 0 6.344920166156953e-06
The O 0 2.088312633929945e-08
APC B-Disease 0 1.5394883234876033e-07
gene O 0 4.8229551907752466e-08
was O 0 5.918115775216393e-09
analysed O 0 2.1578724584969677e-08
in O 0 5.207954623109856e-10
190 O 0 4.638037953696994e-09
unrelated O 0 3.4465216458556824e-08
FAP B-Disease 0 3.250218583161768e-07
and O 0 9.077582241445725e-09
15 O 0 3.77859805666958e-08
non O 0 0.0013706550234928727
- O 1 0.99998939037323
FAP O 1 0.9999674558639526
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 5.861253953298728e-07
using O 0 4.0555065083935915e-08
denaturing O 0 3.251159068895504e-05
gradient O 0 6.831906830484513e-06
gel O 0 0.00014221988385543227
electrophoresis O 0 9.526656867819838e-06
, O 0 2.590230918642078e-09
the O 0 3.8831482473966616e-10
protein O 0 6.533737106906301e-09
truncation O 0 1.5259018937285873e-07
test O 0 8.06356865723501e-08
, O 0 1.9526850969509013e-10
and O 0 2.1137411265748085e-10
direct O 0 8.02727306847828e-09
sequencing O 0 5.009845835957094e-07
. O 0 4.3961321694041544e-07

RESULTS O 0 1.0526530786592048e-05
Chain O 0 8.623925396022969e-07
terminating O 0 3.860760955376463e-07
signals O 0 5.748337272848403e-08
were O 0 1.054713871795343e-09
only O 0 1.2394964221673632e-10
identified O 0 6.971569543878786e-09
in O 0 8.972025900000347e-10
patients O 0 6.580926026344969e-09
belonging O 0 1.6719451378932604e-09
to O 0 1.3902534679033351e-09
the O 0 1.6801096069940513e-09
FAP B-Disease 0 1.9697488085057557e-07
group O 0 7.158353909630932e-09
( O 0 4.558567412438208e-10
105 O 0 5.148028670021176e-09
patients O 0 1.0593135613135019e-07
) O 0 5.481888276648306e-09
. O 0 9.472687878542274e-08

Amino O 0 2.5556910259183496e-05
acid O 0 4.432882178662112e-06
changes O 0 1.522591297486997e-08
were O 0 4.018228527691292e-10
identified O 0 1.921653502989784e-09
in O 0 2.175359059553017e-10
four O 0 8.23138779360022e-10
patients O 0 4.6657473440347985e-09
, O 0 3.4517791402954856e-11
three O 0 5.1841263920548997e-11
of O 0 2.050415566501318e-11
whom O 0 3.0210640655781162e-09
belonged O 0 8.358099989891343e-09
to O 0 4.611704351731305e-10
the O 0 5.991632745505626e-10
non O 0 9.600440534995869e-06
- O 0 1.1959907169512007e-05
FAP O 0 1.1681205478453194e-06
group O 0 1.1923275167191605e-07
of O 0 3.553827809810173e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.127716627204791e-05
. O 0 3.3130339716080925e-07

Genotype O 1 0.9965865612030029
- O 1 0.9992247819900513
phenotype O 0 7.056696631480008e-05
correlations O 0 5.446369414130459e-06
identified O 0 2.4154496713890694e-07
significant O 0 2.011972277671248e-08
differences O 0 1.8609338781061524e-07
in O 0 1.3428257394920706e-09
the O 0 2.233134926976632e-10
nature O 0 9.912223264407771e-10
of O 0 4.5315355634567567e-11
certain O 0 2.4251005648068258e-09
extracolonic O 0 7.539057946814864e-07
manifestations O 0 1.8184080374794576e-07
in O 0 7.683044422890362e-09
FAP B-Disease 0 5.601655175269116e-07
patients O 0 5.198085517577056e-08
belonging O 0 2.91426438536746e-09
to O 0 7.021461745360114e-10
three O 0 1.1562205415316384e-08
mutation O 0 2.0414997834450332e-06
subgroups O 0 1.6507274267496541e-06
. O 0 5.149396429260378e-07

CONCLUSIONS O 0 6.334194949886296e-06
Extended O 0 7.789722644702124e-07
genotype O 0 0.00015335284115280956
- O 0 0.00023324813810177147
phenotype O 0 7.845953291507612e-07
correlations O 0 1.7265209351080557e-07
made O 0 7.794480616496458e-10
in O 0 1.2298646823172277e-10
this O 0 4.903694117430746e-11
study O 0 3.100406598122163e-10
may O 0 9.822298530082207e-10
have O 0 7.814453945043098e-11
the O 0 1.791039538900918e-11
potential O 0 5.510693013022205e-10
to O 0 4.047239973714589e-11
determine O 0 7.484564079618394e-10
the O 0 1.3892606683107989e-11
most O 0 4.07166071692e-11
appropriate O 0 1.7285778364239945e-10
surveillance O 0 3.1882758655399357e-09
and O 0 1.6298032368133875e-10
prophylactic O 0 2.901741780192424e-08
treatment O 0 4.150340071618075e-09
regimens O 0 1.0639664260736481e-08
for O 0 4.2403709016314295e-11
those O 0 3.4780042734716687e-10
patients O 0 1.080517364471234e-08
with O 0 2.1950315176599844e-10
mutations O 0 2.1968121188820078e-07
associated O 0 7.158817982855226e-09
with O 0 1.6075719644348396e-09
life O 0 2.1438550845687132e-07
threatening O 0 6.324776768451557e-05
conditions O 0 2.1001917502871947e-06
. O 0 8.239585440605879e-07

This O 0 1.117317971477405e-08
study O 0 3.6781759860105012e-09
also O 0 1.373657437797604e-10
provided O 0 3.3708542901411676e-11
evidence O 0 3.2407437844383935e-10
for O 0 6.793771101243351e-11
the O 0 2.936475507198111e-10
pathological O 0 6.10968413639057e-08
nature O 0 1.2721677933313913e-08
of O 0 5.318903095741234e-10
amino O 0 1.3067858617432648e-07
acid O 0 1.1887181727843199e-07
changes O 0 6.611977632076105e-09
in O 0 1.3793949316109888e-09
APC O 0 1.4368088940841517e-08
associated O 0 9.99678895219347e-10
with O 0 1.2936501869731387e-10
both O 0 1.8812675861568096e-09
FAP B-Disease 0 2.741439004694257e-07
and O 0 3.2707777819496187e-08
non O 0 0.018675068393349648
- O 1 0.9999926090240479
FAP O 1 0.9999860525131226
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.1320936209813226e-05
. O 0 3.1116183407675635e-08
. O 0 2.1811159456319729e-07

Inherited B-Disease 1 0.9999606609344482
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999994039535522
and O 0 0.12479068338871002
cancer B-Disease 1 0.9984740614891052
risk O 0 0.001294167130254209
of O 0 1.9813981566585426e-09
the O 0 1.6750167475265698e-08
APC O 0 2.7236894766247133e-06
I1307K O 0 6.721890713379253e-06
polymorphism O 0 1.4682374967378564e-05
. O 0 7.42554618682334e-07

Germ O 0 0.005839744582772255
- O 0 0.025829479098320007
line O 0 1.275792897104111e-06
and O 0 8.962777187093707e-09
somatic O 0 5.291668685458717e-07
truncating O 0 1.8718981209531194e-06
mutations O 0 5.534234901460877e-07
of O 0 4.402466724506837e-10
the O 0 4.797810482237708e-10
APC B-Disease 0 7.571204996281722e-09
gene O 0 4.1887679991248206e-09
are O 0 2.1979473796562843e-10
thought O 0 1.7979656652400422e-09
to O 0 1.6270955693897804e-09
initiate O 0 2.342957259315881e-06
colorectal B-Disease 1 1.0
tumor I-Disease 0 0.00010550359002081677
formation O 0 5.227004749031039e-06
in O 0 0.0002070005430141464
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.5279145120293833e-05
sporadic O 1 0.9991558790206909
colorectal O 1 1.0
carcinogenesis O 1 0.997583270072937
, O 0 5.39072857463907e-07
respectively O 0 2.6702600735006854e-06
. O 0 1.5808417401785846e-06

Recently O 0 5.429240445664618e-06
, O 0 1.3776524809827606e-08
an O 0 3.9104124383015915e-09
isoleucine O 0 3.937591827707365e-05
- O 0 6.812201900174841e-05
- O 0 1.1159100722579751e-05
> O 0 3.7249157003316213e-07
lysine O 0 6.852695833003963e-07
polymorphism O 0 7.535852546425303e-07
at O 0 2.4792470298962144e-08
codon O 0 2.8739705726366083e-07
1307 O 0 3.804887569458515e-07
( O 0 8.421287556181767e-10
I1307K O 0 2.4995118863557764e-08
) O 0 2.810884858206464e-10
of O 0 1.7485693448726636e-11
the O 0 2.2420761081054508e-10
APC B-Disease 0 6.416486453275638e-09
gene O 0 6.087859549808172e-09
has O 0 2.5470012765538286e-09
been O 0 9.620658714126762e-10
identified O 0 4.573025957910204e-09
in O 0 3.373480106372284e-10
6 O 0 1.329978904784923e-09
% O 0 6.304053945527244e-10
- O 0 1.54883039726883e-07
7 O 0 3.6214686804925122e-09
% O 0 2.2404005040055353e-10
of O 0 5.580361867041361e-11
the O 0 8.716265043062776e-09
Ashkenazi O 0 8.718663593754172e-06
Jewish O 0 3.875191225688468e-07
population O 0 5.883274667439764e-08
. O 0 1.5473629844109382e-07

To O 0 3.651197388876426e-08
assess O 0 3.1122422683438344e-07
the O 0 1.5555229326835729e-09
risk O 0 8.647152327512231e-08
of O 0 2.6334587288623368e-11
this O 0 1.7827449239060655e-10
common O 0 2.223336714735069e-08
APC B-Disease 0 2.491972281859489e-07
allelic O 0 1.2692444215645082e-06
variant O 0 5.338461050996557e-06
in O 0 5.708919275093649e-07
colorectal O 1 1.0
carcinogenesis O 0 0.010984238237142563
, O 0 1.4979910645251948e-08
we O 0 2.3081005995351234e-09
have O 0 1.798839271982544e-10
analyzed O 0 3.304071016785315e-09
a O 0 2.97280172700809e-10
large O 0 4.608040171660832e-09
cohort O 0 4.7110162881836004e-07
of O 0 1.786970571515667e-09
unselected O 0 8.13453079899773e-05
Ashkenazi O 0 0.00016383045294787735
Jewish O 0 4.031960258998879e-07
subjects O 0 1.723648637153019e-07
with O 0 6.850144895764743e-09
adenomatous B-Disease 0 5.225545828579925e-05
polyps I-Disease 0 2.512765240680892e-05
and O 0 4.5388923730627084e-09
. O 0 1.1591883897210664e-08
or O 1 0.9439351558685303
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.6048973261462152e-09
for O 0 2.507053176170615e-10
the O 0 2.64660382498505e-09
APC O 0 1.055430743690522e-06
I1307K O 0 2.802013113978319e-06
polymorphism O 0 6.609523552469909e-06
. O 0 5.082997063254879e-07

The O 0 4.5921703417661774e-07
APC O 0 4.267202712071594e-06
I1307K O 0 2.2908668597665383e-06
allele O 0 1.1939778232772369e-06
was O 0 1.0723704590986927e-08
identified O 0 1.0467680944259428e-08
in O 0 3.817735294564528e-10
48 O 0 2.3554294070748938e-09
( O 0 1.0950457207670183e-10
10 O 0 8.462212874871256e-11
. O 0 4.1049827426142826e-10
1 O 0 2.7732731666674226e-09
% O 0 5.25020249497743e-10
) O 0 2.8530813822591483e-10
of O 0 4.350014515264178e-10
476 O 0 4.0552055224907235e-07
patients O 0 7.699345019318571e-07
. O 0 2.3355279665793205e-07

Compared O 0 2.8419455588846176e-07
with O 0 4.2195094640540276e-10
the O 0 1.0577897585628548e-10
frequency O 0 1.0536587602416603e-08
in O 0 2.643081309372519e-10
two O 0 1.333786275869997e-10
separate O 0 2.6661000074312824e-09
population O 0 1.6050596407524154e-09
control O 0 1.225010315408781e-08
groups O 0 1.999881149572502e-09
, O 0 4.3743597633039144e-10
the O 0 4.4757378359072675e-10
APC O 0 3.2545976580422575e-08
I1307K O 0 9.562783276351183e-08
allele O 0 8.170952980890434e-08
is O 0 7.226751419509014e-10
associated O 0 1.1400980159947949e-09
with O 0 1.4010496929284244e-10
an O 0 2.1319332410563163e-10
estimated O 0 5.6195132991376795e-09
relative O 0 1.9911981326004025e-06
risk O 0 0.003482027444988489
of O 0 3.802440140532326e-09
1 O 0 2.9955154445815424e-07
. O 0 4.2881364947788825e-07

5 O 0 5.928443897573743e-06
- O 0 0.00014475316856987774
1 O 0 9.238190727955953e-07
. O 0 2.64736314647962e-07

7 O 0 3.342371428516344e-06
for O 0 6.048989575901942e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.09606767445802689
( O 0 2.20131006756219e-08
both O 0 3.634383105577399e-08
P O 1 0.9569965600967407
= O 0 1.8871731299441308e-05
. O 0 6.697823096146749e-08
01 O 0 3.131139465040178e-06
) O 0 1.9705675313730353e-08
. O 0 1.2125461523737613e-07

Furthermore O 0 3.508584711653384e-07
, O 0 2.425651013382435e-09
compared O 0 3.2117988268964837e-09
with O 0 5.140078918053348e-10
noncarriers O 0 4.7038602701832133e-07
, O 0 1.7690005016390842e-09
APC O 0 2.4432878831248672e-08
I1307K O 0 7.37263832206736e-08
carriers O 0 2.1613326239844355e-08
had O 0 1.0531880922926007e-09
increased O 0 4.70977146171947e-10
numbers O 0 1.2851097963562097e-09
of O 0 6.050880907437772e-10
adenomas B-Disease 0 0.0024617454037070274
and O 0 0.0006767026497982442
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.999895453453064
per O 0 4.3717950148902673e-08
patient O 0 2.454510195093462e-07
( O 0 5.278903092431619e-09
P O 0 0.008146028965711594
= O 0 1.632228645576106e-06
. O 0 7.47575068515971e-09
03 O 0 1.2981085717456153e-07
) O 0 2.858474013045509e-10
, O 0 3.667201958768018e-11
as O 0 1.0663992605630668e-10
well O 0 5.48684375711872e-10
as O 0 2.982724067734921e-10
a O 0 9.248868892974826e-10
younger O 0 2.3313569741389983e-08
age O 0 1.1621414941487274e-08
at O 0 2.7769957000600698e-08
diagnosis O 0 4.855542101722676e-06
. O 0 4.0934006051429606e-07

We O 0 4.3502765834091406e-07
conclude O 0 2.6688336873803564e-08
that O 0 5.921770851458064e-10
the O 0 6.21470541695146e-10
APC O 0 6.016396980612626e-08
I1307K O 0 5.6929845726472195e-08
variant O 0 6.644685868195666e-08
leads O 0 8.030626830191068e-09
to O 0 2.9023823344687116e-09
increased O 0 1.0201882361116077e-07
adenoma B-Disease 1 1.0
formation O 0 2.5934012271022766e-08
and O 0 1.5996837188225754e-09
directly O 0 7.944272462090396e-10
contributes O 0 1.0984351206388965e-09
to O 0 1.5325483937456141e-10
3 O 0 3.2693148188656096e-10
% O 0 1.975819508004406e-10
- O 0 2.70161688575854e-08
4 O 0 1.1967372648413743e-09
% O 0 1.6866588681274663e-10
of O 0 8.042667226648703e-11
all O 0 1.714784225725907e-08
Ashkenazi O 0 0.1606011986732483
Jewish O 1 0.9994377493858337
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.9368538889684714e-06

The O 0 2.7555531190159854e-08
estimated O 0 1.7675816366136132e-08
relative O 0 9.629810193700905e-08
risk O 0 1.219603745994391e-06
for O 0 1.0175619236107991e-09
carriers O 0 4.850132029332599e-08
may O 0 2.386460362657772e-09
justify O 0 4.356135896443902e-09
specific O 0 1.0235358116617022e-09
clinical O 0 5.021031146412724e-09
screening O 0 1.2791795400701744e-09
for O 0 2.5370592779405676e-11
the O 0 1.8106972518583397e-11
360 O 0 3.103601542431278e-10
, O 0 4.463936165155502e-11
000 O 0 5.62360658040717e-10
Americans O 0 1.2213094979784955e-09
expected O 0 4.441940981703141e-10
to O 0 2.5911439660575297e-10
harbor O 0 6.289116338820122e-09
this O 0 3.2706729685694214e-11
allele O 0 5.521869628211107e-09
, O 0 2.174346674932437e-10
and O 0 1.0537300892954349e-10
genetic O 0 6.601254209925855e-09
testing O 0 6.978753575026531e-09
in O 0 5.2749124512807555e-11
the O 0 3.8627354786990864e-11
setting O 0 4.83622475400125e-10
of O 0 3.858847616444727e-11
long O 0 3.385227387298073e-08
- O 0 1.9899055132555077e-06
term O 0 1.2906591564387782e-06
- O 0 1.9681115759340173e-07
outcome O 0 6.719266032462201e-09
studies O 0 2.7095314880654087e-09
may O 0 8.707287668663355e-10
impact O 0 2.30611174600881e-09
significantly O 0 7.47478452467476e-08
on O 0 0.20431293547153473
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 5.979912742759552e-08
in O 0 4.329883118714406e-10
this O 0 7.68589913935358e-10
population O 0 4.6910653139775604e-08
. O 0 1.5008831155682856e-07

Localization O 0 4.73893123853486e-06
of O 0 4.898622840698863e-09
human O 0 6.14449557900798e-09
BRCA1 O 0 4.4351472183734586e-07
and O 0 3.053843400380174e-09
its O 0 1.2117266079414435e-09
loss O 0 1.2847335995047615e-07
in O 0 1.8007833002542384e-09
high O 0 1.3397267366599408e-06
- O 0 0.0019782634917646646
grade O 0 1.5131412510527298e-05
, O 0 2.818724809117157e-09
non B-Disease 0 3.7195984532445436e-06
- I-Disease 0 0.043582506477832794
inherited I-Disease 1 0.9917762279510498
breast I-Disease 1 0.9998636245727539
carcinomas I-Disease 1 1.0
. O 0 6.8959907366661355e-06

Although O 0 1.981978243748017e-07
the O 0 1.5026031530140926e-09
link O 0 6.166582267042031e-08
between O 0 5.1463402428453264e-09
the O 0 1.4525924463271167e-08
BRCA1 O 0 0.001494505675509572
tumour B-Disease 1 1.0
- O 0 5.123179107613396e-06
suppressor O 0 2.6051468466903316e-06
gene O 0 1.6745873381296406e-06
and O 0 3.0594773647862894e-07
hereditary B-Disease 1 0.9998911619186401
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 4.277677767561272e-09
established O 0 1.3507168716841988e-09
, O 0 1.2210386868272138e-10
the O 0 3.5724399133352236e-11
role O 0 3.615409083224108e-09
, O 0 1.0321041937766395e-10
if O 0 3.970399842234684e-10
any O 0 2.8041216570962035e-10
, O 0 8.123545586213865e-11
of O 0 7.083077180336517e-11
BRCA1 O 0 5.89746434798144e-07
in O 0 2.0504851150349168e-08
non B-Disease 0 0.35682281851768494
- I-Disease 1 0.999861478805542
familial I-Disease 1 0.9999557733535767
cancers I-Disease 1 0.9999970197677612
is O 0 9.49461025356868e-08
unclear O 0 1.5273111557689845e-06
. O 0 5.316961733115022e-07

BRCA1 O 0 0.0008567663608118892
mutations O 0 2.4184369976865128e-05
are O 0 1.180834452441104e-08
rare O 0 1.1929776277952442e-08
in O 0 6.54908305364188e-09
sporadic B-Disease 0 8.623526809969917e-05
cancers I-Disease 1 0.9999946355819702
, O 0 5.529289470729282e-09
but O 0 2.653995778700846e-08
loss O 0 5.331687091825188e-08
of O 0 3.233951439973737e-10
BRCA1 O 0 1.2344955848675454e-06
resulting O 0 2.1425996976631723e-08
from O 0 1.942244587382902e-09
reduced O 0 1.807335792136655e-08
expression O 0 1.6709577721485402e-08
or O 0 1.193920073916388e-08
incorrect O 0 7.491512121760024e-08
subcellular O 0 3.3205878935405053e-07
localization O 0 5.28192742876854e-08
is O 0 2.4715390845031493e-10
postulated O 0 1.3891348071837228e-09
to O 0 5.309879619330715e-11
be O 0 2.4979733559415962e-11
important O 0 1.0250299220526671e-10
in O 0 7.233936227812876e-10
non B-Disease 0 3.7509278172365157e-06
- I-Disease 0 0.005118568427860737
familial I-Disease 1 0.9988853335380554
breast I-Disease 1 0.9999992847442627
and I-Disease 1 0.9999959468841553
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.8206304705236107e-06

Epigenetic O 0 4.665948654292151e-05
loss O 0 4.155720671406016e-05
, O 0 4.4280872302238095e-09
however O 0 9.76552949616405e-10
, O 0 2.3519264313875965e-10
has O 0 3.990777708295923e-10
not O 0 2.1720091003540887e-10
received O 0 1.3291946709959035e-10
general O 0 1.1934497834431568e-10
acceptance O 0 8.312930788179074e-09
due O 0 4.5391348457712866e-09
to O 0 2.545222643757228e-10
controversy O 0 3.915682000865672e-09
regarding O 0 2.156933298635977e-09
the O 0 4.938604525328572e-10
subcellular O 0 2.8152024356131733e-07
localization O 0 6.410543562651583e-08
of O 0 2.1455827392546922e-10
BRCA1 O 0 5.2902759506423536e-08
proteins O 0 6.734428570354112e-10
, O 0 1.0435256825314099e-10
reports O 0 3.165454565134951e-10
of O 0 7.3514770659866e-12
which O 0 7.088514220043862e-10
have O 0 3.742501586412317e-10
ranged O 0 8.786248950620745e-10
from O 0 1.1905214314378298e-10
exclusively O 0 2.002713550552926e-09
nuclear O 0 4.977979983777914e-07
, O 0 1.0437366942950277e-10
to O 0 9.264118638885321e-11
conditionally O 0 3.7292018362222734e-08
nuclear O 0 5.422707971547425e-08
, O 0 8.142626156670829e-11
to O 0 9.374000187190035e-11
the O 0 4.2320508208959495e-10
ER O 0 6.459134169745084e-07
/ O 0 2.9635089049406815e-08
golgi O 0 1.5913103368347947e-07
, O 0 5.650798162726289e-10
to O 0 7.679026858831151e-10
cytoplasmic O 0 9.83010508548432e-08
invaginations O 0 1.0097392078023404e-06
into O 0 7.642822374975822e-09
the O 0 7.0049455125342774e-09
nucleus O 0 3.181225451953651e-07
. O 0 1.3582787516952521e-07

In O 0 3.288204553086871e-08
an O 0 4.422227029010628e-10
attempt O 0 1.0535804229050427e-08
to O 0 8.490833591778824e-10
resolve O 0 8.235852000382238e-09
this O 0 3.916663868230863e-11
issue O 0 6.007366826210614e-10
, O 0 7.871327895037084e-11
we O 0 3.396788406107021e-10
have O 0 2.023330530898093e-10
comprehensively O 0 4.226037830790119e-08
characterized O 0 1.2136424309971972e-08
19 O 0 1.072994582074216e-08
anti O 0 2.2040329383798962e-07
- O 0 4.639032340492122e-06
BRCA1 O 0 2.690933433768805e-05
antibodies O 0 3.3922713100764668e-06
. O 0 3.909594852302689e-07

These O 0 5.9478470149088025e-08
reagents O 0 4.87427712414501e-07
detect O 0 2.0403222151799127e-06
a O 0 5.950033798995946e-09
220 O 0 2.445670332917871e-08
- O 0 3.452265673331567e-07
kD O 0 1.9463529952190584e-06
protein O 0 3.606897891472727e-08
localized O 0 4.827428412568224e-08
in O 0 8.211237800814786e-10
discrete O 0 7.956791137075925e-08
nuclear O 0 7.453243711097457e-07
foci O 0 1.2367043211725104e-07
in O 0 1.6162604588032536e-09
all O 0 7.79210251877771e-10
epithelial O 0 2.0731404148932597e-08
cell O 0 1.4209790322183835e-07
lines O 0 1.8561148351636803e-07
, O 0 2.4167740031444396e-10
including O 0 6.813365843738595e-11
those O 0 1.8623802500172815e-10
derived O 0 6.925025441972821e-09
from O 0 1.293449258810142e-08
breast B-Disease 0 0.12343508750200272
malignancies I-Disease 0 0.04500548914074898
. O 0 1.0536406307437574e-06

Immunohistochemical O 0 0.0034269222524017096
staining O 0 0.00086146843386814
of O 0 1.5791126628528218e-08
human O 0 4.623510818646537e-08
breast O 0 1.4333280887512956e-05
specimens O 0 1.6075398434622912e-07
also O 0 2.7595188356599465e-08
revealed O 0 9.088809633794881e-07
BRCA1 O 0 1.3290562492329627e-05
nuclear O 0 8.032405389712949e-07
foci O 0 9.172489399134065e-07
in O 0 1.0136474770661152e-08
benign O 0 1.7984119040193036e-05
breast O 0 0.0033472946379333735
, O 0 8.168880327730221e-08
invasive B-Disease 0 0.0063444324769079685
lobular I-Disease 1 0.999916672706604
cancers I-Disease 1 0.9999990463256836
and O 0 1.0008041044784477e-06
low B-Disease 0 0.056221362203359604
- I-Disease 1 0.9970760345458984
grade I-Disease 0 0.09924754500389099
ductal I-Disease 1 0.7989418506622314
carcinomas I-Disease 1 1.0
. O 0 2.1214140360825695e-05

Conversely O 0 1.835423245211132e-05
, O 0 8.94314240440508e-08
BRCA1 O 0 2.6362529297330184e-06
expression O 0 8.134612272669983e-08
was O 0 5.5561450551522285e-08
reduced O 0 1.0021688368055948e-08
or O 0 5.472381658933045e-09
undetectable O 0 2.8119933404013864e-07
in O 0 2.075282862223915e-10
the O 0 3.905148426852634e-10
majority O 0 1.1660626242360195e-08
of O 0 5.134336844569987e-10
high O 0 2.749297345872037e-05
- O 0 0.007707578130066395
grade O 0 2.4281164314743364e-06
, O 0 2.70228550647289e-09
ductal B-Disease 0 7.717974767729174e-06
carcinomas I-Disease 1 1.0
, O 0 2.6539235253864035e-09
suggesting O 0 2.1157640972546687e-08
that O 0 3.92884669242477e-10
absence O 0 1.9810280083021325e-09
of O 0 1.9458551436812854e-10
BRCA1 O 0 3.4009482874353125e-07
may O 0 7.585182260072543e-09
contribute O 0 2.2575757929743645e-10
to O 0 6.726440238136178e-11
the O 0 4.7815834625097864e-11
pathogenesis O 0 1.894283840897515e-09
of O 0 1.4129158780462614e-11
a O 0 1.5734469283046337e-10
significant O 0 5.328085084244094e-09
percentage O 0 2.2014430101080507e-07
of O 0 2.689902744990036e-09
sporadic B-Disease 0 0.2422846108675003
breast I-Disease 1 0.9999991655349731
cancers I-Disease 1 0.9999912977218628
. O 0 1.3555198563608428e-07
. O 0 2.826894842655747e-07

